data_1egr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1egr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 108.285 -1.006 . . . . 3.46 108.285 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -106.76 102.78 12.13 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.744 0.783 . . . . 5.7000000000000002 111.761 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.3 m -94.22 129.77 40.71 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.348 -1.353 . . . . 1.75 107.348 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.67 134.71 62.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.034 -1.066 . . . . 2.0600000000000001 110.318 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.3 mp -107.55 121.51 60.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.789 -2.3 . . . . 2.3599999999999999 104.789 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -114.99 91.13 3.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 102.977 -2.972 . . . . 2.5299999999999998 102.977 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.627 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -128.05 -167.34 12.23 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 118.535 -1.793 . . . . 1.78 114.375 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.96 95.2 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.838 -1.181 . . . . 6.2199999999999998 110.717 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.409 ' OG ' ' NH1' ' A' ' 8' ' ' ARG . 2.9 p -53.36 144.27 16.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.94 -1.133 . . . . 5.6600000000000001 107.94 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.9 -36.0 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.082 -2.407 . . . . 3.2999999999999998 107.082 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -97.78 133.71 23.13 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.205 -1.035 . . . . 4.3099999999999996 108.205 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.77 51.27 0.89 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.455 2.103 . . . . 3.48 111.488 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.89 -64.33 1.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.048 -1.093 . . . . 4.5199999999999996 108.048 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.627 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -54.98 -29.91 58.04 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 115.149 -0.932 . . . . 2.4300000000000002 108.902 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.1 t -42.79 -44.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.367 -1.288 . . . . 2.3399999999999999 109.914 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 4.4 mmp_? -63.44 -52.03 63.21 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.087 -1.045 . . . . 3.6499999999999999 111.008 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 62' ' ' ILE . . . -59.62 -45.06 93.05 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.468 -0.893 . . . . 1.5700000000000001 110.572 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 7.3 ttpp -61.25 -52.12 66.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.172 -1.011 . . . . 2.9300000000000002 108.851 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -53.65 -53.66 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.252 -0.579 . . . . 2.3599999999999999 109.848 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.52 -65.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.344 -0.942 . . . . 2.25 109.038 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.55 -46.47 19.38 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.987 -0.685 . . . . 1.8899999999999999 110.411 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.478 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 43.8 tt0 -58.77 -54.17 50.08 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.251 1.024 . . . . 2.1400000000000001 111.38 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.64 ' CA ' ' HZ1' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -54.49 -50.36 67.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 113.694 -1.594 . . . . 7.79 106.822 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -53.38 -50.81 64.33 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.261 -1.385 . . . . 2.1299999999999999 107.261 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 7.6 t -43.78 -24.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.433 -0.803 . . . . 1.49 112.507 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.09 -31.29 8.34 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.439 -0.801 . . . . 2.9700000000000002 110.864 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.52 -36.47 73.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.088 . . . . 3.8500000000000001 108.061 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -119.03 117.31 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.477 0.656 . . . . 4.5499999999999998 109.597 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -63.88 3.68 0.36 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.956 1.095 . . . . 3.7999999999999998 113.956 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 1' ' ' MET . 11.4 p-10 -114.67 7.61 16.02 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.058 -0.719 . . . . 3.0899999999999999 109.058 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.448 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 12.6 t80 -109.35 129.65 55.52 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.866 -0.734 . . . . 1.3700000000000001 112.855 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -129.56 150.85 50.71 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.627 -1.62 . . . . 4.6200000000000001 106.627 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.478 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 8.4 p90 -133.89 160.06 38.8 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.316 -1.354 . . . . 1.1699999999999999 110.821 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -134.07 135.38 43.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.73 0.644 . . . . 5.2199999999999998 110.342 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -108.08 109.84 21.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.003 -1.851 . . . . 2.4900000000000002 106.003 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.24 141.4 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.379 -1.711 . . . . 2.7999999999999998 106.379 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 9.0 t70 -110.17 155.05 22.47 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.074 -1.05 . . . . 2.7799999999999998 110.844 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 pt -84.16 -34.87 10.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 117.993 -1.483 . . . . 2.6000000000000001 112.435 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.467 ' HE ' ' N ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -98.24 -58.01 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.321 -1.752 . . . . 6.2199999999999998 108.845 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.467 ' N ' ' HE ' ' A' ' 39' ' ' ARG . . . -39.09 -39.91 0.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 124.198 0.936 . . . . 3.8900000000000001 111.255 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.48 -36.38 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.071 -1.451 . . . . 4.6399999999999997 110.862 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.23 69.77 0.61 Allowed Glycine 0 N--CA 1.5 2.948 0 C-N-CA 118.448 -1.834 . . . . 2.5499999999999998 113.128 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 mm -115.04 157.18 15.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.148 -1.797 . . . . 3.6400000000000001 106.148 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.7 p -107.39 137.14 45.98 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.69 -1.204 . . . . 3.6499999999999999 110.454 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -55.04 -31.39 61.06 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.716 -1.216 . . . . 4.4299999999999997 107.716 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 7.1 mp0 -59.42 -64.94 0.76 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.209 -0.663 . . . . 3.46 109.209 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 4.6 t70 -48.1 -49.45 31.82 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.069 0.938 . . . . 2.9700000000000002 111.185 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.2 mt -61.8 -54.46 42.03 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.606 -1.179 . . . . 3.4199999999999999 109.295 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -44.44 -46.12 9.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.837 -1.171 . . . . 4.3600000000000003 107.837 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 8.5 tm0? -60.13 -58.89 6.58 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.781 -1.554 . . . . 5.46 110.974 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -17.89 63.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.141 1.534 . . . . 3.8700000000000001 115.141 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.68 -38.28 13.19 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.736 -0.786 . . . . 2.5800000000000001 111.143 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.46 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . . . 112.94 57.82 0.42 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.274 -1.93 . . . . 2.8100000000000001 108.274 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 37.2 76.03 0.49 Allowed Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 124.954 1.032 . . . . 7.6699999999999999 111.651 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 1.8 Cg_endo -90.35 33.79 0.33 Allowed 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 122.821 2.348 . . . . 7.7800000000000002 111.103 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.421 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.4 t 32.06 -102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 113.685 -1.598 . . . . 7.4100000000000001 113.826 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.471 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 7.6 tp10 -125.04 46.11 2.41 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.579 -0.448 . . . . 8.0099999999999998 110.216 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.0 p -119.44 124.36 46.32 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.285 1.217 . . . . 5.6100000000000003 114.285 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 33.1 m -132.93 166.11 31.69 Favored Pre-proline 0 N--CA 1.504 2.238 0 N-CA-C 107.27 -1.381 . . . . 3.4199999999999999 107.27 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 50.9 Cg_endo -79.61 170.72 66.53 Favored 'Cis proline' 0 N--CA 1.491 1.35 0 O-C-N 122.19 0.574 . . . . 1.95 110.886 -7.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.54 150.57 50.13 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.786 -0.766 . . . . 3.0699999999999998 111.109 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 17' ' ' ALA . 36.9 mm -119.69 141.45 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.039 -0.982 . . . . 3.1099999999999999 110.295 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -120.69 153.85 36.36 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.69 -1.141 . . . . 1.6899999999999999 109.162 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 66' ' ' GLN . 85.9 t -129.83 100.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.06 -1.459 . . . . 1.8100000000000001 107.06 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 54.93 -79.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 124.409 1.068 . . . . 2.5800000000000001 112.721 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 64' ' ' VAL . 1.4 tm0? -120.53 -24.78 5.72 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.518 -1.219 . . . . 7.4400000000000004 112.666 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -95.18 155.18 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.355 -0.938 . . . . 4.6200000000000001 111.705 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -102.36 140.03 37.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 105.341 -2.096 . . . . 1.1699999999999999 105.341 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.52 -42.3 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 118.11 -1.436 . . . . 2.04 110.793 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.0 -129.51 5.14 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.463 -1.455 . . . . 1.1200000000000001 109.463 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.4 178.65 25.43 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.679 -1.248 . . . . 1.29 110.424 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.533 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 45.7 t80 -45.45 -36.03 4.15 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.311 -0.956 . . . . 2.46 111.422 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -58.94 -62.06 2.17 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.602 -0.839 . . . . 2.0499999999999998 109.426 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.26 -39.99 64.3 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.895 -1.048 . . . . 2.21 109.109 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.82 -56.37 22.02 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.199 -1.0 . . . . 1.73 109.683 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.0 -51.12 64.95 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.86 -0.736 . . . . 1.8500000000000001 110.054 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -53.81 54.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.833 -0.747 . . . . 1.8 109.465 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -48.05 -53.29 16.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.44 -0.948 . . . . 1.05 108.44 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.9 -61.18 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 114.648 -1.16 . . . . 1.75 109.185 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.48 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.14 -51.94 7.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.739 0.649 . . . . 3.0099999999999998 112.581 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.85 16.28 7.12 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.664 -1.214 . . . . 4.7300000000000004 113.845 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -128.28 -43.98 1.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.61 -0.836 . . . . 2.1499999999999999 110.393 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.07 36.51 2.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.867 -0.733 . . . . 2.4500000000000002 110.722 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.48 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 2.3 t70 . . . . . 0 C--N 1.292 -1.922 0 N-CA-C 106.181 -1.785 . . . . 4.1699999999999999 106.181 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.522 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.66 -0.867 . . . . 3.0499999999999998 108.66 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -84.89 111.57 19.78 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.262 0.977 . . . . 5.8600000000000003 109.583 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.9 m -104.12 123.39 47.18 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 1.75 109.208 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.13 130.89 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.347 -0.941 . . . . 1.95 109.928 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.419 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 1.3 mp -106.12 131.9 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.974 -1.862 . . . . 2.23 105.974 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -117.42 108.57 15.72 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 105.563 -2.014 . . . . 2.0 105.563 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.64 -160.07 8.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.505 -1.331 . . . . 1.6000000000000001 110.381 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -113.62 -162.04 0.79 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.222 -0.991 . . . . 5.6299999999999999 108.732 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -128.89 154.54 46.4 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.49 -1.232 . . . . 5.6699999999999999 109.452 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 -44.83 1.37 Allowed Glycine 0 N--CA 1.5 2.908 0 C-N-CA 119.386 -1.388 . . . . 3.8500000000000001 114.229 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.5 m -106.33 146.89 33.89 Favored Pre-proline 0 N--CA 1.498 1.936 0 C-N-CA 118.694 -1.202 . . . . 4.1600000000000001 111.944 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.49 65.61 8.2 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.41 2.073 . . . . 3.46 111.276 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -112.92 -73.54 0.66 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.655 -1.239 . . . . 4.9699999999999998 107.655 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.0 m -53.53 -25.15 15.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.356 -0.979 . . . . 2.71 108.356 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -41.65 -39.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 114.624 -1.171 . . . . 2.4300000000000002 109.779 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.58 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 1.1 tpm_? -75.83 -50.24 15.71 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.15 -1.02 . . . . 4.5800000000000001 110.255 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.69 54.17 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.758 -1.177 . . . . 1.97 108.321 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 14.6 ttpp -67.59 -58.38 4.8 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 107.448 -1.315 . . . . 2.9700000000000002 107.448 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.415 ' CG ' HH21 ' A' ' 16' ' ' ARG . 2.5 t70 -45.04 -42.93 8.95 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.539 -0.864 . . . . 2.3900000000000001 109.696 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.9 tp -62.62 -63.73 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.668 -1.151 . . . . 2.2200000000000002 108.275 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.84 -45.9 15.29 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.444 0.64 . . . . 1.45 109.833 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 26.7 tt0 -64.57 -44.28 91.2 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.6 -1.182 . . . . 2.8300000000000001 109.583 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.495 ' CB ' ' HZ1' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -57.32 -54.7 43.79 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.872 -1.529 . . . . 7.2800000000000002 106.872 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.27 -45.53 68.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.761 -1.563 . . . . 2.1000000000000001 107.691 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 32' ' ' GLN . 8.3 t -54.9 -25.82 31.62 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.979 -1.009 . . . . 1.3799999999999999 111.447 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.422 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.1 t30 -105.63 9.83 33.13 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.888 -0.782 . . . . 2.1800000000000002 108.888 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -117.65 -32.73 4.77 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 115.985 -0.552 . . . . 3.2599999999999998 110.53 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.44 153.59 24.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.819 -0.808 . . . . 5.29 108.819 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.71 -26.59 25.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.865 -0.607 . . . . 4.2800000000000002 110.565 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.51 13.67 29.14 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.694 -0.802 . . . . 2.7400000000000002 110.471 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -112.47 124.79 53.29 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.297 1.591 . . . . 1.6100000000000001 115.297 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.403 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 63.4 mt-30 -143.02 156.54 44.86 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.397 -2.075 . . . . 3.8999999999999999 105.397 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -142.3 170.9 14.83 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 117.71 -1.596 . . . . 1.4099999999999999 111.77 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -138.17 145.21 41.24 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.654 -1.612 . . . . 5.3499999999999996 109.112 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -122.5 122.76 39.7 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.944 -1.873 . . . . 2.5800000000000001 105.944 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.71 137.41 54.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.651 -1.241 . . . . 2.23 107.651 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.69 129.83 47.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.034 -1.099 . . . . 2.3100000000000001 108.034 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.51 -28.9 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 119.935 -0.706 . . . . 3.1600000000000001 111.005 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.578 ' NH1' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -79.79 -40.52 28.49 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.588 -1.264 . . . . 7.96 107.588 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.578 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -39.17 -54.18 1.8 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 120.962 -0.295 . . . . 1.9299999999999999 110.727 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' GLY . 48.9 mt-10 -110.79 41.42 1.8 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 124.502 1.126 . . . . 4.2000000000000002 109.95 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 20.1 66.17 0.01 OUTLIER Glycine 0 N--CA 1.508 3.48 0 O-C-N 124.205 0.94 . . . . 2.6200000000000001 113.31 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 44' ' ' THR . 48.4 mt -93.4 162.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.863 -0.735 . . . . 2.8199999999999998 109.807 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.43 ' N ' HG23 ' A' ' 43' ' ' ILE . 45.9 p -113.12 178.38 4.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.798 -0.637 . . . . 2.79 109.925 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -73.55 -52.86 12.07 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.607 -1.237 . . . . 7.3700000000000001 109.864 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.4 mp0 -43.3 -52.67 5.65 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.339 -0.544 . . . . 3.8799999999999999 110.162 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.541 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 4.1 t70 -51.57 -57.36 9.32 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.06 -0.656 . . . . 2.4700000000000002 110.3 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mt -53.51 -46.05 69.93 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 115.02 -0.991 . . . . 2.2599999999999998 110.245 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -47.07 -54.78 9.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.47 -0.937 . . . . 3.6600000000000001 108.47 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -49.23 -29.85 6.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.215 1.572 . . . . 4.7300000000000004 111.285 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.541 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 10.8 mptt -82.54 -47.36 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.127 -0.942 . . . . 3.2799999999999998 112.311 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' HB1' ' NE2' ' A' ' 61' ' ' GLN . . . -75.27 -45.96 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.628 1.344 . . . . 1.8100000000000001 114.628 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.63 -42.65 1.91 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 107.295 -2.322 . . . . 2.3999999999999999 107.295 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 10.8 ptmm? -84.18 169.53 16.64 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 106.696 -1.594 . . . . 7.8099999999999996 106.696 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.509 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 13.0 Cg_endo -56.04 163.53 5.9 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.942 -1.215 . . . . 4.8499999999999996 108.942 161.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -124.0 38.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.93 -1.108 . . . . 6.4000000000000004 109.762 179.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -26.14 -64.06 0.07 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.257 -1.338 . . . . 5.1600000000000001 111.163 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -116.79 -154.5 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.122 -0.944 . . . . 4.9299999999999997 109.763 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.44 175.76 3.25 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.068 -1.086 . . . . 2.9399999999999999 108.068 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.446 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 71.6 Cg_endo -103.6 -170.71 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.112 0 O-C-N 122.406 0.687 . . . . 1.99 111.672 -18.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.525 ' NE2' ' HB1' ' A' ' 52' ' ' ALA . 13.6 mt-30 -141.94 151.79 42.91 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 115.686 -0.688 . . . . 3.3900000000000001 110.716 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.492 ' N ' HD13 ' A' ' 62' ' ' ILE . 3.9 mp -124.79 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 115.527 -0.76 . . . . 2.8500000000000001 109.286 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 16.8 m-85 -127.27 150.74 49.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.19 -1.368 . . . . 1.28 109.894 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.5 t -120.5 125.32 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.055 -1.461 . . . . 1.8200000000000001 107.055 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 11.1 t70 57.41 -94.76 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.775 -1.194 . . . . 4.4699999999999998 107.775 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -131.99 2.47 3.99 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.389 -0.823 . . . . 4.5999999999999996 110.938 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.448 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 1.4 mt-30 -97.09 167.31 11.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 110.018 -0.364 . . . . 5.1900000000000004 110.018 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 15.0 t-160 -108.28 139.53 42.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.587 -1.264 . . . . 1.05 107.587 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.7 mm -101.73 -42.89 9.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.075 -1.05 . . . . 2.1600000000000001 108.55 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.52 -132.43 5.45 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.07 -2.012 . . . . 1.3400000000000001 108.07 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 72' ' ' TYR . . . -114.74 -175.22 18.59 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.054 -1.218 . . . . 1.3100000000000001 110.054 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.47 ' OH ' ' HG2' ' A' ' 16' ' ' ARG . 1.8 t80 -33.03 -54.42 0.38 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.405 0.622 . . . . 3.25 111.194 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.98 -68.77 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.562 -1.199 . . . . 2.3700000000000001 110.939 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -51.1 -38.94 54.79 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.696 -1.593 . . . . 2.4100000000000001 110.846 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -64.99 -51.71 60.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.833 -1.147 . . . . 1.0900000000000001 109.903 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.12 76.18 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.185 -1.006 . . . . 1.98 109.6 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.02 -58.99 5.45 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.102 -1.039 . . . . 1.8300000000000001 109.109 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -42.58 -51.01 5.3 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.196 -1.039 . . . . 0.84999999999999998 108.196 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -52.66 -65.58 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.296 0 N-CA-C 107.857 -1.164 . . . . 2.1600000000000001 107.857 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.518 ' HZ2' ' CG ' ' A' ' 84' ' ' ASP . 22.1 tptp -49.25 -29.48 5.84 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.507 1.299 . . . . 3.3799999999999999 114.507 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -105.82 7.64 32.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.231 0.826 . . . . 4.0599999999999996 113.231 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -129.05 -35.54 1.83 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.01 -0.676 . . . . 1.5600000000000001 110.378 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -106.35 26.02 10.37 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.131 -0.628 . . . . 2.2000000000000002 109.872 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.518 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 5.3 t70 . . . . . 0 C--N 1.299 -1.603 0 N-CA-C 108.548 -0.908 . . . . 3.8700000000000001 108.548 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.448 ' N ' ' O ' ' A' ' 30' ' ' ASP . 47.5 mtm . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.531 -0.914 . . . . 3.5800000000000001 108.531 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.07 155.13 20.72 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 123.833 0.708 . . . . 4.9400000000000004 109.107 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 m -143.74 143.7 31.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.021 -1.103 . . . . 2.8999999999999999 108.021 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.0 t -127.84 126.61 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 119.033 -1.067 . . . . 2.3199999999999998 112.526 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.34 130.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.787 -1.19 . . . . 2.0099999999999998 107.787 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -111.02 111.67 22.94 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 105.006 -2.22 . . . . 2.2400000000000002 105.006 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.651 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -129.09 -143.82 5.6 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.536 -1.316 . . . . 2.2200000000000002 112.8 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.32 -167.27 1.83 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 114.404 -0.898 . . . . 7.2000000000000002 109.969 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m -86.53 64.25 8.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.096 -0.642 . . . . 5.8499999999999996 111.428 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.63 53.83 1.1 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.504 -1.332 . . . . 4.0499999999999998 109.78 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' TYR . 49.4 t -107.31 98.03 21.33 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.568 -1.271 . . . . 4.8099999999999996 107.568 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.43 -20.76 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.264 2.642 . . . . 3.7400000000000002 113.699 -159.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' CYS . 30.1 m-85 -71.62 -30.92 66.32 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.325 -0.55 . . . . 5.1900000000000004 112.099 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -83.8 -30.41 26.59 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.7 -1.6 . . . . 2.4700000000000002 106.811 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -50.05 -49.85 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 115.483 -0.78 . . . . 2.1200000000000001 109.344 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.573 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 3.9 mmp_? -58.59 -52.47 65.54 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.38 -0.928 . . . . 3.8799999999999999 111.047 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.92 63.44 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.261 -1.375 . . . . 1.4299999999999999 107.729 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -49.19 -58.8 4.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 124.42 1.075 . . . . 3.5699999999999998 109.265 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.74 -52.19 50.45 Favored 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 120.025 -0.67 . . . . 2.6299999999999999 110.952 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 tp -52.5 -63.86 1.0 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.078 -0.712 . . . . 2.04 109.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.76 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.059 -0.719 . . . . 1.51 109.059 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.2 tt0 -55.36 -42.01 73.34 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.129 -0.941 . . . . 2.6299999999999999 110.273 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.636 ' CA ' ' HZ1' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -64.13 -54.63 30.87 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.036 -1.066 . . . . 6.7199999999999998 108.339 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 43.1 mt -49.1 -47.55 45.13 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.124 -2.176 . . . . 2.1200000000000001 105.124 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.19 -47.77 24.03 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.943 -1.026 . . . . 1.3899999999999999 110.831 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.22 -35.24 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.656 -0.818 . . . . 2.96 112.154 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -72.3 -36.55 68.97 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.084 -0.646 . . . . 4.2400000000000002 111.323 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.533 HH21 ' CG ' ' A' ' 30' ' ' ASP . 10.9 ptm85 -136.49 113.59 10.56 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.683 -0.807 . . . . 4.4699999999999998 111.559 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -62.17 12.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 114.572 1.323 . . . . 4.7000000000000002 114.572 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.533 ' CG ' HH21 ' A' ' 28' ' ' ARG . 10.1 p-10 -111.65 -1.88 15.57 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.066 -0.716 . . . . 3.6400000000000001 109.066 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.495 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 91.4 t80 -109.65 116.81 32.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.637 -0.825 . . . . 1.6499999999999999 110.352 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -121.73 167.81 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.148 -0.686 . . . . 4.0199999999999996 109.148 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 30.1 p90 -161.55 168.78 22.96 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.091 -0.644 . . . . 1.75 110.21 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 152.09 41.11 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 109.599 -0.519 . . . . 6.2599999999999998 109.599 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -118.44 135.7 54.21 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.306 -0.958 . . . . 2.1000000000000001 109.284 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -127.8 159.33 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.401 -0.963 . . . . 2.4199999999999999 108.401 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -113.71 129.11 56.62 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.698 -1.964 . . . . 2.5299999999999998 105.698 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -43.67 -26.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.393 -0.523 . . . . 3.27 111.585 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -73.0 -59.44 2.7 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 120.469 -0.492 . . . . 8.1099999999999994 109.993 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.32 -47.15 0.4 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.467 1.105 . . . . 2.4500000000000002 111.202 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.82 -45.68 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.511 -1.222 . . . . 4.2699999999999996 110.813 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.49 49.45 0.8 Allowed Glycine 0 N--CA 1.505 3.268 0 N-CA-C 109.417 -1.473 . . . . 2.79 109.417 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.429 HG22 ' HG ' ' A' ' 48' ' ' LEU . 15.9 mt -113.19 148.51 16.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.064 -0.568 . . . . 3.79 111.015 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.6 p -118.7 -92.77 0.53 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.01 -1.076 . . . . 5.9100000000000001 110.113 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.428 ' NZ ' ' OE1' ' A' ' 46' ' ' GLU . 11.4 tttm -138.45 -55.16 0.63 Allowed 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.652 -1.24 . . . . 5.1799999999999997 107.652 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.8 mm-40 -43.24 -50.43 6.48 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.367 -0.933 . . . . 5.5199999999999996 110.92 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.433 ' OD2' ' NZ ' ' A' ' 51' ' ' LYS . 33.3 t70 -63.31 -54.74 32.34 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.35 -0.94 . . . . 3.27 111.195 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HG ' HG22 ' A' ' 43' ' ' ILE . 6.1 mt -53.52 -43.86 68.69 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.698 -0.801 . . . . 2.73 110.025 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.83 -53.76 54.57 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.495 -1.298 . . . . 4.6500000000000004 107.495 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -53.11 -58.11 8.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 124.188 0.93 . . . . 5.29 110.367 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' NZ ' ' OD2' ' A' ' 47' ' ' ASP . 48.0 mttp -54.0 -50.23 67.09 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.166 -0.925 . . . . 3.8300000000000001 111.367 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' HA ' ' CG ' ' A' ' 68' ' ' HIS . . . -54.45 -55.94 23.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.723 -1.581 . . . . 2.3999999999999999 111.418 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.04 36.44 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.271 -1.532 . . . . 3.1200000000000001 109.271 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -102.79 161.35 23.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.164 -0.68 . . . . 8.5399999999999991 109.164 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.32 111.21 3.23 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.784 1.656 . . . . 5.4100000000000001 111.451 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.02 159.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 123.335 0.397 . . . . 7.1100000000000003 110.082 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -133.65 -43.08 0.83 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 123.511 0.507 . . . . 6.5700000000000003 111.957 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.437 ' HG1' ' HG2' ' A' ' 57' ' ' GLU . 1.2 m -114.54 -148.31 0.43 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.651 -0.82 . . . . 6.0300000000000002 109.696 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.81 173.6 2.9 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 109.576 -0.527 . . . . 3.52 109.576 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 73.9 Cg_endo -100.03 -177.68 4.0 Favored 'Cis proline' 0 N--CA 1.483 0.874 0 O-C-N 122.348 0.657 . . . . 2.02 111.319 -11.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.46 145.01 48.44 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.445 -0.798 . . . . 2.79 111.025 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.528 HG22 ' CD1' ' A' ' 75' ' ' PHE . 4.3 mp -124.77 145.78 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 115.171 -0.922 . . . . 2.9399999999999999 110.863 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.72 160.99 33.88 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.084 -1.871 . . . . 1.3799999999999999 108.539 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.47 HG22 ' CG1' ' A' ' 69' ' ' ILE . 60.6 t -112.4 175.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.827 -1.916 . . . . 2.3799999999999999 105.827 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' HG13 ' A' ' 64' ' ' VAL . 38.8 t70 -61.35 -8.84 4.31 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.991 -1.084 . . . . 3.71 111.014 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -122.95 -56.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.459 1.281 . . . . 7.9800000000000004 114.459 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.56 176.02 5.91 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.816 -0.753 . . . . 8.1699999999999999 112.641 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.511 ' CG ' ' HA ' ' A' ' 52' ' ' ALA . 13.2 t-80 -93.05 154.56 18.04 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.483 -2.043 . . . . 1.3300000000000001 105.483 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.47 ' CG1' HG22 ' A' ' 64' ' ' VAL . 37.0 mm -115.07 -49.13 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.379 -1.328 . . . . 2.29 111.291 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.453 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 145.49 -130.99 4.0 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 1.1799999999999999 109.708 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.84 -173.39 20.63 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.248 -1.141 . . . . 1.2 110.248 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.91 -52.34 1.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 120.163 -0.615 . . . . 2.52 110.746 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -50.47 -58.76 5.0 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.843 0.83 . . . . 2.02 110.106 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.408 ' HB3' HG23 ' A' ' 69' ' ' ILE . 1.7 m-20 -54.33 -54.31 42.1 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.792 -1.095 . . . . 2.71 110.126 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CD1' HG22 ' A' ' 62' ' ' ILE . 25.7 t80 -54.2 -52.34 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.778 -0.769 . . . . 1.26 110.997 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.61 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.625 -0.83 . . . . 2.4700000000000002 109.014 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.07 -55.85 28.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.376 -0.929 . . . . 2.3900000000000001 110.021 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -49.71 -51.84 35.7 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.705 -0.798 . . . . 1.3600000000000001 109.346 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.0 t -49.73 -63.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 124.131 0.894 . . . . 2.04 108.706 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -44.63 -48.48 10.47 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.03 -0.986 . . . . 3.1800000000000002 111.154 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.57 27.55 2.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 117.567 -1.653 . . . . 3.7999999999999998 113.987 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.68 -41.79 0.28 Allowed 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 119.437 -0.905 . . . . 1.24 112.108 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.7 mt -109.98 2.96 20.01 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 120.012 -0.675 . . . . 2.5600000000000001 111.845 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 . . . . . 0 C--N 1.308 -1.2 0 CA-C-O 121.569 0.7 . . . . 4.9800000000000004 109.577 -178.357 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mmm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.208 -0.664 . . . . 3.5699999999999998 109.208 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -88.96 97.75 11.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.879 -0.601 . . . . 5.0099999999999998 110.172 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.431 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 29.9 m -84.4 123.38 30.16 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.828 -1.149 . . . . 1.8700000000000001 109.207 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.67 131.41 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.828 -0.749 . . . . 2.21 112.277 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.45 116.89 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.703 -1.962 . . . . 2.0499999999999998 105.703 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -99.43 103.89 15.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.661 -1.607 . . . . 2.1000000000000001 106.661 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.78 -123.33 2.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.523 -1.431 . . . . 1.9299999999999999 109.523 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' N ' ' OH ' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -135.88 -114.37 0.19 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.879 -1.128 . . . . 7.2300000000000004 109.403 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 p -113.58 -74.81 0.61 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.808 -1.182 . . . . 5.5099999999999998 107.808 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.92 63.36 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.534 -2.227 . . . . 3.6699999999999999 107.534 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 49.6 t -100.19 97.47 6.28 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.935 -0.706 . . . . 4.9800000000000004 109.524 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.56 -25.57 41.6 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.062 1.841 . . . . 3.8500000000000001 111.847 -170.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.91 -9.74 58.95 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.332 -0.947 . . . . 6.5099999999999998 111.576 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 3.5 m -101.07 -37.3 8.66 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.784 -1.561 . . . . 2.9700000000000002 106.784 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -42.71 -35.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 114.721 -1.127 . . . . 2.2000000000000002 110.128 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 7.3 mmm180 -71.51 -55.17 8.38 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.049 -1.46 . . . . 4.8600000000000003 110.525 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.7 43.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.622 -1.251 . . . . 1.97 107.622 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -58.79 -49.88 76.01 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.539 -1.664 . . . . 2.98 109.035 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.492 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.6 t70 -60.44 -49.33 78.02 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.735 -1.186 . . . . 2.8900000000000001 111.075 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 42.1 tp -60.51 -55.32 34.91 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.979 -1.088 . . . . 2.0 110.0 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.85 64.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.335 -1.357 . . . . 1.73 107.335 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.603 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 31.8 tt0 -48.61 -49.43 36.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.388 1.055 . . . . 2.1400000000000001 109.359 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HE3' ' CA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -50.74 -63.52 1.1 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.344 -1.354 . . . . 7.6799999999999997 107.344 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.431 HD11 ' CD1' ' A' ' 83' ' ' LEU . 54.3 mt -45.53 -53.54 8.83 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.872 -1.158 . . . . 2.2799999999999998 107.872 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 15.1 t -52.02 -33.25 37.67 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.21 -1.359 . . . . 1.74 112.939 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -112.32 25.33 11.63 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.161 -0.927 . . . . 3.8500000000000001 109.197 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -133.62 -48.47 0.82 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.161 -0.927 . . . . 3.2400000000000002 111.568 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 30' ' ' ASP . 21.9 mtp85 -113.38 133.08 55.35 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.194 -0.912 . . . . 4.0700000000000003 110.508 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -80.9 35.04 0.36 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.395 -1.322 . . . . 3.7000000000000002 111.372 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.4 p30 -130.2 -4.58 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.843 -1.526 . . . . 3.8999999999999999 108.132 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 25' ' ' SER . 23.7 t80 -127.86 141.45 51.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.599 -0.84 . . . . 1.3200000000000001 112.608 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 35.4 mm-40 -140.75 141.04 34.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.218 -1.401 . . . . 5.3399999999999999 107.218 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.603 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -127.21 162.34 26.39 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 118.62 -1.232 . . . . 1.74 113.721 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 147.45 27.99 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.611 -1.632 . . . . 5.7800000000000002 109.333 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.538 ' OH ' ' N ' ' A' ' 8' ' ' ARG . 57.6 t80 -113.41 146.34 39.67 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.765 -1.198 . . . . 1.75 107.765 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.21 163.96 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.616 -0.834 . . . . 2.77 110.25 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -121.13 121.24 37.43 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.24 -2.133 . . . . 2.23 105.24 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -51.29 -17.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 118.825 -1.15 . . . . 2.9900000000000002 110.806 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 4.2 ttp-105 -95.05 23.97 5.23 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.72 -0.792 . . . . 7.5599999999999996 109.666 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.84 -43.69 3.97 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.102 -1.444 . . . . 2.5899999999999999 107.102 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -93.48 -42.37 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.541 -2.022 . . . . 4.6500000000000004 105.541 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.21 56.71 0.58 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.222 -1.951 . . . . 1.48 108.222 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.7 149.84 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.501 . . . . 2.2400000000000002 111.067 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 -170.87 1.92 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.607 -0.724 . . . . 2.5299999999999998 109.431 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 13.3 ttpp -77.06 -28.29 54.67 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.491 -0.884 . . . . 6.0700000000000003 110.668 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 16.7 mp0 -70.71 -57.13 5.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 3.3199999999999998 108.149 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.593 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 38.7 t70 -48.52 -42.66 33.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.104 -0.953 . . . . 2.3999999999999999 110.422 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.76 -38.77 53.55 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.954 -1.021 . . . . 2.73 110.895 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.483 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 5.2 tt0 -55.74 -47.71 76.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.306 -1.368 . . . . 4.7400000000000002 107.306 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.0 -30.83 26.83 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.322 -1.308 . . . . 6.21 110.811 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.593 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 58.2 mttp -88.97 -57.6 2.84 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.536 -1.211 . . . . 3.0800000000000001 112.244 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.515 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -50.5 -33.35 21.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.783 -1.099 . . . . 1.99 112.029 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.79 73.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 106.521 -2.632 . . . . 3.6699999999999999 106.521 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -133.26 -169.9 0.22 Allowed Pre-proline 0 C--N 1.296 -1.737 0 CA-C-N 113.089 -1.555 . . . . 7.0499999999999998 107.834 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -86.6 143.5 7.34 Favored 'Trans proline' 0 C--N 1.299 -2.026 0 C-N-CA 120.893 1.062 . . . . 4.0599999999999996 110.989 138.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -118.29 160.46 17.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.731 -1.211 . . . . 6.5999999999999996 107.731 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -101.65 -109.69 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.084 -1.046 . . . . 6.7300000000000004 108.693 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.9 p -120.26 -73.48 0.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.266 -1.013 . . . . 5.6600000000000001 108.266 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -147.8 149.76 34.26 Favored Pre-proline 0 C--N 1.289 -2.048 0 CA-C-N 114.149 -1.387 . . . . 3.6899999999999999 107.966 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.627 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 26.0 Cg_endo -103.66 155.8 3.01 Favored 'Cis proline' 0 C--N 1.32 -0.966 0 CA-C-N 118.671 0.561 . . . . 2.0299999999999998 112.241 -6.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.46 149.43 41.28 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 107.085 -1.45 . . . . 3.6099999999999999 107.085 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 58.0 mt -127.48 141.33 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.651 -0.82 . . . . 2.3900000000000001 113.136 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -124.54 145.15 49.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.306 -1.77 . . . . 1.8899999999999999 110.283 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG13 ' CZ2' ' A' ' 78' ' ' TRP . 71.1 t -117.75 90.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.412 -0.959 . . . . 1.8799999999999999 108.412 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 t70 70.9 -75.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.263 -0.88 . . . . 2.5699999999999998 109.05 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -134.18 -20.87 1.88 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.786 -1.097 . . . . 4.2599999999999998 111.381 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -89.51 158.1 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.759 -1.176 . . . . 6.2999999999999998 110.8 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 11.8 t-160 -103.71 142.32 34.54 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.473 -0.936 . . . . 1.1599999999999999 108.473 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 mm -111.55 -46.14 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.041 -1.063 . . . . 2.0299999999999998 108.959 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.15 -113.82 1.01 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.504 -1.439 . . . . 1.1699999999999999 109.504 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -119.25 -173.81 15.61 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.372 -1.091 . . . . 1.22 110.372 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 18.5 t80 -47.1 -49.2 22.36 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.354 -0.939 . . . . 1.79 111.516 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -54.67 17.17 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.687 0.756 . . . . 1.8999999999999999 110.123 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -58.38 -52.64 64.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.666 -1.606 . . . . 2.4399999999999999 110.481 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.97 -44.68 96.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.508 -0.769 . . . . 1.6000000000000001 111.834 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.91 -58.18 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.728 -0.789 . . . . 2.1000000000000001 109.226 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.76 -55.43 35.21 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.569 -1.253 . . . . 2.3300000000000001 108.893 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.412 ' CZ2' HG13 ' A' ' 64' ' ' VAL . 63.6 t90 -44.75 -54.18 6.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 123.549 0.531 . . . . 1.05 111.485 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -43.54 -59.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.962 -0.563 . . . . 2.0600000000000001 110.265 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -43.8 -30.19 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.394 1.628 . . . . 3.1800000000000002 115.394 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -107.82 4.5 25.57 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 119.579 1.082 . . . . 4.7400000000000002 112.62 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -120.56 -31.57 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.721 -0.791 . . . . 1.3799999999999999 111.045 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' A' ' 24' ' ' LEU . 55.0 mt -116.94 26.84 9.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.792 -0.763 . . . . 2.4300000000000002 111.954 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 C-N-CA 119.698 -0.801 . . . . 3.6000000000000001 110.647 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.494 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 3.9 ptm . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 107.728 -1.212 . . . . 4.5099999999999998 107.728 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.439 HE22 ' C ' ' A' ' 33' ' ' TYR . 60.5 tp60 -111.57 142.0 44.42 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 123.478 0.487 . . . . 5.9100000000000001 109.839 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 m -120.4 148.72 43.41 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.771 -0.771 . . . . 2.5600000000000001 109.025 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.49 139.19 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 118.868 -1.133 . . . . 2.0600000000000001 112.595 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -111.1 136.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.55 -1.278 . . . . 2.9900000000000002 107.55 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.15 84.98 2.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.585 -1.635 . . . . 2.79 106.585 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.461 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -135.1 -163.28 10.05 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.496 -2.241 . . . . 1.7 107.496 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 4.2 tpt180 -141.35 167.68 21.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.256 -0.977 . . . . 7.1799999999999997 108.581 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 8' ' ' ARG . 78.9 p -85.76 64.83 8.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.307 -0.627 . . . . 5.3399999999999999 109.307 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 11' ' ' CYS . . . -120.75 61.13 0.52 Allowed Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.505 -1.438 . . . . 4.7699999999999996 109.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.742 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 30.7 t 108.82 165.44 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.685 0 N-CA-C 105.605 -1.998 . . . . 5.0899999999999999 105.605 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.742 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 50.5 Cg_exo -54.76 75.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.023 1.149 . . . . 3.7999999999999998 113.023 165.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -113.82 -77.89 0.58 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.573 -0.451 . . . . 5.4199999999999999 109.915 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.461 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.7 m -55.02 -29.12 56.7 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 118.041 -1.464 . . . . 3.27 108.022 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -42.54 -38.59 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.164 -1.38 . . . . 2.5899999999999999 110.205 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.493 ' NH2' ' O ' ' A' ' 16' ' ' ARG . 6.6 mmm180 -77.11 -53.63 7.54 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.957 -1.497 . . . . 4.3799999999999999 110.093 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.16 -42.59 40.25 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.208 -0.997 . . . . 2.3999999999999999 109.185 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HE3' ' CZ ' ' A' ' 33' ' ' TYR . 2.3 tptm -60.19 -60.0 4.51 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.898 -1.501 . . . . 3.9199999999999999 108.687 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.481 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 3.4 t70 -50.51 -42.65 55.15 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.984 -1.086 . . . . 2.6000000000000001 110.029 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.449 HD22 HG23 ' A' ' 79' ' ' VAL . 8.6 tp -63.22 -66.93 0.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.686 -1.205 . . . . 2.1200000000000001 109.185 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.97 -39.82 9.48 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 120.312 -0.555 . . . . 1.9299999999999999 110.524 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.504 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 26.6 tt0 -65.55 -53.04 47.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.151 -0.932 . . . . 2.3100000000000001 110.389 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -53.54 39.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.566 -1.642 . . . . 7.9699999999999998 106.566 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.4 mt -53.51 -40.62 65.55 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.544 -1.207 . . . . 2.4199999999999999 108.216 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -59.7 -35.62 74.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.874 -1.057 . . . . 1.29 110.594 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -83.98 -28.08 27.99 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.042 -0.663 . . . . 2.5899999999999999 110.891 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.3 -47.22 44.5 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.208 -0.597 . . . . 3.4199999999999999 111.35 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -109.18 164.97 11.96 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.143 -1.023 . . . . 5.6299999999999999 110.907 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.632 -1.618 . . . . 4.0 106.632 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 1' ' ' MET . 3.5 t70 -82.86 41.19 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.924 -1.489 . . . . 3.5800000000000001 108.686 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -145.46 93.23 2.34 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.546 -1.262 . . . . 1.4299999999999999 112.651 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -99.55 155.06 17.78 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 104.526 -2.398 . . . . 4.4100000000000001 104.526 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.532 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 7.3 p90 -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.059 -1.056 . . . . 2.3700000000000001 108.784 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -149.02 152.44 36.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.701 -0.852 . . . . 5.1900000000000004 108.701 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -121.46 123.15 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.841 -1.17 . . . . 2.9100000000000001 107.841 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.28 145.39 20.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.97 -2.233 . . . . 3.1099999999999999 104.97 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -111.18 160.1 17.25 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.544 -1.263 . . . . 2.5499999999999998 108.512 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.26 -30.24 5.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 117.778 -1.569 . . . . 2.3199999999999998 108.87 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 3.1 tpm_? -93.18 -59.31 2.06 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.74 -0.664 . . . . 6.5700000000000003 110.339 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -47.19 -33.29 5.15 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.655 -0.818 . . . . 2.6200000000000001 110.972 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.22 -46.31 8.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.954 0.784 . . . . 3.9700000000000002 109.334 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 54.23 1.05 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.722 -1.751 . . . . 1.49 108.722 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 mt -99.74 162.7 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.544 -0.91 . . . . 2.5600000000000001 108.544 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 p -113.36 148.78 35.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.942 0.776 . . . . 3.1899999999999999 112.184 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HG3' ' CG1' ' A' ' 56' ' ' VAL . 35.0 tttm -49.3 -54.26 17.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.588 -0.893 . . . . 4.9400000000000004 108.588 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 3.6 mp0 -46.62 -62.91 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.725 -1.125 . . . . 3.25 111.006 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.15 -56.71 8.33 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 120.401 -0.519 . . . . 2.1600000000000001 110.895 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.8 -50.17 69.2 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.7 -0.682 . . . . 2.4100000000000001 110.229 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.97 -56.14 16.06 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 3.6400000000000001 107.535 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.77 -43.92 48.48 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.107 -1.406 . . . . 5.1299999999999999 109.071 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -63.85 -46.39 85.23 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.133 -1.394 . . . . 8.0800000000000001 112.231 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.521 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -71.19 -48.51 51.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 113.068 0.766 . . . . 1.76 113.068 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.94 -33.85 6.18 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.065 -2.414 . . . . 2.54 107.065 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -83.83 141.53 41.25 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 114.447 -0.876 . . . . 8.3699999999999992 108.649 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -41.92 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 122.358 2.039 . . . . 4.5700000000000003 110.712 161.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.583 ' CG1' ' HG3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER 33.32 -95.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 115.637 1.717 . . . . 6.2999999999999998 115.637 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 5.3 tp10 109.14 -170.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 102.475 -3.158 . . . . 7.1799999999999997 102.475 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.509 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 14.9 p -104.03 -152.49 0.46 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.181 -1.414 . . . . 4.5800000000000001 107.181 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.07 146.64 51.88 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 107.881 -1.155 . . . . 3.8500000000000001 107.881 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 96.6 Cg_endo -98.46 162.46 10.42 Favored 'Cis proline' 0 N--CA 1.489 1.223 0 O-C-N 122.858 0.925 . . . . 2.8599999999999999 111.637 10.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -114.06 151.34 32.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.578 -1.267 . . . . 3.7799999999999998 107.578 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.413 HD11 ' CG ' ' A' ' 75' ' ' PHE . 6.2 mt -123.2 143.24 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.066 -1.054 . . . . 2.7400000000000002 111.798 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -136.36 159.06 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.751 -1.568 . . . . 1.28 107.874 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 66' ' ' GLN . 74.6 t -127.6 130.44 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.531 -0.914 . . . . 1.9099999999999999 108.531 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.08 -81.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 124.398 1.061 . . . . 2.77 110.603 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.3 pt20 -138.33 -14.2 1.32 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.229 -0.896 . . . . 4.6900000000000004 110.976 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -85.46 168.96 14.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.696 0.623 . . . . 5.1200000000000001 111.209 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 10.3 t-160 -113.01 139.66 48.47 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.617 -0.72 . . . . 1.0600000000000001 109.267 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mm -109.69 -34.37 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.304 -1.358 . . . . 2.3500000000000001 109.215 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.96 -136.17 8.77 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.169 -1.491 . . . . 1.2 109.539 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.39 169.2 17.1 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.749 -1.215 . . . . 1.49 110.656 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.6 t80 -40.53 -57.27 1.87 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 112.608 0.596 . . . . 1.8899999999999999 112.608 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 p -43.25 -69.31 0.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.026 0.917 . . . . 2.8300000000000001 111.213 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -52.1 30.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.174 -1.83 . . . . 2.8300000000000001 110.316 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' CE1' ' CE3' ' A' ' 78' ' ' TRP . 58.3 t80 -44.61 -46.54 10.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.345 -0.843 . . . . 1.99 111.03 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -40.83 -48.17 3.03 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 119.62 -0.832 . . . . 1.9299999999999999 111.006 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.99 77.93 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.839 -1.144 . . . . 2.3599999999999999 109.713 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.451 ' CE3' ' CE1' ' A' ' 75' ' ' PHE . 90.5 t90 -50.94 -44.99 60.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.724 -0.843 . . . . 0.81999999999999995 108.724 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.449 HG23 HD22 ' A' ' 20' ' ' LEU . 79.7 t -57.23 -33.99 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.662 -1.154 . . . . 2.0699999999999998 110.23 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' NZ ' ' OD2' ' A' ' 84' ' ' ASP . 13.7 tptp -87.57 18.52 3.88 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.265 -0.974 . . . . 3.27 111.726 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.21 -45.47 0.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.271 -0.972 . . . . 3.8500000000000001 111.826 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -84.86 -2.16 57.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.992 -1.083 . . . . 1.76 111.745 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.406 HD11 HG11 ' A' ' 79' ' ' VAL . 86.0 mt -123.25 21.32 9.63 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.209 -0.996 . . . . 2.6699999999999999 110.742 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 2.3 m-20 . . . . . 0 C--N 1.297 -1.686 0 N-CA-C 108.075 -1.084 . . . . 4.0899999999999999 108.075 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.387 -0.598 . . . . 4.1500000000000004 109.387 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -112.01 164.51 13.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.118 0.485 . . . . 4.8099999999999996 111.82 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.1 m -152.35 121.48 6.67 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 116.434 -0.348 . . . . 2.1699999999999999 110.159 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.412 HG23 ' CG ' ' A' ' 34' ' ' GLN . 6.6 t -109.19 137.91 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.103 -1.039 . . . . 1.98 110.09 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.408 HD13 ' C ' ' A' ' 4' ' ' VAL . 1.6 mp -109.32 98.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 124.768 1.293 . . . . 2.2400000000000002 108.077 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.76 92.75 7.61 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 105.774 -1.936 . . . . 1.9299999999999999 105.774 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.583 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -125.07 -150.69 7.85 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.825 -1.178 . . . . 1.5600000000000001 111.766 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.459 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.3 tpt180 -124.26 123.53 40.45 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.812 -0.81 . . . . 6.3399999999999999 108.812 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -78.45 53.78 1.34 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.662 0.744 . . . . 5.7800000000000002 109.397 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.34 -46.37 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.733 -1.347 . . . . 3.9300000000000002 109.733 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.576 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 32.1 t -111.78 156.1 42.12 Favored Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.779 -0.822 . . . . 4.29 108.779 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.576 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 6.1 Cg_endo -72.55 48.53 1.31 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.491 1.461 . . . . 3.7200000000000002 111.446 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -99.99 -58.62 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.361 -0.978 . . . . 4.3799999999999999 108.361 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.3 m -53.26 -36.19 60.84 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.423 -1.325 . . . . 3.2400000000000002 107.423 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.41 -30.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.079 -1.873 . . . . 2.3700000000000001 111.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -72.28 -39.85 68.02 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.983 -1.087 . . . . 6.6799999999999997 110.302 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.7 79.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.217 -1.771 . . . . 2.0299999999999998 106.217 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 2.1 ttpp -51.99 -48.91 64.2 Favored 'General case' 0 C--O 1.2 -1.532 0 CA-C-N 114.099 -1.409 . . . . 2.5 108.97 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -57.42 -65.68 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.646 -0.706 . . . . 2.9399999999999999 111.251 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.4 tp -51.31 -51.85 50.57 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.083 -1.047 . . . . 2.2599999999999998 110.073 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.13 -51.52 63.98 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.618 -1.173 . . . . 2.1299999999999999 109.747 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 19.6 tt0 -55.93 -49.0 74.69 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.047 -0.978 . . . . 1.8799999999999999 109.35 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -52.23 -55.1 23.36 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.034 -1.466 . . . . 4.7999999999999998 107.657 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.82 -37.17 63.3 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.756 -0.831 . . . . 2.2799999999999998 108.756 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 5.7 t -55.71 -40.74 72.84 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.815 -1.18 . . . . 1.21 107.815 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -98.3 40.36 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.961 -1.496 . . . . 2.5 106.961 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.53 -52.3 0.39 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.242 -1.344 . . . . 2.8700000000000001 111.663 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -106.23 -11.45 16.04 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.973 -1.091 . . . . 5.6299999999999999 111.177 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 71.51 -40.55 0.48 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 124.15 0.906 . . . . 4.7199999999999998 112.59 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 1' ' ' MET . 5.3 p-10 -80.96 4.23 20.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.705 -1.198 . . . . 2.71 107.863 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.494 ' CD2' ' HE2' ' A' ' 1' ' ' MET . 6.0 t80 -95.23 102.35 14.15 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.554 1.159 . . . . 1.9299999999999999 108.011 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -119.29 118.62 31.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.201 -1.037 . . . . 4.0199999999999996 108.201 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.41 160.04 15.94 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.731 -1.188 . . . . 1.3799999999999999 110.574 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.412 ' CG ' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -142.26 148.84 38.76 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.076 -1.42 . . . . 5.0700000000000003 108.9 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -112.21 136.19 51.93 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.042 -1.096 . . . . 2.1000000000000001 108.042 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.42 152.04 27.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.213 -1.773 . . . . 2.2000000000000002 106.213 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.68 142.2 47.52 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.409 -0.916 . . . . 2.1899999999999999 109.008 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.9 pt -48.3 -36.95 6.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.927 -0.709 . . . . 2.27 111.188 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -76.74 -44.88 31.38 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.002 -1.079 . . . . 7.5499999999999998 111.473 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.76 -54.36 2.65 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 119.529 -0.868 . . . . 2.9100000000000001 110.422 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 42' ' ' GLY . 64.9 mt-10 -93.47 25.18 3.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 114.3 -1.318 . . . . 4.2699999999999996 111.255 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 30.51 57.0 0.24 Allowed Glycine 0 N--CA 1.508 3.455 0 N-CA-C 112.074 -0.41 . . . . 1.7 112.074 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.6 161.52 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.933 -0.766 . . . . 2.8900000000000001 108.933 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -119.93 154.62 34.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.706 0.765 . . . . 2.6200000000000001 109.513 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -45.13 -42.12 8.63 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.071 1.137 . . . . 4.8700000000000001 114.071 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.588 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 14.2 mp0 -65.02 -56.5 12.73 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.818 -0.753 . . . . 3.0699999999999998 110.608 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.481 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -47.56 -50.21 24.49 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.19 -1.041 . . . . 2.4399999999999999 108.19 179.256 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.94 -48.94 74.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.159 -1.382 . . . . 2.25 108.551 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.43 HE21 ' H ' ' A' ' 56' ' ' VAL . 5.4 tp60 -44.78 -45.02 9.77 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.936 -1.135 . . . . 6.1399999999999997 107.936 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.15 -49.54 69.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.898 1.374 . . . . 4.4100000000000001 109.587 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER -51.58 -48.95 62.98 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.155 -0.683 . . . . 3.4300000000000002 109.155 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -19.69 56.98 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.429 -0.952 . . . . 2.0099999999999998 108.429 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.67 32.57 17.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.375 -1.89 . . . . 2.73 108.375 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -143.66 158.21 57.19 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-N 114.096 -1.052 . . . . 8.2699999999999996 108.707 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.86 68.87 4.67 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.675 1.584 . . . . 4.3200000000000003 111.25 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.43 ' H ' HE21 ' A' ' 49' ' ' GLN . 4.8 p -101.71 125.1 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.982 -0.687 . . . . 7.1799999999999997 110.804 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.71 -2.82 10.36 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 112.918 0.711 . . . . 6.2000000000000002 112.918 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 p -116.08 -169.27 1.57 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.637 -0.825 . . . . 4.7199999999999998 111.579 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.8 164.59 33.93 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.415 -0.811 . . . . 4.0599999999999996 108.992 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.69 157.44 71.82 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 124.236 -1.152 . . . . 3.5099999999999998 109.747 -7.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -98.25 101.42 12.88 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 103.916 -2.624 . . . . 3.9700000000000002 103.916 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mt -91.59 133.12 34.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 113.167 -1.833 . . . . 2.3700000000000001 111.266 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -125.64 153.57 43.6 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 112.979 -1.919 . . . . 1.3100000000000001 109.798 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 66' ' ' GLN . 80.0 t -122.2 95.91 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.882 -1.155 . . . . 1.6899999999999999 107.882 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.5 -72.72 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 125.189 1.556 . . . . 2.6299999999999999 110.557 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 64' ' ' VAL . 41.7 tp60 -129.78 -18.06 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.475 -1.239 . . . . 7.1600000000000001 111.363 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -91.61 172.95 8.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.276 -0.97 . . . . 4.3600000000000003 111.18 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -119.92 149.72 41.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 106.797 -1.557 . . . . 2.2200000000000002 106.797 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.472 HD13 ' CD1' ' A' ' 78' ' ' TRP . 21.3 mm -116.25 -55.95 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.687 -0.805 . . . . 2.1099999999999999 111.069 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.58 -135.05 4.76 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.667 -1.254 . . . . 1.53 110.26 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.37 -74.31 0.94 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 111.141 -0.783 . . . . 2.4700000000000002 111.141 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -137.97 -55.85 0.66 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 118.724 -1.19 . . . . 3.6000000000000001 109.343 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 p -41.95 -52.4 4.14 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 123.118 1.437 . . . . 2.6299999999999999 109.658 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -36.46 84.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.005 -2.362 . . . . 2.0800000000000001 109.964 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.19 -51.01 61.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.496 -0.882 . . . . 1.6499999999999999 109.108 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.5 64.81 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.276 -0.969 . . . . 2.6499999999999999 109.28 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.88 -58.9 6.14 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.788 -1.165 . . . . 2.1299999999999999 108.998 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.472 ' CD1' HD13 ' A' ' 69' ' ' ILE . 87.6 t90 -44.5 -55.54 5.02 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.519 -0.764 . . . . 0.85999999999999999 109.301 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 83' ' ' LEU . 2.7 t -44.79 -60.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 114.231 -1.35 . . . . 1.8500000000000001 108.853 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HZ2' ' CG ' ' A' ' 84' ' ' ASP . 21.9 tptp -50.21 -39.88 45.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.21 -0.905 . . . . 3.4199999999999999 112.937 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -104.52 36.09 2.52 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.592 -0.843 . . . . 4.3300000000000001 113.067 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -147.5 -36.11 0.22 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.216 1.007 . . . . 1.5600000000000001 110.038 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.413 HD11 HG11 ' A' ' 79' ' ' VAL . 22.3 mt -99.44 -24.03 14.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.523 -1.217 . . . . 2.6499999999999999 110.794 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.443 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 6.8 t0 . . . . . 0 N--CA 1.499 2.008 0 O-C-N 125.105 1.503 . . . . 4.0999999999999996 108.082 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.496 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.4 mpp? . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 108.004 -1.11 . . . . 3.0600000000000001 108.004 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.16 102.61 11.98 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 124.023 0.827 . . . . 5.1900000000000004 109.459 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 5.7 m -96.69 116.38 29.03 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.963 -1.095 . . . . 2.1699999999999999 109.925 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 t -123.7 136.95 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.397 -0.819 . . . . 2.1600000000000001 112.448 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.421 HG23 ' SG ' ' A' ' 14' ' ' CYS . 5.4 mm -110.39 125.03 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.747 -1.205 . . . . 2.3100000000000001 107.747 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -102.47 114.99 29.67 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.21 -1.774 . . . . 2.29 106.21 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.29 -148.78 7.99 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.409 -1.077 . . . . 1.8799999999999999 110.409 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.5 ttm180 -138.8 141.74 38.74 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.846 -0.742 . . . . 7.5 110.613 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 t -54.98 73.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.983 -1.462 . . . . 6.9500000000000002 112.761 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 118.5 26.62 2.58 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 120.45 -0.881 . . . . 4.1299999999999999 113.096 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 13' ' ' TYR . 9.7 t -122.31 138.0 28.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 C-N-CA 118.728 -1.189 . . . . 5.1299999999999999 110.048 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.02 53.08 4.42 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.884 1.723 . . . . 5.0199999999999996 111.2 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.545 ' CE2' ' SG ' ' A' ' 11' ' ' CYS . 20.3 m-30 -111.73 -68.21 0.95 Allowed 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.302 -0.559 . . . . 6.25 112.147 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.529 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 3.5 t -54.49 -29.34 49.89 Favored 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 118.014 -1.474 . . . . 5.0899999999999999 108.912 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 t -44.75 -12.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 114.027 -1.442 . . . . 3.4399999999999999 112.072 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.559 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -108.87 -42.37 4.49 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.534 -0.867 . . . . 4.3200000000000003 109.607 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.17 75.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.345 -1.724 . . . . 1.73 106.345 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -54.97 -39.82 69.36 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 114.588 -1.187 . . . . 2.9100000000000001 108.686 179.14 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' CG ' HH12 ' A' ' 16' ' ' ARG . 0.2 OUTLIER -66.32 -62.42 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.212 0.529 . . . . 2.7599999999999998 111.488 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.3 tp -56.36 -43.27 78.98 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.408 -0.917 . . . . 2.27 110.045 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.08 72.69 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.725 -1.19 . . . . 1.6399999999999999 108.296 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 11.3 tt0 -48.14 -47.33 34.83 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.44 -0.948 . . . . 2.4199999999999999 108.44 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -48.57 -52.9 20.49 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 118.756 -1.178 . . . . 4.7000000000000002 110.62 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.5 mt -65.52 -46.24 80.4 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 123.721 0.638 . . . . 2.2000000000000002 111.78 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' A' ' 22' ' ' GLU . 1.5 p -57.9 -25.37 60.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 118.922 -1.111 . . . . 3.7599999999999998 111.15 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.456 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.8 t30 -91.75 27.98 1.91 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.028 -1.069 . . . . 2.5800000000000001 108.647 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 72.5 mt-10 -121.17 -65.7 1.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.951 -0.7 . . . . 3.3999999999999999 110.252 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -122.26 -166.77 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.811 -1.086 . . . . 4.4500000000000002 111.746 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -107.45 -4.65 18.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.912 -1.04 . . . . 5.79 111.027 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.9 p-10 -84.29 -9.59 58.35 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.919 -1.141 . . . . 3.2599999999999998 107.919 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -116.02 96.9 5.79 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.492 -0.883 . . . . 1.98 110.817 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -112.11 128.07 56.1 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.255 -2.128 . . . . 5.2300000000000004 105.255 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -123.28 143.25 50.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.118 -1.433 . . . . 1.7 113.74 -177.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -139.1 161.67 36.81 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 113.822 -1.536 . . . . 5.0300000000000002 109.409 178.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.529 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 30.6 t80 -118.98 142.62 47.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 1.8999999999999999 109.115 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -132.19 147.02 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.348 -0.982 . . . . 2.6299999999999999 108.348 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.3 t70 -122.48 114.74 21.11 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 119.038 -1.065 . . . . 2.5800000000000001 112.434 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -49.3 -31.46 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.477 -0.783 . . . . 2.77 111.522 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.506 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.03 -63.44 1.31 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.284 -1.766 . . . . 6.7000000000000002 108.723 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 37' ' ' ASP . . . -30.49 -45.51 0.06 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.667 1.23 . . . . 2.7799999999999998 111.671 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -94.22 -53.37 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.905 -1.118 . . . . 3.6400000000000001 111.465 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.58 51.87 0.2 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 118.989 -1.576 . . . . 1.77 111.47 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.7 mt -103.87 157.73 5.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.775 -1.565 . . . . 2.9199999999999999 106.775 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.0 p -115.88 158.35 23.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.653 -0.819 . . . . 2.5600000000000001 109.084 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -52.18 -40.29 61.27 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.961 -1.096 . . . . 5.5999999999999996 111.833 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 23.3 mp0 -47.73 -63.76 0.97 Allowed 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 121.663 0.744 . . . . 3.3999999999999999 110.261 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.555 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 2.8 t70 -44.31 -44.62 8.25 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 114.354 -1.294 . . . . 2.8199999999999998 111.978 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.77 -41.7 64.76 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.336 -1.302 . . . . 3.0800000000000001 110.5 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 54' ' ' LYS . 14.0 tt0 -57.28 -40.12 77.1 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.301 -1.741 . . . . 3.4300000000000002 106.301 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -15.54 11.84 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.355 -1.293 . . . . 4.8799999999999999 110.692 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.555 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 54.7 mttp -104.11 -37.73 7.21 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.671 -0.695 . . . . 3.2599999999999998 110.51 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -72.0 -37.79 69.75 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.725 -1.125 . . . . 2.0899999999999999 112.65 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -45.62 1.87 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 107.957 -2.057 . . . . 2.8399999999999999 107.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 17.8 pttp -101.35 176.31 1.94 Allowed Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.556 -1.646 . . . . 6.5899999999999999 106.556 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 64.9 Cg_exo -48.67 155.15 2.53 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 120.67 0.913 . . . . 4.6799999999999997 110.93 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.43 -30.99 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.447 -0.901 . . . . 6.7599999999999998 111.312 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.58 -145.92 0.32 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.047 -0.661 . . . . 7.4000000000000004 109.383 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -95.38 168.04 10.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.604 -0.838 . . . . 5.1200000000000001 110.003 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.01 152.26 39.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.634 -1.247 . . . . 3.6400000000000001 107.634 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 13' ' ' TYR . 73.7 Cg_endo -97.03 160.2 12.07 Favored 'Cis proline' 0 C--N 1.304 -1.78 0 C-N-CA 123.828 -1.322 . . . . 2.8199999999999998 109.664 17.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 1.4 tp-100 -110.16 132.45 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.069 -2.197 . . . . 4.0700000000000003 105.069 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 75' ' ' PHE . 5.3 mt -112.71 137.53 45.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.037 -1.065 . . . . 2.7599999999999998 111.013 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -127.5 138.78 53.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.407 -1.724 . . . . 1.55 107.807 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 66' ' ' GLN . 40.6 t -121.73 108.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 124.462 1.101 . . . . 1.8100000000000001 109.183 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.01 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.141 -0.689 . . . . 2.9399999999999999 109.141 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -138.05 -9.82 1.53 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.484 -1.234 . . . . 4.96 110.034 179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.82 146.62 26.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.678 -0.49 . . . . 5.3600000000000003 109.678 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 14.6 t-160 -105.85 135.55 47.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.159 -1.423 . . . . 1.3700000000000001 107.159 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 78' ' ' TRP . 9.9 mm -103.7 -41.06 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 118.588 -1.245 . . . . 1.8999999999999999 109.775 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 128.39 -114.74 1.88 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.324 -2.31 . . . . 1.3600000000000001 107.324 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.87 -169.13 12.46 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 118.558 -1.782 . . . . 1.4399999999999999 111.23 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.7 t80 -61.96 176.28 0.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 105.738 -1.949 . . . . 3.0699999999999998 105.738 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.471 ' CB ' ' O ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 78.23 -64.69 0.27 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.413 -1.328 . . . . 3.6200000000000001 107.413 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -41.62 83.05 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.398 -1.334 . . . . 2.6200000000000001 107.398 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.435 ' HB2' HD11 ' A' ' 62' ' ' ILE . 15.8 t80 -41.84 -49.88 4.43 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 113.915 -1.493 . . . . 1.3100000000000001 110.041 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.66 71.28 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.412 -0.915 . . . . 2.2599999999999998 109.061 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.14 -53.99 51.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.887 -1.125 . . . . 2.0899999999999999 109.435 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.421 ' CD1' HD13 ' A' ' 69' ' ' ILE . 70.2 t90 -50.3 -53.45 28.58 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.746 -0.782 . . . . 1.26 110.065 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.0 t -43.98 -56.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.312 -0.858 . . . . 2.1200000000000001 109.336 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.433 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 6.2 tmtm? -44.83 -23.86 0.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 116.953 -1.499 . . . . 3.9300000000000002 115.044 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.18 6.2 10.26 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 120.94 1.7 . . . . 4.79 112.971 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.23 -25.74 5.63 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.846 -0.742 . . . . 1.3100000000000001 109.725 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.89 28.03 4.22 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.16 -0.927 . . . . 2.5 111.096 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 18.6 p-10 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 122.229 1.014 . . . . 4.4000000000000004 109.099 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.427 ' N ' ' O ' ' A' ' 30' ' ' ASP . 98.8 mtp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.838 -0.801 . . . . 3.6000000000000001 108.838 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.442 ' OE1' ' HB2' ' A' ' 34' ' ' GLN . 6.2 tt0 -84.17 144.52 28.93 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 119.104 -1.039 . . . . 5.0899999999999999 109.447 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.7 m -96.39 134.73 39.18 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.169 -1.419 . . . . 2.3399999999999999 107.169 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.404 ' C ' HD13 ' A' ' 5' ' ' ILE . 6.7 t -125.42 122.22 62.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.593 -1.262 . . . . 2.2999999999999998 107.593 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.3 mp -107.17 123.65 62.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 105.419 -2.067 . . . . 1.8600000000000001 105.419 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -117.78 117.07 28.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 4.0099999999999998 108.587 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.46 159.43 8.39 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.875 -1.155 . . . . 2.9199999999999999 111.247 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -112.89 139.09 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.194 -1.039 . . . . 6.2000000000000002 108.194 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.549 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 10.9 p -102.89 -65.15 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.124 -1.03 . . . . 7.4800000000000004 109.709 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.27 -47.88 0.99 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 105.967 -2.853 . . . . 4.1100000000000003 105.967 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.5 m -94.7 165.2 17.73 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 106.354 -1.721 . . . . 5.4000000000000004 106.354 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.04 67.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.844 2.363 . . . . 3.8599999999999999 112.528 165.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -115.0 -65.34 1.2 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.628 -0.878 . . . . 6.5999999999999996 108.628 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 18.1 m -53.46 -33.82 55.59 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.404 1.097 . . . . 2.9500000000000002 108.388 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -44.46 -47.12 2.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 113.002 -1.908 . . . . 2.52 111.259 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -50.01 -48.8 52.34 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.71 -0.796 . . . . 3.9300000000000002 110.534 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.27 -52.69 25.81 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.552 -1.277 . . . . 1.73 107.552 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -53.76 -45.21 70.54 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 114.759 -1.11 . . . . 2.9300000000000002 110.53 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 43.7 m-20 -62.21 -56.72 15.85 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.336 -0.546 . . . . 3.1899999999999999 111.663 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.79 -52.02 67.2 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.029 -0.73 . . . . 1.96 109.029 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.73 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.74 -0.837 . . . . 1.4099999999999999 108.74 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.466 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 42.3 tt0 -58.38 -47.76 82.8 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.7 -0.8 . . . . 2.3500000000000001 110.428 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 17.6 tptp -57.45 -54.96 40.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 116.563 -2.055 . . . . 5.4699999999999998 107.879 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' LYS . 47.7 mt -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.533 -1.667 . . . . 2.7400000000000002 107.63 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 6.5 t -49.84 -42.44 47.34 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.785 -0.643 . . . . 1.29 109.494 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.433 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 t-20 -72.89 -29.49 63.2 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.742 -0.663 . . . . 2.77 111.13 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.522 ' CD ' ' HZ3' ' A' ' 23' ' ' LYS . 1.6 mm-40 -86.33 -40.14 15.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.292 1.219 . . . . 3.8399999999999999 114.292 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -114.25 139.36 49.46 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.923 -0.711 . . . . 5.3499999999999996 112.216 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.35 -40.88 98.48 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.225 -0.898 . . . . 4.0800000000000001 113.273 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -84.75 20.28 1.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.405 -0.918 . . . . 3.4399999999999999 111.36 -178.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.44 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 4.4 t80 -115.28 123.02 47.72 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.544 -1.262 . . . . 1.52 111.63 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -136.04 172.39 13.08 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.824 -1.547 . . . . 4.3099999999999996 106.824 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -145.35 149.45 34.81 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.501 -1.28 . . . . 1.4199999999999999 110.919 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HB2' ' OE1' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -136.87 139.78 41.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.113 0.883 . . . . 6.3099999999999996 109.252 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.67 121.2 34.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.178 -1.009 . . . . 2.6099999999999999 108.83 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.99 153.59 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.866 -0.734 . . . . 2.5600000000000001 109.708 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -108.69 124.3 50.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.092 -1.447 . . . . 2.5099999999999998 107.092 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.7 pt -40.02 -41.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.709 -0.796 . . . . 2.3199999999999998 111.816 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -31.47 61.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 118.998 -1.081 . . . . 6.4299999999999997 111.778 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.1 -53.59 32.76 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.416 -0.914 . . . . 2.1200000000000001 111.593 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -94.63 -34.49 12.59 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.477 -0.889 . . . . 3.6499999999999999 111.872 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.48 50.43 0.66 Allowed Glycine 0 N--CA 1.503 3.12 0 N-CA-C 109.332 -1.507 . . . . 1.51 109.332 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.8 mt -96.55 137.15 25.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.312 -0.995 . . . . 2.5699999999999998 108.312 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.4 p -107.35 166.34 10.72 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.929 -1.108 . . . . 2.9300000000000002 112.067 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -56.86 -35.25 68.66 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.573 -1.194 . . . . 5.5499999999999998 109.967 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 24.0 mp0 -68.93 -47.72 65.02 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.052 -1.092 . . . . 3.54 108.052 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.427 ' OD2' ' NZ ' ' A' ' 51' ' ' LYS . 25.0 t70 -57.66 -49.96 74.74 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 117.793 -1.563 . . . . 2.5299999999999998 108.332 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -53.66 -54.46 37.42 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.017 -1.073 . . . . 2.27 108.367 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.46 -51.79 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.544 0.527 . . . . 6.4800000000000004 109.95 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -53.09 -54.32 37.32 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.38 -0.971 . . . . 5.4699999999999998 108.38 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' NZ ' ' OD2' ' A' ' 47' ' ' ASP . 46.5 mttp -55.72 -38.25 69.49 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.724 -1.126 . . . . 3.6299999999999999 110.523 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -59.54 -48.0 83.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 123.68 0.612 . . . . 2.4900000000000002 110.4 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.42 -40.47 2.72 Favored Glycine 0 N--CA 1.499 2.833 0 C-N-CA 120.152 -1.023 . . . . 4.2999999999999998 112.102 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -124.23 154.53 68.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 C-N-CA 120.066 -0.654 . . . . 11.199999999999999 109.316 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.11 70.05 6.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.91 2.407 . . . . 6.5999999999999996 113.563 -138.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.99 128.58 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.983 -0.687 . . . . 7.6600000000000001 109.97 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -122.15 67.23 0.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.75 -0.833 . . . . 8.8499999999999996 108.75 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 p -113.8 149.15 35.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.137 0.791 . . . . 6.0 113.137 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -117.92 144.13 34.0 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.086 -1.079 . . . . 4.3600000000000003 108.086 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.509 ' HG2' ' SG ' ' A' ' 14' ' ' CYS . 22.7 Cg_exo -66.31 171.05 39.35 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 123.933 -1.278 . . . . 3.8900000000000001 110.871 -18.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -130.55 152.65 49.7 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.845 -1.539 . . . . 3.5 106.845 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 mt -121.55 143.66 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 119.586 -0.845 . . . . 2.27 111.402 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -131.07 165.82 22.41 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.873 -1.512 . . . . 1.05 108.161 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.497 HG13 ' CH2' ' A' ' 78' ' ' TRP . 32.0 t -138.61 105.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 124.174 0.921 . . . . 2.3700000000000001 110.921 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' GLN . 3.6 t70 54.5 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.996 0.81 . . . . 2.96 113.019 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . 66.4 mt-30 -137.85 23.83 2.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 123.476 0.485 . . . . 6.3099999999999996 111.295 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -131.03 159.45 37.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.222 -1.029 . . . . 5.0800000000000001 108.222 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.506 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 7.6 t-160 -112.0 137.11 50.46 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 107.871 -1.159 . . . . 1.52 107.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.3 -46.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 119.682 -0.807 . . . . 2.8500000000000001 112.131 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.26 -98.94 0.56 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.856 -1.298 . . . . 1.3300000000000001 109.856 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.87 177.92 17.32 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 120.234 -0.984 . . . . 1.21 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -50.41 -47.43 56.51 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.787 -0.765 . . . . 2.1400000000000001 111.048 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -43.96 -57.26 3.42 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.609 0.718 . . . . 2.2799999999999998 111.11 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.71 -49.01 79.23 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.658 -1.155 . . . . 2.0499999999999998 109.069 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -44.82 -52.07 8.88 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.277 -0.969 . . . . 1.1200000000000001 110.145 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 -57.96 9.48 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 120.007 -0.677 . . . . 1.9399999999999999 111.562 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.34 42.35 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 118.372 -1.331 . . . . 2.1499999999999999 109.303 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.614 ' CH2' HD22 ' A' ' 83' ' ' LEU . 75.8 t90 -41.61 -52.4 3.79 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.323 -0.853 . . . . 1.1100000000000001 110.631 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -44.59 -46.2 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 115.551 -0.749 . . . . 2.0299999999999998 110.721 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HD3' ' C ' ' A' ' 80' ' ' LYS . 5.8 tmtm? -48.92 -38.77 23.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.981 1.104 . . . . 4.25 113.981 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -108.19 -31.72 7.79 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 114.716 1.376 . . . . 4.8399999999999999 114.716 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -83.5 -22.95 32.34 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.976 -1.49 . . . . 1.8899999999999999 110.574 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.614 HD22 ' CH2' ' A' ' 78' ' ' TRP . 3.3 mm? -108.6 -55.65 2.36 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.619 -0.832 . . . . 3.3199999999999998 108.949 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 O-C-N 126.852 2.595 . . . . 4.3200000000000003 112.728 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.8 mtm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.975 -1.12 . . . . 3.1099999999999999 107.975 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -113.73 116.45 29.43 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.489 0.493 . . . . 5.2699999999999996 110.743 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 24.1 m -110.81 119.04 37.8 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.013 -1.106 . . . . 1.74 108.013 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.405 ' C ' HD13 ' A' ' 5' ' ' ILE . 43.3 t -114.57 135.54 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 119.687 -0.805 . . . . 2.0299999999999998 111.248 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.3 mp -113.43 123.31 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 124.52 1.138 . . . . 2.1600000000000001 108.016 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -108.92 92.58 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.322 -2.103 . . . . 3.29 105.322 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.05 -171.81 15.9 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.04 -2.424 . . . . 1.6299999999999999 107.04 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -95.44 174.53 6.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 116.726 -1.99 . . . . 5.6900000000000004 110.365 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -55.76 76.65 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.906 -1.952 . . . . 6.9100000000000001 109.323 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 97.07 74.04 1.17 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 106.885 -2.486 . . . . 3.8599999999999999 106.885 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.1 t -111.95 94.9 26.8 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 119.749 -0.78 . . . . 6.4100000000000001 109.213 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -41.11 -21.77 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.368 2.045 . . . . 4.5999999999999996 113.026 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -72.85 -45.03 60.55 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.464 -1.294 . . . . 4.1500000000000004 109.339 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 5' ' ' ILE . 5.2 t -54.83 -39.8 68.94 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.283 -0.967 . . . . 4.8899999999999997 108.79 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.8 t -43.75 -36.56 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 115.387 -0.824 . . . . 2.3399999999999999 111.7 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.594 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 2.9 mmp_? -82.41 -45.63 14.57 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 119.106 -1.038 . . . . 4.21 109.708 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.03 60.76 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.683 -1.599 . . . . 1.5600000000000001 106.683 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.577 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.8 tmtt? -56.73 -59.62 4.76 Favored 'General case' 0 C--O 1.187 -2.187 0 CA-C-N 113.342 -1.754 . . . . 3.3900000000000001 108.657 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.577 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -48.58 -54.04 16.06 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 118.909 -1.116 . . . . 2.5099999999999998 111.141 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.51 -60.89 2.74 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.494 -0.775 . . . . 1.8400000000000001 110.574 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.82 77.73 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.278 -0.569 . . . . 1.8200000000000001 110.564 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 25' ' ' SER . 31.4 tt0 -56.24 -49.52 73.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 124.445 1.091 . . . . 1.95 109.528 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 26.0 tptp -49.95 -61.56 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.125 -1.03 . . . . 5.0300000000000002 108.259 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' O ' ' HD2' ' A' ' 28' ' ' ARG . 47.1 mt -50.6 -57.63 7.74 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.108 -1.071 . . . . 2.5899999999999999 108.108 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 8.3 t -34.59 -47.79 0.34 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.191 -1.368 . . . . 1.27 110.885 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.42 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -85.52 -30.72 23.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.628 1.205 . . . . 3.21 112.654 -179.24 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 28' ' ' ARG . 80.8 mt-10 -70.0 -32.45 70.63 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.071 -1.052 . . . . 3.2200000000000002 110.629 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.502 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.54 37.52 2.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.203 -1.399 . . . . 5.5800000000000001 113.831 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' ARG . 48.0 m-20 28.81 52.76 0.07 Allowed 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 114.611 1.337 . . . . 4.9000000000000004 114.611 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -155.18 -45.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 117.983 -1.487 . . . . 3.7000000000000002 113.679 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -81.38 69.04 7.93 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.553 -0.859 . . . . 2.6400000000000001 110.306 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -83.48 147.03 28.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.701 -1.222 . . . . 4.71 107.701 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 3' ' ' THR . 46.5 p90 -119.46 161.75 20.01 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.561 -1.255 . . . . 1.29 112.196 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -129.78 136.04 49.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.305 -1.316 . . . . 4.9500000000000002 107.91 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 3.6 t80 -113.7 117.94 32.95 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.615 -1.254 . . . . 2.48 107.615 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.13 146.9 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.833 -1.173 . . . . 2.2599999999999998 107.833 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.1 143.42 45.51 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.629 1.204 . . . . 2.3199999999999998 111.749 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.8 pt -56.93 -40.75 74.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 112.262 -2.245 . . . . 2.21 112.257 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.402 ' NH2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -86.41 -10.07 55.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.216 -0.994 . . . . 6.2000000000000002 111.656 -178.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.51 -49.02 6.92 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.699 -0.852 . . . . 2.1200000000000001 108.699 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.37 -37.66 43.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.669 -1.605 . . . . 3.6400000000000001 111.191 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 46.42 1.86 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.634 -1.786 . . . . 1.3600000000000001 108.634 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.441 HG22 ' HG ' ' A' ' 48' ' ' LEU . 22.2 mt -87.25 146.94 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.847 -1.168 . . . . 2.8100000000000001 107.847 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -110.64 176.4 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.919 -0.712 . . . . 3.3700000000000001 111.124 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -67.31 -57.77 6.04 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.188 -1.412 . . . . 6.25 107.188 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 1.7 mp0 -47.86 -48.51 31.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.753 -1.112 . . . . 4.5800000000000001 110.023 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.547 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 26.6 t70 -64.64 -56.59 12.87 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.353 -0.939 . . . . 2.02 110.48 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.441 ' HG ' HG22 ' A' ' 43' ' ' ILE . 1.3 mt -56.69 -40.23 75.23 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.459 -0.896 . . . . 2.3199999999999998 111.131 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -62.0 -43.83 98.0 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.722 -1.585 . . . . 4.3499999999999996 106.722 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -56.78 -40.05 75.17 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.276 -0.875 . . . . 4.6799999999999997 108.762 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 48.2 mmtm -64.12 -51.95 61.45 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.261 -0.882 . . . . 3.3900000000000001 111.459 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.62 70.06 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 112.877 0.695 . . . . 2.2999999999999998 112.877 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.36 -47.53 1.01 Allowed Glycine 0 N--CA 1.503 3.152 0 C-N-CA 119.44 -1.362 . . . . 2.7200000000000002 112.205 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -110.45 174.36 2.41 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.732 . . . . 8.5099999999999998 109.022 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.36 68.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.98 1.787 . . . . 6.5300000000000002 110.903 143.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.4 47.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.18 -1.045 . . . . 7.4400000000000004 108.18 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -82.66 72.47 9.73 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.908 -1.042 . . . . 8.1699999999999999 108.671 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 p -103.57 100.62 10.46 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.753 -1.112 . . . . 5.5599999999999996 108.798 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 m -74.56 138.36 74.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 C-N-CA 117.759 -1.576 . . . . 2.7000000000000002 109.598 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -93.91 137.56 6.87 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 O-C-N 122.932 0.964 . . . . 2.0699999999999998 111.623 7.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.402 ' NE2' HD21 ' A' ' 48' ' ' LEU . 7.2 mp0 -97.65 142.87 28.92 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.287 -1.746 . . . . 4.2699999999999996 106.287 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 62' ' ' ILE . 3.8 mp -115.29 143.77 24.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.416 -0.913 . . . . 2.8700000000000001 109.474 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.286 -1.779 . . . . 1.5900000000000001 108.785 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.67 118.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 105.466 -2.05 . . . . 2.0899999999999999 105.466 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 64.67 -86.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.621 -1.251 . . . . 3.27 107.621 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.62 5.3 1.04 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.084 -0.962 . . . . 4.25 109.204 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -91.2 162.16 14.76 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.359 -0.978 . . . . 4.4900000000000002 108.359 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -108.67 138.15 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.633 -0.877 . . . . 1.1699999999999999 108.633 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -106.87 -43.85 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.383 -0.927 . . . . 1.8999999999999999 109.151 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.7 -134.9 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.015 -1.634 . . . . 1.1499999999999999 109.015 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.44 179.27 25.62 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 108.969 -1.652 . . . . 1.1899999999999999 108.969 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -45.62 -38.52 6.71 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 118.953 -1.099 . . . . 2.2400000000000002 110.789 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -54.15 -63.29 1.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.372 0.606 . . . . 2.4100000000000001 109.72 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.79 -47.28 80.54 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.115 -0.948 . . . . 2.3599999999999999 108.538 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.422 ' CD1' HG22 ' A' ' 62' ' ' ILE . 42.4 t80 -47.16 -51.63 17.75 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.339 -0.846 . . . . 1.1599999999999999 110.536 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.11 -53.08 62.12 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.02 -1.072 . . . . 1.76 109.687 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.34 -56.43 16.72 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.139 -1.024 . . . . 1.8799999999999999 109.967 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -48.94 -57.62 6.19 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.038 -0.983 . . . . 0.79000000000000004 108.605 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 t -46.08 -52.84 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 124.255 0.972 . . . . 1.8100000000000001 108.725 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -57.73 -54.92 41.47 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.81 1.041 . . . . 4.4000000000000004 113.81 -178.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HA ' ' HZ3' ' A' ' 80' ' ' LYS . 1.5 pt-20 -73.11 -29.16 62.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.432 1.271 . . . . 4.4199999999999999 114.432 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -90.57 -31.94 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.803 -1.159 . . . . 1.8 109.919 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.16 53.07 0.93 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.749 -1.204 . . . . 2.8199999999999998 107.749 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.521 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 4.8 t0 . . . . . 0 C--N 1.289 -2.033 0 CA-C-N 114.345 -1.298 . . . . 4.7699999999999996 109.361 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 107.062 -1.458 . . . . 4.1200000000000001 107.062 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -106.44 107.04 17.85 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.529 -0.915 . . . . 5.0300000000000002 108.529 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.436 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 25.0 m -93.13 136.14 33.66 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.685 -0.806 . . . . 1.8999999999999999 109.403 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.418 ' C ' HD13 ' A' ' 5' ' ' ILE . 5.3 t -122.62 128.57 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 119.397 -0.921 . . . . 2.02 108.709 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.428 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 1.5 mp -111.27 136.98 45.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 124.29 0.994 . . . . 2.02 108.898 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -108.16 112.34 24.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 102.456 -3.164 . . . . 3.2000000000000002 102.456 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.51 ' HA2' ' SG ' ' A' ' 14' ' ' CYS . . . -109.32 -166.15 20.31 Favored Glycine 0 N--CA 1.501 2.975 0 C-N-CA 118.552 -1.785 . . . . 2.5800000000000001 114.195 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.473 HH12 ' CB ' ' A' ' 58' ' ' THR . 7.8 ttt85 -108.76 -141.6 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.892 -1.154 . . . . 9.1400000000000006 109.348 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.51 176.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.572 0.701 . . . . 6.5700000000000003 112.073 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.05 67.23 2.75 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.837 -0.905 . . . . 5.4299999999999997 110.837 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 50.5 t -128.37 152.75 78.63 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.247 -1.39 . . . . 5.7599999999999998 107.247 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 32.0 Cg_endo -70.21 67.16 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.42 1.414 . . . . 5.6699999999999999 111.334 172.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -109.4 -94.6 0.41 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.92 -1.141 . . . . 5.1200000000000001 107.92 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.51 ' SG ' ' HA2' ' A' ' 7' ' ' GLY . 46.5 m -52.46 -20.47 2.9 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.618 -0.833 . . . . 2.6600000000000001 109.132 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 18' ' ' LYS . 91.6 t -45.89 -33.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.923 -1.035 . . . . 4.0899999999999999 110.301 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.505 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -44.87 -35.84 3.0 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.461 -0.896 . . . . 3.7400000000000002 110.379 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.37 86.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.097 -1.446 . . . . 2.2599999999999998 107.097 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HZ3' ' CD ' ' A' ' 22' ' ' GLU . 3.3 tmpt? -57.7 -45.28 85.89 Favored 'General case' 0 C--O 1.196 -1.724 0 N-CA-C 107.855 -1.165 . . . . 2.8900000000000001 107.855 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 68.9 m-20 -63.09 -60.76 3.0 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.835 -0.62 . . . . 3.3100000000000001 109.788 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 tp -48.41 -55.21 11.45 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.951 -0.7 . . . . 1.98 109.815 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.33 82.21 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.872 -0.731 . . . . 2.0099999999999998 109.919 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.496 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 27.5 tt0 -45.43 -49.77 13.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 123.593 0.558 . . . . 1.96 110.789 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.467 ' HZ1' ' HB2' ' A' ' 27' ' ' GLU . 23.0 tptp -52.07 -56.22 15.77 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 118.316 -1.353 . . . . 5.4699999999999998 110.972 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.42 HD13 ' CG1' ' A' ' 79' ' ' VAL . 33.7 mt -52.7 -48.85 66.31 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.326 -1.731 . . . . 2.3999999999999999 106.326 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.19 -38.69 12.42 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.543 -2.117 . . . . 1.25 108.731 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -117.75 42.25 2.67 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.136 -0.938 . . . . 3.1099999999999999 110.201 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.486 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 30.8 tt0 -117.29 -59.63 1.92 Allowed 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.152 -1.425 . . . . 3.3100000000000001 107.152 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' HD3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -117.97 16.36 14.23 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.698 -2.334 . . . . 4.4400000000000004 104.698 177.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 34.46 47.2 0.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 123.221 1.486 . . . . 6.0 109.156 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.02 9.52 8.73 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 111.694 -2.503 . . . . 4.8200000000000003 111.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.436 ' CZ ' ' OG1' ' A' ' 3' ' ' THR . 21.0 t80 -134.85 147.73 49.96 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.963 -0.695 . . . . 2.1099999999999999 110.012 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -135.25 151.53 50.68 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.07 -0.715 . . . . 4.0300000000000002 109.07 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.421 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 42.6 p90 -139.29 155.94 47.38 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.2 -1.0 . . . . 1.6699999999999999 111.367 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -135.97 138.56 42.41 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.839 -1.171 . . . . 4.5700000000000003 107.839 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -114.05 133.27 55.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.749 -1.18 . . . . 1.8799999999999999 109.091 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.7 167.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.889 0.852 . . . . 2.29 110.857 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -118.48 128.12 54.29 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.296 -1.002 . . . . 2.1400000000000001 108.296 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.3 pt -43.81 -34.53 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.49 0.662 . . . . 2.6299999999999999 111.235 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 2.3 ttm105 -74.6 -54.97 6.44 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.222 -0.899 . . . . 7.3499999999999996 110.007 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -36.54 -55.13 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.168 0.918 . . . . 2.7000000000000002 112.237 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -74.6 -41.47 60.38 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 124.147 0.904 . . . . 4.5199999999999996 109.748 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.45 46.4 1.14 Allowed Glycine 0 N--CA 1.502 3.082 0 N-CA-C 108.317 -1.913 . . . . 2.0600000000000001 108.317 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mt -98.93 152.97 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.128 -1.036 . . . . 2.9700000000000002 110.474 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.1 p -116.69 141.3 48.38 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.768 -1.106 . . . . 3.27 108.852 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -45.04 -51.05 10.45 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.258 -0.977 . . . . 5.8700000000000001 110.807 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 2.7 mp0 -50.94 -47.25 61.12 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.875 -0.73 . . . . 5.8200000000000003 110.358 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.433 ' OD1' ' NZ ' ' A' ' 51' ' ' LYS . 4.5 t0 -53.94 -55.5 26.48 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.401 -0.92 . . . . 3.6699999999999999 108.55 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.21 -50.94 63.68 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 114.962 -1.017 . . . . 2.71 109.198 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.49 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 20.3 mt-30 -49.19 -49.24 43.61 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.293 -1.321 . . . . 6.5800000000000001 108.283 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.64 -55.94 19.65 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.79 -1.095 . . . . 6.0199999999999996 110.527 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' NZ ' ' OD1' ' A' ' 47' ' ' ASP . 41.3 mttp -53.88 -47.68 70.84 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 115.633 -0.712 . . . . 3.96 111.843 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.486 ' HA ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.31 -55.96 26.93 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.481 -1.236 . . . . 2.7999999999999998 112.601 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.29 -34.49 5.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.001 -1.64 . . . . 3.9500000000000002 109.001 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -106.21 146.37 32.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 120.09 -0.644 . . . . 7.6500000000000004 109.645 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.23 89.79 0.32 Allowed 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.825 2.35 . . . . 5.5199999999999996 111.635 -171.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.422 HG22 ' OE1' ' A' ' 61' ' ' GLN . 5.1 m -98.46 -177.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 C-N-CA 119.828 -0.749 . . . . 7.2800000000000002 109.102 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -110.15 -68.7 0.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.966 0.791 . . . . 7.5300000000000002 110.679 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.473 ' CB ' HH12 ' A' ' 8' ' ' ARG . 2.0 p -144.39 -61.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.645 1.212 . . . . 6.7000000000000002 109.746 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 27.4 m -132.11 178.76 1.6 Allowed Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 112.749 -2.023 . . . . 3.7400000000000002 107.863 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 28.7 Cg_endo -70.01 138.36 49.32 Favored 'Cis proline' 0 N--CA 1.491 1.335 0 O-C-N 122.994 0.997 . . . . 3.8500000000000001 111.369 -25.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.422 ' OE1' HG22 ' A' ' 56' ' ' VAL . 6.6 mm-40 -125.49 125.39 43.22 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.461 -0.94 . . . . 3.1099999999999999 108.461 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.537 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.5 mp -122.54 141.37 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.042 0.925 . . . . 3.2000000000000002 110.92 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -128.04 163.0 25.52 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 113.13 -1.85 . . . . 1.52 108.783 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.01 124.26 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 118.587 -0.72 . . . . 2.4700000000000002 109.252 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 50.95 -97.38 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.773 -0.771 . . . . 2.21 111.778 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -129.63 27.52 5.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.447 -1.252 . . . . 4.6500000000000004 111.02 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -130.66 168.61 16.86 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 116.293 -0.412 . . . . 4.46 111.019 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' ND1' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t-80 -116.72 144.34 44.56 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.964 -0.754 . . . . 1.3400000000000001 108.964 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.35 -54.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 118.612 -1.235 . . . . 2.25 109.602 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 144.47 -128.41 3.24 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.617 -1.277 . . . . 1.1699999999999999 110.626 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -111.96 -171.81 18.91 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.261 -1.447 . . . . 1.1799999999999999 110.284 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -44.99 -40.61 6.61 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.671 -1.211 . . . . 2.0499999999999998 109.694 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -55.21 -63.98 0.99 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.417 0.627 . . . . 2.3599999999999999 110.062 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -46.48 71.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.769 -1.105 . . . . 2.8799999999999999 110.002 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -61.23 -50.5 72.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.748 -0.781 . . . . 1.46 111.312 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.93 -57.07 10.51 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.569 -0.852 . . . . 2.21 109.441 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.16 24.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.688 -0.805 . . . . 1.9399999999999999 110.112 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -43.42 -46.9 6.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 124.118 0.886 . . . . 1.3700000000000001 109.395 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.42 ' CG1' HD13 ' A' ' 24' ' ' LEU . 19.1 t -62.75 -67.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.923 -1.035 . . . . 1.97 108.896 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -45.35 -34.99 3.29 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 115.845 1.794 . . . . 3.2799999999999998 115.845 -176.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.447 ' OE2' ' NZ ' ' A' ' 80' ' ' LYS . 1.3 mp0 -101.63 9.41 41.13 Favored 'General case' 0 N--CA 1.512 2.652 0 C-N-CA 118.376 -1.33 . . . . 4.71 113.841 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -128.07 -35.83 2.01 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.951 -0.7 . . . . 1.8100000000000001 109.325 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.92 23.13 14.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.546 -0.862 . . . . 2.54 109.643 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 8.7 t70 . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 107.382 -1.34 . . . . 3.9399999999999999 107.382 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.5 mpp? . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.226 1.013 . . . . 3.6800000000000002 109.291 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.444 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 2.0 mp0 -104.0 105.19 15.29 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.312 -1.313 . . . . 6.5999999999999996 108.173 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.4 m -97.26 117.99 32.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.338 -0.945 . . . . 1.9199999999999999 110.392 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.9 t -113.9 142.31 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 115.532 -0.758 . . . . 2.1200000000000001 109.79 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.7 mm -114.25 133.77 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.585 -2.006 . . . . 3.3500000000000001 105.585 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -121.65 80.09 1.64 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.629 -1.619 . . . . 2.48 106.629 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.28 -177.35 24.17 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.727 -1.225 . . . . 1.73 111.823 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -122.54 94.15 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.362 -1.347 . . . . 7.75 107.362 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.439 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 4.6 t -74.31 73.6 1.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.008 -1.077 . . . . 7.1699999999999999 111.097 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -41.02 -50.88 4.25 Favored Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.096 -0.802 . . . . 3.9199999999999999 111.096 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.414 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 17.3 m -111.87 -170.1 0.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 106.691 -1.596 . . . . 5.5599999999999996 106.691 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 52.8 Cg_exo -53.0 73.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 120.856 1.038 . . . . 5.25 111.409 153.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -119.54 -85.09 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.042 -0.725 . . . . 5.1799999999999997 109.042 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -60.19 -24.73 65.02 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 106.993 -1.484 . . . . 2.5499999999999998 106.993 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -43.81 -32.65 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 CA-C-N 114.278 -1.328 . . . . 2.5099999999999998 109.634 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -71.56 -50.12 34.13 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.55 -1.26 . . . . 4.4299999999999997 109.666 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.93 -44.46 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.018 -1.845 . . . . 1.6499999999999999 106.018 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.45 ' HD2' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -56.09 -58.91 5.93 Favored 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 113.712 -1.586 . . . . 3.2000000000000002 107.034 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -43.04 -57.96 2.65 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 120.11 -0.636 . . . . 3.52 110.798 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.98 -62.92 1.29 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.874 -1.057 . . . . 2.04 110.086 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.1 -54.57 33.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.15 -1.02 . . . . 1.8 109.28 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.481 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 41.5 tt0 -45.33 -52.63 9.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.088 0.867 . . . . 2.1099999999999999 110.778 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.532 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -58.85 -53.0 63.32 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.881 -1.128 . . . . 5.6200000000000001 108.457 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -51.93 -41.29 61.91 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.625 -0.83 . . . . 2.1600000000000001 110.233 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.1 p -73.9 -6.58 48.08 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.272 -0.971 . . . . 2.96 112.047 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -115.72 31.53 6.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.076 -1.453 . . . . 3.6699999999999999 107.076 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' CD ' ' HZ1' ' A' ' 23' ' ' LYS . 5.8 mm-40 -140.73 -51.65 0.47 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.009 -1.45 . . . . 4.5999999999999996 107.884 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.572 HH12 ' CG ' ' A' ' 30' ' ' ASP . 13.5 mtp-105 -93.63 -170.42 2.35 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.519 -1.218 . . . . 5.2400000000000002 111.119 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -111.09 -48.77 3.08 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.453 -0.794 . . . . 5.2599999999999998 111.24 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.572 ' CG ' HH12 ' A' ' 28' ' ' ARG . 2.8 p30 -83.33 8.1 14.57 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.533 -0.867 . . . . 2.7599999999999998 111.16 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 25' ' ' SER . 3.3 t80 -104.34 114.44 28.67 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.567 -0.853 . . . . 1.76 111.602 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -130.14 157.5 42.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.048 -1.834 . . . . 4.7300000000000004 106.048 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.481 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 21.2 p90 -129.47 160.89 31.74 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.411 -1.315 . . . . 1.3999999999999999 110.881 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -141.62 149.22 40.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.019 0.824 . . . . 5.5800000000000001 110.193 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -126.29 113.39 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.687 -1.597 . . . . 2.21 106.687 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.04 157.82 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.073 -1.825 . . . . 2.5099999999999998 106.073 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -124.74 140.46 52.91 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.28 -1.368 . . . . 2.5800000000000001 111.239 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.427 ' C ' HH11 ' A' ' 39' ' ' ARG . 16.7 pt -61.78 -21.94 27.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.066 -0.97 . . . . 2.5 111.517 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.462 ' CA ' HH11 ' A' ' 39' ' ' ARG . 3.3 tpp180 -95.43 -51.48 4.55 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.789 -0.819 . . . . 8.5800000000000001 108.789 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.75 -49.3 5.69 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.538 1.149 . . . . 2.1899999999999999 110.148 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -99.55 36.82 1.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.576 -0.85 . . . . 4.6399999999999997 112.553 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 34.27 65.16 0.36 Allowed Glycine 0 N--CA 1.512 3.715 0 CA-C-O 121.792 0.662 . . . . 2.04 114.168 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.442 HG22 ' HB3' ' A' ' 47' ' ' ASP . 58.1 mt -109.96 148.08 13.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.004 -0.598 . . . . 2.7400000000000002 109.607 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -126.18 177.86 6.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.965 -1.494 . . . . 2.75 106.965 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -51.68 -47.92 63.68 Favored 'General case' 0 C--O 1.191 -1.984 0 C-N-CA 119.798 -0.761 . . . . 6.0999999999999996 110.427 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 6.3 mp0 -44.18 -52.59 7.24 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 113.862 1.06 . . . . 3.52 113.862 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' HG22 ' A' ' 43' ' ' ILE . 50.2 t0 -65.97 -55.86 14.64 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.052 -1.059 . . . . 3.0299999999999998 109.564 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.489 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.2 mt -53.66 -42.33 67.75 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.548 -0.861 . . . . 2.0499999999999998 110.201 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -59.21 -42.26 90.53 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.174 -1.417 . . . . 4.6900000000000004 107.174 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.75 -20.92 60.36 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.851 -1.068 . . . . 4.4400000000000004 110.589 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -79.96 -46.48 16.61 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.959 -0.696 . . . . 4.4000000000000004 111.386 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.09 -28.3 11.1 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.73 -0.788 . . . . 2.2999999999999998 113.009 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.92 -56.76 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 105.767 -2.933 . . . . 4.0599999999999996 105.767 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.5 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 57.3 mttp 60.1 126.85 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.997 0 CA-C-O 123.266 1.508 . . . . 10.32 114.935 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.53 139.3 56.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.69 2.26 . . . . 4.5 109.391 96.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 58' ' ' THR . 7.9 p -74.35 72.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 118.952 -1.099 . . . . 7.2000000000000002 110.768 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' C ' ' HG1' ' A' ' 58' ' ' THR . 5.5 pt-20 -79.08 33.0 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 119.743 -0.783 . . . . 7.7300000000000004 112.169 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 56' ' ' VAL . 80.5 p 39.27 -109.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 115.035 1.494 . . . . 4.8600000000000003 115.035 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.87 149.33 72.77 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 114.219 -1.355 . . . . 2.6899999999999999 109.724 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.406 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 98.7 Cg_endo -96.37 -175.4 4.63 Favored 'Cis proline' 0 C--N 1.32 -0.925 0 O-C-N 123.15 1.079 . . . . 2.4399999999999999 110.049 0.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 1.9 mt-30 -138.89 133.78 32.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 124.489 1.118 . . . . 3.27 109.788 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.8 mt -118.07 140.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 120.107 -0.637 . . . . 2.4500000000000002 110.926 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.85 148.82 52.66 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.73 -1.577 . . . . 1.1299999999999999 110.658 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.559 HG13 ' CZ2' ' A' ' 78' ' ' TRP . 38.2 t -123.17 111.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.14 -1.059 . . . . 1.8100000000000001 108.14 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.98 -76.07 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.103 0.954 . . . . 3.21 109.403 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 64' ' ' VAL . 45.0 tt0 -142.94 -9.11 0.8 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.058 -1.428 . . . . 5.0899999999999999 110.663 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -92.12 168.79 11.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.746 -0.382 . . . . 5.6100000000000003 110.677 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.413 ' CE1' ' NE2' ' A' ' 61' ' ' GLN . 44.1 t-80 -119.19 153.17 35.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.708 -1.219 . . . . 1.54 107.708 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.0 -50.75 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 119.007 -1.077 . . . . 2.0899999999999999 109.698 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 164.98 -158.25 31.01 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.959 -1.656 . . . . 1.1899999999999999 108.959 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 60' ' ' PRO . . . -87.59 -67.6 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.88 -1.629 . . . . 2.8500000000000001 110.159 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 73' ' ' THR . 61.7 t80 -152.03 179.92 8.05 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.547 -0.861 . . . . 3.75 108.788 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 72' ' ' TYR . 85.0 m 67.73 -68.14 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.629 0.581 . . . . 3.6899999999999999 110.212 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.53 -51.1 5.21 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.105 0.955 . . . . 3.71 110.155 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.44 -36.96 2.16 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.615 -1.63 . . . . 1.51 112.696 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.59 -49.19 57.09 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.325 -0.95 . . . . 2.4700000000000002 109.848 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.06 62.51 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.463 -0.94 . . . . 2.6499999999999999 108.463 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.559 ' CZ2' HG13 ' A' ' 64' ' ' VAL . 78.3 t90 -46.61 -53.81 10.77 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.775 -1.102 . . . . 1.0600000000000001 109.038 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.42 -41.61 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.904 -1.119 . . . . 1.8100000000000001 109.534 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.506 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -65.01 -38.89 92.43 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.88 -1.054 . . . . 3.0499999999999998 113.437 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.37 -12.53 12.99 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 115.815 1.783 . . . . 4.71 115.815 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.436 ' CG ' ' NE1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -92.22 -16.33 26.34 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.544 -0.862 . . . . 1.74 109.996 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.6 mt -102.31 -73.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.454 -0.898 . . . . 3.4399999999999999 109.16 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.25 0 O-C-N 124.287 0.992 . . . . 4.1399999999999997 112.003 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.664 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.498 -0.556 . . . . 4.0599999999999996 109.498 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -94.1 96.97 9.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 123.703 0.627 . . . . 5.04 110.809 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.408 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 54.6 m -91.62 126.04 36.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.043 -0.725 . . . . 2.2200000000000002 109.043 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.434 ' C ' HD13 ' A' ' 5' ' ' ILE . 16.6 t -129.02 141.76 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.708 -1.197 . . . . 2.2999999999999998 109.664 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.5 mp -111.28 132.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.117 -2.179 . . . . 2.48 105.117 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 50.0 m-85 -124.2 116.31 22.49 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.262 -0.644 . . . . 2.3700000000000001 109.262 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.11 -179.35 20.47 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.251 -1.452 . . . . 3.4100000000000001 112.353 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -127.23 163.61 23.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.76 -0.72 . . . . 6.4100000000000001 109.623 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -106.11 -53.12 2.68 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.113 0.959 . . . . 8.7599999999999998 109.363 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.79 -61.51 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 105.814 -2.914 . . . . 5.8600000000000003 105.814 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 13' ' ' TYR . 9.6 m -96.24 170.39 7.61 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 106.388 -1.708 . . . . 5.3499999999999996 106.388 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.93 73.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.365 2.043 . . . . 3.8999999999999999 111.605 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' CYS . 6.3 t80 -119.63 -60.93 1.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.768 . . . . 5.54 108.925 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.627 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 29.8 m -54.64 -39.53 68.06 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 122.615 1.198 . . . . 2.9399999999999999 108.193 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.0 t -44.41 -50.29 2.01 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 CA-C-N 113.396 -1.729 . . . . 2.1099999999999999 111.278 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 8.5 mmm180 -56.92 -41.17 77.68 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.105 -1.038 . . . . 4.8200000000000003 110.243 -178.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.12 80.05 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.218 -1.401 . . . . 1.6499999999999999 107.218 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.627 ' HZ3' ' CD ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -57.2 -52.5 65.06 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.76 -1.176 . . . . 2.79 107.855 178.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.05 -52.17 9.26 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.458 -0.897 . . . . 3.1299999999999999 110.628 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 75' ' ' PHE . 40.9 tp -58.49 -60.38 3.89 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 120.41 -0.516 . . . . 1.8100000000000001 110.656 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.31 -44.22 44.13 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.969 -1.014 . . . . 1.73 109.45 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.627 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 27.8 tt0 -62.91 -51.46 66.84 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 124.709 1.256 . . . . 1.74 109.358 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -50.21 -56.16 12.25 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.394 -0.922 . . . . 5.1200000000000001 108.674 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.444 HD13 HG22 ' A' ' 79' ' ' VAL . 44.6 mt -57.3 -44.36 84.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.341 1.026 . . . . 2.1600000000000001 109.179 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 t -51.89 -29.9 21.78 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.979 -1.464 . . . . 1.24 109.61 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 5.9 t-20 -96.38 25.77 4.79 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.152 -0.931 . . . . 2.71 110.935 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.7 mt-10 -138.74 -35.44 0.58 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.504 -0.771 . . . . 2.52 110.537 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.545 ' C ' ' H ' ' A' ' 30' ' ' ASP . 43.3 mtp85 -114.71 129.86 56.74 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.759 -0.776 . . . . 4.5199999999999996 112.017 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.16 32.56 0.28 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.242 1.02 . . . . 3.6200000000000001 109.742 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.545 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.3 p30 -136.49 -1.7 2.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.708 -1.587 . . . . 3.1600000000000001 109.243 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.408 ' CZ ' ' OG1' ' A' ' 3' ' ' THR . 8.6 t80 -120.64 124.53 45.47 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.653 0.739 . . . . 1.24 112.635 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -142.76 155.13 44.8 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.131 -1.433 . . . . 6.1200000000000001 107.131 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -134.76 163.88 28.81 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.105 -1.438 . . . . 1.27 112.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.65 154.52 44.43 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 124.604 1.19 . . . . 6.4299999999999997 109.389 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -127.88 124.63 37.94 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.9 -0.72 . . . . 4.1799999999999997 110.162 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.41 149.88 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.379 -1.341 . . . . 2.6000000000000001 107.379 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -123.55 124.91 43.89 Favored 'General case' 0 N--CA 1.51 2.57 0 C-N-CA 117.816 -1.554 . . . . 2.3700000000000001 110.412 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 pt -43.5 -38.76 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 113.435 -1.711 . . . . 2.7799999999999998 114.017 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 24.35 6.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.237 -0.985 . . . . 9.8100000000000005 112.905 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.95 -43.96 2.74 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.012 -1.107 . . . . 2.48 108.012 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -92.45 -28.68 16.69 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.686 -1.597 . . . . 5.96 111.288 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.4 0.66 Allowed Glycine 0 N--CA 1.503 3.103 0 C-N-CA 119.364 -1.398 . . . . 1.95 111.132 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.9 mt -112.46 156.84 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.665 -0.814 . . . . 3.3399999999999999 108.984 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -101.24 -170.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.428 -0.953 . . . . 3.54 108.428 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -49.98 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.722 -1.584 . . . . 5.4299999999999997 106.722 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.69 -52.25 24.38 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.372 -0.931 . . . . 3.8700000000000001 110.118 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.531 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 1.0 OUTLIER -48.85 -44.93 40.11 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 120.064 -0.654 . . . . 2.6499999999999999 111.49 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 1.8 mt -70.14 -42.83 72.06 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.886 0.85 . . . . 2.5699999999999998 109.011 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -58.27 -32.48 68.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.625 -1.25 . . . . 5.7300000000000004 107.625 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 0.96 7.74 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.048 -1.433 . . . . 5.5300000000000002 110.263 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 57.3 mttp -115.85 -42.72 3.06 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.57 -1.195 . . . . 3.1299999999999999 109.824 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -81.02 -50.89 9.12 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.358 -0.837 . . . . 2.04 111.476 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.74 -55.54 2.28 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.65 -2.18 . . . . 2.77 107.65 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 58' ' ' THR . 44.4 mtmt 31.14 -147.39 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 CA-C-N 112.526 -1.837 . . . . 8.5999999999999996 113.566 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 57.2 Cg_endo -92.37 -166.95 0.17 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.962 1.775 . . . . 5.04 112.416 128.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -98.52 81.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.369 -0.832 . . . . 7.7300000000000004 109.543 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -115.4 -94.25 0.48 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.948 1.092 . . . . 5.4100000000000001 113.948 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.574 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.3 m -142.86 -156.05 0.65 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 118.972 -1.091 . . . . 5.1100000000000003 113.738 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.522 ' H ' HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -114.78 -169.05 0.14 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 114.389 -1.278 . . . . 4.7000000000000002 108.966 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.627 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 31.7 Cg_endo -68.57 -175.42 9.49 Favored 'Cis proline' 0 N--CA 1.499 1.815 0 O-C-N 122.182 0.57 . . . . 3.2799999999999998 111.553 -28.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -134.74 150.95 50.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 123.976 0.798 . . . . 3.6600000000000001 111.864 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mt -123.67 142.51 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.711 -1.218 . . . . 2.0499999999999998 107.711 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.21 156.56 48.5 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.844 -1.071 . . . . 1.4299999999999999 110.004 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.6 t -138.12 115.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.017 -0.673 . . . . 2.25 109.653 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 1' ' ' MET . 1.2 m-20 54.44 -101.94 0.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.253 -1.017 . . . . 3.2799999999999998 108.253 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -125.75 39.55 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.857 -0.794 . . . . 4.9699999999999998 108.857 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -127.51 161.78 27.97 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.416 -0.811 . . . . 4.6200000000000001 109.984 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.509 ' CD2' ' N ' ' A' ' 69' ' ' ILE . 5.5 t-160 -122.54 142.42 50.62 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.753 -1.203 . . . . 1.5 107.753 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.509 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 28.1 mm -101.33 -99.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 118.704 -1.198 . . . . 2.8100000000000001 107.877 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.42 65.29 0.21 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.401 -1.38 . . . . 4.2300000000000004 110.611 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.66 -175.33 17.52 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.995 -1.642 . . . . 2.4199999999999999 108.995 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' PHE . 13.6 t80 -110.08 -60.75 1.75 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.356 -0.938 . . . . 2.4900000000000002 109.947 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -46.09 -34.11 3.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.578 -1.638 . . . . 5.1399999999999997 106.578 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.6 -44.11 97.61 Favored 'General case' 0 C--O 1.2 -1.537 0 CA-C-N 113.077 -1.874 . . . . 3.4100000000000001 108.87 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 20' ' ' LEU . 11.9 t80 -63.45 -41.52 98.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.476 -0.935 . . . . 1.3700000000000001 108.476 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -62.48 -56.15 20.86 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.365 -0.934 . . . . 2.27 108.966 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.15 43.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.325 -1.361 . . . . 2.3399999999999999 107.325 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.424 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 80.1 t90 -36.47 -54.73 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.981 0.801 . . . . 1.23 110.413 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.444 HG22 HD13 ' A' ' 24' ' ' LEU . 41.4 t -43.92 -60.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 115.199 -0.91 . . . . 2.2799999999999998 111.92 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -44.33 -29.61 0.7 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.614 0.968 . . . . 3.7799999999999998 113.614 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -109.06 -27.02 9.86 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.628 -0.829 . . . . 4.1299999999999999 113.044 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -83.98 -34.13 24.43 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.042 -1.063 . . . . 1.8400000000000001 111.017 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 68.0 mt -102.47 -44.79 5.26 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.042 -1.836 . . . . 3.4500000000000002 106.042 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 126.497 2.373 . . . . 5.1900000000000004 111.501 179.551 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.453 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.344 0.592 . . . . 3.3100000000000001 110.04 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -109.65 99.44 8.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.579 -2.378 . . . . 5.71 104.579 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.447 HG23 ' CE1' ' A' ' 75' ' ' PHE . 27.1 m -88.4 103.42 15.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.906 -1.497 . . . . 1.9199999999999999 109.868 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 63.3 t -94.47 130.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.751 -0.659 . . . . 2.2799999999999998 110.292 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.43 HG22 ' SG ' ' A' ' 14' ' ' CYS . 1.6 mp -113.74 116.86 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.411 -1.7 . . . . 2.25 106.411 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.606 ' CE2' HD12 ' A' ' 43' ' ' ILE . 2.8 m-30 -106.33 98.38 8.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.826 -1.916 . . . . 3.79 105.826 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 60' ' ' PRO . . . -130.59 -159.99 9.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.42 -1.371 . . . . 1.6200000000000001 112.481 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' CZ ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -124.4 130.1 51.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.02 -1.474 . . . . 6.0700000000000003 107.02 179.016 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.474 ' OG ' ' CZ ' ' A' ' 8' ' ' ARG . 1.6 p -51.77 106.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.632 -0.827 . . . . 5.3899999999999997 108.95 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . 134.08 -12.42 4.73 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.699 -1.238 . . . . 3.6099999999999999 111.16 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 97.1 m -95.3 90.94 0.66 Allowed Pre-proline 0 N--CA 1.501 2.122 0 C-N-CA 119.493 -0.883 . . . . 5.8799999999999999 110.682 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 10' ' ' GLY . 28.3 Cg_endo -58.78 -3.57 1.55 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.741 2.961 . . . . 4.2300000000000004 112.719 -162.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 11' ' ' CYS . 9.5 m-30 -71.44 -37.27 71.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.62 -1.252 . . . . 5.46 107.62 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 3.6 t -58.56 -43.19 89.29 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.143 -1.423 . . . . 4.1600000000000001 108.21 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.42 -57.74 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.428 -0.952 . . . . 2.3500000000000001 108.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 6.5 mmp_? -49.93 -48.45 51.81 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.649 -1.22 . . . . 4.7300000000000004 109.649 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.0 -54.77 40.86 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.887 -1.525 . . . . 1.6699999999999999 108.266 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -46.22 -49.08 17.58 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.177 -0.609 . . . . 2.8199999999999998 109.879 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.462 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 35.1 m-20 -63.28 -55.68 22.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.887 -0.597 . . . . 3.29 110.188 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.5 tp -48.53 -55.73 10.27 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.987 -1.085 . . . . 1.8100000000000001 109.239 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.69 -36.22 73.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.656 -0.818 . . . . 1.8999999999999999 109.668 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.6 tt0 -51.31 -47.55 62.58 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.051 -1.059 . . . . 1.8999999999999999 109.819 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -44.73 -60.15 2.16 Favored 'General case' 0 N--CA 1.514 2.751 0 C-N-CA 119.419 -0.912 . . . . 7.8600000000000003 109.657 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 47.6 mt -45.53 -52.39 10.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.224 -1.353 . . . . 3.4399999999999999 107.916 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -53.48 -37.34 62.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.662 -1.608 . . . . 1.3999999999999999 111.415 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -104.22 37.1 2.17 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.048 0.928 . . . . 2.8900000000000001 108.549 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 28' ' ' ARG . 58.9 tt0 -130.11 -51.39 1.11 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.177 -1.374 . . . . 4.7599999999999998 107.517 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 27' ' ' GLU . 9.7 ptp180 -124.79 -178.39 4.14 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 112.368 -2.196 . . . . 3.8500000000000001 108.619 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -116.29 27.95 8.9 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.486 0.66 . . . . 4.6200000000000001 110.685 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -120.26 -8.41 9.68 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.453 -0.794 . . . . 3.0600000000000001 112.701 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -108.68 130.15 55.34 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.109 1.522 . . . . 1.72 115.109 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' N ' ' NE2' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -138.31 153.14 49.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.891 -1.152 . . . . 4.5199999999999996 107.891 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.91 156.25 35.04 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.528 -0.869 . . . . 1.23 109.978 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -130.12 118.22 21.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.62 0.575 . . . . 5.5599999999999996 109.914 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.496 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -107.47 112.62 25.49 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.721 -0.792 . . . . 3.3199999999999998 109.287 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 156.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 123.89 0.744 . . . . 2.7999999999999998 109.642 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -114.06 131.47 56.37 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 106.869 -1.53 . . . . 2.3599999999999999 106.869 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 pt -47.78 -39.96 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 114.348 1.24 . . . . 2.1600000000000001 114.348 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -85.98 -45.14 11.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.607 -1.637 . . . . 6.1799999999999997 108.422 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 39' ' ' ARG . . . -35.38 -56.86 0.62 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 124.068 0.855 . . . . 2.8999999999999999 110.918 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -105.5 44.53 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 124.083 0.864 . . . . 5.7400000000000002 110.97 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 23.53 68.15 0.03 OUTLIER Glycine 0 N--CA 1.504 3.215 0 CA-C-N 114.773 -1.103 . . . . 2.29 114.597 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.606 HD12 ' CE2' ' A' ' 6' ' ' PHE . 34.3 mt -101.08 140.26 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.432 -1.692 . . . . 2.98 106.432 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.9 p -104.41 169.98 8.16 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.442 -0.903 . . . . 3.8599999999999999 111.195 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.467 ' CA ' ' HZ1' ' A' ' 45' ' ' LYS . 5.0 mmmp? -70.83 -35.33 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 117.806 -1.558 . . . . 5.7300000000000004 111.963 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.72 -55.18 38.26 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.924 -1.51 . . . . 6.5499999999999998 106.924 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.465 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 25.0 t70 -48.68 -48.1 40.27 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 115.094 -0.957 . . . . 2.8500000000000001 111.657 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.84 -50.22 67.5 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.836 -1.074 . . . . 2.6000000000000001 110.743 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.45 -45.44 66.04 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.418 -1.327 . . . . 5.2400000000000002 107.418 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -23.33 40.13 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.613 -1.63 . . . . 5.04 111.211 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 7.9 mtmm -96.8 -32.74 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.308 -0.557 . . . . 3.1600000000000001 110.849 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB1' HE22 ' A' ' 61' ' ' GLN . . . -75.41 -44.26 45.6 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.093 -0.643 . . . . 2.46 112.021 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.0 -48.75 0.91 Allowed Glycine 0 N--CA 1.501 3.031 0 N-CA-C 108.232 -1.947 . . . . 3.3199999999999998 108.232 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.565 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 3.8 ttpm? -91.4 166.58 17.88 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.245 -2.131 . . . . 7.0899999999999999 105.245 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.565 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.5 Cg_endo -48.22 155.61 1.92 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.685 -1.313 . . . . 6.1100000000000003 108.685 146.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 m -118.79 149.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.897 -1.121 . . . . 5.9699999999999998 110.562 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' C ' ' HG1' ' A' ' 58' ' ' THR . 15.6 mp0 -87.19 -69.47 0.68 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.073 0.858 . . . . 6.2999999999999998 111.17 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.473 ' HG1' ' C ' ' A' ' 57' ' ' GLU . 26.7 m -143.8 173.64 11.5 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.731 -0.788 . . . . 4.6100000000000003 110.871 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 15.7 m -101.92 159.17 30.18 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.818 -1.179 . . . . 2.71 107.818 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 10.0 Cg_endo -92.01 147.26 14.33 Favored 'Cis proline' 0 C--N 1.318 -1.057 0 CA-C-N 118.554 0.519 . . . . 2.0299999999999998 111.454 9.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.413 HE22 ' HB1' ' A' ' 52' ' ' ALA . 18.6 mt-30 -107.78 147.47 30.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.922 -0.711 . . . . 3.5499999999999998 109.47 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.456 HD11 ' CG ' ' A' ' 75' ' ' PHE . 4.4 mt -121.18 141.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.268 -0.973 . . . . 2.6699999999999999 112.489 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 19.7 m-85 -128.62 153.28 47.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 114.608 -1.178 . . . . 1.29 108.998 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.6 t -122.33 102.05 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.487 -1.301 . . . . 2.0299999999999998 107.487 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 1' ' ' MET . 37.2 m-20 65.49 -83.58 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.772 0.796 . . . . 2.3799999999999999 110.25 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -126.3 -15.43 5.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.398 -1.274 . . . . 5.4000000000000004 109.717 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -81.37 167.86 19.0 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.421 -0.512 . . . . 4.5099999999999998 111.27 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -123.43 136.26 54.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.439 -1.689 . . . . 1.51 106.439 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 75' ' ' PHE . 26.0 mm -107.07 -31.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.33 -0.948 . . . . 1.8400000000000001 110.204 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.4 -117.98 3.8 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.48 -1.448 . . . . 1.3300000000000001 109.48 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.36 -172.77 18.96 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.285 -1.126 . . . . 1.3200000000000001 110.285 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -56.01 -53.21 59.67 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.095 -1.042 . . . . 2.1800000000000002 113.253 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 p -40.92 -58.63 1.65 Allowed 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.726 -0.79 . . . . 1.97 110.833 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.56 -57.74 10.68 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 113.677 -1.601 . . . . 2.0499999999999998 108.964 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CG ' HD11 ' A' ' 62' ' ' ILE . 70.1 t80 -45.82 -52.91 10.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.747 -0.781 . . . . 1.23 111.497 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -55.99 18.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.469 -0.892 . . . . 2.1099999999999999 109.145 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.62 -58.98 5.36 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.623 -0.831 . . . . 1.8999999999999999 109.518 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 82' ' ' ASN . 74.3 t90 -41.99 -53.61 3.8 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.738 -0.664 . . . . 1.1299999999999999 109.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.18 -60.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 124.094 0.871 . . . . 1.8999999999999999 109.796 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.78 -55.79 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.127 1.158 . . . . 3.8599999999999999 114.127 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -93.42 28.6 2.2 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 117.184 -1.807 . . . . 5.4900000000000002 114.305 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 78' ' ' TRP . 40.9 m-80 -140.2 -36.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 119.124 -1.03 . . . . 2.8599999999999999 110.195 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.0 -26.25 9.36 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.518 -0.765 . . . . 2.48 111.161 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 124.002 0.814 . . . . 6.5700000000000003 110.365 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.47 0.652 . . . . 4.0999999999999996 110.013 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.74 160.77 14.05 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.15 -0.932 . . . . 7.2199999999999998 111.602 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.3 m -124.68 146.61 49.03 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 109.843 -0.429 . . . . 1.8899999999999999 109.843 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.77 132.95 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.415 -0.957 . . . . 2.9100000000000001 108.415 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mp -118.29 121.99 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.48 -0.933 . . . . 2.1200000000000001 108.48 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -115.04 113.57 24.24 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 106.745 -1.576 . . . . 2.2799999999999998 106.745 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . 160.94 -169.3 36.54 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.279 -1.915 . . . . 1.8100000000000001 108.443 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -126.51 173.66 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 116.854 -1.938 . . . . 5.6299999999999999 112.3 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.12 -179.96 4.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.008 -1.451 . . . . 6.7300000000000004 109.778 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.48 -49.22 0.91 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.116 -1.993 . . . . 4.4800000000000004 108.116 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.8 t -128.24 101.04 22.44 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 107.391 -1.337 . . . . 5.0099999999999998 107.391 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 14' ' ' CYS . 2.3 Cg_endo -31.05 -56.14 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.634 2.223 . . . . 5.1600000000000001 113.06 -122.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 53.15 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.874 1.065 . . . . 6.5199999999999996 113.874 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' PRO . 18.2 m -115.85 -6.22 12.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.348 -0.541 . . . . 2.4199999999999999 110.797 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -43.03 -57.54 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 119.743 -0.783 . . . . 3.4700000000000002 111.78 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.592 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -60.09 -35.47 75.27 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 117.481 -1.688 . . . . 5.2400000000000002 109.891 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.27 -51.64 68.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.177 -1.409 . . . . 1.74 107.667 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 18.0 tptp -53.14 -50.52 64.38 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 120.26 -0.576 . . . . 3.6600000000000001 111.724 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.592 ' CG ' HH22 ' A' ' 16' ' ' ARG . 6.9 t0 -66.36 -53.91 30.71 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.784 0.802 . . . . 2.6600000000000001 110.165 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 tp -49.93 -53.44 26.13 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.199 -1.037 . . . . 2.6000000000000001 108.199 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.95 76.18 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.427 -0.953 . . . . 2.3500000000000001 108.427 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 4.8 tp10 -46.68 -62.98 1.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.465 1.126 . . . . 2.9100000000000001 110.677 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.42 -50.1 17.18 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 113.585 -1.643 . . . . 4.8700000000000001 110.921 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 mt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.169 -0.923 . . . . 2.77 110.321 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -58.52 -40.89 84.14 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.024 -0.732 . . . . 1.5900000000000001 109.024 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -89.05 29.84 1.01 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.947 -1.131 . . . . 2.7400000000000002 107.947 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -120.82 -59.19 1.77 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.257 -1.016 . . . . 3.4700000000000002 108.257 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.475 HH12 ' CG ' ' A' ' 84' ' ' ASP . 3.4 mtt180 -116.5 152.28 34.39 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.352 -0.981 . . . . 4.75 108.352 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -74.98 -36.05 62.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.644 -0.822 . . . . 4.9100000000000001 110.176 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 30' ' ' ASP . 5.5 t70 -83.51 41.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.666 -0.813 . . . . 4.3099999999999996 109.998 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 25' ' ' SER . 50.9 t80 -142.65 72.43 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.322 -0.951 . . . . 1.6899999999999999 108.622 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -100.2 138.13 37.69 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.272 -1.01 . . . . 4.5899999999999999 108.272 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -118.36 155.77 30.11 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.15 -1.02 . . . . 1.6399999999999999 112.84 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -121.69 130.21 53.3 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 4.4900000000000002 107.92 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -119.49 114.6 22.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.65 -1.241 . . . . 2.21 107.65 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.84 145.93 32.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.483 -0.781 . . . . 4.1200000000000001 109.653 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 11.3 t70 -97.62 140.19 32.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.126 -1.435 . . . . 3.21 107.126 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.424 ' C ' HH11 ' A' ' 39' ' ' ARG . 9.5 pt -48.31 -29.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 112.895 0.702 . . . . 3.2200000000000002 112.895 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HA ' HH11 ' A' ' 39' ' ' ARG . 0.7 OUTLIER -94.75 22.65 6.14 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.276 -0.97 . . . . 8.1400000000000006 111.749 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.2 -50.68 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.246 -0.581 . . . . 2.1099999999999999 109.662 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -95.58 -13.81 24.1 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.5 -0.88 . . . . 3.3700000000000001 109.755 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.59 58.76 1.17 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.137 -1.985 . . . . 1.5600000000000001 108.137 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -101.1 141.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 120.117 -0.633 . . . . 3.2400000000000002 111.582 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 p -123.14 161.54 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 124.538 1.149 . . . . 3.73 109.437 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -43.91 -57.34 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.705 -0.68 . . . . 5.2300000000000004 109.493 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -44.49 -49.28 9.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 123.826 0.704 . . . . 3.8500000000000001 111.128 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.491 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 11.8 t70 -60.78 -50.66 72.58 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.976 -1.49 . . . . 3.0800000000000001 109.221 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -42.82 64.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.152 -0.931 . . . . 2.75 108.92 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.0 -47.87 79.8 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.6 -1.259 . . . . 5.0700000000000003 107.6 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -60.19 -50.29 74.25 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.984 0.803 . . . . 5.8099999999999996 110.562 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.491 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 2.8 tppt? -55.62 -50.23 70.71 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.428 -1.26 . . . . 4.4100000000000001 111.508 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.565 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -74.24 -47.49 34.92 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.315 -1.311 . . . . 1.8100000000000001 113.077 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.86 42.71 5.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.048 -1.621 . . . . 2.48 109.048 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 75.5 mmtt -128.41 -176.29 0.51 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.521 -0.918 . . . . 6.9800000000000004 108.521 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 50.9 Cg_exo -50.82 -157.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.46 1.44 . . . . 4.75 111.235 147.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 m -114.16 70.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.784 -0.643 . . . . 7.0300000000000002 112.273 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 3.1 mp0 -75.03 54.51 0.67 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.14 -0.936 . . . . 6.1699999999999999 112.217 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.465 ' HG1' ' C ' ' A' ' 57' ' ' GLU . 81.3 p 41.26 -112.53 0.16 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 115.666 1.728 . . . . 4.7800000000000002 115.666 178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.12 171.55 6.43 Favored Pre-proline 0 N--CA 1.498 1.955 0 CA-C-N 115.569 -0.741 . . . . 3.1699999999999999 109.402 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.51 173.35 11.98 Favored 'Cis proline' 0 N--CA 1.487 1.109 0 O-C-N 122.616 0.798 . . . . 2.1899999999999999 110.351 -20.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.75 150.49 49.78 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.905 . . . . 3.3799999999999999 110.521 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.418 ' C ' ' CD1' ' A' ' 63' ' ' PHE . 48.2 mt -123.16 148.03 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.747 -0.66 . . . . 2.1699999999999999 109.267 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 9.4 m-85 -131.06 165.39 23.34 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.767 -1.106 . . . . 1.4099999999999999 109.494 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.426 HG12 ' CZ2' ' A' ' 78' ' ' TRP . 55.7 t -134.8 112.31 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.481 -1.236 . . . . 2.0299999999999998 110.148 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.94 -85.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.464 0.542 . . . . 2.6400000000000001 112.464 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 64' ' ' VAL . 54.0 mt-30 -139.13 23.18 2.58 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.82 -0.627 . . . . 5.3700000000000001 110.334 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -123.99 153.96 40.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.398 -0.964 . . . . 4.6600000000000001 108.398 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.565 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 7.0 t-160 -108.6 139.77 42.91 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.829 -1.174 . . . . 1.3300000000000001 107.829 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.75 -45.94 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 118.744 -1.183 . . . . 1.9099999999999999 110.032 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.415 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 138.21 -123.83 2.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.391 -1.484 . . . . 1.3700000000000001 109.391 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.11 -174.72 19.64 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.147 -1.181 . . . . 1.4399999999999999 110.147 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -47.4 -60.33 2.59 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.817 1.043 . . . . 3.1099999999999999 113.817 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -36.31 -59.82 0.61 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.685 1.231 . . . . 2.8599999999999999 111.369 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -51.78 68.32 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.374 -2.193 . . . . 2.0800000000000001 109.584 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -47.15 -50.54 20.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.516 -1.274 . . . . 1.1200000000000001 109.632 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.09 13.14 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.51 -1.276 . . . . 2.1800000000000002 109.253 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.25 -54.12 35.23 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.484 -0.886 . . . . 1.8899999999999999 110.861 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.426 ' CZ2' HG12 ' A' ' 64' ' ' VAL . 89.7 t90 -51.17 -50.58 58.7 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.146 -0.479 . . . . 0.81000000000000005 110.441 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -49.41 -50.62 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.213 -0.903 . . . . 2.3300000000000001 111.681 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -40.42 -38.5 0.83 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.703 1.372 . . . . 3.0099999999999998 114.703 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.88 -25.8 6.67 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.973 1.101 . . . . 5.6399999999999997 113.973 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -79.47 -14.36 58.95 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 117.491 -1.683 . . . . 1.9199999999999999 108.101 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -121.8 13.34 10.7 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.905 -1.146 . . . . 2.8700000000000001 107.905 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.475 ' CG ' HH12 ' A' ' 28' ' ' ARG . 3.7 p30 . . . . . 0 N--CA 1.488 1.472 0 CA-C-N 113.469 -1.696 . . . . 6.2300000000000004 114.661 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 107.996 -1.113 . . . . 3.4300000000000002 107.996 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -109.67 128.77 55.48 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.194 -0.669 . . . . 5.8700000000000001 109.194 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -112.71 125.07 53.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.731 -0.788 . . . . 1.8999999999999999 109.476 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.404 ' CG1' ' HB2' ' A' ' 63' ' ' PHE . 14.5 p -121.35 144.46 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.405 -0.918 . . . . 4.0499999999999998 109.362 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -118.35 118.77 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 125.173 1.545 . . . . 3.54 108.98 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -107.81 73.41 0.9 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.446 -1.687 . . . . 2.6499999999999999 106.446 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.4 -179.66 21.84 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.786 -1.673 . . . . 2.0699999999999998 111.431 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 126.47 52.68 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.076 -1.824 . . . . 7.3099999999999996 106.076 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -117.29 -168.19 1.44 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.139 0.971 . . . . 7.7199999999999998 112.768 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.56 -47.32 1.02 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.253 -1.939 . . . . 4.2199999999999998 108.253 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.91 116.25 31.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.476 -1.305 . . . . 6.3399999999999999 107.476 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 14' ' ' CYS . 50.1 Cg_exo -17.74 -68.49 0.02 OUTLIER 'Trans proline' 0 C--O 1.197 -1.533 0 C-N-CA 122.598 2.199 . . . . 4.8300000000000001 112.924 -127.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 47.36 -66.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 113.028 0.751 . . . . 6.4699999999999998 113.028 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 12' ' ' PRO . 23.5 m -116.39 -18.75 10.37 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.468 -0.893 . . . . 2.29 109.544 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -47.03 -33.94 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.266 -0.573 . . . . 2.23 110.479 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.511 HH21 ' CB ' ' A' ' 19' ' ' ASP . 1.2 mmp_? -78.64 -38.15 40.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.853 -1.139 . . . . 4.4299999999999997 110.408 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.9 -49.24 73.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.954 -1.869 . . . . 1.73 105.954 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.439 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 3.7 tmtm? -57.44 -51.58 68.85 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.641 -1.163 . . . . 2.5600000000000001 110.047 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.511 ' CB ' HH21 ' A' ' 16' ' ' ARG . 9.7 t70 -57.66 -59.12 5.69 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.394 -0.922 . . . . 2.73 109.401 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 tp -49.07 -60.08 3.08 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.883 0.849 . . . . 1.96 109.599 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.66 -53.13 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.668 -1.151 . . . . 2.0 109.362 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.439 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 tt0 -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.212 1.006 . . . . 2.0699999999999998 108.615 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.424 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -49.11 -49.99 39.27 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.11 -1.405 . . . . 5.5099999999999998 107.984 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.1 mt -63.89 -31.54 72.76 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.848 -0.797 . . . . 2.4199999999999999 108.848 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 t -64.06 -29.52 70.65 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.173 -1.788 . . . . 1.28 106.173 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.458 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 7.0 t30 -95.73 32.38 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.014 -1.106 . . . . 2.6600000000000001 108.014 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 40.5 mt-10 -130.09 -66.06 0.8 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.681 -1.145 . . . . 2.79 108.791 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.3 mpt_? -116.17 132.72 56.58 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 108.258 -1.016 . . . . 5.6200000000000001 108.258 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.5 30.06 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.775 -0.77 . . . . 4.25 111.732 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -112.78 -25.82 8.88 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.141 -1.429 . . . . 2.8399999999999999 107.141 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -98.02 117.64 32.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.574 -1.194 . . . . 1.5900000000000001 112.999 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -124.27 136.59 54.25 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.136 -1.847 . . . . 4.3300000000000001 106.551 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.428 ' C ' ' NE2' ' A' ' 34' ' ' GLN . 7.9 p90 -117.66 158.73 24.14 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 118.622 -1.231 . . . . 1.1699999999999999 109.176 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.432 ' NE2' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -144.7 119.82 10.1 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.206 -0.906 . . . . 5.4199999999999999 110.227 -178.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -98.33 119.06 36.35 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.064 -1.828 . . . . 1.9199999999999999 106.064 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.4 154.2 21.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.608 -1.627 . . . . 2.6600000000000001 106.608 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -117.95 131.54 56.49 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.184 -1.406 . . . . 2.8300000000000001 108.565 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.0 pt -46.73 -37.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.08 -1.418 . . . . 2.1600000000000001 113.912 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -95.26 18.44 12.38 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.76 -1.176 . . . . 6.7599999999999998 112.651 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.86 -47.54 3.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.722 -0.844 . . . . 2.1099999999999999 108.722 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -88.99 -22.72 22.87 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.798 -1.092 . . . . 4.8200000000000003 110.635 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.49 52.85 1.39 Allowed Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.589 -1.291 . . . . 1.9399999999999999 110.615 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.8 mt -106.71 134.78 47.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 106.287 -1.746 . . . . 2.5699999999999998 106.287 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -91.96 -144.16 0.2 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.817 -1.153 . . . . 3.5600000000000001 109.173 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -116.74 -33.52 4.79 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.577 -1.638 . . . . 7.5499999999999998 106.577 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.17 -46.58 80.24 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.362 -1.718 . . . . 3.96 106.362 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' CG ' ' NZ ' ' A' ' 51' ' ' LYS . 26.9 t70 -63.88 -16.85 62.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.914 -1.039 . . . . 2.2000000000000002 111.343 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.64 -48.14 5.63 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 108.468 -0.938 . . . . 2.2400000000000002 108.468 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.35 -47.03 62.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 4.46 107.271 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -18.73 64.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.702 -1.135 . . . . 4.7699999999999996 111.451 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' NZ ' ' CG ' ' A' ' 47' ' ' ASP . 36.5 mttp -86.65 -41.58 14.12 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.827 -0.749 . . . . 2.7999999999999998 111.218 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.23 -36.17 13.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.144 -0.622 . . . . 2.2200000000000002 110.676 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.95 -66.91 0.38 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 105.501 -3.039 . . . . 3.4100000000000001 105.501 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HZ1' ' CD ' ' A' ' 57' ' ' GLU . 33.2 mttm 31.44 -162.61 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 CA-C-N 112.533 -1.834 . . . . 8.2400000000000002 113.178 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -103.75 -157.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.202 1.935 . . . . 5.0099999999999998 109.915 131.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.04 113.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.946 -1.501 . . . . 8.1099999999999994 106.946 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' CD ' ' HZ1' ' A' ' 54' ' ' LYS . 24.9 mt-10 -119.31 -175.6 2.97 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.503 -0.771 . . . . 5.96 112.692 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.9 t -92.07 -136.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.42 -1.326 . . . . 5.3099999999999996 107.42 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 7.0 m -127.26 162.66 46.96 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.627 -0.879 . . . . 3.0800000000000001 108.627 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.415 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 83.7 Cg_endo -100.34 163.51 8.2 Favored 'Cis proline' 0 N--CA 1.486 1.085 0 O-C-N 122.507 0.741 . . . . 2.25 111.888 2.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -119.7 112.1 18.85 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.644 -1.243 . . . . 3.9199999999999999 107.644 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -101.48 143.62 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.761 -0.776 . . . . 2.02 111.011 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.404 ' HB2' ' CG1' ' A' ' 4' ' ' VAL . 24.7 m-85 -134.31 156.48 48.37 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 113.245 -1.798 . . . . 1.6299999999999999 109.964 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 66' ' ' GLN . 54.5 t -131.56 122.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.869 -1.53 . . . . 1.75 106.869 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 55.02 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.059 -0.657 . . . . 3.2599999999999998 109.29 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.4 tt0 -133.18 -16.93 2.41 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.604 -1.18 . . . . 5.9800000000000004 110.692 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -81.59 161.54 23.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.921 -0.711 . . . . 5.21 110.503 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -108.34 147.56 31.33 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.184 -0.917 . . . . 1.9299999999999999 108.611 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.406 HD13 ' CD1' ' A' ' 78' ' ' TRP . 5.2 mm -116.21 -49.66 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.12 -1.032 . . . . 1.8400000000000001 109.483 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.27 -121.07 3.05 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.954 -1.258 . . . . 1.1599999999999999 109.954 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.97 -164.47 18.53 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.623 -0.991 . . . . 1.1100000000000001 110.623 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -53.52 -56.51 16.41 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 120.903 0.382 . . . . 2.6899999999999999 111.203 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -45.39 -53.18 9.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.035 0.921 . . . . 1.9099999999999999 110.779 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.39 65.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.158 -1.837 . . . . 2.79 109.295 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -48.24 -52.91 19.02 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.133 -1.027 . . . . 1.1499999999999999 110.08 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.11 -56.7 14.24 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.097 -1.041 . . . . 1.73 110.122 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -55.66 28.49 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.54 -0.864 . . . . 1.9199999999999999 109.922 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.406 ' CD1' HD13 ' A' ' 69' ' ' ILE . 89.7 t90 -48.89 -53.31 20.04 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.22 -0.592 . . . . 0.80000000000000004 110.077 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.2 t -46.69 -58.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 CA-C-N 115.05 -0.977 . . . . 1.7 110.614 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -43.07 -43.09 4.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.816 1.413 . . . . 3.2999999999999998 114.816 -177.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -97.79 3.56 49.97 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 118.15 -1.42 . . . . 3.8700000000000001 113.536 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -117.09 -39.89 3.17 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.793 -0.763 . . . . 1.3400000000000001 111.306 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.2 mt -113.56 37.83 3.11 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.619 -0.719 . . . . 2.5899999999999999 112.051 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 C-N-CA 119.057 -1.057 . . . . 4.21 109.322 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 30' ' ' ASP . 58.9 tpp . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 109.005 -0.739 . . . . 3.9700000000000002 109.005 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -119.6 118.7 31.69 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.569 -1.271 . . . . 5.5499999999999998 107.569 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 11.1 m -114.27 131.58 56.45 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.341 -0.543 . . . . 1.73 110.996 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.99 146.72 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.822 -1.151 . . . . 2.9500000000000002 112.57 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.486 HD11 ' N ' ' A' ' 5' ' ' ILE . 4.4 mp -111.34 129.58 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.458 -1.682 . . . . 3.3500000000000001 106.458 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -118.63 119.92 35.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.15 -0.62 . . . . 2.2000000000000002 110.492 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 60' ' ' PRO . . . 142.27 -158.72 26.96 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 124.637 1.211 . . . . 2.8399999999999999 112.037 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -106.26 107.43 18.43 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.44 0.638 . . . . 6.7599999999999998 110.097 -179.1 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t -78.11 -155.05 0.07 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.897 -0.592 . . . . 8.0199999999999996 111.113 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 25.02 21.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.22 -1.552 . . . . 4.6900000000000004 109.22 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.433 ' C ' ' H ' ' A' ' 13' ' ' TYR . 59.2 m -142.38 150.92 56.57 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 120.46 -0.496 . . . . 4.4800000000000004 110.587 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.87 31.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.629 2.219 . . . . 5.5 112.479 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 11' ' ' CYS . 83.6 t80 -125.13 -63.78 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.626 -1.249 . . . . 8.1300000000000008 107.626 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.592 ' SG ' ' HD2' ' A' ' 60' ' ' PRO . 89.5 m -78.68 -29.16 45.42 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 118.554 -1.258 . . . . 4.21 109.4 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.19 -48.14 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.376 -1.342 . . . . 2.5899999999999999 107.376 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -57.71 -28.5 63.9 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.155 -1.018 . . . . 4.7800000000000002 109.853 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' HD13 ' A' ' 62' ' ' ILE . . . -69.86 -48.44 58.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.749 -1.945 . . . . 2.1099999999999999 105.749 177.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HE2' ' N ' ' A' ' 19' ' ' ASP . 3.5 tmpt? -50.21 -45.61 53.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.399 -1.704 . . . . 3.0899999999999999 106.399 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.491 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 72.8 m-20 -58.44 -62.77 1.6 Allowed 'General case' 0 C--O 1.19 -2.029 0 C-N-CA 119.277 -0.969 . . . . 2.9300000000000002 109.949 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 62.0 tp -46.5 -48.63 19.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.765 -0.774 . . . . 2.0600000000000001 110.287 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.69 85.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.112 -0.699 . . . . 1.8999999999999999 109.112 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.414 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 26.5 tt0 -59.63 -38.68 82.01 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.734 -0.839 . . . . 1.79 108.734 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 23.6 tttm -58.77 -65.17 0.7 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.608 -1.627 . . . . 6.3399999999999999 106.608 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.0 mt -45.6 -44.69 13.22 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.935 -1.135 . . . . 1.95 107.935 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.0 t -54.44 -43.42 71.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.419 -1.264 . . . . 1.22 109.809 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 18.3 t30 -78.39 -2.09 36.57 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.999 -0.68 . . . . 2.9900000000000002 110.241 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 23' ' ' LYS . 77.2 mm-40 -89.7 -50.35 6.12 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.197 -0.601 . . . . 3.1400000000000001 112.411 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.484 ' C ' ' H ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -137.81 155.91 48.51 Favored 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 118.679 -1.208 . . . . 4.9800000000000004 113.986 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.05 31.03 0.08 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.029 -0.987 . . . . 4.2300000000000004 111.825 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -125.52 -24.95 3.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.595 -0.73 . . . . 3.2599999999999998 109.261 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 25' ' ' SER . 15.5 t80 -101.58 122.48 43.93 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 114.468 1.285 . . . . 1.45 114.468 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' ' 33' ' ' TYR . 61.2 tp60 -133.64 159.51 40.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.646 -1.983 . . . . 7.2800000000000002 105.646 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 3' ' ' THR . 15.6 p90 -141.8 167.37 22.31 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.266 -0.974 . . . . 1.1499999999999999 108.851 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.3 152.24 31.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 124.023 0.827 . . . . 5.1799999999999997 109.511 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.62 124.49 49.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.914 -1.143 . . . . 2.4700000000000002 107.914 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.87 152.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.249 -0.98 . . . . 2.8399999999999999 110.435 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -102.82 142.08 34.56 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.664 1.221 . . . . 3.48 111.133 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 15.4 pt -66.45 -32.96 60.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 113.084 -1.871 . . . . 2.1400000000000001 111.665 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -10.72 44.17 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.403 -0.919 . . . . 7.2599999999999998 111.29 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.29 14.99 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.468 -0.938 . . . . 2.73 108.468 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.33 -43.53 13.62 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.61 -0.836 . . . . 3.7799999999999998 110.651 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.47 49.0 0.57 Allowed Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.318 -1.113 . . . . 2.3500000000000001 110.318 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.2 mt -106.48 135.14 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.052 -1.462 . . . . 2.4399999999999999 107.052 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.416 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 4.9 p -108.09 171.53 7.35 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.59 -1.244 . . . . 3.0600000000000001 113.111 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -17.24 62.74 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.194 -0.912 . . . . 4.5 109.586 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 16.2 mp0 -94.57 -50.02 5.38 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.487 -1.301 . . . . 3.7000000000000002 107.487 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 44' ' ' THR . 53.8 t0 -55.75 -50.9 69.14 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 108.3 -1.0 . . . . 2.8900000000000001 108.3 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.06 -49.5 68.86 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.345 -0.983 . . . . 2.8500000000000001 108.345 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.4 tt0 -47.07 -52.04 16.12 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.51 -0.876 . . . . 3.7400000000000002 108.969 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -62.31 -48.61 79.1 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.99 -1.004 . . . . 8.0999999999999996 112.008 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -52.15 -44.25 64.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.642 0.589 . . . . 3.29 110.54 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB1' ' CD ' ' A' ' 55' ' ' PRO . . . -88.84 -57.25 2.97 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.963 -1.095 . . . . 2.2799999999999998 109.339 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.1 -67.38 0.47 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.466 -1.854 . . . . 3.2000000000000002 108.466 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 22.8 mmtm -143.84 55.64 3.73 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.336 0.865 . . . . 9.5999999999999996 113.336 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.44 ' CD ' ' HB1' ' A' ' 52' ' ' ALA . 10.2 Cg_endo -91.26 159.06 3.77 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.703 1.602 . . . . 8.1600000000000001 109.087 137.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.18 -61.46 2.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.056 -0.658 . . . . 6.3799999999999999 109.724 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -128.67 33.05 4.71 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.335 -0.987 . . . . 7.2199999999999998 108.335 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.9 p -89.67 69.63 7.75 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.954 -0.698 . . . . 5.9000000000000004 110.139 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.423 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -114.37 140.43 25.11 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.26 -0.882 . . . . 3.9500000000000002 110.28 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.592 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 5.3 Cg_exo -72.5 155.09 99.03 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.615 -1.411 . . . . 4.2599999999999998 112.598 -0.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.592 ' CG ' ' NE2' ' A' ' 68' ' ' HIS . 1.7 tp-100 -121.45 165.84 15.01 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.426 -1.324 . . . . 5.5800000000000001 107.426 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 17' ' ' ALA . 34.4 mt -121.38 145.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.296 -0.962 . . . . 2.79 112.977 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -127.21 152.63 47.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.589 -2.096 . . . . 1.23 106.823 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 66' ' ' GLN . 55.9 t -125.38 126.17 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.95 -1.5 . . . . 1.9299999999999999 106.95 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 53.55 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.076 0.86 . . . . 2.5099999999999998 109.304 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -139.55 10.53 2.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.866 0.691 . . . . 7.1699999999999999 112.866 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -118.17 179.91 3.96 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.439 -0.504 . . . . 8.25 111.086 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 61' ' ' GLN . 29.5 t-80 -117.48 143.67 45.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.961 0.788 . . . . 2.0699999999999998 109.467 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -115.63 -39.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.793 -1.163 . . . . 2.0299999999999998 111.141 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.67 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.852 -2.099 . . . . 1.53 107.852 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.28 -72.76 0.81 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.427 -1.368 . . . . 2.8900000000000001 110.646 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 10.5 t80 -136.03 -50.61 0.7 Allowed 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 119.964 -0.694 . . . . 2.0699999999999998 109.77 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.01 61.69 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.678 1.228 . . . . 2.1000000000000001 108.823 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -57.26 12.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 111.929 -2.396 . . . . 2.5800000000000001 109.012 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -47.04 -52.33 15.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.643 -0.823 . . . . 1.1699999999999999 109.997 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.13 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.816 -1.154 . . . . 1.6899999999999999 109.099 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.69 -53.52 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.975 -1.09 . . . . 2.0 109.797 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -53.92 -51.34 64.06 Favored 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.285 0.564 . . . . 0.78000000000000003 110.355 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.5 t -48.38 -49.44 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.987 -1.006 . . . . 1.8 111.473 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -44.13 -30.18 0.73 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.891 1.441 . . . . 3.0299999999999998 114.891 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 82' ' ' ASN . 13.9 pt-20 -112.48 -35.23 5.62 Favored 'General case' 0 N--CA 1.506 2.363 0 C-N-CA 119.537 -0.865 . . . . 4.9500000000000002 113.219 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.436 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 39.5 m-80 -82.01 -23.84 35.75 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.037 -1.065 . . . . 1.3400000000000001 109.579 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 83' ' ' LEU . 2.2 mm? -113.09 -41.19 3.77 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.631 -0.713 . . . . 3.0099999999999998 109.67 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 N--CA 1.502 2.132 0 O-C-N 125.5 1.75 . . . . 3.9199999999999999 111.713 179.609 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.46 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 32.0 tpp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.805 . . . . 3.9100000000000001 108.825 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.68 110.65 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.731 0.777 . . . . 6.4100000000000001 109.45 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.41 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 18.0 m -92.81 105.96 18.01 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.378 -1.712 . . . . 2.23 106.378 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 19.9 t -105.29 138.72 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.438 -0.905 . . . . 2.0699999999999998 110.811 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.95 103.67 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.779 1.299 . . . . 2.5 108.337 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -85.65 90.14 7.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.509 -1.293 . . . . 2.1299999999999999 107.509 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.44 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -124.48 145.06 15.67 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.254 -1.938 . . . . 1.78 108.254 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 139.82 49.41 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.644 -1.222 . . . . 6.0499999999999998 110.205 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 10' ' ' GLY . 3.4 m 61.34 55.48 2.89 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.946 -1.024 . . . . 5.9500000000000002 108.902 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' SER . . . -3.15 83.83 0.0 OUTLIER Glycine 0 N--CA 1.511 3.635 0 O-C-N 124.782 1.301 . . . . 4.8799999999999999 114.872 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.4 m -112.74 157.13 41.32 Favored Pre-proline 0 N--CA 1.498 1.948 0 C-N-CA 119.577 -0.849 . . . . 4.9299999999999997 109.79 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.0 -13.82 0.24 Allowed 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.922 2.414 . . . . 3.2200000000000002 114.056 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -73.11 -14.1 61.32 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.688 -0.805 . . . . 4.8899999999999997 111.889 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.555 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.4 m -107.13 -29.23 9.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.24 -1.022 . . . . 2.6600000000000001 108.24 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.1 t -44.24 -63.65 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 114.506 1.299 . . . . 3.1600000000000001 114.506 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -52.04 -44.39 64.21 Favored 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 118.044 -1.462 . . . . 4.75 111.808 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.9 63.39 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.742 -1.207 . . . . 2.46 107.742 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 5.1 ttpp -47.09 -55.89 7.54 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.327 -0.851 . . . . 2.4500000000000002 109.256 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.439 ' CG ' ' NH2' ' A' ' 16' ' ' ARG . 5.8 t70 -52.8 -58.35 7.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 123.683 0.614 . . . . 3.21 110.013 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -50.92 -55.41 17.28 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.545 -0.862 . . . . 2.0099999999999998 111.126 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.15 83.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.411 -0.915 . . . . 1.52 108.68 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.3 tt0 -59.52 -46.37 89.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.252 -0.885 . . . . 1.97 110.086 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -52.54 -57.16 10.82 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.979 -1.089 . . . . 4.96 108.117 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.6 mt -48.49 -43.66 35.18 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 2.3700000000000001 107.601 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.9 t -58.53 -46.25 87.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.192 -1.367 . . . . 1.27 110.58 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.96 41.51 1.07 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.807 -1.553 . . . . 2.2799999999999998 106.807 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 23' ' ' LYS . 2.9 tp10 -128.29 -66.06 0.87 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.709 -2.042 . . . . 3.3900000000000001 106.483 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.448 ' NH2' ' HB2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -122.45 153.46 39.08 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 106.341 -1.725 . . . . 5.0 106.341 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.07 32.3 1.52 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 118.367 -1.333 . . . . 5.5099999999999998 111.933 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -113.64 -23.23 9.85 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.959 -1.497 . . . . 3.21 106.959 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 25' ' ' SER . 28.6 t80 -103.04 118.23 36.36 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.584 -1.189 . . . . 1.3 109.342 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -130.28 142.26 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.381 -1.34 . . . . 5.4299999999999997 107.381 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -117.67 159.86 22.25 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 118.479 -1.288 . . . . 1.3400000000000001 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.61 142.6 37.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.275 0.985 . . . . 4.6100000000000003 109.255 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 35' ' ' TYR . 10.0 t80 -106.34 135.4 47.9 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.542 -2.021 . . . . 2.3599999999999999 105.542 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.97 156.91 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.296 -0.961 . . . . 3.9199999999999999 109.215 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.97 160.1 24.23 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.153 0.501 . . . . 2.7999999999999998 109.796 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 pt -75.79 -32.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.998 -1.081 . . . . 2.7599999999999998 111.439 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -35.87 55.16 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.356 -1.338 . . . . 6.6299999999999999 108.494 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.56 -53.26 18.97 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.307 -0.86 . . . . 2.6800000000000002 109.196 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.35 -46.38 10.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.042 0.839 . . . . 3.7400000000000002 109.942 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.08 52.01 0.58 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 108.948 -1.661 . . . . 1.5700000000000001 108.948 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.82 160.76 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 115.047 -0.577 . . . . 2.5800000000000001 110.885 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -119.68 -170.82 2.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.787 -1.19 . . . . 2.6699999999999999 107.787 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -90.86 -24.17 20.33 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 118.0 -1.48 . . . . 7.4500000000000002 109.339 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 3.0 mp0 -72.87 -47.56 44.97 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.126 -1.435 . . . . 3.2200000000000002 107.126 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.528 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 30.3 t70 -57.38 -39.2 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.071 0.939 . . . . 2.7999999999999998 108.619 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.32 -46.03 78.3 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.49 -1.232 . . . . 2.2400000000000002 107.714 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -46.21 -48.98 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.281 -1.377 . . . . 3.77 107.281 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.97 -59.13 5.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.152 -0.931 . . . . 5.5199999999999996 110.62 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 17.3 mtmm -66.83 -5.41 12.21 Favored 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 120.338 -0.545 . . . . 3.2999999999999998 112.457 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.509 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -105.3 -33.51 8.18 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.727 -0.67 . . . . 2.0 111.769 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.96 31.63 2.88 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.712 -1.755 . . . . 3.3900000000000001 108.712 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 50.7 tttm -144.62 121.28 6.28 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.91 -1.144 . . . . 7.7800000000000002 107.91 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -19.8 -131.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 124.472 3.448 . . . . 4.8899999999999997 114.641 -143.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.79 -54.18 7.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 113.862 -1.517 . . . . 6.25 107.719 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 50.23 -160.36 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.772 -0.649 . . . . 8.2200000000000006 112.099 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -139.59 -151.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.494 -0.882 . . . . 4.79 109.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.08 151.72 42.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.001 -0.74 . . . . 2.8500000000000001 109.001 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -93.22 167.25 22.24 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 O-C-N 123.236 1.124 . . . . 2.2999999999999998 111.135 2.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.504 HE22 ' CB ' ' A' ' 52' ' ' ALA . 25.8 mt-30 -116.84 131.12 57.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.181 -1.415 . . . . 3.2999999999999998 107.181 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 94.9 mt -104.73 144.96 13.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 118.989 -1.084 . . . . 2.29 109.943 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -135.69 148.57 48.96 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 113.373 -1.74 . . . . 1.2 108.816 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 66' ' ' GLN . 68.6 t -115.1 92.99 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 104.651 -2.352 . . . . 1.97 104.651 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 1' ' ' MET . 5.3 m-20 66.82 -74.5 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.32 1.013 . . . . 2.5800000000000001 109.656 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 64' ' ' VAL . 63.4 mt-30 -133.8 -15.59 2.35 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.808 -1.087 . . . . 4.1699999999999999 110.999 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -75.34 128.19 34.83 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.425 -0.954 . . . . 5.0999999999999996 108.425 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.509 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 10.9 t-160 -90.36 136.56 32.98 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.081 -1.822 . . . . 1.3100000000000001 106.081 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.473 HD11 ' CD1' ' A' ' 78' ' ' TRP . 16.8 mm -108.5 -50.27 7.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.665 -0.814 . . . . 1.95 109.413 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.412 ' HA3' ' HZ3' ' A' ' 54' ' ' LYS . . . 121.55 -122.76 5.26 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 118.94 -1.6 . . . . 1.53 111.85 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.97 -173.66 39.27 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.085 -1.055 . . . . 1.22 111.67 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 29.6 t80 -60.07 -51.19 70.71 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.758 -0.777 . . . . 2.0099999999999998 111.354 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -43.98 -48.53 8.68 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.736 1.255 . . . . 2.1600000000000001 108.91 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -58.69 -57.49 12.77 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.051 -2.34 . . . . 2.7799999999999998 108.616 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.433 ' HA ' HG22 ' A' ' 69' ' ' ILE . 7.6 t80 -48.7 -54.19 15.84 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.009 -0.996 . . . . 1.28 110.864 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.02 -53.01 56.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.69 -1.226 . . . . 2.0 107.69 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.07 -59.21 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.283 -0.967 . . . . 2.27 109.835 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.473 ' CD1' HD11 ' A' ' 69' ' ' ILE . 62.9 t90 -48.65 -52.87 21.0 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 119.852 -0.739 . . . . 1.79 110.964 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.423 ' CG2' ' CE1' ' A' ' 75' ' ' PHE . 43.0 t -54.49 -43.81 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.779 -1.168 . . . . 2.4199999999999999 109.031 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -78.39 11.1 2.59 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.733 -0.667 . . . . 4.0300000000000002 112.793 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.88 -36.28 2.4 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 120.505 -0.478 . . . . 4.6799999999999997 110.819 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -96.93 -29.52 13.64 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.366 -0.834 . . . . 1.8500000000000001 112.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.1 mt -119.58 26.13 9.58 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.071 -1.052 . . . . 3.0600000000000001 111.586 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 C-N-CA 119.056 -1.057 . . . . 4.4199999999999999 110.252 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 122.503 1.144 . . . . 3.8199999999999998 108.356 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -114.6 158.83 21.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.455 -1.313 . . . . 6.0499999999999998 107.455 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 34' ' ' GLN . 5.5 m -107.15 142.14 37.31 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.296 -1.001 . . . . 2.2999999999999998 108.296 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 t -129.04 117.57 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.881 -1.526 . . . . 2.21 106.881 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.4 mp -107.35 131.72 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.913 -1.143 . . . . 2.04 107.913 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.72 108.42 17.86 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 106.506 -1.664 . . . . 2.9700000000000002 106.506 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.8 -171.11 12.75 Favored Glycine 0 N--CA 1.503 3.128 0 C-N-CA 118.832 -1.652 . . . . 1.78 112.514 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.87 147.25 37.39 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 114.611 -0.795 . . . . 5.9299999999999997 108.875 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -53.04 130.54 34.24 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 120.067 -0.653 . . . . 6.5599999999999996 112.389 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 155.26 25.32 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.618 -0.801 . . . . 3.3300000000000001 111.394 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.5 m 74.56 108.51 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.951 1.03 . . . . 4.0899999999999999 111.767 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.61 59.43 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.799 1.666 . . . . 5.71 111.255 162.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -115.18 -69.84 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.254 -0.885 . . . . 5.9500000000000002 108.767 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.424 ' HG ' ' HB3' ' A' ' 60' ' ' PRO . 6.1 m -52.4 -41.69 63.4 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.04 -1.467 . . . . 3.1200000000000001 107.04 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -43.3 -42.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.833 -1.531 . . . . 4.2400000000000002 110.113 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.22 -33.74 1.65 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 123.508 0.505 . . . . 6.1399999999999997 112.225 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HB1' HG12 ' A' ' 5' ' ' ILE . . . -67.5 -44.35 78.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.446 -0.946 . . . . 1.9399999999999999 108.446 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HG3' ' CD1' ' A' ' 33' ' ' TYR . 9.4 ttpp -52.99 -49.58 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.457 -1.683 . . . . 3.23 106.457 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' LEU . 65.7 m-20 -55.85 -60.1 3.93 Favored 'General case' 0 C--O 1.183 -2.414 0 CA-C-N 113.317 -1.765 . . . . 3.9500000000000002 110.305 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' ASP . 31.5 tp -43.8 -61.25 1.49 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.485 -1.286 . . . . 2.21 109.323 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.47 67.27 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.352 -0.84 . . . . 2.1499999999999999 111.277 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.438 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 40.1 tt0 -65.17 -56.07 14.99 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.955 0.883 . . . . 2.02 111.083 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.557 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -50.8 -43.38 58.73 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.448 -1.315 . . . . 4.5300000000000002 107.448 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -66.73 -44.17 82.26 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.289 -1.004 . . . . 2.6400000000000001 108.289 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.505 ' C ' ' H ' ' A' ' 27' ' ' GLU . 28.9 t -50.07 -48.75 52.89 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.906 -1.043 . . . . 2.0899999999999999 108.699 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.459 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 11.6 t30 -83.72 38.64 0.64 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.878 1.323 . . . . 2.98 108.782 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 tt0 -137.61 -50.3 0.61 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 113.164 -1.835 . . . . 3.1600000000000001 109.117 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -104.03 -32.71 9.08 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.05 -0.977 . . . . 4.4100000000000001 111.371 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 78.49 8.62 2.15 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.193 0.933 . . . . 4.7599999999999998 111.026 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.51 7.58 17.51 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.496 -0.882 . . . . 3.9300000000000002 112.443 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -124.54 142.37 51.39 Favored 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 119.717 -0.793 . . . . 2.8500000000000001 110.798 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -126.49 170.98 11.45 Favored 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 120.428 -0.509 . . . . 5.5700000000000003 111.109 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.489 ' HA ' ' H ' ' A' ' 3' ' ' THR . 18.7 p90 -142.84 169.33 17.77 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.726 0.774 . . . . 2.4199999999999999 112.694 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 3' ' ' THR . 43.7 mm-40 -148.31 128.31 13.59 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 113.829 -1.532 . . . . 4.7999999999999998 108.085 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -113.63 111.2 21.46 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.083 -1.451 . . . . 1.8400000000000001 107.083 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.8 157.77 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.935 -0.706 . . . . 2.8199999999999998 110.167 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.28 139.08 43.5 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 105.049 -2.204 . . . . 2.96 105.049 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.4 pt -50.19 -33.47 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.935 -1.106 . . . . 2.25 113.666 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -50.08 25.89 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 117.67 -1.612 . . . . 7.7199999999999998 110.379 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -31.08 -52.67 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.256 0.973 . . . . 2.3399999999999999 111.672 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.23 -43.13 18.01 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.62 1.2 . . . . 4.3499999999999996 111.069 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.72 51.56 0.45 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.432 -2.267 . . . . 1.73 107.432 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 75.6 mt -108.16 141.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.562 -0.819 . . . . 3.0899999999999999 110.626 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.3 p -117.08 -89.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.855 -1.165 . . . . 3.8100000000000001 107.855 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.538 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 33.5 tttp -140.87 -48.07 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.37 -0.974 . . . . 4.9500000000000002 108.37 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 10.3 mp0 -47.9 -55.64 9.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.02 0.825 . . . . 2.8599999999999999 109.711 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 10.3 t70 -53.08 -60.86 2.76 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.559 -0.746 . . . . 2.71 109.533 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.58 -38.44 59.98 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.348 -0.941 . . . . 2.71 110.045 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.521 ' CD ' ' HZ3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -55.96 -53.33 58.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.209 -1.404 . . . . 5.5700000000000003 107.209 178.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.07 -47.98 79.68 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.25 -1.795 . . . . 5.0300000000000002 110.476 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 31.6 mmtp -56.66 -50.5 71.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.377 -0.829 . . . . 3.7400000000000002 110.182 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -53.74 46.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.152 -0.931 . . . . 2.1899999999999999 111.676 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.19 -15.59 43.08 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.519 -1.432 . . . . 2.5600000000000001 109.519 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.8 pttp -123.96 -178.91 0.72 Allowed Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.955 -0.698 . . . . 6.8899999999999997 110.133 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 49.2 Cg_exo -56.6 142.56 90.49 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.235 1.29 . . . . 5.1100000000000003 112.077 165.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -153.84 102.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 5.7400000000000002 107.025 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.538 ' CD ' ' HZ2' ' A' ' 45' ' ' LYS . 15.6 mm-40 -111.77 -15.78 13.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.703 -0.799 . . . . 7.1200000000000001 110.705 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -121.69 172.29 8.24 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.979 -0.688 . . . . 4.8200000000000003 110.265 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.22 169.38 7.14 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 109.278 -0.638 . . . . 3.6200000000000001 109.278 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HB3' ' HG ' ' A' ' 14' ' ' CYS . 49.1 Cg_endo -99.97 176.6 6.73 Favored 'Cis proline' 0 N--CA 1.488 1.192 0 O-C-N 122.815 0.903 . . . . 2.3399999999999999 110.544 -8.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 99.5 mm-40 -125.35 140.78 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.075 -1.05 . . . . 4.3300000000000001 108.693 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -126.7 145.17 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.874 -0.73 . . . . 2.21 110.444 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.08 162.51 31.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.538 -1.21 . . . . 1.6499999999999999 109.461 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG12 ' CH2' ' A' ' 78' ' ' TRP . 49.6 t -141.45 119.19 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 124.526 1.141 . . . . 2.1299999999999999 108.979 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 50.81 -102.73 0.12 Allowed 'General case' 0 N--CA 1.514 2.742 0 CA-C-N 119.774 1.17 . . . . 2.3500000000000001 111.008 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -123.82 31.88 5.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.618 -1.174 . . . . 5.1500000000000004 109.43 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -122.59 164.49 18.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.568 -0.742 . . . . 5.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -122.54 125.6 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.155 -1.054 . . . . 1.54 108.155 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.65 -54.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.951 -1.5 . . . . 2.5699999999999998 106.951 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 112.23 -99.23 1.04 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.471 -1.347 . . . . 1.52 110.572 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.56 163.63 13.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.414 -1.374 . . . . 1.24 110.707 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.41 -54.29 33.99 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.074 -0.65 . . . . 2.3799999999999999 111.759 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -34.58 -64.69 0.24 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.663 0.986 . . . . 2.4199999999999999 113.663 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.94 -38.0 75.15 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.925 -0.71 . . . . 4.54 111.649 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -43.49 -41.54 4.44 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.794 -0.817 . . . . 1.7 108.794 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.96 -52.03 64.3 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.497 -0.774 . . . . 2.5600000000000001 110.773 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 80' ' ' LYS . . . -67.22 -53.8 26.83 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.342 -0.844 . . . . 2.5499999999999998 109.172 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.52 ' CH2' HG12 ' A' ' 64' ' ' VAL . 84.3 t90 -42.23 -55.54 3.26 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.16 -1.052 . . . . 1.25 108.16 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -46.04 -50.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 114.984 -1.007 . . . . 2.2400000000000002 109.94 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -42.56 -57.45 2.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 124.568 1.168 . . . . 4.6500000000000004 113.295 -178.184 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -106.01 25.43 10.95 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.351 -1.34 . . . . 3.6099999999999999 112.365 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -119.33 -36.43 3.37 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.947 -1.131 . . . . 2.27 107.947 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.44 11.45 17.2 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.238 -1.764 . . . . 2.6200000000000001 106.238 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.487 1.377 0 O-C-N 125.338 1.649 . . . . 7.9900000000000002 112.484 179.636 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.5 mpp? . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.19 -1.041 . . . . 3.6299999999999999 108.19 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 65' ' ' ASP . 49.7 mt-30 -100.24 102.72 14.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.516 -0.92 . . . . 5.3899999999999997 108.516 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.4 m -84.32 100.27 11.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.264 -1.754 . . . . 2.25 106.264 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.32 127.44 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.313 -1.312 . . . . 2.02 110.206 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mm -96.38 119.16 44.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 104.568 -2.382 . . . . 2.5800000000000001 104.568 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.477 ' CE1' HG13 ' A' ' 36' ' ' VAL . 2.4 m-85 -104.71 109.29 21.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.318 -1.364 . . . . 1.99 107.318 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.61 118.9 0.46 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 116.208 -2.901 . . . . 2.2799999999999998 112.708 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.41 ' HB3' ' OD1' ' A' ' 37' ' ' ASP . 4.8 ptm180 -86.11 55.74 3.67 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.413 -1.393 . . . . 5.7800000000000002 111.902 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.0 p -90.47 -54.05 4.17 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 117.434 -1.706 . . . . 6.9500000000000002 109.144 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.68 -52.73 4.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 106.4 -2.68 . . . . 4.0599999999999996 106.4 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' TYR . 8.3 m -78.05 156.78 79.31 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.758 -1.571 . . . . 4.9500000000000002 106.758 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.85 64.26 0.15 Allowed 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 123.55 2.834 . . . . 3.5099999999999998 115.135 -147.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' CYS . 21.2 m-30 -121.69 -70.24 0.79 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.029 -1.841 . . . . 5.7999999999999998 106.029 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.3 m -65.06 -32.46 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.337 -1.745 . . . . 2.71 106.613 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.4 t -44.13 -45.08 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 114.895 -1.048 . . . . 2.3999999999999999 109.907 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.525 HH12 ' CG ' ' A' ' 19' ' ' ASP . 2.5 tpt180 -68.91 -47.09 66.65 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.852 -0.739 . . . . 4.9500000000000002 110.239 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.67 -46.31 70.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.121 -1.437 . . . . 1.6499999999999999 107.121 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HZ3' ' CD ' ' A' ' 22' ' ' GLU . 1.1 tmtt? -54.14 -60.53 3.21 Favored 'General case' 0 C--O 1.203 -1.37 0 CA-C-N 114.824 -1.08 . . . . 3.1299999999999999 108.402 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.525 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.5 t70 -48.53 -54.64 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.817 -0.753 . . . . 2.77 110.442 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.9 tp -54.85 -57.18 12.61 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.308 -0.957 . . . . 2.8399999999999999 109.954 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.24 -42.95 52.75 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.949 -1.023 . . . . 1.46 109.906 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.459 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 36.6 tt0 -65.62 -51.74 57.33 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.544 -0.753 . . . . 2.1600000000000001 109.07 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 23.6 ttpp -44.55 -54.21 6.28 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.457 -1.312 . . . . 6.46 107.457 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 50.9 mt -60.67 -36.38 78.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.58 1.175 . . . . 2.2999999999999998 109.707 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -59.32 -28.46 66.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.057 -0.974 . . . . 1.23 109.532 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -89.19 29.37 1.08 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.548 0.689 . . . . 3.5499999999999998 109.149 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.493 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 73.3 mt-10 -135.07 -65.96 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.184 -1.006 . . . . 3.29 112.621 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -104.42 149.38 25.46 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.976 -1.09 . . . . 5.6200000000000001 108.585 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -53.26 57.44 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.852 1.797 . . . . 4.0999999999999996 115.852 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 1' ' ' MET . 50.6 t0 -84.45 44.82 1.07 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.657 -1.617 . . . . 5.8399999999999999 111.683 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.517 ' CD1' HD12 ' A' ' 83' ' ' LEU . 16.2 t80 -126.04 84.63 2.29 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 105.997 -1.853 . . . . 1.4399999999999999 105.997 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -109.51 143.75 38.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.866 -1.531 . . . . 4.6900000000000004 106.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -123.56 157.49 33.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.143 -1.423 . . . . 1.26 110.371 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -145.33 150.12 36.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.788 -1.097 . . . . 4.4400000000000004 108.62 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -110.77 127.15 55.25 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.198 -1.038 . . . . 3.1800000000000002 108.198 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 6' ' ' PHE . 2.3 p -131.02 151.33 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 118.819 -1.153 . . . . 3.6499999999999999 109.826 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.41 ' OD1' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -113.66 135.4 53.97 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.345 -1.354 . . . . 3.0 107.345 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 37.7 pt -61.29 -27.18 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.631 -1.228 . . . . 3.2000000000000002 110.586 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -74.38 -24.87 59.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.894 -1.122 . . . . 7.0199999999999996 110.996 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.1 -40.4 15.74 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 2.25 110.124 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -77.36 -40.6 43.37 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.403 -1.272 . . . . 4.25 111.362 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.63 51.02 0.72 Allowed Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.188 -1.482 . . . . 2.3900000000000001 110.038 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 8.2 mt -112.32 135.2 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.456 -0.898 . . . . 3.6099999999999999 109.304 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 47.1 p -106.8 173.76 6.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.242 -0.583 . . . . 2.6800000000000002 110.014 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 46' ' ' GLU . 8.0 tttm -52.52 -51.58 58.86 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.219 -1.4 . . . . 5.9000000000000004 107.219 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.6 -60.66 3.12 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.77 -1.559 . . . . 3.77 110.45 178.015 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.487 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 33.3 t70 -51.92 -41.86 62.33 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.392 -0.923 . . . . 2.0800000000000001 111.305 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HG ' HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -59.63 -57.91 10.9 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.577 -0.849 . . . . 3.2799999999999998 109.356 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 33.8 tt0 -44.36 -52.3 7.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.962 -1.125 . . . . 3.79 107.962 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.58 -45.26 85.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.796 -1.093 . . . . 4.8700000000000001 111.404 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.487 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -50.51 -40.24 50.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.703 1.252 . . . . 3.77 110.924 -178.126 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HB1' ' CD ' ' A' ' 55' ' ' PRO . . . -90.65 -48.71 6.9 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.732 -1.122 . . . . 2.1499999999999999 109.946 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.23 -68.6 0.53 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 107.373 -2.291 . . . . 3.1400000000000001 107.373 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 51.9 mttp -155.22 56.24 1.35 Allowed Pre-proline 0 N--CA 1.51 2.544 0 N-CA-C 113.252 0.834 . . . . 11.119999999999999 113.252 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.406 ' CD ' ' HB1' ' A' ' 52' ' ' ALA . 91.3 Cg_endo -98.66 42.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 121.758 1.639 . . . . 7.5999999999999996 110.129 152.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t 36.48 -118.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.255 -1.338 . . . . 6.8099999999999996 110.707 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -120.03 39.41 3.69 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.742 -0.383 . . . . 8.0800000000000001 110.83 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.7 p -88.12 149.84 23.69 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.326 -1.349 . . . . 5.7000000000000002 111.417 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.08 165.57 17.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 CA-C-N 115.075 -0.966 . . . . 4.1600000000000001 108.757 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -78.81 171.96 63.17 Favored 'Cis proline' 0 N--CA 1.485 0.978 0 C-N-CA 123.636 -1.402 . . . . 2.6600000000000001 110.354 -5.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -136.63 157.75 46.05 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.941 -1.103 . . . . 3.0699999999999998 109.944 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.4 mm -114.09 139.76 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 120.303 -0.559 . . . . 2.73 110.527 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.6 145.71 48.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.726 0.641 . . . . 1.3999999999999999 109.781 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.424 HG12 ' CZ2' ' A' ' 78' ' ' TRP . 72.2 t -124.57 95.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.761 -0.776 . . . . 1.99 109.951 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HA ' ' HB2' ' A' ' 2' ' ' GLN . 0.6 OUTLIER 65.21 -74.41 0.05 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.639 -1.619 . . . . 3.27 110.942 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -133.84 -7.34 2.77 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.232 -0.895 . . . . 5.0 112.294 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -104.82 165.09 11.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.955 -0.698 . . . . 4.8600000000000003 110.556 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -105.96 143.79 33.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.191 -1.781 . . . . 1.26 106.191 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 78' ' ' TRP . 23.4 mm -106.0 -37.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.621 -1.231 . . . . 2.1200000000000001 109.65 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -132.86 7.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.09 -2.004 . . . . 1.2 108.09 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.66 -164.25 24.3 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.527 -1.429 . . . . 1.3400000000000001 109.527 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 16' ' ' ARG . 44.0 t80 -61.34 -49.17 78.05 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.027 -1.069 . . . . 2.0499999999999998 111.408 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.39 -52.38 13.07 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 2.3599999999999999 109.991 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.23 -53.64 54.28 Favored 'General case' 0 C--O 1.197 -1.695 0 CA-C-N 113.461 -1.7 . . . . 2.1200000000000001 109.045 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -48.45 -48.45 37.57 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.821 -0.627 . . . . 1.24 110.74 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.36 69.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.18 -1.008 . . . . 1.6599999999999999 108.485 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.4 -62.67 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.919 -1.112 . . . . 2.04 110.126 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.509 ' CD1' HD11 ' A' ' 69' ' ' ILE . 67.2 t90 -42.69 -51.42 5.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.698 -0.853 . . . . 1.0600000000000001 108.698 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.6 t -53.65 -59.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.906 -1.043 . . . . 1.8300000000000001 109.482 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -54.35 -16.73 2.38 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.252 -0.886 . . . . 4.3300000000000001 113.226 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -107.54 -44.61 4.24 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.29 -0.964 . . . . 3.6699999999999999 113.384 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -82.7 -25.16 33.22 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.846 -0.741 . . . . 1.5 110.104 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.517 HD12 ' CD1' ' A' ' 31' ' ' PHE . 2.6 mm? -109.08 -41.36 4.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.255 -0.646 . . . . 3.2400000000000002 109.255 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-N 113.862 -1.517 . . . . 4.0199999999999996 108.652 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 107.851 -1.166 . . . . 3.6200000000000001 107.851 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -115.81 110.27 18.82 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.32 -0.552 . . . . 5.4100000000000001 110.567 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.5 m -96.5 150.0 21.11 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.861 -0.736 . . . . 1.98 110.611 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.417 ' C ' HD13 ' A' ' 5' ' ' ILE . 17.2 t -133.77 139.44 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 115.791 -0.641 . . . . 2.0 110.788 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 1.2 mp -113.73 126.48 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.127 -1.805 . . . . 2.0699999999999998 106.127 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 63' ' ' PHE . 22.7 m-85 -108.83 109.3 20.38 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.698 -1.223 . . . . 2.25 107.698 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.556 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -134.02 -169.31 12.02 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.788 -1.672 . . . . 1.7 112.134 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.0 tmm_? -102.03 64.24 0.94 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.891 -1.522 . . . . 6.8499999999999996 106.891 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.417 ' OG ' ' NH2' ' A' ' 39' ' ' ARG . 4.5 m 58.31 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.495 -1.229 . . . . 5.75 111.152 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -123.1 84.27 0.37 Allowed Glycine 0 N--CA 1.499 2.88 0 N-CA-C 110.53 -1.028 . . . . 3.6699999999999999 110.53 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' TYR . 41.3 t -128.93 109.98 18.44 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.455 -0.572 . . . . 5.5899999999999999 109.455 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -40.55 -27.57 0.28 Allowed 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 124.534 3.489 . . . . 4.5700000000000003 115.817 -153.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' CYS . 98.9 m-85 -72.5 -37.4 68.4 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.241 -0.984 . . . . 4.7999999999999998 110.701 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.556 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.2 m -61.01 -39.91 91.53 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.401 -1.703 . . . . 2.3999999999999999 106.401 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.69 -38.46 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.287 -0.965 . . . . 2.0800000000000001 109.078 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.512 HH12 ' CG ' ' A' ' 19' ' ' ASP . 9.6 mmm180 -76.81 -51.01 12.13 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.683 -0.689 . . . . 4.8499999999999996 110.978 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.32 -42.78 64.11 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.738 -1.579 . . . . 1.54 106.738 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -58.32 -57.87 11.01 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 113.66 -1.609 . . . . 2.8599999999999999 107.731 178.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.512 ' CG ' HH12 ' A' ' 16' ' ' ARG . 2.2 t70 -51.56 -57.27 9.58 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.428 -1.309 . . . . 3.1299999999999999 109.986 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.1 tp -47.16 -50.71 19.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.131 -0.692 . . . . 2.1499999999999999 109.131 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.488 ' HB3' ' CB ' ' A' ' 33' ' ' TYR . . . -60.1 -45.43 92.99 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.612 -0.835 . . . . 1.7 110.496 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 25' ' ' SER . 18.0 tt0 -65.04 -49.8 68.72 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.464 0.65 . . . . 2.3100000000000001 110.767 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.54 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -56.95 -51.85 67.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.063 -1.458 . . . . 5.2699999999999996 107.063 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.4 mt -52.02 -51.35 57.97 Favored 'General case' 0 C--O 1.199 -1.566 0 N-CA-C 106.441 -1.689 . . . . 2.23 106.441 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 4.6 t -43.32 -24.53 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.57 -0.741 . . . . 1.3700000000000001 112.037 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.07 -39.5 8.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.214 0.321 . . . . 2.6800000000000002 111.005 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.54 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 28.2 mt-10 -72.96 -26.74 61.47 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.327 0.584 . . . . 3.3100000000000001 110.657 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -101.44 175.05 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.352 -0.84 . . . . 5.4000000000000004 110.888 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -107.74 -41.09 5.1 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 115.225 -0.898 . . . . 5.5599999999999996 110.511 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 30' ' ' ASP . 8.3 t70 -109.63 53.46 0.69 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 122.438 1.113 . . . . 4.9900000000000002 109.283 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -131.71 110.42 10.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.256 -0.978 . . . . 1.3999999999999999 110.055 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -124.27 152.37 43.1 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.988 -1.856 . . . . 4.3200000000000003 105.988 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.488 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 7.1 p90 -140.46 154.57 46.68 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 117.884 -1.527 . . . . 1.1599999999999999 111.153 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.51 154.72 47.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.692 -1.225 . . . . 5.0300000000000002 107.692 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.61 139.73 49.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.926 -1.509 . . . . 2.1099999999999999 106.926 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.32 139.03 51.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 124.24 0.963 . . . . 3.1800000000000002 109.955 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -105.95 116.68 32.35 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.694 -1.595 . . . . 2.5299999999999998 106.694 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.8 pt -54.88 -20.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 118.788 -1.165 . . . . 2.3100000000000001 111.299 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.417 ' NH2' ' OG ' ' A' ' 9' ' ' SER . 40.6 ttp-105 -86.13 -61.44 1.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.561 -0.855 . . . . 8.25 109.285 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.18 -43.48 0.22 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.093 0.871 . . . . 1.9299999999999999 111.514 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -94.0 -44.75 7.9 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.582 -0.847 . . . . 3.1099999999999999 112.04 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.51 54.31 0.65 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.212 -1.555 . . . . 1.98 109.212 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.91 127.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 107.497 -1.297 . . . . 2.3700000000000001 107.497 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 p -119.85 166.22 13.57 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.197 -1.001 . . . . 3.96 110.697 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' H ' ' CD ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -41.69 -45.9 3.59 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.379 -0.828 . . . . 6.2599999999999998 110.885 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.489 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 19.9 mp0 -60.51 -55.24 35.76 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.071 -0.651 . . . . 4.1900000000000004 110.239 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.483 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 25.0 t70 -60.32 -39.86 88.53 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.598 -0.841 . . . . 2.9199999999999999 110.689 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.08 -48.73 78.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.124 -0.944 . . . . 2.5499999999999998 109.128 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.76 -59.96 2.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.205 -0.907 . . . . 4.6699999999999999 108.709 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -46.64 -40.84 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 125.029 1.456 . . . . 5.4199999999999999 112.341 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.483 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 25.1 mtmm -94.46 -4.24 48.57 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.578 -1.192 . . . . 3.5899999999999999 114.101 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.582 ' CB ' HE22 ' A' ' 61' ' ' GLN . . . -113.49 -38.37 4.37 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.799 -0.76 . . . . 2.1899999999999999 112.724 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.46 43.98 66.69 Favored Glycine 0 N--CA 1.491 2.365 0 O-C-N 124.395 1.059 . . . . 3.3599999999999999 113.151 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HD2' ' CE1' ' A' ' 68' ' ' HIS . 59.5 mttm -138.53 180.0 1.18 Allowed Pre-proline 0 N--CA 1.504 2.256 0 C-N-CA 119.296 -0.962 . . . . 8.2400000000000002 110.345 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -33.46 82.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.111 2.54 . . . . 6.5700000000000003 112.37 127.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 57' ' ' GLU . 27.6 m -101.66 -42.99 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 115.791 -0.64 . . . . 6.0700000000000003 112.34 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.426 ' N ' HG22 ' A' ' 56' ' ' VAL . 2.4 tt0 61.37 -108.39 0.32 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.651 -0.87 . . . . 7.0499999999999998 108.651 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.5 p -129.92 -86.51 0.53 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.623 -1.231 . . . . 5.3099999999999996 111.143 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 m -137.98 164.66 39.23 Favored Pre-proline 0 C--N 1.291 -1.966 0 N-CA-C 109.771 -0.455 . . . . 2.54 109.771 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HB3' ' HG ' ' A' ' 14' ' ' CYS . 12.2 Cg_endo -94.36 148.08 10.18 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 124.594 -1.002 . . . . 1.97 110.314 -9.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.582 HE22 ' CB ' ' A' ' 52' ' ' ALA . 33.4 mt-30 -111.23 142.78 42.98 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.984 -1.086 . . . . 3.5499999999999998 108.282 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.506 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.1 mp -113.44 142.31 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.987 0.898 . . . . 3.04 110.02 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 6' ' ' PHE . 20.0 m-85 -121.21 136.3 55.0 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.354 -2.091 . . . . 1.7 105.354 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.607 HG12 ' CH2' ' A' ' 78' ' ' TRP . 5.8 t -115.05 106.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.817 -0.753 . . . . 2.2000000000000002 109.114 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 66.91 -72.6 0.08 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.581 -0.736 . . . . 2.5 111.982 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -136.74 -11.02 1.81 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 113.704 1.002 . . . . 4.8499999999999996 113.704 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -117.01 161.6 19.13 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.749 -1.18 . . . . 7.4900000000000002 114.003 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.511 ' CE1' HE21 ' A' ' 61' ' ' GLN . 10.0 t-160 -90.06 133.67 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.725 -1.213 . . . . 1.27 107.725 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.53 -39.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.541 -0.863 . . . . 1.9199999999999999 110.235 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.82 -142.27 13.69 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.177 -1.569 . . . . 1.1699999999999999 109.177 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.85 173.65 41.8 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.389 -1.484 . . . . 1.22 109.389 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 23.7 t80 -42.87 -45.99 5.13 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.301 -0.96 . . . . 2.3900000000000001 111.209 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.4 -58.12 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.797 0.808 . . . . 2.3100000000000001 110.054 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.2 -39.84 80.01 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.148 -1.387 . . . . 2.0699999999999998 109.581 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.66 -56.83 17.16 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.897 -1.121 . . . . 1.8100000000000001 109.384 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.26 -56.01 19.99 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.83 -0.748 . . . . 1.96 110.284 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.59 -54.5 43.34 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.432 -0.907 . . . . 2.1099999999999999 109.43 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.607 ' CH2' HG12 ' A' ' 64' ' ' VAL . 89.3 t90 -46.74 -55.5 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.836 -0.746 . . . . 1.3799999999999999 110.457 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.5 t -47.94 -55.5 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.847 -1.07 . . . . 1.72 111.218 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HZ3' ' CG ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -43.72 -46.86 7.73 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.615 0.968 . . . . 3.1000000000000001 113.615 -177.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -103.96 34.42 3.03 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 118.956 -1.097 . . . . 4.4000000000000004 112.512 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -141.05 -49.03 0.42 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.929 -0.767 . . . . 1.51 108.929 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.8 mt -112.71 46.15 1.24 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.964 -1.017 . . . . 2.5299999999999998 109.434 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.446 ' CG ' ' HZ3' ' A' ' 80' ' ' LYS . 3.8 t0 . . . . . 0 C--N 1.291 -1.969 0 N-CA-C 107.092 -1.448 . . . . 3.7000000000000002 107.092 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 108.285 -1.006 . . . . 3.46 108.285 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -106.76 102.78 12.13 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.744 0.783 . . . . 5.7000000000000002 111.761 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.3 m -94.22 129.77 40.71 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.348 -1.353 . . . . 1.75 107.348 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.67 134.71 62.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.034 -1.066 . . . . 2.0600000000000001 110.318 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.3 mp -107.55 121.51 60.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.789 -2.3 . . . . 2.3599999999999999 104.789 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -114.99 91.13 3.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 102.977 -2.972 . . . . 2.5299999999999998 102.977 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.627 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -128.05 -167.34 12.23 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 118.535 -1.793 . . . . 1.78 114.375 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.96 95.2 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.838 -1.181 . . . . 6.2199999999999998 110.717 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.409 ' OG ' ' NH1' ' A' ' 8' ' ' ARG . 2.9 p -53.36 144.27 16.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.94 -1.133 . . . . 5.6600000000000001 107.94 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.9 -36.0 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.082 -2.407 . . . . 3.2999999999999998 107.082 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -97.78 133.71 23.13 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.205 -1.035 . . . . 4.3099999999999996 108.205 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.77 51.27 0.89 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.455 2.103 . . . . 3.48 111.488 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.89 -64.33 1.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.048 -1.093 . . . . 4.5199999999999996 108.048 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.627 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -54.98 -29.91 58.04 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 115.149 -0.932 . . . . 2.4300000000000002 108.902 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.1 t -42.79 -44.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.367 -1.288 . . . . 2.3399999999999999 109.914 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 4.4 mmp_? -63.44 -52.03 63.21 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.087 -1.045 . . . . 3.6499999999999999 111.008 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 62' ' ' ILE . . . -59.62 -45.06 93.05 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.468 -0.893 . . . . 1.5700000000000001 110.572 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 7.3 ttpp -61.25 -52.12 66.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.172 -1.011 . . . . 2.9300000000000002 108.851 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -53.65 -53.66 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.252 -0.579 . . . . 2.3599999999999999 109.848 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.52 -65.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.344 -0.942 . . . . 2.25 109.038 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.55 -46.47 19.38 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.987 -0.685 . . . . 1.8899999999999999 110.411 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.478 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 43.8 tt0 -58.77 -54.17 50.08 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.251 1.024 . . . . 2.1400000000000001 111.38 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.64 ' CA ' ' HZ1' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -54.49 -50.36 67.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 113.694 -1.594 . . . . 7.79 106.822 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -53.38 -50.81 64.33 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.261 -1.385 . . . . 2.1299999999999999 107.261 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 7.6 t -43.78 -24.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.433 -0.803 . . . . 1.49 112.507 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.09 -31.29 8.34 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.439 -0.801 . . . . 2.9700000000000002 110.864 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.52 -36.47 73.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.088 . . . . 3.8500000000000001 108.061 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.455 HH11 ' C ' ' A' ' 85' ' ' ALA . 19.4 mtp180 -119.03 117.31 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.477 0.656 . . . . 4.5499999999999998 109.597 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -63.88 3.68 0.36 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.956 1.095 . . . . 3.7999999999999998 113.956 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 1' ' ' MET . 11.4 p-10 -114.67 7.61 16.02 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.058 -0.719 . . . . 3.0899999999999999 109.058 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.448 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 12.6 t80 -109.35 129.65 55.52 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.866 -0.734 . . . . 1.3700000000000001 112.855 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -129.56 150.85 50.71 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.627 -1.62 . . . . 4.6200000000000001 106.627 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.478 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 8.4 p90 -133.89 160.06 38.8 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.316 -1.354 . . . . 1.1699999999999999 110.821 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -134.07 135.38 43.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.73 0.644 . . . . 5.2199999999999998 110.342 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -108.08 109.84 21.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.003 -1.851 . . . . 2.4900000000000002 106.003 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.24 141.4 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.379 -1.711 . . . . 2.7999999999999998 106.379 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 9.0 t70 -110.17 155.05 22.47 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.074 -1.05 . . . . 2.7799999999999998 110.844 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 pt -84.16 -34.87 10.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 117.993 -1.483 . . . . 2.6000000000000001 112.435 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.467 ' HE ' ' N ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -98.24 -58.01 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.321 -1.752 . . . . 6.2199999999999998 108.845 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.467 ' N ' ' HE ' ' A' ' 39' ' ' ARG . . . -39.09 -39.91 0.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 124.198 0.936 . . . . 3.8900000000000001 111.255 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.48 -36.38 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.071 -1.451 . . . . 4.6399999999999997 110.862 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.23 69.77 0.61 Allowed Glycine 0 N--CA 1.5 2.948 0 C-N-CA 118.448 -1.834 . . . . 2.5499999999999998 113.128 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 mm -115.04 157.18 15.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.148 -1.797 . . . . 3.6400000000000001 106.148 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.7 p -107.39 137.14 45.98 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.69 -1.204 . . . . 3.6499999999999999 110.454 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -55.04 -31.39 61.06 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.716 -1.216 . . . . 4.4299999999999997 107.716 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 7.1 mp0 -59.42 -64.94 0.76 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.209 -0.663 . . . . 3.46 109.209 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 4.6 t70 -48.1 -49.45 31.82 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.069 0.938 . . . . 2.9700000000000002 111.185 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.2 mt -61.8 -54.46 42.03 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.606 -1.179 . . . . 3.4199999999999999 109.295 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -44.44 -46.12 9.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.837 -1.171 . . . . 4.3600000000000003 107.837 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 8.5 tm0? -60.13 -58.89 6.58 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.781 -1.554 . . . . 5.46 110.974 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -17.89 63.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.141 1.534 . . . . 3.8700000000000001 115.141 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.68 -38.28 13.19 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.736 -0.786 . . . . 2.5800000000000001 111.143 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.46 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . . . 112.94 57.82 0.42 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.274 -1.93 . . . . 2.8100000000000001 108.274 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 37.2 76.03 0.49 Allowed Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 124.954 1.032 . . . . 7.6699999999999999 111.651 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 1.8 Cg_endo -90.35 33.79 0.33 Allowed 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 122.821 2.348 . . . . 7.7800000000000002 111.103 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.421 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.4 t 32.06 -102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 113.685 -1.598 . . . . 7.4100000000000001 113.826 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.471 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 7.6 tp10 -125.04 46.11 2.41 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.579 -0.448 . . . . 8.0099999999999998 110.216 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.0 p -119.44 124.36 46.32 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.285 1.217 . . . . 5.6100000000000003 114.285 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 33.1 m -132.93 166.11 31.69 Favored Pre-proline 0 N--CA 1.504 2.238 0 N-CA-C 107.27 -1.381 . . . . 3.4199999999999999 107.27 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 50.9 Cg_endo -79.61 170.72 66.53 Favored 'Cis proline' 0 N--CA 1.491 1.35 0 O-C-N 122.19 0.574 . . . . 1.95 110.886 -7.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.54 150.57 50.13 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.786 -0.766 . . . . 3.0699999999999998 111.109 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 17' ' ' ALA . 36.9 mm -119.69 141.45 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.039 -0.982 . . . . 3.1099999999999999 110.295 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -120.69 153.85 36.36 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.69 -1.141 . . . . 1.6899999999999999 109.162 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 66' ' ' GLN . 85.9 t -129.83 100.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.06 -1.459 . . . . 1.8100000000000001 107.06 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 54.93 -79.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 124.409 1.068 . . . . 2.5800000000000001 112.721 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 64' ' ' VAL . 1.4 tm0? -120.53 -24.78 5.72 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.518 -1.219 . . . . 7.4400000000000004 112.666 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -95.18 155.18 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.355 -0.938 . . . . 4.6200000000000001 111.705 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -102.36 140.03 37.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 105.341 -2.096 . . . . 1.1699999999999999 105.341 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.52 -42.3 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 118.11 -1.436 . . . . 2.04 110.793 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.0 -129.51 5.14 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.463 -1.455 . . . . 1.1200000000000001 109.463 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.4 178.65 25.43 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.679 -1.248 . . . . 1.29 110.424 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.533 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 45.7 t80 -45.45 -36.03 4.15 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.311 -0.956 . . . . 2.46 111.422 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -58.94 -62.06 2.17 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.602 -0.839 . . . . 2.0499999999999998 109.426 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.26 -39.99 64.3 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.895 -1.048 . . . . 2.21 109.109 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.82 -56.37 22.02 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.199 -1.0 . . . . 1.73 109.683 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.0 -51.12 64.95 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.86 -0.736 . . . . 1.8500000000000001 110.054 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -53.81 54.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.833 -0.747 . . . . 1.8 109.465 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -48.05 -53.29 16.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.44 -0.948 . . . . 1.05 108.44 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.9 -61.18 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 114.648 -1.16 . . . . 1.75 109.185 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.14 -51.94 7.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.739 0.649 . . . . 3.0099999999999998 112.581 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.85 16.28 7.12 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.664 -1.214 . . . . 4.7300000000000004 113.845 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -128.28 -43.98 1.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.61 -0.836 . . . . 2.1499999999999999 110.393 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.07 36.51 2.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.867 -0.733 . . . . 2.4500000000000002 110.722 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.48 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 2.3 t70 -89.25 54.05 2.84 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.181 -1.785 . . . . 4.1699999999999999 106.181 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.455 ' C ' HH11 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.501 2.115 0 CA-C-N 112.645 -2.07 . . . . 5.0700000000000003 107.196 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.522 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.66 -0.867 . . . . 3.0499999999999998 108.66 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -84.89 111.57 19.78 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.262 0.977 . . . . 5.8600000000000003 109.583 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.9 m -104.12 123.39 47.18 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 1.75 109.208 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.13 130.89 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.347 -0.941 . . . . 1.95 109.928 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 1.3 mp -106.12 131.9 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.974 -1.862 . . . . 2.23 105.974 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -117.42 108.57 15.72 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 105.563 -2.014 . . . . 2.0 105.563 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.64 -160.07 8.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.505 -1.331 . . . . 1.6000000000000001 110.381 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -113.62 -162.04 0.79 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.222 -0.991 . . . . 5.6299999999999999 108.732 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -128.89 154.54 46.4 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.49 -1.232 . . . . 5.6699999999999999 109.452 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 -44.83 1.37 Allowed Glycine 0 N--CA 1.5 2.908 0 C-N-CA 119.386 -1.388 . . . . 3.8500000000000001 114.229 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.5 m -106.33 146.89 33.89 Favored Pre-proline 0 N--CA 1.498 1.936 0 C-N-CA 118.694 -1.202 . . . . 4.1600000000000001 111.944 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.49 65.61 8.2 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.41 2.073 . . . . 3.46 111.276 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -112.92 -73.54 0.66 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.655 -1.239 . . . . 4.9699999999999998 107.655 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.0 m -53.53 -25.15 15.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.356 -0.979 . . . . 2.71 108.356 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -41.65 -39.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 114.624 -1.171 . . . . 2.4300000000000002 109.779 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.58 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 1.1 tpm_? -75.83 -50.24 15.71 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.15 -1.02 . . . . 4.5800000000000001 110.255 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.69 54.17 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.758 -1.177 . . . . 1.97 108.321 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 14.6 ttpp -67.59 -58.38 4.8 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 107.448 -1.315 . . . . 2.9700000000000002 107.448 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.415 ' CG ' HH21 ' A' ' 16' ' ' ARG . 2.5 t70 -45.04 -42.93 8.95 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.539 -0.864 . . . . 2.3900000000000001 109.696 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.9 tp -62.62 -63.73 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.668 -1.151 . . . . 2.2200000000000002 108.275 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.84 -45.9 15.29 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.444 0.64 . . . . 1.45 109.833 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 26.7 tt0 -64.57 -44.28 91.2 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.6 -1.182 . . . . 2.8300000000000001 109.583 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.495 ' CB ' ' HZ1' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -57.32 -54.7 43.79 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.872 -1.529 . . . . 7.2800000000000002 106.872 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.27 -45.53 68.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.761 -1.563 . . . . 2.1000000000000001 107.691 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 32' ' ' GLN . 8.3 t -54.9 -25.82 31.62 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.979 -1.009 . . . . 1.3799999999999999 111.447 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.422 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.1 t30 -105.63 9.83 33.13 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.888 -0.782 . . . . 2.1800000000000002 108.888 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -117.65 -32.73 4.77 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 115.985 -0.552 . . . . 3.2599999999999998 110.53 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.56 HH12 ' C ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -110.44 153.59 24.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.819 -0.808 . . . . 5.29 108.819 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.71 -26.59 25.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.865 -0.607 . . . . 4.2800000000000002 110.565 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.51 13.67 29.14 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.694 -0.802 . . . . 2.7400000000000002 110.471 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -112.47 124.79 53.29 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.297 1.591 . . . . 1.6100000000000001 115.297 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.403 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 63.4 mt-30 -143.02 156.54 44.86 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.397 -2.075 . . . . 3.8999999999999999 105.397 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -142.3 170.9 14.83 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 117.71 -1.596 . . . . 1.4099999999999999 111.77 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -138.17 145.21 41.24 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.654 -1.612 . . . . 5.3499999999999996 109.112 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -122.5 122.76 39.7 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.944 -1.873 . . . . 2.5800000000000001 105.944 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.71 137.41 54.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.651 -1.241 . . . . 2.23 107.651 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.69 129.83 47.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.034 -1.099 . . . . 2.3100000000000001 108.034 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.51 -28.9 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 119.935 -0.706 . . . . 3.1600000000000001 111.005 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.578 ' NH1' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -79.79 -40.52 28.49 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.588 -1.264 . . . . 7.96 107.588 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.578 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -39.17 -54.18 1.8 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 120.962 -0.295 . . . . 1.9299999999999999 110.727 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' GLY . 48.9 mt-10 -110.79 41.42 1.8 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 124.502 1.126 . . . . 4.2000000000000002 109.95 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 20.1 66.17 0.01 OUTLIER Glycine 0 N--CA 1.508 3.48 0 O-C-N 124.205 0.94 . . . . 2.6200000000000001 113.31 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 44' ' ' THR . 48.4 mt -93.4 162.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.863 -0.735 . . . . 2.8199999999999998 109.807 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.43 ' N ' HG23 ' A' ' 43' ' ' ILE . 45.9 p -113.12 178.38 4.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.798 -0.637 . . . . 2.79 109.925 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -73.55 -52.86 12.07 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.607 -1.237 . . . . 7.3700000000000001 109.864 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.4 mp0 -43.3 -52.67 5.65 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.339 -0.544 . . . . 3.8799999999999999 110.162 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.541 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 4.1 t70 -51.57 -57.36 9.32 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.06 -0.656 . . . . 2.4700000000000002 110.3 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mt -53.51 -46.05 69.93 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 115.02 -0.991 . . . . 2.2599999999999998 110.245 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -47.07 -54.78 9.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.47 -0.937 . . . . 3.6600000000000001 108.47 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -49.23 -29.85 6.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.215 1.572 . . . . 4.7300000000000004 111.285 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.541 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 10.8 mptt -82.54 -47.36 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.127 -0.942 . . . . 3.2799999999999998 112.311 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' HB1' ' NE2' ' A' ' 61' ' ' GLN . . . -75.27 -45.96 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.628 1.344 . . . . 1.8100000000000001 114.628 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.63 -42.65 1.91 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 107.295 -2.322 . . . . 2.3999999999999999 107.295 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 10.8 ptmm? -84.18 169.53 16.64 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 106.696 -1.594 . . . . 7.8099999999999996 106.696 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.509 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 13.0 Cg_endo -56.04 163.53 5.9 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.942 -1.215 . . . . 4.8499999999999996 108.942 161.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -124.0 38.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.93 -1.108 . . . . 6.4000000000000004 109.762 179.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -26.14 -64.06 0.07 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.257 -1.338 . . . . 5.1600000000000001 111.163 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -116.79 -154.5 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.122 -0.944 . . . . 4.9299999999999997 109.763 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.44 175.76 3.25 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.068 -1.086 . . . . 2.9399999999999999 108.068 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.446 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 71.6 Cg_endo -103.6 -170.71 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.112 0 O-C-N 122.406 0.687 . . . . 1.99 111.672 -18.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.525 ' NE2' ' HB1' ' A' ' 52' ' ' ALA . 13.6 mt-30 -141.94 151.79 42.91 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 115.686 -0.688 . . . . 3.3900000000000001 110.716 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.492 ' N ' HD13 ' A' ' 62' ' ' ILE . 3.9 mp -124.79 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 115.527 -0.76 . . . . 2.8500000000000001 109.286 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 16.8 m-85 -127.27 150.74 49.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.19 -1.368 . . . . 1.28 109.894 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.5 t -120.5 125.32 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.055 -1.461 . . . . 1.8200000000000001 107.055 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 11.1 t70 57.41 -94.76 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.775 -1.194 . . . . 4.4699999999999998 107.775 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -131.99 2.47 3.99 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.389 -0.823 . . . . 4.5999999999999996 110.938 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.448 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 1.4 mt-30 -97.09 167.31 11.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 110.018 -0.364 . . . . 5.1900000000000004 110.018 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 15.0 t-160 -108.28 139.53 42.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.587 -1.264 . . . . 1.05 107.587 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.7 mm -101.73 -42.89 9.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.075 -1.05 . . . . 2.1600000000000001 108.55 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.52 -132.43 5.45 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.07 -2.012 . . . . 1.3400000000000001 108.07 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 72' ' ' TYR . . . -114.74 -175.22 18.59 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.054 -1.218 . . . . 1.3100000000000001 110.054 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.47 ' OH ' ' HG2' ' A' ' 16' ' ' ARG . 1.8 t80 -33.03 -54.42 0.38 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.405 0.622 . . . . 3.25 111.194 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.98 -68.77 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.562 -1.199 . . . . 2.3700000000000001 110.939 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -51.1 -38.94 54.79 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.696 -1.593 . . . . 2.4100000000000001 110.846 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -64.99 -51.71 60.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.833 -1.147 . . . . 1.0900000000000001 109.903 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.12 76.18 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.185 -1.006 . . . . 1.98 109.6 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.02 -58.99 5.45 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.102 -1.039 . . . . 1.8300000000000001 109.109 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -42.58 -51.01 5.3 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.196 -1.039 . . . . 0.84999999999999998 108.196 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -52.66 -65.58 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.296 0 N-CA-C 107.857 -1.164 . . . . 2.1600000000000001 107.857 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.518 ' HZ2' ' CG ' ' A' ' 84' ' ' ASP . 22.1 tptp -49.25 -29.48 5.84 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.507 1.299 . . . . 3.3799999999999999 114.507 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -105.82 7.64 32.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.231 0.826 . . . . 4.0599999999999996 113.231 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -129.05 -35.54 1.83 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.01 -0.676 . . . . 1.5600000000000001 110.378 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -106.35 26.02 10.37 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.131 -0.628 . . . . 2.2000000000000002 109.872 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.518 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 5.3 t70 -82.36 53.6 2.34 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.548 -0.908 . . . . 3.8700000000000001 108.548 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.56 ' C ' HH12 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.878 -1.058 . . . . 5.4800000000000004 109.3 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' N ' ' O ' ' A' ' 30' ' ' ASP . 47.5 mtm . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.531 -0.914 . . . . 3.5800000000000001 108.531 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.07 155.13 20.72 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 123.833 0.708 . . . . 4.9400000000000004 109.107 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 m -143.74 143.7 31.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.021 -1.103 . . . . 2.8999999999999999 108.021 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.0 t -127.84 126.61 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 119.033 -1.067 . . . . 2.3199999999999998 112.526 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.34 130.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.787 -1.19 . . . . 2.0099999999999998 107.787 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -111.02 111.67 22.94 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 105.006 -2.22 . . . . 2.2400000000000002 105.006 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.651 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -129.09 -143.82 5.6 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.536 -1.316 . . . . 2.2200000000000002 112.8 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.32 -167.27 1.83 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 114.404 -0.898 . . . . 7.2000000000000002 109.969 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m -86.53 64.25 8.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.096 -0.642 . . . . 5.8499999999999996 111.428 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.63 53.83 1.1 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.504 -1.332 . . . . 4.0499999999999998 109.78 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' TYR . 49.4 t -107.31 98.03 21.33 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.568 -1.271 . . . . 4.8099999999999996 107.568 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.43 -20.76 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.264 2.642 . . . . 3.7400000000000002 113.699 -159.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' CYS . 30.1 m-85 -71.62 -30.92 66.32 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.325 -0.55 . . . . 5.1900000000000004 112.099 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -83.8 -30.41 26.59 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.7 -1.6 . . . . 2.4700000000000002 106.811 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -50.05 -49.85 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 115.483 -0.78 . . . . 2.1200000000000001 109.344 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.573 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 3.9 mmp_? -58.59 -52.47 65.54 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.38 -0.928 . . . . 3.8799999999999999 111.047 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.92 63.44 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.261 -1.375 . . . . 1.4299999999999999 107.729 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -49.19 -58.8 4.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 124.42 1.075 . . . . 3.5699999999999998 109.265 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.74 -52.19 50.45 Favored 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 120.025 -0.67 . . . . 2.6299999999999999 110.952 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 tp -52.5 -63.86 1.0 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.078 -0.712 . . . . 2.04 109.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.76 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.059 -0.719 . . . . 1.51 109.059 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.2 tt0 -55.36 -42.01 73.34 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.129 -0.941 . . . . 2.6299999999999999 110.273 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.636 ' CA ' ' HZ1' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -64.13 -54.63 30.87 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.036 -1.066 . . . . 6.7199999999999998 108.339 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 43.1 mt -49.1 -47.55 45.13 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.124 -2.176 . . . . 2.1200000000000001 105.124 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.19 -47.77 24.03 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.943 -1.026 . . . . 1.3899999999999999 110.831 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.22 -35.24 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.656 -0.818 . . . . 2.96 112.154 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -72.3 -36.55 68.97 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.084 -0.646 . . . . 4.2400000000000002 111.323 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.533 HH21 ' CG ' ' A' ' 30' ' ' ASP . 10.9 ptm85 -136.49 113.59 10.56 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.683 -0.807 . . . . 4.4699999999999998 111.559 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -62.17 12.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 114.572 1.323 . . . . 4.7000000000000002 114.572 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.533 ' CG ' HH21 ' A' ' 28' ' ' ARG . 10.1 p-10 -111.65 -1.88 15.57 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.066 -0.716 . . . . 3.6400000000000001 109.066 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.495 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 91.4 t80 -109.65 116.81 32.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.637 -0.825 . . . . 1.6499999999999999 110.352 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -121.73 167.81 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.148 -0.686 . . . . 4.0199999999999996 109.148 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 30.1 p90 -161.55 168.78 22.96 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.091 -0.644 . . . . 1.75 110.21 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 152.09 41.11 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 109.599 -0.519 . . . . 6.2599999999999998 109.599 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -118.44 135.7 54.21 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.306 -0.958 . . . . 2.1000000000000001 109.284 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -127.8 159.33 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.401 -0.963 . . . . 2.4199999999999999 108.401 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -113.71 129.11 56.62 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.698 -1.964 . . . . 2.5299999999999998 105.698 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -43.67 -26.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.393 -0.523 . . . . 3.27 111.585 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -73.0 -59.44 2.7 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 120.469 -0.492 . . . . 8.1099999999999994 109.993 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.32 -47.15 0.4 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.467 1.105 . . . . 2.4500000000000002 111.202 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.82 -45.68 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.511 -1.222 . . . . 4.2699999999999996 110.813 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.49 49.45 0.8 Allowed Glycine 0 N--CA 1.505 3.268 0 N-CA-C 109.417 -1.473 . . . . 2.79 109.417 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.429 HG22 ' HG ' ' A' ' 48' ' ' LEU . 15.9 mt -113.19 148.51 16.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.064 -0.568 . . . . 3.79 111.015 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.6 p -118.7 -92.77 0.53 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.01 -1.076 . . . . 5.9100000000000001 110.113 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' NZ ' ' OE1' ' A' ' 46' ' ' GLU . 11.4 tttm -138.45 -55.16 0.63 Allowed 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.652 -1.24 . . . . 5.1799999999999997 107.652 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.8 mm-40 -43.24 -50.43 6.48 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.367 -0.933 . . . . 5.5199999999999996 110.92 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.433 ' OD2' ' NZ ' ' A' ' 51' ' ' LYS . 33.3 t70 -63.31 -54.74 32.34 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.35 -0.94 . . . . 3.27 111.195 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HG ' HG22 ' A' ' 43' ' ' ILE . 6.1 mt -53.52 -43.86 68.69 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.698 -0.801 . . . . 2.73 110.025 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.83 -53.76 54.57 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.495 -1.298 . . . . 4.6500000000000004 107.495 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -53.11 -58.11 8.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 124.188 0.93 . . . . 5.29 110.367 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' NZ ' ' OD2' ' A' ' 47' ' ' ASP . 48.0 mttp -54.0 -50.23 67.09 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.166 -0.925 . . . . 3.8300000000000001 111.367 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' HA ' ' CG ' ' A' ' 68' ' ' HIS . . . -54.45 -55.94 23.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.723 -1.581 . . . . 2.3999999999999999 111.418 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.04 36.44 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.271 -1.532 . . . . 3.1200000000000001 109.271 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -102.79 161.35 23.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.164 -0.68 . . . . 8.5399999999999991 109.164 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.32 111.21 3.23 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.784 1.656 . . . . 5.4100000000000001 111.451 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.02 159.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 123.335 0.397 . . . . 7.1100000000000003 110.082 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -133.65 -43.08 0.83 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 123.511 0.507 . . . . 6.5700000000000003 111.957 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.437 ' HG1' ' HG2' ' A' ' 57' ' ' GLU . 1.2 m -114.54 -148.31 0.43 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.651 -0.82 . . . . 6.0300000000000002 109.696 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.81 173.6 2.9 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 109.576 -0.527 . . . . 3.52 109.576 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 73.9 Cg_endo -100.03 -177.68 4.0 Favored 'Cis proline' 0 N--CA 1.483 0.874 0 O-C-N 122.348 0.657 . . . . 2.02 111.319 -11.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.46 145.01 48.44 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.445 -0.798 . . . . 2.79 111.025 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.528 HG22 ' CD1' ' A' ' 75' ' ' PHE . 4.3 mp -124.77 145.78 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 115.171 -0.922 . . . . 2.9399999999999999 110.863 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.72 160.99 33.88 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.084 -1.871 . . . . 1.3799999999999999 108.539 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.47 HG22 ' CG1' ' A' ' 69' ' ' ILE . 60.6 t -112.4 175.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.827 -1.916 . . . . 2.3799999999999999 105.827 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' N ' HG13 ' A' ' 64' ' ' VAL . 38.8 t70 -61.35 -8.84 4.31 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.991 -1.084 . . . . 3.71 111.014 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -122.95 -56.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.459 1.281 . . . . 7.9800000000000004 114.459 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.56 176.02 5.91 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.816 -0.753 . . . . 8.1699999999999999 112.641 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.511 ' CG ' ' HA ' ' A' ' 52' ' ' ALA . 13.2 t-80 -93.05 154.56 18.04 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.483 -2.043 . . . . 1.3300000000000001 105.483 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.47 ' CG1' HG22 ' A' ' 64' ' ' VAL . 37.0 mm -115.07 -49.13 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.379 -1.328 . . . . 2.29 111.291 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.453 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 145.49 -130.99 4.0 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 1.1799999999999999 109.708 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.84 -173.39 20.63 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.248 -1.141 . . . . 1.2 110.248 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.91 -52.34 1.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 120.163 -0.615 . . . . 2.52 110.746 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -50.47 -58.76 5.0 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.843 0.83 . . . . 2.02 110.106 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.408 ' HB3' HG23 ' A' ' 69' ' ' ILE . 1.7 m-20 -54.33 -54.31 42.1 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.792 -1.095 . . . . 2.71 110.126 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CD1' HG22 ' A' ' 62' ' ' ILE . 25.7 t80 -54.2 -52.34 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.778 -0.769 . . . . 1.26 110.997 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.61 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.625 -0.83 . . . . 2.4700000000000002 109.014 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.07 -55.85 28.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.376 -0.929 . . . . 2.3900000000000001 110.021 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -49.71 -51.84 35.7 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.705 -0.798 . . . . 1.3600000000000001 109.346 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.0 t -49.73 -63.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 124.131 0.894 . . . . 2.04 108.706 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -44.63 -48.48 10.47 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.03 -0.986 . . . . 3.1800000000000002 111.154 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.57 27.55 2.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 117.567 -1.653 . . . . 3.7999999999999998 113.987 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.68 -41.79 0.28 Allowed 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 119.437 -0.905 . . . . 1.24 112.108 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.7 mt -109.98 2.96 20.01 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 120.012 -0.675 . . . . 2.5600000000000001 111.845 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -103.26 -134.7 0.32 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.569 0.7 . . . . 4.9800000000000004 109.577 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.964 0 CA-C-N 113.895 -1.502 . . . . 7.8200000000000003 107.591 179.384 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mmm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.208 -0.664 . . . . 3.5699999999999998 109.208 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -88.96 97.75 11.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.879 -0.601 . . . . 5.0099999999999998 110.172 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.431 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 29.9 m -84.4 123.38 30.16 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.828 -1.149 . . . . 1.8700000000000001 109.207 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.67 131.41 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.828 -0.749 . . . . 2.21 112.277 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.45 116.89 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.703 -1.962 . . . . 2.0499999999999998 105.703 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -99.43 103.89 15.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.661 -1.607 . . . . 2.1000000000000001 106.661 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.78 -123.33 2.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.523 -1.431 . . . . 1.9299999999999999 109.523 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' N ' ' OH ' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -135.88 -114.37 0.19 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.879 -1.128 . . . . 7.2300000000000004 109.403 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 p -113.58 -74.81 0.61 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.808 -1.182 . . . . 5.5099999999999998 107.808 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.92 63.36 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.534 -2.227 . . . . 3.6699999999999999 107.534 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 49.6 t -100.19 97.47 6.28 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.935 -0.706 . . . . 4.9800000000000004 109.524 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.56 -25.57 41.6 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.062 1.841 . . . . 3.8500000000000001 111.847 -170.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.91 -9.74 58.95 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.332 -0.947 . . . . 6.5099999999999998 111.576 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 3.5 m -101.07 -37.3 8.66 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.784 -1.561 . . . . 2.9700000000000002 106.784 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -42.71 -35.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 114.721 -1.127 . . . . 2.2000000000000002 110.128 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 7.3 mmm180 -71.51 -55.17 8.38 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.049 -1.46 . . . . 4.8600000000000003 110.525 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.7 43.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.622 -1.251 . . . . 1.97 107.622 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -58.79 -49.88 76.01 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.539 -1.664 . . . . 2.98 109.035 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.492 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.6 t70 -60.44 -49.33 78.02 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.735 -1.186 . . . . 2.8900000000000001 111.075 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 42.1 tp -60.51 -55.32 34.91 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.979 -1.088 . . . . 2.0 110.0 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.85 64.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.335 -1.357 . . . . 1.73 107.335 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.603 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 31.8 tt0 -48.61 -49.43 36.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.388 1.055 . . . . 2.1400000000000001 109.359 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HE3' ' CA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -50.74 -63.52 1.1 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.344 -1.354 . . . . 7.6799999999999997 107.344 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.431 HD11 ' CD1' ' A' ' 83' ' ' LEU . 54.3 mt -45.53 -53.54 8.83 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.872 -1.158 . . . . 2.2799999999999998 107.872 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 15.1 t -52.02 -33.25 37.67 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.21 -1.359 . . . . 1.74 112.939 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -112.32 25.33 11.63 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.161 -0.927 . . . . 3.8500000000000001 109.197 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -133.62 -48.47 0.82 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.161 -0.927 . . . . 3.2400000000000002 111.568 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 30' ' ' ASP . 21.9 mtp85 -113.38 133.08 55.35 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.194 -0.912 . . . . 4.0700000000000003 110.508 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -80.9 35.04 0.36 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.395 -1.322 . . . . 3.7000000000000002 111.372 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.4 p30 -130.2 -4.58 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.843 -1.526 . . . . 3.8999999999999999 108.132 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 25' ' ' SER . 23.7 t80 -127.86 141.45 51.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.599 -0.84 . . . . 1.3200000000000001 112.608 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 35.4 mm-40 -140.75 141.04 34.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.218 -1.401 . . . . 5.3399999999999999 107.218 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.603 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -127.21 162.34 26.39 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 118.62 -1.232 . . . . 1.74 113.721 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 147.45 27.99 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.611 -1.632 . . . . 5.7800000000000002 109.333 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.538 ' OH ' ' N ' ' A' ' 8' ' ' ARG . 57.6 t80 -113.41 146.34 39.67 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.765 -1.198 . . . . 1.75 107.765 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.21 163.96 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.616 -0.834 . . . . 2.77 110.25 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -121.13 121.24 37.43 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.24 -2.133 . . . . 2.23 105.24 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -51.29 -17.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 118.825 -1.15 . . . . 2.9900000000000002 110.806 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 4.2 ttp-105 -95.05 23.97 5.23 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.72 -0.792 . . . . 7.5599999999999996 109.666 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.84 -43.69 3.97 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.102 -1.444 . . . . 2.5899999999999999 107.102 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -93.48 -42.37 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.541 -2.022 . . . . 4.6500000000000004 105.541 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.21 56.71 0.58 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.222 -1.951 . . . . 1.48 108.222 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.7 149.84 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.501 . . . . 2.2400000000000002 111.067 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 -170.87 1.92 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.607 -0.724 . . . . 2.5299999999999998 109.431 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 13.3 ttpp -77.06 -28.29 54.67 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.491 -0.884 . . . . 6.0700000000000003 110.668 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 16.7 mp0 -70.71 -57.13 5.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 3.3199999999999998 108.149 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.593 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 38.7 t70 -48.52 -42.66 33.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.104 -0.953 . . . . 2.3999999999999999 110.422 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.76 -38.77 53.55 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.954 -1.021 . . . . 2.73 110.895 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.483 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 5.2 tt0 -55.74 -47.71 76.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.306 -1.368 . . . . 4.7400000000000002 107.306 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.0 -30.83 26.83 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.322 -1.308 . . . . 6.21 110.811 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.593 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 58.2 mttp -88.97 -57.6 2.84 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.536 -1.211 . . . . 3.0800000000000001 112.244 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.515 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -50.5 -33.35 21.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.783 -1.099 . . . . 1.99 112.029 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.79 73.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 106.521 -2.632 . . . . 3.6699999999999999 106.521 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -133.26 -169.9 0.22 Allowed Pre-proline 0 C--N 1.296 -1.737 0 CA-C-N 113.089 -1.555 . . . . 7.0499999999999998 107.834 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -86.6 143.5 7.34 Favored 'Trans proline' 0 C--N 1.299 -2.026 0 C-N-CA 120.893 1.062 . . . . 4.0599999999999996 110.989 138.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -118.29 160.46 17.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.731 -1.211 . . . . 6.5999999999999996 107.731 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -101.65 -109.69 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.084 -1.046 . . . . 6.7300000000000004 108.693 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.9 p -120.26 -73.48 0.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.266 -1.013 . . . . 5.6600000000000001 108.266 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -147.8 149.76 34.26 Favored Pre-proline 0 C--N 1.289 -2.048 0 CA-C-N 114.149 -1.387 . . . . 3.6899999999999999 107.966 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.627 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 26.0 Cg_endo -103.66 155.8 3.01 Favored 'Cis proline' 0 C--N 1.32 -0.966 0 CA-C-N 118.671 0.561 . . . . 2.0299999999999998 112.241 -6.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.46 149.43 41.28 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 107.085 -1.45 . . . . 3.6099999999999999 107.085 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 58.0 mt -127.48 141.33 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.651 -0.82 . . . . 2.3900000000000001 113.136 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -124.54 145.15 49.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.306 -1.77 . . . . 1.8899999999999999 110.283 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG13 ' CZ2' ' A' ' 78' ' ' TRP . 71.1 t -117.75 90.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.412 -0.959 . . . . 1.8799999999999999 108.412 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 t70 70.9 -75.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.263 -0.88 . . . . 2.5699999999999998 109.05 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -134.18 -20.87 1.88 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.786 -1.097 . . . . 4.2599999999999998 111.381 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -89.51 158.1 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.759 -1.176 . . . . 6.2999999999999998 110.8 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 11.8 t-160 -103.71 142.32 34.54 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.473 -0.936 . . . . 1.1599999999999999 108.473 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 mm -111.55 -46.14 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.041 -1.063 . . . . 2.0299999999999998 108.959 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.15 -113.82 1.01 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.504 -1.439 . . . . 1.1699999999999999 109.504 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -119.25 -173.81 15.61 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.372 -1.091 . . . . 1.22 110.372 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 18.5 t80 -47.1 -49.2 22.36 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.354 -0.939 . . . . 1.79 111.516 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -54.67 17.17 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.687 0.756 . . . . 1.8999999999999999 110.123 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -58.38 -52.64 64.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.666 -1.606 . . . . 2.4399999999999999 110.481 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.97 -44.68 96.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.508 -0.769 . . . . 1.6000000000000001 111.834 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.91 -58.18 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.728 -0.789 . . . . 2.1000000000000001 109.226 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.76 -55.43 35.21 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.569 -1.253 . . . . 2.3300000000000001 108.893 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.412 ' CZ2' HG13 ' A' ' 64' ' ' VAL . 63.6 t90 -44.75 -54.18 6.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 123.549 0.531 . . . . 1.05 111.485 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -43.54 -59.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.962 -0.563 . . . . 2.0600000000000001 110.265 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -43.8 -30.19 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.394 1.628 . . . . 3.1800000000000002 115.394 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -107.82 4.5 25.57 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 119.579 1.082 . . . . 4.7400000000000002 112.62 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -120.56 -31.57 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.721 -0.791 . . . . 1.3799999999999999 111.045 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' A' ' 24' ' ' LEU . 55.0 mt -116.94 26.84 9.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.792 -0.763 . . . . 2.4300000000000002 111.954 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.42 50.15 1.95 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.698 -0.801 . . . . 3.6000000000000001 110.647 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.413 ' C ' HH12 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.499 2.02 0 CA-C-O 116.035 -1.936 . . . . 5.5499999999999998 111.57 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.494 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 3.9 ptm . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 107.728 -1.212 . . . . 4.5099999999999998 107.728 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.439 HE22 ' C ' ' A' ' 33' ' ' TYR . 60.5 tp60 -111.57 142.0 44.42 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 123.478 0.487 . . . . 5.9100000000000001 109.839 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 m -120.4 148.72 43.41 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.771 -0.771 . . . . 2.5600000000000001 109.025 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.49 139.19 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 118.868 -1.133 . . . . 2.0600000000000001 112.595 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -111.1 136.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.55 -1.278 . . . . 2.9900000000000002 107.55 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.15 84.98 2.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.585 -1.635 . . . . 2.79 106.585 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -135.1 -163.28 10.05 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.496 -2.241 . . . . 1.7 107.496 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 4.2 tpt180 -141.35 167.68 21.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.256 -0.977 . . . . 7.1799999999999997 108.581 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 8' ' ' ARG . 78.9 p -85.76 64.83 8.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.307 -0.627 . . . . 5.3399999999999999 109.307 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 11' ' ' CYS . . . -120.75 61.13 0.52 Allowed Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.505 -1.438 . . . . 4.7699999999999996 109.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.742 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 30.7 t 108.82 165.44 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.685 0 N-CA-C 105.605 -1.998 . . . . 5.0899999999999999 105.605 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.742 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 50.5 Cg_exo -54.76 75.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.023 1.149 . . . . 3.7999999999999998 113.023 165.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -113.82 -77.89 0.58 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.573 -0.451 . . . . 5.4199999999999999 109.915 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.461 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.7 m -55.02 -29.12 56.7 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 118.041 -1.464 . . . . 3.27 108.022 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -42.54 -38.59 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.164 -1.38 . . . . 2.5899999999999999 110.205 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.493 ' NH2' ' O ' ' A' ' 16' ' ' ARG . 6.6 mmm180 -77.11 -53.63 7.54 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.957 -1.497 . . . . 4.3799999999999999 110.093 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.16 -42.59 40.25 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.208 -0.997 . . . . 2.3999999999999999 109.185 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HE3' ' CZ ' ' A' ' 33' ' ' TYR . 2.3 tptm -60.19 -60.0 4.51 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.898 -1.501 . . . . 3.9199999999999999 108.687 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 3.4 t70 -50.51 -42.65 55.15 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.984 -1.086 . . . . 2.6000000000000001 110.029 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.449 HD22 HG23 ' A' ' 79' ' ' VAL . 8.6 tp -63.22 -66.93 0.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.686 -1.205 . . . . 2.1200000000000001 109.185 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.97 -39.82 9.48 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 120.312 -0.555 . . . . 1.9299999999999999 110.524 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.504 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 26.6 tt0 -65.55 -53.04 47.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.151 -0.932 . . . . 2.3100000000000001 110.389 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -53.54 39.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.566 -1.642 . . . . 7.9699999999999998 106.566 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.4 mt -53.51 -40.62 65.55 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.544 -1.207 . . . . 2.4199999999999999 108.216 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -59.7 -35.62 74.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.874 -1.057 . . . . 1.29 110.594 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -83.98 -28.08 27.99 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.042 -0.663 . . . . 2.5899999999999999 110.891 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.3 -47.22 44.5 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.208 -0.597 . . . . 3.4199999999999999 111.35 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -109.18 164.97 11.96 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.143 -1.023 . . . . 5.6299999999999999 110.907 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.632 -1.618 . . . . 4.0 106.632 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 1' ' ' MET . 3.5 t70 -82.86 41.19 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.924 -1.489 . . . . 3.5800000000000001 108.686 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -145.46 93.23 2.34 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.546 -1.262 . . . . 1.4299999999999999 112.651 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -99.55 155.06 17.78 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 104.526 -2.398 . . . . 4.4100000000000001 104.526 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.532 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 7.3 p90 -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.059 -1.056 . . . . 2.3700000000000001 108.784 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -149.02 152.44 36.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.701 -0.852 . . . . 5.1900000000000004 108.701 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -121.46 123.15 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.841 -1.17 . . . . 2.9100000000000001 107.841 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.28 145.39 20.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.97 -2.233 . . . . 3.1099999999999999 104.97 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -111.18 160.1 17.25 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.544 -1.263 . . . . 2.5499999999999998 108.512 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.26 -30.24 5.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 117.778 -1.569 . . . . 2.3199999999999998 108.87 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 3.1 tpm_? -93.18 -59.31 2.06 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.74 -0.664 . . . . 6.5700000000000003 110.339 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -47.19 -33.29 5.15 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.655 -0.818 . . . . 2.6200000000000001 110.972 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.22 -46.31 8.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.954 0.784 . . . . 3.9700000000000002 109.334 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 54.23 1.05 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.722 -1.751 . . . . 1.49 108.722 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 mt -99.74 162.7 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.544 -0.91 . . . . 2.5600000000000001 108.544 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 p -113.36 148.78 35.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.942 0.776 . . . . 3.1899999999999999 112.184 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HG3' ' CG1' ' A' ' 56' ' ' VAL . 35.0 tttm -49.3 -54.26 17.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.588 -0.893 . . . . 4.9400000000000004 108.588 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 3.6 mp0 -46.62 -62.91 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.725 -1.125 . . . . 3.25 111.006 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.15 -56.71 8.33 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 120.401 -0.519 . . . . 2.1600000000000001 110.895 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.8 -50.17 69.2 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.7 -0.682 . . . . 2.4100000000000001 110.229 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.97 -56.14 16.06 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 3.6400000000000001 107.535 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.77 -43.92 48.48 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.107 -1.406 . . . . 5.1299999999999999 109.071 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -63.85 -46.39 85.23 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.133 -1.394 . . . . 8.0800000000000001 112.231 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.521 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -71.19 -48.51 51.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 113.068 0.766 . . . . 1.76 113.068 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.94 -33.85 6.18 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.065 -2.414 . . . . 2.54 107.065 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -83.83 141.53 41.25 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 114.447 -0.876 . . . . 8.3699999999999992 108.649 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -41.92 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 122.358 2.039 . . . . 4.5700000000000003 110.712 161.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.583 ' CG1' ' HG3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER 33.32 -95.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 115.637 1.717 . . . . 6.2999999999999998 115.637 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 5.3 tp10 109.14 -170.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 102.475 -3.158 . . . . 7.1799999999999997 102.475 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.509 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 14.9 p -104.03 -152.49 0.46 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.181 -1.414 . . . . 4.5800000000000001 107.181 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.07 146.64 51.88 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 107.881 -1.155 . . . . 3.8500000000000001 107.881 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 96.6 Cg_endo -98.46 162.46 10.42 Favored 'Cis proline' 0 N--CA 1.489 1.223 0 O-C-N 122.858 0.925 . . . . 2.8599999999999999 111.637 10.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -114.06 151.34 32.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.578 -1.267 . . . . 3.7799999999999998 107.578 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.413 HD11 ' CG ' ' A' ' 75' ' ' PHE . 6.2 mt -123.2 143.24 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.066 -1.054 . . . . 2.7400000000000002 111.798 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -136.36 159.06 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.751 -1.568 . . . . 1.28 107.874 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 66' ' ' GLN . 74.6 t -127.6 130.44 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.531 -0.914 . . . . 1.9099999999999999 108.531 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.08 -81.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 124.398 1.061 . . . . 2.77 110.603 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.3 pt20 -138.33 -14.2 1.32 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.229 -0.896 . . . . 4.6900000000000004 110.976 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -85.46 168.96 14.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.696 0.623 . . . . 5.1200000000000001 111.209 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 10.3 t-160 -113.01 139.66 48.47 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.617 -0.72 . . . . 1.0600000000000001 109.267 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mm -109.69 -34.37 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.304 -1.358 . . . . 2.3500000000000001 109.215 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.96 -136.17 8.77 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.169 -1.491 . . . . 1.2 109.539 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.39 169.2 17.1 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.749 -1.215 . . . . 1.49 110.656 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.6 t80 -40.53 -57.27 1.87 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 112.608 0.596 . . . . 1.8899999999999999 112.608 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 p -43.25 -69.31 0.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.026 0.917 . . . . 2.8300000000000001 111.213 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -52.1 30.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.174 -1.83 . . . . 2.8300000000000001 110.316 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' CE1' ' CE3' ' A' ' 78' ' ' TRP . 58.3 t80 -44.61 -46.54 10.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.345 -0.843 . . . . 1.99 111.03 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -40.83 -48.17 3.03 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 119.62 -0.832 . . . . 1.9299999999999999 111.006 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.99 77.93 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.839 -1.144 . . . . 2.3599999999999999 109.713 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.451 ' CE3' ' CE1' ' A' ' 75' ' ' PHE . 90.5 t90 -50.94 -44.99 60.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.724 -0.843 . . . . 0.81999999999999995 108.724 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.449 HG23 HD22 ' A' ' 20' ' ' LEU . 79.7 t -57.23 -33.99 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.662 -1.154 . . . . 2.0699999999999998 110.23 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' NZ ' ' OD2' ' A' ' 84' ' ' ASP . 13.7 tptp -87.57 18.52 3.88 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.265 -0.974 . . . . 3.27 111.726 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.21 -45.47 0.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.271 -0.972 . . . . 3.8500000000000001 111.826 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -84.86 -2.16 57.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.992 -1.083 . . . . 1.76 111.745 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.406 HD11 HG11 ' A' ' 79' ' ' VAL . 86.0 mt -123.25 21.32 9.63 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.209 -0.996 . . . . 2.6699999999999999 110.742 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 2.3 m-20 -89.08 46.62 1.4 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.075 -1.084 . . . . 4.0899999999999999 108.075 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.957 0 CA-C-N 113.078 -1.874 . . . . 6.7599999999999998 109.506 -179.374 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.387 -0.598 . . . . 4.1500000000000004 109.387 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -112.01 164.51 13.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.118 0.485 . . . . 4.8099999999999996 111.82 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.1 m -152.35 121.48 6.67 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 116.434 -0.348 . . . . 2.1699999999999999 110.159 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.412 HG23 ' CG ' ' A' ' 34' ' ' GLN . 6.6 t -109.19 137.91 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.103 -1.039 . . . . 1.98 110.09 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.408 HD13 ' C ' ' A' ' 4' ' ' VAL . 1.6 mp -109.32 98.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 124.768 1.293 . . . . 2.2400000000000002 108.077 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.76 92.75 7.61 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 105.774 -1.936 . . . . 1.9299999999999999 105.774 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.583 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -125.07 -150.69 7.85 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.825 -1.178 . . . . 1.5600000000000001 111.766 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.3 tpt180 -124.26 123.53 40.45 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.812 -0.81 . . . . 6.3399999999999999 108.812 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -78.45 53.78 1.34 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.662 0.744 . . . . 5.7800000000000002 109.397 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.34 -46.37 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.733 -1.347 . . . . 3.9300000000000002 109.733 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.576 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 32.1 t -111.78 156.1 42.12 Favored Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.779 -0.822 . . . . 4.29 108.779 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.576 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 6.1 Cg_endo -72.55 48.53 1.31 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.491 1.461 . . . . 3.7200000000000002 111.446 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -99.99 -58.62 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.361 -0.978 . . . . 4.3799999999999999 108.361 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.3 m -53.26 -36.19 60.84 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.423 -1.325 . . . . 3.2400000000000002 107.423 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.41 -30.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.079 -1.873 . . . . 2.3700000000000001 111.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -72.28 -39.85 68.02 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.983 -1.087 . . . . 6.6799999999999997 110.302 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.7 79.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.217 -1.771 . . . . 2.0299999999999998 106.217 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 2.1 ttpp -51.99 -48.91 64.2 Favored 'General case' 0 C--O 1.2 -1.532 0 CA-C-N 114.099 -1.409 . . . . 2.5 108.97 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -57.42 -65.68 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.646 -0.706 . . . . 2.9399999999999999 111.251 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.4 tp -51.31 -51.85 50.57 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.083 -1.047 . . . . 2.2599999999999998 110.073 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.13 -51.52 63.98 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.618 -1.173 . . . . 2.1299999999999999 109.747 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 19.6 tt0 -55.93 -49.0 74.69 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.047 -0.978 . . . . 1.8799999999999999 109.35 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -52.23 -55.1 23.36 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.034 -1.466 . . . . 4.7999999999999998 107.657 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.82 -37.17 63.3 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.756 -0.831 . . . . 2.2799999999999998 108.756 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 5.7 t -55.71 -40.74 72.84 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.815 -1.18 . . . . 1.21 107.815 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -98.3 40.36 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.961 -1.496 . . . . 2.5 106.961 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.53 -52.3 0.39 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.242 -1.344 . . . . 2.8700000000000001 111.663 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -106.23 -11.45 16.04 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.973 -1.091 . . . . 5.6299999999999999 111.177 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 71.51 -40.55 0.48 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 124.15 0.906 . . . . 4.7199999999999998 112.59 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 1' ' ' MET . 5.3 p-10 -80.96 4.23 20.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.705 -1.198 . . . . 2.71 107.863 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.494 ' CD2' ' HE2' ' A' ' 1' ' ' MET . 6.0 t80 -95.23 102.35 14.15 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.554 1.159 . . . . 1.9299999999999999 108.011 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -119.29 118.62 31.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.201 -1.037 . . . . 4.0199999999999996 108.201 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.41 160.04 15.94 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.731 -1.188 . . . . 1.3799999999999999 110.574 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.412 ' CG ' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -142.26 148.84 38.76 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.076 -1.42 . . . . 5.0700000000000003 108.9 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -112.21 136.19 51.93 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.042 -1.096 . . . . 2.1000000000000001 108.042 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.42 152.04 27.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.213 -1.773 . . . . 2.2000000000000002 106.213 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.68 142.2 47.52 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.409 -0.916 . . . . 2.1899999999999999 109.008 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.9 pt -48.3 -36.95 6.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.927 -0.709 . . . . 2.27 111.188 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -76.74 -44.88 31.38 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.002 -1.079 . . . . 7.5499999999999998 111.473 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.76 -54.36 2.65 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 119.529 -0.868 . . . . 2.9100000000000001 110.422 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 42' ' ' GLY . 64.9 mt-10 -93.47 25.18 3.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 114.3 -1.318 . . . . 4.2699999999999996 111.255 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 30.51 57.0 0.24 Allowed Glycine 0 N--CA 1.508 3.455 0 N-CA-C 112.074 -0.41 . . . . 1.7 112.074 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.6 161.52 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.933 -0.766 . . . . 2.8900000000000001 108.933 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -119.93 154.62 34.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.706 0.765 . . . . 2.6200000000000001 109.513 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -45.13 -42.12 8.63 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.071 1.137 . . . . 4.8700000000000001 114.071 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.588 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 14.2 mp0 -65.02 -56.5 12.73 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.818 -0.753 . . . . 3.0699999999999998 110.608 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.481 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -47.56 -50.21 24.49 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.19 -1.041 . . . . 2.4399999999999999 108.19 179.256 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.94 -48.94 74.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.159 -1.382 . . . . 2.25 108.551 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.43 HE21 ' H ' ' A' ' 56' ' ' VAL . 5.4 tp60 -44.78 -45.02 9.77 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.936 -1.135 . . . . 6.1399999999999997 107.936 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.15 -49.54 69.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.898 1.374 . . . . 4.4100000000000001 109.587 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER -51.58 -48.95 62.98 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.155 -0.683 . . . . 3.4300000000000002 109.155 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -19.69 56.98 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.429 -0.952 . . . . 2.0099999999999998 108.429 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.67 32.57 17.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.375 -1.89 . . . . 2.73 108.375 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -143.66 158.21 57.19 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-N 114.096 -1.052 . . . . 8.2699999999999996 108.707 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.86 68.87 4.67 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.675 1.584 . . . . 4.3200000000000003 111.25 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.43 ' H ' HE21 ' A' ' 49' ' ' GLN . 4.8 p -101.71 125.1 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.982 -0.687 . . . . 7.1799999999999997 110.804 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.71 -2.82 10.36 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 112.918 0.711 . . . . 6.2000000000000002 112.918 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 p -116.08 -169.27 1.57 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.637 -0.825 . . . . 4.7199999999999998 111.579 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.8 164.59 33.93 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.415 -0.811 . . . . 4.0599999999999996 108.992 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.69 157.44 71.82 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 124.236 -1.152 . . . . 3.5099999999999998 109.747 -7.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -98.25 101.42 12.88 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 103.916 -2.624 . . . . 3.9700000000000002 103.916 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mt -91.59 133.12 34.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 113.167 -1.833 . . . . 2.3700000000000001 111.266 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -125.64 153.57 43.6 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 112.979 -1.919 . . . . 1.3100000000000001 109.798 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 66' ' ' GLN . 80.0 t -122.2 95.91 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.882 -1.155 . . . . 1.6899999999999999 107.882 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.5 -72.72 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 125.189 1.556 . . . . 2.6299999999999999 110.557 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 64' ' ' VAL . 41.7 tp60 -129.78 -18.06 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.475 -1.239 . . . . 7.1600000000000001 111.363 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -91.61 172.95 8.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.276 -0.97 . . . . 4.3600000000000003 111.18 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -119.92 149.72 41.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 106.797 -1.557 . . . . 2.2200000000000002 106.797 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.472 HD13 ' CD1' ' A' ' 78' ' ' TRP . 21.3 mm -116.25 -55.95 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.687 -0.805 . . . . 2.1099999999999999 111.069 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.58 -135.05 4.76 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.667 -1.254 . . . . 1.53 110.26 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.37 -74.31 0.94 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 111.141 -0.783 . . . . 2.4700000000000002 111.141 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -137.97 -55.85 0.66 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 118.724 -1.19 . . . . 3.6000000000000001 109.343 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 p -41.95 -52.4 4.14 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 123.118 1.437 . . . . 2.6299999999999999 109.658 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -36.46 84.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.005 -2.362 . . . . 2.0800000000000001 109.964 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.19 -51.01 61.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.496 -0.882 . . . . 1.6499999999999999 109.108 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.5 64.81 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.276 -0.969 . . . . 2.6499999999999999 109.28 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.88 -58.9 6.14 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.788 -1.165 . . . . 2.1299999999999999 108.998 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.472 ' CD1' HD13 ' A' ' 69' ' ' ILE . 87.6 t90 -44.5 -55.54 5.02 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.519 -0.764 . . . . 0.85999999999999999 109.301 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 83' ' ' LEU . 2.7 t -44.79 -60.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 114.231 -1.35 . . . . 1.8500000000000001 108.853 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HZ2' ' CG ' ' A' ' 84' ' ' ASP . 21.9 tptp -50.21 -39.88 45.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.21 -0.905 . . . . 3.4199999999999999 112.937 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -104.52 36.09 2.52 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.592 -0.843 . . . . 4.3300000000000001 113.067 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -147.5 -36.11 0.22 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.216 1.007 . . . . 1.5600000000000001 110.038 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.413 HD11 HG11 ' A' ' 79' ' ' VAL . 22.3 mt -99.44 -24.03 14.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.523 -1.217 . . . . 2.6499999999999999 110.794 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.443 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 6.8 t0 -93.29 -64.82 1.05 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 125.105 1.503 . . . . 4.0999999999999996 108.082 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.803 0 CA-C-N 112.708 -2.042 . . . . 8.7200000000000006 109.261 179.878 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.4 mpp? . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 108.004 -1.11 . . . . 3.0600000000000001 108.004 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.16 102.61 11.98 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 124.023 0.827 . . . . 5.1900000000000004 109.459 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 5.7 m -96.69 116.38 29.03 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.963 -1.095 . . . . 2.1699999999999999 109.925 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 t -123.7 136.95 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.397 -0.819 . . . . 2.1600000000000001 112.448 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.421 HG23 ' SG ' ' A' ' 14' ' ' CYS . 5.4 mm -110.39 125.03 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.747 -1.205 . . . . 2.3100000000000001 107.747 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -102.47 114.99 29.67 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.21 -1.774 . . . . 2.29 106.21 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.29 -148.78 7.99 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.409 -1.077 . . . . 1.8799999999999999 110.409 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.5 ttm180 -138.8 141.74 38.74 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.846 -0.742 . . . . 7.5 110.613 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 t -54.98 73.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.983 -1.462 . . . . 6.9500000000000002 112.761 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 118.5 26.62 2.58 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 120.45 -0.881 . . . . 4.1299999999999999 113.096 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 13' ' ' TYR . 9.7 t -122.31 138.0 28.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 C-N-CA 118.728 -1.189 . . . . 5.1299999999999999 110.048 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.02 53.08 4.42 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.884 1.723 . . . . 5.0199999999999996 111.2 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.545 ' CE2' ' SG ' ' A' ' 11' ' ' CYS . 20.3 m-30 -111.73 -68.21 0.95 Allowed 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.302 -0.559 . . . . 6.25 112.147 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.529 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 3.5 t -54.49 -29.34 49.89 Favored 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 118.014 -1.474 . . . . 5.0899999999999999 108.912 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 t -44.75 -12.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 114.027 -1.442 . . . . 3.4399999999999999 112.072 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.559 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -108.87 -42.37 4.49 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.534 -0.867 . . . . 4.3200000000000003 109.607 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.17 75.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.345 -1.724 . . . . 1.73 106.345 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -54.97 -39.82 69.36 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 114.588 -1.187 . . . . 2.9100000000000001 108.686 179.14 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' CG ' HH12 ' A' ' 16' ' ' ARG . 0.2 OUTLIER -66.32 -62.42 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.212 0.529 . . . . 2.7599999999999998 111.488 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.3 tp -56.36 -43.27 78.98 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.408 -0.917 . . . . 2.27 110.045 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.08 72.69 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.725 -1.19 . . . . 1.6399999999999999 108.296 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 11.3 tt0 -48.14 -47.33 34.83 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.44 -0.948 . . . . 2.4199999999999999 108.44 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -48.57 -52.9 20.49 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 118.756 -1.178 . . . . 4.7000000000000002 110.62 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.5 mt -65.52 -46.24 80.4 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 123.721 0.638 . . . . 2.2000000000000002 111.78 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' A' ' 22' ' ' GLU . 1.5 p -57.9 -25.37 60.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 118.922 -1.111 . . . . 3.7599999999999998 111.15 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.8 t30 -91.75 27.98 1.91 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.028 -1.069 . . . . 2.5800000000000001 108.647 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 72.5 mt-10 -121.17 -65.7 1.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.951 -0.7 . . . . 3.3999999999999999 110.252 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.499 HH22 ' C ' ' A' ' 85' ' ' ALA . 2.9 mpt_? -122.26 -166.77 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.811 -1.086 . . . . 4.4500000000000002 111.746 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -107.45 -4.65 18.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.912 -1.04 . . . . 5.79 111.027 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.9 p-10 -84.29 -9.59 58.35 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.919 -1.141 . . . . 3.2599999999999998 107.919 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -116.02 96.9 5.79 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.492 -0.883 . . . . 1.98 110.817 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -112.11 128.07 56.1 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.255 -2.128 . . . . 5.2300000000000004 105.255 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -123.28 143.25 50.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.118 -1.433 . . . . 1.7 113.74 -177.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -139.1 161.67 36.81 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 113.822 -1.536 . . . . 5.0300000000000002 109.409 178.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.529 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 30.6 t80 -118.98 142.62 47.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 1.8999999999999999 109.115 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -132.19 147.02 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.348 -0.982 . . . . 2.6299999999999999 108.348 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.3 t70 -122.48 114.74 21.11 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 119.038 -1.065 . . . . 2.5800000000000001 112.434 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -49.3 -31.46 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.477 -0.783 . . . . 2.77 111.522 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.506 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.03 -63.44 1.31 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.284 -1.766 . . . . 6.7000000000000002 108.723 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 37' ' ' ASP . . . -30.49 -45.51 0.06 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.667 1.23 . . . . 2.7799999999999998 111.671 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -94.22 -53.37 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.905 -1.118 . . . . 3.6400000000000001 111.465 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.58 51.87 0.2 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 118.989 -1.576 . . . . 1.77 111.47 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.7 mt -103.87 157.73 5.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.775 -1.565 . . . . 2.9199999999999999 106.775 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.0 p -115.88 158.35 23.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.653 -0.819 . . . . 2.5600000000000001 109.084 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -52.18 -40.29 61.27 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.961 -1.096 . . . . 5.5999999999999996 111.833 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 23.3 mp0 -47.73 -63.76 0.97 Allowed 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 121.663 0.744 . . . . 3.3999999999999999 110.261 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.555 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 2.8 t70 -44.31 -44.62 8.25 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 114.354 -1.294 . . . . 2.8199999999999998 111.978 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.77 -41.7 64.76 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.336 -1.302 . . . . 3.0800000000000001 110.5 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 54' ' ' LYS . 14.0 tt0 -57.28 -40.12 77.1 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.301 -1.741 . . . . 3.4300000000000002 106.301 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -15.54 11.84 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.355 -1.293 . . . . 4.8799999999999999 110.692 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.555 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 54.7 mttp -104.11 -37.73 7.21 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.671 -0.695 . . . . 3.2599999999999998 110.51 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -72.0 -37.79 69.75 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.725 -1.125 . . . . 2.0899999999999999 112.65 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -45.62 1.87 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 107.957 -2.057 . . . . 2.8399999999999999 107.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 17.8 pttp -101.35 176.31 1.94 Allowed Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.556 -1.646 . . . . 6.5899999999999999 106.556 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 64.9 Cg_exo -48.67 155.15 2.53 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 120.67 0.913 . . . . 4.6799999999999997 110.93 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.43 -30.99 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.447 -0.901 . . . . 6.7599999999999998 111.312 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.58 -145.92 0.32 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.047 -0.661 . . . . 7.4000000000000004 109.383 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -95.38 168.04 10.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.604 -0.838 . . . . 5.1200000000000001 110.003 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.01 152.26 39.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.634 -1.247 . . . . 3.6400000000000001 107.634 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 13' ' ' TYR . 73.7 Cg_endo -97.03 160.2 12.07 Favored 'Cis proline' 0 C--N 1.304 -1.78 0 C-N-CA 123.828 -1.322 . . . . 2.8199999999999998 109.664 17.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 1.4 tp-100 -110.16 132.45 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.069 -2.197 . . . . 4.0700000000000003 105.069 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 75' ' ' PHE . 5.3 mt -112.71 137.53 45.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.037 -1.065 . . . . 2.7599999999999998 111.013 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -127.5 138.78 53.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.407 -1.724 . . . . 1.55 107.807 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 66' ' ' GLN . 40.6 t -121.73 108.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 124.462 1.101 . . . . 1.8100000000000001 109.183 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.01 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.141 -0.689 . . . . 2.9399999999999999 109.141 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -138.05 -9.82 1.53 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.484 -1.234 . . . . 4.96 110.034 179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.82 146.62 26.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.678 -0.49 . . . . 5.3600000000000003 109.678 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 14.6 t-160 -105.85 135.55 47.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.159 -1.423 . . . . 1.3700000000000001 107.159 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 78' ' ' TRP . 9.9 mm -103.7 -41.06 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 118.588 -1.245 . . . . 1.8999999999999999 109.775 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 128.39 -114.74 1.88 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.324 -2.31 . . . . 1.3600000000000001 107.324 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.87 -169.13 12.46 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 118.558 -1.782 . . . . 1.4399999999999999 111.23 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.7 t80 -61.96 176.28 0.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 105.738 -1.949 . . . . 3.0699999999999998 105.738 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.471 ' CB ' ' O ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 78.23 -64.69 0.27 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.413 -1.328 . . . . 3.6200000000000001 107.413 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -41.62 83.05 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.398 -1.334 . . . . 2.6200000000000001 107.398 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.435 ' HB2' HD11 ' A' ' 62' ' ' ILE . 15.8 t80 -41.84 -49.88 4.43 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 113.915 -1.493 . . . . 1.3100000000000001 110.041 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.66 71.28 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.412 -0.915 . . . . 2.2599999999999998 109.061 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.14 -53.99 51.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.887 -1.125 . . . . 2.0899999999999999 109.435 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.421 ' CD1' HD13 ' A' ' 69' ' ' ILE . 70.2 t90 -50.3 -53.45 28.58 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.746 -0.782 . . . . 1.26 110.065 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.0 t -43.98 -56.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.312 -0.858 . . . . 2.1200000000000001 109.336 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.433 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 6.2 tmtm? -44.83 -23.86 0.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 116.953 -1.499 . . . . 3.9300000000000002 115.044 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.18 6.2 10.26 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 120.94 1.7 . . . . 4.79 112.971 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.23 -25.74 5.63 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.846 -0.742 . . . . 1.3100000000000001 109.725 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.89 28.03 4.22 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.16 -0.927 . . . . 2.5 111.096 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 18.6 p-10 -93.89 30.08 1.93 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.229 1.014 . . . . 4.4000000000000004 109.099 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.499 ' C ' HH22 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.544 0 CA-C-N 113.227 -1.806 . . . . 5.5300000000000002 108.042 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' N ' ' O ' ' A' ' 30' ' ' ASP . 98.8 mtp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.838 -0.801 . . . . 3.6000000000000001 108.838 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.442 ' OE1' ' HB2' ' A' ' 34' ' ' GLN . 6.2 tt0 -84.17 144.52 28.93 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 119.104 -1.039 . . . . 5.0899999999999999 109.447 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.7 m -96.39 134.73 39.18 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.169 -1.419 . . . . 2.3399999999999999 107.169 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 ' C ' HD13 ' A' ' 5' ' ' ILE . 6.7 t -125.42 122.22 62.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.593 -1.262 . . . . 2.2999999999999998 107.593 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.3 mp -107.17 123.65 62.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 105.419 -2.067 . . . . 1.8600000000000001 105.419 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -117.78 117.07 28.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 4.0099999999999998 108.587 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.46 159.43 8.39 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.875 -1.155 . . . . 2.9199999999999999 111.247 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -112.89 139.09 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.194 -1.039 . . . . 6.2000000000000002 108.194 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.549 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 10.9 p -102.89 -65.15 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.124 -1.03 . . . . 7.4800000000000004 109.709 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.27 -47.88 0.99 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 105.967 -2.853 . . . . 4.1100000000000003 105.967 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.5 m -94.7 165.2 17.73 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 106.354 -1.721 . . . . 5.4000000000000004 106.354 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.04 67.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.844 2.363 . . . . 3.8599999999999999 112.528 165.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -115.0 -65.34 1.2 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.628 -0.878 . . . . 6.5999999999999996 108.628 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 18.1 m -53.46 -33.82 55.59 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.404 1.097 . . . . 2.9500000000000002 108.388 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -44.46 -47.12 2.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 113.002 -1.908 . . . . 2.52 111.259 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -50.01 -48.8 52.34 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.71 -0.796 . . . . 3.9300000000000002 110.534 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.27 -52.69 25.81 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.552 -1.277 . . . . 1.73 107.552 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -53.76 -45.21 70.54 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 114.759 -1.11 . . . . 2.9300000000000002 110.53 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 43.7 m-20 -62.21 -56.72 15.85 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.336 -0.546 . . . . 3.1899999999999999 111.663 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.79 -52.02 67.2 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.029 -0.73 . . . . 1.96 109.029 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.73 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.74 -0.837 . . . . 1.4099999999999999 108.74 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.466 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 42.3 tt0 -58.38 -47.76 82.8 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.7 -0.8 . . . . 2.3500000000000001 110.428 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 17.6 tptp -57.45 -54.96 40.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 116.563 -2.055 . . . . 5.4699999999999998 107.879 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' LYS . 47.7 mt -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.533 -1.667 . . . . 2.7400000000000002 107.63 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 6.5 t -49.84 -42.44 47.34 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.785 -0.643 . . . . 1.29 109.494 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.433 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 t-20 -72.89 -29.49 63.2 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.742 -0.663 . . . . 2.77 111.13 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.522 ' CD ' ' HZ3' ' A' ' 23' ' ' LYS . 1.6 mm-40 -86.33 -40.14 15.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.292 1.219 . . . . 3.8399999999999999 114.292 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HE ' ' C ' ' A' ' 85' ' ' ALA . 28.4 mtp180 -114.25 139.36 49.46 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.923 -0.711 . . . . 5.3499999999999996 112.216 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.35 -40.88 98.48 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.225 -0.898 . . . . 4.0800000000000001 113.273 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -84.75 20.28 1.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.405 -0.918 . . . . 3.4399999999999999 111.36 -178.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.44 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 4.4 t80 -115.28 123.02 47.72 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.544 -1.262 . . . . 1.52 111.63 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -136.04 172.39 13.08 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.824 -1.547 . . . . 4.3099999999999996 106.824 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -145.35 149.45 34.81 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.501 -1.28 . . . . 1.4199999999999999 110.919 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HB2' ' OE1' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -136.87 139.78 41.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.113 0.883 . . . . 6.3099999999999996 109.252 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.67 121.2 34.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.178 -1.009 . . . . 2.6099999999999999 108.83 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.99 153.59 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.866 -0.734 . . . . 2.5600000000000001 109.708 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -108.69 124.3 50.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.092 -1.447 . . . . 2.5099999999999998 107.092 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.7 pt -40.02 -41.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.709 -0.796 . . . . 2.3199999999999998 111.816 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -31.47 61.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 118.998 -1.081 . . . . 6.4299999999999997 111.778 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.1 -53.59 32.76 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.416 -0.914 . . . . 2.1200000000000001 111.593 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -94.63 -34.49 12.59 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.477 -0.889 . . . . 3.6499999999999999 111.872 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.48 50.43 0.66 Allowed Glycine 0 N--CA 1.503 3.12 0 N-CA-C 109.332 -1.507 . . . . 1.51 109.332 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.8 mt -96.55 137.15 25.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.312 -0.995 . . . . 2.5699999999999998 108.312 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.4 p -107.35 166.34 10.72 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.929 -1.108 . . . . 2.9300000000000002 112.067 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -56.86 -35.25 68.66 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.573 -1.194 . . . . 5.5499999999999998 109.967 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 24.0 mp0 -68.93 -47.72 65.02 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.052 -1.092 . . . . 3.54 108.052 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.427 ' OD2' ' NZ ' ' A' ' 51' ' ' LYS . 25.0 t70 -57.66 -49.96 74.74 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 117.793 -1.563 . . . . 2.5299999999999998 108.332 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -53.66 -54.46 37.42 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.017 -1.073 . . . . 2.27 108.367 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.46 -51.79 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.544 0.527 . . . . 6.4800000000000004 109.95 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -53.09 -54.32 37.32 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.38 -0.971 . . . . 5.4699999999999998 108.38 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' NZ ' ' OD2' ' A' ' 47' ' ' ASP . 46.5 mttp -55.72 -38.25 69.49 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.724 -1.126 . . . . 3.6299999999999999 110.523 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -59.54 -48.0 83.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 123.68 0.612 . . . . 2.4900000000000002 110.4 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.42 -40.47 2.72 Favored Glycine 0 N--CA 1.499 2.833 0 C-N-CA 120.152 -1.023 . . . . 4.2999999999999998 112.102 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -124.23 154.53 68.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 C-N-CA 120.066 -0.654 . . . . 11.199999999999999 109.316 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.11 70.05 6.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.91 2.407 . . . . 6.5999999999999996 113.563 -138.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.99 128.58 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.983 -0.687 . . . . 7.6600000000000001 109.97 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -122.15 67.23 0.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.75 -0.833 . . . . 8.8499999999999996 108.75 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 p -113.8 149.15 35.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.137 0.791 . . . . 6.0 113.137 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -117.92 144.13 34.0 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.086 -1.079 . . . . 4.3600000000000003 108.086 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.509 ' HG2' ' SG ' ' A' ' 14' ' ' CYS . 22.7 Cg_exo -66.31 171.05 39.35 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 123.933 -1.278 . . . . 3.8900000000000001 110.871 -18.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -130.55 152.65 49.7 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.845 -1.539 . . . . 3.5 106.845 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 mt -121.55 143.66 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 119.586 -0.845 . . . . 2.27 111.402 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -131.07 165.82 22.41 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.873 -1.512 . . . . 1.05 108.161 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.497 HG13 ' CH2' ' A' ' 78' ' ' TRP . 32.0 t -138.61 105.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 124.174 0.921 . . . . 2.3700000000000001 110.921 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' GLN . 3.6 t70 54.5 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.996 0.81 . . . . 2.96 113.019 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . 66.4 mt-30 -137.85 23.83 2.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 123.476 0.485 . . . . 6.3099999999999996 111.295 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -131.03 159.45 37.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.222 -1.029 . . . . 5.0800000000000001 108.222 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.506 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 7.6 t-160 -112.0 137.11 50.46 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 107.871 -1.159 . . . . 1.52 107.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.3 -46.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 119.682 -0.807 . . . . 2.8500000000000001 112.131 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.26 -98.94 0.56 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.856 -1.298 . . . . 1.3300000000000001 109.856 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.87 177.92 17.32 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 120.234 -0.984 . . . . 1.21 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -50.41 -47.43 56.51 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.787 -0.765 . . . . 2.1400000000000001 111.048 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -43.96 -57.26 3.42 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.609 0.718 . . . . 2.2799999999999998 111.11 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.71 -49.01 79.23 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.658 -1.155 . . . . 2.0499999999999998 109.069 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -44.82 -52.07 8.88 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.277 -0.969 . . . . 1.1200000000000001 110.145 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 -57.96 9.48 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 120.007 -0.677 . . . . 1.9399999999999999 111.562 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.34 42.35 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 118.372 -1.331 . . . . 2.1499999999999999 109.303 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.614 ' CH2' HD22 ' A' ' 83' ' ' LEU . 75.8 t90 -41.61 -52.4 3.79 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.323 -0.853 . . . . 1.1100000000000001 110.631 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -44.59 -46.2 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 115.551 -0.749 . . . . 2.0299999999999998 110.721 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HD3' ' C ' ' A' ' 80' ' ' LYS . 5.8 tmtm? -48.92 -38.77 23.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.981 1.104 . . . . 4.25 113.981 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -108.19 -31.72 7.79 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 114.716 1.376 . . . . 4.8399999999999999 114.716 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -83.5 -22.95 32.34 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.976 -1.49 . . . . 1.8899999999999999 110.574 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.614 HD22 ' CH2' ' A' ' 78' ' ' TRP . 3.3 mm? -108.6 -55.65 2.36 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.619 -0.832 . . . . 3.3199999999999998 108.949 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.11 -69.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 126.852 2.595 . . . . 4.3200000000000003 112.728 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . . . . . . 0 C--N 1.28 -2.438 0 CA-C-O 116.349 -1.786 . . . . 5.5800000000000001 109.995 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.8 mtm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.975 -1.12 . . . . 3.1099999999999999 107.975 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -113.73 116.45 29.43 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.489 0.493 . . . . 5.2699999999999996 110.743 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 24.1 m -110.81 119.04 37.8 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.013 -1.106 . . . . 1.74 108.013 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.405 ' C ' HD13 ' A' ' 5' ' ' ILE . 43.3 t -114.57 135.54 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 119.687 -0.805 . . . . 2.0299999999999998 111.248 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.3 mp -113.43 123.31 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 124.52 1.138 . . . . 2.1600000000000001 108.016 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -108.92 92.58 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.322 -2.103 . . . . 3.29 105.322 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.05 -171.81 15.9 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.04 -2.424 . . . . 1.6299999999999999 107.04 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -95.44 174.53 6.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 116.726 -1.99 . . . . 5.6900000000000004 110.365 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -55.76 76.65 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.906 -1.952 . . . . 6.9100000000000001 109.323 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 97.07 74.04 1.17 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 106.885 -2.486 . . . . 3.8599999999999999 106.885 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.1 t -111.95 94.9 26.8 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 119.749 -0.78 . . . . 6.4100000000000001 109.213 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -41.11 -21.77 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.368 2.045 . . . . 4.5999999999999996 113.026 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -72.85 -45.03 60.55 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.464 -1.294 . . . . 4.1500000000000004 109.339 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 5' ' ' ILE . 5.2 t -54.83 -39.8 68.94 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.283 -0.967 . . . . 4.8899999999999997 108.79 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.8 t -43.75 -36.56 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 115.387 -0.824 . . . . 2.3399999999999999 111.7 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.594 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 2.9 mmp_? -82.41 -45.63 14.57 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 119.106 -1.038 . . . . 4.21 109.708 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.03 60.76 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.683 -1.599 . . . . 1.5600000000000001 106.683 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.577 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.8 tmtt? -56.73 -59.62 4.76 Favored 'General case' 0 C--O 1.187 -2.187 0 CA-C-N 113.342 -1.754 . . . . 3.3900000000000001 108.657 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.577 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -48.58 -54.04 16.06 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 118.909 -1.116 . . . . 2.5099999999999998 111.141 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.51 -60.89 2.74 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.494 -0.775 . . . . 1.8400000000000001 110.574 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.82 77.73 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.278 -0.569 . . . . 1.8200000000000001 110.564 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 25' ' ' SER . 31.4 tt0 -56.24 -49.52 73.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 124.445 1.091 . . . . 1.95 109.528 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 26.0 tptp -49.95 -61.56 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.125 -1.03 . . . . 5.0300000000000002 108.259 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' O ' ' HD2' ' A' ' 28' ' ' ARG . 47.1 mt -50.6 -57.63 7.74 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.108 -1.071 . . . . 2.5899999999999999 108.108 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 8.3 t -34.59 -47.79 0.34 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.191 -1.368 . . . . 1.27 110.885 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.42 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -85.52 -30.72 23.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.628 1.205 . . . . 3.21 112.654 -179.24 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 28' ' ' ARG . 80.8 mt-10 -70.0 -32.45 70.63 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.071 -1.052 . . . . 3.2200000000000002 110.629 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.502 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.54 37.52 2.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.203 -1.399 . . . . 5.5800000000000001 113.831 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' ARG . 48.0 m-20 28.81 52.76 0.07 Allowed 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 114.611 1.337 . . . . 4.9000000000000004 114.611 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -155.18 -45.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 117.983 -1.487 . . . . 3.7000000000000002 113.679 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -81.38 69.04 7.93 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.553 -0.859 . . . . 2.6400000000000001 110.306 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -83.48 147.03 28.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.701 -1.222 . . . . 4.71 107.701 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 3' ' ' THR . 46.5 p90 -119.46 161.75 20.01 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.561 -1.255 . . . . 1.29 112.196 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -129.78 136.04 49.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.305 -1.316 . . . . 4.9500000000000002 107.91 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 3.6 t80 -113.7 117.94 32.95 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.615 -1.254 . . . . 2.48 107.615 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.13 146.9 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.833 -1.173 . . . . 2.2599999999999998 107.833 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.1 143.42 45.51 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.629 1.204 . . . . 2.3199999999999998 111.749 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.8 pt -56.93 -40.75 74.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 112.262 -2.245 . . . . 2.21 112.257 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.402 ' NH2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -86.41 -10.07 55.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.216 -0.994 . . . . 6.2000000000000002 111.656 -178.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.51 -49.02 6.92 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.699 -0.852 . . . . 2.1200000000000001 108.699 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.37 -37.66 43.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.669 -1.605 . . . . 3.6400000000000001 111.191 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 46.42 1.86 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.634 -1.786 . . . . 1.3600000000000001 108.634 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.441 HG22 ' HG ' ' A' ' 48' ' ' LEU . 22.2 mt -87.25 146.94 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.847 -1.168 . . . . 2.8100000000000001 107.847 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -110.64 176.4 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.919 -0.712 . . . . 3.3700000000000001 111.124 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -67.31 -57.77 6.04 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.188 -1.412 . . . . 6.25 107.188 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 1.7 mp0 -47.86 -48.51 31.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.753 -1.112 . . . . 4.5800000000000001 110.023 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.547 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 26.6 t70 -64.64 -56.59 12.87 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.353 -0.939 . . . . 2.02 110.48 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.441 ' HG ' HG22 ' A' ' 43' ' ' ILE . 1.3 mt -56.69 -40.23 75.23 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.459 -0.896 . . . . 2.3199999999999998 111.131 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -62.0 -43.83 98.0 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.722 -1.585 . . . . 4.3499999999999996 106.722 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -56.78 -40.05 75.17 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.276 -0.875 . . . . 4.6799999999999997 108.762 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 48.2 mmtm -64.12 -51.95 61.45 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.261 -0.882 . . . . 3.3900000000000001 111.459 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.62 70.06 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 112.877 0.695 . . . . 2.2999999999999998 112.877 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.36 -47.53 1.01 Allowed Glycine 0 N--CA 1.503 3.152 0 C-N-CA 119.44 -1.362 . . . . 2.7200000000000002 112.205 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -110.45 174.36 2.41 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.732 . . . . 8.5099999999999998 109.022 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.36 68.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.98 1.787 . . . . 6.5300000000000002 110.903 143.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.4 47.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.18 -1.045 . . . . 7.4400000000000004 108.18 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -82.66 72.47 9.73 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.908 -1.042 . . . . 8.1699999999999999 108.671 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 p -103.57 100.62 10.46 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.753 -1.112 . . . . 5.5599999999999996 108.798 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 m -74.56 138.36 74.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 C-N-CA 117.759 -1.576 . . . . 2.7000000000000002 109.598 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -93.91 137.56 6.87 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 O-C-N 122.932 0.964 . . . . 2.0699999999999998 111.623 7.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.402 ' NE2' HD21 ' A' ' 48' ' ' LEU . 7.2 mp0 -97.65 142.87 28.92 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.287 -1.746 . . . . 4.2699999999999996 106.287 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 62' ' ' ILE . 3.8 mp -115.29 143.77 24.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.416 -0.913 . . . . 2.8700000000000001 109.474 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.286 -1.779 . . . . 1.5900000000000001 108.785 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.67 118.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 105.466 -2.05 . . . . 2.0899999999999999 105.466 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 64.67 -86.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.621 -1.251 . . . . 3.27 107.621 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.62 5.3 1.04 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.084 -0.962 . . . . 4.25 109.204 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -91.2 162.16 14.76 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.359 -0.978 . . . . 4.4900000000000002 108.359 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -108.67 138.15 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.633 -0.877 . . . . 1.1699999999999999 108.633 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -106.87 -43.85 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.383 -0.927 . . . . 1.8999999999999999 109.151 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.7 -134.9 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.015 -1.634 . . . . 1.1499999999999999 109.015 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.44 179.27 25.62 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 108.969 -1.652 . . . . 1.1899999999999999 108.969 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -45.62 -38.52 6.71 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 118.953 -1.099 . . . . 2.2400000000000002 110.789 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -54.15 -63.29 1.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.372 0.606 . . . . 2.4100000000000001 109.72 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.79 -47.28 80.54 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.115 -0.948 . . . . 2.3599999999999999 108.538 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.422 ' CD1' HG22 ' A' ' 62' ' ' ILE . 42.4 t80 -47.16 -51.63 17.75 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.339 -0.846 . . . . 1.1599999999999999 110.536 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.11 -53.08 62.12 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.02 -1.072 . . . . 1.76 109.687 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.34 -56.43 16.72 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.139 -1.024 . . . . 1.8799999999999999 109.967 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -48.94 -57.62 6.19 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.038 -0.983 . . . . 0.79000000000000004 108.605 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 t -46.08 -52.84 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 124.255 0.972 . . . . 1.8100000000000001 108.725 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -57.73 -54.92 41.47 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.81 1.041 . . . . 4.4000000000000004 113.81 -178.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HA ' ' HZ3' ' A' ' 80' ' ' LYS . 1.5 pt-20 -73.11 -29.16 62.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.432 1.271 . . . . 4.4199999999999999 114.432 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -90.57 -31.94 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.803 -1.159 . . . . 1.8 109.919 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.16 53.07 0.93 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.749 -1.204 . . . . 2.8199999999999998 107.749 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.521 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 4.8 t0 -78.95 49.83 0.96 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.345 -1.298 . . . . 4.7699999999999996 109.361 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' C ' HH12 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.503 2.225 0 CA-C-O 116.481 -1.723 . . . . 5.0999999999999996 109.162 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 107.062 -1.458 . . . . 4.1200000000000001 107.062 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -106.44 107.04 17.85 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.529 -0.915 . . . . 5.0300000000000002 108.529 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.436 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 25.0 m -93.13 136.14 33.66 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.685 -0.806 . . . . 1.8999999999999999 109.403 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.418 ' C ' HD13 ' A' ' 5' ' ' ILE . 5.3 t -122.62 128.57 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 119.397 -0.921 . . . . 2.02 108.709 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.428 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 1.5 mp -111.27 136.98 45.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 124.29 0.994 . . . . 2.02 108.898 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -108.16 112.34 24.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 102.456 -3.164 . . . . 3.2000000000000002 102.456 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.51 ' HA2' ' SG ' ' A' ' 14' ' ' CYS . . . -109.32 -166.15 20.31 Favored Glycine 0 N--CA 1.501 2.975 0 C-N-CA 118.552 -1.785 . . . . 2.5800000000000001 114.195 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.473 HH12 ' CB ' ' A' ' 58' ' ' THR . 7.8 ttt85 -108.76 -141.6 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.892 -1.154 . . . . 9.1400000000000006 109.348 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.51 176.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.572 0.701 . . . . 6.5700000000000003 112.073 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.05 67.23 2.75 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.837 -0.905 . . . . 5.4299999999999997 110.837 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 50.5 t -128.37 152.75 78.63 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.247 -1.39 . . . . 5.7599999999999998 107.247 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 32.0 Cg_endo -70.21 67.16 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.42 1.414 . . . . 5.6699999999999999 111.334 172.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -109.4 -94.6 0.41 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.92 -1.141 . . . . 5.1200000000000001 107.92 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.51 ' SG ' ' HA2' ' A' ' 7' ' ' GLY . 46.5 m -52.46 -20.47 2.9 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.618 -0.833 . . . . 2.6600000000000001 109.132 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 18' ' ' LYS . 91.6 t -45.89 -33.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.923 -1.035 . . . . 4.0899999999999999 110.301 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.505 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -44.87 -35.84 3.0 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.461 -0.896 . . . . 3.7400000000000002 110.379 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.37 86.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.097 -1.446 . . . . 2.2599999999999998 107.097 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HZ3' ' CD ' ' A' ' 22' ' ' GLU . 3.3 tmpt? -57.7 -45.28 85.89 Favored 'General case' 0 C--O 1.196 -1.724 0 N-CA-C 107.855 -1.165 . . . . 2.8900000000000001 107.855 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 68.9 m-20 -63.09 -60.76 3.0 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.835 -0.62 . . . . 3.3100000000000001 109.788 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 tp -48.41 -55.21 11.45 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.951 -0.7 . . . . 1.98 109.815 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.33 82.21 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.872 -0.731 . . . . 2.0099999999999998 109.919 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 27.5 tt0 -45.43 -49.77 13.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 123.593 0.558 . . . . 1.96 110.789 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.467 ' HZ1' ' HB2' ' A' ' 27' ' ' GLU . 23.0 tptp -52.07 -56.22 15.77 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 118.316 -1.353 . . . . 5.4699999999999998 110.972 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.42 HD13 ' CG1' ' A' ' 79' ' ' VAL . 33.7 mt -52.7 -48.85 66.31 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.326 -1.731 . . . . 2.3999999999999999 106.326 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.19 -38.69 12.42 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.543 -2.117 . . . . 1.25 108.731 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -117.75 42.25 2.67 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.136 -0.938 . . . . 3.1099999999999999 110.201 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.486 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 30.8 tt0 -117.29 -59.63 1.92 Allowed 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.152 -1.425 . . . . 3.3100000000000001 107.152 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' HD3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -117.97 16.36 14.23 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.698 -2.334 . . . . 4.4400000000000004 104.698 177.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 34.46 47.2 0.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 123.221 1.486 . . . . 6.0 109.156 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.02 9.52 8.73 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 111.694 -2.503 . . . . 4.8200000000000003 111.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.436 ' CZ ' ' OG1' ' A' ' 3' ' ' THR . 21.0 t80 -134.85 147.73 49.96 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.963 -0.695 . . . . 2.1099999999999999 110.012 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -135.25 151.53 50.68 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.07 -0.715 . . . . 4.0300000000000002 109.07 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.421 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 42.6 p90 -139.29 155.94 47.38 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.2 -1.0 . . . . 1.6699999999999999 111.367 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -135.97 138.56 42.41 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.839 -1.171 . . . . 4.5700000000000003 107.839 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -114.05 133.27 55.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.749 -1.18 . . . . 1.8799999999999999 109.091 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.7 167.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.889 0.852 . . . . 2.29 110.857 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -118.48 128.12 54.29 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.296 -1.002 . . . . 2.1400000000000001 108.296 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.3 pt -43.81 -34.53 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.49 0.662 . . . . 2.6299999999999999 111.235 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 2.3 ttm105 -74.6 -54.97 6.44 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.222 -0.899 . . . . 7.3499999999999996 110.007 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -36.54 -55.13 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.168 0.918 . . . . 2.7000000000000002 112.237 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -74.6 -41.47 60.38 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 124.147 0.904 . . . . 4.5199999999999996 109.748 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.45 46.4 1.14 Allowed Glycine 0 N--CA 1.502 3.082 0 N-CA-C 108.317 -1.913 . . . . 2.0600000000000001 108.317 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mt -98.93 152.97 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.128 -1.036 . . . . 2.9700000000000002 110.474 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.1 p -116.69 141.3 48.38 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.768 -1.106 . . . . 3.27 108.852 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -45.04 -51.05 10.45 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.258 -0.977 . . . . 5.8700000000000001 110.807 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 2.7 mp0 -50.94 -47.25 61.12 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.875 -0.73 . . . . 5.8200000000000003 110.358 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.433 ' OD1' ' NZ ' ' A' ' 51' ' ' LYS . 4.5 t0 -53.94 -55.5 26.48 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.401 -0.92 . . . . 3.6699999999999999 108.55 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.21 -50.94 63.68 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 114.962 -1.017 . . . . 2.71 109.198 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.49 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 20.3 mt-30 -49.19 -49.24 43.61 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.293 -1.321 . . . . 6.5800000000000001 108.283 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.64 -55.94 19.65 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.79 -1.095 . . . . 6.0199999999999996 110.527 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' NZ ' ' OD1' ' A' ' 47' ' ' ASP . 41.3 mttp -53.88 -47.68 70.84 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 115.633 -0.712 . . . . 3.96 111.843 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.486 ' HA ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.31 -55.96 26.93 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.481 -1.236 . . . . 2.7999999999999998 112.601 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.29 -34.49 5.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.001 -1.64 . . . . 3.9500000000000002 109.001 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -106.21 146.37 32.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 120.09 -0.644 . . . . 7.6500000000000004 109.645 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.23 89.79 0.32 Allowed 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.825 2.35 . . . . 5.5199999999999996 111.635 -171.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.422 HG22 ' OE1' ' A' ' 61' ' ' GLN . 5.1 m -98.46 -177.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 C-N-CA 119.828 -0.749 . . . . 7.2800000000000002 109.102 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -110.15 -68.7 0.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.966 0.791 . . . . 7.5300000000000002 110.679 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.473 ' CB ' HH12 ' A' ' 8' ' ' ARG . 2.0 p -144.39 -61.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.645 1.212 . . . . 6.7000000000000002 109.746 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 27.4 m -132.11 178.76 1.6 Allowed Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 112.749 -2.023 . . . . 3.7400000000000002 107.863 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 28.7 Cg_endo -70.01 138.36 49.32 Favored 'Cis proline' 0 N--CA 1.491 1.335 0 O-C-N 122.994 0.997 . . . . 3.8500000000000001 111.369 -25.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.422 ' OE1' HG22 ' A' ' 56' ' ' VAL . 6.6 mm-40 -125.49 125.39 43.22 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.461 -0.94 . . . . 3.1099999999999999 108.461 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.537 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.5 mp -122.54 141.37 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.042 0.925 . . . . 3.2000000000000002 110.92 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -128.04 163.0 25.52 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 113.13 -1.85 . . . . 1.52 108.783 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.01 124.26 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 118.587 -0.72 . . . . 2.4700000000000002 109.252 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 50.95 -97.38 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.773 -0.771 . . . . 2.21 111.778 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -129.63 27.52 5.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.447 -1.252 . . . . 4.6500000000000004 111.02 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -130.66 168.61 16.86 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 116.293 -0.412 . . . . 4.46 111.019 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' ND1' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t-80 -116.72 144.34 44.56 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.964 -0.754 . . . . 1.3400000000000001 108.964 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.35 -54.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 118.612 -1.235 . . . . 2.25 109.602 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 144.47 -128.41 3.24 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.617 -1.277 . . . . 1.1699999999999999 110.626 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -111.96 -171.81 18.91 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.261 -1.447 . . . . 1.1799999999999999 110.284 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -44.99 -40.61 6.61 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.671 -1.211 . . . . 2.0499999999999998 109.694 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -55.21 -63.98 0.99 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.417 0.627 . . . . 2.3599999999999999 110.062 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -46.48 71.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.769 -1.105 . . . . 2.8799999999999999 110.002 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -61.23 -50.5 72.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.748 -0.781 . . . . 1.46 111.312 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.93 -57.07 10.51 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.569 -0.852 . . . . 2.21 109.441 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.16 24.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.688 -0.805 . . . . 1.9399999999999999 110.112 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -43.42 -46.9 6.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 124.118 0.886 . . . . 1.3700000000000001 109.395 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.42 ' CG1' HD13 ' A' ' 24' ' ' LEU . 19.1 t -62.75 -67.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.923 -1.035 . . . . 1.97 108.896 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -45.35 -34.99 3.29 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 115.845 1.794 . . . . 3.2799999999999998 115.845 -176.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.447 ' OE2' ' NZ ' ' A' ' 80' ' ' LYS . 1.3 mp0 -101.63 9.41 41.13 Favored 'General case' 0 N--CA 1.512 2.652 0 C-N-CA 118.376 -1.33 . . . . 4.71 113.841 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -128.07 -35.83 2.01 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.951 -0.7 . . . . 1.8100000000000001 109.325 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.92 23.13 14.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.546 -0.862 . . . . 2.54 109.643 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 8.7 t70 -70.63 -20.82 62.69 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.382 -1.34 . . . . 3.9399999999999999 107.382 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.651 0 N-CA-C 105.857 -1.905 . . . . 5.1900000000000004 105.857 178.134 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.5 mpp? . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.226 1.013 . . . . 3.6800000000000002 109.291 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.444 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 2.0 mp0 -104.0 105.19 15.29 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.312 -1.313 . . . . 6.5999999999999996 108.173 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.4 m -97.26 117.99 32.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.338 -0.945 . . . . 1.9199999999999999 110.392 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.9 t -113.9 142.31 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 115.532 -0.758 . . . . 2.1200000000000001 109.79 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.7 mm -114.25 133.77 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.585 -2.006 . . . . 3.3500000000000001 105.585 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -121.65 80.09 1.64 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.629 -1.619 . . . . 2.48 106.629 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.28 -177.35 24.17 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.727 -1.225 . . . . 1.73 111.823 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -122.54 94.15 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.362 -1.347 . . . . 7.75 107.362 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.439 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 4.6 t -74.31 73.6 1.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.008 -1.077 . . . . 7.1699999999999999 111.097 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -41.02 -50.88 4.25 Favored Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.096 -0.802 . . . . 3.9199999999999999 111.096 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.414 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 17.3 m -111.87 -170.1 0.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 106.691 -1.596 . . . . 5.5599999999999996 106.691 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 52.8 Cg_exo -53.0 73.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 120.856 1.038 . . . . 5.25 111.409 153.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -119.54 -85.09 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.042 -0.725 . . . . 5.1799999999999997 109.042 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -60.19 -24.73 65.02 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 106.993 -1.484 . . . . 2.5499999999999998 106.993 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -43.81 -32.65 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 CA-C-N 114.278 -1.328 . . . . 2.5099999999999998 109.634 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -71.56 -50.12 34.13 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.55 -1.26 . . . . 4.4299999999999997 109.666 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.93 -44.46 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.018 -1.845 . . . . 1.6499999999999999 106.018 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.45 ' HD2' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -56.09 -58.91 5.93 Favored 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 113.712 -1.586 . . . . 3.2000000000000002 107.034 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -43.04 -57.96 2.65 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 120.11 -0.636 . . . . 3.52 110.798 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.98 -62.92 1.29 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.874 -1.057 . . . . 2.04 110.086 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.1 -54.57 33.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.15 -1.02 . . . . 1.8 109.28 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.481 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 41.5 tt0 -45.33 -52.63 9.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.088 0.867 . . . . 2.1099999999999999 110.778 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.532 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -58.85 -53.0 63.32 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.881 -1.128 . . . . 5.6200000000000001 108.457 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -51.93 -41.29 61.91 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.625 -0.83 . . . . 2.1600000000000001 110.233 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.1 p -73.9 -6.58 48.08 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.272 -0.971 . . . . 2.96 112.047 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -115.72 31.53 6.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.076 -1.453 . . . . 3.6699999999999999 107.076 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' CD ' ' HZ1' ' A' ' 23' ' ' LYS . 5.8 mm-40 -140.73 -51.65 0.47 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.009 -1.45 . . . . 4.5999999999999996 107.884 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.577 ' HE ' ' C ' ' A' ' 85' ' ' ALA . 13.5 mtp-105 -93.63 -170.42 2.35 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.519 -1.218 . . . . 5.2400000000000002 111.119 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -111.09 -48.77 3.08 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.453 -0.794 . . . . 5.2599999999999998 111.24 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.572 ' CG ' HH12 ' A' ' 28' ' ' ARG . 2.8 p30 -83.33 8.1 14.57 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.533 -0.867 . . . . 2.7599999999999998 111.16 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 25' ' ' SER . 3.3 t80 -104.34 114.44 28.67 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.567 -0.853 . . . . 1.76 111.602 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -130.14 157.5 42.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.048 -1.834 . . . . 4.7300000000000004 106.048 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.481 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 21.2 p90 -129.47 160.89 31.74 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.411 -1.315 . . . . 1.3999999999999999 110.881 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -141.62 149.22 40.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.019 0.824 . . . . 5.5800000000000001 110.193 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -126.29 113.39 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.687 -1.597 . . . . 2.21 106.687 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.04 157.82 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.073 -1.825 . . . . 2.5099999999999998 106.073 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -124.74 140.46 52.91 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.28 -1.368 . . . . 2.5800000000000001 111.239 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.427 ' C ' HH11 ' A' ' 39' ' ' ARG . 16.7 pt -61.78 -21.94 27.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.066 -0.97 . . . . 2.5 111.517 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.462 ' CA ' HH11 ' A' ' 39' ' ' ARG . 3.3 tpp180 -95.43 -51.48 4.55 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.789 -0.819 . . . . 8.5800000000000001 108.789 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.75 -49.3 5.69 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.538 1.149 . . . . 2.1899999999999999 110.148 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -99.55 36.82 1.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.576 -0.85 . . . . 4.6399999999999997 112.553 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 34.27 65.16 0.36 Allowed Glycine 0 N--CA 1.512 3.715 0 CA-C-O 121.792 0.662 . . . . 2.04 114.168 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.442 HG22 ' HB3' ' A' ' 47' ' ' ASP . 58.1 mt -109.96 148.08 13.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.004 -0.598 . . . . 2.7400000000000002 109.607 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -126.18 177.86 6.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.965 -1.494 . . . . 2.75 106.965 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -51.68 -47.92 63.68 Favored 'General case' 0 C--O 1.191 -1.984 0 C-N-CA 119.798 -0.761 . . . . 6.0999999999999996 110.427 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 6.3 mp0 -44.18 -52.59 7.24 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 113.862 1.06 . . . . 3.52 113.862 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' HG22 ' A' ' 43' ' ' ILE . 50.2 t0 -65.97 -55.86 14.64 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.052 -1.059 . . . . 3.0299999999999998 109.564 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.489 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.2 mt -53.66 -42.33 67.75 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.548 -0.861 . . . . 2.0499999999999998 110.201 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -59.21 -42.26 90.53 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.174 -1.417 . . . . 4.6900000000000004 107.174 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.75 -20.92 60.36 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.851 -1.068 . . . . 4.4400000000000004 110.589 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -79.96 -46.48 16.61 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.959 -0.696 . . . . 4.4000000000000004 111.386 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.09 -28.3 11.1 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.73 -0.788 . . . . 2.2999999999999998 113.009 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.92 -56.76 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 105.767 -2.933 . . . . 4.0599999999999996 105.767 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.5 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 57.3 mttp 60.1 126.85 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.997 0 CA-C-O 123.266 1.508 . . . . 10.32 114.935 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.53 139.3 56.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.69 2.26 . . . . 4.5 109.391 96.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 58' ' ' THR . 7.9 p -74.35 72.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 118.952 -1.099 . . . . 7.2000000000000002 110.768 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' C ' ' HG1' ' A' ' 58' ' ' THR . 5.5 pt-20 -79.08 33.0 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 119.743 -0.783 . . . . 7.7300000000000004 112.169 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 56' ' ' VAL . 80.5 p 39.27 -109.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 115.035 1.494 . . . . 4.8600000000000003 115.035 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.87 149.33 72.77 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 114.219 -1.355 . . . . 2.6899999999999999 109.724 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.406 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 98.7 Cg_endo -96.37 -175.4 4.63 Favored 'Cis proline' 0 C--N 1.32 -0.925 0 O-C-N 123.15 1.079 . . . . 2.4399999999999999 110.049 0.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 1.9 mt-30 -138.89 133.78 32.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 124.489 1.118 . . . . 3.27 109.788 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.8 mt -118.07 140.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 120.107 -0.637 . . . . 2.4500000000000002 110.926 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.85 148.82 52.66 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.73 -1.577 . . . . 1.1299999999999999 110.658 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.559 HG13 ' CZ2' ' A' ' 78' ' ' TRP . 38.2 t -123.17 111.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.14 -1.059 . . . . 1.8100000000000001 108.14 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.98 -76.07 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.103 0.954 . . . . 3.21 109.403 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 64' ' ' VAL . 45.0 tt0 -142.94 -9.11 0.8 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.058 -1.428 . . . . 5.0899999999999999 110.663 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -92.12 168.79 11.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.746 -0.382 . . . . 5.6100000000000003 110.677 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.413 ' CE1' ' NE2' ' A' ' 61' ' ' GLN . 44.1 t-80 -119.19 153.17 35.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.708 -1.219 . . . . 1.54 107.708 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.0 -50.75 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 119.007 -1.077 . . . . 2.0899999999999999 109.698 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 164.98 -158.25 31.01 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.959 -1.656 . . . . 1.1899999999999999 108.959 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 60' ' ' PRO . . . -87.59 -67.6 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.88 -1.629 . . . . 2.8500000000000001 110.159 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 73' ' ' THR . 61.7 t80 -152.03 179.92 8.05 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.547 -0.861 . . . . 3.75 108.788 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 72' ' ' TYR . 85.0 m 67.73 -68.14 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.629 0.581 . . . . 3.6899999999999999 110.212 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.53 -51.1 5.21 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.105 0.955 . . . . 3.71 110.155 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.44 -36.96 2.16 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.615 -1.63 . . . . 1.51 112.696 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.59 -49.19 57.09 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.325 -0.95 . . . . 2.4700000000000002 109.848 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.06 62.51 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.463 -0.94 . . . . 2.6499999999999999 108.463 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.559 ' CZ2' HG13 ' A' ' 64' ' ' VAL . 78.3 t90 -46.61 -53.81 10.77 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.775 -1.102 . . . . 1.0600000000000001 109.038 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.42 -41.61 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.904 -1.119 . . . . 1.8100000000000001 109.534 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.506 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -65.01 -38.89 92.43 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.88 -1.054 . . . . 3.0499999999999998 113.437 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.37 -12.53 12.99 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 115.815 1.783 . . . . 4.71 115.815 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.436 ' CG ' ' NE1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -92.22 -16.33 26.34 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.544 -0.862 . . . . 1.74 109.996 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.6 mt -102.31 -73.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.454 -0.898 . . . . 3.4399999999999999 109.16 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 31.65 42.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 124.287 0.992 . . . . 4.1399999999999997 112.003 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.577 ' C ' ' HE ' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 115.984 -1.96 . . . . 6.0599999999999996 107.455 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.664 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.498 -0.556 . . . . 4.0599999999999996 109.498 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -94.1 96.97 9.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 123.703 0.627 . . . . 5.04 110.809 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.408 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 54.6 m -91.62 126.04 36.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.043 -0.725 . . . . 2.2200000000000002 109.043 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.434 ' C ' HD13 ' A' ' 5' ' ' ILE . 16.6 t -129.02 141.76 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.708 -1.197 . . . . 2.2999999999999998 109.664 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.5 mp -111.28 132.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.117 -2.179 . . . . 2.48 105.117 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 50.0 m-85 -124.2 116.31 22.49 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.262 -0.644 . . . . 2.3700000000000001 109.262 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.11 -179.35 20.47 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.251 -1.452 . . . . 3.4100000000000001 112.353 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -127.23 163.61 23.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.76 -0.72 . . . . 6.4100000000000001 109.623 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -106.11 -53.12 2.68 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.113 0.959 . . . . 8.7599999999999998 109.363 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.79 -61.51 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 105.814 -2.914 . . . . 5.8600000000000003 105.814 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 13' ' ' TYR . 9.6 m -96.24 170.39 7.61 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 106.388 -1.708 . . . . 5.3499999999999996 106.388 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.93 73.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.365 2.043 . . . . 3.8999999999999999 111.605 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' CYS . 6.3 t80 -119.63 -60.93 1.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.768 . . . . 5.54 108.925 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.627 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 29.8 m -54.64 -39.53 68.06 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 122.615 1.198 . . . . 2.9399999999999999 108.193 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.0 t -44.41 -50.29 2.01 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 CA-C-N 113.396 -1.729 . . . . 2.1099999999999999 111.278 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 8.5 mmm180 -56.92 -41.17 77.68 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.105 -1.038 . . . . 4.8200000000000003 110.243 -178.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.12 80.05 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.218 -1.401 . . . . 1.6499999999999999 107.218 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.627 ' HZ3' ' CD ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -57.2 -52.5 65.06 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.76 -1.176 . . . . 2.79 107.855 178.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.05 -52.17 9.26 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.458 -0.897 . . . . 3.1299999999999999 110.628 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 75' ' ' PHE . 40.9 tp -58.49 -60.38 3.89 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 120.41 -0.516 . . . . 1.8100000000000001 110.656 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.31 -44.22 44.13 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.969 -1.014 . . . . 1.73 109.45 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.627 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 27.8 tt0 -62.91 -51.46 66.84 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 124.709 1.256 . . . . 1.74 109.358 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -50.21 -56.16 12.25 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.394 -0.922 . . . . 5.1200000000000001 108.674 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD13 HG22 ' A' ' 79' ' ' VAL . 44.6 mt -57.3 -44.36 84.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.341 1.026 . . . . 2.1600000000000001 109.179 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 t -51.89 -29.9 21.78 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.979 -1.464 . . . . 1.24 109.61 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 5.9 t-20 -96.38 25.77 4.79 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.152 -0.931 . . . . 2.71 110.935 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.7 mt-10 -138.74 -35.44 0.58 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.504 -0.771 . . . . 2.52 110.537 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.545 ' C ' ' H ' ' A' ' 30' ' ' ASP . 43.3 mtp85 -114.71 129.86 56.74 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.759 -0.776 . . . . 4.5199999999999996 112.017 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.16 32.56 0.28 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.242 1.02 . . . . 3.6200000000000001 109.742 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.545 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.3 p30 -136.49 -1.7 2.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.708 -1.587 . . . . 3.1600000000000001 109.243 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.408 ' CZ ' ' OG1' ' A' ' 3' ' ' THR . 8.6 t80 -120.64 124.53 45.47 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.653 0.739 . . . . 1.24 112.635 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -142.76 155.13 44.8 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.131 -1.433 . . . . 6.1200000000000001 107.131 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -134.76 163.88 28.81 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.105 -1.438 . . . . 1.27 112.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.65 154.52 44.43 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 124.604 1.19 . . . . 6.4299999999999997 109.389 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -127.88 124.63 37.94 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.9 -0.72 . . . . 4.1799999999999997 110.162 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.41 149.88 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.379 -1.341 . . . . 2.6000000000000001 107.379 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -123.55 124.91 43.89 Favored 'General case' 0 N--CA 1.51 2.57 0 C-N-CA 117.816 -1.554 . . . . 2.3700000000000001 110.412 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 pt -43.5 -38.76 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 113.435 -1.711 . . . . 2.7799999999999998 114.017 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 24.35 6.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.237 -0.985 . . . . 9.8100000000000005 112.905 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.95 -43.96 2.74 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.012 -1.107 . . . . 2.48 108.012 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -92.45 -28.68 16.69 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.686 -1.597 . . . . 5.96 111.288 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.4 0.66 Allowed Glycine 0 N--CA 1.503 3.103 0 C-N-CA 119.364 -1.398 . . . . 1.95 111.132 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.9 mt -112.46 156.84 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.665 -0.814 . . . . 3.3399999999999999 108.984 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -101.24 -170.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.428 -0.953 . . . . 3.54 108.428 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -49.98 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.722 -1.584 . . . . 5.4299999999999997 106.722 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.69 -52.25 24.38 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.372 -0.931 . . . . 3.8700000000000001 110.118 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.531 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 1.0 OUTLIER -48.85 -44.93 40.11 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 120.064 -0.654 . . . . 2.6499999999999999 111.49 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 1.8 mt -70.14 -42.83 72.06 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.886 0.85 . . . . 2.5699999999999998 109.011 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -58.27 -32.48 68.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.625 -1.25 . . . . 5.7300000000000004 107.625 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 0.96 7.74 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.048 -1.433 . . . . 5.5300000000000002 110.263 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 57.3 mttp -115.85 -42.72 3.06 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.57 -1.195 . . . . 3.1299999999999999 109.824 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -81.02 -50.89 9.12 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.358 -0.837 . . . . 2.04 111.476 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.74 -55.54 2.28 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.65 -2.18 . . . . 2.77 107.65 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 58' ' ' THR . 44.4 mtmt 31.14 -147.39 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 CA-C-N 112.526 -1.837 . . . . 8.5999999999999996 113.566 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 57.2 Cg_endo -92.37 -166.95 0.17 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.962 1.775 . . . . 5.04 112.416 128.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -98.52 81.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.369 -0.832 . . . . 7.7300000000000004 109.543 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -115.4 -94.25 0.48 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.948 1.092 . . . . 5.4100000000000001 113.948 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.574 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.3 m -142.86 -156.05 0.65 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 118.972 -1.091 . . . . 5.1100000000000003 113.738 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.522 ' H ' HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -114.78 -169.05 0.14 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 114.389 -1.278 . . . . 4.7000000000000002 108.966 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.627 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 31.7 Cg_endo -68.57 -175.42 9.49 Favored 'Cis proline' 0 N--CA 1.499 1.815 0 O-C-N 122.182 0.57 . . . . 3.2799999999999998 111.553 -28.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -134.74 150.95 50.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 123.976 0.798 . . . . 3.6600000000000001 111.864 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mt -123.67 142.51 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.711 -1.218 . . . . 2.0499999999999998 107.711 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.21 156.56 48.5 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.844 -1.071 . . . . 1.4299999999999999 110.004 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.6 t -138.12 115.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.017 -0.673 . . . . 2.25 109.653 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 1' ' ' MET . 1.2 m-20 54.44 -101.94 0.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.253 -1.017 . . . . 3.2799999999999998 108.253 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -125.75 39.55 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.857 -0.794 . . . . 4.9699999999999998 108.857 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -127.51 161.78 27.97 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.416 -0.811 . . . . 4.6200000000000001 109.984 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.509 ' CD2' ' N ' ' A' ' 69' ' ' ILE . 5.5 t-160 -122.54 142.42 50.62 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.753 -1.203 . . . . 1.5 107.753 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.509 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 28.1 mm -101.33 -99.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 118.704 -1.198 . . . . 2.8100000000000001 107.877 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.42 65.29 0.21 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.401 -1.38 . . . . 4.2300000000000004 110.611 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.66 -175.33 17.52 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.995 -1.642 . . . . 2.4199999999999999 108.995 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' PHE . 13.6 t80 -110.08 -60.75 1.75 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.356 -0.938 . . . . 2.4900000000000002 109.947 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -46.09 -34.11 3.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.578 -1.638 . . . . 5.1399999999999997 106.578 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.6 -44.11 97.61 Favored 'General case' 0 C--O 1.2 -1.537 0 CA-C-N 113.077 -1.874 . . . . 3.4100000000000001 108.87 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 20' ' ' LEU . 11.9 t80 -63.45 -41.52 98.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.476 -0.935 . . . . 1.3700000000000001 108.476 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -62.48 -56.15 20.86 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.365 -0.934 . . . . 2.27 108.966 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.15 43.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.325 -1.361 . . . . 2.3399999999999999 107.325 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.424 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 80.1 t90 -36.47 -54.73 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.981 0.801 . . . . 1.23 110.413 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.444 HG22 HD13 ' A' ' 24' ' ' LEU . 41.4 t -43.92 -60.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 115.199 -0.91 . . . . 2.2799999999999998 111.92 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -44.33 -29.61 0.7 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.614 0.968 . . . . 3.7799999999999998 113.614 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -109.06 -27.02 9.86 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.628 -0.829 . . . . 4.1299999999999999 113.044 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -83.98 -34.13 24.43 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.042 -1.063 . . . . 1.8400000000000001 111.017 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 68.0 mt -102.47 -44.79 5.26 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.042 -1.836 . . . . 3.4500000000000002 106.042 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 60.67 -65.92 0.05 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 126.497 2.373 . . . . 5.1900000000000004 111.501 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.234 0 O-C-N 125.197 1.561 . . . . 5.3300000000000001 109.45 179.481 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.344 0.592 . . . . 3.3100000000000001 110.04 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -109.65 99.44 8.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.579 -2.378 . . . . 5.71 104.579 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.447 HG23 ' CE1' ' A' ' 75' ' ' PHE . 27.1 m -88.4 103.42 15.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.906 -1.497 . . . . 1.9199999999999999 109.868 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 63.3 t -94.47 130.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.751 -0.659 . . . . 2.2799999999999998 110.292 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.43 HG22 ' SG ' ' A' ' 14' ' ' CYS . 1.6 mp -113.74 116.86 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.411 -1.7 . . . . 2.25 106.411 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.606 ' CE2' HD12 ' A' ' 43' ' ' ILE . 2.8 m-30 -106.33 98.38 8.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.826 -1.916 . . . . 3.79 105.826 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 60' ' ' PRO . . . -130.59 -159.99 9.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.42 -1.371 . . . . 1.6200000000000001 112.481 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' CZ ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -124.4 130.1 51.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.02 -1.474 . . . . 6.0700000000000003 107.02 179.016 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.474 ' OG ' ' CZ ' ' A' ' 8' ' ' ARG . 1.6 p -51.77 106.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.632 -0.827 . . . . 5.3899999999999997 108.95 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . 134.08 -12.42 4.73 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.699 -1.238 . . . . 3.6099999999999999 111.16 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 97.1 m -95.3 90.94 0.66 Allowed Pre-proline 0 N--CA 1.501 2.122 0 C-N-CA 119.493 -0.883 . . . . 5.8799999999999999 110.682 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 10' ' ' GLY . 28.3 Cg_endo -58.78 -3.57 1.55 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.741 2.961 . . . . 4.2300000000000004 112.719 -162.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 11' ' ' CYS . 9.5 m-30 -71.44 -37.27 71.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.62 -1.252 . . . . 5.46 107.62 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 3.6 t -58.56 -43.19 89.29 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.143 -1.423 . . . . 4.1600000000000001 108.21 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.42 -57.74 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.428 -0.952 . . . . 2.3500000000000001 108.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 6.5 mmp_? -49.93 -48.45 51.81 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.649 -1.22 . . . . 4.7300000000000004 109.649 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.0 -54.77 40.86 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.887 -1.525 . . . . 1.6699999999999999 108.266 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -46.22 -49.08 17.58 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.177 -0.609 . . . . 2.8199999999999998 109.879 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 35.1 m-20 -63.28 -55.68 22.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.887 -0.597 . . . . 3.29 110.188 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.5 tp -48.53 -55.73 10.27 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.987 -1.085 . . . . 1.8100000000000001 109.239 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.69 -36.22 73.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.656 -0.818 . . . . 1.8999999999999999 109.668 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.6 tt0 -51.31 -47.55 62.58 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.051 -1.059 . . . . 1.8999999999999999 109.819 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -44.73 -60.15 2.16 Favored 'General case' 0 N--CA 1.514 2.751 0 C-N-CA 119.419 -0.912 . . . . 7.8600000000000003 109.657 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 47.6 mt -45.53 -52.39 10.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.224 -1.353 . . . . 3.4399999999999999 107.916 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -53.48 -37.34 62.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.662 -1.608 . . . . 1.3999999999999999 111.415 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -104.22 37.1 2.17 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.048 0.928 . . . . 2.8900000000000001 108.549 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 28' ' ' ARG . 58.9 tt0 -130.11 -51.39 1.11 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.177 -1.374 . . . . 4.7599999999999998 107.517 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 27' ' ' GLU . 9.7 ptp180 -124.79 -178.39 4.14 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 112.368 -2.196 . . . . 3.8500000000000001 108.619 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -116.29 27.95 8.9 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.486 0.66 . . . . 4.6200000000000001 110.685 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -120.26 -8.41 9.68 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.453 -0.794 . . . . 3.0600000000000001 112.701 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -108.68 130.15 55.34 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.109 1.522 . . . . 1.72 115.109 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' N ' ' NE2' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -138.31 153.14 49.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.891 -1.152 . . . . 4.5199999999999996 107.891 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.91 156.25 35.04 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.528 -0.869 . . . . 1.23 109.978 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -130.12 118.22 21.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.62 0.575 . . . . 5.5599999999999996 109.914 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.496 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -107.47 112.62 25.49 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.721 -0.792 . . . . 3.3199999999999998 109.287 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 156.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 123.89 0.744 . . . . 2.7999999999999998 109.642 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -114.06 131.47 56.37 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 106.869 -1.53 . . . . 2.3599999999999999 106.869 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 pt -47.78 -39.96 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 114.348 1.24 . . . . 2.1600000000000001 114.348 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -85.98 -45.14 11.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.607 -1.637 . . . . 6.1799999999999997 108.422 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 39' ' ' ARG . . . -35.38 -56.86 0.62 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 124.068 0.855 . . . . 2.8999999999999999 110.918 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -105.5 44.53 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 124.083 0.864 . . . . 5.7400000000000002 110.97 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 23.53 68.15 0.03 OUTLIER Glycine 0 N--CA 1.504 3.215 0 CA-C-N 114.773 -1.103 . . . . 2.29 114.597 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.606 HD12 ' CE2' ' A' ' 6' ' ' PHE . 34.3 mt -101.08 140.26 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.432 -1.692 . . . . 2.98 106.432 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.9 p -104.41 169.98 8.16 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.442 -0.903 . . . . 3.8599999999999999 111.195 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' CA ' ' HZ1' ' A' ' 45' ' ' LYS . 5.0 mmmp? -70.83 -35.33 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 117.806 -1.558 . . . . 5.7300000000000004 111.963 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.72 -55.18 38.26 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.924 -1.51 . . . . 6.5499999999999998 106.924 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.465 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 25.0 t70 -48.68 -48.1 40.27 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 115.094 -0.957 . . . . 2.8500000000000001 111.657 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.84 -50.22 67.5 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.836 -1.074 . . . . 2.6000000000000001 110.743 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.45 -45.44 66.04 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.418 -1.327 . . . . 5.2400000000000002 107.418 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -23.33 40.13 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.613 -1.63 . . . . 5.04 111.211 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 7.9 mtmm -96.8 -32.74 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.308 -0.557 . . . . 3.1600000000000001 110.849 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB1' HE22 ' A' ' 61' ' ' GLN . . . -75.41 -44.26 45.6 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.093 -0.643 . . . . 2.46 112.021 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.0 -48.75 0.91 Allowed Glycine 0 N--CA 1.501 3.031 0 N-CA-C 108.232 -1.947 . . . . 3.3199999999999998 108.232 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.565 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 3.8 ttpm? -91.4 166.58 17.88 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.245 -2.131 . . . . 7.0899999999999999 105.245 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.565 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.5 Cg_endo -48.22 155.61 1.92 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.685 -1.313 . . . . 6.1100000000000003 108.685 146.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 m -118.79 149.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.897 -1.121 . . . . 5.9699999999999998 110.562 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' C ' ' HG1' ' A' ' 58' ' ' THR . 15.6 mp0 -87.19 -69.47 0.68 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.073 0.858 . . . . 6.2999999999999998 111.17 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.473 ' HG1' ' C ' ' A' ' 57' ' ' GLU . 26.7 m -143.8 173.64 11.5 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.731 -0.788 . . . . 4.6100000000000003 110.871 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 15.7 m -101.92 159.17 30.18 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.818 -1.179 . . . . 2.71 107.818 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 10.0 Cg_endo -92.01 147.26 14.33 Favored 'Cis proline' 0 C--N 1.318 -1.057 0 CA-C-N 118.554 0.519 . . . . 2.0299999999999998 111.454 9.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.413 HE22 ' HB1' ' A' ' 52' ' ' ALA . 18.6 mt-30 -107.78 147.47 30.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.922 -0.711 . . . . 3.5499999999999998 109.47 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.456 HD11 ' CG ' ' A' ' 75' ' ' PHE . 4.4 mt -121.18 141.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.268 -0.973 . . . . 2.6699999999999999 112.489 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 19.7 m-85 -128.62 153.28 47.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 114.608 -1.178 . . . . 1.29 108.998 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.6 t -122.33 102.05 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.487 -1.301 . . . . 2.0299999999999998 107.487 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 1' ' ' MET . 37.2 m-20 65.49 -83.58 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.772 0.796 . . . . 2.3799999999999999 110.25 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -126.3 -15.43 5.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.398 -1.274 . . . . 5.4000000000000004 109.717 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -81.37 167.86 19.0 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.421 -0.512 . . . . 4.5099999999999998 111.27 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -123.43 136.26 54.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.439 -1.689 . . . . 1.51 106.439 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 75' ' ' PHE . 26.0 mm -107.07 -31.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.33 -0.948 . . . . 1.8400000000000001 110.204 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.4 -117.98 3.8 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.48 -1.448 . . . . 1.3300000000000001 109.48 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.36 -172.77 18.96 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.285 -1.126 . . . . 1.3200000000000001 110.285 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -56.01 -53.21 59.67 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.095 -1.042 . . . . 2.1800000000000002 113.253 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 p -40.92 -58.63 1.65 Allowed 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.726 -0.79 . . . . 1.97 110.833 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.56 -57.74 10.68 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 113.677 -1.601 . . . . 2.0499999999999998 108.964 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CG ' HD11 ' A' ' 62' ' ' ILE . 70.1 t80 -45.82 -52.91 10.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.747 -0.781 . . . . 1.23 111.497 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -55.99 18.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.469 -0.892 . . . . 2.1099999999999999 109.145 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.62 -58.98 5.36 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.623 -0.831 . . . . 1.8999999999999999 109.518 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 82' ' ' ASN . 74.3 t90 -41.99 -53.61 3.8 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.738 -0.664 . . . . 1.1299999999999999 109.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.18 -60.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 124.094 0.871 . . . . 1.8999999999999999 109.796 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.445 ' NZ ' ' C ' ' A' ' 85' ' ' ALA . 0.1 OUTLIER -44.78 -55.79 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.127 1.158 . . . . 3.8599999999999999 114.127 -177.048 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -93.42 28.6 2.2 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 117.184 -1.807 . . . . 5.4900000000000002 114.305 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 78' ' ' TRP . 40.9 m-80 -140.2 -36.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 119.124 -1.03 . . . . 2.8599999999999999 110.195 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.0 -26.25 9.36 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.518 -0.765 . . . . 2.48 111.161 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 0.2 OUTLIER -89.52 -69.9 0.69 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.002 0.814 . . . . 6.5700000000000003 110.365 -179.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.445 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.5 2.058 0 O-C-N 126.519 2.387 . . . . 8.7200000000000006 106.211 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.47 0.652 . . . . 4.0999999999999996 110.013 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.74 160.77 14.05 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.15 -0.932 . . . . 7.2199999999999998 111.602 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.3 m -124.68 146.61 49.03 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 109.843 -0.429 . . . . 1.8899999999999999 109.843 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.77 132.95 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.415 -0.957 . . . . 2.9100000000000001 108.415 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mp -118.29 121.99 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.48 -0.933 . . . . 2.1200000000000001 108.48 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -115.04 113.57 24.24 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 106.745 -1.576 . . . . 2.2799999999999998 106.745 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . 160.94 -169.3 36.54 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.279 -1.915 . . . . 1.8100000000000001 108.443 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -126.51 173.66 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 116.854 -1.938 . . . . 5.6299999999999999 112.3 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.12 -179.96 4.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.008 -1.451 . . . . 6.7300000000000004 109.778 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.48 -49.22 0.91 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.116 -1.993 . . . . 4.4800000000000004 108.116 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.8 t -128.24 101.04 22.44 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 107.391 -1.337 . . . . 5.0099999999999998 107.391 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 14' ' ' CYS . 2.3 Cg_endo -31.05 -56.14 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.634 2.223 . . . . 5.1600000000000001 113.06 -122.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 53.15 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.874 1.065 . . . . 6.5199999999999996 113.874 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' PRO . 18.2 m -115.85 -6.22 12.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.348 -0.541 . . . . 2.4199999999999999 110.797 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -43.03 -57.54 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 119.743 -0.783 . . . . 3.4700000000000002 111.78 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.592 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -60.09 -35.47 75.27 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 117.481 -1.688 . . . . 5.2400000000000002 109.891 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.27 -51.64 68.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.177 -1.409 . . . . 1.74 107.667 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 18.0 tptp -53.14 -50.52 64.38 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 120.26 -0.576 . . . . 3.6600000000000001 111.724 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.592 ' CG ' HH22 ' A' ' 16' ' ' ARG . 6.9 t0 -66.36 -53.91 30.71 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.784 0.802 . . . . 2.6600000000000001 110.165 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 tp -49.93 -53.44 26.13 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.199 -1.037 . . . . 2.6000000000000001 108.199 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.95 76.18 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.427 -0.953 . . . . 2.3500000000000001 108.427 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 4.8 tp10 -46.68 -62.98 1.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.465 1.126 . . . . 2.9100000000000001 110.677 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.42 -50.1 17.18 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 113.585 -1.643 . . . . 4.8700000000000001 110.921 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 mt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.169 -0.923 . . . . 2.77 110.321 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -58.52 -40.89 84.14 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.024 -0.732 . . . . 1.5900000000000001 109.024 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -89.05 29.84 1.01 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.947 -1.131 . . . . 2.7400000000000002 107.947 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -120.82 -59.19 1.77 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.257 -1.016 . . . . 3.4700000000000002 108.257 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.475 HH12 ' CG ' ' A' ' 84' ' ' ASP . 3.4 mtt180 -116.5 152.28 34.39 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.352 -0.981 . . . . 4.75 108.352 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -74.98 -36.05 62.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.644 -0.822 . . . . 4.9100000000000001 110.176 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 30' ' ' ASP . 5.5 t70 -83.51 41.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.666 -0.813 . . . . 4.3099999999999996 109.998 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 25' ' ' SER . 50.9 t80 -142.65 72.43 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.322 -0.951 . . . . 1.6899999999999999 108.622 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -100.2 138.13 37.69 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.272 -1.01 . . . . 4.5899999999999999 108.272 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -118.36 155.77 30.11 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.15 -1.02 . . . . 1.6399999999999999 112.84 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -121.69 130.21 53.3 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 4.4900000000000002 107.92 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -119.49 114.6 22.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.65 -1.241 . . . . 2.21 107.65 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.84 145.93 32.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.483 -0.781 . . . . 4.1200000000000001 109.653 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 11.3 t70 -97.62 140.19 32.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.126 -1.435 . . . . 3.21 107.126 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.424 ' C ' HH11 ' A' ' 39' ' ' ARG . 9.5 pt -48.31 -29.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 112.895 0.702 . . . . 3.2200000000000002 112.895 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HA ' HH11 ' A' ' 39' ' ' ARG . 0.7 OUTLIER -94.75 22.65 6.14 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.276 -0.97 . . . . 8.1400000000000006 111.749 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.2 -50.68 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.246 -0.581 . . . . 2.1099999999999999 109.662 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -95.58 -13.81 24.1 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.5 -0.88 . . . . 3.3700000000000001 109.755 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.59 58.76 1.17 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.137 -1.985 . . . . 1.5600000000000001 108.137 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -101.1 141.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 120.117 -0.633 . . . . 3.2400000000000002 111.582 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 p -123.14 161.54 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 124.538 1.149 . . . . 3.73 109.437 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -43.91 -57.34 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.705 -0.68 . . . . 5.2300000000000004 109.493 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -44.49 -49.28 9.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 123.826 0.704 . . . . 3.8500000000000001 111.128 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.491 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 11.8 t70 -60.78 -50.66 72.58 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.976 -1.49 . . . . 3.0800000000000001 109.221 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -42.82 64.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.152 -0.931 . . . . 2.75 108.92 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.0 -47.87 79.8 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.6 -1.259 . . . . 5.0700000000000003 107.6 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -60.19 -50.29 74.25 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.984 0.803 . . . . 5.8099999999999996 110.562 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.491 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 2.8 tppt? -55.62 -50.23 70.71 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.428 -1.26 . . . . 4.4100000000000001 111.508 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.565 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -74.24 -47.49 34.92 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.315 -1.311 . . . . 1.8100000000000001 113.077 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.86 42.71 5.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.048 -1.621 . . . . 2.48 109.048 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 75.5 mmtt -128.41 -176.29 0.51 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.521 -0.918 . . . . 6.9800000000000004 108.521 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 50.9 Cg_exo -50.82 -157.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.46 1.44 . . . . 4.75 111.235 147.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 m -114.16 70.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.784 -0.643 . . . . 7.0300000000000002 112.273 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 3.1 mp0 -75.03 54.51 0.67 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.14 -0.936 . . . . 6.1699999999999999 112.217 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.465 ' HG1' ' C ' ' A' ' 57' ' ' GLU . 81.3 p 41.26 -112.53 0.16 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 115.666 1.728 . . . . 4.7800000000000002 115.666 178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.12 171.55 6.43 Favored Pre-proline 0 N--CA 1.498 1.955 0 CA-C-N 115.569 -0.741 . . . . 3.1699999999999999 109.402 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.51 173.35 11.98 Favored 'Cis proline' 0 N--CA 1.487 1.109 0 O-C-N 122.616 0.798 . . . . 2.1899999999999999 110.351 -20.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.75 150.49 49.78 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.905 . . . . 3.3799999999999999 110.521 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.418 ' C ' ' CD1' ' A' ' 63' ' ' PHE . 48.2 mt -123.16 148.03 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.747 -0.66 . . . . 2.1699999999999999 109.267 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 9.4 m-85 -131.06 165.39 23.34 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.767 -1.106 . . . . 1.4099999999999999 109.494 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.426 HG12 ' CZ2' ' A' ' 78' ' ' TRP . 55.7 t -134.8 112.31 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.481 -1.236 . . . . 2.0299999999999998 110.148 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.94 -85.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.464 0.542 . . . . 2.6400000000000001 112.464 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 64' ' ' VAL . 54.0 mt-30 -139.13 23.18 2.58 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.82 -0.627 . . . . 5.3700000000000001 110.334 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -123.99 153.96 40.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.398 -0.964 . . . . 4.6600000000000001 108.398 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.565 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 7.0 t-160 -108.6 139.77 42.91 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.829 -1.174 . . . . 1.3300000000000001 107.829 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.75 -45.94 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 118.744 -1.183 . . . . 1.9099999999999999 110.032 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.415 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 138.21 -123.83 2.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.391 -1.484 . . . . 1.3700000000000001 109.391 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.11 -174.72 19.64 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.147 -1.181 . . . . 1.4399999999999999 110.147 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -47.4 -60.33 2.59 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.817 1.043 . . . . 3.1099999999999999 113.817 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -36.31 -59.82 0.61 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.685 1.231 . . . . 2.8599999999999999 111.369 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -51.78 68.32 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.374 -2.193 . . . . 2.0800000000000001 109.584 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -47.15 -50.54 20.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.516 -1.274 . . . . 1.1200000000000001 109.632 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.09 13.14 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.51 -1.276 . . . . 2.1800000000000002 109.253 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.25 -54.12 35.23 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.484 -0.886 . . . . 1.8899999999999999 110.861 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.426 ' CZ2' HG12 ' A' ' 64' ' ' VAL . 89.7 t90 -51.17 -50.58 58.7 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.146 -0.479 . . . . 0.81000000000000005 110.441 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -49.41 -50.62 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.213 -0.903 . . . . 2.3300000000000001 111.681 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -40.42 -38.5 0.83 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.703 1.372 . . . . 3.0099999999999998 114.703 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.88 -25.8 6.67 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.973 1.101 . . . . 5.6399999999999997 113.973 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -79.47 -14.36 58.95 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 117.491 -1.683 . . . . 1.9199999999999999 108.101 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -121.8 13.34 10.7 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.905 -1.146 . . . . 2.8700000000000001 107.905 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.475 ' CG ' HH12 ' A' ' 28' ' ' ARG . 3.7 p30 32.27 80.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.469 -1.696 . . . . 6.2300000000000004 114.661 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 116.546 -1.692 . . . . 9.1400000000000006 108.948 178.357 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 107.996 -1.113 . . . . 3.4300000000000002 107.996 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -109.67 128.77 55.48 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.194 -0.669 . . . . 5.8700000000000001 109.194 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -112.71 125.07 53.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.731 -0.788 . . . . 1.8999999999999999 109.476 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 ' CG1' ' HB2' ' A' ' 63' ' ' PHE . 14.5 p -121.35 144.46 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.405 -0.918 . . . . 4.0499999999999998 109.362 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -118.35 118.77 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 125.173 1.545 . . . . 3.54 108.98 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -107.81 73.41 0.9 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.446 -1.687 . . . . 2.6499999999999999 106.446 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.4 -179.66 21.84 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.786 -1.673 . . . . 2.0699999999999998 111.431 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 126.47 52.68 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.076 -1.824 . . . . 7.3099999999999996 106.076 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -117.29 -168.19 1.44 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.139 0.971 . . . . 7.7199999999999998 112.768 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.56 -47.32 1.02 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.253 -1.939 . . . . 4.2199999999999998 108.253 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.91 116.25 31.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.476 -1.305 . . . . 6.3399999999999999 107.476 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 14' ' ' CYS . 50.1 Cg_exo -17.74 -68.49 0.02 OUTLIER 'Trans proline' 0 C--O 1.197 -1.533 0 C-N-CA 122.598 2.199 . . . . 4.8300000000000001 112.924 -127.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 47.36 -66.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 113.028 0.751 . . . . 6.4699999999999998 113.028 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 12' ' ' PRO . 23.5 m -116.39 -18.75 10.37 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.468 -0.893 . . . . 2.29 109.544 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -47.03 -33.94 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.266 -0.573 . . . . 2.23 110.479 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.511 HH21 ' CB ' ' A' ' 19' ' ' ASP . 1.2 mmp_? -78.64 -38.15 40.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.853 -1.139 . . . . 4.4299999999999997 110.408 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.9 -49.24 73.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.954 -1.869 . . . . 1.73 105.954 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.439 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 3.7 tmtm? -57.44 -51.58 68.85 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.641 -1.163 . . . . 2.5600000000000001 110.047 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.511 ' CB ' HH21 ' A' ' 16' ' ' ARG . 9.7 t70 -57.66 -59.12 5.69 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.394 -0.922 . . . . 2.73 109.401 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 tp -49.07 -60.08 3.08 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.883 0.849 . . . . 1.96 109.599 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.66 -53.13 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.668 -1.151 . . . . 2.0 109.362 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.439 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 tt0 -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.212 1.006 . . . . 2.0699999999999998 108.615 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.424 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -49.11 -49.99 39.27 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.11 -1.405 . . . . 5.5099999999999998 107.984 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.1 mt -63.89 -31.54 72.76 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.848 -0.797 . . . . 2.4199999999999999 108.848 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 t -64.06 -29.52 70.65 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.173 -1.788 . . . . 1.28 106.173 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 7.0 t30 -95.73 32.38 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.014 -1.106 . . . . 2.6600000000000001 108.014 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 40.5 mt-10 -130.09 -66.06 0.8 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.681 -1.145 . . . . 2.79 108.791 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.3 mpt_? -116.17 132.72 56.58 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 108.258 -1.016 . . . . 5.6200000000000001 108.258 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.5 30.06 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.775 -0.77 . . . . 4.25 111.732 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -112.78 -25.82 8.88 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.141 -1.429 . . . . 2.8399999999999999 107.141 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -98.02 117.64 32.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.574 -1.194 . . . . 1.5900000000000001 112.999 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -124.27 136.59 54.25 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.136 -1.847 . . . . 4.3300000000000001 106.551 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' C ' ' NE2' ' A' ' 34' ' ' GLN . 7.9 p90 -117.66 158.73 24.14 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 118.622 -1.231 . . . . 1.1699999999999999 109.176 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.432 ' NE2' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -144.7 119.82 10.1 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.206 -0.906 . . . . 5.4199999999999999 110.227 -178.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -98.33 119.06 36.35 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.064 -1.828 . . . . 1.9199999999999999 106.064 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.4 154.2 21.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.608 -1.627 . . . . 2.6600000000000001 106.608 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -117.95 131.54 56.49 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.184 -1.406 . . . . 2.8300000000000001 108.565 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.0 pt -46.73 -37.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.08 -1.418 . . . . 2.1600000000000001 113.912 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -95.26 18.44 12.38 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.76 -1.176 . . . . 6.7599999999999998 112.651 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.86 -47.54 3.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.722 -0.844 . . . . 2.1099999999999999 108.722 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -88.99 -22.72 22.87 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.798 -1.092 . . . . 4.8200000000000003 110.635 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.49 52.85 1.39 Allowed Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.589 -1.291 . . . . 1.9399999999999999 110.615 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.8 mt -106.71 134.78 47.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 106.287 -1.746 . . . . 2.5699999999999998 106.287 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -91.96 -144.16 0.2 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.817 -1.153 . . . . 3.5600000000000001 109.173 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -116.74 -33.52 4.79 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.577 -1.638 . . . . 7.5499999999999998 106.577 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.17 -46.58 80.24 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.362 -1.718 . . . . 3.96 106.362 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' CG ' ' NZ ' ' A' ' 51' ' ' LYS . 26.9 t70 -63.88 -16.85 62.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.914 -1.039 . . . . 2.2000000000000002 111.343 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.64 -48.14 5.63 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 108.468 -0.938 . . . . 2.2400000000000002 108.468 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.35 -47.03 62.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 4.46 107.271 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -18.73 64.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.702 -1.135 . . . . 4.7699999999999996 111.451 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' NZ ' ' CG ' ' A' ' 47' ' ' ASP . 36.5 mttp -86.65 -41.58 14.12 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.827 -0.749 . . . . 2.7999999999999998 111.218 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.23 -36.17 13.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.144 -0.622 . . . . 2.2200000000000002 110.676 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.95 -66.91 0.38 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 105.501 -3.039 . . . . 3.4100000000000001 105.501 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HZ1' ' CD ' ' A' ' 57' ' ' GLU . 33.2 mttm 31.44 -162.61 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 CA-C-N 112.533 -1.834 . . . . 8.2400000000000002 113.178 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -103.75 -157.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.202 1.935 . . . . 5.0099999999999998 109.915 131.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.04 113.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.946 -1.501 . . . . 8.1099999999999994 106.946 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' CD ' ' HZ1' ' A' ' 54' ' ' LYS . 24.9 mt-10 -119.31 -175.6 2.97 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.503 -0.771 . . . . 5.96 112.692 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.9 t -92.07 -136.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.42 -1.326 . . . . 5.3099999999999996 107.42 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 7.0 m -127.26 162.66 46.96 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.627 -0.879 . . . . 3.0800000000000001 108.627 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.415 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 83.7 Cg_endo -100.34 163.51 8.2 Favored 'Cis proline' 0 N--CA 1.486 1.085 0 O-C-N 122.507 0.741 . . . . 2.25 111.888 2.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -119.7 112.1 18.85 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.644 -1.243 . . . . 3.9199999999999999 107.644 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -101.48 143.62 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.761 -0.776 . . . . 2.02 111.011 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.404 ' HB2' ' CG1' ' A' ' 4' ' ' VAL . 24.7 m-85 -134.31 156.48 48.37 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 113.245 -1.798 . . . . 1.6299999999999999 109.964 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 66' ' ' GLN . 54.5 t -131.56 122.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.869 -1.53 . . . . 1.75 106.869 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 55.02 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.059 -0.657 . . . . 3.2599999999999998 109.29 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.4 tt0 -133.18 -16.93 2.41 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.604 -1.18 . . . . 5.9800000000000004 110.692 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -81.59 161.54 23.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.921 -0.711 . . . . 5.21 110.503 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -108.34 147.56 31.33 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.184 -0.917 . . . . 1.9299999999999999 108.611 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.406 HD13 ' CD1' ' A' ' 78' ' ' TRP . 5.2 mm -116.21 -49.66 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.12 -1.032 . . . . 1.8400000000000001 109.483 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.27 -121.07 3.05 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.954 -1.258 . . . . 1.1599999999999999 109.954 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.97 -164.47 18.53 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.623 -0.991 . . . . 1.1100000000000001 110.623 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -53.52 -56.51 16.41 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 120.903 0.382 . . . . 2.6899999999999999 111.203 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -45.39 -53.18 9.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.035 0.921 . . . . 1.9099999999999999 110.779 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.39 65.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.158 -1.837 . . . . 2.79 109.295 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -48.24 -52.91 19.02 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.133 -1.027 . . . . 1.1499999999999999 110.08 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.11 -56.7 14.24 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.097 -1.041 . . . . 1.73 110.122 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -55.66 28.49 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.54 -0.864 . . . . 1.9199999999999999 109.922 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.406 ' CD1' HD13 ' A' ' 69' ' ' ILE . 89.7 t90 -48.89 -53.31 20.04 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.22 -0.592 . . . . 0.80000000000000004 110.077 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.2 t -46.69 -58.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 CA-C-N 115.05 -0.977 . . . . 1.7 110.614 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -43.07 -43.09 4.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.816 1.413 . . . . 3.2999999999999998 114.816 -177.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -97.79 3.56 49.97 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 118.15 -1.42 . . . . 3.8700000000000001 113.536 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -117.09 -39.89 3.17 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.793 -0.763 . . . . 1.3400000000000001 111.306 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.2 mt -113.56 37.83 3.11 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.619 -0.719 . . . . 2.5899999999999999 112.051 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -101.0 37.99 1.64 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.057 -1.057 . . . . 4.21 109.322 178.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 116.689 -1.624 . . . . 5.7800000000000002 108.148 179.333 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 30' ' ' ASP . 58.9 tpp . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 109.005 -0.739 . . . . 3.9700000000000002 109.005 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -119.6 118.7 31.69 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.569 -1.271 . . . . 5.5499999999999998 107.569 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 11.1 m -114.27 131.58 56.45 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.341 -0.543 . . . . 1.73 110.996 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.99 146.72 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.822 -1.151 . . . . 2.9500000000000002 112.57 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.486 HD11 ' N ' ' A' ' 5' ' ' ILE . 4.4 mp -111.34 129.58 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.458 -1.682 . . . . 3.3500000000000001 106.458 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -118.63 119.92 35.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.15 -0.62 . . . . 2.2000000000000002 110.492 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 60' ' ' PRO . . . 142.27 -158.72 26.96 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 124.637 1.211 . . . . 2.8399999999999999 112.037 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -106.26 107.43 18.43 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.44 0.638 . . . . 6.7599999999999998 110.097 -179.1 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t -78.11 -155.05 0.07 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.897 -0.592 . . . . 8.0199999999999996 111.113 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 25.02 21.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.22 -1.552 . . . . 4.6900000000000004 109.22 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.433 ' C ' ' H ' ' A' ' 13' ' ' TYR . 59.2 m -142.38 150.92 56.57 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 120.46 -0.496 . . . . 4.4800000000000004 110.587 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.87 31.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.629 2.219 . . . . 5.5 112.479 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 11' ' ' CYS . 83.6 t80 -125.13 -63.78 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.626 -1.249 . . . . 8.1300000000000008 107.626 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.592 ' SG ' ' HD2' ' A' ' 60' ' ' PRO . 89.5 m -78.68 -29.16 45.42 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 118.554 -1.258 . . . . 4.21 109.4 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.19 -48.14 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.376 -1.342 . . . . 2.5899999999999999 107.376 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -57.71 -28.5 63.9 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.155 -1.018 . . . . 4.7800000000000002 109.853 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' HD13 ' A' ' 62' ' ' ILE . . . -69.86 -48.44 58.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.749 -1.945 . . . . 2.1099999999999999 105.749 177.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HE2' ' N ' ' A' ' 19' ' ' ASP . 3.5 tmpt? -50.21 -45.61 53.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.399 -1.704 . . . . 3.0899999999999999 106.399 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.491 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 72.8 m-20 -58.44 -62.77 1.6 Allowed 'General case' 0 C--O 1.19 -2.029 0 C-N-CA 119.277 -0.969 . . . . 2.9300000000000002 109.949 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 62.0 tp -46.5 -48.63 19.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.765 -0.774 . . . . 2.0600000000000001 110.287 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.69 85.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.112 -0.699 . . . . 1.8999999999999999 109.112 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.414 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 26.5 tt0 -59.63 -38.68 82.01 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.734 -0.839 . . . . 1.79 108.734 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 23.6 tttm -58.77 -65.17 0.7 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.608 -1.627 . . . . 6.3399999999999999 106.608 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.0 mt -45.6 -44.69 13.22 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.935 -1.135 . . . . 1.95 107.935 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.0 t -54.44 -43.42 71.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.419 -1.264 . . . . 1.22 109.809 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 18.3 t30 -78.39 -2.09 36.57 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.999 -0.68 . . . . 2.9900000000000002 110.241 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 23' ' ' LYS . 77.2 mm-40 -89.7 -50.35 6.12 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.197 -0.601 . . . . 3.1400000000000001 112.411 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' C ' ' H ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -137.81 155.91 48.51 Favored 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 118.679 -1.208 . . . . 4.9800000000000004 113.986 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.05 31.03 0.08 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.029 -0.987 . . . . 4.2300000000000004 111.825 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -125.52 -24.95 3.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.595 -0.73 . . . . 3.2599999999999998 109.261 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 25' ' ' SER . 15.5 t80 -101.58 122.48 43.93 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 114.468 1.285 . . . . 1.45 114.468 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' ' 33' ' ' TYR . 61.2 tp60 -133.64 159.51 40.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.646 -1.983 . . . . 7.2800000000000002 105.646 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 3' ' ' THR . 15.6 p90 -141.8 167.37 22.31 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.266 -0.974 . . . . 1.1499999999999999 108.851 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.3 152.24 31.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 124.023 0.827 . . . . 5.1799999999999997 109.511 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.62 124.49 49.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.914 -1.143 . . . . 2.4700000000000002 107.914 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.87 152.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.249 -0.98 . . . . 2.8399999999999999 110.435 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -102.82 142.08 34.56 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.664 1.221 . . . . 3.48 111.133 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 15.4 pt -66.45 -32.96 60.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 113.084 -1.871 . . . . 2.1400000000000001 111.665 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -10.72 44.17 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.403 -0.919 . . . . 7.2599999999999998 111.29 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.29 14.99 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.468 -0.938 . . . . 2.73 108.468 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.33 -43.53 13.62 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.61 -0.836 . . . . 3.7799999999999998 110.651 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.47 49.0 0.57 Allowed Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.318 -1.113 . . . . 2.3500000000000001 110.318 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.2 mt -106.48 135.14 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.052 -1.462 . . . . 2.4399999999999999 107.052 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.416 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 4.9 p -108.09 171.53 7.35 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.59 -1.244 . . . . 3.0600000000000001 113.111 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -17.24 62.74 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.194 -0.912 . . . . 4.5 109.586 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 16.2 mp0 -94.57 -50.02 5.38 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.487 -1.301 . . . . 3.7000000000000002 107.487 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 44' ' ' THR . 53.8 t0 -55.75 -50.9 69.14 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 108.3 -1.0 . . . . 2.8900000000000001 108.3 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.06 -49.5 68.86 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.345 -0.983 . . . . 2.8500000000000001 108.345 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.4 tt0 -47.07 -52.04 16.12 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.51 -0.876 . . . . 3.7400000000000002 108.969 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -62.31 -48.61 79.1 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.99 -1.004 . . . . 8.0999999999999996 112.008 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -52.15 -44.25 64.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.642 0.589 . . . . 3.29 110.54 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB1' ' CD ' ' A' ' 55' ' ' PRO . . . -88.84 -57.25 2.97 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.963 -1.095 . . . . 2.2799999999999998 109.339 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.1 -67.38 0.47 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.466 -1.854 . . . . 3.2000000000000002 108.466 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 22.8 mmtm -143.84 55.64 3.73 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.336 0.865 . . . . 9.5999999999999996 113.336 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.44 ' CD ' ' HB1' ' A' ' 52' ' ' ALA . 10.2 Cg_endo -91.26 159.06 3.77 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.703 1.602 . . . . 8.1600000000000001 109.087 137.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.18 -61.46 2.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.056 -0.658 . . . . 6.3799999999999999 109.724 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -128.67 33.05 4.71 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.335 -0.987 . . . . 7.2199999999999998 108.335 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.9 p -89.67 69.63 7.75 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.954 -0.698 . . . . 5.9000000000000004 110.139 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.423 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -114.37 140.43 25.11 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.26 -0.882 . . . . 3.9500000000000002 110.28 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.592 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 5.3 Cg_exo -72.5 155.09 99.03 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.615 -1.411 . . . . 4.2599999999999998 112.598 -0.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.592 ' CG ' ' NE2' ' A' ' 68' ' ' HIS . 1.7 tp-100 -121.45 165.84 15.01 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.426 -1.324 . . . . 5.5800000000000001 107.426 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 17' ' ' ALA . 34.4 mt -121.38 145.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.296 -0.962 . . . . 2.79 112.977 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -127.21 152.63 47.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.589 -2.096 . . . . 1.23 106.823 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 66' ' ' GLN . 55.9 t -125.38 126.17 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.95 -1.5 . . . . 1.9299999999999999 106.95 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 53.55 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.076 0.86 . . . . 2.5099999999999998 109.304 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -139.55 10.53 2.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.866 0.691 . . . . 7.1699999999999999 112.866 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -118.17 179.91 3.96 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.439 -0.504 . . . . 8.25 111.086 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 61' ' ' GLN . 29.5 t-80 -117.48 143.67 45.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.961 0.788 . . . . 2.0699999999999998 109.467 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -115.63 -39.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.793 -1.163 . . . . 2.0299999999999998 111.141 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.67 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.852 -2.099 . . . . 1.53 107.852 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.28 -72.76 0.81 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.427 -1.368 . . . . 2.8900000000000001 110.646 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 10.5 t80 -136.03 -50.61 0.7 Allowed 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 119.964 -0.694 . . . . 2.0699999999999998 109.77 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.01 61.69 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.678 1.228 . . . . 2.1000000000000001 108.823 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -57.26 12.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 111.929 -2.396 . . . . 2.5800000000000001 109.012 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -47.04 -52.33 15.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.643 -0.823 . . . . 1.1699999999999999 109.997 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.13 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.816 -1.154 . . . . 1.6899999999999999 109.099 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.69 -53.52 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.975 -1.09 . . . . 2.0 109.797 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -53.92 -51.34 64.06 Favored 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.285 0.564 . . . . 0.78000000000000003 110.355 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.5 t -48.38 -49.44 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.987 -1.006 . . . . 1.8 111.473 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -44.13 -30.18 0.73 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.891 1.441 . . . . 3.0299999999999998 114.891 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 82' ' ' ASN . 13.9 pt-20 -112.48 -35.23 5.62 Favored 'General case' 0 N--CA 1.506 2.363 0 C-N-CA 119.537 -0.865 . . . . 4.9500000000000002 113.219 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.436 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 39.5 m-80 -82.01 -23.84 35.75 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.037 -1.065 . . . . 1.3400000000000001 109.579 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 83' ' ' LEU . 2.2 mm? -113.09 -41.19 3.77 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.631 -0.713 . . . . 3.0099999999999998 109.67 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 t0 33.75 48.18 0.2 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 125.5 1.75 . . . . 3.9199999999999999 111.713 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.421 ' C ' HH22 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 116.823 -1.56 . . . . 6.9100000000000001 107.734 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 32.0 tpp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.805 . . . . 3.9100000000000001 108.825 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.68 110.65 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.731 0.777 . . . . 6.4100000000000001 109.45 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.41 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 18.0 m -92.81 105.96 18.01 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.378 -1.712 . . . . 2.23 106.378 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 19.9 t -105.29 138.72 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.438 -0.905 . . . . 2.0699999999999998 110.811 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.95 103.67 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.779 1.299 . . . . 2.5 108.337 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -85.65 90.14 7.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.509 -1.293 . . . . 2.1299999999999999 107.509 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.44 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -124.48 145.06 15.67 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.254 -1.938 . . . . 1.78 108.254 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 139.82 49.41 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.644 -1.222 . . . . 6.0499999999999998 110.205 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 10' ' ' GLY . 3.4 m 61.34 55.48 2.89 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.946 -1.024 . . . . 5.9500000000000002 108.902 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' SER . . . -3.15 83.83 0.0 OUTLIER Glycine 0 N--CA 1.511 3.635 0 O-C-N 124.782 1.301 . . . . 4.8799999999999999 114.872 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.4 m -112.74 157.13 41.32 Favored Pre-proline 0 N--CA 1.498 1.948 0 C-N-CA 119.577 -0.849 . . . . 4.9299999999999997 109.79 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.0 -13.82 0.24 Allowed 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.922 2.414 . . . . 3.2200000000000002 114.056 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -73.11 -14.1 61.32 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.688 -0.805 . . . . 4.8899999999999997 111.889 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.555 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.4 m -107.13 -29.23 9.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.24 -1.022 . . . . 2.6600000000000001 108.24 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.1 t -44.24 -63.65 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 114.506 1.299 . . . . 3.1600000000000001 114.506 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -52.04 -44.39 64.21 Favored 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 118.044 -1.462 . . . . 4.75 111.808 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.9 63.39 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.742 -1.207 . . . . 2.46 107.742 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 5.1 ttpp -47.09 -55.89 7.54 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.327 -0.851 . . . . 2.4500000000000002 109.256 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.439 ' CG ' ' NH2' ' A' ' 16' ' ' ARG . 5.8 t70 -52.8 -58.35 7.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 123.683 0.614 . . . . 3.21 110.013 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -50.92 -55.41 17.28 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.545 -0.862 . . . . 2.0099999999999998 111.126 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.15 83.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.411 -0.915 . . . . 1.52 108.68 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.3 tt0 -59.52 -46.37 89.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.252 -0.885 . . . . 1.97 110.086 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -52.54 -57.16 10.82 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.979 -1.089 . . . . 4.96 108.117 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.6 mt -48.49 -43.66 35.18 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 2.3700000000000001 107.601 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.9 t -58.53 -46.25 87.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.192 -1.367 . . . . 1.27 110.58 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.96 41.51 1.07 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.807 -1.553 . . . . 2.2799999999999998 106.807 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 23' ' ' LYS . 2.9 tp10 -128.29 -66.06 0.87 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.709 -2.042 . . . . 3.3900000000000001 106.483 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.448 ' NH2' ' HB2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -122.45 153.46 39.08 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 106.341 -1.725 . . . . 5.0 106.341 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.07 32.3 1.52 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 118.367 -1.333 . . . . 5.5099999999999998 111.933 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -113.64 -23.23 9.85 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.959 -1.497 . . . . 3.21 106.959 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 25' ' ' SER . 28.6 t80 -103.04 118.23 36.36 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.584 -1.189 . . . . 1.3 109.342 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -130.28 142.26 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.381 -1.34 . . . . 5.4299999999999997 107.381 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -117.67 159.86 22.25 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 118.479 -1.288 . . . . 1.3400000000000001 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.61 142.6 37.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.275 0.985 . . . . 4.6100000000000003 109.255 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 35' ' ' TYR . 10.0 t80 -106.34 135.4 47.9 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.542 -2.021 . . . . 2.3599999999999999 105.542 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.97 156.91 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.296 -0.961 . . . . 3.9199999999999999 109.215 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.97 160.1 24.23 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.153 0.501 . . . . 2.7999999999999998 109.796 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 pt -75.79 -32.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.998 -1.081 . . . . 2.7599999999999998 111.439 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -35.87 55.16 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.356 -1.338 . . . . 6.6299999999999999 108.494 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.56 -53.26 18.97 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.307 -0.86 . . . . 2.6800000000000002 109.196 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.35 -46.38 10.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.042 0.839 . . . . 3.7400000000000002 109.942 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.08 52.01 0.58 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 108.948 -1.661 . . . . 1.5700000000000001 108.948 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.82 160.76 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 115.047 -0.577 . . . . 2.5800000000000001 110.885 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -119.68 -170.82 2.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.787 -1.19 . . . . 2.6699999999999999 107.787 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -90.86 -24.17 20.33 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 118.0 -1.48 . . . . 7.4500000000000002 109.339 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 3.0 mp0 -72.87 -47.56 44.97 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.126 -1.435 . . . . 3.2200000000000002 107.126 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.528 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 30.3 t70 -57.38 -39.2 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.071 0.939 . . . . 2.7999999999999998 108.619 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.32 -46.03 78.3 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.49 -1.232 . . . . 2.2400000000000002 107.714 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -46.21 -48.98 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.281 -1.377 . . . . 3.77 107.281 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.97 -59.13 5.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.152 -0.931 . . . . 5.5199999999999996 110.62 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 17.3 mtmm -66.83 -5.41 12.21 Favored 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 120.338 -0.545 . . . . 3.2999999999999998 112.457 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.509 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -105.3 -33.51 8.18 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.727 -0.67 . . . . 2.0 111.769 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.96 31.63 2.88 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.712 -1.755 . . . . 3.3900000000000001 108.712 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 50.7 tttm -144.62 121.28 6.28 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.91 -1.144 . . . . 7.7800000000000002 107.91 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -19.8 -131.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 124.472 3.448 . . . . 4.8899999999999997 114.641 -143.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.79 -54.18 7.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 113.862 -1.517 . . . . 6.25 107.719 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 50.23 -160.36 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.772 -0.649 . . . . 8.2200000000000006 112.099 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -139.59 -151.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.494 -0.882 . . . . 4.79 109.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.08 151.72 42.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.001 -0.74 . . . . 2.8500000000000001 109.001 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -93.22 167.25 22.24 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 O-C-N 123.236 1.124 . . . . 2.2999999999999998 111.135 2.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.504 HE22 ' CB ' ' A' ' 52' ' ' ALA . 25.8 mt-30 -116.84 131.12 57.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.181 -1.415 . . . . 3.2999999999999998 107.181 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 94.9 mt -104.73 144.96 13.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 118.989 -1.084 . . . . 2.29 109.943 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -135.69 148.57 48.96 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 113.373 -1.74 . . . . 1.2 108.816 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 66' ' ' GLN . 68.6 t -115.1 92.99 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 104.651 -2.352 . . . . 1.97 104.651 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 1' ' ' MET . 5.3 m-20 66.82 -74.5 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.32 1.013 . . . . 2.5800000000000001 109.656 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 64' ' ' VAL . 63.4 mt-30 -133.8 -15.59 2.35 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.808 -1.087 . . . . 4.1699999999999999 110.999 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -75.34 128.19 34.83 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.425 -0.954 . . . . 5.0999999999999996 108.425 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.509 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 10.9 t-160 -90.36 136.56 32.98 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.081 -1.822 . . . . 1.3100000000000001 106.081 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.473 HD11 ' CD1' ' A' ' 78' ' ' TRP . 16.8 mm -108.5 -50.27 7.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.665 -0.814 . . . . 1.95 109.413 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.412 ' HA3' ' HZ3' ' A' ' 54' ' ' LYS . . . 121.55 -122.76 5.26 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 118.94 -1.6 . . . . 1.53 111.85 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.97 -173.66 39.27 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.085 -1.055 . . . . 1.22 111.67 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 29.6 t80 -60.07 -51.19 70.71 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.758 -0.777 . . . . 2.0099999999999998 111.354 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -43.98 -48.53 8.68 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.736 1.255 . . . . 2.1600000000000001 108.91 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -58.69 -57.49 12.77 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.051 -2.34 . . . . 2.7799999999999998 108.616 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.433 ' HA ' HG22 ' A' ' 69' ' ' ILE . 7.6 t80 -48.7 -54.19 15.84 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.009 -0.996 . . . . 1.28 110.864 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.02 -53.01 56.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.69 -1.226 . . . . 2.0 107.69 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.07 -59.21 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.283 -0.967 . . . . 2.27 109.835 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.473 ' CD1' HD11 ' A' ' 69' ' ' ILE . 62.9 t90 -48.65 -52.87 21.0 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 119.852 -0.739 . . . . 1.79 110.964 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.423 ' CG2' ' CE1' ' A' ' 75' ' ' PHE . 43.0 t -54.49 -43.81 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.779 -1.168 . . . . 2.4199999999999999 109.031 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -78.39 11.1 2.59 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.733 -0.667 . . . . 4.0300000000000002 112.793 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.88 -36.28 2.4 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 120.505 -0.478 . . . . 4.6799999999999997 110.819 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -96.93 -29.52 13.64 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.366 -0.834 . . . . 1.8500000000000001 112.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.1 mt -119.58 26.13 9.58 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.071 -1.052 . . . . 3.0600000000000001 111.586 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.12 41.56 1.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.056 -1.057 . . . . 4.4199999999999999 110.252 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 116.04 -1.933 . . . . 6.5199999999999996 109.172 -179.91 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 122.503 1.144 . . . . 3.8199999999999998 108.356 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -114.6 158.83 21.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.455 -1.313 . . . . 6.0499999999999998 107.455 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 34' ' ' GLN . 5.5 m -107.15 142.14 37.31 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.296 -1.001 . . . . 2.2999999999999998 108.296 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 t -129.04 117.57 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.881 -1.526 . . . . 2.21 106.881 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.4 mp -107.35 131.72 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.913 -1.143 . . . . 2.04 107.913 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.72 108.42 17.86 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 106.506 -1.664 . . . . 2.9700000000000002 106.506 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.8 -171.11 12.75 Favored Glycine 0 N--CA 1.503 3.128 0 C-N-CA 118.832 -1.652 . . . . 1.78 112.514 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.87 147.25 37.39 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 114.611 -0.795 . . . . 5.9299999999999997 108.875 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -53.04 130.54 34.24 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 120.067 -0.653 . . . . 6.5599999999999996 112.389 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 155.26 25.32 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.618 -0.801 . . . . 3.3300000000000001 111.394 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.5 m 74.56 108.51 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.951 1.03 . . . . 4.0899999999999999 111.767 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.61 59.43 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.799 1.666 . . . . 5.71 111.255 162.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -115.18 -69.84 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.254 -0.885 . . . . 5.9500000000000002 108.767 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.424 ' HG ' ' HB3' ' A' ' 60' ' ' PRO . 6.1 m -52.4 -41.69 63.4 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.04 -1.467 . . . . 3.1200000000000001 107.04 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -43.3 -42.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.833 -1.531 . . . . 4.2400000000000002 110.113 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.22 -33.74 1.65 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 123.508 0.505 . . . . 6.1399999999999997 112.225 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HB1' HG12 ' A' ' 5' ' ' ILE . . . -67.5 -44.35 78.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.446 -0.946 . . . . 1.9399999999999999 108.446 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HG3' ' CD1' ' A' ' 33' ' ' TYR . 9.4 ttpp -52.99 -49.58 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.457 -1.683 . . . . 3.23 106.457 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' LEU . 65.7 m-20 -55.85 -60.1 3.93 Favored 'General case' 0 C--O 1.183 -2.414 0 CA-C-N 113.317 -1.765 . . . . 3.9500000000000002 110.305 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' ASP . 31.5 tp -43.8 -61.25 1.49 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.485 -1.286 . . . . 2.21 109.323 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.47 67.27 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.352 -0.84 . . . . 2.1499999999999999 111.277 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.438 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 40.1 tt0 -65.17 -56.07 14.99 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.955 0.883 . . . . 2.02 111.083 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.557 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -50.8 -43.38 58.73 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.448 -1.315 . . . . 4.5300000000000002 107.448 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -66.73 -44.17 82.26 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.289 -1.004 . . . . 2.6400000000000001 108.289 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.505 ' C ' ' H ' ' A' ' 27' ' ' GLU . 28.9 t -50.07 -48.75 52.89 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.906 -1.043 . . . . 2.0899999999999999 108.699 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.459 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 11.6 t30 -83.72 38.64 0.64 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.878 1.323 . . . . 2.98 108.782 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 tt0 -137.61 -50.3 0.61 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 113.164 -1.835 . . . . 3.1600000000000001 109.117 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -104.03 -32.71 9.08 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.05 -0.977 . . . . 4.4100000000000001 111.371 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 78.49 8.62 2.15 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.193 0.933 . . . . 4.7599999999999998 111.026 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.51 7.58 17.51 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.496 -0.882 . . . . 3.9300000000000002 112.443 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -124.54 142.37 51.39 Favored 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 119.717 -0.793 . . . . 2.8500000000000001 110.798 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -126.49 170.98 11.45 Favored 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 120.428 -0.509 . . . . 5.5700000000000003 111.109 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.489 ' HA ' ' H ' ' A' ' 3' ' ' THR . 18.7 p90 -142.84 169.33 17.77 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.726 0.774 . . . . 2.4199999999999999 112.694 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 3' ' ' THR . 43.7 mm-40 -148.31 128.31 13.59 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 113.829 -1.532 . . . . 4.7999999999999998 108.085 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -113.63 111.2 21.46 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.083 -1.451 . . . . 1.8400000000000001 107.083 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.8 157.77 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.935 -0.706 . . . . 2.8199999999999998 110.167 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.28 139.08 43.5 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 105.049 -2.204 . . . . 2.96 105.049 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.4 pt -50.19 -33.47 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.935 -1.106 . . . . 2.25 113.666 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -50.08 25.89 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 117.67 -1.612 . . . . 7.7199999999999998 110.379 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -31.08 -52.67 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.256 0.973 . . . . 2.3399999999999999 111.672 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.23 -43.13 18.01 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.62 1.2 . . . . 4.3499999999999996 111.069 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.72 51.56 0.45 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.432 -2.267 . . . . 1.73 107.432 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 75.6 mt -108.16 141.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.562 -0.819 . . . . 3.0899999999999999 110.626 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.3 p -117.08 -89.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.855 -1.165 . . . . 3.8100000000000001 107.855 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.538 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 33.5 tttp -140.87 -48.07 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.37 -0.974 . . . . 4.9500000000000002 108.37 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 10.3 mp0 -47.9 -55.64 9.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.02 0.825 . . . . 2.8599999999999999 109.711 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 10.3 t70 -53.08 -60.86 2.76 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.559 -0.746 . . . . 2.71 109.533 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.58 -38.44 59.98 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.348 -0.941 . . . . 2.71 110.045 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.521 ' CD ' ' HZ3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -55.96 -53.33 58.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.209 -1.404 . . . . 5.5700000000000003 107.209 178.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.07 -47.98 79.68 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.25 -1.795 . . . . 5.0300000000000002 110.476 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 31.6 mmtp -56.66 -50.5 71.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.377 -0.829 . . . . 3.7400000000000002 110.182 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -53.74 46.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.152 -0.931 . . . . 2.1899999999999999 111.676 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.19 -15.59 43.08 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.519 -1.432 . . . . 2.5600000000000001 109.519 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.8 pttp -123.96 -178.91 0.72 Allowed Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.955 -0.698 . . . . 6.8899999999999997 110.133 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 49.2 Cg_exo -56.6 142.56 90.49 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.235 1.29 . . . . 5.1100000000000003 112.077 165.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -153.84 102.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 5.7400000000000002 107.025 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.538 ' CD ' ' HZ2' ' A' ' 45' ' ' LYS . 15.6 mm-40 -111.77 -15.78 13.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.703 -0.799 . . . . 7.1200000000000001 110.705 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -121.69 172.29 8.24 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.979 -0.688 . . . . 4.8200000000000003 110.265 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.22 169.38 7.14 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 109.278 -0.638 . . . . 3.6200000000000001 109.278 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HB3' ' HG ' ' A' ' 14' ' ' CYS . 49.1 Cg_endo -99.97 176.6 6.73 Favored 'Cis proline' 0 N--CA 1.488 1.192 0 O-C-N 122.815 0.903 . . . . 2.3399999999999999 110.544 -8.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 99.5 mm-40 -125.35 140.78 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.075 -1.05 . . . . 4.3300000000000001 108.693 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -126.7 145.17 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.874 -0.73 . . . . 2.21 110.444 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.08 162.51 31.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.538 -1.21 . . . . 1.6499999999999999 109.461 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG12 ' CH2' ' A' ' 78' ' ' TRP . 49.6 t -141.45 119.19 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 124.526 1.141 . . . . 2.1299999999999999 108.979 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 50.81 -102.73 0.12 Allowed 'General case' 0 N--CA 1.514 2.742 0 CA-C-N 119.774 1.17 . . . . 2.3500000000000001 111.008 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -123.82 31.88 5.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.618 -1.174 . . . . 5.1500000000000004 109.43 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -122.59 164.49 18.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.568 -0.742 . . . . 5.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -122.54 125.6 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.155 -1.054 . . . . 1.54 108.155 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.65 -54.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.951 -1.5 . . . . 2.5699999999999998 106.951 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 112.23 -99.23 1.04 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.471 -1.347 . . . . 1.52 110.572 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.56 163.63 13.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.414 -1.374 . . . . 1.24 110.707 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.41 -54.29 33.99 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.074 -0.65 . . . . 2.3799999999999999 111.759 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -34.58 -64.69 0.24 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.663 0.986 . . . . 2.4199999999999999 113.663 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.94 -38.0 75.15 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.925 -0.71 . . . . 4.54 111.649 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -43.49 -41.54 4.44 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.794 -0.817 . . . . 1.7 108.794 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.96 -52.03 64.3 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.497 -0.774 . . . . 2.5600000000000001 110.773 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 80' ' ' LYS . . . -67.22 -53.8 26.83 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.342 -0.844 . . . . 2.5499999999999998 109.172 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.52 ' CH2' HG12 ' A' ' 64' ' ' VAL . 84.3 t90 -42.23 -55.54 3.26 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.16 -1.052 . . . . 1.25 108.16 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -46.04 -50.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 114.984 -1.007 . . . . 2.2400000000000002 109.94 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' NZ ' ' C ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -42.56 -57.45 2.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 124.568 1.168 . . . . 4.6500000000000004 113.295 -178.184 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -106.01 25.43 10.95 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.351 -1.34 . . . . 3.6099999999999999 112.365 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -119.33 -36.43 3.37 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.947 -1.131 . . . . 2.27 107.947 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.44 11.45 17.2 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.238 -1.764 . . . . 2.6200000000000001 106.238 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 p30 31.58 70.22 0.09 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 125.338 1.649 . . . . 7.9900000000000002 112.484 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.484 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-N 113.675 -1.602 . . . . 6.7000000000000002 110.138 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.5 mpp? . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.19 -1.041 . . . . 3.6299999999999999 108.19 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 65' ' ' ASP . 49.7 mt-30 -100.24 102.72 14.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.516 -0.92 . . . . 5.3899999999999997 108.516 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.4 m -84.32 100.27 11.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.264 -1.754 . . . . 2.25 106.264 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.32 127.44 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.313 -1.312 . . . . 2.02 110.206 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mm -96.38 119.16 44.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 104.568 -2.382 . . . . 2.5800000000000001 104.568 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.477 ' CE1' HG13 ' A' ' 36' ' ' VAL . 2.4 m-85 -104.71 109.29 21.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.318 -1.364 . . . . 1.99 107.318 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.61 118.9 0.46 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 116.208 -2.901 . . . . 2.2799999999999998 112.708 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.41 ' HB3' ' OD1' ' A' ' 37' ' ' ASP . 4.8 ptm180 -86.11 55.74 3.67 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.413 -1.393 . . . . 5.7800000000000002 111.902 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.0 p -90.47 -54.05 4.17 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 117.434 -1.706 . . . . 6.9500000000000002 109.144 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.68 -52.73 4.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 106.4 -2.68 . . . . 4.0599999999999996 106.4 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' TYR . 8.3 m -78.05 156.78 79.31 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.758 -1.571 . . . . 4.9500000000000002 106.758 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.85 64.26 0.15 Allowed 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 123.55 2.834 . . . . 3.5099999999999998 115.135 -147.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' CYS . 21.2 m-30 -121.69 -70.24 0.79 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.029 -1.841 . . . . 5.7999999999999998 106.029 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.3 m -65.06 -32.46 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.337 -1.745 . . . . 2.71 106.613 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.4 t -44.13 -45.08 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 114.895 -1.048 . . . . 2.3999999999999999 109.907 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.525 HH12 ' CG ' ' A' ' 19' ' ' ASP . 2.5 tpt180 -68.91 -47.09 66.65 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.852 -0.739 . . . . 4.9500000000000002 110.239 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.67 -46.31 70.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.121 -1.437 . . . . 1.6499999999999999 107.121 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HZ3' ' CD ' ' A' ' 22' ' ' GLU . 1.1 tmtt? -54.14 -60.53 3.21 Favored 'General case' 0 C--O 1.203 -1.37 0 CA-C-N 114.824 -1.08 . . . . 3.1299999999999999 108.402 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.525 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.5 t70 -48.53 -54.64 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.817 -0.753 . . . . 2.77 110.442 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.9 tp -54.85 -57.18 12.61 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.308 -0.957 . . . . 2.8399999999999999 109.954 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.24 -42.95 52.75 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.949 -1.023 . . . . 1.46 109.906 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.459 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 36.6 tt0 -65.62 -51.74 57.33 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.544 -0.753 . . . . 2.1600000000000001 109.07 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 23.6 ttpp -44.55 -54.21 6.28 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.457 -1.312 . . . . 6.46 107.457 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 50.9 mt -60.67 -36.38 78.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.58 1.175 . . . . 2.2999999999999998 109.707 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -59.32 -28.46 66.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.057 -0.974 . . . . 1.23 109.532 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -89.19 29.37 1.08 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.548 0.689 . . . . 3.5499999999999998 109.149 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.493 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 73.3 mt-10 -135.07 -65.96 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.184 -1.006 . . . . 3.29 112.621 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -104.42 149.38 25.46 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.976 -1.09 . . . . 5.6200000000000001 108.585 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -53.26 57.44 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.852 1.797 . . . . 4.0999999999999996 115.852 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 1' ' ' MET . 50.6 t0 -84.45 44.82 1.07 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.657 -1.617 . . . . 5.8399999999999999 111.683 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.517 ' CD1' HD12 ' A' ' 83' ' ' LEU . 16.2 t80 -126.04 84.63 2.29 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 105.997 -1.853 . . . . 1.4399999999999999 105.997 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -109.51 143.75 38.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.866 -1.531 . . . . 4.6900000000000004 106.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -123.56 157.49 33.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.143 -1.423 . . . . 1.26 110.371 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -145.33 150.12 36.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.788 -1.097 . . . . 4.4400000000000004 108.62 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -110.77 127.15 55.25 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.198 -1.038 . . . . 3.1800000000000002 108.198 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 6' ' ' PHE . 2.3 p -131.02 151.33 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 118.819 -1.153 . . . . 3.6499999999999999 109.826 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.41 ' OD1' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -113.66 135.4 53.97 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.345 -1.354 . . . . 3.0 107.345 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 37.7 pt -61.29 -27.18 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.631 -1.228 . . . . 3.2000000000000002 110.586 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -74.38 -24.87 59.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.894 -1.122 . . . . 7.0199999999999996 110.996 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.1 -40.4 15.74 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 2.25 110.124 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -77.36 -40.6 43.37 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.403 -1.272 . . . . 4.25 111.362 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.63 51.02 0.72 Allowed Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.188 -1.482 . . . . 2.3900000000000001 110.038 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 8.2 mt -112.32 135.2 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.456 -0.898 . . . . 3.6099999999999999 109.304 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 47.1 p -106.8 173.76 6.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.242 -0.583 . . . . 2.6800000000000002 110.014 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 46' ' ' GLU . 8.0 tttm -52.52 -51.58 58.86 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.219 -1.4 . . . . 5.9000000000000004 107.219 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.6 -60.66 3.12 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.77 -1.559 . . . . 3.77 110.45 178.015 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.487 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 33.3 t70 -51.92 -41.86 62.33 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.392 -0.923 . . . . 2.0800000000000001 111.305 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HG ' HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -59.63 -57.91 10.9 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.577 -0.849 . . . . 3.2799999999999998 109.356 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 33.8 tt0 -44.36 -52.3 7.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.962 -1.125 . . . . 3.79 107.962 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.58 -45.26 85.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.796 -1.093 . . . . 4.8700000000000001 111.404 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.487 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -50.51 -40.24 50.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.703 1.252 . . . . 3.77 110.924 -178.126 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HB1' ' CD ' ' A' ' 55' ' ' PRO . . . -90.65 -48.71 6.9 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.732 -1.122 . . . . 2.1499999999999999 109.946 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.23 -68.6 0.53 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 107.373 -2.291 . . . . 3.1400000000000001 107.373 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 51.9 mttp -155.22 56.24 1.35 Allowed Pre-proline 0 N--CA 1.51 2.544 0 N-CA-C 113.252 0.834 . . . . 11.119999999999999 113.252 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.406 ' CD ' ' HB1' ' A' ' 52' ' ' ALA . 91.3 Cg_endo -98.66 42.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 121.758 1.639 . . . . 7.5999999999999996 110.129 152.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t 36.48 -118.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.255 -1.338 . . . . 6.8099999999999996 110.707 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -120.03 39.41 3.69 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.742 -0.383 . . . . 8.0800000000000001 110.83 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.7 p -88.12 149.84 23.69 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.326 -1.349 . . . . 5.7000000000000002 111.417 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.08 165.57 17.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 CA-C-N 115.075 -0.966 . . . . 4.1600000000000001 108.757 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -78.81 171.96 63.17 Favored 'Cis proline' 0 N--CA 1.485 0.978 0 C-N-CA 123.636 -1.402 . . . . 2.6600000000000001 110.354 -5.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -136.63 157.75 46.05 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.941 -1.103 . . . . 3.0699999999999998 109.944 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.4 mm -114.09 139.76 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 120.303 -0.559 . . . . 2.73 110.527 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.6 145.71 48.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.726 0.641 . . . . 1.3999999999999999 109.781 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.424 HG12 ' CZ2' ' A' ' 78' ' ' TRP . 72.2 t -124.57 95.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.761 -0.776 . . . . 1.99 109.951 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HA ' ' HB2' ' A' ' 2' ' ' GLN . 0.6 OUTLIER 65.21 -74.41 0.05 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.639 -1.619 . . . . 3.27 110.942 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -133.84 -7.34 2.77 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.232 -0.895 . . . . 5.0 112.294 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -104.82 165.09 11.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.955 -0.698 . . . . 4.8600000000000003 110.556 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -105.96 143.79 33.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.191 -1.781 . . . . 1.26 106.191 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 78' ' ' TRP . 23.4 mm -106.0 -37.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.621 -1.231 . . . . 2.1200000000000001 109.65 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -132.86 7.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.09 -2.004 . . . . 1.2 108.09 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.66 -164.25 24.3 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.527 -1.429 . . . . 1.3400000000000001 109.527 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 16' ' ' ARG . 44.0 t80 -61.34 -49.17 78.05 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.027 -1.069 . . . . 2.0499999999999998 111.408 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.39 -52.38 13.07 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 2.3599999999999999 109.991 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.23 -53.64 54.28 Favored 'General case' 0 C--O 1.197 -1.695 0 CA-C-N 113.461 -1.7 . . . . 2.1200000000000001 109.045 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -48.45 -48.45 37.57 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.821 -0.627 . . . . 1.24 110.74 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.36 69.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.18 -1.008 . . . . 1.6599999999999999 108.485 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.4 -62.67 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.919 -1.112 . . . . 2.04 110.126 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.509 ' CD1' HD11 ' A' ' 69' ' ' ILE . 67.2 t90 -42.69 -51.42 5.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.698 -0.853 . . . . 1.0600000000000001 108.698 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.6 t -53.65 -59.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.906 -1.043 . . . . 1.8300000000000001 109.482 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -54.35 -16.73 2.38 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.252 -0.886 . . . . 4.3300000000000001 113.226 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -107.54 -44.61 4.24 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.29 -0.964 . . . . 3.6699999999999999 113.384 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -82.7 -25.16 33.22 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.846 -0.741 . . . . 1.5 110.104 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.517 HD12 ' CD1' ' A' ' 31' ' ' PHE . 2.6 mm? -109.08 -41.36 4.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.255 -0.646 . . . . 3.2400000000000002 109.255 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.78 80.7 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.862 -1.517 . . . . 4.0199999999999996 108.652 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-N 112.118 -2.31 . . . . 8.9000000000000004 110.367 -179.456 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 107.851 -1.166 . . . . 3.6200000000000001 107.851 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -115.81 110.27 18.82 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.32 -0.552 . . . . 5.4100000000000001 110.567 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.5 m -96.5 150.0 21.11 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.861 -0.736 . . . . 1.98 110.611 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.417 ' C ' HD13 ' A' ' 5' ' ' ILE . 17.2 t -133.77 139.44 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 115.791 -0.641 . . . . 2.0 110.788 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 1.2 mp -113.73 126.48 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.127 -1.805 . . . . 2.0699999999999998 106.127 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 63' ' ' PHE . 22.7 m-85 -108.83 109.3 20.38 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.698 -1.223 . . . . 2.25 107.698 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.556 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -134.02 -169.31 12.02 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.788 -1.672 . . . . 1.7 112.134 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.0 tmm_? -102.03 64.24 0.94 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.891 -1.522 . . . . 6.8499999999999996 106.891 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.417 ' OG ' ' NH2' ' A' ' 39' ' ' ARG . 4.5 m 58.31 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.495 -1.229 . . . . 5.75 111.152 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -123.1 84.27 0.37 Allowed Glycine 0 N--CA 1.499 2.88 0 N-CA-C 110.53 -1.028 . . . . 3.6699999999999999 110.53 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' TYR . 41.3 t -128.93 109.98 18.44 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.455 -0.572 . . . . 5.5899999999999999 109.455 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -40.55 -27.57 0.28 Allowed 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 124.534 3.489 . . . . 4.5700000000000003 115.817 -153.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' CYS . 98.9 m-85 -72.5 -37.4 68.4 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.241 -0.984 . . . . 4.7999999999999998 110.701 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.556 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.2 m -61.01 -39.91 91.53 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.401 -1.703 . . . . 2.3999999999999999 106.401 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.69 -38.46 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.287 -0.965 . . . . 2.0800000000000001 109.078 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.512 HH12 ' CG ' ' A' ' 19' ' ' ASP . 9.6 mmm180 -76.81 -51.01 12.13 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.683 -0.689 . . . . 4.8499999999999996 110.978 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.32 -42.78 64.11 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.738 -1.579 . . . . 1.54 106.738 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -58.32 -57.87 11.01 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 113.66 -1.609 . . . . 2.8599999999999999 107.731 178.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.512 ' CG ' HH12 ' A' ' 16' ' ' ARG . 2.2 t70 -51.56 -57.27 9.58 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.428 -1.309 . . . . 3.1299999999999999 109.986 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.1 tp -47.16 -50.71 19.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.131 -0.692 . . . . 2.1499999999999999 109.131 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.488 ' HB3' ' CB ' ' A' ' 33' ' ' TYR . . . -60.1 -45.43 92.99 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.612 -0.835 . . . . 1.7 110.496 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 25' ' ' SER . 18.0 tt0 -65.04 -49.8 68.72 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.464 0.65 . . . . 2.3100000000000001 110.767 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -56.95 -51.85 67.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.063 -1.458 . . . . 5.2699999999999996 107.063 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.4 mt -52.02 -51.35 57.97 Favored 'General case' 0 C--O 1.199 -1.566 0 N-CA-C 106.441 -1.689 . . . . 2.23 106.441 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 4.6 t -43.32 -24.53 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.57 -0.741 . . . . 1.3700000000000001 112.037 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.07 -39.5 8.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.214 0.321 . . . . 2.6800000000000002 111.005 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.54 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 28.2 mt-10 -72.96 -26.74 61.47 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.327 0.584 . . . . 3.3100000000000001 110.657 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HE ' ' C ' ' A' ' 85' ' ' ALA . 2.1 mmp_? -101.44 175.05 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.352 -0.84 . . . . 5.4000000000000004 110.888 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -107.74 -41.09 5.1 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 115.225 -0.898 . . . . 5.5599999999999996 110.511 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 30' ' ' ASP . 8.3 t70 -109.63 53.46 0.69 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 122.438 1.113 . . . . 4.9900000000000002 109.283 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -131.71 110.42 10.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.256 -0.978 . . . . 1.3999999999999999 110.055 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -124.27 152.37 43.1 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.988 -1.856 . . . . 4.3200000000000003 105.988 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.488 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 7.1 p90 -140.46 154.57 46.68 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 117.884 -1.527 . . . . 1.1599999999999999 111.153 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.51 154.72 47.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.692 -1.225 . . . . 5.0300000000000002 107.692 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.61 139.73 49.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.926 -1.509 . . . . 2.1099999999999999 106.926 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.32 139.03 51.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 124.24 0.963 . . . . 3.1800000000000002 109.955 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -105.95 116.68 32.35 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.694 -1.595 . . . . 2.5299999999999998 106.694 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.8 pt -54.88 -20.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 118.788 -1.165 . . . . 2.3100000000000001 111.299 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.417 ' NH2' ' OG ' ' A' ' 9' ' ' SER . 40.6 ttp-105 -86.13 -61.44 1.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.561 -0.855 . . . . 8.25 109.285 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.18 -43.48 0.22 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.093 0.871 . . . . 1.9299999999999999 111.514 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -94.0 -44.75 7.9 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.582 -0.847 . . . . 3.1099999999999999 112.04 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.51 54.31 0.65 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.212 -1.555 . . . . 1.98 109.212 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.91 127.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 107.497 -1.297 . . . . 2.3700000000000001 107.497 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 p -119.85 166.22 13.57 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.197 -1.001 . . . . 3.96 110.697 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' H ' ' CD ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -41.69 -45.9 3.59 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.379 -0.828 . . . . 6.2599999999999998 110.885 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 19.9 mp0 -60.51 -55.24 35.76 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.071 -0.651 . . . . 4.1900000000000004 110.239 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.483 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 25.0 t70 -60.32 -39.86 88.53 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.598 -0.841 . . . . 2.9199999999999999 110.689 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.08 -48.73 78.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.124 -0.944 . . . . 2.5499999999999998 109.128 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.76 -59.96 2.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.205 -0.907 . . . . 4.6699999999999999 108.709 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -46.64 -40.84 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 125.029 1.456 . . . . 5.4199999999999999 112.341 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.483 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 25.1 mtmm -94.46 -4.24 48.57 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.578 -1.192 . . . . 3.5899999999999999 114.101 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.582 ' CB ' HE22 ' A' ' 61' ' ' GLN . . . -113.49 -38.37 4.37 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.799 -0.76 . . . . 2.1899999999999999 112.724 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.46 43.98 66.69 Favored Glycine 0 N--CA 1.491 2.365 0 O-C-N 124.395 1.059 . . . . 3.3599999999999999 113.151 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HD2' ' CE1' ' A' ' 68' ' ' HIS . 59.5 mttm -138.53 180.0 1.18 Allowed Pre-proline 0 N--CA 1.504 2.256 0 C-N-CA 119.296 -0.962 . . . . 8.2400000000000002 110.345 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -33.46 82.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.111 2.54 . . . . 6.5700000000000003 112.37 127.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 57' ' ' GLU . 27.6 m -101.66 -42.99 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 115.791 -0.64 . . . . 6.0700000000000003 112.34 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.426 ' N ' HG22 ' A' ' 56' ' ' VAL . 2.4 tt0 61.37 -108.39 0.32 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.651 -0.87 . . . . 7.0499999999999998 108.651 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.5 p -129.92 -86.51 0.53 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.623 -1.231 . . . . 5.3099999999999996 111.143 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 m -137.98 164.66 39.23 Favored Pre-proline 0 C--N 1.291 -1.966 0 N-CA-C 109.771 -0.455 . . . . 2.54 109.771 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HB3' ' HG ' ' A' ' 14' ' ' CYS . 12.2 Cg_endo -94.36 148.08 10.18 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 124.594 -1.002 . . . . 1.97 110.314 -9.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.582 HE22 ' CB ' ' A' ' 52' ' ' ALA . 33.4 mt-30 -111.23 142.78 42.98 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.984 -1.086 . . . . 3.5499999999999998 108.282 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.506 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.1 mp -113.44 142.31 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.987 0.898 . . . . 3.04 110.02 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 6' ' ' PHE . 20.0 m-85 -121.21 136.3 55.0 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.354 -2.091 . . . . 1.7 105.354 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.607 HG12 ' CH2' ' A' ' 78' ' ' TRP . 5.8 t -115.05 106.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.817 -0.753 . . . . 2.2000000000000002 109.114 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 66.91 -72.6 0.08 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.581 -0.736 . . . . 2.5 111.982 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -136.74 -11.02 1.81 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 113.704 1.002 . . . . 4.8499999999999996 113.704 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -117.01 161.6 19.13 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.749 -1.18 . . . . 7.4900000000000002 114.003 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.511 ' CE1' HE21 ' A' ' 61' ' ' GLN . 10.0 t-160 -90.06 133.67 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.725 -1.213 . . . . 1.27 107.725 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.53 -39.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.541 -0.863 . . . . 1.9199999999999999 110.235 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.82 -142.27 13.69 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.177 -1.569 . . . . 1.1699999999999999 109.177 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.85 173.65 41.8 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.389 -1.484 . . . . 1.22 109.389 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 23.7 t80 -42.87 -45.99 5.13 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.301 -0.96 . . . . 2.3900000000000001 111.209 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.4 -58.12 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.797 0.808 . . . . 2.3100000000000001 110.054 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.2 -39.84 80.01 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.148 -1.387 . . . . 2.0699999999999998 109.581 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.66 -56.83 17.16 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.897 -1.121 . . . . 1.8100000000000001 109.384 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.26 -56.01 19.99 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.83 -0.748 . . . . 1.96 110.284 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.59 -54.5 43.34 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.432 -0.907 . . . . 2.1099999999999999 109.43 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.607 ' CH2' HG12 ' A' ' 64' ' ' VAL . 89.3 t90 -46.74 -55.5 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.836 -0.746 . . . . 1.3799999999999999 110.457 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.5 t -47.94 -55.5 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.847 -1.07 . . . . 1.72 111.218 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HZ3' ' CG ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -43.72 -46.86 7.73 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.615 0.968 . . . . 3.1000000000000001 113.615 -177.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -103.96 34.42 3.03 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 118.956 -1.097 . . . . 4.4000000000000004 112.512 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -141.05 -49.03 0.42 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.929 -0.767 . . . . 1.51 108.929 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 85' ' ' ALA . 29.8 mt -112.71 46.15 1.24 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.964 -1.017 . . . . 2.5299999999999998 109.434 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.446 ' CG ' ' HZ3' ' A' ' 80' ' ' LYS . 3.8 t0 -83.4 50.06 1.69 Allowed 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.092 -1.448 . . . . 3.7000000000000002 107.092 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.481 ' C ' ' HE ' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 115.996 -1.954 . . . . 5.1500000000000004 107.34 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 108.285 -1.006 . . . . 2.99 108.285 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -106.76 102.78 12.13 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.744 0.783 . . . . 4.59 111.761 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.3 m -94.22 129.77 40.71 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.348 -1.353 . . . . 0.92 107.348 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 43.3 t -119.67 134.71 62.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.034 -1.066 . . . . 1.05 110.318 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -107.55 121.51 60.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.789 -2.3 . . . . 1.23 104.789 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -114.99 91.13 3.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 102.977 -2.972 . . . . 1.84 102.977 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -128.05 -167.34 12.23 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 118.535 -1.793 . . . . 1.29 114.375 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.96 95.2 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.838 -1.181 . . . . 5.01 110.717 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.409 ' OG ' ' NH1' ' A' ' 8' ' ' ARG . 2.9 p -53.36 144.27 16.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.94 -1.133 . . . . 4.93 107.94 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.9 -36.0 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.082 -2.407 . . . . 2.74 107.082 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -97.78 133.71 23.13 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.205 -1.035 . . . . 4.31 108.205 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.77 51.27 0.89 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.455 2.103 . . . . 2.96 111.488 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.89 -64.33 1.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.048 -1.093 . . . . 4.33 108.048 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -54.98 -29.91 58.04 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 115.149 -0.932 . . . . 2.1 108.902 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.1 t -42.79 -44.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.367 -1.288 . . . . 1.38 109.914 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 4.4 mmp_? -63.44 -52.03 63.21 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.087 -1.045 . . . . 2.89 111.008 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' CB ' HD11 ' A' ' 62' ' ' ILE . . . -59.62 -45.06 93.05 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.468 -0.893 . . . . 0.99 110.572 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 7.3 ttpp -61.25 -52.12 66.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.172 -1.011 . . . . 2.05 108.851 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -53.65 -53.66 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.252 -0.579 . . . . 2.36 109.848 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 79' ' ' VAL . 14.8 tp -55.52 -65.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.344 -0.942 . . . . 1.21 109.038 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.55 -46.47 19.38 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.987 -0.685 . . . . 1.03 110.411 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.482 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 43.8 tt0 -58.77 -54.17 50.08 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.251 1.024 . . . . 2.14 111.38 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -54.49 -50.36 67.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 113.694 -1.594 . . . . 6.82 106.822 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -53.38 -50.81 64.33 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.261 -1.385 . . . . 1.11 107.261 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.501 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 7.6 t -43.78 -24.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.433 -0.803 . . . . 1.33 112.507 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -107.09 -31.29 8.34 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.439 -0.801 . . . . 2.22 110.864 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.52 -36.47 73.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.088 . . . . 3.85 108.061 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -119.03 117.31 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.477 0.656 . . . . 3.67 109.597 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -63.88 3.68 0.36 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.956 1.095 . . . . 3.8 113.956 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 1' ' ' MET . 11.4 p-10 -114.67 7.61 16.02 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.058 -0.719 . . . . 3.09 109.058 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 12.6 t80 -109.35 129.65 55.52 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.866 -0.734 . . . . 1.14 112.855 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -129.56 150.85 50.71 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.627 -1.62 . . . . 3.58 106.627 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 8.4 p90 -133.89 160.06 38.8 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.316 -1.354 . . . . 1.17 110.821 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -134.07 135.38 43.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.73 0.644 . . . . 4.39 110.342 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -108.08 109.84 21.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.003 -1.851 . . . . 1.75 106.003 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.24 141.4 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.379 -1.711 . . . . 1.55 106.379 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 9.0 t70 -110.17 155.05 22.47 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.074 -1.05 . . . . 2.78 110.844 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 pt -84.16 -34.87 10.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 117.993 -1.483 . . . . 1.46 112.435 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.508 ' HE ' ' N ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -98.24 -58.01 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.321 -1.752 . . . . 5.14 108.845 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -39.09 -39.91 0.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 124.198 0.936 . . . . 3.18 111.255 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.48 -36.38 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.071 -1.451 . . . . 4.64 110.862 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.23 69.77 0.61 Allowed Glycine 0 N--CA 1.5 2.948 0 C-N-CA 118.448 -1.834 . . . . 2.55 113.128 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 mm -115.04 157.18 15.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.148 -1.797 . . . . 2.43 106.148 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.7 p -107.39 137.14 45.98 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.69 -1.204 . . . . 3.0 110.454 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -55.04 -31.39 61.06 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.716 -1.216 . . . . 3.79 107.716 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 7.1 mp0 -59.42 -64.94 0.76 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.209 -0.663 . . . . 3.46 109.209 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 4.6 t70 -48.1 -49.45 31.82 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.069 0.938 . . . . 2.97 111.185 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.2 mt -61.8 -54.46 42.03 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.606 -1.179 . . . . 2.37 109.295 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -44.44 -46.12 9.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.837 -1.171 . . . . 3.61 107.837 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 8.5 tm0? -60.13 -58.89 6.58 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.781 -1.554 . . . . 4.31 110.974 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -17.89 63.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.141 1.534 . . . . 2.93 115.141 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.68 -38.28 13.19 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.736 -0.786 . . . . 1.36 111.143 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.481 ' C ' ' HG3' ' A' ' 54' ' ' LYS . . . 112.94 57.82 0.42 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.274 -1.93 . . . . 2.81 108.274 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HG3' ' C ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 37.2 76.03 0.49 Allowed Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 124.954 1.032 . . . . 6.94 111.651 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 1.8 Cg_endo -90.35 33.79 0.33 Allowed 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 122.821 2.348 . . . . 6.61 111.103 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.421 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.4 t 32.06 -102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 113.685 -1.598 . . . . 6.47 113.826 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 7.6 tp10 -125.04 46.11 2.41 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.579 -0.448 . . . . 8.01 110.216 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.0 p -119.44 124.36 46.32 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.285 1.217 . . . . 5.11 114.285 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 33.1 m -132.93 166.11 31.69 Favored Pre-proline 0 N--CA 1.504 2.238 0 N-CA-C 107.27 -1.381 . . . . 2.34 107.27 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 50.9 Cg_endo -79.61 170.72 66.53 Favored 'Cis proline' 0 N--CA 1.491 1.35 0 O-C-N 122.19 0.574 . . . . 1.65 110.886 -7.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.54 150.57 50.13 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.786 -0.766 . . . . 2.38 111.109 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.427 HD11 ' CB ' ' A' ' 17' ' ' ALA . 36.9 mm -119.69 141.45 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.039 -0.982 . . . . 1.88 110.295 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.406 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 23.7 m-85 -120.69 153.85 36.36 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.69 -1.141 . . . . 1.38 109.162 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 66' ' ' GLN . 85.9 t -129.83 100.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.06 -1.459 . . . . 1.0 107.06 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 1' ' ' MET . 23.8 m-20 54.93 -79.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 124.409 1.068 . . . . 2.58 112.721 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 64' ' ' VAL . 1.4 tm0? -120.53 -24.78 5.72 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.518 -1.219 . . . . 6.16 112.666 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -95.18 155.18 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.355 -0.938 . . . . 4.3 111.705 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -102.36 140.03 37.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 105.341 -2.096 . . . . 0.93 105.341 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.52 -42.3 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 118.11 -1.436 . . . . 0.92 110.793 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.0 -129.51 5.14 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.463 -1.455 . . . . 1.12 109.463 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.4 178.65 25.43 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.679 -1.248 . . . . 1.29 110.424 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 45.7 t80 -45.45 -36.03 4.15 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.311 -0.956 . . . . 1.63 111.422 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -58.94 -62.06 2.17 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.602 -0.839 . . . . 1.7 109.426 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.26 -39.99 64.3 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.895 -1.048 . . . . 2.21 109.109 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.82 -56.37 22.02 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.199 -1.0 . . . . 1.2 109.683 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.0 -51.12 64.95 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.86 -0.736 . . . . 0.84 110.054 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -53.81 54.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.833 -0.747 . . . . 0.8 109.465 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -48.05 -53.29 16.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.44 -0.948 . . . . 0.88 108.44 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 20' ' ' LEU . 25.2 t -50.9 -61.18 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 114.648 -1.16 . . . . 0.84 109.185 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.48 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.14 -51.94 7.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.739 0.649 . . . . 2.04 112.581 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.85 16.28 7.12 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.664 -1.214 . . . . 4.73 113.845 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -128.28 -43.98 1.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.61 -0.836 . . . . 2.15 110.393 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.07 36.51 2.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.867 -0.733 . . . . 2.41 110.722 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.48 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 2.3 t70 . . . . . 0 C--N 1.292 -1.922 0 N-CA-C 106.181 -1.785 . . . . 4.17 106.181 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.66 -0.867 . . . . 2.36 108.66 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -84.89 111.57 19.78 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.262 0.977 . . . . 4.74 109.583 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.9 m -104.12 123.39 47.18 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 0.88 109.208 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.406 ' C ' HD12 ' A' ' 5' ' ' ILE . 40.2 t -116.13 130.89 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.347 -0.941 . . . . 1.02 109.928 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -106.12 131.9 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.974 -1.862 . . . . 1.16 105.974 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -117.42 108.57 15.72 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 105.563 -2.014 . . . . 1.46 105.563 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.64 -160.07 8.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.505 -1.331 . . . . 1.47 110.381 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -113.62 -162.04 0.79 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.222 -0.991 . . . . 4.66 108.732 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -128.89 154.54 46.4 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.49 -1.232 . . . . 5.11 109.452 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 -44.83 1.37 Allowed Glycine 0 N--CA 1.5 2.908 0 C-N-CA 119.386 -1.388 . . . . 3.1 114.229 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.5 m -106.33 146.89 33.89 Favored Pre-proline 0 N--CA 1.498 1.936 0 C-N-CA 118.694 -1.202 . . . . 3.78 111.944 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.49 65.61 8.2 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.41 2.073 . . . . 3.0 111.276 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -112.92 -73.54 0.66 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.655 -1.239 . . . . 4.97 107.655 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.0 m -53.53 -25.15 15.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.356 -0.979 . . . . 2.09 108.356 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -41.65 -39.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 114.624 -1.171 . . . . 1.39 109.779 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.613 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 1.1 tpm_? -75.83 -50.24 15.71 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.15 -1.02 . . . . 3.5 110.255 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.69 54.17 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.758 -1.177 . . . . 1.03 108.321 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 14.6 ttpp -67.59 -58.38 4.8 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 107.448 -1.315 . . . . 2.11 107.448 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -45.04 -42.93 8.95 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.539 -0.864 . . . . 2.39 109.696 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.9 tp -62.62 -63.73 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.668 -1.151 . . . . 0.95 108.275 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.84 -45.9 15.29 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.444 0.64 . . . . 0.86 109.833 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 26.7 tt0 -64.57 -44.28 91.2 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.6 -1.182 . . . . 2.83 109.583 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -54.7 43.79 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.872 -1.529 . . . . 6.1 106.872 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.27 -45.53 68.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.761 -1.563 . . . . 1.11 107.691 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 32' ' ' GLN . 8.3 t -54.9 -25.82 31.62 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.979 -1.009 . . . . 1.15 111.447 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 1.1 t30 -105.63 9.83 33.13 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.888 -0.782 . . . . 2.08 108.888 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -117.65 -32.73 4.77 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 115.985 -0.552 . . . . 3.26 110.53 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.44 153.59 24.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.819 -0.808 . . . . 4.37 108.819 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.71 -26.59 25.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.865 -0.607 . . . . 4.28 110.565 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.51 13.67 29.14 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.694 -0.802 . . . . 2.74 110.471 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -112.47 124.79 53.29 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.297 1.591 . . . . 1.23 115.297 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.404 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 63.4 mt-30 -143.02 156.54 44.86 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.397 -2.075 . . . . 3.64 105.397 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -142.3 170.9 14.83 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 117.71 -1.596 . . . . 1.39 111.77 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -138.17 145.21 41.24 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.654 -1.612 . . . . 4.14 109.112 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -122.5 122.76 39.7 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.944 -1.873 . . . . 2.05 105.944 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.71 137.41 54.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.651 -1.241 . . . . 1.29 107.651 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.69 129.83 47.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.034 -1.099 . . . . 2.31 108.034 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.51 -28.9 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 119.935 -0.706 . . . . 1.81 111.005 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.606 ' NH1' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -79.79 -40.52 28.49 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.588 -1.264 . . . . 6.78 107.588 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.606 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -39.17 -54.18 1.8 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 120.962 -0.295 . . . . 1.51 110.727 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' GLY . 48.9 mt-10 -110.79 41.42 1.8 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 124.502 1.126 . . . . 4.2 109.95 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 20.1 66.17 0.01 OUTLIER Glycine 0 N--CA 1.508 3.48 0 O-C-N 124.205 0.94 . . . . 2.39 113.31 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 44' ' ' THR . 48.4 mt -93.4 162.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.863 -0.735 . . . . 1.75 109.807 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 43' ' ' ILE . 45.9 p -113.12 178.38 4.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.798 -0.637 . . . . 2.08 109.925 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -73.55 -52.86 12.07 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.607 -1.237 . . . . 6.27 109.864 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.4 mp0 -43.3 -52.67 5.65 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.339 -0.544 . . . . 3.88 110.162 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.583 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 4.1 t70 -51.57 -57.36 9.32 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.06 -0.656 . . . . 2.47 110.3 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mt -53.51 -46.05 69.93 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 115.02 -0.991 . . . . 1.31 110.245 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -47.07 -54.78 9.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.47 -0.937 . . . . 3.64 108.47 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -49.23 -29.85 6.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.215 1.572 . . . . 3.77 111.285 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.583 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 10.8 mptt -82.54 -47.36 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.127 -0.942 . . . . 2.53 112.311 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HB2' ' NE2' ' A' ' 61' ' ' GLN . . . -75.27 -45.96 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.628 1.344 . . . . 1.0 114.628 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.63 -42.65 1.91 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 107.295 -2.322 . . . . 2.4 107.295 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -84.18 169.53 16.64 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 106.696 -1.594 . . . . 7.22 106.696 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.04 163.53 5.9 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.942 -1.215 . . . . 4.16 108.942 161.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -124.0 38.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.93 -1.108 . . . . 5.41 109.762 179.372 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -26.14 -64.06 0.07 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.257 -1.338 . . . . 5.16 111.163 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -116.79 -154.5 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.122 -0.944 . . . . 4.12 109.763 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.44 175.76 3.25 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.068 -1.086 . . . . 1.81 108.068 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.459 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 71.6 Cg_endo -103.6 -170.71 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.112 0 O-C-N 122.406 0.687 . . . . 1.71 111.672 -18.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.548 ' NE2' ' HB2' ' A' ' 52' ' ' ALA . 13.6 mt-30 -141.94 151.79 42.91 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 115.686 -0.688 . . . . 2.63 110.716 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.9 mp -124.79 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 115.527 -0.76 . . . . 1.55 109.286 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 16.8 m-85 -127.27 150.74 49.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.19 -1.368 . . . . 1.01 109.894 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.449 HG23 ' CG1' ' A' ' 69' ' ' ILE . 55.5 t -120.5 125.32 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.055 -1.461 . . . . 0.91 107.055 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 57.41 -94.76 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.775 -1.194 . . . . 4.47 107.775 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -131.99 2.47 3.99 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.389 -0.823 . . . . 3.89 110.938 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.09 167.31 11.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 110.018 -0.364 . . . . 4.27 110.018 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 15.0 t-160 -108.28 139.53 42.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.587 -1.264 . . . . 0.83 107.587 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.449 ' CG1' HG23 ' A' ' 64' ' ' VAL . 26.7 mm -101.73 -42.89 9.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.075 -1.05 . . . . 1.08 108.55 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.52 -132.43 5.45 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.07 -2.012 . . . . 1.34 108.07 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 72' ' ' TYR . . . -114.74 -175.22 18.59 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.054 -1.218 . . . . 1.31 110.054 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.508 ' OH ' ' HG2' ' A' ' 16' ' ' ARG . 1.8 t80 -33.03 -54.42 0.38 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.405 0.622 . . . . 2.19 111.194 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.98 -68.77 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.562 -1.199 . . . . 1.91 110.939 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -51.1 -38.94 54.79 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.696 -1.593 . . . . 2.41 110.846 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 62' ' ' ILE . 37.9 t80 -64.99 -51.71 60.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.833 -1.147 . . . . 0.83 109.903 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.12 76.18 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.185 -1.006 . . . . 0.95 109.6 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.02 -58.99 5.45 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.102 -1.039 . . . . 0.82 109.109 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.418 ' CH2' HG21 ' A' ' 64' ' ' VAL . 90.7 t90 -42.58 -51.01 5.3 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.196 -1.039 . . . . 0.73 108.196 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -52.66 -65.58 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.296 0 N-CA-C 107.857 -1.164 . . . . 0.82 107.857 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -49.25 -29.48 5.84 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.507 1.299 . . . . 2.3 114.507 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -105.82 7.64 32.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.231 0.826 . . . . 4.06 113.231 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -129.05 -35.54 1.83 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.01 -0.676 . . . . 1.56 110.378 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -106.35 26.02 10.37 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.131 -0.628 . . . . 2.02 109.872 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 C--N 1.299 -1.603 0 N-CA-C 108.548 -0.908 . . . . 3.87 108.548 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 30' ' ' ASP . 47.5 mtm . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.531 -0.914 . . . . 2.98 108.531 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.07 155.13 20.72 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 123.833 0.708 . . . . 4.06 109.107 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 2.8 m -143.74 143.7 31.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.021 -1.103 . . . . 1.51 108.021 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.0 t -127.84 126.61 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 119.033 -1.067 . . . . 1.22 112.526 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.8 mp -109.34 130.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.787 -1.19 . . . . 1.27 107.787 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -111.02 111.67 22.94 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 105.006 -2.22 . . . . 1.66 105.006 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.676 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -129.09 -143.82 5.6 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.536 -1.316 . . . . 1.58 112.8 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.32 -167.27 1.83 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 114.404 -0.898 . . . . 5.73 109.969 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m -86.53 64.25 8.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.096 -0.642 . . . . 5.65 111.428 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.63 53.83 1.1 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.504 -1.332 . . . . 3.28 109.78 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' TYR . 49.4 t -107.31 98.03 21.33 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.568 -1.271 . . . . 4.63 107.568 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.43 -20.76 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.264 2.642 . . . . 3.15 113.699 -159.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' CYS . 30.1 m-85 -71.62 -30.92 66.32 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.325 -0.55 . . . . 5.19 112.099 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -83.8 -30.41 26.59 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.7 -1.6 . . . . 1.94 106.811 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -50.05 -49.85 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 115.483 -0.78 . . . . 1.24 109.344 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.604 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 3.9 mmp_? -58.59 -52.47 65.54 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.38 -0.928 . . . . 2.86 111.047 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.92 63.44 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.261 -1.375 . . . . 0.63 107.729 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -49.19 -58.8 4.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 124.42 1.075 . . . . 2.21 109.265 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.74 -52.19 50.45 Favored 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 120.025 -0.67 . . . . 2.63 110.952 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 tp -52.5 -63.86 1.0 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.078 -0.712 . . . . 0.86 109.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.76 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.059 -0.719 . . . . 0.66 109.059 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.2 tt0 -55.36 -42.01 73.34 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.129 -0.941 . . . . 2.63 110.273 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -64.13 -54.63 30.87 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.036 -1.066 . . . . 5.94 108.339 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.524 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 43.1 mt -49.1 -47.55 45.13 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.124 -2.176 . . . . 1.04 105.124 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.19 -47.77 24.03 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.943 -1.026 . . . . 1.1 110.831 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.22 -35.24 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.656 -0.818 . . . . 2.13 112.154 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -72.3 -36.55 68.97 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.084 -0.646 . . . . 4.24 111.323 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.529 HH21 ' CG ' ' A' ' 30' ' ' ASP . 10.9 ptm85 -136.49 113.59 10.56 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.683 -0.807 . . . . 3.65 111.559 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -62.17 12.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 114.572 1.323 . . . . 4.7 114.572 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.529 ' CG ' HH21 ' A' ' 28' ' ' ARG . 10.1 p-10 -111.65 -1.88 15.57 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.066 -0.716 . . . . 3.64 109.066 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 91.4 t80 -109.65 116.81 32.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.637 -0.825 . . . . 1.15 110.352 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -121.73 167.81 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.148 -0.686 . . . . 3.13 109.148 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 30.1 p90 -161.55 168.78 22.96 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.091 -0.644 . . . . 1.7 110.21 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 152.09 41.11 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 109.599 -0.519 . . . . 4.93 109.599 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -118.44 135.7 54.21 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.306 -0.958 . . . . 1.39 109.284 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -127.8 159.33 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.401 -0.963 . . . . 1.36 108.401 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -113.71 129.11 56.62 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.698 -1.964 . . . . 2.53 105.698 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -43.67 -26.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.393 -0.523 . . . . 2.14 111.585 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -73.0 -59.44 2.7 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 120.469 -0.492 . . . . 6.78 109.993 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.32 -47.15 0.4 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.467 1.105 . . . . 1.95 111.202 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.82 -45.68 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.511 -1.222 . . . . 4.27 110.813 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.49 49.45 0.8 Allowed Glycine 0 N--CA 1.505 3.268 0 N-CA-C 109.417 -1.473 . . . . 2.79 109.417 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.472 HG21 ' HG ' ' A' ' 48' ' ' LEU . 15.9 mt -113.19 148.51 16.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.064 -0.568 . . . . 2.84 111.015 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.6 p -118.7 -92.77 0.53 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.01 -1.076 . . . . 5.13 110.113 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.428 ' NZ ' ' OE1' ' A' ' 46' ' ' GLU . 11.4 tttm -138.45 -55.16 0.63 Allowed 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.652 -1.24 . . . . 4.48 107.652 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.8 mm-40 -43.24 -50.43 6.48 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.367 -0.933 . . . . 5.52 110.92 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 51' ' ' LYS . 33.3 t70 -63.31 -54.74 32.34 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.35 -0.94 . . . . 3.24 111.195 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HG ' HG21 ' A' ' 43' ' ' ILE . 6.1 mt -53.52 -43.86 68.69 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.698 -0.801 . . . . 2.56 110.025 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.83 -53.76 54.57 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.495 -1.298 . . . . 4.52 107.495 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -53.11 -58.11 8.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 124.188 0.93 . . . . 4.58 110.367 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 47' ' ' ASP . 48.0 mttp -54.0 -50.23 67.09 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.166 -0.925 . . . . 2.81 111.367 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' CG ' ' A' ' 68' ' ' HIS . . . -54.45 -55.94 23.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.723 -1.581 . . . . 1.57 111.418 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.04 36.44 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.271 -1.532 . . . . 3.12 109.271 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -102.79 161.35 23.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.164 -0.68 . . . . 7.67 109.164 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.32 111.21 3.23 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.784 1.656 . . . . 4.69 111.451 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.402 HG11 ' NE2' ' A' ' 61' ' ' GLN . 15.4 m -131.02 159.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 123.335 0.397 . . . . 6.01 110.082 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -133.65 -43.08 0.83 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 123.511 0.507 . . . . 6.57 111.957 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -114.54 -148.31 0.43 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.651 -0.82 . . . . 4.96 109.696 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.81 173.6 2.9 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 109.576 -0.527 . . . . 2.45 109.576 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.557 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 73.9 Cg_endo -100.03 -177.68 4.0 Favored 'Cis proline' 0 N--CA 1.483 0.874 0 O-C-N 122.348 0.657 . . . . 1.67 111.319 -11.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.402 ' NE2' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -134.46 145.01 48.44 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.445 -0.798 . . . . 2.48 111.025 -179.42 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.566 HG21 ' CD1' ' A' ' 75' ' ' PHE . 4.3 mp -124.77 145.78 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 115.171 -0.922 . . . . 1.65 110.863 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.72 160.99 33.88 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.084 -1.871 . . . . 1.1 108.539 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.478 HG23 ' CG1' ' A' ' 69' ' ' ILE . 60.6 t -112.4 175.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.827 -1.916 . . . . 2.15 105.827 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 64' ' ' VAL . 38.8 t70 -61.35 -8.84 4.31 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.991 -1.084 . . . . 3.71 111.014 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -122.95 -56.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.459 1.281 . . . . 7.51 114.459 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.56 176.02 5.91 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.816 -0.753 . . . . 6.78 112.641 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.526 ' CG ' ' HA ' ' A' ' 52' ' ' ALA . 13.2 t-80 -93.05 154.56 18.04 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.483 -2.043 . . . . 0.94 105.483 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.478 ' CG1' HG23 ' A' ' 64' ' ' VAL . 37.0 mm -115.07 -49.13 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.379 -1.328 . . . . 1.08 111.291 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 145.49 -130.99 4.0 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 1.18 109.708 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.84 -173.39 20.63 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.248 -1.141 . . . . 1.2 110.248 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.91 -52.34 1.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 120.163 -0.615 . . . . 1.97 110.746 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -50.47 -58.76 5.0 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.843 0.83 . . . . 1.85 110.106 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.468 ' HB3' HG22 ' A' ' 69' ' ' ILE . 1.7 m-20 -54.33 -54.31 42.1 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.792 -1.095 . . . . 2.71 110.126 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD1' HG21 ' A' ' 62' ' ' ILE . 25.7 t80 -54.2 -52.34 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.778 -0.769 . . . . 1.09 110.997 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.61 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.625 -0.83 . . . . 1.19 109.014 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.07 -55.85 28.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.376 -0.929 . . . . 1.25 110.021 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -49.71 -51.84 35.7 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.705 -0.798 . . . . 1.15 109.346 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.429 ' CG1' HD11 ' A' ' 24' ' ' LEU . 29.0 t -49.73 -63.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 124.131 0.894 . . . . 1.06 108.706 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -44.63 -48.48 10.47 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.03 -0.986 . . . . 2.15 111.154 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.57 27.55 2.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 117.567 -1.653 . . . . 3.8 113.987 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.68 -41.79 0.28 Allowed 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 119.437 -0.905 . . . . 1.24 112.108 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.413 ' CD1' HD13 ' A' ' 24' ' ' LEU . 18.7 mt -109.98 2.96 20.01 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 120.012 -0.675 . . . . 1.98 111.845 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 . . . . . 0 C--N 1.308 -1.2 0 CA-C-O 121.569 0.7 . . . . 4.98 109.577 -178.357 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mmm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.208 -0.664 . . . . 3.22 109.208 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -88.96 97.75 11.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.879 -0.601 . . . . 3.86 110.172 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.9 m -84.4 123.38 30.16 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.828 -1.149 . . . . 0.99 109.207 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.67 131.41 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.828 -0.749 . . . . 1.1 112.277 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.45 116.89 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.703 -1.962 . . . . 1.15 105.703 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -99.43 103.89 15.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.661 -1.607 . . . . 1.58 106.661 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -122.78 -123.33 2.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.523 -1.431 . . . . 1.45 109.523 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' N ' ' OH ' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -135.88 -114.37 0.19 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.879 -1.128 . . . . 5.89 109.403 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 p -113.58 -74.81 0.61 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.808 -1.182 . . . . 4.86 107.808 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.92 63.36 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.534 -2.227 . . . . 2.9 107.534 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.6 t -100.19 97.47 6.28 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.935 -0.706 . . . . 4.98 109.524 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.56 -25.57 41.6 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.062 1.841 . . . . 3.27 111.847 -170.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.91 -9.74 58.95 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.332 -0.947 . . . . 6.19 111.576 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 3.5 m -101.07 -37.3 8.66 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.784 -1.561 . . . . 2.25 106.784 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -42.71 -35.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 114.721 -1.127 . . . . 1.27 110.128 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 7.3 mmm180 -71.51 -55.17 8.38 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.049 -1.46 . . . . 4.05 110.525 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.7 43.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.622 -1.251 . . . . 0.86 107.622 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -58.79 -49.88 76.01 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.539 -1.664 . . . . 1.94 109.035 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.6 t70 -60.44 -49.33 78.02 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.735 -1.186 . . . . 2.89 111.075 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 42.1 tp -60.51 -55.32 34.91 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.979 -1.088 . . . . 0.88 110.0 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.85 64.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.335 -1.357 . . . . 0.96 107.335 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.628 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 31.8 tt0 -48.61 -49.43 36.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.388 1.055 . . . . 2.14 109.359 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HE3' ' CA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -50.74 -63.52 1.1 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.344 -1.354 . . . . 6.66 107.344 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 83' ' ' LEU . 54.3 mt -45.53 -53.54 8.83 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.872 -1.158 . . . . 1.33 107.872 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 15.1 t -52.02 -33.25 37.67 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.21 -1.359 . . . . 1.73 112.939 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -112.32 25.33 11.63 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.161 -0.927 . . . . 3.13 109.197 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -133.62 -48.47 0.82 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.161 -0.927 . . . . 3.24 111.568 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 30' ' ' ASP . 21.9 mtp85 -113.38 133.08 55.35 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.194 -0.912 . . . . 3.12 110.508 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -80.9 35.04 0.36 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.395 -1.322 . . . . 3.7 111.372 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.4 p30 -130.2 -4.58 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.843 -1.526 . . . . 3.9 108.132 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' A' ' 25' ' ' SER . 23.7 t80 -127.86 141.45 51.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.599 -0.84 . . . . 1.15 112.608 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.427 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 35.4 mm-40 -140.75 141.04 34.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.218 -1.401 . . . . 3.99 107.218 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.628 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -127.21 162.34 26.39 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 118.62 -1.232 . . . . 1.28 113.721 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 147.45 27.99 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.611 -1.632 . . . . 4.65 109.333 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.538 ' OH ' ' N ' ' A' ' 8' ' ' ARG . 57.6 t80 -113.41 146.34 39.67 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.765 -1.198 . . . . 1.19 107.765 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.21 163.96 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.616 -0.834 . . . . 1.65 110.25 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -121.13 121.24 37.43 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.24 -2.133 . . . . 2.23 105.24 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -51.29 -17.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 118.825 -1.15 . . . . 1.88 110.806 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 4.2 ttp-105 -95.05 23.97 5.23 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.72 -0.792 . . . . 6.25 109.666 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.84 -43.69 3.97 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.102 -1.444 . . . . 1.55 107.102 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -93.48 -42.37 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.541 -2.022 . . . . 4.65 105.541 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.21 56.71 0.58 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.222 -1.951 . . . . 1.35 108.222 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.7 149.84 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.501 . . . . 1.37 111.067 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 -170.87 1.92 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.607 -0.724 . . . . 1.94 109.431 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 13.3 ttpp -77.06 -28.29 54.67 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.491 -0.884 . . . . 5.33 110.668 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 16.7 mp0 -70.71 -57.13 5.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 3.32 108.149 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -48.52 -42.66 33.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.104 -0.953 . . . . 2.4 110.422 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.76 -38.77 53.55 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.954 -1.021 . . . . 1.74 110.895 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.483 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 5.2 tt0 -55.74 -47.71 76.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.306 -1.368 . . . . 3.43 107.306 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.0 -30.83 26.83 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.322 -1.308 . . . . 5.1 110.811 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -88.97 -57.6 2.84 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.536 -1.211 . . . . 2.34 112.244 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -50.5 -33.35 21.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.783 -1.099 . . . . 1.45 112.029 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.79 73.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 106.521 -2.632 . . . . 3.67 106.521 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -133.26 -169.9 0.22 Allowed Pre-proline 0 C--N 1.296 -1.737 0 CA-C-N 113.089 -1.555 . . . . 6.32 107.834 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -86.6 143.5 7.34 Favored 'Trans proline' 0 C--N 1.299 -2.026 0 C-N-CA 120.893 1.062 . . . . 3.5 110.989 138.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -118.29 160.46 17.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.731 -1.211 . . . . 5.75 107.731 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -101.65 -109.69 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.084 -1.046 . . . . 6.73 108.693 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.9 p -120.26 -73.48 0.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.266 -1.013 . . . . 4.88 108.266 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -147.8 149.76 34.26 Favored Pre-proline 0 C--N 1.289 -2.048 0 CA-C-N 114.149 -1.387 . . . . 2.47 107.966 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.636 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 26.0 Cg_endo -103.66 155.8 3.01 Favored 'Cis proline' 0 C--N 1.32 -0.966 0 CA-C-N 118.671 0.561 . . . . 1.69 112.241 -6.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.46 149.43 41.28 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 107.085 -1.45 . . . . 2.74 107.085 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 58.0 mt -127.48 141.33 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.651 -0.82 . . . . 1.27 113.136 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -124.54 145.15 49.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.306 -1.77 . . . . 1.5 110.283 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 71.1 t -117.75 90.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.412 -0.959 . . . . 1.2 108.412 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 t70 70.9 -75.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.263 -0.88 . . . . 2.57 109.05 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -134.18 -20.87 1.88 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.786 -1.097 . . . . 3.55 111.381 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -89.51 158.1 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.759 -1.176 . . . . 4.9 110.8 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.576 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 11.8 t-160 -103.71 142.32 34.54 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.473 -0.936 . . . . 0.92 108.473 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 mm -111.55 -46.14 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.041 -1.063 . . . . 0.93 108.959 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.15 -113.82 1.01 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.504 -1.439 . . . . 1.17 109.504 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.429 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -119.25 -173.81 15.61 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.372 -1.091 . . . . 1.22 110.372 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 18.5 t80 -47.1 -49.2 22.36 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.354 -0.939 . . . . 1.39 111.516 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -54.67 17.17 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.687 0.756 . . . . 1.65 110.123 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -58.38 -52.64 64.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.666 -1.606 . . . . 2.44 110.481 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.97 -44.68 96.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.508 -0.769 . . . . 1.19 111.834 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.91 -58.18 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.728 -0.789 . . . . 1.03 109.226 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.76 -55.43 35.21 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.569 -1.253 . . . . 1.14 108.893 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.43 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 63.6 t90 -44.75 -54.18 6.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 123.549 0.531 . . . . 0.95 111.485 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -43.54 -59.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.962 -0.563 . . . . 0.82 110.265 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HG3' ' OE2' ' A' ' 81' ' ' GLU . 18.2 tptp -43.8 -30.19 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.394 1.628 . . . . 2.11 115.394 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.422 ' OE2' ' HG3' ' A' ' 80' ' ' LYS . 2.9 mp0 -107.82 4.5 25.57 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 119.579 1.082 . . . . 4.74 112.62 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -120.56 -31.57 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.721 -0.791 . . . . 1.38 111.045 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 24' ' ' LEU . 55.0 mt -116.94 26.84 9.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.792 -0.763 . . . . 1.7 111.954 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 C-N-CA 119.698 -0.801 . . . . 3.6 110.647 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.446 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 3.9 ptm . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 107.728 -1.212 . . . . 3.83 107.728 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.48 HE22 ' C ' ' A' ' 33' ' ' TYR . 60.5 tp60 -111.57 142.0 44.42 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 123.478 0.487 . . . . 4.73 109.839 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 m -120.4 148.72 43.41 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.771 -0.771 . . . . 1.39 109.025 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.49 139.19 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 118.868 -1.133 . . . . 1.05 112.595 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.463 HD12 ' HB1' ' A' ' 17' ' ' ALA . 17.2 mm -111.1 136.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.55 -1.278 . . . . 1.54 107.55 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.15 84.98 2.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.585 -1.635 . . . . 2.2 106.585 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -135.1 -163.28 10.05 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.496 -2.241 . . . . 1.27 107.496 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 9' ' ' SER . 4.2 tpt180 -141.35 167.68 21.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.256 -0.977 . . . . 6.19 108.581 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 8' ' ' ARG . 78.9 p -85.76 64.83 8.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.307 -0.627 . . . . 4.68 109.307 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 11' ' ' CYS . . . -120.75 61.13 0.52 Allowed Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.505 -1.438 . . . . 4.68 109.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.755 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 30.7 t 108.82 165.44 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.685 0 N-CA-C 105.605 -1.998 . . . . 4.71 105.605 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 50.5 Cg_exo -54.76 75.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.023 1.149 . . . . 3.11 113.023 165.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.403 ' CD2' ' HB3' ' A' ' 11' ' ' CYS . 6.5 m-85 -113.82 -77.89 0.58 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.573 -0.451 . . . . 4.85 109.915 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.45 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.7 m -55.02 -29.12 56.7 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 118.041 -1.464 . . . . 2.44 108.022 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -42.54 -38.59 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.164 -1.38 . . . . 1.51 110.205 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.495 ' NH2' ' HB3' ' A' ' 19' ' ' ASP . 6.6 mmm180 -77.11 -53.63 7.54 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.957 -1.497 . . . . 3.61 110.093 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.463 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -49.16 -42.59 40.25 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.208 -0.997 . . . . 1.07 109.185 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HE3' ' CZ ' ' A' ' 33' ' ' TYR . 2.3 tptm -60.19 -60.0 4.51 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.898 -1.501 . . . . 2.74 108.687 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.495 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 3.4 t70 -50.51 -42.65 55.15 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.984 -1.086 . . . . 2.6 110.029 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 79' ' ' VAL . 8.6 tp -63.22 -66.93 0.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.686 -1.205 . . . . 1.11 109.185 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.97 -39.82 9.48 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 120.312 -0.555 . . . . 1.04 110.524 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 26.6 tt0 -65.55 -53.04 47.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.151 -0.932 . . . . 2.31 110.389 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -53.54 39.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.566 -1.642 . . . . 6.81 106.566 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.4 mt -53.51 -40.62 65.55 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.544 -1.207 . . . . 1.39 108.216 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -59.7 -35.62 74.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.874 -1.057 . . . . 1.03 110.594 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -83.98 -28.08 27.99 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.042 -0.663 . . . . 1.77 110.891 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.3 -47.22 44.5 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.208 -0.597 . . . . 3.42 111.35 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -109.18 164.97 11.96 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.143 -1.023 . . . . 4.44 110.907 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.632 -1.618 . . . . 4.0 106.632 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 1' ' ' MET . 3.5 t70 -82.86 41.19 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.924 -1.489 . . . . 3.58 108.686 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -145.46 93.23 2.34 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.546 -1.262 . . . . 1.07 112.651 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -99.55 155.06 17.78 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 104.526 -2.398 . . . . 3.35 104.526 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.548 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 7.3 p90 -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.059 -1.056 . . . . 1.73 108.784 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -149.02 152.44 36.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.701 -0.852 . . . . 4.77 108.701 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -121.46 123.15 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.841 -1.17 . . . . 2.11 107.841 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.28 145.39 20.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.97 -2.233 . . . . 1.92 104.97 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 11.1 t70 -111.18 160.1 17.25 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.544 -1.263 . . . . 2.55 108.512 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.26 -30.24 5.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 117.778 -1.569 . . . . 1.25 108.87 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 3.1 tpm_? -93.18 -59.31 2.06 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.74 -0.664 . . . . 5.31 110.339 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -47.19 -33.29 5.15 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.655 -0.818 . . . . 1.66 110.972 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.22 -46.31 8.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.954 0.784 . . . . 3.97 109.334 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 54.23 1.05 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.722 -1.751 . . . . 1.49 108.722 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 mt -99.74 162.7 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.544 -0.91 . . . . 1.53 108.544 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 p -113.36 148.78 35.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.942 0.776 . . . . 2.43 112.184 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.606 ' HG3' ' CG1' ' A' ' 56' ' ' VAL . 35.0 tttm -49.3 -54.26 17.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.588 -0.893 . . . . 4.26 108.588 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 3.6 mp0 -46.62 -62.91 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.725 -1.125 . . . . 3.25 111.006 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.15 -56.71 8.33 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 120.401 -0.519 . . . . 2.16 110.895 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.8 -50.17 69.2 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.7 -0.682 . . . . 1.25 110.229 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.97 -56.14 16.06 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 3.04 107.535 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -49.77 -43.92 48.48 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.107 -1.406 . . . . 3.96 109.071 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HD2' ' CE2' ' A' ' 63' ' ' PHE . 6.2 tmtt? -63.85 -46.39 85.23 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.133 -1.394 . . . . 7.24 112.231 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -71.19 -48.51 51.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 113.068 0.766 . . . . 1.06 113.068 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.94 -33.85 6.18 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.065 -2.414 . . . . 2.54 107.065 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -83.83 141.53 41.25 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 114.447 -0.876 . . . . 7.78 108.649 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -41.92 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 122.358 2.039 . . . . 3.87 110.712 161.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.606 ' CG1' ' HG3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER 33.32 -95.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 115.637 1.717 . . . . 5.22 115.637 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 5.3 tp10 109.14 -170.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 102.475 -3.158 . . . . 7.18 102.475 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.498 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 14.9 p -104.03 -152.49 0.46 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.181 -1.414 . . . . 4.33 107.181 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.07 146.64 51.88 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 107.881 -1.155 . . . . 2.8 107.881 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 96.6 Cg_endo -98.46 162.46 10.42 Favored 'Cis proline' 0 N--CA 1.489 1.223 0 O-C-N 122.858 0.925 . . . . 2.43 111.637 10.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -114.06 151.34 32.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.578 -1.267 . . . . 2.85 107.578 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.423 HD12 ' CB ' ' A' ' 75' ' ' PHE . 6.2 mt -123.2 143.24 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.066 -1.054 . . . . 1.8 111.798 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.422 ' CE2' ' HD2' ' A' ' 51' ' ' LYS . 31.7 m-85 -136.36 159.06 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.751 -1.568 . . . . 1.09 107.874 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 66' ' ' GLN . 74.6 t -127.6 130.44 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.531 -0.914 . . . . 0.87 108.531 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.08 -81.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 124.398 1.061 . . . . 2.77 110.603 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.3 pt20 -138.33 -14.2 1.32 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.229 -0.896 . . . . 3.87 110.976 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -85.46 168.96 14.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.696 0.623 . . . . 4.88 111.209 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.53 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.3 t-160 -113.01 139.66 48.47 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.617 -0.72 . . . . 0.87 109.267 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mm -109.69 -34.37 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.304 -1.358 . . . . 1.15 109.215 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.96 -136.17 8.77 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.169 -1.491 . . . . 1.2 109.539 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.39 169.2 17.1 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.749 -1.215 . . . . 1.49 110.656 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.6 t80 -40.53 -57.27 1.87 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 112.608 0.596 . . . . 1.52 112.608 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 p -43.25 -69.31 0.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.026 0.917 . . . . 1.6 111.213 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -52.1 30.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.174 -1.83 . . . . 2.83 110.316 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' CE1' ' CE3' ' A' ' 78' ' ' TRP . 58.3 t80 -44.61 -46.54 10.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.345 -0.843 . . . . 1.74 111.03 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -40.83 -48.17 3.03 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 119.62 -0.832 . . . . 1.1 111.006 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.99 77.93 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.839 -1.144 . . . . 1.17 109.713 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.464 ' CZ2' HG21 ' A' ' 64' ' ' VAL . 90.5 t90 -50.94 -44.99 60.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.724 -0.843 . . . . 0.7 108.724 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG21 HD21 ' A' ' 20' ' ' LEU . 79.7 t -57.23 -33.99 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.662 -1.154 . . . . 1.08 110.23 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 13.7 tptp -87.57 18.52 3.88 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.265 -0.974 . . . . 2.26 111.726 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.21 -45.47 0.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.271 -0.972 . . . . 3.85 111.826 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -84.86 -2.16 57.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.992 -1.083 . . . . 1.76 111.745 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.416 HD12 HG13 ' A' ' 79' ' ' VAL . 86.0 mt -123.25 21.32 9.63 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.209 -0.996 . . . . 1.8 110.742 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.297 -1.686 0 N-CA-C 108.075 -1.084 . . . . 4.09 108.075 179.48 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.387 -0.598 . . . . 3.46 109.387 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 18.6 mt-30 -112.01 164.51 13.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.118 0.485 . . . . 3.85 111.82 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.1 m -152.35 121.48 6.67 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 116.434 -0.348 . . . . 1.14 110.159 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.491 ' C ' HD12 ' A' ' 5' ' ' ILE . 6.6 t -109.19 137.91 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.103 -1.039 . . . . 1.02 110.09 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp -109.32 98.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 124.768 1.293 . . . . 1.05 108.077 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CE1' HG11 ' A' ' 4' ' ' VAL . 76.4 m-85 -93.76 92.75 7.61 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 105.774 -1.936 . . . . 1.41 105.774 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -125.07 -150.69 7.85 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.825 -1.178 . . . . 1.27 111.766 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.459 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.3 tpt180 -124.26 123.53 40.45 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.812 -0.81 . . . . 5.27 108.812 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -78.45 53.78 1.34 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.662 0.744 . . . . 5.39 109.397 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.34 -46.37 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.733 -1.347 . . . . 3.16 109.733 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.575 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 32.1 t -111.78 156.1 42.12 Favored Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.779 -0.822 . . . . 3.76 108.779 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 6.1 Cg_endo -72.55 48.53 1.31 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.491 1.461 . . . . 3.23 111.446 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -99.99 -58.62 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.361 -0.978 . . . . 4.36 108.361 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.3 m -53.26 -36.19 60.84 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.423 -1.325 . . . . 2.46 107.423 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.41 -30.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.079 -1.873 . . . . 1.34 111.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' ARG . 39.4 mmt180 -72.28 -39.85 68.02 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.983 -1.087 . . . . 5.82 110.302 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 62' ' ' ILE . . . -65.22 -46.7 79.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.217 -1.771 . . . . 0.84 106.217 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 2.1 ttpp -51.99 -48.91 64.2 Favored 'General case' 0 C--O 1.2 -1.532 0 CA-C-N 114.099 -1.409 . . . . 1.59 108.97 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -57.42 -65.68 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.646 -0.706 . . . . 2.94 111.251 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.4 tp -51.31 -51.85 50.57 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.083 -1.047 . . . . 1.05 110.073 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.13 -51.52 63.98 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.618 -1.173 . . . . 0.79 109.747 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 19.6 tt0 -55.93 -49.0 74.69 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.047 -0.978 . . . . 1.88 109.35 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HD2' ' C ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -52.23 -55.1 23.36 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.034 -1.466 . . . . 4.35 107.657 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.82 -37.17 63.3 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.756 -0.831 . . . . 1.01 108.756 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 5.7 t -55.71 -40.74 72.84 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.815 -1.18 . . . . 1.04 107.815 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -98.3 40.36 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.961 -1.496 . . . . 2.05 106.961 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.53 -52.3 0.39 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.242 -1.344 . . . . 2.8 111.663 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -106.23 -11.45 16.04 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.973 -1.091 . . . . 4.61 111.177 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 71.51 -40.55 0.48 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 124.15 0.906 . . . . 4.72 112.59 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 1' ' ' MET . 5.3 p-10 -80.96 4.23 20.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.705 -1.198 . . . . 2.71 107.863 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.502 ' CD2' ' HE3' ' A' ' 1' ' ' MET . 6.0 t80 -95.23 102.35 14.15 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.554 1.159 . . . . 1.48 108.011 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 37.7 mt-30 -119.29 118.62 31.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.201 -1.037 . . . . 3.12 108.201 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.41 160.04 15.94 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.731 -1.188 . . . . 1.38 110.574 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.429 ' CG ' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -142.26 148.84 38.76 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.076 -1.42 . . . . 4.71 108.9 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -112.21 136.19 51.93 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.042 -1.096 . . . . 1.45 108.042 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.42 152.04 27.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.213 -1.773 . . . . 1.3 106.213 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.68 142.2 47.52 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.409 -0.916 . . . . 2.19 109.008 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.9 pt -48.3 -36.95 6.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.927 -0.709 . . . . 1.27 111.188 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -76.74 -44.88 31.38 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.002 -1.079 . . . . 6.42 111.473 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.76 -54.36 2.65 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 119.529 -0.868 . . . . 1.75 110.422 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 42' ' ' GLY . 64.9 mt-10 -93.47 25.18 3.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 114.3 -1.318 . . . . 4.27 111.255 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 30.51 57.0 0.24 Allowed Glycine 0 N--CA 1.508 3.455 0 N-CA-C 112.074 -0.41 . . . . 1.63 112.074 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.6 161.52 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.933 -0.766 . . . . 1.88 108.933 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -119.93 154.62 34.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.706 0.765 . . . . 1.98 109.513 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -45.13 -42.12 8.63 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.071 1.137 . . . . 4.13 114.071 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.702 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 14.2 mp0 -65.02 -56.5 12.73 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.818 -0.753 . . . . 3.07 110.608 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.56 -50.21 24.49 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.19 -1.041 . . . . 2.44 108.19 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.94 -48.94 74.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.159 -1.382 . . . . 1.29 108.551 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.511 HE21 ' H ' ' A' ' 56' ' ' VAL . 5.4 tp60 -44.78 -45.02 9.77 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.936 -1.135 . . . . 4.88 107.936 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -65.15 -49.54 69.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.898 1.374 . . . . 3.45 109.587 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.58 -48.95 62.98 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.155 -0.683 . . . . 2.42 109.155 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -19.69 56.98 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.429 -0.952 . . . . 1.04 108.429 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.67 32.57 17.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.375 -1.89 . . . . 2.73 108.375 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -143.66 158.21 57.19 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-N 114.096 -1.052 . . . . 7.45 108.707 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.86 68.87 4.67 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.675 1.584 . . . . 3.68 111.25 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.511 ' H ' HE21 ' A' ' 49' ' ' GLN . 4.8 p -101.71 125.1 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.982 -0.687 . . . . 6.39 110.804 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.71 -2.82 10.36 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 112.918 0.711 . . . . 6.2 112.918 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 p -116.08 -169.27 1.57 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.637 -0.825 . . . . 4.25 111.579 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.8 164.59 33.93 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.415 -0.811 . . . . 2.89 108.992 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.69 157.44 71.82 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 124.236 -1.152 . . . . 2.88 109.747 -7.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -98.25 101.42 12.88 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 103.916 -2.624 . . . . 3.37 103.916 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 17' ' ' ALA . 8.2 mt -91.59 133.12 34.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 113.167 -1.833 . . . . 1.34 111.266 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -125.64 153.57 43.6 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 112.979 -1.919 . . . . 1.09 109.798 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 66' ' ' GLN . 80.0 t -122.2 95.91 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.882 -1.155 . . . . 0.84 107.882 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.5 -72.72 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 125.189 1.556 . . . . 2.63 110.557 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 64' ' ' VAL . 41.7 tp60 -129.78 -18.06 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.475 -1.239 . . . . 6.0 111.363 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -91.61 172.95 8.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.276 -0.97 . . . . 3.52 111.18 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -119.92 149.72 41.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 106.797 -1.557 . . . . 1.74 106.797 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 78' ' ' TRP . 21.3 mm -116.25 -55.95 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.687 -0.805 . . . . 0.89 111.069 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.58 -135.05 4.76 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.667 -1.254 . . . . 1.53 110.26 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.37 -74.31 0.94 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 111.141 -0.783 . . . . 2.47 111.141 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -137.97 -55.85 0.66 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 118.724 -1.19 . . . . 2.73 109.343 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 p -41.95 -52.4 4.14 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 123.118 1.437 . . . . 2.05 109.658 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -36.46 84.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.005 -2.362 . . . . 2.08 109.964 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.19 -51.01 61.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.496 -0.882 . . . . 1.21 109.108 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.5 64.81 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.276 -0.969 . . . . 1.34 109.28 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.88 -58.9 6.14 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.788 -1.165 . . . . 1.03 108.998 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.481 ' CD1' HD12 ' A' ' 69' ' ' ILE . 87.6 t90 -44.5 -55.54 5.02 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.519 -0.764 . . . . 0.76 109.301 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.466 HG13 HD12 ' A' ' 83' ' ' LEU . 2.7 t -44.79 -60.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 114.231 -1.35 . . . . 1.04 108.853 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -50.21 -39.88 45.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.21 -0.905 . . . . 2.52 112.937 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 11.7 pt-20 -104.52 36.09 2.52 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.592 -0.843 . . . . 4.33 113.067 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -147.5 -36.11 0.22 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.216 1.007 . . . . 1.56 110.038 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 79' ' ' VAL . 22.3 mt -99.44 -24.03 14.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.523 -1.217 . . . . 2.65 110.794 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t0 . . . . . 0 N--CA 1.499 2.008 0 O-C-N 125.105 1.503 . . . . 4.1 108.082 179.802 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.487 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.4 mpp? . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 108.004 -1.11 . . . . 2.38 108.004 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -83.16 102.61 11.98 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 124.023 0.827 . . . . 4.04 109.459 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 5.7 m -96.69 116.38 29.03 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.963 -1.095 . . . . 1.48 109.925 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 t -123.7 136.95 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.397 -0.819 . . . . 1.01 112.448 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.41 HG21 ' SG ' ' A' ' 14' ' ' CYS . 5.4 mm -110.39 125.03 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.747 -1.205 . . . . 1.27 107.747 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 82.1 m-85 -102.47 114.99 29.67 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.21 -1.774 . . . . 1.73 106.21 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.29 -148.78 7.99 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.409 -1.077 . . . . 1.69 110.409 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.5 ttm180 -138.8 141.74 38.74 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.846 -0.742 . . . . 6.24 110.613 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 t -54.98 73.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.983 -1.462 . . . . 6.59 112.761 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 118.5 26.62 2.58 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 120.45 -0.881 . . . . 4.03 113.096 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 13' ' ' TYR . 9.7 t -122.31 138.0 28.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 C-N-CA 118.728 -1.189 . . . . 4.8 110.048 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.02 53.08 4.42 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.884 1.723 . . . . 4.44 111.2 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.545 ' CE2' ' SG ' ' A' ' 11' ' ' CYS . 20.3 m-30 -111.73 -68.21 0.95 Allowed 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.302 -0.559 . . . . 5.67 112.147 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 16' ' ' ARG . 3.5 t -54.49 -29.34 49.89 Favored 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 118.014 -1.474 . . . . 4.4 108.912 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 15' ' ' VAL . 7.2 t -44.75 -12.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 114.027 -1.442 . . . . 2.3 112.072 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.599 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -108.87 -42.37 4.49 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.534 -0.867 . . . . 3.54 109.607 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.17 75.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.345 -1.724 . . . . 0.75 106.345 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -54.97 -39.82 69.36 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 114.588 -1.187 . . . . 2.11 108.686 179.14 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.457 ' CG ' HH12 ' A' ' 16' ' ' ARG . 0.2 OUTLIER -66.32 -62.42 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.212 0.529 . . . . 2.76 111.488 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' CD2' ' A' ' 75' ' ' PHE . 15.3 tp -56.36 -43.27 78.98 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.408 -0.917 . . . . 1.09 110.045 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.08 72.69 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.725 -1.19 . . . . 1.08 108.296 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 11.3 tt0 -48.14 -47.33 34.83 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.44 -0.948 . . . . 2.42 108.44 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -48.57 -52.9 20.49 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 118.756 -1.178 . . . . 4.15 110.62 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.5 mt -65.52 -46.24 80.4 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 123.721 0.638 . . . . 1.18 111.78 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 22' ' ' GLU . 1.5 p -57.9 -25.37 60.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 118.922 -1.111 . . . . 2.81 111.15 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -91.75 27.98 1.91 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.028 -1.069 . . . . 1.78 108.647 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 72.5 mt-10 -121.17 -65.7 1.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.951 -0.7 . . . . 3.4 110.252 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -122.26 -166.77 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.811 -1.086 . . . . 3.83 111.746 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -107.45 -4.65 18.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.912 -1.04 . . . . 5.79 111.027 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.9 p-10 -84.29 -9.59 58.35 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.919 -1.141 . . . . 3.26 107.919 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CZ ' HG21 ' A' ' 3' ' ' THR . 29.8 t80 -116.02 96.9 5.79 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.492 -0.883 . . . . 1.56 110.817 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -112.11 128.07 56.1 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.255 -2.128 . . . . 4.23 105.255 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.1 OUTLIER -123.28 143.25 50.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.118 -1.433 . . . . 1.58 113.74 -177.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -139.1 161.67 36.81 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 113.822 -1.536 . . . . 4.39 109.409 178.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.451 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 30.6 t80 -118.98 142.62 47.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 1.37 109.115 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -132.19 147.02 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.348 -0.982 . . . . 1.39 108.348 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 3.3 t70 -122.48 114.74 21.11 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 119.038 -1.065 . . . . 2.58 112.434 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -49.3 -31.46 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.477 -0.783 . . . . 1.51 111.522 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.506 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.03 -63.44 1.31 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.284 -1.766 . . . . 5.41 108.723 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -30.49 -45.51 0.06 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.667 1.23 . . . . 2.62 111.671 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -94.22 -53.37 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.905 -1.118 . . . . 3.64 111.465 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.58 51.87 0.2 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 118.989 -1.576 . . . . 1.75 111.47 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.7 mt -103.87 157.73 5.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.775 -1.565 . . . . 1.87 106.775 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.0 p -115.88 158.35 23.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.653 -0.819 . . . . 2.34 109.084 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -52.18 -40.29 61.27 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.961 -1.096 . . . . 4.75 111.833 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 23.3 mp0 -47.73 -63.76 0.97 Allowed 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 121.663 0.744 . . . . 3.4 110.261 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -44.31 -44.62 8.25 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 114.354 -1.294 . . . . 2.82 111.978 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.77 -41.7 64.76 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.336 -1.302 . . . . 2.07 110.5 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 55' ' ' PRO . 14.0 tt0 -57.28 -40.12 77.1 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.301 -1.741 . . . . 3.17 106.301 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -15.54 11.84 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.355 -1.293 . . . . 3.59 110.692 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -104.11 -37.73 7.21 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.671 -0.695 . . . . 2.5 110.51 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.497 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -72.0 -37.79 69.75 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.725 -1.125 . . . . 1.51 112.65 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -45.62 1.87 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 107.957 -2.057 . . . . 2.84 107.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 17.8 pttp -101.35 176.31 1.94 Allowed Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.556 -1.646 . . . . 5.93 106.556 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 64.9 Cg_exo -48.67 155.15 2.53 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 120.67 0.913 . . . . 3.79 110.93 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 56' ' ' VAL . 3.9 m -72.43 -30.99 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.447 -0.901 . . . . 5.99 111.312 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.58 -145.92 0.32 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.047 -0.661 . . . . 7.4 109.383 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -95.38 168.04 10.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.604 -0.838 . . . . 4.27 110.003 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.01 152.26 39.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.634 -1.247 . . . . 2.4 107.634 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 13' ' ' TYR . 73.7 Cg_endo -97.03 160.2 12.07 Favored 'Cis proline' 0 C--N 1.304 -1.78 0 C-N-CA 123.828 -1.322 . . . . 2.43 109.664 17.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 1.4 tp-100 -110.16 132.45 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.069 -2.197 . . . . 3.4 105.069 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' A' ' 75' ' ' PHE . 5.3 mt -112.71 137.53 45.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.037 -1.065 . . . . 1.79 111.013 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -127.5 138.78 53.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.407 -1.724 . . . . 1.27 107.807 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 66' ' ' GLN . 40.6 t -121.73 108.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 124.462 1.101 . . . . 1.26 109.183 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.01 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.141 -0.689 . . . . 2.94 109.141 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 64' ' ' VAL . 32.2 mm-40 -138.05 -9.82 1.53 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.484 -1.234 . . . . 3.87 110.034 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.82 146.62 26.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.678 -0.49 . . . . 4.57 109.678 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.497 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 14.6 t-160 -105.85 135.55 47.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.159 -1.423 . . . . 1.19 107.159 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 78' ' ' TRP . 9.9 mm -103.7 -41.06 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 118.588 -1.245 . . . . 0.89 109.775 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 128.39 -114.74 1.88 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.324 -2.31 . . . . 1.36 107.324 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 60' ' ' PRO . . . -129.87 -169.13 12.46 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 118.558 -1.782 . . . . 1.15 111.23 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.7 t80 -61.96 176.28 0.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 105.738 -1.949 . . . . 3.07 105.738 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.471 ' CB ' ' O ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 78.23 -64.69 0.27 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.413 -1.328 . . . . 3.06 107.413 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -41.62 83.05 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.398 -1.334 . . . . 2.62 107.398 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.56 ' HB2' HD12 ' A' ' 62' ' ' ILE . 15.8 t80 -41.84 -49.88 4.43 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 113.915 -1.493 . . . . 1.15 110.041 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.66 71.28 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.412 -0.915 . . . . 1.06 109.061 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.14 -53.99 51.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.887 -1.125 . . . . 0.94 109.435 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.43 ' CD1' HD12 ' A' ' 69' ' ' ILE . 70.2 t90 -50.3 -53.45 28.58 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.746 -0.782 . . . . 1.11 110.065 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.0 t -43.98 -56.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.312 -0.858 . . . . 0.94 109.336 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 80' ' ' LYS . 6.2 tmtm? -44.83 -23.86 0.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 116.953 -1.499 . . . . 2.86 115.044 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.18 6.2 10.26 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 120.94 1.7 . . . . 4.79 112.971 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.23 -25.74 5.63 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.846 -0.742 . . . . 1.31 109.725 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.89 28.03 4.22 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.16 -0.927 . . . . 2.02 111.096 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 18.6 p-10 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 122.229 1.014 . . . . 4.4 109.099 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.838 -0.801 . . . . 2.9 108.838 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.458 ' OE1' ' HB2' ' A' ' 34' ' ' GLN . 6.2 tt0 -84.17 144.52 28.93 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 119.104 -1.039 . . . . 4.85 109.447 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.7 m -96.39 134.73 39.18 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.169 -1.419 . . . . 1.81 107.169 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.487 ' C ' HD12 ' A' ' 5' ' ' ILE . 6.7 t -125.42 122.22 62.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.593 -1.262 . . . . 1.14 107.593 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -107.17 123.65 62.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 105.419 -2.067 . . . . 1.01 105.419 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -117.78 117.07 28.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 2.72 108.587 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.46 159.43 8.39 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.875 -1.155 . . . . 1.98 111.247 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -112.89 139.09 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.194 -1.039 . . . . 5.13 108.194 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.538 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 10.9 p -102.89 -65.15 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.124 -1.03 . . . . 6.46 109.709 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.27 -47.88 0.99 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 105.967 -2.853 . . . . 3.43 105.967 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.5 m -94.7 165.2 17.73 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 106.354 -1.721 . . . . 4.53 106.354 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.04 67.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.844 2.363 . . . . 3.38 112.528 165.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -115.0 -65.34 1.2 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.628 -0.878 . . . . 6.11 108.628 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 18.1 m -53.46 -33.82 55.59 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.404 1.097 . . . . 2.22 108.388 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 15' ' ' VAL . 22.3 t -44.46 -47.12 2.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 113.002 -1.908 . . . . 1.43 111.259 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -50.01 -48.8 52.34 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.71 -0.796 . . . . 3.21 110.534 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.27 -52.69 25.81 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.552 -1.277 . . . . 0.87 107.552 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -53.76 -45.21 70.54 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 114.759 -1.11 . . . . 1.95 110.53 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.525 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 43.7 m-20 -62.21 -56.72 15.85 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.336 -0.546 . . . . 3.19 111.663 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.407 HD23 ' CD2' ' A' ' 75' ' ' PHE . 18.7 tp -57.79 -52.02 67.2 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.029 -0.73 . . . . 0.79 109.029 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.73 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.74 -0.837 . . . . 0.65 108.74 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.442 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 42.3 tt0 -58.38 -47.76 82.8 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.7 -0.8 . . . . 2.35 110.428 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' NZ ' ' OE1' ' A' ' 27' ' ' GLU . 17.6 tptp -57.45 -54.96 40.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 116.563 -2.055 . . . . 4.63 107.879 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' LYS . 47.7 mt -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.533 -1.667 . . . . 1.4 107.63 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 6.5 t -49.84 -42.44 47.34 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.785 -0.643 . . . . 1.04 109.494 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.433 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 t-20 -72.89 -29.49 63.2 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.742 -0.663 . . . . 2.77 111.13 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 1.6 mm-40 -86.33 -40.14 15.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.292 1.219 . . . . 3.84 114.292 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -114.25 139.36 49.46 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.923 -0.711 . . . . 4.32 112.216 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.35 -40.88 98.48 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.225 -0.898 . . . . 4.08 113.273 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.75 20.28 1.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.405 -0.918 . . . . 3.44 111.36 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 4.4 t80 -115.28 123.02 47.72 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.544 -1.262 . . . . 1.13 111.63 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -136.04 172.39 13.08 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.824 -1.547 . . . . 3.45 106.824 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -145.35 149.45 34.81 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.501 -1.28 . . . . 1.36 110.919 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.458 ' HB2' ' OE1' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -136.87 139.78 41.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.113 0.883 . . . . 5.02 109.252 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.67 121.2 34.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.178 -1.009 . . . . 1.71 108.83 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.99 153.59 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.866 -0.734 . . . . 1.64 109.708 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -108.69 124.3 50.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.092 -1.447 . . . . 2.51 107.092 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.7 pt -40.02 -41.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.709 -0.796 . . . . 1.29 111.816 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -31.47 61.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 118.998 -1.081 . . . . 5.37 111.778 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.1 -53.59 32.76 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.416 -0.914 . . . . 1.4 111.593 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -94.63 -34.49 12.59 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.477 -0.889 . . . . 3.65 111.872 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.48 50.43 0.66 Allowed Glycine 0 N--CA 1.503 3.12 0 N-CA-C 109.332 -1.507 . . . . 1.51 109.332 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.8 mt -96.55 137.15 25.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.312 -0.995 . . . . 1.61 108.312 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.4 p -107.35 166.34 10.72 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.929 -1.108 . . . . 2.37 112.067 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 57' ' ' GLU . 8.8 ttpt -56.86 -35.25 68.66 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.573 -1.194 . . . . 4.78 109.967 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 24.0 mp0 -68.93 -47.72 65.02 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.052 -1.092 . . . . 3.54 108.052 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.66 -49.96 74.74 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 117.793 -1.563 . . . . 2.53 108.332 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -53.66 -54.46 37.42 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.017 -1.073 . . . . 1.63 108.367 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.46 -51.79 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.544 0.527 . . . . 5.32 109.95 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -53.09 -54.32 37.32 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.38 -0.971 . . . . 4.67 108.38 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -55.72 -38.25 69.49 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.724 -1.126 . . . . 2.78 110.523 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -59.54 -48.0 83.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 123.68 0.612 . . . . 1.99 110.4 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.42 -40.47 2.72 Favored Glycine 0 N--CA 1.499 2.833 0 C-N-CA 120.152 -1.023 . . . . 4.3 112.102 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.427 ' O ' HG12 ' A' ' 56' ' ' VAL . 64.4 mttp -124.23 154.53 68.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 C-N-CA 120.066 -0.654 . . . . 10.46 109.316 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.11 70.05 6.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.91 2.407 . . . . 5.73 113.563 -138.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 54' ' ' LYS . 2.7 p -136.99 128.58 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.983 -0.687 . . . . 6.75 109.97 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 2.3 mt-10 -122.15 67.23 0.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.75 -0.833 . . . . 8.85 108.75 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 p -113.8 149.15 35.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.137 0.791 . . . . 5.4 113.137 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -117.92 144.13 34.0 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.086 -1.079 . . . . 3.11 108.086 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HG2' ' SG ' ' A' ' 14' ' ' CYS . 22.7 Cg_exo -66.31 171.05 39.35 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 123.933 -1.278 . . . . 3.02 110.871 -18.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -130.55 152.65 49.7 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.845 -1.539 . . . . 2.96 106.845 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 mt -121.55 143.66 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 119.586 -0.845 . . . . 1.16 111.402 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -131.07 165.82 22.41 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.873 -1.512 . . . . 1.05 108.161 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.537 HG11 ' CH2' ' A' ' 78' ' ' TRP . 32.0 t -138.61 105.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 124.174 0.921 . . . . 1.3 110.921 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' GLN . 3.6 t70 54.5 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.996 0.81 . . . . 2.81 113.019 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . 66.4 mt-30 -137.85 23.83 2.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 123.476 0.485 . . . . 5.48 111.295 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 68' ' ' HIS . 31.6 tt0 -131.03 159.45 37.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.222 -1.029 . . . . 4.45 108.222 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.504 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.6 t-160 -112.0 137.11 50.46 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 107.871 -1.159 . . . . 1.24 107.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.443 HD12 ' C ' ' A' ' 68' ' ' HIS . 1.7 mp -106.3 -46.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 119.682 -0.807 . . . . 1.59 112.131 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.26 -98.94 0.56 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.856 -1.298 . . . . 1.33 109.856 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.87 177.92 17.32 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 120.234 -0.984 . . . . 1.21 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -50.41 -47.43 56.51 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.787 -0.765 . . . . 1.45 111.048 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -43.96 -57.26 3.42 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.609 0.718 . . . . 1.66 111.11 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.71 -49.01 79.23 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.658 -1.155 . . . . 2.05 109.069 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CD2' HD23 ' A' ' 20' ' ' LEU . 15.3 t80 -44.82 -52.07 8.88 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.277 -0.969 . . . . 0.95 110.145 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 -57.96 9.48 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 120.007 -0.677 . . . . 0.83 111.562 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.34 42.35 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 118.372 -1.331 . . . . 1.08 109.303 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.61 ' CH2' HD21 ' A' ' 83' ' ' LEU . 75.8 t90 -41.61 -52.4 3.79 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.323 -0.853 . . . . 0.98 110.631 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -44.59 -46.2 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 115.551 -0.749 . . . . 0.91 110.721 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.535 ' C ' ' HD3' ' A' ' 80' ' ' LYS . 5.8 tmtm? -48.92 -38.77 23.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.981 1.104 . . . . 3.26 113.981 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -108.19 -31.72 7.79 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 114.716 1.376 . . . . 4.84 114.716 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.445 ' C ' HD22 ' A' ' 83' ' ' LEU . 3.3 m120 -83.5 -22.95 32.34 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.976 -1.49 . . . . 1.89 110.574 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.61 HD21 ' CH2' ' A' ' 78' ' ' TRP . 3.3 mm? -108.6 -55.65 2.36 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.619 -0.832 . . . . 2.62 108.949 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 O-C-N 126.852 2.595 . . . . 4.32 112.728 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.8 mtm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.975 -1.12 . . . . 2.29 107.975 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -113.73 116.45 29.43 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.489 0.493 . . . . 4.18 110.743 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 24.1 m -110.81 119.04 37.8 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.013 -1.106 . . . . 0.92 108.013 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.489 ' C ' HD12 ' A' ' 5' ' ' ILE . 43.3 t -114.57 135.54 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 119.687 -0.805 . . . . 0.96 111.248 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -113.43 123.31 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 124.52 1.138 . . . . 1.12 108.016 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -108.92 92.58 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.322 -2.103 . . . . 2.14 105.322 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.05 -171.81 15.9 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.04 -2.424 . . . . 1.41 107.04 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -95.44 174.53 6.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 116.726 -1.99 . . . . 4.67 110.365 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -55.76 76.65 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.906 -1.952 . . . . 5.97 109.323 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 97.07 74.04 1.17 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 106.885 -2.486 . . . . 3.67 106.885 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.465 ' HB2' ' H ' ' A' ' 8' ' ' ARG . 42.1 t -111.95 94.9 26.8 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 119.749 -0.78 . . . . 6.41 109.213 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 1.3 Cg_endo -41.11 -21.77 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.368 2.045 . . . . 3.95 113.026 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -72.85 -45.03 60.55 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.464 -1.294 . . . . 4.09 109.339 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.481 ' SG ' HG21 ' A' ' 5' ' ' ILE . 5.2 t -54.83 -39.8 68.94 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.283 -0.967 . . . . 4.34 108.79 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.8 t -43.75 -36.56 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 115.387 -0.824 . . . . 1.31 111.7 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.621 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 2.9 mmp_? -82.41 -45.63 14.57 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 119.106 -1.038 . . . . 3.33 109.708 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.03 60.76 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.683 -1.599 . . . . 0.81 106.683 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.615 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.8 tmtt? -56.73 -59.62 4.76 Favored 'General case' 0 C--O 1.187 -2.187 0 CA-C-N 113.342 -1.754 . . . . 2.21 108.657 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.615 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -48.58 -54.04 16.06 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 118.909 -1.116 . . . . 2.51 111.141 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.51 -60.89 2.74 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.494 -0.775 . . . . 0.9 110.574 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.82 77.73 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.278 -0.569 . . . . 0.99 110.564 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' SER . 31.4 tt0 -56.24 -49.52 73.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 124.445 1.091 . . . . 1.95 109.528 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -49.95 -61.56 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.125 -1.03 . . . . 4.5 108.259 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.451 HD11 HG13 ' A' ' 79' ' ' VAL . 47.1 mt -50.6 -57.63 7.74 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.108 -1.071 . . . . 1.28 108.108 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 8.3 t -34.59 -47.79 0.34 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.191 -1.368 . . . . 1.01 110.885 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -85.52 -30.72 23.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.628 1.205 . . . . 2.36 112.654 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.548 ' HB2' ' HD2' ' A' ' 28' ' ' ARG . 80.8 mt-10 -70.0 -32.45 70.63 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.071 -1.052 . . . . 3.22 110.629 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.548 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.54 37.52 2.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.203 -1.399 . . . . 4.9 113.831 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' ARG . 48.0 m-20 28.81 52.76 0.07 Allowed 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 114.611 1.337 . . . . 4.9 114.611 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -155.18 -45.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 117.983 -1.487 . . . . 3.7 113.679 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -81.38 69.04 7.93 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.553 -0.859 . . . . 2.56 110.306 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.41 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 1.1 mp0 -83.48 147.03 28.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.701 -1.222 . . . . 4.71 107.701 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 3' ' ' THR . 46.5 p90 -119.46 161.75 20.01 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.561 -1.255 . . . . 1.1 112.196 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -129.78 136.04 49.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.305 -1.316 . . . . 3.93 107.91 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 3.6 t80 -113.7 117.94 32.95 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.615 -1.254 . . . . 1.56 107.615 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.13 146.9 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.833 -1.173 . . . . 1.4 107.833 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.1 143.42 45.51 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.629 1.204 . . . . 2.32 111.749 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 8' ' ' ARG . 18.8 pt -56.93 -40.75 74.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 112.262 -2.245 . . . . 1.23 112.257 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.402 ' NH2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -86.41 -10.07 55.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.216 -0.994 . . . . 5.32 111.656 -178.078 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.51 -49.02 6.92 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.699 -0.852 . . . . 1.41 108.699 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.37 -37.66 43.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.669 -1.605 . . . . 3.6 111.191 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 46.42 1.86 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.634 -1.786 . . . . 1.36 108.634 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.495 HG21 ' HG ' ' A' ' 48' ' ' LEU . 22.2 mt -87.25 146.94 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.847 -1.168 . . . . 1.57 107.847 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -110.64 176.4 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.919 -0.712 . . . . 2.47 111.124 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -67.31 -57.77 6.04 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.188 -1.412 . . . . 5.32 107.188 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 1.7 mp0 -47.86 -48.51 31.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.753 -1.112 . . . . 4.58 110.023 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 26.6 t70 -64.64 -56.59 12.87 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.353 -0.939 . . . . 2.02 110.48 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.495 ' HG ' HG21 ' A' ' 43' ' ' ILE . 1.3 mt -56.69 -40.23 75.23 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.459 -0.896 . . . . 1.55 111.131 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -62.0 -43.83 98.0 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.722 -1.585 . . . . 3.64 106.722 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.78 -40.05 75.17 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.276 -0.875 . . . . 3.74 108.762 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 48.2 mmtm -64.12 -51.95 61.45 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.261 -0.882 . . . . 2.27 111.459 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.62 70.06 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 112.877 0.695 . . . . 1.63 112.877 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.36 -47.53 1.01 Allowed Glycine 0 N--CA 1.503 3.152 0 C-N-CA 119.44 -1.362 . . . . 2.72 112.205 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -110.45 174.36 2.41 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.732 . . . . 7.59 109.022 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.36 68.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.98 1.787 . . . . 5.6 110.903 143.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.4 47.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.18 -1.045 . . . . 6.29 108.18 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -82.66 72.47 9.73 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.908 -1.042 . . . . 8.17 108.671 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 p -103.57 100.62 10.46 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.753 -1.112 . . . . 5.09 108.798 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 m -74.56 138.36 74.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 C-N-CA 117.759 -1.576 . . . . 1.68 109.598 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -93.91 137.56 6.87 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 O-C-N 122.932 0.964 . . . . 1.79 111.623 7.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.42 ' NE2' HD22 ' A' ' 48' ' ' LEU . 7.2 mp0 -97.65 142.87 28.92 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.287 -1.746 . . . . 3.73 106.287 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.8 mp -115.29 143.77 24.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.416 -0.913 . . . . 1.57 109.474 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.286 -1.779 . . . . 1.17 108.785 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.67 118.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 105.466 -2.05 . . . . 0.93 105.466 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 64.67 -86.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.621 -1.251 . . . . 3.27 107.621 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.62 5.3 1.04 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.084 -0.962 . . . . 3.58 109.204 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -91.2 162.16 14.76 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.359 -0.978 . . . . 3.71 108.359 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -108.67 138.15 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.633 -0.877 . . . . 0.91 108.633 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -106.87 -43.85 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.383 -0.927 . . . . 0.83 109.151 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.7 -134.9 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.015 -1.634 . . . . 1.15 109.015 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.44 179.27 25.62 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 108.969 -1.652 . . . . 1.19 108.969 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -45.62 -38.52 6.71 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 118.953 -1.099 . . . . 1.53 110.789 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -54.15 -63.29 1.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.372 0.606 . . . . 1.77 109.72 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.79 -47.28 80.54 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.115 -0.948 . . . . 2.36 108.538 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.45 ' CD1' HG21 ' A' ' 62' ' ' ILE . 42.4 t80 -47.16 -51.63 17.75 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.339 -0.846 . . . . 0.87 110.536 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.11 -53.08 62.12 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.02 -1.072 . . . . 0.81 109.687 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.34 -56.43 16.72 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.139 -1.024 . . . . 0.82 109.967 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -48.94 -57.62 6.19 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.038 -0.983 . . . . 0.7 108.605 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.451 HG13 HD11 ' A' ' 24' ' ' LEU . 26.9 t -46.08 -52.84 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 124.255 0.972 . . . . 0.8 108.725 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -57.73 -54.92 41.47 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.81 1.041 . . . . 3.19 113.81 -178.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.405 ' N ' ' HE3' ' A' ' 80' ' ' LYS . 1.5 pt-20 -73.11 -29.16 62.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.432 1.271 . . . . 4.42 114.432 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -90.57 -31.94 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.803 -1.159 . . . . 1.8 109.919 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.16 53.07 0.93 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.749 -1.204 . . . . 2.82 107.749 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.521 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 4.8 t0 . . . . . 0 C--N 1.289 -2.033 0 CA-C-N 114.345 -1.298 . . . . 4.77 109.361 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 107.062 -1.458 . . . . 3.0 107.062 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -106.44 107.04 17.85 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.529 -0.915 . . . . 4.03 108.529 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.436 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 25.0 m -93.13 136.14 33.66 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.685 -0.806 . . . . 0.97 109.403 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.524 ' C ' HD12 ' A' ' 5' ' ' ILE . 5.3 t -122.62 128.57 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 119.397 -0.921 . . . . 0.97 108.709 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -111.27 136.98 45.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 124.29 0.994 . . . . 1.13 108.898 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -108.16 112.34 24.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 102.456 -3.164 . . . . 2.45 102.456 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.531 ' HA2' ' SG ' ' A' ' 14' ' ' CYS . . . -109.32 -166.15 20.31 Favored Glycine 0 N--CA 1.501 2.975 0 C-N-CA 118.552 -1.785 . . . . 1.83 114.195 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.479 HH12 ' CB ' ' A' ' 58' ' ' THR . 7.8 ttt85 -108.76 -141.6 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.892 -1.154 . . . . 7.96 109.348 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.51 176.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.572 0.701 . . . . 5.71 112.073 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.05 67.23 2.75 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.837 -0.905 . . . . 5.16 110.837 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 50.5 t -128.37 152.75 78.63 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.247 -1.39 . . . . 5.67 107.247 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.515 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 32.0 Cg_endo -70.21 67.16 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.42 1.414 . . . . 5.15 111.334 172.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -109.4 -94.6 0.41 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.92 -1.141 . . . . 4.22 107.92 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' HA2' ' A' ' 7' ' ' GLY . 46.5 m -52.46 -20.47 2.9 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.618 -0.833 . . . . 2.5 109.132 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 18' ' ' LYS . 91.6 t -45.89 -33.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.923 -1.035 . . . . 2.79 110.301 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -44.87 -35.84 3.0 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.461 -0.896 . . . . 2.99 110.379 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 5' ' ' ILE . . . -66.37 -43.37 86.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.097 -1.446 . . . . 1.09 107.097 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HE2' ' N ' ' A' ' 19' ' ' ASP . 3.3 tmpt? -57.7 -45.28 85.89 Favored 'General case' 0 C--O 1.196 -1.724 0 N-CA-C 107.855 -1.165 . . . . 1.74 107.855 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 68.9 m-20 -63.09 -60.76 3.0 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.835 -0.62 . . . . 3.31 109.788 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 tp -48.41 -55.21 11.45 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.951 -0.7 . . . . 0.92 109.815 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.33 82.21 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.872 -0.731 . . . . 1.16 109.919 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 27.5 tt0 -45.43 -49.77 13.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 123.593 0.558 . . . . 1.96 110.789 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 23.0 tptp -52.07 -56.22 15.77 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 118.316 -1.353 . . . . 4.71 110.972 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.448 HD11 ' CG1' ' A' ' 79' ' ' VAL . 33.7 mt -52.7 -48.85 66.31 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.326 -1.731 . . . . 1.31 106.326 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -47.19 -38.69 12.42 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.543 -2.117 . . . . 1.06 108.731 178.369 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -117.75 42.25 2.67 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.136 -0.938 . . . . 2.38 110.201 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.527 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 30.8 tt0 -117.29 -59.63 1.92 Allowed 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.152 -1.425 . . . . 3.31 107.152 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.527 ' HD3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -117.97 16.36 14.23 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.698 -2.334 . . . . 3.71 104.698 177.54 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.0 OUTLIER 34.46 47.2 0.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 123.221 1.486 . . . . 6.0 109.156 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.02 9.52 8.73 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 111.694 -2.503 . . . . 4.82 111.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.436 ' CZ ' ' OG1' ' A' ' 3' ' ' THR . 21.0 t80 -134.85 147.73 49.96 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.963 -0.695 . . . . 1.67 110.012 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -135.25 151.53 50.68 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.07 -0.715 . . . . 3.17 109.07 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 42.6 p90 -139.29 155.94 47.38 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.2 -1.0 . . . . 1.67 111.367 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -135.97 138.56 42.41 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.839 -1.171 . . . . 4.47 107.839 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -114.05 133.27 55.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.749 -1.18 . . . . 1.26 109.091 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 37' ' ' ASP . 92.4 t -129.7 167.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.889 0.852 . . . . 1.37 110.857 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 36' ' ' VAL . 29.6 t0 -118.48 128.12 54.29 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.296 -1.002 . . . . 2.14 108.296 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.3 pt -43.81 -34.53 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.49 0.662 . . . . 1.59 111.235 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 2.3 ttm105 -74.6 -54.97 6.44 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.222 -0.899 . . . . 5.98 110.007 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -36.54 -55.13 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.168 0.918 . . . . 2.1 112.237 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -74.6 -41.47 60.38 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 124.147 0.904 . . . . 4.52 109.748 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.45 46.4 1.14 Allowed Glycine 0 N--CA 1.502 3.082 0 N-CA-C 108.317 -1.913 . . . . 2.06 108.317 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mt -98.93 152.97 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.128 -1.036 . . . . 2.08 110.474 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.1 p -116.69 141.3 48.38 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.768 -1.106 . . . . 2.53 108.852 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -45.04 -51.05 10.45 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.258 -0.977 . . . . 5.04 110.807 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 2.7 mp0 -50.94 -47.25 61.12 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.875 -0.73 . . . . 5.82 110.358 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' OD1' ' NZ ' ' A' ' 51' ' ' LYS . 4.5 t0 -53.94 -55.5 26.48 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.401 -0.92 . . . . 3.67 108.55 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.21 -50.94 63.68 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 114.962 -1.017 . . . . 2.6 109.198 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 20.3 mt-30 -49.19 -49.24 43.61 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.293 -1.321 . . . . 6.58 108.283 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -63.64 -55.94 19.65 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.79 -1.095 . . . . 5.33 110.527 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' NZ ' ' OD1' ' A' ' 47' ' ' ASP . 41.3 mttp -53.88 -47.68 70.84 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 115.633 -0.712 . . . . 3.34 111.843 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.31 -55.96 26.93 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.481 -1.236 . . . . 2.26 112.601 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.29 -34.49 5.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.001 -1.64 . . . . 3.95 109.001 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -106.21 146.37 32.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 120.09 -0.644 . . . . 6.61 109.645 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.23 89.79 0.32 Allowed 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.825 2.35 . . . . 4.89 111.635 -171.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.423 HG11 HE22 ' A' ' 61' ' ' GLN . 5.1 m -98.46 -177.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 C-N-CA 119.828 -0.749 . . . . 6.18 109.102 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 11.1 tp10 -110.15 -68.7 0.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.966 0.791 . . . . 7.53 110.679 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.479 ' CB ' HH12 ' A' ' 8' ' ' ARG . 2.0 p -144.39 -61.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.645 1.212 . . . . 5.91 109.746 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 8' ' ' ARG . 27.4 m -132.11 178.76 1.6 Allowed Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 112.749 -2.023 . . . . 2.59 107.863 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 28.7 Cg_endo -70.01 138.36 49.32 Favored 'Cis proline' 0 N--CA 1.491 1.335 0 O-C-N 122.994 0.997 . . . . 3.13 111.369 -25.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.423 HE22 HG11 ' A' ' 56' ' ' VAL . 6.6 mm-40 -125.49 125.39 43.22 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.461 -0.94 . . . . 2.46 108.461 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.5 mp -122.54 141.37 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.042 0.925 . . . . 1.93 110.92 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -128.04 163.0 25.52 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 113.13 -1.85 . . . . 1.2 108.783 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.01 124.26 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 118.587 -0.72 . . . . 1.48 109.252 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 50.95 -97.38 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.773 -0.771 . . . . 2.21 111.778 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -129.63 27.52 5.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.447 -1.252 . . . . 3.87 111.02 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -130.66 168.61 16.86 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 116.293 -0.412 . . . . 3.75 111.019 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.526 ' ND1' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t-80 -116.72 144.34 44.56 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.964 -0.754 . . . . 1.06 108.964 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.35 -54.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 118.612 -1.235 . . . . 1.1 109.602 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 144.47 -128.41 3.24 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.617 -1.277 . . . . 1.17 110.626 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -111.96 -171.81 18.91 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.261 -1.447 . . . . 1.18 110.284 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -44.99 -40.61 6.61 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.671 -1.211 . . . . 1.5 109.694 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -55.21 -63.98 0.99 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.417 0.627 . . . . 2.05 110.062 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -46.48 71.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.769 -1.105 . . . . 2.88 110.002 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.401 ' CD1' HG21 ' A' ' 62' ' ' ILE . 41.5 t80 -61.23 -50.5 72.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.748 -0.781 . . . . 1.09 111.312 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.93 -57.07 10.51 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.569 -0.852 . . . . 1.08 109.441 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.16 24.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.688 -0.805 . . . . 0.9 110.112 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -43.42 -46.9 6.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 124.118 0.886 . . . . 1.25 109.395 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.448 ' CG1' HD11 ' A' ' 24' ' ' LEU . 19.1 t -62.75 -67.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.923 -1.035 . . . . 0.99 108.896 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -45.35 -34.99 3.29 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 115.845 1.794 . . . . 2.24 115.845 -176.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' OE2' ' NZ ' ' A' ' 80' ' ' LYS . 1.3 mp0 -101.63 9.41 41.13 Favored 'General case' 0 N--CA 1.512 2.652 0 C-N-CA 118.376 -1.33 . . . . 4.71 113.841 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -128.07 -35.83 2.01 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.951 -0.7 . . . . 1.81 109.325 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.92 23.13 14.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.546 -0.862 . . . . 1.99 109.643 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 8.7 t70 . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 107.382 -1.34 . . . . 3.94 107.382 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpp? . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.226 1.013 . . . . 2.74 109.291 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.444 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 2.0 mp0 -104.0 105.19 15.29 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.312 -1.313 . . . . 5.71 108.173 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.4 m -97.26 117.99 32.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.338 -0.945 . . . . 1.11 110.392 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.9 t -113.9 142.31 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 115.532 -0.758 . . . . 1.09 109.79 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.7 mm -114.25 133.77 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.585 -2.006 . . . . 2.0 105.585 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -121.65 80.09 1.64 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.629 -1.619 . . . . 1.9 106.629 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.28 -177.35 24.17 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.727 -1.225 . . . . 1.35 111.823 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -122.54 94.15 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.362 -1.347 . . . . 6.56 107.362 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.439 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 4.6 t -74.31 73.6 1.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.008 -1.077 . . . . 6.95 111.097 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -41.02 -50.88 4.25 Favored Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.096 -0.802 . . . . 3.12 111.096 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.452 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 17.3 m -111.87 -170.1 0.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 106.691 -1.596 . . . . 4.67 106.691 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 52.8 Cg_exo -53.0 73.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 120.856 1.038 . . . . 4.32 111.409 153.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -119.54 -85.09 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.042 -0.725 . . . . 4.76 109.042 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -60.19 -24.73 65.02 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 106.993 -1.484 . . . . 2.06 106.993 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' OG ' ' A' ' 9' ' ' SER . 57.3 t -43.81 -32.65 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 CA-C-N 114.278 -1.328 . . . . 1.63 109.634 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -71.56 -50.12 34.13 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.55 -1.26 . . . . 3.53 109.666 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.93 -44.46 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.018 -1.845 . . . . 0.78 106.018 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.464 ' C ' ' HD2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -56.09 -58.91 5.93 Favored 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 113.712 -1.586 . . . . 1.67 107.034 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -43.04 -57.96 2.65 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 120.11 -0.636 . . . . 3.52 110.798 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.98 -62.92 1.29 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.874 -1.057 . . . . 0.78 110.086 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB1' ' CB ' ' A' ' 33' ' ' TYR . . . -53.1 -54.57 33.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.15 -1.02 . . . . 0.69 109.28 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 41.5 tt0 -45.33 -52.63 9.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.088 0.867 . . . . 2.11 110.778 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -58.85 -53.0 63.32 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.881 -1.128 . . . . 4.81 108.457 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -51.93 -41.29 61.91 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.625 -0.83 . . . . 1.12 110.233 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.1 p -73.9 -6.58 48.08 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.272 -0.971 . . . . 1.97 112.047 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -115.72 31.53 6.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.076 -1.453 . . . . 2.5 107.076 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 23' ' ' LYS . 5.8 mm-40 -140.73 -51.65 0.47 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.009 -1.45 . . . . 4.6 107.884 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.587 HH12 ' CG ' ' A' ' 30' ' ' ASP . 13.5 mtp-105 -93.63 -170.42 2.35 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.519 -1.218 . . . . 4.05 111.119 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -111.09 -48.77 3.08 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.453 -0.794 . . . . 5.26 111.24 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.587 ' CG ' HH12 ' A' ' 28' ' ' ARG . 2.8 p30 -83.33 8.1 14.57 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.533 -0.867 . . . . 2.76 111.16 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 25' ' ' SER . 3.3 t80 -104.34 114.44 28.67 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.567 -0.853 . . . . 1.32 111.602 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -130.14 157.5 42.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.048 -1.834 . . . . 3.7 106.048 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 21.2 p90 -129.47 160.89 31.74 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.411 -1.315 . . . . 1.4 110.881 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -141.62 149.22 40.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.019 0.824 . . . . 4.52 110.193 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -126.29 113.39 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.687 -1.597 . . . . 1.54 106.687 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.04 157.82 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.073 -1.825 . . . . 1.39 106.073 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -124.74 140.46 52.91 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.28 -1.368 . . . . 2.58 111.239 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.442 ' C ' HH11 ' A' ' 39' ' ' ARG . 16.7 pt -61.78 -21.94 27.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.066 -0.97 . . . . 1.29 111.517 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.506 ' HA ' HH11 ' A' ' 39' ' ' ARG . 3.3 tpp180 -95.43 -51.48 4.55 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.789 -0.819 . . . . 7.39 108.789 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.75 -49.3 5.69 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.538 1.149 . . . . 1.4 110.148 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -99.55 36.82 1.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.576 -0.85 . . . . 4.64 112.553 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 34.27 65.16 0.36 Allowed Glycine 0 N--CA 1.512 3.715 0 CA-C-O 121.792 0.662 . . . . 1.59 114.168 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.469 HG23 ' HB3' ' A' ' 47' ' ' ASP . 58.1 mt -109.96 148.08 13.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.004 -0.598 . . . . 1.61 109.607 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -126.18 177.86 6.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.965 -1.494 . . . . 2.22 106.965 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -51.68 -47.92 63.68 Favored 'General case' 0 C--O 1.191 -1.984 0 C-N-CA 119.798 -0.761 . . . . 5.36 110.427 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 6.3 mp0 -44.18 -52.59 7.24 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 113.862 1.06 . . . . 3.31 113.862 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 43' ' ' ILE . 50.2 t0 -65.97 -55.86 14.64 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.052 -1.059 . . . . 3.03 109.564 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.489 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.2 mt -53.66 -42.33 67.75 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.548 -0.861 . . . . 1.52 110.201 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -59.21 -42.26 90.53 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.174 -1.417 . . . . 3.99 107.174 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -73.75 -20.92 60.36 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.851 -1.068 . . . . 3.45 110.589 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -79.96 -46.48 16.61 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.959 -0.696 . . . . 3.28 111.386 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.09 -28.3 11.1 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.73 -0.788 . . . . 1.45 113.009 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.92 -56.76 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 105.767 -2.933 . . . . 4.06 105.767 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.5 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 57.3 mttp 60.1 126.85 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.997 0 CA-C-O 123.266 1.508 . . . . 9.06 114.935 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' C ' ' HB3' ' A' ' 54' ' ' LYS . 12.0 Cg_endo -52.53 139.3 56.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.69 2.26 . . . . 3.65 109.391 96.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 58' ' ' THR . 7.9 p -74.35 72.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 118.952 -1.099 . . . . 5.98 110.768 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.08 33.0 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 119.743 -0.783 . . . . 7.73 112.169 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 56' ' ' VAL . 80.5 p 39.27 -109.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 115.035 1.494 . . . . 3.98 115.035 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.87 149.33 72.77 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 114.219 -1.355 . . . . 1.69 109.724 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.452 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 98.7 Cg_endo -96.37 -175.4 4.63 Favored 'Cis proline' 0 C--N 1.32 -0.925 0 O-C-N 123.15 1.079 . . . . 2.04 110.049 0.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 1.9 mt-30 -138.89 133.78 32.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 124.489 1.118 . . . . 3.01 109.788 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.8 mt -118.07 140.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 120.107 -0.637 . . . . 1.35 110.926 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.85 148.82 52.66 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.73 -1.577 . . . . 0.96 110.658 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.599 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 38.2 t -123.17 111.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.14 -1.059 . . . . 0.87 108.14 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.98 -76.07 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.103 0.954 . . . . 3.21 109.403 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 64' ' ' VAL . 45.0 tt0 -142.94 -9.11 0.8 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.058 -1.428 . . . . 4.38 110.663 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -92.12 168.79 11.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.746 -0.382 . . . . 5.37 110.677 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.47 ' CE1' ' NE2' ' A' ' 61' ' ' GLN . 85.9 t60 -119.19 153.17 35.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.708 -1.219 . . . . 1.27 107.708 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.0 -50.75 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 119.007 -1.077 . . . . 1.1 109.698 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 164.98 -158.25 31.01 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.959 -1.656 . . . . 1.19 108.959 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 60' ' ' PRO . . . -87.59 -67.6 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.88 -1.629 . . . . 2.85 110.159 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 73' ' ' THR . 61.7 t80 -152.03 179.92 8.05 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.547 -0.861 . . . . 3.75 108.788 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 72' ' ' TYR . 85.0 m 67.73 -68.14 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.629 0.581 . . . . 2.99 110.212 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.53 -51.1 5.21 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.105 0.955 . . . . 3.71 110.155 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.44 -36.96 2.16 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.615 -1.63 . . . . 1.3 112.696 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.59 -49.19 57.09 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.325 -0.95 . . . . 1.37 109.848 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.06 62.51 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.463 -0.94 . . . . 1.46 108.463 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.599 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 78.3 t90 -46.61 -53.81 10.77 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.775 -1.102 . . . . 0.92 109.038 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.555 HG13 HD12 ' A' ' 83' ' ' LEU . 80.4 t -55.42 -41.61 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.904 -1.119 . . . . 1.08 109.534 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.501 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -65.01 -38.89 92.43 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.88 -1.054 . . . . 2.21 113.437 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.37 -12.53 12.99 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 115.815 1.783 . . . . 4.71 115.815 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.436 ' CG ' ' NE1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -92.22 -16.33 26.34 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.544 -0.862 . . . . 1.72 109.996 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.555 HD12 HG13 ' A' ' 79' ' ' VAL . 59.6 mt -102.31 -73.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.454 -0.898 . . . . 3.44 109.16 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.25 0 O-C-N 124.287 0.992 . . . . 4.14 112.003 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.658 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.498 -0.556 . . . . 2.83 109.498 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.1 96.97 9.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 123.703 0.627 . . . . 3.97 110.809 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.6 m -91.62 126.04 36.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.043 -0.725 . . . . 1.06 109.043 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.527 ' C ' HD12 ' A' ' 5' ' ' ILE . 16.6 t -129.02 141.76 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.708 -1.197 . . . . 1.18 109.664 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -111.28 132.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.117 -2.179 . . . . 1.26 105.117 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 50.0 m-85 -124.2 116.31 22.49 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.262 -0.644 . . . . 1.89 109.262 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.11 -179.35 20.47 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.251 -1.452 . . . . 2.24 112.353 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -127.23 163.61 23.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.76 -0.72 . . . . 5.52 109.623 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -106.11 -53.12 2.68 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.113 0.959 . . . . 7.76 109.363 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.79 -61.51 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 105.814 -2.914 . . . . 4.92 105.814 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 13' ' ' TYR . 9.6 m -96.24 170.39 7.61 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 106.388 -1.708 . . . . 5.25 106.388 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.93 73.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.365 2.043 . . . . 3.06 111.605 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' CYS . 6.3 t80 -119.63 -60.93 1.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.768 . . . . 5.54 108.925 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 29.8 m -54.64 -39.53 68.06 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 122.615 1.198 . . . . 2.27 108.193 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.0 t -44.41 -50.29 2.01 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 CA-C-N 113.396 -1.729 . . . . 1.28 111.278 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 8.5 mmm180 -56.92 -41.17 77.68 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.105 -1.038 . . . . 3.78 110.243 -178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.12 80.05 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.218 -1.401 . . . . 0.77 107.218 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -52.5 65.06 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.76 -1.176 . . . . 1.79 107.855 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.05 -52.17 9.26 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.458 -0.897 . . . . 3.13 110.628 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' A' ' 75' ' ' PHE . 40.9 tp -58.49 -60.38 3.89 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 120.41 -0.516 . . . . 0.81 110.656 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.31 -44.22 44.13 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.969 -1.014 . . . . 0.64 109.45 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.91 -51.46 66.84 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 124.709 1.256 . . . . 1.74 109.358 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -50.21 -56.16 12.25 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.394 -0.922 . . . . 4.33 108.674 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.497 HD11 HG21 ' A' ' 79' ' ' VAL . 44.6 mt -57.3 -44.36 84.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.341 1.026 . . . . 1.14 109.179 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 t -51.89 -29.9 21.78 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.979 -1.464 . . . . 0.99 109.61 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.474 ' CG ' ' O ' ' A' ' 26' ' ' ASN . 5.9 t-20 -96.38 25.77 4.79 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.152 -0.931 . . . . 2.71 110.935 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.7 mt-10 -138.74 -35.44 0.58 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.504 -0.771 . . . . 2.52 110.537 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 30' ' ' ASP . 43.3 mtp85 -114.71 129.86 56.74 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.759 -0.776 . . . . 3.75 112.017 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.16 32.56 0.28 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.242 1.02 . . . . 3.62 109.742 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.3 p30 -136.49 -1.7 2.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.708 -1.587 . . . . 3.16 109.243 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -120.64 124.53 45.47 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.653 0.739 . . . . 0.92 112.635 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -142.76 155.13 44.8 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.131 -1.433 . . . . 4.85 107.131 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -134.76 163.88 28.81 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.105 -1.438 . . . . 1.27 112.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.65 154.52 44.43 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 124.604 1.19 . . . . 5.21 109.389 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.42 ' HD1' ' N ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -127.88 124.63 37.94 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.9 -0.72 . . . . 2.7 110.162 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' N ' ' HD1' ' A' ' 35' ' ' TYR . 2.4 t -123.41 149.88 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.379 -1.341 . . . . 1.87 107.379 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -123.55 124.91 43.89 Favored 'General case' 0 N--CA 1.51 2.57 0 C-N-CA 117.816 -1.554 . . . . 2.37 110.412 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 pt -43.5 -38.76 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 113.435 -1.711 . . . . 1.52 114.017 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 24.35 6.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.237 -0.985 . . . . 8.48 112.905 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.95 -43.96 2.74 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.012 -1.107 . . . . 2.02 108.012 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -92.45 -28.68 16.69 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.686 -1.597 . . . . 5.96 111.288 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.4 0.66 Allowed Glycine 0 N--CA 1.503 3.103 0 C-N-CA 119.364 -1.398 . . . . 1.95 111.132 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.9 mt -112.46 156.84 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.665 -0.814 . . . . 2.11 108.984 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -101.24 -170.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.428 -0.953 . . . . 2.54 108.428 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -49.98 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.722 -1.584 . . . . 4.65 106.722 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.69 -52.25 24.38 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.372 -0.931 . . . . 3.87 110.118 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.85 -44.93 40.11 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 120.064 -0.654 . . . . 2.65 111.49 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 1.8 mt -70.14 -42.83 72.06 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.886 0.85 . . . . 1.63 109.011 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 49' ' ' GLN . 3.4 tp-100 -58.27 -32.48 68.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.625 -1.25 . . . . 5.06 107.625 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.81 0.96 7.74 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.048 -1.433 . . . . 4.15 110.263 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 57.3 mttp -115.85 -42.72 3.06 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.57 -1.195 . . . . 2.3 109.824 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -81.02 -50.89 9.12 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.358 -0.837 . . . . 1.05 111.476 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.74 -55.54 2.28 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.65 -2.18 . . . . 2.77 107.65 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HD3' HE22 ' A' ' 61' ' ' GLN . 44.4 mtmt 31.14 -147.39 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 CA-C-N 112.526 -1.837 . . . . 7.92 113.566 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 57.2 Cg_endo -92.37 -166.95 0.17 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.962 1.775 . . . . 4.08 112.416 128.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -98.52 81.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.369 -0.832 . . . . 6.85 109.543 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -115.4 -94.25 0.48 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.948 1.092 . . . . 5.41 113.948 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 59' ' ' VAL . 1.3 m -142.86 -156.05 0.65 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 118.972 -1.091 . . . . 4.55 113.738 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.572 ' H ' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -114.78 -169.05 0.14 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 114.389 -1.278 . . . . 3.35 108.966 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.651 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 31.7 Cg_endo -68.57 -175.42 9.49 Favored 'Cis proline' 0 N--CA 1.499 1.815 0 O-C-N 122.182 0.57 . . . . 2.75 111.553 -28.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.462 HE22 ' HD3' ' A' ' 54' ' ' LYS . 19.3 tp60 -134.74 150.95 50.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 123.976 0.798 . . . . 2.83 111.864 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mt -123.67 142.51 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.711 -1.218 . . . . 1.07 107.711 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.21 156.56 48.5 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.844 -1.071 . . . . 1.01 110.004 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.6 t -138.12 115.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.017 -0.673 . . . . 1.33 109.653 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 1' ' ' MET . 1.2 m-20 54.44 -101.94 0.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.253 -1.017 . . . . 3.28 108.253 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -125.75 39.55 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.857 -0.794 . . . . 3.98 108.857 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -127.51 161.78 27.97 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.416 -0.811 . . . . 3.49 109.984 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.509 ' CD2' ' N ' ' A' ' 69' ' ' ILE . 5.5 t-160 -122.54 142.42 50.62 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.753 -1.203 . . . . 1.15 107.753 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.509 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 28.1 mm -101.33 -99.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 118.704 -1.198 . . . . 1.83 107.877 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.42 65.29 0.21 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.401 -1.38 . . . . 4.23 110.611 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.66 -175.33 17.52 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.995 -1.642 . . . . 1.52 108.995 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' PHE . 13.6 t80 -110.08 -60.75 1.75 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.356 -0.938 . . . . 1.51 109.947 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -46.09 -34.11 3.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.578 -1.638 . . . . 4.91 106.578 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.6 -44.11 97.61 Favored 'General case' 0 C--O 1.2 -1.537 0 CA-C-N 113.077 -1.874 . . . . 3.41 108.87 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CD2' HD23 ' A' ' 20' ' ' LEU . 11.9 t80 -63.45 -41.52 98.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.476 -0.935 . . . . 1.11 108.476 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -62.48 -56.15 20.86 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.365 -0.934 . . . . 1.3 108.966 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.15 43.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.325 -1.361 . . . . 1.28 107.325 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.438 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 80.1 t90 -36.47 -54.73 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.981 0.801 . . . . 1.1 110.413 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.497 HG21 HD11 ' A' ' 24' ' ' LEU . 41.4 t -43.92 -60.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 115.199 -0.91 . . . . 1.48 111.92 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -44.33 -29.61 0.7 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.614 0.968 . . . . 3.16 113.614 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -109.06 -27.02 9.86 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.628 -0.829 . . . . 4.13 113.044 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -83.98 -34.13 24.43 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.042 -1.063 . . . . 1.84 111.017 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.44 HD12 HG13 ' A' ' 79' ' ' VAL . 68.0 mt -102.47 -44.79 5.26 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.042 -1.836 . . . . 3.45 106.042 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 126.497 2.373 . . . . 5.19 111.501 179.551 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.579 ' H2 ' ' CG ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.344 0.592 . . . . 2.69 110.04 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -109.65 99.44 8.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.579 -2.378 . . . . 4.43 104.579 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.461 HG21 ' CE1' ' A' ' 75' ' ' PHE . 27.1 m -88.4 103.42 15.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.906 -1.497 . . . . 1.37 109.868 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 63.3 t -94.47 130.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.751 -0.659 . . . . 1.28 110.292 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.494 HG21 ' SG ' ' A' ' 14' ' ' CYS . 1.6 mp -113.74 116.86 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.411 -1.7 . . . . 1.08 106.411 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.627 ' CE2' HD13 ' A' ' 43' ' ' ILE . 2.8 m-30 -106.33 98.38 8.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.826 -1.916 . . . . 2.65 105.826 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 60' ' ' PRO . . . -130.59 -159.99 9.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.42 -1.371 . . . . 1.62 112.481 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' CZ ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -124.4 130.1 51.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.02 -1.474 . . . . 5.0 107.02 179.016 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.474 ' OG ' ' CZ ' ' A' ' 8' ' ' ARG . 1.6 p -51.77 106.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.632 -0.827 . . . . 4.9 108.95 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . 134.08 -12.42 4.73 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.699 -1.238 . . . . 3.61 111.16 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 97.1 m -95.3 90.94 0.66 Allowed Pre-proline 0 N--CA 1.501 2.122 0 C-N-CA 119.493 -0.883 . . . . 5.57 110.682 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 10' ' ' GLY . 28.3 Cg_endo -58.78 -3.57 1.55 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.741 2.961 . . . . 3.69 112.719 -162.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 11' ' ' CYS . 9.5 m-30 -71.44 -37.27 71.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.62 -1.252 . . . . 4.92 107.62 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 3.6 t -58.56 -43.19 89.29 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.143 -1.423 . . . . 3.62 108.21 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.42 -57.74 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.428 -0.952 . . . . 1.34 108.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 6.5 mmp_? -49.93 -48.45 51.81 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.649 -1.22 . . . . 3.73 109.649 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.0 -54.77 40.86 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.887 -1.525 . . . . 0.83 108.266 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -46.22 -49.08 17.58 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.177 -0.609 . . . . 1.71 109.879 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.479 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 35.1 m-20 -63.28 -55.68 22.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.887 -0.597 . . . . 3.29 110.188 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.5 tp -48.53 -55.73 10.27 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.987 -1.085 . . . . 0.91 109.239 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -58.69 -36.22 73.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.656 -0.818 . . . . 1.07 109.668 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.6 tt0 -51.31 -47.55 62.58 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.051 -1.059 . . . . 1.9 109.819 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -44.73 -60.15 2.16 Favored 'General case' 0 N--CA 1.514 2.751 0 C-N-CA 119.419 -0.912 . . . . 6.99 109.657 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 47.6 mt -45.53 -52.39 10.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.224 -1.353 . . . . 2.03 107.916 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -53.48 -37.34 62.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.662 -1.608 . . . . 1.36 111.415 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -104.22 37.1 2.17 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.048 0.928 . . . . 2.02 108.549 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 28' ' ' ARG . 58.9 tt0 -130.11 -51.39 1.11 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.177 -1.374 . . . . 4.76 107.517 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 27' ' ' GLU . 9.7 ptp180 -124.79 -178.39 4.14 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 112.368 -2.196 . . . . 3.11 108.619 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -116.29 27.95 8.9 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.486 0.66 . . . . 4.62 110.685 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.421 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 3.0 p30 -120.26 -8.41 9.68 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.453 -0.794 . . . . 3.06 112.701 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -108.68 130.15 55.34 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.109 1.522 . . . . 1.34 115.109 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -138.31 153.14 49.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.891 -1.152 . . . . 3.58 107.891 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.91 156.25 35.04 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.528 -0.869 . . . . 1.16 109.978 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -130.12 118.22 21.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.62 0.575 . . . . 4.7 109.914 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.496 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -107.47 112.62 25.49 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.721 -0.792 . . . . 2.23 109.287 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 156.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 123.89 0.744 . . . . 1.6 109.642 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.3 t70 -114.06 131.47 56.37 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 106.869 -1.53 . . . . 2.36 106.869 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 pt -47.78 -39.96 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 114.348 1.24 . . . . 1.18 114.348 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.506 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -85.98 -45.14 11.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.607 -1.637 . . . . 5.04 108.422 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 39' ' ' ARG . . . -35.38 -56.86 0.62 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 124.068 0.855 . . . . 1.73 110.918 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -105.5 44.53 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 124.083 0.864 . . . . 5.74 110.97 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 23.53 68.15 0.03 OUTLIER Glycine 0 N--CA 1.504 3.215 0 CA-C-N 114.773 -1.103 . . . . 2.0 114.597 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.627 HD13 ' CE2' ' A' ' 6' ' ' PHE . 34.3 mt -101.08 140.26 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.432 -1.692 . . . . 1.91 106.432 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.9 p -104.41 169.98 8.16 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.442 -0.903 . . . . 3.27 111.195 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.458 ' CA ' ' HZ2' ' A' ' 45' ' ' LYS . 5.0 mmmp? -70.83 -35.33 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 117.806 -1.558 . . . . 5.01 111.963 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.72 -55.18 38.26 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.924 -1.51 . . . . 6.55 106.924 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.476 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 25.0 t70 -48.68 -48.1 40.27 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 115.094 -0.957 . . . . 2.85 111.657 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.84 -50.22 67.5 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.836 -1.074 . . . . 2.01 110.743 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.45 -45.44 66.04 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.418 -1.327 . . . . 4.66 107.418 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -56.6 -23.33 40.13 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.613 -1.63 . . . . 4.01 111.211 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 7.9 mtmm -96.8 -32.74 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.308 -0.557 . . . . 2.35 110.849 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.531 ' HB2' HE22 ' A' ' 61' ' ' GLN . . . -75.41 -44.26 45.6 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.093 -0.643 . . . . 1.38 112.021 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.0 -48.75 0.91 Allowed Glycine 0 N--CA 1.501 3.031 0 N-CA-C 108.232 -1.947 . . . . 3.32 108.232 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.565 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 3.8 ttpm? -91.4 166.58 17.88 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.245 -2.131 . . . . 6.29 105.245 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.565 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.5 Cg_endo -48.22 155.61 1.92 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.685 -1.313 . . . . 5.29 108.685 146.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 m -118.79 149.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.897 -1.121 . . . . 5.11 110.562 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 15.6 mp0 -87.19 -69.47 0.68 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.073 0.858 . . . . 6.3 111.17 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 59' ' ' VAL . 26.7 m -143.8 173.64 11.5 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.731 -0.788 . . . . 3.64 110.871 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 58' ' ' THR . 15.7 m -101.92 159.17 30.18 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.818 -1.179 . . . . 1.94 107.818 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 10.0 Cg_endo -92.01 147.26 14.33 Favored 'Cis proline' 0 C--N 1.318 -1.057 0 CA-C-N 118.554 0.519 . . . . 1.67 111.454 9.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.531 HE22 ' HB2' ' A' ' 52' ' ' ALA . 18.6 mt-30 -107.78 147.47 30.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.922 -0.711 . . . . 2.85 109.47 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.459 HD12 ' CB ' ' A' ' 75' ' ' PHE . 4.4 mt -121.18 141.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.268 -0.973 . . . . 1.37 112.489 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 19.7 m-85 -128.62 153.28 47.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 114.608 -1.178 . . . . 0.97 108.998 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.6 t -122.33 102.05 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.487 -1.301 . . . . 0.98 107.487 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.579 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 37.2 m-20 65.49 -83.58 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.772 0.796 . . . . 2.38 110.25 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -126.3 -15.43 5.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.398 -1.274 . . . . 4.23 109.717 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -81.37 167.86 19.0 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.421 -0.512 . . . . 3.69 111.27 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -123.43 136.26 54.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.439 -1.689 . . . . 1.22 106.439 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' A' ' 75' ' ' PHE . 26.0 mm -107.07 -31.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.33 -0.948 . . . . 0.79 110.204 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.4 -117.98 3.8 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.48 -1.448 . . . . 1.33 109.48 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.36 -172.77 18.96 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.285 -1.126 . . . . 1.32 110.285 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -56.01 -53.21 59.67 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.095 -1.042 . . . . 1.54 113.253 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 p -40.92 -58.63 1.65 Allowed 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.726 -0.79 . . . . 1.74 110.833 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.56 -57.74 10.68 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 113.677 -1.601 . . . . 2.05 108.964 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HA ' HG21 ' A' ' 69' ' ' ILE . 70.1 t80 -45.82 -52.91 10.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.747 -0.781 . . . . 0.88 111.497 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -55.99 18.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.469 -0.892 . . . . 1.05 109.145 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.62 -58.98 5.36 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.623 -0.831 . . . . 0.9 109.518 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.406 ' O ' ' HB2' ' A' ' 82' ' ' ASN . 74.3 t90 -41.99 -53.61 3.8 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.738 -0.664 . . . . 0.89 109.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.18 -60.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 124.094 0.871 . . . . 0.98 109.796 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.78 -55.79 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.127 1.158 . . . . 2.68 114.127 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -93.42 28.6 2.2 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 117.184 -1.807 . . . . 5.49 114.305 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 78' ' ' TRP . 40.9 m-80 -140.2 -36.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 119.124 -1.03 . . . . 2.86 110.195 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.0 -26.25 9.36 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.518 -0.765 . . . . 1.99 111.161 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 124.002 0.814 . . . . 6.57 110.365 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.47 0.652 . . . . 3.28 110.013 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.74 160.77 14.05 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.15 -0.932 . . . . 5.85 111.602 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.3 m -124.68 146.61 49.03 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 109.843 -0.429 . . . . 1.4 109.843 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.77 132.95 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.415 -0.957 . . . . 1.7 108.415 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.3 mp -118.29 121.99 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.48 -0.933 . . . . 1.31 108.48 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -115.04 113.57 24.24 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 106.745 -1.576 . . . . 1.65 106.745 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . 160.94 -169.3 36.54 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.279 -1.915 . . . . 1.77 108.443 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -126.51 173.66 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 116.854 -1.938 . . . . 4.78 112.3 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.12 -179.96 4.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.008 -1.451 . . . . 5.73 109.778 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.48 -49.22 0.91 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.116 -1.993 . . . . 3.97 108.116 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.8 t -128.24 101.04 22.44 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 107.391 -1.337 . . . . 4.81 107.391 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 14' ' ' CYS . 2.3 Cg_endo -31.05 -56.14 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.634 2.223 . . . . 4.32 113.06 -122.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 53.15 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.874 1.065 . . . . 6.52 113.874 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' PRO . 18.2 m -115.85 -6.22 12.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.348 -0.541 . . . . 2.29 110.797 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -43.03 -57.54 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 119.743 -0.783 . . . . 2.42 111.78 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.576 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -60.09 -35.47 75.27 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 117.481 -1.688 . . . . 4.27 109.891 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.27 -51.64 68.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.177 -1.409 . . . . 0.82 107.667 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 18.0 tptp -53.14 -50.52 64.38 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 120.26 -0.576 . . . . 2.45 111.724 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.576 ' CG ' HH22 ' A' ' 16' ' ' ARG . 6.9 t0 -66.36 -53.91 30.71 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.784 0.802 . . . . 2.66 110.165 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 tp -49.93 -53.44 26.13 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.199 -1.037 . . . . 1.47 108.199 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.95 76.18 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.427 -0.953 . . . . 1.06 108.427 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 4.8 tp10 -46.68 -62.98 1.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.465 1.126 . . . . 2.91 110.677 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.42 -50.1 17.18 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 113.585 -1.643 . . . . 4.28 110.921 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 mt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.169 -0.923 . . . . 1.53 110.321 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -58.52 -40.89 84.14 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.024 -0.732 . . . . 1.27 109.024 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -89.05 29.84 1.01 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.947 -1.131 . . . . 2.74 107.947 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -120.82 -59.19 1.77 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.257 -1.016 . . . . 3.47 108.257 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' A' ' 84' ' ' ASP . 3.4 mtt180 -116.5 152.28 34.39 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.352 -0.981 . . . . 4.08 108.352 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -74.98 -36.05 62.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.644 -0.822 . . . . 4.91 110.176 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 30' ' ' ASP . 5.5 t70 -83.51 41.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.666 -0.813 . . . . 4.31 109.998 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 25' ' ' SER . 50.9 t80 -142.65 72.43 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.322 -0.951 . . . . 1.21 108.622 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -100.2 138.13 37.69 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.272 -1.01 . . . . 3.69 108.272 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -118.36 155.77 30.11 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.15 -1.02 . . . . 1.42 112.84 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -121.69 130.21 53.3 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 3.76 107.92 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -119.49 114.6 22.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.65 -1.241 . . . . 1.7 107.65 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.84 145.93 32.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.483 -0.781 . . . . 2.88 109.653 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 11.3 t70 -97.62 140.19 32.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.126 -1.435 . . . . 3.21 107.126 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.426 ' C ' HH11 ' A' ' 39' ' ' ARG . 9.5 pt -48.31 -29.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 112.895 0.702 . . . . 2.07 112.895 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.463 ' HA ' HH11 ' A' ' 39' ' ' ARG . 0.7 OUTLIER -94.75 22.65 6.14 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.276 -0.97 . . . . 6.91 111.749 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.2 -50.68 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.246 -0.581 . . . . 1.52 109.662 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -95.58 -13.81 24.1 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.5 -0.88 . . . . 3.37 109.755 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.59 58.76 1.17 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.137 -1.985 . . . . 1.56 108.137 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -101.1 141.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 120.117 -0.633 . . . . 2.22 111.582 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 p -123.14 161.54 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 124.538 1.149 . . . . 2.59 109.437 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -43.91 -57.34 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.705 -0.68 . . . . 4.29 109.493 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -44.49 -49.28 9.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 123.826 0.704 . . . . 3.85 111.128 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.78 -50.66 72.58 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.976 -1.49 . . . . 3.08 109.221 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -42.82 64.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.152 -0.931 . . . . 1.83 108.92 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.0 -47.87 79.8 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.6 -1.259 . . . . 4.18 107.6 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -60.19 -50.29 74.25 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.984 0.803 . . . . 4.83 110.562 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 51' ' ' LYS . 2.8 tppt? -55.62 -50.23 70.71 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.428 -1.26 . . . . 3.16 111.508 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.596 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -74.24 -47.49 34.92 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.315 -1.311 . . . . 1.18 113.077 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.86 42.71 5.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.048 -1.621 . . . . 2.48 109.048 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 54' ' ' LYS . 75.5 mmtt -128.41 -176.29 0.51 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.521 -0.918 . . . . 6.36 108.521 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 50.9 Cg_exo -50.82 -157.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.46 1.44 . . . . 4.04 111.235 147.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 m -114.16 70.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.784 -0.643 . . . . 5.81 112.273 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 3.1 mp0 -75.03 54.51 0.67 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.14 -0.936 . . . . 6.17 112.217 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p 41.26 -112.53 0.16 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 115.666 1.728 . . . . 3.98 115.666 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.12 171.55 6.43 Favored Pre-proline 0 N--CA 1.498 1.955 0 CA-C-N 115.569 -0.741 . . . . 1.98 109.402 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.51 173.35 11.98 Favored 'Cis proline' 0 N--CA 1.487 1.109 0 O-C-N 122.616 0.798 . . . . 1.9 110.351 -20.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.75 150.49 49.78 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.905 . . . . 2.74 110.521 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.418 ' C ' ' CD1' ' A' ' 63' ' ' PHE . 48.2 mt -123.16 148.03 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.747 -0.66 . . . . 1.17 109.267 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 9.4 m-85 -131.06 165.39 23.34 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.767 -1.106 . . . . 1.13 109.494 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.428 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 55.7 t -134.8 112.31 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.481 -1.236 . . . . 0.89 110.148 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 66' ' ' GLN . 0.6 OUTLIER 53.94 -85.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.464 0.542 . . . . 2.64 112.464 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.438 ' H ' ' HB3' ' A' ' 65' ' ' ASP . 54.0 mt-30 -139.13 23.18 2.58 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.82 -0.627 . . . . 4.55 110.334 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -123.99 153.96 40.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.398 -0.964 . . . . 3.86 108.398 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.596 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.0 t-160 -108.6 139.77 42.91 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.829 -1.174 . . . . 1.08 107.829 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.75 -45.94 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 118.744 -1.183 . . . . 0.92 110.032 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 138.21 -123.83 2.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.391 -1.484 . . . . 1.37 109.391 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.11 -174.72 19.64 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.147 -1.181 . . . . 1.44 110.147 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -47.4 -60.33 2.59 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.817 1.043 . . . . 2.21 113.817 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -36.31 -59.82 0.61 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.685 1.231 . . . . 2.08 111.369 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -51.78 68.32 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.374 -2.193 . . . . 2.08 109.584 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -47.15 -50.54 20.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.516 -1.274 . . . . 0.94 109.632 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.09 13.14 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.51 -1.276 . . . . 1.14 109.253 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.25 -54.12 35.23 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.484 -0.886 . . . . 0.93 110.861 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.428 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 89.7 t90 -51.17 -50.58 58.7 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.146 -0.479 . . . . 0.74 110.441 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -49.41 -50.62 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.213 -0.903 . . . . 1.17 111.681 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -40.42 -38.5 0.83 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.703 1.372 . . . . 2.24 114.703 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.88 -25.8 6.67 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.973 1.101 . . . . 5.64 113.973 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -79.47 -14.36 58.95 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 117.491 -1.683 . . . . 1.92 108.101 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -121.8 13.34 10.7 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.905 -1.146 . . . . 2.17 107.905 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 28' ' ' ARG . 3.7 p30 . . . . . 0 N--CA 1.488 1.472 0 CA-C-N 113.469 -1.696 . . . . 6.23 114.661 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 107.996 -1.113 . . . . 2.45 107.996 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -109.67 128.77 55.48 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.194 -0.669 . . . . 4.97 109.194 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -112.71 125.07 53.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.731 -0.788 . . . . 0.91 109.476 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 63' ' ' PHE . 14.5 p -121.35 144.46 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.405 -0.918 . . . . 2.72 109.362 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -118.35 118.77 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 125.173 1.545 . . . . 2.17 108.98 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -107.81 73.41 0.9 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.446 -1.687 . . . . 1.98 106.446 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.4 -179.66 21.84 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.786 -1.673 . . . . 1.45 111.431 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 126.47 52.68 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.076 -1.824 . . . . 6.1 106.076 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -117.29 -168.19 1.44 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.139 0.971 . . . . 6.91 112.768 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.56 -47.32 1.02 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.253 -1.939 . . . . 4.22 108.253 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.91 116.25 31.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.476 -1.305 . . . . 5.48 107.476 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 14' ' ' CYS . 50.1 Cg_exo -17.74 -68.49 0.02 OUTLIER 'Trans proline' 0 C--O 1.197 -1.533 0 C-N-CA 122.598 2.199 . . . . 4.03 112.924 -127.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 47.36 -66.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 113.028 0.751 . . . . 6.09 113.028 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 12' ' ' PRO . 23.5 m -116.39 -18.75 10.37 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.468 -0.893 . . . . 2.06 109.544 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -47.03 -33.94 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.266 -0.573 . . . . 1.36 110.479 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.526 HH21 ' CB ' ' A' ' 19' ' ' ASP . 1.2 mmp_? -78.64 -38.15 40.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.853 -1.139 . . . . 3.74 110.408 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.9 -49.24 73.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.954 -1.869 . . . . 0.65 105.954 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.439 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 3.7 tmtm? -57.44 -51.58 68.85 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.641 -1.163 . . . . 1.53 110.047 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.526 ' CB ' HH21 ' A' ' 16' ' ' ARG . 9.7 t70 -57.66 -59.12 5.69 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.394 -0.922 . . . . 2.73 109.401 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 tp -49.07 -60.08 3.08 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.883 0.849 . . . . 0.95 109.599 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 33' ' ' TYR . . . -48.66 -53.13 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.668 -1.151 . . . . 0.7 109.362 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.439 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 tt0 -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.212 1.006 . . . . 2.07 108.615 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -49.11 -49.99 39.27 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.11 -1.405 . . . . 4.76 107.984 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.1 mt -63.89 -31.54 72.76 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.848 -0.797 . . . . 1.28 108.848 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 t -64.06 -29.52 70.65 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.173 -1.788 . . . . 1.14 106.173 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 7.0 t30 -95.73 32.38 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.014 -1.106 . . . . 1.82 108.014 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.467 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 40.5 mt-10 -130.09 -66.06 0.8 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.681 -1.145 . . . . 2.79 108.791 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.3 mpt_? -116.17 132.72 56.58 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 108.258 -1.016 . . . . 4.63 108.258 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.5 30.06 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.775 -0.77 . . . . 4.25 111.732 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -112.78 -25.82 8.88 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.141 -1.429 . . . . 2.84 107.141 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -98.02 117.64 32.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.574 -1.194 . . . . 1.16 112.999 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -124.27 136.59 54.25 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.136 -1.847 . . . . 3.28 106.551 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.444 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 7.9 p90 -117.66 158.73 24.14 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 118.622 -1.231 . . . . 1.16 109.176 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -144.7 119.82 10.1 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.206 -0.906 . . . . 4.27 110.227 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -98.33 119.06 36.35 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.064 -1.828 . . . . 1.36 106.064 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.4 154.2 21.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.608 -1.627 . . . . 1.38 106.608 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -117.95 131.54 56.49 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.184 -1.406 . . . . 2.83 108.565 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.0 pt -46.73 -37.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.08 -1.418 . . . . 1.22 113.912 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -95.26 18.44 12.38 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.76 -1.176 . . . . 5.69 112.651 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.86 -47.54 3.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.722 -0.844 . . . . 1.54 108.722 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -88.99 -22.72 22.87 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.798 -1.092 . . . . 4.82 110.635 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.49 52.85 1.39 Allowed Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.589 -1.291 . . . . 1.94 110.615 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.8 mt -106.71 134.78 47.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 106.287 -1.746 . . . . 1.6 106.287 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -91.96 -144.16 0.2 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.817 -1.153 . . . . 2.51 109.173 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 57' ' ' GLU . 26.5 mmmt -116.74 -33.52 4.79 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.577 -1.638 . . . . 6.64 106.577 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.17 -46.58 80.24 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.362 -1.718 . . . . 3.96 106.362 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' CG ' ' NZ ' ' A' ' 51' ' ' LYS . 26.9 t70 -63.88 -16.85 62.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.914 -1.039 . . . . 2.2 111.343 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.64 -48.14 5.63 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 108.468 -0.938 . . . . 1.36 108.468 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.35 -47.03 62.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 3.48 107.271 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -67.87 -18.73 64.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.702 -1.135 . . . . 3.8 111.451 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' NZ ' ' CG ' ' A' ' 47' ' ' ASP . 36.5 mttp -86.65 -41.58 14.12 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.827 -0.749 . . . . 2.26 111.218 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . . . -92.23 -36.17 13.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.144 -0.622 . . . . 1.25 110.676 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.95 -66.91 0.38 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 105.501 -3.039 . . . . 3.41 105.501 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 33.2 mttm 31.44 -162.61 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 CA-C-N 112.533 -1.834 . . . . 7.04 113.178 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -103.75 -157.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.202 1.935 . . . . 4.29 109.915 131.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.04 113.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.946 -1.501 . . . . 7.06 106.946 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 24.9 mt-10 -119.31 -175.6 2.97 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.503 -0.771 . . . . 5.96 112.692 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 59' ' ' VAL . 4.9 t -92.07 -136.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.42 -1.326 . . . . 4.63 107.42 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.413 ' N ' HG23 ' A' ' 58' ' ' THR . 7.0 m -127.26 162.66 46.96 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.627 -0.879 . . . . 1.81 108.627 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 83.7 Cg_endo -100.34 163.51 8.2 Favored 'Cis proline' 0 N--CA 1.486 1.085 0 O-C-N 122.507 0.741 . . . . 1.9 111.888 2.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -119.7 112.1 18.85 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.644 -1.243 . . . . 3.56 107.644 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -101.48 143.62 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.761 -0.776 . . . . 1.08 111.011 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.422 ' HB2' ' CG1' ' A' ' 4' ' ' VAL . 24.7 m-85 -134.31 156.48 48.37 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 113.245 -1.798 . . . . 1.38 109.964 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 66' ' ' GLN . 54.5 t -131.56 122.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.869 -1.53 . . . . 0.9 106.869 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 66' ' ' GLN . 12.3 m-20 55.02 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.059 -0.657 . . . . 3.26 109.29 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.4 tt0 -133.18 -16.93 2.41 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.604 -1.18 . . . . 5.15 110.692 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' VAL . 19.1 pt20 -81.59 161.54 23.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.921 -0.711 . . . . 4.4 110.503 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -108.34 147.56 31.33 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.184 -0.917 . . . . 1.41 108.611 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 78' ' ' TRP . 5.2 mm -116.21 -49.66 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.12 -1.032 . . . . 0.79 109.483 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.27 -121.07 3.05 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.954 -1.258 . . . . 1.16 109.954 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.97 -164.47 18.53 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.623 -0.991 . . . . 1.11 110.623 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -53.52 -56.51 16.41 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 120.903 0.382 . . . . 2.13 111.203 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -45.39 -53.18 9.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.035 0.921 . . . . 1.61 110.779 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.39 65.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.158 -1.837 . . . . 2.79 109.295 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -48.24 -52.91 19.02 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.133 -1.027 . . . . 0.85 110.08 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.11 -56.7 14.24 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.097 -1.041 . . . . 0.79 110.122 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -55.66 28.49 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.54 -0.864 . . . . 0.87 109.922 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.422 ' CD1' HD12 ' A' ' 69' ' ' ILE . 89.7 t90 -48.89 -53.31 20.04 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.22 -0.592 . . . . 0.67 110.077 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.2 t -46.69 -58.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 CA-C-N 115.05 -0.977 . . . . 0.77 110.614 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -43.07 -43.09 4.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.816 1.413 . . . . 2.2 114.816 -177.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -97.79 3.56 49.97 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 118.15 -1.42 . . . . 3.87 113.536 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -117.09 -39.89 3.17 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.793 -0.763 . . . . 1.34 111.306 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.2 mt -113.56 37.83 3.11 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.619 -0.719 . . . . 2.4 112.051 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 C-N-CA 119.057 -1.057 . . . . 4.21 109.322 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 tpp . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 109.005 -0.739 . . . . 3.08 109.005 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.446 ' NE2' ' HB3' ' A' ' 32' ' ' GLN . 33.4 mm-40 -119.6 118.7 31.69 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.569 -1.271 . . . . 4.32 107.569 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 11.1 m -114.27 131.58 56.45 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.341 -0.543 . . . . 0.91 110.996 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.99 146.72 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.822 -1.151 . . . . 1.69 112.57 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.4 mp -111.34 129.58 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.458 -1.682 . . . . 1.81 106.458 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 81.0 m-85 -118.63 119.92 35.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.15 -0.62 . . . . 1.7 110.492 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.27 -158.72 26.96 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 124.637 1.211 . . . . 1.86 112.037 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -106.26 107.43 18.43 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.44 0.638 . . . . 5.74 110.097 -179.1 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t -78.11 -155.05 0.07 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.897 -0.592 . . . . 7.27 111.113 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 25.02 21.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.22 -1.552 . . . . 4.12 109.22 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' ' 15' ' ' VAL . 59.2 m -142.38 150.92 56.57 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 120.46 -0.496 . . . . 3.95 110.587 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.87 31.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.629 2.219 . . . . 4.93 112.479 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 83.6 t80 -125.13 -63.78 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.626 -1.249 . . . . 7.9 107.626 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 60' ' ' PRO . 89.5 m -78.68 -29.16 45.42 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 118.554 -1.258 . . . . 3.66 109.4 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 11' ' ' CYS . 67.4 t -62.19 -48.14 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.376 -1.342 . . . . 1.68 107.376 178.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -57.71 -28.5 63.9 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.155 -1.018 . . . . 3.85 109.853 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 62' ' ' ILE . . . -69.86 -48.44 58.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.749 -1.945 . . . . 1.18 105.749 177.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HE2' ' N ' ' A' ' 19' ' ' ASP . 3.5 tmpt? -50.21 -45.61 53.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.399 -1.704 . . . . 2.04 106.399 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.523 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 72.8 m-20 -58.44 -62.77 1.6 Allowed 'General case' 0 C--O 1.19 -2.029 0 C-N-CA 119.277 -0.969 . . . . 2.93 109.949 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 62.0 tp -46.5 -48.63 19.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.765 -0.774 . . . . 0.91 110.287 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.69 85.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.112 -0.699 . . . . 0.68 109.112 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.63 -38.68 82.01 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.734 -0.839 . . . . 1.79 108.734 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.5 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 23.6 tttm -58.77 -65.17 0.7 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.608 -1.627 . . . . 5.31 106.608 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.419 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 37.0 mt -45.6 -44.69 13.22 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.935 -1.135 . . . . 0.97 107.935 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.0 t -54.44 -43.42 71.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.419 -1.264 . . . . 0.99 109.809 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 18.3 t30 -78.39 -2.09 36.57 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.999 -0.68 . . . . 2.12 110.241 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.5 ' CD ' ' HZ3' ' A' ' 23' ' ' LYS . 77.2 mm-40 -89.7 -50.35 6.12 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.197 -0.601 . . . . 3.14 112.411 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.478 HH21 ' CB ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -137.81 155.91 48.51 Favored 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 118.679 -1.208 . . . . 4.1 113.986 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.05 31.03 0.08 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.029 -0.987 . . . . 4.23 111.825 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -125.52 -24.95 3.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.595 -0.73 . . . . 3.26 109.261 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 25' ' ' SER . 15.5 t80 -101.58 122.48 43.93 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 114.468 1.285 . . . . 1.13 114.468 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.446 ' HB3' ' NE2' ' A' ' 2' ' ' GLN . 11.0 tp-100 -133.64 159.51 40.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.646 -1.983 . . . . 6.03 105.646 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 3' ' ' THR . 15.6 p90 -141.8 167.37 22.31 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.266 -0.974 . . . . 1.02 108.851 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.3 152.24 31.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 124.023 0.827 . . . . 4.45 109.511 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.62 124.49 49.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.914 -1.143 . . . . 1.63 107.914 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.87 152.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.249 -0.98 . . . . 1.55 110.435 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -102.82 142.08 34.56 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.664 1.221 . . . . 3.48 111.133 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 38' ' ' ILE . 15.4 pt -66.45 -32.96 60.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 113.084 -1.871 . . . . 1.18 111.665 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -10.72 44.17 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.403 -0.919 . . . . 6.07 111.29 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.29 14.99 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.468 -0.938 . . . . 2.23 108.468 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.33 -43.53 13.62 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.61 -0.836 . . . . 3.78 110.651 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.47 49.0 0.57 Allowed Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.318 -1.113 . . . . 2.18 110.318 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.2 mt -106.48 135.14 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.052 -1.462 . . . . 1.65 107.052 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.504 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 4.9 p -108.09 171.53 7.35 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.59 -1.244 . . . . 2.23 113.111 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -17.24 62.74 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.194 -0.912 . . . . 3.78 109.586 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 16.2 mp0 -94.57 -50.02 5.38 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.487 -1.301 . . . . 3.7 107.487 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.504 ' HB3' ' H ' ' A' ' 44' ' ' THR . 53.8 t0 -55.75 -50.9 69.14 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 108.3 -1.0 . . . . 2.89 108.3 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.06 -49.5 68.86 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.345 -0.983 . . . . 1.56 108.345 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.4 tt0 -47.07 -52.04 16.12 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.51 -0.876 . . . . 3.59 108.969 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -62.31 -48.61 79.1 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.99 -1.004 . . . . 6.64 112.008 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -52.15 -44.25 64.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.642 0.589 . . . . 2.5 110.54 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.468 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -88.84 -57.25 2.97 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.963 -1.095 . . . . 1.17 109.339 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.1 -67.38 0.47 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.466 -1.854 . . . . 3.2 108.466 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 22.8 mmtm -143.84 55.64 3.73 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.336 0.865 . . . . 8.95 113.336 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.468 ' CD ' ' HB3' ' A' ' 52' ' ' ALA . 10.2 Cg_endo -91.26 159.06 3.77 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.703 1.602 . . . . 6.87 109.087 137.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.18 -61.46 2.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.056 -0.658 . . . . 5.36 109.724 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -128.67 33.05 4.71 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.335 -0.987 . . . . 6.7 108.335 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.9 p -89.67 69.63 7.75 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.954 -0.698 . . . . 4.9 110.139 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -114.37 140.43 25.11 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.26 -0.882 . . . . 2.99 110.28 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 5.3 Cg_exo -72.5 155.09 99.03 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.615 -1.411 . . . . 3.62 112.598 -0.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.592 ' CG ' ' NE2' ' A' ' 68' ' ' HIS . 1.7 tp-100 -121.45 165.84 15.01 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.426 -1.324 . . . . 4.47 107.426 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.47 HD11 ' HB1' ' A' ' 17' ' ' ALA . 34.4 mt -121.38 145.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.296 -0.962 . . . . 1.54 112.977 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 68' ' ' HIS . 40.5 m-85 -127.21 152.63 47.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.589 -2.096 . . . . 1.05 106.823 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 66' ' ' GLN . 55.9 t -125.38 126.17 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.95 -1.5 . . . . 1.12 106.95 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 53.55 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.076 0.86 . . . . 2.51 109.304 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 64' ' ' VAL . 6.3 mm-40 -139.55 10.53 2.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.866 0.691 . . . . 5.79 112.866 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' A' ' 67' ' ' GLN . 22.1 mm-40 -118.17 179.91 3.96 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.439 -0.504 . . . . 6.71 111.086 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 61' ' ' GLN . 29.5 t-80 -117.48 143.67 45.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.961 0.788 . . . . 1.57 109.467 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -115.63 -39.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.793 -1.163 . . . . 0.95 111.141 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.67 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.852 -2.099 . . . . 1.36 107.852 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.28 -72.76 0.81 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.427 -1.368 . . . . 2.89 110.646 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 10.5 t80 -136.03 -50.61 0.7 Allowed 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 119.964 -0.694 . . . . 1.54 109.77 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.01 61.69 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.678 1.228 . . . . 1.58 108.823 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -57.26 12.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 111.929 -2.396 . . . . 2.58 109.012 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -47.04 -52.33 15.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.643 -0.823 . . . . 0.92 109.997 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.13 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.816 -1.154 . . . . 0.84 109.099 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.69 -53.52 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.975 -1.09 . . . . 0.9 109.797 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -53.92 -51.34 64.06 Favored 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.285 0.564 . . . . 0.68 110.355 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.5 t -48.38 -49.44 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.987 -1.006 . . . . 0.75 111.473 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -44.13 -30.18 0.73 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.891 1.441 . . . . 2.01 114.891 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 82' ' ' ASN . 13.9 pt-20 -112.48 -35.23 5.62 Favored 'General case' 0 N--CA 1.506 2.363 0 C-N-CA 119.537 -0.865 . . . . 4.95 113.219 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.48 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 16.1 m120 -82.01 -23.84 35.75 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.037 -1.065 . . . . 1.34 109.579 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.471 HD22 ' C ' ' A' ' 82' ' ' ASN . 2.2 mm? -113.09 -41.19 3.77 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.631 -0.713 . . . . 1.75 109.67 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 N--CA 1.502 2.132 0 O-C-N 125.5 1.75 . . . . 3.92 111.713 179.609 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.46 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 32.0 tpp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.805 . . . . 2.95 108.825 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.68 110.65 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.731 0.777 . . . . 5.12 109.45 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.0 m -92.81 105.96 18.01 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.378 -1.712 . . . . 1.21 106.378 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 19.9 t -105.29 138.72 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.438 -0.905 . . . . 1.1 110.811 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.95 103.67 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.779 1.299 . . . . 1.18 108.337 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -85.65 90.14 7.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.509 -1.293 . . . . 1.55 107.509 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.459 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -124.48 145.06 15.67 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.254 -1.938 . . . . 1.66 108.254 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 139.82 49.41 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.644 -1.222 . . . . 5.06 110.205 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 10' ' ' GLY . 3.4 m 61.34 55.48 2.89 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.946 -1.024 . . . . 5.8 108.902 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' SER . . . -3.15 83.83 0.0 OUTLIER Glycine 0 N--CA 1.511 3.635 0 O-C-N 124.782 1.301 . . . . 3.77 114.872 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.4 m -112.74 157.13 41.32 Favored Pre-proline 0 N--CA 1.498 1.948 0 C-N-CA 119.577 -0.849 . . . . 4.2 109.79 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.0 -13.82 0.24 Allowed 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.922 2.414 . . . . 2.74 114.056 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -73.11 -14.1 61.32 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.688 -0.805 . . . . 4.89 111.889 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.555 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.4 m -107.13 -29.23 9.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.24 -1.022 . . . . 1.97 108.24 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.1 t -44.24 -63.65 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 114.506 1.299 . . . . 2.11 114.506 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -52.04 -44.39 64.21 Favored 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 118.044 -1.462 . . . . 3.84 111.808 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.9 63.39 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.742 -1.207 . . . . 1.04 107.742 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 5.1 ttpp -47.09 -55.89 7.54 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.327 -0.851 . . . . 1.48 109.256 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.439 ' CG ' ' NH2' ' A' ' 16' ' ' ARG . 5.8 t70 -52.8 -58.35 7.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 123.683 0.614 . . . . 3.21 110.013 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -50.92 -55.41 17.28 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.545 -0.862 . . . . 0.91 111.126 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.15 83.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.411 -0.915 . . . . 0.71 108.68 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.3 tt0 -59.52 -46.37 89.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.252 -0.885 . . . . 1.97 110.086 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.585 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -52.54 -57.16 10.82 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.979 -1.089 . . . . 4.28 108.117 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 42.6 mt -48.49 -43.66 35.18 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 1.17 107.601 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.9 t -58.53 -46.25 87.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.192 -1.367 . . . . 1.06 110.58 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -91.96 41.51 1.07 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.807 -1.553 . . . . 2.07 106.807 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.585 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.9 tp10 -128.29 -66.06 0.87 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.709 -2.042 . . . . 3.39 106.483 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.47 ' NH2' ' HB2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -122.45 153.46 39.08 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 106.341 -1.725 . . . . 4.35 106.341 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.07 32.3 1.52 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 118.367 -1.333 . . . . 5.51 111.933 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -113.64 -23.23 9.85 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.959 -1.497 . . . . 3.21 106.959 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 25' ' ' SER . 28.6 t80 -103.04 118.23 36.36 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.584 -1.189 . . . . 1.0 109.342 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -130.28 142.26 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.381 -1.34 . . . . 4.13 107.381 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -117.67 159.86 22.25 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 118.479 -1.288 . . . . 1.32 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.61 142.6 37.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.275 0.985 . . . . 4.58 109.255 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 35' ' ' TYR . 10.0 t80 -106.34 135.4 47.9 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.542 -2.021 . . . . 1.44 105.542 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.97 156.91 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.296 -0.961 . . . . 2.62 109.215 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.97 160.1 24.23 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.153 0.501 . . . . 2.8 109.796 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 pt -75.79 -32.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.998 -1.081 . . . . 1.82 111.439 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -35.87 55.16 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.356 -1.338 . . . . 5.64 108.494 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.56 -53.26 18.97 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.307 -0.86 . . . . 1.92 109.196 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.35 -46.38 10.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.042 0.839 . . . . 3.74 109.942 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.08 52.01 0.58 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 108.948 -1.661 . . . . 1.5 108.948 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.82 160.76 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 115.047 -0.577 . . . . 1.56 110.885 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -119.68 -170.82 2.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.787 -1.19 . . . . 2.08 107.787 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -90.86 -24.17 20.33 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 118.0 -1.48 . . . . 6.45 109.339 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.662 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 3.0 mp0 -72.87 -47.56 44.97 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.126 -1.435 . . . . 3.22 107.126 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.58 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 30.3 t70 -57.38 -39.2 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.071 0.939 . . . . 2.8 108.619 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.32 -46.03 78.3 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.49 -1.232 . . . . 1.39 107.714 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -46.21 -48.98 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.281 -1.377 . . . . 3.77 107.281 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.97 -59.13 5.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.152 -0.931 . . . . 4.41 110.62 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.58 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 17.3 mtmm -66.83 -5.41 12.21 Favored 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 120.338 -0.545 . . . . 2.75 112.457 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' CB ' HE22 ' A' ' 61' ' ' GLN . . . -105.3 -33.51 8.18 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.727 -0.67 . . . . 1.03 111.769 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.96 31.63 2.88 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.712 -1.755 . . . . 3.39 108.712 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.533 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 50.7 tttm -144.62 121.28 6.28 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.91 -1.144 . . . . 6.98 107.91 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -19.8 -131.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 124.472 3.448 . . . . 4.32 114.641 -143.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.79 -54.18 7.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 113.862 -1.517 . . . . 5.25 107.719 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 50.23 -160.36 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.772 -0.649 . . . . 8.22 112.099 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -139.59 -151.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.494 -0.882 . . . . 3.99 109.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.08 151.72 42.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.001 -0.74 . . . . 1.76 109.001 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -93.22 167.25 22.24 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 O-C-N 123.236 1.124 . . . . 1.92 111.135 2.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.542 HE22 ' CB ' ' A' ' 52' ' ' ALA . 25.8 mt-30 -116.84 131.12 57.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.181 -1.415 . . . . 2.58 107.181 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 75' ' ' PHE . 94.9 mt -104.73 144.96 13.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 118.989 -1.084 . . . . 1.27 109.943 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -135.69 148.57 48.96 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 113.373 -1.74 . . . . 0.99 108.816 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 66' ' ' GLN . 68.6 t -115.1 92.99 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 104.651 -2.352 . . . . 0.93 104.651 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 1' ' ' MET . 5.3 m-20 66.82 -74.5 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.32 1.013 . . . . 2.58 109.656 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 64' ' ' VAL . 63.4 mt-30 -133.8 -15.59 2.35 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.808 -1.087 . . . . 3.43 110.999 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.408 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 71.6 mt-30 -75.34 128.19 34.83 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.425 -0.954 . . . . 4.17 108.425 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.533 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 10.9 t-160 -90.36 136.56 32.98 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.081 -1.822 . . . . 1.03 106.081 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 75' ' ' PHE . 16.8 mm -108.5 -50.27 7.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.665 -0.814 . . . . 1.02 109.413 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.55 -122.76 5.26 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 118.94 -1.6 . . . . 1.53 111.85 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.97 -173.66 39.27 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.085 -1.055 . . . . 1.16 111.67 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 29.6 t80 -60.07 -51.19 70.71 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.758 -0.777 . . . . 1.66 111.354 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -43.98 -48.53 8.68 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.736 1.255 . . . . 1.57 108.91 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -58.69 -57.49 12.77 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.051 -2.34 . . . . 2.78 108.616 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HA ' HG21 ' A' ' 69' ' ' ILE . 7.6 t80 -48.7 -54.19 15.84 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.009 -0.996 . . . . 1.08 110.864 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.02 -53.01 56.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.69 -1.226 . . . . 0.84 107.69 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.07 -59.21 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.283 -0.967 . . . . 1.16 109.835 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.487 ' CD1' HD12 ' A' ' 69' ' ' ILE . 62.9 t90 -48.65 -52.87 21.0 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 119.852 -0.739 . . . . 1.44 110.964 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.423 ' CG2' ' CE1' ' A' ' 75' ' ' PHE . 43.0 t -54.49 -43.81 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.779 -1.168 . . . . 1.04 109.031 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -78.39 11.1 2.59 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.733 -0.667 . . . . 3.0 112.793 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.88 -36.28 2.4 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 120.505 -0.478 . . . . 4.68 110.819 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -96.93 -29.52 13.64 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.366 -0.834 . . . . 1.85 112.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.1 mt -119.58 26.13 9.58 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.071 -1.052 . . . . 2.15 111.586 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 C-N-CA 119.056 -1.057 . . . . 4.42 110.252 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 122.503 1.144 . . . . 3.03 108.356 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -114.6 158.83 21.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.455 -1.313 . . . . 5.28 107.455 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.622 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 5.5 m -107.15 142.14 37.31 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.296 -1.001 . . . . 1.68 108.296 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.441 ' C ' HD12 ' A' ' 5' ' ' ILE . 3.2 t -129.04 117.57 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.881 -1.526 . . . . 1.11 106.881 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.4 mp -107.35 131.72 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.913 -1.143 . . . . 1.08 107.913 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.72 108.42 17.86 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 106.506 -1.664 . . . . 2.18 106.506 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.8 -171.11 12.75 Favored Glycine 0 N--CA 1.503 3.128 0 C-N-CA 118.832 -1.652 . . . . 1.77 112.514 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.87 147.25 37.39 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 114.611 -0.795 . . . . 5.23 108.875 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -53.04 130.54 34.24 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 120.067 -0.653 . . . . 5.77 112.389 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 155.26 25.32 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.618 -0.801 . . . . 3.18 111.394 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.5 m 74.56 108.51 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.951 1.03 . . . . 3.64 111.767 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.61 59.43 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.799 1.666 . . . . 4.78 111.255 162.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -115.18 -69.84 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.254 -0.885 . . . . 4.76 108.767 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -52.4 -41.69 63.4 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.04 -1.467 . . . . 2.61 107.04 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -43.3 -42.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.833 -1.531 . . . . 2.93 110.113 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.22 -33.74 1.65 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 123.508 0.505 . . . . 4.77 112.225 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.476 ' HB3' HG12 ' A' ' 5' ' ' ILE . . . -67.5 -44.35 78.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.446 -0.946 . . . . 1.09 108.446 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HG3' ' CD1' ' A' ' 33' ' ' TYR . 9.4 ttpp -52.99 -49.58 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.457 -1.683 . . . . 2.27 106.457 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' LEU . 65.7 m-20 -55.85 -60.1 3.93 Favored 'General case' 0 C--O 1.183 -2.414 0 CA-C-N 113.317 -1.765 . . . . 3.95 110.305 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' ASP . 31.5 tp -43.8 -61.25 1.49 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.485 -1.286 . . . . 0.96 109.323 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.47 67.27 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.352 -0.84 . . . . 1.19 111.277 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 40.1 tt0 -65.17 -56.07 14.99 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.955 0.883 . . . . 2.02 111.083 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.557 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -50.8 -43.38 58.73 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.448 -1.315 . . . . 3.9 107.448 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -66.73 -44.17 82.26 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.289 -1.004 . . . . 1.72 108.289 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 27' ' ' GLU . 28.9 t -50.07 -48.75 52.89 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.906 -1.043 . . . . 2.09 108.699 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -83.72 38.64 0.64 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.878 1.323 . . . . 2.01 108.782 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 tt0 -137.61 -50.3 0.61 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 113.164 -1.835 . . . . 3.16 109.117 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -104.03 -32.71 9.08 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.05 -0.977 . . . . 3.67 111.371 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 78.49 8.62 2.15 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.193 0.933 . . . . 4.76 111.026 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.51 7.58 17.51 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.496 -0.882 . . . . 3.93 112.443 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -124.54 142.37 51.39 Favored 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 119.717 -0.793 . . . . 1.99 110.798 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -126.49 170.98 11.45 Favored 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 120.428 -0.509 . . . . 4.39 111.109 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.622 ' HA ' ' H ' ' A' ' 3' ' ' THR . 18.7 p90 -142.84 169.33 17.77 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.726 0.774 . . . . 2.18 112.694 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 3' ' ' THR . 43.7 mm-40 -148.31 128.31 13.59 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 113.829 -1.532 . . . . 4.03 108.085 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -113.63 111.2 21.46 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.083 -1.451 . . . . 1.3 107.083 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.8 157.77 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.935 -0.706 . . . . 1.65 110.167 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.28 139.08 43.5 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 105.049 -2.204 . . . . 2.96 105.049 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.4 pt -50.19 -33.47 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.935 -1.106 . . . . 1.22 113.666 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -50.08 25.89 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 117.67 -1.612 . . . . 6.71 110.379 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -31.08 -52.67 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.256 0.973 . . . . 1.95 111.672 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.23 -43.13 18.01 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.62 1.2 . . . . 4.35 111.069 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.72 51.56 0.45 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.432 -2.267 . . . . 1.58 107.432 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 75.6 mt -108.16 141.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.562 -0.819 . . . . 1.91 110.626 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.3 p -117.08 -89.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.855 -1.165 . . . . 3.31 107.855 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.569 ' HZ3' ' CD ' ' A' ' 57' ' ' GLU . 33.5 tttp -140.87 -48.07 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.37 -0.974 . . . . 4.25 108.37 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 10.3 mp0 -47.9 -55.64 9.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.02 0.825 . . . . 2.86 109.711 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -53.08 -60.86 2.76 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.559 -0.746 . . . . 2.71 109.533 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.58 -38.44 59.98 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.348 -0.941 . . . . 1.44 110.045 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.96 -53.33 58.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.209 -1.404 . . . . 4.36 107.209 178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.07 -47.98 79.68 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.25 -1.795 . . . . 4.09 110.476 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -56.66 -50.5 71.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.377 -0.829 . . . . 2.74 110.182 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -53.74 46.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.152 -0.931 . . . . 1.37 111.676 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.19 -15.59 43.08 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.519 -1.432 . . . . 2.56 109.519 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.8 pttp -123.96 -178.91 0.72 Allowed Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.955 -0.698 . . . . 6.07 110.133 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 49.2 Cg_exo -56.6 142.56 90.49 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.235 1.29 . . . . 4.36 112.077 165.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -153.84 102.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 4.95 107.025 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.569 ' CD ' ' HZ3' ' A' ' 45' ' ' LYS . 15.6 mm-40 -111.77 -15.78 13.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.703 -0.799 . . . . 7.12 110.705 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 59' ' ' VAL . 24.0 m -121.69 172.29 8.24 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.979 -0.688 . . . . 4.65 110.265 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 58' ' ' THR . 27.3 m -105.22 169.38 7.14 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 109.278 -0.638 . . . . 2.6 109.278 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -99.97 176.6 6.73 Favored 'Cis proline' 0 N--CA 1.488 1.192 0 O-C-N 122.815 0.903 . . . . 1.99 110.544 -8.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 99.5 mm-40 -125.35 140.78 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.075 -1.05 . . . . 3.42 108.693 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -126.7 145.17 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.874 -0.73 . . . . 1.12 110.444 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.08 162.51 31.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.538 -1.21 . . . . 1.37 109.461 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.533 HG11 ' CH2' ' A' ' 78' ' ' TRP . 49.6 t -141.45 119.19 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 124.526 1.141 . . . . 1.17 108.979 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 50.81 -102.73 0.12 Allowed 'General case' 0 N--CA 1.514 2.742 0 CA-C-N 119.774 1.17 . . . . 2.35 111.008 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -123.82 31.88 5.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.618 -1.174 . . . . 4.48 109.43 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -122.59 164.49 18.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.568 -0.742 . . . . 4.09 110.361 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -122.54 125.6 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.155 -1.054 . . . . 1.25 108.155 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.65 -54.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.951 -1.5 . . . . 1.57 106.951 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 112.23 -99.23 1.04 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.471 -1.347 . . . . 1.52 110.572 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.56 163.63 13.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.414 -1.374 . . . . 1.24 110.707 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.41 -54.29 33.99 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.074 -0.65 . . . . 1.75 111.759 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -34.58 -64.69 0.24 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.663 0.986 . . . . 1.69 113.663 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.94 -38.0 75.15 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.925 -0.71 . . . . 4.54 111.649 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -43.49 -41.54 4.44 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.794 -0.817 . . . . 1.18 108.794 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.96 -52.03 64.3 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.497 -0.774 . . . . 1.3 110.773 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' LYS . . . -67.22 -53.8 26.83 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.342 -0.844 . . . . 1.36 109.172 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.533 ' CH2' HG11 ' A' ' 64' ' ' VAL . 84.3 t90 -42.23 -55.54 3.26 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.16 -1.052 . . . . 1.03 108.16 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -46.04 -50.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 114.984 -1.007 . . . . 1.4 109.94 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -42.56 -57.45 2.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 124.568 1.168 . . . . 3.63 113.295 -178.184 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -106.01 25.43 10.95 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.351 -1.34 . . . . 3.51 112.365 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 78' ' ' TRP . 12.3 m-80 -119.33 -36.43 3.37 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.947 -1.131 . . . . 2.27 107.947 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.44 11.45 17.2 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.238 -1.764 . . . . 2.32 106.238 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.487 1.377 0 O-C-N 125.338 1.649 . . . . 7.99 112.484 179.636 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.5 mpp? . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.19 -1.041 . . . . 2.6 108.19 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 65' ' ' ASP . 38.8 mt-30 -100.24 102.72 14.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.516 -0.92 . . . . 4.32 108.516 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.4 m -84.32 100.27 11.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.264 -1.754 . . . . 1.13 106.264 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.32 127.44 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.313 -1.312 . . . . 1.08 110.206 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mm -96.38 119.16 44.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 104.568 -2.382 . . . . 1.29 104.568 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.523 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.4 m-85 -104.71 109.29 21.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.318 -1.364 . . . . 1.43 107.318 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.61 118.9 0.46 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 116.208 -2.901 . . . . 2.28 112.708 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.455 ' HB3' ' OD1' ' A' ' 37' ' ' ASP . 4.8 ptm180 -86.11 55.74 3.67 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.413 -1.393 . . . . 5.05 111.902 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.0 p -90.47 -54.05 4.17 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 117.434 -1.706 . . . . 6.3 109.144 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.68 -52.73 4.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 106.4 -2.68 . . . . 4.06 106.4 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' TYR . 8.3 m -78.05 156.78 79.31 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.758 -1.571 . . . . 4.87 106.758 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.85 64.26 0.15 Allowed 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 123.55 2.834 . . . . 2.95 115.135 -147.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' CYS . 21.2 m-30 -121.69 -70.24 0.79 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.029 -1.841 . . . . 5.8 106.029 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.3 m -65.06 -32.46 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.337 -1.745 . . . . 1.99 106.613 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.4 t -44.13 -45.08 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 114.895 -1.048 . . . . 1.34 109.907 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.478 HH12 ' CG ' ' A' ' 19' ' ' ASP . 2.5 tpt180 -68.91 -47.09 66.65 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.852 -0.739 . . . . 4.13 110.239 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.67 -46.31 70.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.121 -1.437 . . . . 0.73 107.121 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.1 tmtt? -54.14 -60.53 3.21 Favored 'General case' 0 C--O 1.203 -1.37 0 CA-C-N 114.824 -1.08 . . . . 2.03 108.402 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.5 t70 -48.53 -54.64 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.817 -0.753 . . . . 2.77 110.442 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.9 tp -54.85 -57.18 12.61 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.308 -0.957 . . . . 1.48 109.954 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.24 -42.95 52.75 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.949 -1.023 . . . . 0.74 109.906 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 36.6 tt0 -65.62 -51.74 57.33 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.544 -0.753 . . . . 2.16 109.07 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 23.6 ttpp -44.55 -54.21 6.28 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.457 -1.312 . . . . 5.7 107.457 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 50.9 mt -60.67 -36.38 78.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.58 1.175 . . . . 1.18 109.707 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -59.32 -28.46 66.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.057 -0.974 . . . . 1.09 109.532 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -89.19 29.37 1.08 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.548 0.689 . . . . 2.72 109.149 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 73.3 mt-10 -135.07 -65.96 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.184 -1.006 . . . . 3.29 112.621 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -104.42 149.38 25.46 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.976 -1.09 . . . . 4.65 108.585 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -53.26 57.44 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.852 1.797 . . . . 4.1 115.852 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 1' ' ' MET . 50.6 t0 -84.45 44.82 1.07 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.657 -1.617 . . . . 5.84 111.683 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 83' ' ' LEU . 16.2 t80 -126.04 84.63 2.29 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 105.997 -1.853 . . . . 1.07 105.997 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -109.51 143.75 38.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.866 -1.531 . . . . 3.65 106.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -123.56 157.49 33.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.143 -1.423 . . . . 1.18 110.371 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -145.33 150.12 36.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.788 -1.097 . . . . 4.13 108.62 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -110.77 127.15 55.25 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.198 -1.038 . . . . 2.16 108.198 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.523 HG11 ' CE1' ' A' ' 6' ' ' PHE . 2.3 p -131.02 151.33 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 118.819 -1.153 . . . . 2.31 109.826 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -113.66 135.4 53.97 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.345 -1.354 . . . . 3.0 107.345 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 37.7 pt -61.29 -27.18 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.631 -1.228 . . . . 1.9 110.586 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -74.38 -24.87 59.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.894 -1.122 . . . . 5.76 110.996 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.1 -40.4 15.74 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 1.99 110.124 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -77.36 -40.6 43.37 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.403 -1.272 . . . . 4.25 111.362 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.63 51.02 0.72 Allowed Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.188 -1.482 . . . . 2.13 110.038 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 8.2 mt -112.32 135.2 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.456 -0.898 . . . . 2.32 109.304 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 47.1 p -106.8 173.76 6.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.242 -0.583 . . . . 1.88 110.014 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -52.52 -51.58 58.86 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.219 -1.4 . . . . 4.92 107.219 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.6 -60.66 3.12 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.77 -1.559 . . . . 3.77 110.45 178.015 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 44' ' ' THR . 33.3 t70 -51.92 -41.86 62.33 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.392 -0.923 . . . . 2.08 111.305 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.464 ' HG ' HG21 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -59.63 -57.91 10.9 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.577 -0.849 . . . . 1.91 109.356 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 33.8 tt0 -44.36 -52.3 7.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.962 -1.125 . . . . 3.28 107.962 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.58 -45.26 85.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.796 -1.093 . . . . 4.23 111.404 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -40.24 50.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.703 1.252 . . . . 2.73 110.924 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -90.65 -48.71 6.9 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.732 -1.122 . . . . 1.33 109.946 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.411 ' C ' ' HG3' ' A' ' 54' ' ' LYS . . . 135.23 -68.6 0.53 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 107.373 -2.291 . . . . 3.14 107.373 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 53' ' ' GLY . 51.9 mttp -155.22 56.24 1.35 Allowed Pre-proline 0 N--CA 1.51 2.544 0 N-CA-C 113.252 0.834 . . . . 10.25 113.252 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.458 ' CD ' ' HB3' ' A' ' 52' ' ' ALA . 91.3 Cg_endo -98.66 42.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 121.758 1.639 . . . . 6.08 110.129 152.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t 36.48 -118.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.255 -1.338 . . . . 5.95 110.707 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -120.03 39.41 3.69 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.742 -0.383 . . . . 8.08 110.83 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.7 p -88.12 149.84 23.69 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.326 -1.349 . . . . 5.12 111.417 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.08 165.57 17.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 CA-C-N 115.075 -0.966 . . . . 2.74 108.757 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -78.81 171.96 63.17 Favored 'Cis proline' 0 N--CA 1.485 0.978 0 C-N-CA 123.636 -1.402 . . . . 2.09 110.354 -5.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.456 HE22 ' HG2' ' A' ' 55' ' ' PRO . 42.6 mt-30 -136.63 157.75 46.05 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.941 -1.103 . . . . 2.91 109.944 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.4 mm -114.09 139.76 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 120.303 -0.559 . . . . 1.5 110.527 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.6 145.71 48.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.726 0.641 . . . . 1.1 109.781 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 72.2 t -124.57 95.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.761 -0.776 . . . . 0.9 109.951 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.435 ' HA ' ' HB2' ' A' ' 2' ' ' GLN . 0.6 OUTLIER 65.21 -74.41 0.05 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.639 -1.619 . . . . 3.27 110.942 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -133.84 -7.34 2.77 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.232 -0.895 . . . . 4.22 112.294 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.409 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 6.7 pt20 -104.82 165.09 11.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.955 -0.698 . . . . 4.17 110.556 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -105.96 143.79 33.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.191 -1.781 . . . . 1.04 106.191 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.522 HD12 ' CD1' ' A' ' 78' ' ' TRP . 23.4 mm -106.0 -37.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.621 -1.231 . . . . 1.09 109.65 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -132.86 7.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.09 -2.004 . . . . 1.2 108.09 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.66 -164.25 24.3 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.527 -1.429 . . . . 1.34 109.527 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 16' ' ' ARG . 44.0 t80 -61.34 -49.17 78.05 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.027 -1.069 . . . . 1.62 111.408 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.39 -52.38 13.07 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 1.73 109.991 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.23 -53.64 54.28 Favored 'General case' 0 C--O 1.197 -1.695 0 CA-C-N 113.461 -1.7 . . . . 2.12 109.045 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -48.45 -48.45 37.57 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.821 -0.627 . . . . 0.98 110.74 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.36 69.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.18 -1.008 . . . . 0.88 108.485 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.4 -62.67 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.919 -1.112 . . . . 0.94 110.126 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.522 ' CD1' HD12 ' A' ' 69' ' ' ILE . 67.2 t90 -42.69 -51.42 5.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.698 -0.853 . . . . 0.87 108.698 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.433 ' CG1' HD11 ' A' ' 24' ' ' LEU . 6.6 t -53.65 -59.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.906 -1.043 . . . . 0.81 109.482 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 18.4 tptt -54.35 -16.73 2.38 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.252 -0.886 . . . . 3.36 113.226 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -107.54 -44.61 4.24 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.29 -0.964 . . . . 3.67 113.384 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' C ' HD22 ' A' ' 83' ' ' LEU . 14.1 m-80 -82.7 -25.16 33.22 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.846 -0.741 . . . . 1.5 110.104 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.551 HD11 ' CD1' ' A' ' 31' ' ' PHE . 2.6 mm? -109.08 -41.36 4.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.255 -0.646 . . . . 2.18 109.255 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-N 113.862 -1.517 . . . . 4.02 108.652 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 107.851 -1.166 . . . . 3.04 107.851 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -115.81 110.27 18.82 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.32 -0.552 . . . . 4.53 110.567 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.5 m -96.5 150.0 21.11 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.861 -0.736 . . . . 1.0 110.611 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.509 ' C ' HD12 ' A' ' 5' ' ' ILE . 17.2 t -133.77 139.44 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 115.791 -0.641 . . . . 0.92 110.788 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 4' ' ' VAL . 1.2 mp -113.73 126.48 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.127 -1.805 . . . . 1.06 106.127 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 63' ' ' PHE . 22.7 m-85 -108.83 109.3 20.38 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.698 -1.223 . . . . 1.69 107.698 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.574 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -134.02 -169.31 12.02 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.788 -1.672 . . . . 1.33 112.134 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.0 tmm_? -102.03 64.24 0.94 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.891 -1.522 . . . . 5.83 106.891 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.455 ' OG ' ' NH2' ' A' ' 39' ' ' ARG . 4.5 m 58.31 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.495 -1.229 . . . . 5.38 111.152 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -123.1 84.27 0.37 Allowed Glycine 0 N--CA 1.499 2.88 0 N-CA-C 110.53 -1.028 . . . . 2.98 110.53 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' TYR . 41.3 t -128.93 109.98 18.44 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.455 -0.572 . . . . 4.92 109.455 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -40.55 -27.57 0.28 Allowed 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 124.534 3.489 . . . . 3.93 115.817 -153.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' CYS . 98.9 m-85 -72.5 -37.4 68.4 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.241 -0.984 . . . . 4.4 110.701 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.574 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.2 m -61.01 -39.91 91.53 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.401 -1.703 . . . . 2.0 106.401 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.69 -38.46 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.287 -0.965 . . . . 1.29 109.078 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.536 HH12 ' CG ' ' A' ' 19' ' ' ASP . 9.6 mmm180 -76.81 -51.01 12.13 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.683 -0.689 . . . . 4.07 110.978 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.419 ' HB1' HG13 ' A' ' 5' ' ' ILE . . . -52.32 -42.78 64.11 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.738 -1.579 . . . . 0.83 106.738 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -58.32 -57.87 11.01 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 113.66 -1.609 . . . . 1.75 107.731 178.153 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.536 ' CG ' HH12 ' A' ' 16' ' ' ARG . 2.2 t70 -51.56 -57.27 9.58 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.428 -1.309 . . . . 3.13 109.986 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 79' ' ' VAL . 37.1 tp -47.16 -50.71 19.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.131 -0.692 . . . . 1.11 109.131 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 33' ' ' TYR . . . -60.1 -45.43 92.99 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.612 -0.835 . . . . 1.06 110.496 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 25' ' ' SER . 18.0 tt0 -65.04 -49.8 68.72 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.464 0.65 . . . . 2.31 110.767 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.54 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -56.95 -51.85 67.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.063 -1.458 . . . . 4.19 107.063 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.4 mt -52.02 -51.35 57.97 Favored 'General case' 0 C--O 1.199 -1.566 0 N-CA-C 106.441 -1.689 . . . . 1.18 106.441 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 4.6 t -43.32 -24.53 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.57 -0.741 . . . . 1.18 112.037 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -100.07 -39.5 8.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.214 0.321 . . . . 2.16 111.005 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.54 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 28.2 mt-10 -72.96 -26.74 61.47 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.327 0.584 . . . . 3.31 110.657 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -101.44 175.05 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.352 -0.84 . . . . 4.06 110.888 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -107.74 -41.09 5.1 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 115.225 -0.898 . . . . 5.56 110.511 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 30' ' ' ASP . 8.3 t70 -109.63 53.46 0.69 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 122.438 1.113 . . . . 4.99 109.283 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 25' ' ' SER . 8.1 t80 -131.71 110.42 10.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.256 -0.978 . . . . 1.08 110.055 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -124.27 152.37 43.1 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.988 -1.856 . . . . 3.37 105.988 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.53 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 7.1 p90 -140.46 154.57 46.68 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 117.884 -1.527 . . . . 1.16 111.153 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.51 154.72 47.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.692 -1.225 . . . . 4.04 107.692 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.61 139.73 49.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.926 -1.509 . . . . 1.34 106.926 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.32 139.03 51.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 124.24 0.963 . . . . 2.12 109.955 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -105.95 116.68 32.35 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.694 -1.595 . . . . 2.53 106.694 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.8 pt -54.88 -20.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 118.788 -1.165 . . . . 1.17 111.299 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.455 ' NH2' ' OG ' ' A' ' 9' ' ' SER . 40.6 ttp-105 -86.13 -61.44 1.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.561 -0.855 . . . . 6.86 109.285 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.18 -43.48 0.22 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.093 0.871 . . . . 1.45 111.514 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -94.0 -44.75 7.9 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.582 -0.847 . . . . 3.11 112.04 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.51 54.31 0.65 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.212 -1.555 . . . . 1.98 109.212 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.91 127.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 107.497 -1.297 . . . . 2.24 107.497 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 p -119.85 166.22 13.57 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.197 -1.001 . . . . 3.17 110.697 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.617 ' CD ' ' H ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -41.69 -45.9 3.59 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.379 -0.828 . . . . 5.29 110.885 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 19.9 mp0 -60.51 -55.24 35.76 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.071 -0.651 . . . . 4.19 110.239 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 25.0 t70 -60.32 -39.86 88.53 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.598 -0.841 . . . . 2.92 110.689 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB3' HE22 ' A' ' 61' ' ' GLN . 59.0 mt -62.08 -48.73 78.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.124 -0.944 . . . . 1.61 109.128 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.76 -59.96 2.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.205 -0.907 . . . . 4.67 108.709 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -46.64 -40.84 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 125.029 1.456 . . . . 4.17 112.341 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 25.1 mtmm -94.46 -4.24 48.57 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.578 -1.192 . . . . 2.91 114.101 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -113.49 -38.37 4.37 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.799 -0.76 . . . . 1.1 112.724 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.46 43.98 66.69 Favored Glycine 0 N--CA 1.491 2.365 0 O-C-N 124.395 1.059 . . . . 3.36 113.151 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HD2' ' CE1' ' A' ' 68' ' ' HIS . 59.5 mttm -138.53 180.0 1.18 Allowed Pre-proline 0 N--CA 1.504 2.256 0 C-N-CA 119.296 -0.962 . . . . 7.55 110.345 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -33.46 82.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.111 2.54 . . . . 5.74 112.37 127.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 57' ' ' GLU . 27.6 m -101.66 -42.99 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 115.791 -0.64 . . . . 5.41 112.34 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.462 ' N ' HG23 ' A' ' 56' ' ' VAL . 2.4 tt0 61.37 -108.39 0.32 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.651 -0.87 . . . . 7.05 108.651 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 59' ' ' VAL . 53.5 p -129.92 -86.51 0.53 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.623 -1.231 . . . . 4.3 111.143 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.41 ' N ' ' OG1' ' A' ' 58' ' ' THR . 14.2 m -137.98 164.66 39.23 Favored Pre-proline 0 C--N 1.291 -1.966 0 N-CA-C 109.771 -0.455 . . . . 1.77 109.771 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -94.36 148.08 10.18 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 124.594 -1.002 . . . . 1.62 110.314 -9.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.422 HE22 ' HB3' ' A' ' 48' ' ' LEU . 67.6 mt-30 -111.23 142.78 42.98 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.984 -1.086 . . . . 2.55 108.282 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.1 mp -113.44 142.31 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.987 0.898 . . . . 1.64 110.02 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 6' ' ' PHE . 20.0 m-85 -121.21 136.3 55.0 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.354 -2.091 . . . . 1.36 105.354 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.618 HG11 ' CH2' ' A' ' 78' ' ' TRP . 5.8 t -115.05 106.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.817 -0.753 . . . . 1.33 109.114 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 66.91 -72.6 0.08 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.581 -0.736 . . . . 2.49 111.982 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 64' ' ' VAL . 8.7 mm-40 -136.74 -11.02 1.81 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 113.704 1.002 . . . . 3.88 113.704 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -117.01 161.6 19.13 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.749 -1.18 . . . . 5.96 114.003 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.542 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.0 t-160 -90.06 133.67 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.725 -1.213 . . . . 1.01 107.725 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.53 -39.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.541 -0.863 . . . . 0.87 110.235 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.82 -142.27 13.69 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.177 -1.569 . . . . 1.17 109.177 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.85 173.65 41.8 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.389 -1.484 . . . . 1.22 109.389 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 23.7 t80 -42.87 -45.99 5.13 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.301 -0.96 . . . . 1.8 111.209 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.4 -58.12 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.797 0.808 . . . . 1.8 110.054 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.2 -39.84 80.01 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.148 -1.387 . . . . 2.07 109.581 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.66 -56.83 17.16 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.897 -1.121 . . . . 1.28 109.384 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.26 -56.01 19.99 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.83 -0.748 . . . . 0.92 110.284 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.59 -54.5 43.34 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.432 -0.907 . . . . 1.04 109.43 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.618 ' CH2' HG11 ' A' ' 64' ' ' VAL . 89.3 t90 -46.74 -55.5 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.836 -0.746 . . . . 1.17 110.457 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.429 HG21 HD21 ' A' ' 20' ' ' LEU . 53.5 t -47.94 -55.5 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.847 -1.07 . . . . 0.8 111.218 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.72 -46.86 7.73 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.615 0.968 . . . . 2.03 113.615 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -103.96 34.42 3.03 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 118.956 -1.097 . . . . 4.4 112.512 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -141.05 -49.03 0.42 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.929 -0.767 . . . . 1.51 108.929 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.8 mt -112.71 46.15 1.24 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.964 -1.017 . . . . 2.07 109.434 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t0 . . . . . 0 C--N 1.291 -1.969 0 N-CA-C 107.092 -1.448 . . . . 3.7 107.092 179.091 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 108.285 -1.006 . . . . 2.99 108.285 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -106.76 102.78 12.13 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.744 0.783 . . . . 4.59 111.761 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.3 m -94.22 129.77 40.71 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.348 -1.353 . . . . 0.92 107.348 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 43.3 t -119.67 134.71 62.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.034 -1.066 . . . . 1.05 110.318 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -107.55 121.51 60.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.789 -2.3 . . . . 1.23 104.789 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -114.99 91.13 3.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 102.977 -2.972 . . . . 1.84 102.977 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -128.05 -167.34 12.23 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 118.535 -1.793 . . . . 1.29 114.375 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.96 95.2 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.838 -1.181 . . . . 5.01 110.717 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.409 ' OG ' ' NH1' ' A' ' 8' ' ' ARG . 2.9 p -53.36 144.27 16.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.94 -1.133 . . . . 4.93 107.94 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.9 -36.0 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.082 -2.407 . . . . 2.74 107.082 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -97.78 133.71 23.13 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.205 -1.035 . . . . 4.31 108.205 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.77 51.27 0.89 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.455 2.103 . . . . 2.96 111.488 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.89 -64.33 1.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.048 -1.093 . . . . 4.33 108.048 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -54.98 -29.91 58.04 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 115.149 -0.932 . . . . 2.1 108.902 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.1 t -42.79 -44.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.367 -1.288 . . . . 1.38 109.914 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 4.4 mmp_? -63.44 -52.03 63.21 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.087 -1.045 . . . . 2.89 111.008 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' CB ' HD11 ' A' ' 62' ' ' ILE . . . -59.62 -45.06 93.05 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.468 -0.893 . . . . 0.99 110.572 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 7.3 ttpp -61.25 -52.12 66.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.172 -1.011 . . . . 2.05 108.851 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -53.65 -53.66 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.252 -0.579 . . . . 2.36 109.848 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 79' ' ' VAL . 14.8 tp -55.52 -65.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.344 -0.942 . . . . 1.21 109.038 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.55 -46.47 19.38 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.987 -0.685 . . . . 1.03 110.411 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 43.8 tt0 -58.77 -54.17 50.08 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.251 1.024 . . . . 2.14 111.38 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -54.49 -50.36 67.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 113.694 -1.594 . . . . 6.82 106.822 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -53.38 -50.81 64.33 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.261 -1.385 . . . . 1.11 107.261 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.501 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 7.6 t -43.78 -24.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.433 -0.803 . . . . 1.33 112.507 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -107.09 -31.29 8.34 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.439 -0.801 . . . . 2.22 110.864 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.52 -36.47 73.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.088 . . . . 3.85 108.061 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.455 HH11 ' C ' ' A' ' 85' ' ' ALA . 19.4 mtp180 -119.03 117.31 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.477 0.656 . . . . 3.67 109.597 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -63.88 3.68 0.36 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.956 1.095 . . . . 3.8 113.956 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 1' ' ' MET . 11.4 p-10 -114.67 7.61 16.02 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.058 -0.719 . . . . 3.09 109.058 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 12.6 t80 -109.35 129.65 55.52 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.866 -0.734 . . . . 1.14 112.855 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -129.56 150.85 50.71 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.627 -1.62 . . . . 3.58 106.627 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 8.4 p90 -133.89 160.06 38.8 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.316 -1.354 . . . . 1.17 110.821 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -134.07 135.38 43.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.73 0.644 . . . . 4.39 110.342 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -108.08 109.84 21.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.003 -1.851 . . . . 1.75 106.003 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.24 141.4 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.379 -1.711 . . . . 1.55 106.379 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 9.0 t70 -110.17 155.05 22.47 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.074 -1.05 . . . . 2.78 110.844 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 pt -84.16 -34.87 10.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 117.993 -1.483 . . . . 1.46 112.435 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.508 ' HE ' ' N ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -98.24 -58.01 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.321 -1.752 . . . . 5.14 108.845 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -39.09 -39.91 0.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 124.198 0.936 . . . . 3.18 111.255 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.48 -36.38 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.071 -1.451 . . . . 4.64 110.862 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.23 69.77 0.61 Allowed Glycine 0 N--CA 1.5 2.948 0 C-N-CA 118.448 -1.834 . . . . 2.55 113.128 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 mm -115.04 157.18 15.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.148 -1.797 . . . . 2.43 106.148 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.7 p -107.39 137.14 45.98 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.69 -1.204 . . . . 3.0 110.454 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -55.04 -31.39 61.06 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.716 -1.216 . . . . 3.79 107.716 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 7.1 mp0 -59.42 -64.94 0.76 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.209 -0.663 . . . . 3.46 109.209 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 4.6 t70 -48.1 -49.45 31.82 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.069 0.938 . . . . 2.97 111.185 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.2 mt -61.8 -54.46 42.03 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.606 -1.179 . . . . 2.37 109.295 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -44.44 -46.12 9.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.837 -1.171 . . . . 3.61 107.837 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 8.5 tm0? -60.13 -58.89 6.58 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.781 -1.554 . . . . 4.31 110.974 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -17.89 63.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.141 1.534 . . . . 2.93 115.141 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.68 -38.28 13.19 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.736 -0.786 . . . . 1.36 111.143 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.481 ' C ' ' HG3' ' A' ' 54' ' ' LYS . . . 112.94 57.82 0.42 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.274 -1.93 . . . . 2.81 108.274 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HG3' ' C ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 37.2 76.03 0.49 Allowed Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 124.954 1.032 . . . . 6.94 111.651 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 1.8 Cg_endo -90.35 33.79 0.33 Allowed 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 122.821 2.348 . . . . 6.61 111.103 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.421 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.4 t 32.06 -102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 113.685 -1.598 . . . . 6.47 113.826 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 7.6 tp10 -125.04 46.11 2.41 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.579 -0.448 . . . . 8.01 110.216 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.0 p -119.44 124.36 46.32 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.285 1.217 . . . . 5.11 114.285 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 33.1 m -132.93 166.11 31.69 Favored Pre-proline 0 N--CA 1.504 2.238 0 N-CA-C 107.27 -1.381 . . . . 2.34 107.27 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 50.9 Cg_endo -79.61 170.72 66.53 Favored 'Cis proline' 0 N--CA 1.491 1.35 0 O-C-N 122.19 0.574 . . . . 1.65 110.886 -7.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.54 150.57 50.13 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.786 -0.766 . . . . 2.38 111.109 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.427 HD11 ' CB ' ' A' ' 17' ' ' ALA . 36.9 mm -119.69 141.45 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.039 -0.982 . . . . 1.88 110.295 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.406 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 23.7 m-85 -120.69 153.85 36.36 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.69 -1.141 . . . . 1.38 109.162 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 66' ' ' GLN . 85.9 t -129.83 100.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.06 -1.459 . . . . 1.0 107.06 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 1' ' ' MET . 23.8 m-20 54.93 -79.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 124.409 1.068 . . . . 2.58 112.721 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 64' ' ' VAL . 1.4 tm0? -120.53 -24.78 5.72 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.518 -1.219 . . . . 6.16 112.666 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -95.18 155.18 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.355 -0.938 . . . . 4.3 111.705 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -102.36 140.03 37.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 105.341 -2.096 . . . . 0.93 105.341 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.52 -42.3 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 118.11 -1.436 . . . . 0.92 110.793 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.0 -129.51 5.14 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.463 -1.455 . . . . 1.12 109.463 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.4 178.65 25.43 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.679 -1.248 . . . . 1.29 110.424 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 45.7 t80 -45.45 -36.03 4.15 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.311 -0.956 . . . . 1.63 111.422 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -58.94 -62.06 2.17 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.602 -0.839 . . . . 1.7 109.426 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.26 -39.99 64.3 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.895 -1.048 . . . . 2.21 109.109 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.82 -56.37 22.02 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.199 -1.0 . . . . 1.2 109.683 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.0 -51.12 64.95 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.86 -0.736 . . . . 0.84 110.054 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -53.81 54.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.833 -0.747 . . . . 0.8 109.465 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -48.05 -53.29 16.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.44 -0.948 . . . . 0.88 108.44 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 20' ' ' LEU . 25.2 t -50.9 -61.18 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 114.648 -1.16 . . . . 0.84 109.185 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.14 -51.94 7.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.739 0.649 . . . . 2.04 112.581 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.85 16.28 7.12 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.664 -1.214 . . . . 4.73 113.845 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -128.28 -43.98 1.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.61 -0.836 . . . . 2.15 110.393 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.07 36.51 2.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.867 -0.733 . . . . 2.41 110.722 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.48 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 2.3 t70 -89.25 54.05 2.84 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.181 -1.785 . . . . 4.17 106.181 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.455 ' C ' HH11 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.501 2.115 0 CA-C-N 112.645 -2.07 . . . . 4.79 107.196 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.66 -0.867 . . . . 2.36 108.66 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -84.89 111.57 19.78 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.262 0.977 . . . . 4.74 109.583 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.9 m -104.12 123.39 47.18 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 0.88 109.208 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.406 ' C ' HD12 ' A' ' 5' ' ' ILE . 40.2 t -116.13 130.89 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.347 -0.941 . . . . 1.02 109.928 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -106.12 131.9 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.974 -1.862 . . . . 1.16 105.974 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -117.42 108.57 15.72 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 105.563 -2.014 . . . . 1.46 105.563 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.64 -160.07 8.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.505 -1.331 . . . . 1.47 110.381 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -113.62 -162.04 0.79 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.222 -0.991 . . . . 4.66 108.732 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -128.89 154.54 46.4 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.49 -1.232 . . . . 5.11 109.452 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 -44.83 1.37 Allowed Glycine 0 N--CA 1.5 2.908 0 C-N-CA 119.386 -1.388 . . . . 3.1 114.229 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.5 m -106.33 146.89 33.89 Favored Pre-proline 0 N--CA 1.498 1.936 0 C-N-CA 118.694 -1.202 . . . . 3.78 111.944 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.49 65.61 8.2 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.41 2.073 . . . . 3.0 111.276 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -112.92 -73.54 0.66 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.655 -1.239 . . . . 4.97 107.655 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.0 m -53.53 -25.15 15.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.356 -0.979 . . . . 2.09 108.356 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -41.65 -39.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 114.624 -1.171 . . . . 1.39 109.779 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.613 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 1.1 tpm_? -75.83 -50.24 15.71 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.15 -1.02 . . . . 3.5 110.255 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.69 54.17 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.758 -1.177 . . . . 1.03 108.321 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 14.6 ttpp -67.59 -58.38 4.8 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 107.448 -1.315 . . . . 2.11 107.448 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -45.04 -42.93 8.95 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.539 -0.864 . . . . 2.39 109.696 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.9 tp -62.62 -63.73 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.668 -1.151 . . . . 0.95 108.275 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.84 -45.9 15.29 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.444 0.64 . . . . 0.86 109.833 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 26.7 tt0 -64.57 -44.28 91.2 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.6 -1.182 . . . . 2.83 109.583 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -54.7 43.79 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.872 -1.529 . . . . 6.1 106.872 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.27 -45.53 68.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.761 -1.563 . . . . 1.11 107.691 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 32' ' ' GLN . 8.3 t -54.9 -25.82 31.62 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.979 -1.009 . . . . 1.15 111.447 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 1.1 t30 -105.63 9.83 33.13 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.888 -0.782 . . . . 2.08 108.888 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -117.65 -32.73 4.77 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 115.985 -0.552 . . . . 3.26 110.53 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.571 HH12 ' C ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -110.44 153.59 24.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.819 -0.808 . . . . 4.37 108.819 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.71 -26.59 25.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.865 -0.607 . . . . 4.28 110.565 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.51 13.67 29.14 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.694 -0.802 . . . . 2.74 110.471 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -112.47 124.79 53.29 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.297 1.591 . . . . 1.23 115.297 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 63.4 mt-30 -143.02 156.54 44.86 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.397 -2.075 . . . . 3.64 105.397 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -142.3 170.9 14.83 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 117.71 -1.596 . . . . 1.39 111.77 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -138.17 145.21 41.24 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.654 -1.612 . . . . 4.14 109.112 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -122.5 122.76 39.7 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.944 -1.873 . . . . 2.05 105.944 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.71 137.41 54.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.651 -1.241 . . . . 1.29 107.651 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.69 129.83 47.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.034 -1.099 . . . . 2.31 108.034 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.51 -28.9 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 119.935 -0.706 . . . . 1.81 111.005 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.606 ' NH1' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -79.79 -40.52 28.49 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.588 -1.264 . . . . 6.78 107.588 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.606 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -39.17 -54.18 1.8 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 120.962 -0.295 . . . . 1.51 110.727 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' GLY . 48.9 mt-10 -110.79 41.42 1.8 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 124.502 1.126 . . . . 4.2 109.95 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 20.1 66.17 0.01 OUTLIER Glycine 0 N--CA 1.508 3.48 0 O-C-N 124.205 0.94 . . . . 2.39 113.31 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 44' ' ' THR . 48.4 mt -93.4 162.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.863 -0.735 . . . . 1.75 109.807 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 43' ' ' ILE . 45.9 p -113.12 178.38 4.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.798 -0.637 . . . . 2.08 109.925 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -73.55 -52.86 12.07 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.607 -1.237 . . . . 6.27 109.864 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.4 mp0 -43.3 -52.67 5.65 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.339 -0.544 . . . . 3.88 110.162 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.583 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 4.1 t70 -51.57 -57.36 9.32 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.06 -0.656 . . . . 2.47 110.3 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mt -53.51 -46.05 69.93 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 115.02 -0.991 . . . . 1.31 110.245 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -47.07 -54.78 9.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.47 -0.937 . . . . 3.64 108.47 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -49.23 -29.85 6.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.215 1.572 . . . . 3.77 111.285 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.583 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 10.8 mptt -82.54 -47.36 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.127 -0.942 . . . . 2.53 112.311 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HB2' ' NE2' ' A' ' 61' ' ' GLN . . . -75.27 -45.96 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.628 1.344 . . . . 1.0 114.628 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.63 -42.65 1.91 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 107.295 -2.322 . . . . 2.4 107.295 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -84.18 169.53 16.64 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 106.696 -1.594 . . . . 7.22 106.696 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.04 163.53 5.9 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.942 -1.215 . . . . 4.16 108.942 161.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -124.0 38.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.93 -1.108 . . . . 5.41 109.762 179.372 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -26.14 -64.06 0.07 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.257 -1.338 . . . . 5.16 111.163 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -116.79 -154.5 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.122 -0.944 . . . . 4.12 109.763 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.44 175.76 3.25 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.068 -1.086 . . . . 1.81 108.068 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.459 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 71.6 Cg_endo -103.6 -170.71 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.112 0 O-C-N 122.406 0.687 . . . . 1.71 111.672 -18.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.548 ' NE2' ' HB2' ' A' ' 52' ' ' ALA . 13.6 mt-30 -141.94 151.79 42.91 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 115.686 -0.688 . . . . 2.63 110.716 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.9 mp -124.79 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 115.527 -0.76 . . . . 1.55 109.286 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 16.8 m-85 -127.27 150.74 49.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.19 -1.368 . . . . 1.01 109.894 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.449 HG23 ' CG1' ' A' ' 69' ' ' ILE . 55.5 t -120.5 125.32 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.055 -1.461 . . . . 0.91 107.055 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 57.41 -94.76 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.775 -1.194 . . . . 4.47 107.775 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -131.99 2.47 3.99 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.389 -0.823 . . . . 3.89 110.938 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.09 167.31 11.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 110.018 -0.364 . . . . 4.27 110.018 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 15.0 t-160 -108.28 139.53 42.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.587 -1.264 . . . . 0.83 107.587 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.449 ' CG1' HG23 ' A' ' 64' ' ' VAL . 26.7 mm -101.73 -42.89 9.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.075 -1.05 . . . . 1.08 108.55 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.52 -132.43 5.45 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.07 -2.012 . . . . 1.34 108.07 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 72' ' ' TYR . . . -114.74 -175.22 18.59 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.054 -1.218 . . . . 1.31 110.054 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.508 ' OH ' ' HG2' ' A' ' 16' ' ' ARG . 1.8 t80 -33.03 -54.42 0.38 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.405 0.622 . . . . 2.19 111.194 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.98 -68.77 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.562 -1.199 . . . . 1.91 110.939 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -51.1 -38.94 54.79 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.696 -1.593 . . . . 2.41 110.846 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 62' ' ' ILE . 37.9 t80 -64.99 -51.71 60.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.833 -1.147 . . . . 0.83 109.903 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.12 76.18 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.185 -1.006 . . . . 0.95 109.6 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.02 -58.99 5.45 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.102 -1.039 . . . . 0.82 109.109 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.418 ' CH2' HG21 ' A' ' 64' ' ' VAL . 90.7 t90 -42.58 -51.01 5.3 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.196 -1.039 . . . . 0.73 108.196 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -52.66 -65.58 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.296 0 N-CA-C 107.857 -1.164 . . . . 0.82 107.857 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -49.25 -29.48 5.84 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.507 1.299 . . . . 2.3 114.507 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -105.82 7.64 32.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.231 0.826 . . . . 4.06 113.231 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -129.05 -35.54 1.83 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.01 -0.676 . . . . 1.56 110.378 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -106.35 26.02 10.37 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.131 -0.628 . . . . 2.02 109.872 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -82.36 53.6 2.34 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.548 -0.908 . . . . 3.87 108.548 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.571 ' C ' HH12 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.878 -1.058 . . . . 5.48 109.3 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 30' ' ' ASP . 47.5 mtm . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.531 -0.914 . . . . 2.98 108.531 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.07 155.13 20.72 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 123.833 0.708 . . . . 4.06 109.107 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 2.8 m -143.74 143.7 31.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.021 -1.103 . . . . 1.51 108.021 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.0 t -127.84 126.61 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 119.033 -1.067 . . . . 1.22 112.526 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.8 mp -109.34 130.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.787 -1.19 . . . . 1.27 107.787 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -111.02 111.67 22.94 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 105.006 -2.22 . . . . 1.66 105.006 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.676 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -129.09 -143.82 5.6 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.536 -1.316 . . . . 1.58 112.8 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.32 -167.27 1.83 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 114.404 -0.898 . . . . 5.73 109.969 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m -86.53 64.25 8.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.096 -0.642 . . . . 5.65 111.428 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.63 53.83 1.1 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.504 -1.332 . . . . 3.28 109.78 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' TYR . 49.4 t -107.31 98.03 21.33 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.568 -1.271 . . . . 4.63 107.568 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.43 -20.76 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.264 2.642 . . . . 3.15 113.699 -159.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' CYS . 30.1 m-85 -71.62 -30.92 66.32 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.325 -0.55 . . . . 5.19 112.099 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -83.8 -30.41 26.59 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.7 -1.6 . . . . 1.94 106.811 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -50.05 -49.85 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 115.483 -0.78 . . . . 1.24 109.344 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.604 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 3.9 mmp_? -58.59 -52.47 65.54 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.38 -0.928 . . . . 2.86 111.047 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.92 63.44 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.261 -1.375 . . . . 0.63 107.729 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -49.19 -58.8 4.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 124.42 1.075 . . . . 2.21 109.265 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.74 -52.19 50.45 Favored 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 120.025 -0.67 . . . . 2.63 110.952 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 tp -52.5 -63.86 1.0 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.078 -0.712 . . . . 0.86 109.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.76 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.059 -0.719 . . . . 0.66 109.059 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.2 tt0 -55.36 -42.01 73.34 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.129 -0.941 . . . . 2.63 110.273 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -64.13 -54.63 30.87 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.036 -1.066 . . . . 5.94 108.339 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.524 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 43.1 mt -49.1 -47.55 45.13 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.124 -2.176 . . . . 1.04 105.124 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.19 -47.77 24.03 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.943 -1.026 . . . . 1.1 110.831 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.22 -35.24 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.656 -0.818 . . . . 2.13 112.154 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -72.3 -36.55 68.97 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.084 -0.646 . . . . 4.24 111.323 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.529 HH21 ' CG ' ' A' ' 30' ' ' ASP . 10.9 ptm85 -136.49 113.59 10.56 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.683 -0.807 . . . . 3.65 111.559 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -62.17 12.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 114.572 1.323 . . . . 4.7 114.572 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.529 ' CG ' HH21 ' A' ' 28' ' ' ARG . 10.1 p-10 -111.65 -1.88 15.57 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.066 -0.716 . . . . 3.64 109.066 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 91.4 t80 -109.65 116.81 32.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.637 -0.825 . . . . 1.15 110.352 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -121.73 167.81 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.148 -0.686 . . . . 3.13 109.148 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 30.1 p90 -161.55 168.78 22.96 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.091 -0.644 . . . . 1.7 110.21 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 152.09 41.11 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 109.599 -0.519 . . . . 4.93 109.599 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -118.44 135.7 54.21 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.306 -0.958 . . . . 1.39 109.284 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -127.8 159.33 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.401 -0.963 . . . . 1.36 108.401 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -113.71 129.11 56.62 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.698 -1.964 . . . . 2.53 105.698 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -43.67 -26.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.393 -0.523 . . . . 2.14 111.585 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -73.0 -59.44 2.7 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 120.469 -0.492 . . . . 6.78 109.993 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.32 -47.15 0.4 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.467 1.105 . . . . 1.95 111.202 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.82 -45.68 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.511 -1.222 . . . . 4.27 110.813 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.49 49.45 0.8 Allowed Glycine 0 N--CA 1.505 3.268 0 N-CA-C 109.417 -1.473 . . . . 2.79 109.417 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.472 HG21 ' HG ' ' A' ' 48' ' ' LEU . 15.9 mt -113.19 148.51 16.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.064 -0.568 . . . . 2.84 111.015 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.6 p -118.7 -92.77 0.53 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.01 -1.076 . . . . 5.13 110.113 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' NZ ' ' OE1' ' A' ' 46' ' ' GLU . 11.4 tttm -138.45 -55.16 0.63 Allowed 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.652 -1.24 . . . . 4.48 107.652 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.8 mm-40 -43.24 -50.43 6.48 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.367 -0.933 . . . . 5.52 110.92 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 51' ' ' LYS . 33.3 t70 -63.31 -54.74 32.34 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.35 -0.94 . . . . 3.24 111.195 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HG ' HG21 ' A' ' 43' ' ' ILE . 6.1 mt -53.52 -43.86 68.69 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.698 -0.801 . . . . 2.56 110.025 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.83 -53.76 54.57 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.495 -1.298 . . . . 4.52 107.495 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -53.11 -58.11 8.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 124.188 0.93 . . . . 4.58 110.367 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 47' ' ' ASP . 48.0 mttp -54.0 -50.23 67.09 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.166 -0.925 . . . . 2.81 111.367 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' CG ' ' A' ' 68' ' ' HIS . . . -54.45 -55.94 23.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.723 -1.581 . . . . 1.57 111.418 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.04 36.44 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.271 -1.532 . . . . 3.12 109.271 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -102.79 161.35 23.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.164 -0.68 . . . . 7.67 109.164 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.32 111.21 3.23 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.784 1.656 . . . . 4.69 111.451 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.402 HG11 ' NE2' ' A' ' 61' ' ' GLN . 15.4 m -131.02 159.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 123.335 0.397 . . . . 6.01 110.082 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -133.65 -43.08 0.83 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 123.511 0.507 . . . . 6.57 111.957 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -114.54 -148.31 0.43 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.651 -0.82 . . . . 4.96 109.696 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.81 173.6 2.9 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 109.576 -0.527 . . . . 2.45 109.576 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.557 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 73.9 Cg_endo -100.03 -177.68 4.0 Favored 'Cis proline' 0 N--CA 1.483 0.874 0 O-C-N 122.348 0.657 . . . . 1.67 111.319 -11.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.402 ' NE2' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -134.46 145.01 48.44 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.445 -0.798 . . . . 2.48 111.025 -179.42 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.566 HG21 ' CD1' ' A' ' 75' ' ' PHE . 4.3 mp -124.77 145.78 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 115.171 -0.922 . . . . 1.65 110.863 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.72 160.99 33.88 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.084 -1.871 . . . . 1.1 108.539 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.478 HG23 ' CG1' ' A' ' 69' ' ' ILE . 60.6 t -112.4 175.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.827 -1.916 . . . . 2.15 105.827 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 64' ' ' VAL . 38.8 t70 -61.35 -8.84 4.31 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.991 -1.084 . . . . 3.71 111.014 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -122.95 -56.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.459 1.281 . . . . 7.51 114.459 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.56 176.02 5.91 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.816 -0.753 . . . . 6.78 112.641 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' CG ' ' HA ' ' A' ' 52' ' ' ALA . 13.2 t-80 -93.05 154.56 18.04 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.483 -2.043 . . . . 0.94 105.483 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.478 ' CG1' HG23 ' A' ' 64' ' ' VAL . 37.0 mm -115.07 -49.13 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.379 -1.328 . . . . 1.08 111.291 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 145.49 -130.99 4.0 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 1.18 109.708 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.84 -173.39 20.63 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.248 -1.141 . . . . 1.2 110.248 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.91 -52.34 1.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 120.163 -0.615 . . . . 1.97 110.746 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -50.47 -58.76 5.0 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.843 0.83 . . . . 1.85 110.106 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.468 ' HB3' HG22 ' A' ' 69' ' ' ILE . 1.7 m-20 -54.33 -54.31 42.1 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.792 -1.095 . . . . 2.71 110.126 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD1' HG21 ' A' ' 62' ' ' ILE . 25.7 t80 -54.2 -52.34 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.778 -0.769 . . . . 1.09 110.997 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.61 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.625 -0.83 . . . . 1.19 109.014 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.07 -55.85 28.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.376 -0.929 . . . . 1.25 110.021 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -49.71 -51.84 35.7 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.705 -0.798 . . . . 1.15 109.346 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.429 ' CG1' HD11 ' A' ' 24' ' ' LEU . 29.0 t -49.73 -63.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 124.131 0.894 . . . . 1.06 108.706 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -44.63 -48.48 10.47 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.03 -0.986 . . . . 2.15 111.154 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.57 27.55 2.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 117.567 -1.653 . . . . 3.8 113.987 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.68 -41.79 0.28 Allowed 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 119.437 -0.905 . . . . 1.24 112.108 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.413 ' CD1' HD13 ' A' ' 24' ' ' LEU . 18.7 mt -109.98 2.96 20.01 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 120.012 -0.675 . . . . 1.98 111.845 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -103.26 -134.7 0.32 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.569 0.7 . . . . 4.98 109.577 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.964 0 CA-C-N 113.895 -1.502 . . . . 7.82 107.591 179.384 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mmm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.208 -0.664 . . . . 3.22 109.208 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -88.96 97.75 11.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.879 -0.601 . . . . 3.86 110.172 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.9 m -84.4 123.38 30.16 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.828 -1.149 . . . . 0.99 109.207 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.67 131.41 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.828 -0.749 . . . . 1.1 112.277 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.45 116.89 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.703 -1.962 . . . . 1.15 105.703 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -99.43 103.89 15.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.661 -1.607 . . . . 1.58 106.661 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -122.78 -123.33 2.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.523 -1.431 . . . . 1.45 109.523 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' N ' ' OH ' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -135.88 -114.37 0.19 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.879 -1.128 . . . . 5.89 109.403 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 p -113.58 -74.81 0.61 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.808 -1.182 . . . . 4.86 107.808 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.92 63.36 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.534 -2.227 . . . . 2.9 107.534 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.6 t -100.19 97.47 6.28 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.935 -0.706 . . . . 4.98 109.524 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.56 -25.57 41.6 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.062 1.841 . . . . 3.27 111.847 -170.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.91 -9.74 58.95 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.332 -0.947 . . . . 6.19 111.576 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 3.5 m -101.07 -37.3 8.66 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.784 -1.561 . . . . 2.25 106.784 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -42.71 -35.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 114.721 -1.127 . . . . 1.27 110.128 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 7.3 mmm180 -71.51 -55.17 8.38 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.049 -1.46 . . . . 4.05 110.525 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.7 43.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.622 -1.251 . . . . 0.86 107.622 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -58.79 -49.88 76.01 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.539 -1.664 . . . . 1.94 109.035 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.6 t70 -60.44 -49.33 78.02 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.735 -1.186 . . . . 2.89 111.075 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 42.1 tp -60.51 -55.32 34.91 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.979 -1.088 . . . . 0.88 110.0 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.85 64.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.335 -1.357 . . . . 0.96 107.335 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.628 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 31.8 tt0 -48.61 -49.43 36.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.388 1.055 . . . . 2.14 109.359 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HE3' ' CA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -50.74 -63.52 1.1 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.344 -1.354 . . . . 6.66 107.344 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 83' ' ' LEU . 54.3 mt -45.53 -53.54 8.83 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.872 -1.158 . . . . 1.33 107.872 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 15.1 t -52.02 -33.25 37.67 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.21 -1.359 . . . . 1.73 112.939 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -112.32 25.33 11.63 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.161 -0.927 . . . . 3.13 109.197 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -133.62 -48.47 0.82 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.161 -0.927 . . . . 3.24 111.568 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 30' ' ' ASP . 21.9 mtp85 -113.38 133.08 55.35 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.194 -0.912 . . . . 3.12 110.508 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -80.9 35.04 0.36 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.395 -1.322 . . . . 3.7 111.372 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.4 p30 -130.2 -4.58 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.843 -1.526 . . . . 3.9 108.132 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' A' ' 25' ' ' SER . 23.7 t80 -127.86 141.45 51.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.599 -0.84 . . . . 1.15 112.608 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.427 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 35.4 mm-40 -140.75 141.04 34.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.218 -1.401 . . . . 3.99 107.218 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.628 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -127.21 162.34 26.39 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 118.62 -1.232 . . . . 1.28 113.721 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 147.45 27.99 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.611 -1.632 . . . . 4.65 109.333 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.538 ' OH ' ' N ' ' A' ' 8' ' ' ARG . 57.6 t80 -113.41 146.34 39.67 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.765 -1.198 . . . . 1.19 107.765 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.21 163.96 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.616 -0.834 . . . . 1.65 110.25 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -121.13 121.24 37.43 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.24 -2.133 . . . . 2.23 105.24 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -51.29 -17.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 118.825 -1.15 . . . . 1.88 110.806 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 4.2 ttp-105 -95.05 23.97 5.23 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.72 -0.792 . . . . 6.25 109.666 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.84 -43.69 3.97 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.102 -1.444 . . . . 1.55 107.102 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -93.48 -42.37 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.541 -2.022 . . . . 4.65 105.541 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.21 56.71 0.58 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.222 -1.951 . . . . 1.35 108.222 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.7 149.84 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.501 . . . . 1.37 111.067 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 -170.87 1.92 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.607 -0.724 . . . . 1.94 109.431 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 13.3 ttpp -77.06 -28.29 54.67 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.491 -0.884 . . . . 5.33 110.668 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 16.7 mp0 -70.71 -57.13 5.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 3.32 108.149 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -48.52 -42.66 33.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.104 -0.953 . . . . 2.4 110.422 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.76 -38.77 53.55 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.954 -1.021 . . . . 1.74 110.895 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.483 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 5.2 tt0 -55.74 -47.71 76.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.306 -1.368 . . . . 3.43 107.306 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.0 -30.83 26.83 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.322 -1.308 . . . . 5.1 110.811 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -88.97 -57.6 2.84 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.536 -1.211 . . . . 2.34 112.244 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -50.5 -33.35 21.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.783 -1.099 . . . . 1.45 112.029 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.79 73.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 106.521 -2.632 . . . . 3.67 106.521 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -133.26 -169.9 0.22 Allowed Pre-proline 0 C--N 1.296 -1.737 0 CA-C-N 113.089 -1.555 . . . . 6.32 107.834 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -86.6 143.5 7.34 Favored 'Trans proline' 0 C--N 1.299 -2.026 0 C-N-CA 120.893 1.062 . . . . 3.5 110.989 138.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -118.29 160.46 17.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.731 -1.211 . . . . 5.75 107.731 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -101.65 -109.69 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.084 -1.046 . . . . 6.73 108.693 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.9 p -120.26 -73.48 0.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.266 -1.013 . . . . 4.88 108.266 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -147.8 149.76 34.26 Favored Pre-proline 0 C--N 1.289 -2.048 0 CA-C-N 114.149 -1.387 . . . . 2.47 107.966 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.636 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 26.0 Cg_endo -103.66 155.8 3.01 Favored 'Cis proline' 0 C--N 1.32 -0.966 0 CA-C-N 118.671 0.561 . . . . 1.69 112.241 -6.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.46 149.43 41.28 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 107.085 -1.45 . . . . 2.74 107.085 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 58.0 mt -127.48 141.33 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.651 -0.82 . . . . 1.27 113.136 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -124.54 145.15 49.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.306 -1.77 . . . . 1.5 110.283 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 71.1 t -117.75 90.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.412 -0.959 . . . . 1.2 108.412 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 t70 70.9 -75.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.263 -0.88 . . . . 2.57 109.05 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -134.18 -20.87 1.88 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.786 -1.097 . . . . 3.55 111.381 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -89.51 158.1 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.759 -1.176 . . . . 4.9 110.8 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.576 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 11.8 t-160 -103.71 142.32 34.54 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.473 -0.936 . . . . 0.92 108.473 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 mm -111.55 -46.14 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.041 -1.063 . . . . 0.93 108.959 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.15 -113.82 1.01 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.504 -1.439 . . . . 1.17 109.504 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -119.25 -173.81 15.61 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.372 -1.091 . . . . 1.22 110.372 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 18.5 t80 -47.1 -49.2 22.36 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.354 -0.939 . . . . 1.39 111.516 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -54.67 17.17 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.687 0.756 . . . . 1.65 110.123 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -58.38 -52.64 64.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.666 -1.606 . . . . 2.44 110.481 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.97 -44.68 96.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.508 -0.769 . . . . 1.19 111.834 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.91 -58.18 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.728 -0.789 . . . . 1.03 109.226 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.76 -55.43 35.21 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.569 -1.253 . . . . 1.14 108.893 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.43 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 63.6 t90 -44.75 -54.18 6.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 123.549 0.531 . . . . 0.95 111.485 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -43.54 -59.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.962 -0.563 . . . . 0.82 110.265 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HG3' ' OE2' ' A' ' 81' ' ' GLU . 18.2 tptp -43.8 -30.19 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.394 1.628 . . . . 2.11 115.394 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.422 ' OE2' ' HG3' ' A' ' 80' ' ' LYS . 2.9 mp0 -107.82 4.5 25.57 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 119.579 1.082 . . . . 4.74 112.62 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -120.56 -31.57 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.721 -0.791 . . . . 1.38 111.045 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 24' ' ' LEU . 55.0 mt -116.94 26.84 9.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.792 -0.763 . . . . 1.7 111.954 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.42 50.15 1.95 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.698 -0.801 . . . . 3.6 110.647 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.425 ' C ' HH12 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.499 2.02 0 CA-C-O 116.035 -1.936 . . . . 5.55 111.57 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 3.9 ptm . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 107.728 -1.212 . . . . 3.83 107.728 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.48 HE22 ' C ' ' A' ' 33' ' ' TYR . 60.5 tp60 -111.57 142.0 44.42 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 123.478 0.487 . . . . 4.73 109.839 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 m -120.4 148.72 43.41 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.771 -0.771 . . . . 1.39 109.025 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.49 139.19 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 118.868 -1.133 . . . . 1.05 112.595 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.463 HD12 ' HB1' ' A' ' 17' ' ' ALA . 17.2 mm -111.1 136.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.55 -1.278 . . . . 1.54 107.55 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.15 84.98 2.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.585 -1.635 . . . . 2.2 106.585 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -135.1 -163.28 10.05 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.496 -2.241 . . . . 1.27 107.496 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 9' ' ' SER . 4.2 tpt180 -141.35 167.68 21.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.256 -0.977 . . . . 6.19 108.581 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 8' ' ' ARG . 78.9 p -85.76 64.83 8.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.307 -0.627 . . . . 4.68 109.307 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 11' ' ' CYS . . . -120.75 61.13 0.52 Allowed Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.505 -1.438 . . . . 4.68 109.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.755 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 30.7 t 108.82 165.44 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.685 0 N-CA-C 105.605 -1.998 . . . . 4.71 105.605 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 50.5 Cg_exo -54.76 75.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.023 1.149 . . . . 3.11 113.023 165.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.403 ' CD2' ' HB3' ' A' ' 11' ' ' CYS . 6.5 m-85 -113.82 -77.89 0.58 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.573 -0.451 . . . . 4.85 109.915 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.45 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.7 m -55.02 -29.12 56.7 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 118.041 -1.464 . . . . 2.44 108.022 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -42.54 -38.59 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.164 -1.38 . . . . 1.51 110.205 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.495 ' NH2' ' HB3' ' A' ' 19' ' ' ASP . 6.6 mmm180 -77.11 -53.63 7.54 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.957 -1.497 . . . . 3.61 110.093 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.463 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -49.16 -42.59 40.25 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.208 -0.997 . . . . 1.07 109.185 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HE3' ' CZ ' ' A' ' 33' ' ' TYR . 2.3 tptm -60.19 -60.0 4.51 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.898 -1.501 . . . . 2.74 108.687 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.495 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 3.4 t70 -50.51 -42.65 55.15 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.984 -1.086 . . . . 2.6 110.029 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 79' ' ' VAL . 8.6 tp -63.22 -66.93 0.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.686 -1.205 . . . . 1.11 109.185 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.97 -39.82 9.48 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 120.312 -0.555 . . . . 1.04 110.524 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 26.6 tt0 -65.55 -53.04 47.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.151 -0.932 . . . . 2.31 110.389 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -53.54 39.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.566 -1.642 . . . . 6.81 106.566 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.4 mt -53.51 -40.62 65.55 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.544 -1.207 . . . . 1.39 108.216 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -59.7 -35.62 74.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.874 -1.057 . . . . 1.03 110.594 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -83.98 -28.08 27.99 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.042 -0.663 . . . . 1.77 110.891 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.3 -47.22 44.5 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.208 -0.597 . . . . 3.42 111.35 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -109.18 164.97 11.96 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.143 -1.023 . . . . 4.44 110.907 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.632 -1.618 . . . . 4.0 106.632 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 1' ' ' MET . 3.5 t70 -82.86 41.19 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.924 -1.489 . . . . 3.58 108.686 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -145.46 93.23 2.34 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.546 -1.262 . . . . 1.07 112.651 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -99.55 155.06 17.78 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 104.526 -2.398 . . . . 3.35 104.526 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.548 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 7.3 p90 -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.059 -1.056 . . . . 1.73 108.784 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -149.02 152.44 36.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.701 -0.852 . . . . 4.77 108.701 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -121.46 123.15 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.841 -1.17 . . . . 2.11 107.841 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.28 145.39 20.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.97 -2.233 . . . . 1.92 104.97 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 11.1 t70 -111.18 160.1 17.25 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.544 -1.263 . . . . 2.55 108.512 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.26 -30.24 5.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 117.778 -1.569 . . . . 1.25 108.87 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 3.1 tpm_? -93.18 -59.31 2.06 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.74 -0.664 . . . . 5.31 110.339 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -47.19 -33.29 5.15 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.655 -0.818 . . . . 1.66 110.972 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.22 -46.31 8.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.954 0.784 . . . . 3.97 109.334 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 54.23 1.05 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.722 -1.751 . . . . 1.49 108.722 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 mt -99.74 162.7 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.544 -0.91 . . . . 1.53 108.544 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 p -113.36 148.78 35.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.942 0.776 . . . . 2.43 112.184 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.606 ' HG3' ' CG1' ' A' ' 56' ' ' VAL . 35.0 tttm -49.3 -54.26 17.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.588 -0.893 . . . . 4.26 108.588 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 3.6 mp0 -46.62 -62.91 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.725 -1.125 . . . . 3.25 111.006 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.15 -56.71 8.33 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 120.401 -0.519 . . . . 2.16 110.895 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.8 -50.17 69.2 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.7 -0.682 . . . . 1.25 110.229 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.97 -56.14 16.06 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 3.04 107.535 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -49.77 -43.92 48.48 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.107 -1.406 . . . . 3.96 109.071 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HD2' ' CE2' ' A' ' 63' ' ' PHE . 6.2 tmtt? -63.85 -46.39 85.23 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.133 -1.394 . . . . 7.24 112.231 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -71.19 -48.51 51.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 113.068 0.766 . . . . 1.06 113.068 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.94 -33.85 6.18 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.065 -2.414 . . . . 2.54 107.065 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -83.83 141.53 41.25 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 114.447 -0.876 . . . . 7.78 108.649 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -41.92 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 122.358 2.039 . . . . 3.87 110.712 161.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.606 ' CG1' ' HG3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER 33.32 -95.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 115.637 1.717 . . . . 5.22 115.637 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 5.3 tp10 109.14 -170.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 102.475 -3.158 . . . . 7.18 102.475 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.498 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 14.9 p -104.03 -152.49 0.46 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.181 -1.414 . . . . 4.33 107.181 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.07 146.64 51.88 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 107.881 -1.155 . . . . 2.8 107.881 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 96.6 Cg_endo -98.46 162.46 10.42 Favored 'Cis proline' 0 N--CA 1.489 1.223 0 O-C-N 122.858 0.925 . . . . 2.43 111.637 10.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -114.06 151.34 32.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.578 -1.267 . . . . 2.85 107.578 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.423 HD12 ' CB ' ' A' ' 75' ' ' PHE . 6.2 mt -123.2 143.24 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.066 -1.054 . . . . 1.8 111.798 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.422 ' CE2' ' HD2' ' A' ' 51' ' ' LYS . 31.7 m-85 -136.36 159.06 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.751 -1.568 . . . . 1.09 107.874 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 66' ' ' GLN . 74.6 t -127.6 130.44 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.531 -0.914 . . . . 0.87 108.531 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.08 -81.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 124.398 1.061 . . . . 2.77 110.603 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.3 pt20 -138.33 -14.2 1.32 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.229 -0.896 . . . . 3.87 110.976 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -85.46 168.96 14.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.696 0.623 . . . . 4.88 111.209 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.53 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.3 t-160 -113.01 139.66 48.47 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.617 -0.72 . . . . 0.87 109.267 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mm -109.69 -34.37 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.304 -1.358 . . . . 1.15 109.215 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.96 -136.17 8.77 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.169 -1.491 . . . . 1.2 109.539 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.39 169.2 17.1 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.749 -1.215 . . . . 1.49 110.656 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.6 t80 -40.53 -57.27 1.87 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 112.608 0.596 . . . . 1.52 112.608 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 p -43.25 -69.31 0.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.026 0.917 . . . . 1.6 111.213 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -52.1 30.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.174 -1.83 . . . . 2.83 110.316 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' CE1' ' CE3' ' A' ' 78' ' ' TRP . 58.3 t80 -44.61 -46.54 10.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.345 -0.843 . . . . 1.74 111.03 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -40.83 -48.17 3.03 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 119.62 -0.832 . . . . 1.1 111.006 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.99 77.93 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.839 -1.144 . . . . 1.17 109.713 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.464 ' CZ2' HG21 ' A' ' 64' ' ' VAL . 90.5 t90 -50.94 -44.99 60.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.724 -0.843 . . . . 0.7 108.724 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG21 HD21 ' A' ' 20' ' ' LEU . 79.7 t -57.23 -33.99 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.662 -1.154 . . . . 1.08 110.23 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 13.7 tptp -87.57 18.52 3.88 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.265 -0.974 . . . . 2.26 111.726 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.21 -45.47 0.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.271 -0.972 . . . . 3.85 111.826 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -84.86 -2.16 57.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.992 -1.083 . . . . 1.76 111.745 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.416 HD12 HG13 ' A' ' 79' ' ' VAL . 86.0 mt -123.25 21.32 9.63 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.209 -0.996 . . . . 1.8 110.742 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.08 46.62 1.4 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.075 -1.084 . . . . 4.09 108.075 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.957 0 CA-C-N 113.078 -1.874 . . . . 6.25 109.506 -179.374 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.387 -0.598 . . . . 3.46 109.387 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 18.6 mt-30 -112.01 164.51 13.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.118 0.485 . . . . 3.85 111.82 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.1 m -152.35 121.48 6.67 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 116.434 -0.348 . . . . 1.14 110.159 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.491 ' C ' HD12 ' A' ' 5' ' ' ILE . 6.6 t -109.19 137.91 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.103 -1.039 . . . . 1.02 110.09 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp -109.32 98.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 124.768 1.293 . . . . 1.05 108.077 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CE1' HG11 ' A' ' 4' ' ' VAL . 76.4 m-85 -93.76 92.75 7.61 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 105.774 -1.936 . . . . 1.41 105.774 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -125.07 -150.69 7.85 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.825 -1.178 . . . . 1.27 111.766 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.3 tpt180 -124.26 123.53 40.45 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.812 -0.81 . . . . 5.27 108.812 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -78.45 53.78 1.34 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.662 0.744 . . . . 5.39 109.397 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.34 -46.37 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.733 -1.347 . . . . 3.16 109.733 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.575 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 32.1 t -111.78 156.1 42.12 Favored Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.779 -0.822 . . . . 3.76 108.779 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 6.1 Cg_endo -72.55 48.53 1.31 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.491 1.461 . . . . 3.23 111.446 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -99.99 -58.62 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.361 -0.978 . . . . 4.36 108.361 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.3 m -53.26 -36.19 60.84 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.423 -1.325 . . . . 2.46 107.423 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.41 -30.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.079 -1.873 . . . . 1.34 111.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' ARG . 39.4 mmt180 -72.28 -39.85 68.02 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.983 -1.087 . . . . 5.82 110.302 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 62' ' ' ILE . . . -65.22 -46.7 79.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.217 -1.771 . . . . 0.84 106.217 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 2.1 ttpp -51.99 -48.91 64.2 Favored 'General case' 0 C--O 1.2 -1.532 0 CA-C-N 114.099 -1.409 . . . . 1.59 108.97 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -57.42 -65.68 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.646 -0.706 . . . . 2.94 111.251 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.4 tp -51.31 -51.85 50.57 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.083 -1.047 . . . . 1.05 110.073 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.13 -51.52 63.98 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.618 -1.173 . . . . 0.79 109.747 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 19.6 tt0 -55.93 -49.0 74.69 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.047 -0.978 . . . . 1.88 109.35 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HD2' ' C ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -52.23 -55.1 23.36 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.034 -1.466 . . . . 4.35 107.657 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.82 -37.17 63.3 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.756 -0.831 . . . . 1.01 108.756 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 5.7 t -55.71 -40.74 72.84 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.815 -1.18 . . . . 1.04 107.815 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -98.3 40.36 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.961 -1.496 . . . . 2.05 106.961 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.53 -52.3 0.39 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.242 -1.344 . . . . 2.8 111.663 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -106.23 -11.45 16.04 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.973 -1.091 . . . . 4.61 111.177 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 71.51 -40.55 0.48 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 124.15 0.906 . . . . 4.72 112.59 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 1' ' ' MET . 5.3 p-10 -80.96 4.23 20.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.705 -1.198 . . . . 2.71 107.863 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.502 ' CD2' ' HE3' ' A' ' 1' ' ' MET . 6.0 t80 -95.23 102.35 14.15 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.554 1.159 . . . . 1.48 108.011 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 37.7 mt-30 -119.29 118.62 31.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.201 -1.037 . . . . 3.12 108.201 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.41 160.04 15.94 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.731 -1.188 . . . . 1.38 110.574 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.429 ' CG ' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -142.26 148.84 38.76 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.076 -1.42 . . . . 4.71 108.9 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -112.21 136.19 51.93 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.042 -1.096 . . . . 1.45 108.042 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.42 152.04 27.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.213 -1.773 . . . . 1.3 106.213 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.68 142.2 47.52 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.409 -0.916 . . . . 2.19 109.008 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.9 pt -48.3 -36.95 6.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.927 -0.709 . . . . 1.27 111.188 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -76.74 -44.88 31.38 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.002 -1.079 . . . . 6.42 111.473 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.76 -54.36 2.65 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 119.529 -0.868 . . . . 1.75 110.422 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 42' ' ' GLY . 64.9 mt-10 -93.47 25.18 3.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 114.3 -1.318 . . . . 4.27 111.255 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 30.51 57.0 0.24 Allowed Glycine 0 N--CA 1.508 3.455 0 N-CA-C 112.074 -0.41 . . . . 1.63 112.074 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.6 161.52 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.933 -0.766 . . . . 1.88 108.933 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -119.93 154.62 34.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.706 0.765 . . . . 1.98 109.513 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -45.13 -42.12 8.63 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.071 1.137 . . . . 4.13 114.071 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.702 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 14.2 mp0 -65.02 -56.5 12.73 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.818 -0.753 . . . . 3.07 110.608 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.56 -50.21 24.49 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.19 -1.041 . . . . 2.44 108.19 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.94 -48.94 74.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.159 -1.382 . . . . 1.29 108.551 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.511 HE21 ' H ' ' A' ' 56' ' ' VAL . 5.4 tp60 -44.78 -45.02 9.77 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.936 -1.135 . . . . 4.88 107.936 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -65.15 -49.54 69.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.898 1.374 . . . . 3.45 109.587 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.58 -48.95 62.98 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.155 -0.683 . . . . 2.42 109.155 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -19.69 56.98 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.429 -0.952 . . . . 1.04 108.429 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.67 32.57 17.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.375 -1.89 . . . . 2.73 108.375 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -143.66 158.21 57.19 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-N 114.096 -1.052 . . . . 7.45 108.707 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.86 68.87 4.67 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.675 1.584 . . . . 3.68 111.25 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.511 ' H ' HE21 ' A' ' 49' ' ' GLN . 4.8 p -101.71 125.1 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.982 -0.687 . . . . 6.39 110.804 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.71 -2.82 10.36 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 112.918 0.711 . . . . 6.2 112.918 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 p -116.08 -169.27 1.57 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.637 -0.825 . . . . 4.25 111.579 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.8 164.59 33.93 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.415 -0.811 . . . . 2.89 108.992 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.69 157.44 71.82 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 124.236 -1.152 . . . . 2.88 109.747 -7.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -98.25 101.42 12.88 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 103.916 -2.624 . . . . 3.37 103.916 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 17' ' ' ALA . 8.2 mt -91.59 133.12 34.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 113.167 -1.833 . . . . 1.34 111.266 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -125.64 153.57 43.6 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 112.979 -1.919 . . . . 1.09 109.798 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 66' ' ' GLN . 80.0 t -122.2 95.91 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.882 -1.155 . . . . 0.84 107.882 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.5 -72.72 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 125.189 1.556 . . . . 2.63 110.557 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 64' ' ' VAL . 41.7 tp60 -129.78 -18.06 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.475 -1.239 . . . . 6.0 111.363 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -91.61 172.95 8.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.276 -0.97 . . . . 3.52 111.18 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -119.92 149.72 41.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 106.797 -1.557 . . . . 1.74 106.797 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 78' ' ' TRP . 21.3 mm -116.25 -55.95 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.687 -0.805 . . . . 0.89 111.069 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.58 -135.05 4.76 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.667 -1.254 . . . . 1.53 110.26 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.37 -74.31 0.94 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 111.141 -0.783 . . . . 2.47 111.141 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -137.97 -55.85 0.66 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 118.724 -1.19 . . . . 2.73 109.343 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 p -41.95 -52.4 4.14 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 123.118 1.437 . . . . 2.05 109.658 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -36.46 84.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.005 -2.362 . . . . 2.08 109.964 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.19 -51.01 61.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.496 -0.882 . . . . 1.21 109.108 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.5 64.81 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.276 -0.969 . . . . 1.34 109.28 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.88 -58.9 6.14 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.788 -1.165 . . . . 1.03 108.998 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.481 ' CD1' HD12 ' A' ' 69' ' ' ILE . 87.6 t90 -44.5 -55.54 5.02 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.519 -0.764 . . . . 0.76 109.301 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.466 HG13 HD12 ' A' ' 83' ' ' LEU . 2.7 t -44.79 -60.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 114.231 -1.35 . . . . 1.04 108.853 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -50.21 -39.88 45.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.21 -0.905 . . . . 2.52 112.937 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 11.7 pt-20 -104.52 36.09 2.52 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.592 -0.843 . . . . 4.33 113.067 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -147.5 -36.11 0.22 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.216 1.007 . . . . 1.56 110.038 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 79' ' ' VAL . 22.3 mt -99.44 -24.03 14.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.523 -1.217 . . . . 2.65 110.794 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -93.29 -64.82 1.05 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 125.105 1.503 . . . . 4.1 108.082 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.803 0 CA-C-N 112.708 -2.042 . . . . 8.72 109.261 179.878 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.487 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.4 mpp? . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 108.004 -1.11 . . . . 2.38 108.004 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -83.16 102.61 11.98 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 124.023 0.827 . . . . 4.04 109.459 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 5.7 m -96.69 116.38 29.03 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.963 -1.095 . . . . 1.48 109.925 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 t -123.7 136.95 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.397 -0.819 . . . . 1.01 112.448 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.41 HG21 ' SG ' ' A' ' 14' ' ' CYS . 5.4 mm -110.39 125.03 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.747 -1.205 . . . . 1.27 107.747 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 82.1 m-85 -102.47 114.99 29.67 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.21 -1.774 . . . . 1.73 106.21 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.29 -148.78 7.99 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.409 -1.077 . . . . 1.69 110.409 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.5 ttm180 -138.8 141.74 38.74 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.846 -0.742 . . . . 6.24 110.613 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 t -54.98 73.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.983 -1.462 . . . . 6.59 112.761 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 118.5 26.62 2.58 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 120.45 -0.881 . . . . 4.03 113.096 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 13' ' ' TYR . 9.7 t -122.31 138.0 28.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 C-N-CA 118.728 -1.189 . . . . 4.8 110.048 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.02 53.08 4.42 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.884 1.723 . . . . 4.44 111.2 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.545 ' CE2' ' SG ' ' A' ' 11' ' ' CYS . 20.3 m-30 -111.73 -68.21 0.95 Allowed 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.302 -0.559 . . . . 5.67 112.147 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 16' ' ' ARG . 3.5 t -54.49 -29.34 49.89 Favored 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 118.014 -1.474 . . . . 4.4 108.912 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 15' ' ' VAL . 7.2 t -44.75 -12.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 114.027 -1.442 . . . . 2.3 112.072 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.599 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -108.87 -42.37 4.49 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.534 -0.867 . . . . 3.54 109.607 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.17 75.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.345 -1.724 . . . . 0.75 106.345 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -54.97 -39.82 69.36 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 114.588 -1.187 . . . . 2.11 108.686 179.14 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.457 ' CG ' HH12 ' A' ' 16' ' ' ARG . 0.2 OUTLIER -66.32 -62.42 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.212 0.529 . . . . 2.76 111.488 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' CD2' ' A' ' 75' ' ' PHE . 15.3 tp -56.36 -43.27 78.98 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.408 -0.917 . . . . 1.09 110.045 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.08 72.69 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.725 -1.19 . . . . 1.08 108.296 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 11.3 tt0 -48.14 -47.33 34.83 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.44 -0.948 . . . . 2.42 108.44 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -48.57 -52.9 20.49 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 118.756 -1.178 . . . . 4.15 110.62 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.5 mt -65.52 -46.24 80.4 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 123.721 0.638 . . . . 1.18 111.78 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 22' ' ' GLU . 1.5 p -57.9 -25.37 60.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 118.922 -1.111 . . . . 2.81 111.15 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -91.75 27.98 1.91 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.028 -1.069 . . . . 1.78 108.647 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 72.5 mt-10 -121.17 -65.7 1.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.951 -0.7 . . . . 3.4 110.252 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.501 HH22 ' C ' ' A' ' 85' ' ' ALA . 2.9 mpt_? -122.26 -166.77 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.811 -1.086 . . . . 3.83 111.746 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -107.45 -4.65 18.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.912 -1.04 . . . . 5.79 111.027 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.9 p-10 -84.29 -9.59 58.35 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.919 -1.141 . . . . 3.26 107.919 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CZ ' HG21 ' A' ' 3' ' ' THR . 29.8 t80 -116.02 96.9 5.79 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.492 -0.883 . . . . 1.56 110.817 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -112.11 128.07 56.1 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.255 -2.128 . . . . 4.23 105.255 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.1 OUTLIER -123.28 143.25 50.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.118 -1.433 . . . . 1.58 113.74 -177.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -139.1 161.67 36.81 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 113.822 -1.536 . . . . 4.39 109.409 178.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.451 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 30.6 t80 -118.98 142.62 47.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 1.37 109.115 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -132.19 147.02 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.348 -0.982 . . . . 1.39 108.348 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 3.3 t70 -122.48 114.74 21.11 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 119.038 -1.065 . . . . 2.58 112.434 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -49.3 -31.46 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.477 -0.783 . . . . 1.51 111.522 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.506 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.03 -63.44 1.31 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.284 -1.766 . . . . 5.41 108.723 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -30.49 -45.51 0.06 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.667 1.23 . . . . 2.62 111.671 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -94.22 -53.37 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.905 -1.118 . . . . 3.64 111.465 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.58 51.87 0.2 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 118.989 -1.576 . . . . 1.75 111.47 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.7 mt -103.87 157.73 5.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.775 -1.565 . . . . 1.87 106.775 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.0 p -115.88 158.35 23.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.653 -0.819 . . . . 2.34 109.084 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -52.18 -40.29 61.27 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.961 -1.096 . . . . 4.75 111.833 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 23.3 mp0 -47.73 -63.76 0.97 Allowed 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 121.663 0.744 . . . . 3.4 110.261 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -44.31 -44.62 8.25 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 114.354 -1.294 . . . . 2.82 111.978 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.77 -41.7 64.76 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.336 -1.302 . . . . 2.07 110.5 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 55' ' ' PRO . 14.0 tt0 -57.28 -40.12 77.1 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.301 -1.741 . . . . 3.17 106.301 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -15.54 11.84 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.355 -1.293 . . . . 3.59 110.692 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -104.11 -37.73 7.21 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.671 -0.695 . . . . 2.5 110.51 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.497 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -72.0 -37.79 69.75 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.725 -1.125 . . . . 1.51 112.65 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -45.62 1.87 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 107.957 -2.057 . . . . 2.84 107.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 17.8 pttp -101.35 176.31 1.94 Allowed Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.556 -1.646 . . . . 5.93 106.556 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 64.9 Cg_exo -48.67 155.15 2.53 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 120.67 0.913 . . . . 3.79 110.93 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 56' ' ' VAL . 3.9 m -72.43 -30.99 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.447 -0.901 . . . . 5.99 111.312 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.58 -145.92 0.32 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.047 -0.661 . . . . 7.4 109.383 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -95.38 168.04 10.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.604 -0.838 . . . . 4.27 110.003 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.01 152.26 39.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.634 -1.247 . . . . 2.4 107.634 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 13' ' ' TYR . 73.7 Cg_endo -97.03 160.2 12.07 Favored 'Cis proline' 0 C--N 1.304 -1.78 0 C-N-CA 123.828 -1.322 . . . . 2.43 109.664 17.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 1.4 tp-100 -110.16 132.45 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.069 -2.197 . . . . 3.4 105.069 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' A' ' 75' ' ' PHE . 5.3 mt -112.71 137.53 45.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.037 -1.065 . . . . 1.79 111.013 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -127.5 138.78 53.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.407 -1.724 . . . . 1.27 107.807 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 66' ' ' GLN . 40.6 t -121.73 108.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 124.462 1.101 . . . . 1.26 109.183 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.01 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.141 -0.689 . . . . 2.94 109.141 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 64' ' ' VAL . 32.2 mm-40 -138.05 -9.82 1.53 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.484 -1.234 . . . . 3.87 110.034 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.82 146.62 26.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.678 -0.49 . . . . 4.57 109.678 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.497 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 14.6 t-160 -105.85 135.55 47.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.159 -1.423 . . . . 1.19 107.159 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 78' ' ' TRP . 9.9 mm -103.7 -41.06 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 118.588 -1.245 . . . . 0.89 109.775 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 128.39 -114.74 1.88 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.324 -2.31 . . . . 1.36 107.324 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 60' ' ' PRO . . . -129.87 -169.13 12.46 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 118.558 -1.782 . . . . 1.15 111.23 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.7 t80 -61.96 176.28 0.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 105.738 -1.949 . . . . 3.07 105.738 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.471 ' CB ' ' O ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 78.23 -64.69 0.27 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.413 -1.328 . . . . 3.06 107.413 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -41.62 83.05 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.398 -1.334 . . . . 2.62 107.398 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.56 ' HB2' HD12 ' A' ' 62' ' ' ILE . 15.8 t80 -41.84 -49.88 4.43 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 113.915 -1.493 . . . . 1.15 110.041 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.66 71.28 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.412 -0.915 . . . . 1.06 109.061 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.14 -53.99 51.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.887 -1.125 . . . . 0.94 109.435 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.43 ' CD1' HD12 ' A' ' 69' ' ' ILE . 70.2 t90 -50.3 -53.45 28.58 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.746 -0.782 . . . . 1.11 110.065 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.0 t -43.98 -56.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.312 -0.858 . . . . 0.94 109.336 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 80' ' ' LYS . 6.2 tmtm? -44.83 -23.86 0.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 116.953 -1.499 . . . . 2.86 115.044 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.18 6.2 10.26 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 120.94 1.7 . . . . 4.79 112.971 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.23 -25.74 5.63 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.846 -0.742 . . . . 1.31 109.725 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.89 28.03 4.22 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.16 -0.927 . . . . 2.02 111.096 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 18.6 p-10 -93.89 30.08 1.93 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.229 1.014 . . . . 4.4 109.099 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.501 ' C ' HH22 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.544 0 CA-C-N 113.227 -1.806 . . . . 5.53 108.042 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.838 -0.801 . . . . 2.9 108.838 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.458 ' OE1' ' HB2' ' A' ' 34' ' ' GLN . 6.2 tt0 -84.17 144.52 28.93 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 119.104 -1.039 . . . . 4.85 109.447 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.7 m -96.39 134.73 39.18 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.169 -1.419 . . . . 1.81 107.169 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.487 ' C ' HD12 ' A' ' 5' ' ' ILE . 6.7 t -125.42 122.22 62.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.593 -1.262 . . . . 1.14 107.593 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -107.17 123.65 62.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 105.419 -2.067 . . . . 1.01 105.419 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -117.78 117.07 28.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 2.72 108.587 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.46 159.43 8.39 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.875 -1.155 . . . . 1.98 111.247 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -112.89 139.09 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.194 -1.039 . . . . 5.13 108.194 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.538 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 10.9 p -102.89 -65.15 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.124 -1.03 . . . . 6.46 109.709 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.27 -47.88 0.99 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 105.967 -2.853 . . . . 3.43 105.967 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.5 m -94.7 165.2 17.73 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 106.354 -1.721 . . . . 4.53 106.354 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.04 67.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.844 2.363 . . . . 3.38 112.528 165.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -115.0 -65.34 1.2 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.628 -0.878 . . . . 6.11 108.628 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 18.1 m -53.46 -33.82 55.59 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.404 1.097 . . . . 2.22 108.388 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 15' ' ' VAL . 22.3 t -44.46 -47.12 2.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 113.002 -1.908 . . . . 1.43 111.259 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -50.01 -48.8 52.34 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.71 -0.796 . . . . 3.21 110.534 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.27 -52.69 25.81 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.552 -1.277 . . . . 0.87 107.552 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -53.76 -45.21 70.54 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 114.759 -1.11 . . . . 1.95 110.53 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.525 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 43.7 m-20 -62.21 -56.72 15.85 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.336 -0.546 . . . . 3.19 111.663 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.407 HD23 ' CD2' ' A' ' 75' ' ' PHE . 18.7 tp -57.79 -52.02 67.2 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.029 -0.73 . . . . 0.79 109.029 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.73 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.74 -0.837 . . . . 0.65 108.74 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 42.3 tt0 -58.38 -47.76 82.8 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.7 -0.8 . . . . 2.35 110.428 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' NZ ' ' OE1' ' A' ' 27' ' ' GLU . 17.6 tptp -57.45 -54.96 40.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 116.563 -2.055 . . . . 4.63 107.879 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' LYS . 47.7 mt -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.533 -1.667 . . . . 1.4 107.63 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 6.5 t -49.84 -42.44 47.34 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.785 -0.643 . . . . 1.04 109.494 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.433 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 t-20 -72.89 -29.49 63.2 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.742 -0.663 . . . . 2.77 111.13 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 1.6 mm-40 -86.33 -40.14 15.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.292 1.219 . . . . 3.84 114.292 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HE ' ' C ' ' A' ' 85' ' ' ALA . 28.4 mtp180 -114.25 139.36 49.46 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.923 -0.711 . . . . 4.32 112.216 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.35 -40.88 98.48 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.225 -0.898 . . . . 4.08 113.273 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.75 20.28 1.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.405 -0.918 . . . . 3.44 111.36 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 4.4 t80 -115.28 123.02 47.72 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.544 -1.262 . . . . 1.13 111.63 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -136.04 172.39 13.08 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.824 -1.547 . . . . 3.45 106.824 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -145.35 149.45 34.81 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.501 -1.28 . . . . 1.36 110.919 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.458 ' HB2' ' OE1' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -136.87 139.78 41.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.113 0.883 . . . . 5.02 109.252 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.67 121.2 34.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.178 -1.009 . . . . 1.71 108.83 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.99 153.59 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.866 -0.734 . . . . 1.64 109.708 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -108.69 124.3 50.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.092 -1.447 . . . . 2.51 107.092 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.7 pt -40.02 -41.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.709 -0.796 . . . . 1.29 111.816 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -31.47 61.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 118.998 -1.081 . . . . 5.37 111.778 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.1 -53.59 32.76 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.416 -0.914 . . . . 1.4 111.593 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -94.63 -34.49 12.59 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.477 -0.889 . . . . 3.65 111.872 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.48 50.43 0.66 Allowed Glycine 0 N--CA 1.503 3.12 0 N-CA-C 109.332 -1.507 . . . . 1.51 109.332 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.8 mt -96.55 137.15 25.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.312 -0.995 . . . . 1.61 108.312 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.4 p -107.35 166.34 10.72 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.929 -1.108 . . . . 2.37 112.067 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 57' ' ' GLU . 8.8 ttpt -56.86 -35.25 68.66 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.573 -1.194 . . . . 4.78 109.967 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 24.0 mp0 -68.93 -47.72 65.02 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.052 -1.092 . . . . 3.54 108.052 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.66 -49.96 74.74 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 117.793 -1.563 . . . . 2.53 108.332 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -53.66 -54.46 37.42 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.017 -1.073 . . . . 1.63 108.367 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.46 -51.79 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.544 0.527 . . . . 5.32 109.95 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -53.09 -54.32 37.32 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.38 -0.971 . . . . 4.67 108.38 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -55.72 -38.25 69.49 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.724 -1.126 . . . . 2.78 110.523 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -59.54 -48.0 83.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 123.68 0.612 . . . . 1.99 110.4 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.42 -40.47 2.72 Favored Glycine 0 N--CA 1.499 2.833 0 C-N-CA 120.152 -1.023 . . . . 4.3 112.102 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.427 ' O ' HG12 ' A' ' 56' ' ' VAL . 64.4 mttp -124.23 154.53 68.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 C-N-CA 120.066 -0.654 . . . . 10.46 109.316 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.11 70.05 6.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.91 2.407 . . . . 5.73 113.563 -138.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 54' ' ' LYS . 2.7 p -136.99 128.58 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.983 -0.687 . . . . 6.75 109.97 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 2.3 mt-10 -122.15 67.23 0.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.75 -0.833 . . . . 8.85 108.75 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 p -113.8 149.15 35.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.137 0.791 . . . . 5.4 113.137 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -117.92 144.13 34.0 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.086 -1.079 . . . . 3.11 108.086 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HG2' ' SG ' ' A' ' 14' ' ' CYS . 22.7 Cg_exo -66.31 171.05 39.35 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 123.933 -1.278 . . . . 3.02 110.871 -18.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -130.55 152.65 49.7 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.845 -1.539 . . . . 2.96 106.845 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 mt -121.55 143.66 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 119.586 -0.845 . . . . 1.16 111.402 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -131.07 165.82 22.41 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.873 -1.512 . . . . 1.05 108.161 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.537 HG11 ' CH2' ' A' ' 78' ' ' TRP . 32.0 t -138.61 105.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 124.174 0.921 . . . . 1.3 110.921 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' GLN . 3.6 t70 54.5 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.996 0.81 . . . . 2.81 113.019 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . 66.4 mt-30 -137.85 23.83 2.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 123.476 0.485 . . . . 5.48 111.295 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 68' ' ' HIS . 31.6 tt0 -131.03 159.45 37.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.222 -1.029 . . . . 4.45 108.222 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.504 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.6 t-160 -112.0 137.11 50.46 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 107.871 -1.159 . . . . 1.24 107.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.443 HD12 ' C ' ' A' ' 68' ' ' HIS . 1.7 mp -106.3 -46.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 119.682 -0.807 . . . . 1.59 112.131 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.26 -98.94 0.56 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.856 -1.298 . . . . 1.33 109.856 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.87 177.92 17.32 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 120.234 -0.984 . . . . 1.21 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -50.41 -47.43 56.51 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.787 -0.765 . . . . 1.45 111.048 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -43.96 -57.26 3.42 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.609 0.718 . . . . 1.66 111.11 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.71 -49.01 79.23 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.658 -1.155 . . . . 2.05 109.069 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CD2' HD23 ' A' ' 20' ' ' LEU . 15.3 t80 -44.82 -52.07 8.88 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.277 -0.969 . . . . 0.95 110.145 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 -57.96 9.48 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 120.007 -0.677 . . . . 0.83 111.562 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.34 42.35 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 118.372 -1.331 . . . . 1.08 109.303 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.61 ' CH2' HD21 ' A' ' 83' ' ' LEU . 75.8 t90 -41.61 -52.4 3.79 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.323 -0.853 . . . . 0.98 110.631 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -44.59 -46.2 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 115.551 -0.749 . . . . 0.91 110.721 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.535 ' C ' ' HD3' ' A' ' 80' ' ' LYS . 5.8 tmtm? -48.92 -38.77 23.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.981 1.104 . . . . 3.26 113.981 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -108.19 -31.72 7.79 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 114.716 1.376 . . . . 4.84 114.716 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.445 ' C ' HD22 ' A' ' 83' ' ' LEU . 3.3 m120 -83.5 -22.95 32.34 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.976 -1.49 . . . . 1.89 110.574 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.61 HD21 ' CH2' ' A' ' 78' ' ' TRP . 3.3 mm? -108.6 -55.65 2.36 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.619 -0.832 . . . . 2.62 108.949 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.11 -69.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 126.852 2.595 . . . . 4.32 112.728 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . . . . . . 0 C--N 1.28 -2.438 0 CA-C-O 116.349 -1.786 . . . . 5.58 109.995 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.8 mtm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.975 -1.12 . . . . 2.29 107.975 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -113.73 116.45 29.43 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.489 0.493 . . . . 4.18 110.743 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 24.1 m -110.81 119.04 37.8 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.013 -1.106 . . . . 0.92 108.013 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.489 ' C ' HD12 ' A' ' 5' ' ' ILE . 43.3 t -114.57 135.54 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 119.687 -0.805 . . . . 0.96 111.248 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -113.43 123.31 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 124.52 1.138 . . . . 1.12 108.016 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -108.92 92.58 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.322 -2.103 . . . . 2.14 105.322 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.05 -171.81 15.9 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.04 -2.424 . . . . 1.41 107.04 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -95.44 174.53 6.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 116.726 -1.99 . . . . 4.67 110.365 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -55.76 76.65 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.906 -1.952 . . . . 5.97 109.323 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 97.07 74.04 1.17 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 106.885 -2.486 . . . . 3.67 106.885 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.465 ' HB2' ' H ' ' A' ' 8' ' ' ARG . 42.1 t -111.95 94.9 26.8 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 119.749 -0.78 . . . . 6.41 109.213 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 1.3 Cg_endo -41.11 -21.77 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.368 2.045 . . . . 3.95 113.026 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -72.85 -45.03 60.55 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.464 -1.294 . . . . 4.09 109.339 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.481 ' SG ' HG21 ' A' ' 5' ' ' ILE . 5.2 t -54.83 -39.8 68.94 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.283 -0.967 . . . . 4.34 108.79 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.8 t -43.75 -36.56 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 115.387 -0.824 . . . . 1.31 111.7 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.621 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 2.9 mmp_? -82.41 -45.63 14.57 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 119.106 -1.038 . . . . 3.33 109.708 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.03 60.76 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.683 -1.599 . . . . 0.81 106.683 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.615 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.8 tmtt? -56.73 -59.62 4.76 Favored 'General case' 0 C--O 1.187 -2.187 0 CA-C-N 113.342 -1.754 . . . . 2.21 108.657 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.615 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -48.58 -54.04 16.06 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 118.909 -1.116 . . . . 2.51 111.141 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.51 -60.89 2.74 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.494 -0.775 . . . . 0.9 110.574 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.82 77.73 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.278 -0.569 . . . . 0.99 110.564 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' SER . 31.4 tt0 -56.24 -49.52 73.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 124.445 1.091 . . . . 1.95 109.528 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -49.95 -61.56 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.125 -1.03 . . . . 4.5 108.259 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.451 HD11 HG13 ' A' ' 79' ' ' VAL . 47.1 mt -50.6 -57.63 7.74 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.108 -1.071 . . . . 1.28 108.108 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 8.3 t -34.59 -47.79 0.34 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.191 -1.368 . . . . 1.01 110.885 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -85.52 -30.72 23.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.628 1.205 . . . . 2.36 112.654 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.548 ' HB2' ' HD2' ' A' ' 28' ' ' ARG . 80.8 mt-10 -70.0 -32.45 70.63 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.071 -1.052 . . . . 3.22 110.629 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.548 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.54 37.52 2.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.203 -1.399 . . . . 4.9 113.831 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' ARG . 48.0 m-20 28.81 52.76 0.07 Allowed 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 114.611 1.337 . . . . 4.9 114.611 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -155.18 -45.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 117.983 -1.487 . . . . 3.7 113.679 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -81.38 69.04 7.93 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.553 -0.859 . . . . 2.56 110.306 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.41 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 1.1 mp0 -83.48 147.03 28.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.701 -1.222 . . . . 4.71 107.701 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 3' ' ' THR . 46.5 p90 -119.46 161.75 20.01 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.561 -1.255 . . . . 1.1 112.196 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -129.78 136.04 49.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.305 -1.316 . . . . 3.93 107.91 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 3.6 t80 -113.7 117.94 32.95 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.615 -1.254 . . . . 1.56 107.615 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.13 146.9 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.833 -1.173 . . . . 1.4 107.833 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.1 143.42 45.51 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.629 1.204 . . . . 2.32 111.749 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 8' ' ' ARG . 18.8 pt -56.93 -40.75 74.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 112.262 -2.245 . . . . 1.23 112.257 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.402 ' NH2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -86.41 -10.07 55.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.216 -0.994 . . . . 5.32 111.656 -178.078 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.51 -49.02 6.92 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.699 -0.852 . . . . 1.41 108.699 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.37 -37.66 43.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.669 -1.605 . . . . 3.6 111.191 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 46.42 1.86 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.634 -1.786 . . . . 1.36 108.634 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.495 HG21 ' HG ' ' A' ' 48' ' ' LEU . 22.2 mt -87.25 146.94 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.847 -1.168 . . . . 1.57 107.847 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -110.64 176.4 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.919 -0.712 . . . . 2.47 111.124 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -67.31 -57.77 6.04 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.188 -1.412 . . . . 5.32 107.188 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 1.7 mp0 -47.86 -48.51 31.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.753 -1.112 . . . . 4.58 110.023 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 26.6 t70 -64.64 -56.59 12.87 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.353 -0.939 . . . . 2.02 110.48 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.495 ' HG ' HG21 ' A' ' 43' ' ' ILE . 1.3 mt -56.69 -40.23 75.23 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.459 -0.896 . . . . 1.55 111.131 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -62.0 -43.83 98.0 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.722 -1.585 . . . . 3.64 106.722 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.78 -40.05 75.17 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.276 -0.875 . . . . 3.74 108.762 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 48.2 mmtm -64.12 -51.95 61.45 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.261 -0.882 . . . . 2.27 111.459 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.62 70.06 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 112.877 0.695 . . . . 1.63 112.877 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.36 -47.53 1.01 Allowed Glycine 0 N--CA 1.503 3.152 0 C-N-CA 119.44 -1.362 . . . . 2.72 112.205 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -110.45 174.36 2.41 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.732 . . . . 7.59 109.022 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.36 68.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.98 1.787 . . . . 5.6 110.903 143.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.4 47.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.18 -1.045 . . . . 6.29 108.18 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -82.66 72.47 9.73 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.908 -1.042 . . . . 8.17 108.671 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 p -103.57 100.62 10.46 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.753 -1.112 . . . . 5.09 108.798 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 m -74.56 138.36 74.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 C-N-CA 117.759 -1.576 . . . . 1.68 109.598 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -93.91 137.56 6.87 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 O-C-N 122.932 0.964 . . . . 1.79 111.623 7.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.42 ' NE2' HD22 ' A' ' 48' ' ' LEU . 7.2 mp0 -97.65 142.87 28.92 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.287 -1.746 . . . . 3.73 106.287 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.8 mp -115.29 143.77 24.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.416 -0.913 . . . . 1.57 109.474 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.286 -1.779 . . . . 1.17 108.785 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.67 118.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 105.466 -2.05 . . . . 0.93 105.466 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 64.67 -86.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.621 -1.251 . . . . 3.27 107.621 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.62 5.3 1.04 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.084 -0.962 . . . . 3.58 109.204 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -91.2 162.16 14.76 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.359 -0.978 . . . . 3.71 108.359 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -108.67 138.15 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.633 -0.877 . . . . 0.91 108.633 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -106.87 -43.85 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.383 -0.927 . . . . 0.83 109.151 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.7 -134.9 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.015 -1.634 . . . . 1.15 109.015 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.44 179.27 25.62 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 108.969 -1.652 . . . . 1.19 108.969 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -45.62 -38.52 6.71 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 118.953 -1.099 . . . . 1.53 110.789 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -54.15 -63.29 1.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.372 0.606 . . . . 1.77 109.72 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.79 -47.28 80.54 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.115 -0.948 . . . . 2.36 108.538 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.45 ' CD1' HG21 ' A' ' 62' ' ' ILE . 42.4 t80 -47.16 -51.63 17.75 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.339 -0.846 . . . . 0.87 110.536 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.11 -53.08 62.12 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.02 -1.072 . . . . 0.81 109.687 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.34 -56.43 16.72 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.139 -1.024 . . . . 0.82 109.967 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -48.94 -57.62 6.19 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.038 -0.983 . . . . 0.7 108.605 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.451 HG13 HD11 ' A' ' 24' ' ' LEU . 26.9 t -46.08 -52.84 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 124.255 0.972 . . . . 0.8 108.725 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -57.73 -54.92 41.47 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.81 1.041 . . . . 3.19 113.81 -178.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' N ' ' HE3' ' A' ' 80' ' ' LYS . 1.5 pt-20 -73.11 -29.16 62.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.432 1.271 . . . . 4.42 114.432 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -90.57 -31.94 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.803 -1.159 . . . . 1.8 109.919 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.16 53.07 0.93 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.749 -1.204 . . . . 2.82 107.749 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.521 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 4.8 t0 -78.95 49.83 0.96 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.345 -1.298 . . . . 4.77 109.361 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.451 ' C ' HH12 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.503 2.225 0 CA-C-O 116.481 -1.723 . . . . 5.1 109.162 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 107.062 -1.458 . . . . 3.0 107.062 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -106.44 107.04 17.85 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.529 -0.915 . . . . 4.03 108.529 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.436 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 25.0 m -93.13 136.14 33.66 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.685 -0.806 . . . . 0.97 109.403 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.524 ' C ' HD12 ' A' ' 5' ' ' ILE . 5.3 t -122.62 128.57 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 119.397 -0.921 . . . . 0.97 108.709 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -111.27 136.98 45.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 124.29 0.994 . . . . 1.13 108.898 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -108.16 112.34 24.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 102.456 -3.164 . . . . 2.45 102.456 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.531 ' HA2' ' SG ' ' A' ' 14' ' ' CYS . . . -109.32 -166.15 20.31 Favored Glycine 0 N--CA 1.501 2.975 0 C-N-CA 118.552 -1.785 . . . . 1.83 114.195 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.479 HH12 ' CB ' ' A' ' 58' ' ' THR . 7.8 ttt85 -108.76 -141.6 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.892 -1.154 . . . . 7.96 109.348 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.51 176.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.572 0.701 . . . . 5.71 112.073 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.05 67.23 2.75 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.837 -0.905 . . . . 5.16 110.837 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 50.5 t -128.37 152.75 78.63 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.247 -1.39 . . . . 5.67 107.247 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.515 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 32.0 Cg_endo -70.21 67.16 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.42 1.414 . . . . 5.15 111.334 172.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -109.4 -94.6 0.41 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.92 -1.141 . . . . 4.22 107.92 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' HA2' ' A' ' 7' ' ' GLY . 46.5 m -52.46 -20.47 2.9 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.618 -0.833 . . . . 2.5 109.132 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 18' ' ' LYS . 91.6 t -45.89 -33.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.923 -1.035 . . . . 2.79 110.301 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -44.87 -35.84 3.0 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.461 -0.896 . . . . 2.99 110.379 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 5' ' ' ILE . . . -66.37 -43.37 86.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.097 -1.446 . . . . 1.09 107.097 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HE2' ' N ' ' A' ' 19' ' ' ASP . 3.3 tmpt? -57.7 -45.28 85.89 Favored 'General case' 0 C--O 1.196 -1.724 0 N-CA-C 107.855 -1.165 . . . . 1.74 107.855 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 68.9 m-20 -63.09 -60.76 3.0 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.835 -0.62 . . . . 3.31 109.788 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 tp -48.41 -55.21 11.45 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.951 -0.7 . . . . 0.92 109.815 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.33 82.21 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.872 -0.731 . . . . 1.16 109.919 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 27.5 tt0 -45.43 -49.77 13.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 123.593 0.558 . . . . 1.96 110.789 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 23.0 tptp -52.07 -56.22 15.77 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 118.316 -1.353 . . . . 4.71 110.972 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.448 HD11 ' CG1' ' A' ' 79' ' ' VAL . 33.7 mt -52.7 -48.85 66.31 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.326 -1.731 . . . . 1.31 106.326 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -47.19 -38.69 12.42 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.543 -2.117 . . . . 1.06 108.731 178.369 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -117.75 42.25 2.67 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.136 -0.938 . . . . 2.38 110.201 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.527 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 30.8 tt0 -117.29 -59.63 1.92 Allowed 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.152 -1.425 . . . . 3.31 107.152 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.527 ' HD3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -117.97 16.36 14.23 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.698 -2.334 . . . . 3.71 104.698 177.54 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.0 OUTLIER 34.46 47.2 0.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 123.221 1.486 . . . . 6.0 109.156 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.02 9.52 8.73 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 111.694 -2.503 . . . . 4.82 111.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.436 ' CZ ' ' OG1' ' A' ' 3' ' ' THR . 21.0 t80 -134.85 147.73 49.96 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.963 -0.695 . . . . 1.67 110.012 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -135.25 151.53 50.68 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.07 -0.715 . . . . 3.17 109.07 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 42.6 p90 -139.29 155.94 47.38 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.2 -1.0 . . . . 1.67 111.367 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -135.97 138.56 42.41 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.839 -1.171 . . . . 4.47 107.839 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -114.05 133.27 55.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.749 -1.18 . . . . 1.26 109.091 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 37' ' ' ASP . 92.4 t -129.7 167.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.889 0.852 . . . . 1.37 110.857 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 36' ' ' VAL . 29.6 t0 -118.48 128.12 54.29 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.296 -1.002 . . . . 2.14 108.296 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.3 pt -43.81 -34.53 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.49 0.662 . . . . 1.59 111.235 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 2.3 ttm105 -74.6 -54.97 6.44 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.222 -0.899 . . . . 5.98 110.007 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -36.54 -55.13 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.168 0.918 . . . . 2.1 112.237 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -74.6 -41.47 60.38 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 124.147 0.904 . . . . 4.52 109.748 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.45 46.4 1.14 Allowed Glycine 0 N--CA 1.502 3.082 0 N-CA-C 108.317 -1.913 . . . . 2.06 108.317 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mt -98.93 152.97 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.128 -1.036 . . . . 2.08 110.474 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.1 p -116.69 141.3 48.38 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.768 -1.106 . . . . 2.53 108.852 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -45.04 -51.05 10.45 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.258 -0.977 . . . . 5.04 110.807 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 2.7 mp0 -50.94 -47.25 61.12 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.875 -0.73 . . . . 5.82 110.358 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' OD1' ' NZ ' ' A' ' 51' ' ' LYS . 4.5 t0 -53.94 -55.5 26.48 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.401 -0.92 . . . . 3.67 108.55 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.21 -50.94 63.68 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 114.962 -1.017 . . . . 2.6 109.198 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 20.3 mt-30 -49.19 -49.24 43.61 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.293 -1.321 . . . . 6.58 108.283 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -63.64 -55.94 19.65 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.79 -1.095 . . . . 5.33 110.527 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' NZ ' ' OD1' ' A' ' 47' ' ' ASP . 41.3 mttp -53.88 -47.68 70.84 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 115.633 -0.712 . . . . 3.34 111.843 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.31 -55.96 26.93 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.481 -1.236 . . . . 2.26 112.601 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.29 -34.49 5.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.001 -1.64 . . . . 3.95 109.001 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -106.21 146.37 32.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 120.09 -0.644 . . . . 6.61 109.645 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.23 89.79 0.32 Allowed 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.825 2.35 . . . . 4.89 111.635 -171.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.423 HG11 HE22 ' A' ' 61' ' ' GLN . 5.1 m -98.46 -177.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 C-N-CA 119.828 -0.749 . . . . 6.18 109.102 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 11.1 tp10 -110.15 -68.7 0.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.966 0.791 . . . . 7.53 110.679 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.479 ' CB ' HH12 ' A' ' 8' ' ' ARG . 2.0 p -144.39 -61.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.645 1.212 . . . . 5.91 109.746 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 8' ' ' ARG . 27.4 m -132.11 178.76 1.6 Allowed Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 112.749 -2.023 . . . . 2.59 107.863 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 28.7 Cg_endo -70.01 138.36 49.32 Favored 'Cis proline' 0 N--CA 1.491 1.335 0 O-C-N 122.994 0.997 . . . . 3.13 111.369 -25.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.423 HE22 HG11 ' A' ' 56' ' ' VAL . 6.6 mm-40 -125.49 125.39 43.22 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.461 -0.94 . . . . 2.46 108.461 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.5 mp -122.54 141.37 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.042 0.925 . . . . 1.93 110.92 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -128.04 163.0 25.52 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 113.13 -1.85 . . . . 1.2 108.783 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.01 124.26 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 118.587 -0.72 . . . . 1.48 109.252 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 50.95 -97.38 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.773 -0.771 . . . . 2.21 111.778 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -129.63 27.52 5.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.447 -1.252 . . . . 3.87 111.02 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -130.66 168.61 16.86 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 116.293 -0.412 . . . . 3.75 111.019 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' ND1' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t-80 -116.72 144.34 44.56 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.964 -0.754 . . . . 1.06 108.964 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.35 -54.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 118.612 -1.235 . . . . 1.1 109.602 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 144.47 -128.41 3.24 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.617 -1.277 . . . . 1.17 110.626 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -111.96 -171.81 18.91 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.261 -1.447 . . . . 1.18 110.284 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -44.99 -40.61 6.61 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.671 -1.211 . . . . 1.5 109.694 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -55.21 -63.98 0.99 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.417 0.627 . . . . 2.05 110.062 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -46.48 71.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.769 -1.105 . . . . 2.88 110.002 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.401 ' CD1' HG21 ' A' ' 62' ' ' ILE . 41.5 t80 -61.23 -50.5 72.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.748 -0.781 . . . . 1.09 111.312 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.93 -57.07 10.51 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.569 -0.852 . . . . 1.08 109.441 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.16 24.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.688 -0.805 . . . . 0.9 110.112 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -43.42 -46.9 6.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 124.118 0.886 . . . . 1.25 109.395 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.448 ' CG1' HD11 ' A' ' 24' ' ' LEU . 19.1 t -62.75 -67.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.923 -1.035 . . . . 0.99 108.896 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -45.35 -34.99 3.29 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 115.845 1.794 . . . . 2.24 115.845 -176.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' OE2' ' NZ ' ' A' ' 80' ' ' LYS . 1.3 mp0 -101.63 9.41 41.13 Favored 'General case' 0 N--CA 1.512 2.652 0 C-N-CA 118.376 -1.33 . . . . 4.71 113.841 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -128.07 -35.83 2.01 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.951 -0.7 . . . . 1.81 109.325 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.92 23.13 14.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.546 -0.862 . . . . 1.99 109.643 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 8.7 t70 -70.63 -20.82 62.69 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.382 -1.34 . . . . 3.94 107.382 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.651 0 N-CA-C 105.857 -1.905 . . . . 5.19 105.857 178.134 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpp? . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.226 1.013 . . . . 2.74 109.291 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.444 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 2.0 mp0 -104.0 105.19 15.29 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.312 -1.313 . . . . 5.71 108.173 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.4 m -97.26 117.99 32.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.338 -0.945 . . . . 1.11 110.392 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.9 t -113.9 142.31 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 115.532 -0.758 . . . . 1.09 109.79 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.7 mm -114.25 133.77 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.585 -2.006 . . . . 2.0 105.585 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -121.65 80.09 1.64 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.629 -1.619 . . . . 1.9 106.629 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.28 -177.35 24.17 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.727 -1.225 . . . . 1.35 111.823 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -122.54 94.15 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.362 -1.347 . . . . 6.56 107.362 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.439 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 4.6 t -74.31 73.6 1.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.008 -1.077 . . . . 6.95 111.097 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -41.02 -50.88 4.25 Favored Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.096 -0.802 . . . . 3.12 111.096 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.452 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 17.3 m -111.87 -170.1 0.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 106.691 -1.596 . . . . 4.67 106.691 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 52.8 Cg_exo -53.0 73.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 120.856 1.038 . . . . 4.32 111.409 153.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -119.54 -85.09 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.042 -0.725 . . . . 4.76 109.042 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -60.19 -24.73 65.02 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 106.993 -1.484 . . . . 2.06 106.993 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' OG ' ' A' ' 9' ' ' SER . 57.3 t -43.81 -32.65 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 CA-C-N 114.278 -1.328 . . . . 1.63 109.634 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -71.56 -50.12 34.13 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.55 -1.26 . . . . 3.53 109.666 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.93 -44.46 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.018 -1.845 . . . . 0.78 106.018 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.464 ' C ' ' HD2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -56.09 -58.91 5.93 Favored 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 113.712 -1.586 . . . . 1.67 107.034 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -43.04 -57.96 2.65 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 120.11 -0.636 . . . . 3.52 110.798 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.98 -62.92 1.29 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.874 -1.057 . . . . 0.78 110.086 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB1' ' CB ' ' A' ' 33' ' ' TYR . . . -53.1 -54.57 33.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.15 -1.02 . . . . 0.69 109.28 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 41.5 tt0 -45.33 -52.63 9.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.088 0.867 . . . . 2.11 110.778 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -58.85 -53.0 63.32 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.881 -1.128 . . . . 4.81 108.457 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -51.93 -41.29 61.91 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.625 -0.83 . . . . 1.12 110.233 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.1 p -73.9 -6.58 48.08 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.272 -0.971 . . . . 1.97 112.047 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -115.72 31.53 6.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.076 -1.453 . . . . 2.5 107.076 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 23' ' ' LYS . 5.8 mm-40 -140.73 -51.65 0.47 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.009 -1.45 . . . . 4.6 107.884 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HE ' ' C ' ' A' ' 85' ' ' ALA . 13.5 mtp-105 -93.63 -170.42 2.35 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.519 -1.218 . . . . 4.05 111.119 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -111.09 -48.77 3.08 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.453 -0.794 . . . . 5.26 111.24 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.587 ' CG ' HH12 ' A' ' 28' ' ' ARG . 2.8 p30 -83.33 8.1 14.57 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.533 -0.867 . . . . 2.76 111.16 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 25' ' ' SER . 3.3 t80 -104.34 114.44 28.67 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.567 -0.853 . . . . 1.32 111.602 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -130.14 157.5 42.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.048 -1.834 . . . . 3.7 106.048 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 21.2 p90 -129.47 160.89 31.74 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.411 -1.315 . . . . 1.4 110.881 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -141.62 149.22 40.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.019 0.824 . . . . 4.52 110.193 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -126.29 113.39 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.687 -1.597 . . . . 1.54 106.687 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.04 157.82 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.073 -1.825 . . . . 1.39 106.073 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -124.74 140.46 52.91 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.28 -1.368 . . . . 2.58 111.239 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.442 ' C ' HH11 ' A' ' 39' ' ' ARG . 16.7 pt -61.78 -21.94 27.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.066 -0.97 . . . . 1.29 111.517 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.506 ' HA ' HH11 ' A' ' 39' ' ' ARG . 3.3 tpp180 -95.43 -51.48 4.55 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.789 -0.819 . . . . 7.39 108.789 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.75 -49.3 5.69 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.538 1.149 . . . . 1.4 110.148 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -99.55 36.82 1.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.576 -0.85 . . . . 4.64 112.553 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 34.27 65.16 0.36 Allowed Glycine 0 N--CA 1.512 3.715 0 CA-C-O 121.792 0.662 . . . . 1.59 114.168 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.469 HG23 ' HB3' ' A' ' 47' ' ' ASP . 58.1 mt -109.96 148.08 13.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.004 -0.598 . . . . 1.61 109.607 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -126.18 177.86 6.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.965 -1.494 . . . . 2.22 106.965 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -51.68 -47.92 63.68 Favored 'General case' 0 C--O 1.191 -1.984 0 C-N-CA 119.798 -0.761 . . . . 5.36 110.427 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 6.3 mp0 -44.18 -52.59 7.24 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 113.862 1.06 . . . . 3.31 113.862 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 43' ' ' ILE . 50.2 t0 -65.97 -55.86 14.64 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.052 -1.059 . . . . 3.03 109.564 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.489 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.2 mt -53.66 -42.33 67.75 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.548 -0.861 . . . . 1.52 110.201 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -59.21 -42.26 90.53 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.174 -1.417 . . . . 3.99 107.174 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -73.75 -20.92 60.36 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.851 -1.068 . . . . 3.45 110.589 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -79.96 -46.48 16.61 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.959 -0.696 . . . . 3.28 111.386 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.09 -28.3 11.1 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.73 -0.788 . . . . 1.45 113.009 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.92 -56.76 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 105.767 -2.933 . . . . 4.06 105.767 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.5 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 57.3 mttp 60.1 126.85 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.997 0 CA-C-O 123.266 1.508 . . . . 9.06 114.935 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' C ' ' HB3' ' A' ' 54' ' ' LYS . 12.0 Cg_endo -52.53 139.3 56.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.69 2.26 . . . . 3.65 109.391 96.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 58' ' ' THR . 7.9 p -74.35 72.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 118.952 -1.099 . . . . 5.98 110.768 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.08 33.0 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 119.743 -0.783 . . . . 7.73 112.169 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 56' ' ' VAL . 80.5 p 39.27 -109.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 115.035 1.494 . . . . 3.98 115.035 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.87 149.33 72.77 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 114.219 -1.355 . . . . 1.69 109.724 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.452 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 98.7 Cg_endo -96.37 -175.4 4.63 Favored 'Cis proline' 0 C--N 1.32 -0.925 0 O-C-N 123.15 1.079 . . . . 2.04 110.049 0.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 1.9 mt-30 -138.89 133.78 32.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 124.489 1.118 . . . . 3.01 109.788 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.8 mt -118.07 140.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 120.107 -0.637 . . . . 1.35 110.926 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.85 148.82 52.66 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.73 -1.577 . . . . 0.96 110.658 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.599 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 38.2 t -123.17 111.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.14 -1.059 . . . . 0.87 108.14 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.98 -76.07 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.103 0.954 . . . . 3.21 109.403 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 64' ' ' VAL . 45.0 tt0 -142.94 -9.11 0.8 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.058 -1.428 . . . . 4.38 110.663 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -92.12 168.79 11.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.746 -0.382 . . . . 5.37 110.677 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.47 ' CE1' ' NE2' ' A' ' 61' ' ' GLN . 85.9 t60 -119.19 153.17 35.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.708 -1.219 . . . . 1.27 107.708 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.0 -50.75 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 119.007 -1.077 . . . . 1.1 109.698 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 164.98 -158.25 31.01 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.959 -1.656 . . . . 1.19 108.959 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 60' ' ' PRO . . . -87.59 -67.6 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.88 -1.629 . . . . 2.85 110.159 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 73' ' ' THR . 61.7 t80 -152.03 179.92 8.05 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.547 -0.861 . . . . 3.75 108.788 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 72' ' ' TYR . 85.0 m 67.73 -68.14 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.629 0.581 . . . . 2.99 110.212 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.53 -51.1 5.21 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.105 0.955 . . . . 3.71 110.155 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.44 -36.96 2.16 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.615 -1.63 . . . . 1.3 112.696 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.59 -49.19 57.09 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.325 -0.95 . . . . 1.37 109.848 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.06 62.51 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.463 -0.94 . . . . 1.46 108.463 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.599 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 78.3 t90 -46.61 -53.81 10.77 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.775 -1.102 . . . . 0.92 109.038 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.555 HG13 HD12 ' A' ' 83' ' ' LEU . 80.4 t -55.42 -41.61 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.904 -1.119 . . . . 1.08 109.534 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.501 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -65.01 -38.89 92.43 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.88 -1.054 . . . . 2.21 113.437 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.37 -12.53 12.99 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 115.815 1.783 . . . . 4.71 115.815 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.436 ' CG ' ' NE1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -92.22 -16.33 26.34 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.544 -0.862 . . . . 1.72 109.996 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.555 HD12 HG13 ' A' ' 79' ' ' VAL . 59.6 mt -102.31 -73.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.454 -0.898 . . . . 3.44 109.16 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 31.65 42.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 124.287 0.992 . . . . 4.14 112.003 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.603 ' C ' ' HE ' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 115.984 -1.96 . . . . 5.4 107.455 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.658 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.498 -0.556 . . . . 2.83 109.498 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.1 96.97 9.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 123.703 0.627 . . . . 3.97 110.809 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.6 m -91.62 126.04 36.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.043 -0.725 . . . . 1.06 109.043 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.527 ' C ' HD12 ' A' ' 5' ' ' ILE . 16.6 t -129.02 141.76 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.708 -1.197 . . . . 1.18 109.664 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -111.28 132.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.117 -2.179 . . . . 1.26 105.117 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 50.0 m-85 -124.2 116.31 22.49 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.262 -0.644 . . . . 1.89 109.262 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.11 -179.35 20.47 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.251 -1.452 . . . . 2.24 112.353 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -127.23 163.61 23.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.76 -0.72 . . . . 5.52 109.623 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -106.11 -53.12 2.68 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.113 0.959 . . . . 7.76 109.363 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.79 -61.51 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 105.814 -2.914 . . . . 4.92 105.814 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 13' ' ' TYR . 9.6 m -96.24 170.39 7.61 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 106.388 -1.708 . . . . 5.25 106.388 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.93 73.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.365 2.043 . . . . 3.06 111.605 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' CYS . 6.3 t80 -119.63 -60.93 1.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.768 . . . . 5.54 108.925 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 29.8 m -54.64 -39.53 68.06 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 122.615 1.198 . . . . 2.27 108.193 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.0 t -44.41 -50.29 2.01 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 CA-C-N 113.396 -1.729 . . . . 1.28 111.278 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 8.5 mmm180 -56.92 -41.17 77.68 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.105 -1.038 . . . . 3.78 110.243 -178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.12 80.05 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.218 -1.401 . . . . 0.77 107.218 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -52.5 65.06 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.76 -1.176 . . . . 1.79 107.855 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.05 -52.17 9.26 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.458 -0.897 . . . . 3.13 110.628 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' A' ' 75' ' ' PHE . 40.9 tp -58.49 -60.38 3.89 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 120.41 -0.516 . . . . 0.81 110.656 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.31 -44.22 44.13 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.969 -1.014 . . . . 0.64 109.45 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.91 -51.46 66.84 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 124.709 1.256 . . . . 1.74 109.358 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -50.21 -56.16 12.25 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.394 -0.922 . . . . 4.33 108.674 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.497 HD11 HG21 ' A' ' 79' ' ' VAL . 44.6 mt -57.3 -44.36 84.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.341 1.026 . . . . 1.14 109.179 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 t -51.89 -29.9 21.78 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.979 -1.464 . . . . 0.99 109.61 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.474 ' CG ' ' O ' ' A' ' 26' ' ' ASN . 5.9 t-20 -96.38 25.77 4.79 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.152 -0.931 . . . . 2.71 110.935 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.7 mt-10 -138.74 -35.44 0.58 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.504 -0.771 . . . . 2.52 110.537 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 30' ' ' ASP . 43.3 mtp85 -114.71 129.86 56.74 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.759 -0.776 . . . . 3.75 112.017 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.16 32.56 0.28 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.242 1.02 . . . . 3.62 109.742 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.3 p30 -136.49 -1.7 2.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.708 -1.587 . . . . 3.16 109.243 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -120.64 124.53 45.47 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.653 0.739 . . . . 0.92 112.635 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -142.76 155.13 44.8 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.131 -1.433 . . . . 4.85 107.131 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -134.76 163.88 28.81 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.105 -1.438 . . . . 1.27 112.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.65 154.52 44.43 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 124.604 1.19 . . . . 5.21 109.389 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.42 ' HD1' ' N ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -127.88 124.63 37.94 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.9 -0.72 . . . . 2.7 110.162 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' N ' ' HD1' ' A' ' 35' ' ' TYR . 2.4 t -123.41 149.88 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.379 -1.341 . . . . 1.87 107.379 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -123.55 124.91 43.89 Favored 'General case' 0 N--CA 1.51 2.57 0 C-N-CA 117.816 -1.554 . . . . 2.37 110.412 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 pt -43.5 -38.76 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 113.435 -1.711 . . . . 1.52 114.017 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 24.35 6.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.237 -0.985 . . . . 8.48 112.905 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.95 -43.96 2.74 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.012 -1.107 . . . . 2.02 108.012 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -92.45 -28.68 16.69 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.686 -1.597 . . . . 5.96 111.288 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.4 0.66 Allowed Glycine 0 N--CA 1.503 3.103 0 C-N-CA 119.364 -1.398 . . . . 1.95 111.132 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.9 mt -112.46 156.84 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.665 -0.814 . . . . 2.11 108.984 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -101.24 -170.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.428 -0.953 . . . . 2.54 108.428 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -49.98 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.722 -1.584 . . . . 4.65 106.722 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.69 -52.25 24.38 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.372 -0.931 . . . . 3.87 110.118 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.85 -44.93 40.11 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 120.064 -0.654 . . . . 2.65 111.49 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 1.8 mt -70.14 -42.83 72.06 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.886 0.85 . . . . 1.63 109.011 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 49' ' ' GLN . 3.4 tp-100 -58.27 -32.48 68.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.625 -1.25 . . . . 5.06 107.625 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.81 0.96 7.74 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.048 -1.433 . . . . 4.15 110.263 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 57.3 mttp -115.85 -42.72 3.06 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.57 -1.195 . . . . 2.3 109.824 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -81.02 -50.89 9.12 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.358 -0.837 . . . . 1.05 111.476 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.74 -55.54 2.28 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.65 -2.18 . . . . 2.77 107.65 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HD3' HE22 ' A' ' 61' ' ' GLN . 44.4 mtmt 31.14 -147.39 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 CA-C-N 112.526 -1.837 . . . . 7.92 113.566 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 57.2 Cg_endo -92.37 -166.95 0.17 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.962 1.775 . . . . 4.08 112.416 128.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -98.52 81.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.369 -0.832 . . . . 6.85 109.543 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -115.4 -94.25 0.48 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.948 1.092 . . . . 5.41 113.948 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 59' ' ' VAL . 1.3 m -142.86 -156.05 0.65 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 118.972 -1.091 . . . . 4.55 113.738 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.572 ' H ' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -114.78 -169.05 0.14 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 114.389 -1.278 . . . . 3.35 108.966 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.651 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 31.7 Cg_endo -68.57 -175.42 9.49 Favored 'Cis proline' 0 N--CA 1.499 1.815 0 O-C-N 122.182 0.57 . . . . 2.75 111.553 -28.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.462 HE22 ' HD3' ' A' ' 54' ' ' LYS . 19.3 tp60 -134.74 150.95 50.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 123.976 0.798 . . . . 2.83 111.864 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mt -123.67 142.51 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.711 -1.218 . . . . 1.07 107.711 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.21 156.56 48.5 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.844 -1.071 . . . . 1.01 110.004 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.6 t -138.12 115.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.017 -0.673 . . . . 1.33 109.653 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 1' ' ' MET . 1.2 m-20 54.44 -101.94 0.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.253 -1.017 . . . . 3.28 108.253 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -125.75 39.55 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.857 -0.794 . . . . 3.98 108.857 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -127.51 161.78 27.97 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.416 -0.811 . . . . 3.49 109.984 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.509 ' CD2' ' N ' ' A' ' 69' ' ' ILE . 5.5 t-160 -122.54 142.42 50.62 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.753 -1.203 . . . . 1.15 107.753 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.509 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 28.1 mm -101.33 -99.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 118.704 -1.198 . . . . 1.83 107.877 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.42 65.29 0.21 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.401 -1.38 . . . . 4.23 110.611 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.66 -175.33 17.52 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.995 -1.642 . . . . 1.52 108.995 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' PHE . 13.6 t80 -110.08 -60.75 1.75 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.356 -0.938 . . . . 1.51 109.947 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -46.09 -34.11 3.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.578 -1.638 . . . . 4.91 106.578 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.6 -44.11 97.61 Favored 'General case' 0 C--O 1.2 -1.537 0 CA-C-N 113.077 -1.874 . . . . 3.41 108.87 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CD2' HD23 ' A' ' 20' ' ' LEU . 11.9 t80 -63.45 -41.52 98.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.476 -0.935 . . . . 1.11 108.476 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -62.48 -56.15 20.86 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.365 -0.934 . . . . 1.3 108.966 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.15 43.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.325 -1.361 . . . . 1.28 107.325 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.438 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 80.1 t90 -36.47 -54.73 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.981 0.801 . . . . 1.1 110.413 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.497 HG21 HD11 ' A' ' 24' ' ' LEU . 41.4 t -43.92 -60.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 115.199 -0.91 . . . . 1.48 111.92 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -44.33 -29.61 0.7 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.614 0.968 . . . . 3.16 113.614 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -109.06 -27.02 9.86 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.628 -0.829 . . . . 4.13 113.044 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -83.98 -34.13 24.43 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.042 -1.063 . . . . 1.84 111.017 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.44 HD12 HG13 ' A' ' 79' ' ' VAL . 68.0 mt -102.47 -44.79 5.26 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.042 -1.836 . . . . 3.45 106.042 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 60.67 -65.92 0.05 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 126.497 2.373 . . . . 5.19 111.501 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.234 0 O-C-N 125.197 1.561 . . . . 5.33 109.45 179.481 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.579 ' H2 ' ' CG ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.344 0.592 . . . . 2.69 110.04 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -109.65 99.44 8.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.579 -2.378 . . . . 4.43 104.579 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.461 HG21 ' CE1' ' A' ' 75' ' ' PHE . 27.1 m -88.4 103.42 15.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.906 -1.497 . . . . 1.37 109.868 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 63.3 t -94.47 130.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.751 -0.659 . . . . 1.28 110.292 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.494 HG21 ' SG ' ' A' ' 14' ' ' CYS . 1.6 mp -113.74 116.86 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.411 -1.7 . . . . 1.08 106.411 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.627 ' CE2' HD13 ' A' ' 43' ' ' ILE . 2.8 m-30 -106.33 98.38 8.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.826 -1.916 . . . . 2.65 105.826 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 60' ' ' PRO . . . -130.59 -159.99 9.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.42 -1.371 . . . . 1.62 112.481 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' CZ ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -124.4 130.1 51.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.02 -1.474 . . . . 5.0 107.02 179.016 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.474 ' OG ' ' CZ ' ' A' ' 8' ' ' ARG . 1.6 p -51.77 106.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.632 -0.827 . . . . 4.9 108.95 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . 134.08 -12.42 4.73 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.699 -1.238 . . . . 3.61 111.16 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 97.1 m -95.3 90.94 0.66 Allowed Pre-proline 0 N--CA 1.501 2.122 0 C-N-CA 119.493 -0.883 . . . . 5.57 110.682 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 10' ' ' GLY . 28.3 Cg_endo -58.78 -3.57 1.55 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.741 2.961 . . . . 3.69 112.719 -162.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 11' ' ' CYS . 9.5 m-30 -71.44 -37.27 71.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.62 -1.252 . . . . 4.92 107.62 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 3.6 t -58.56 -43.19 89.29 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.143 -1.423 . . . . 3.62 108.21 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.42 -57.74 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.428 -0.952 . . . . 1.34 108.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 6.5 mmp_? -49.93 -48.45 51.81 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.649 -1.22 . . . . 3.73 109.649 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.0 -54.77 40.86 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.887 -1.525 . . . . 0.83 108.266 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -46.22 -49.08 17.58 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.177 -0.609 . . . . 1.71 109.879 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.479 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 35.1 m-20 -63.28 -55.68 22.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.887 -0.597 . . . . 3.29 110.188 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.5 tp -48.53 -55.73 10.27 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.987 -1.085 . . . . 0.91 109.239 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -58.69 -36.22 73.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.656 -0.818 . . . . 1.07 109.668 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.6 tt0 -51.31 -47.55 62.58 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.051 -1.059 . . . . 1.9 109.819 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -44.73 -60.15 2.16 Favored 'General case' 0 N--CA 1.514 2.751 0 C-N-CA 119.419 -0.912 . . . . 6.99 109.657 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 47.6 mt -45.53 -52.39 10.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.224 -1.353 . . . . 2.03 107.916 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -53.48 -37.34 62.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.662 -1.608 . . . . 1.36 111.415 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -104.22 37.1 2.17 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.048 0.928 . . . . 2.02 108.549 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 28' ' ' ARG . 58.9 tt0 -130.11 -51.39 1.11 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.177 -1.374 . . . . 4.76 107.517 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 27' ' ' GLU . 9.7 ptp180 -124.79 -178.39 4.14 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 112.368 -2.196 . . . . 3.11 108.619 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -116.29 27.95 8.9 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.486 0.66 . . . . 4.62 110.685 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.421 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 3.0 p30 -120.26 -8.41 9.68 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.453 -0.794 . . . . 3.06 112.701 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -108.68 130.15 55.34 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.109 1.522 . . . . 1.34 115.109 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -138.31 153.14 49.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.891 -1.152 . . . . 3.58 107.891 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.91 156.25 35.04 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.528 -0.869 . . . . 1.16 109.978 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -130.12 118.22 21.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.62 0.575 . . . . 4.7 109.914 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.496 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -107.47 112.62 25.49 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.721 -0.792 . . . . 2.23 109.287 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 156.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 123.89 0.744 . . . . 1.6 109.642 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.3 t70 -114.06 131.47 56.37 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 106.869 -1.53 . . . . 2.36 106.869 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 pt -47.78 -39.96 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 114.348 1.24 . . . . 1.18 114.348 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.506 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -85.98 -45.14 11.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.607 -1.637 . . . . 5.04 108.422 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 39' ' ' ARG . . . -35.38 -56.86 0.62 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 124.068 0.855 . . . . 1.73 110.918 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -105.5 44.53 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 124.083 0.864 . . . . 5.74 110.97 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 23.53 68.15 0.03 OUTLIER Glycine 0 N--CA 1.504 3.215 0 CA-C-N 114.773 -1.103 . . . . 2.0 114.597 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.627 HD13 ' CE2' ' A' ' 6' ' ' PHE . 34.3 mt -101.08 140.26 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.432 -1.692 . . . . 1.91 106.432 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.9 p -104.41 169.98 8.16 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.442 -0.903 . . . . 3.27 111.195 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.458 ' CA ' ' HZ2' ' A' ' 45' ' ' LYS . 5.0 mmmp? -70.83 -35.33 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 117.806 -1.558 . . . . 5.01 111.963 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.72 -55.18 38.26 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.924 -1.51 . . . . 6.55 106.924 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.476 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 25.0 t70 -48.68 -48.1 40.27 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 115.094 -0.957 . . . . 2.85 111.657 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.84 -50.22 67.5 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.836 -1.074 . . . . 2.01 110.743 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.45 -45.44 66.04 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.418 -1.327 . . . . 4.66 107.418 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -56.6 -23.33 40.13 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.613 -1.63 . . . . 4.01 111.211 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 7.9 mtmm -96.8 -32.74 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.308 -0.557 . . . . 2.35 110.849 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.531 ' HB2' HE22 ' A' ' 61' ' ' GLN . . . -75.41 -44.26 45.6 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.093 -0.643 . . . . 1.38 112.021 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.0 -48.75 0.91 Allowed Glycine 0 N--CA 1.501 3.031 0 N-CA-C 108.232 -1.947 . . . . 3.32 108.232 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.565 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 3.8 ttpm? -91.4 166.58 17.88 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.245 -2.131 . . . . 6.29 105.245 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.565 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.5 Cg_endo -48.22 155.61 1.92 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.685 -1.313 . . . . 5.29 108.685 146.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 m -118.79 149.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.897 -1.121 . . . . 5.11 110.562 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 15.6 mp0 -87.19 -69.47 0.68 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.073 0.858 . . . . 6.3 111.17 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 59' ' ' VAL . 26.7 m -143.8 173.64 11.5 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.731 -0.788 . . . . 3.64 110.871 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 58' ' ' THR . 15.7 m -101.92 159.17 30.18 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.818 -1.179 . . . . 1.94 107.818 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 10.0 Cg_endo -92.01 147.26 14.33 Favored 'Cis proline' 0 C--N 1.318 -1.057 0 CA-C-N 118.554 0.519 . . . . 1.67 111.454 9.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.531 HE22 ' HB2' ' A' ' 52' ' ' ALA . 18.6 mt-30 -107.78 147.47 30.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.922 -0.711 . . . . 2.85 109.47 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.459 HD12 ' CB ' ' A' ' 75' ' ' PHE . 4.4 mt -121.18 141.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.268 -0.973 . . . . 1.37 112.489 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 19.7 m-85 -128.62 153.28 47.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 114.608 -1.178 . . . . 0.97 108.998 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.6 t -122.33 102.05 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.487 -1.301 . . . . 0.98 107.487 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.579 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 37.2 m-20 65.49 -83.58 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.772 0.796 . . . . 2.38 110.25 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -126.3 -15.43 5.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.398 -1.274 . . . . 4.23 109.717 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -81.37 167.86 19.0 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.421 -0.512 . . . . 3.69 111.27 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -123.43 136.26 54.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.439 -1.689 . . . . 1.22 106.439 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' A' ' 75' ' ' PHE . 26.0 mm -107.07 -31.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.33 -0.948 . . . . 0.79 110.204 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.4 -117.98 3.8 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.48 -1.448 . . . . 1.33 109.48 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.36 -172.77 18.96 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.285 -1.126 . . . . 1.32 110.285 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -56.01 -53.21 59.67 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.095 -1.042 . . . . 1.54 113.253 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 p -40.92 -58.63 1.65 Allowed 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.726 -0.79 . . . . 1.74 110.833 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.56 -57.74 10.68 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 113.677 -1.601 . . . . 2.05 108.964 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HA ' HG21 ' A' ' 69' ' ' ILE . 70.1 t80 -45.82 -52.91 10.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.747 -0.781 . . . . 0.88 111.497 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -55.99 18.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.469 -0.892 . . . . 1.05 109.145 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.62 -58.98 5.36 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.623 -0.831 . . . . 0.9 109.518 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.406 ' O ' ' HB2' ' A' ' 82' ' ' ASN . 74.3 t90 -41.99 -53.61 3.8 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.738 -0.664 . . . . 0.89 109.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.18 -60.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 124.094 0.871 . . . . 0.98 109.796 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.445 ' NZ ' ' C ' ' A' ' 85' ' ' ALA . 0.1 OUTLIER -44.78 -55.79 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.127 1.158 . . . . 2.68 114.127 -177.048 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -93.42 28.6 2.2 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 117.184 -1.807 . . . . 5.49 114.305 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 78' ' ' TRP . 40.9 m-80 -140.2 -36.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 119.124 -1.03 . . . . 2.86 110.195 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.0 -26.25 9.36 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.518 -0.765 . . . . 1.99 111.161 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 0.2 OUTLIER -89.52 -69.9 0.69 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.002 0.814 . . . . 6.57 110.365 -179.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.445 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.5 2.058 0 O-C-N 126.519 2.387 . . . . 8.72 106.211 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.47 0.652 . . . . 3.28 110.013 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.74 160.77 14.05 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.15 -0.932 . . . . 5.85 111.602 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.3 m -124.68 146.61 49.03 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 109.843 -0.429 . . . . 1.4 109.843 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.77 132.95 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.415 -0.957 . . . . 1.7 108.415 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.3 mp -118.29 121.99 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.48 -0.933 . . . . 1.31 108.48 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -115.04 113.57 24.24 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 106.745 -1.576 . . . . 1.65 106.745 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . 160.94 -169.3 36.54 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.279 -1.915 . . . . 1.77 108.443 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -126.51 173.66 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 116.854 -1.938 . . . . 4.78 112.3 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.12 -179.96 4.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.008 -1.451 . . . . 5.73 109.778 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.48 -49.22 0.91 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.116 -1.993 . . . . 3.97 108.116 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.8 t -128.24 101.04 22.44 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 107.391 -1.337 . . . . 4.81 107.391 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 14' ' ' CYS . 2.3 Cg_endo -31.05 -56.14 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.634 2.223 . . . . 4.32 113.06 -122.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 53.15 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.874 1.065 . . . . 6.52 113.874 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' PRO . 18.2 m -115.85 -6.22 12.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.348 -0.541 . . . . 2.29 110.797 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -43.03 -57.54 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 119.743 -0.783 . . . . 2.42 111.78 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.576 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -60.09 -35.47 75.27 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 117.481 -1.688 . . . . 4.27 109.891 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.27 -51.64 68.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.177 -1.409 . . . . 0.82 107.667 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 18.0 tptp -53.14 -50.52 64.38 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 120.26 -0.576 . . . . 2.45 111.724 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.576 ' CG ' HH22 ' A' ' 16' ' ' ARG . 6.9 t0 -66.36 -53.91 30.71 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.784 0.802 . . . . 2.66 110.165 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 tp -49.93 -53.44 26.13 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.199 -1.037 . . . . 1.47 108.199 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.95 76.18 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.427 -0.953 . . . . 1.06 108.427 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 4.8 tp10 -46.68 -62.98 1.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.465 1.126 . . . . 2.91 110.677 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.42 -50.1 17.18 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 113.585 -1.643 . . . . 4.28 110.921 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 mt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.169 -0.923 . . . . 1.53 110.321 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -58.52 -40.89 84.14 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.024 -0.732 . . . . 1.27 109.024 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -89.05 29.84 1.01 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.947 -1.131 . . . . 2.74 107.947 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -120.82 -59.19 1.77 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.257 -1.016 . . . . 3.47 108.257 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' A' ' 84' ' ' ASP . 3.4 mtt180 -116.5 152.28 34.39 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.352 -0.981 . . . . 4.08 108.352 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -74.98 -36.05 62.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.644 -0.822 . . . . 4.91 110.176 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 30' ' ' ASP . 5.5 t70 -83.51 41.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.666 -0.813 . . . . 4.31 109.998 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 25' ' ' SER . 50.9 t80 -142.65 72.43 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.322 -0.951 . . . . 1.21 108.622 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -100.2 138.13 37.69 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.272 -1.01 . . . . 3.69 108.272 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -118.36 155.77 30.11 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.15 -1.02 . . . . 1.42 112.84 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -121.69 130.21 53.3 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 3.76 107.92 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -119.49 114.6 22.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.65 -1.241 . . . . 1.7 107.65 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.84 145.93 32.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.483 -0.781 . . . . 2.88 109.653 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 11.3 t70 -97.62 140.19 32.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.126 -1.435 . . . . 3.21 107.126 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.426 ' C ' HH11 ' A' ' 39' ' ' ARG . 9.5 pt -48.31 -29.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 112.895 0.702 . . . . 2.07 112.895 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.463 ' HA ' HH11 ' A' ' 39' ' ' ARG . 0.7 OUTLIER -94.75 22.65 6.14 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.276 -0.97 . . . . 6.91 111.749 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.2 -50.68 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.246 -0.581 . . . . 1.52 109.662 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -95.58 -13.81 24.1 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.5 -0.88 . . . . 3.37 109.755 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.59 58.76 1.17 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.137 -1.985 . . . . 1.56 108.137 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -101.1 141.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 120.117 -0.633 . . . . 2.22 111.582 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 p -123.14 161.54 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 124.538 1.149 . . . . 2.59 109.437 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -43.91 -57.34 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.705 -0.68 . . . . 4.29 109.493 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -44.49 -49.28 9.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 123.826 0.704 . . . . 3.85 111.128 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.78 -50.66 72.58 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.976 -1.49 . . . . 3.08 109.221 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -42.82 64.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.152 -0.931 . . . . 1.83 108.92 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.0 -47.87 79.8 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.6 -1.259 . . . . 4.18 107.6 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -60.19 -50.29 74.25 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.984 0.803 . . . . 4.83 110.562 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 51' ' ' LYS . 2.8 tppt? -55.62 -50.23 70.71 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.428 -1.26 . . . . 3.16 111.508 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.596 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -74.24 -47.49 34.92 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.315 -1.311 . . . . 1.18 113.077 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.86 42.71 5.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.048 -1.621 . . . . 2.48 109.048 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 54' ' ' LYS . 75.5 mmtt -128.41 -176.29 0.51 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.521 -0.918 . . . . 6.36 108.521 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 50.9 Cg_exo -50.82 -157.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.46 1.44 . . . . 4.04 111.235 147.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 m -114.16 70.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.784 -0.643 . . . . 5.81 112.273 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 3.1 mp0 -75.03 54.51 0.67 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.14 -0.936 . . . . 6.17 112.217 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p 41.26 -112.53 0.16 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 115.666 1.728 . . . . 3.98 115.666 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.12 171.55 6.43 Favored Pre-proline 0 N--CA 1.498 1.955 0 CA-C-N 115.569 -0.741 . . . . 1.98 109.402 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.51 173.35 11.98 Favored 'Cis proline' 0 N--CA 1.487 1.109 0 O-C-N 122.616 0.798 . . . . 1.9 110.351 -20.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.75 150.49 49.78 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.905 . . . . 2.74 110.521 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.418 ' C ' ' CD1' ' A' ' 63' ' ' PHE . 48.2 mt -123.16 148.03 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.747 -0.66 . . . . 1.17 109.267 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 9.4 m-85 -131.06 165.39 23.34 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.767 -1.106 . . . . 1.13 109.494 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.428 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 55.7 t -134.8 112.31 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.481 -1.236 . . . . 0.89 110.148 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 66' ' ' GLN . 0.6 OUTLIER 53.94 -85.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.464 0.542 . . . . 2.64 112.464 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' H ' ' HB3' ' A' ' 65' ' ' ASP . 54.0 mt-30 -139.13 23.18 2.58 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.82 -0.627 . . . . 4.55 110.334 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -123.99 153.96 40.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.398 -0.964 . . . . 3.86 108.398 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.596 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.0 t-160 -108.6 139.77 42.91 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.829 -1.174 . . . . 1.08 107.829 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.75 -45.94 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 118.744 -1.183 . . . . 0.92 110.032 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 138.21 -123.83 2.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.391 -1.484 . . . . 1.37 109.391 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.11 -174.72 19.64 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.147 -1.181 . . . . 1.44 110.147 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -47.4 -60.33 2.59 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.817 1.043 . . . . 2.21 113.817 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -36.31 -59.82 0.61 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.685 1.231 . . . . 2.08 111.369 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -51.78 68.32 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.374 -2.193 . . . . 2.08 109.584 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -47.15 -50.54 20.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.516 -1.274 . . . . 0.94 109.632 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.09 13.14 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.51 -1.276 . . . . 1.14 109.253 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.25 -54.12 35.23 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.484 -0.886 . . . . 0.93 110.861 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.428 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 89.7 t90 -51.17 -50.58 58.7 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.146 -0.479 . . . . 0.74 110.441 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -49.41 -50.62 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.213 -0.903 . . . . 1.17 111.681 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -40.42 -38.5 0.83 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.703 1.372 . . . . 2.24 114.703 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.88 -25.8 6.67 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.973 1.101 . . . . 5.64 113.973 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -79.47 -14.36 58.95 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 117.491 -1.683 . . . . 1.92 108.101 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -121.8 13.34 10.7 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.905 -1.146 . . . . 2.17 107.905 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 28' ' ' ARG . 3.7 p30 32.27 80.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.469 -1.696 . . . . 6.23 114.661 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 116.546 -1.692 . . . . 7.94 108.948 178.357 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 107.996 -1.113 . . . . 2.45 107.996 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -109.67 128.77 55.48 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.194 -0.669 . . . . 4.97 109.194 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -112.71 125.07 53.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.731 -0.788 . . . . 0.91 109.476 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 63' ' ' PHE . 14.5 p -121.35 144.46 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.405 -0.918 . . . . 2.72 109.362 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -118.35 118.77 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 125.173 1.545 . . . . 2.17 108.98 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -107.81 73.41 0.9 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.446 -1.687 . . . . 1.98 106.446 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.4 -179.66 21.84 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.786 -1.673 . . . . 1.45 111.431 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 126.47 52.68 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.076 -1.824 . . . . 6.1 106.076 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -117.29 -168.19 1.44 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.139 0.971 . . . . 6.91 112.768 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.56 -47.32 1.02 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.253 -1.939 . . . . 4.22 108.253 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.91 116.25 31.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.476 -1.305 . . . . 5.48 107.476 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 14' ' ' CYS . 50.1 Cg_exo -17.74 -68.49 0.02 OUTLIER 'Trans proline' 0 C--O 1.197 -1.533 0 C-N-CA 122.598 2.199 . . . . 4.03 112.924 -127.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 47.36 -66.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 113.028 0.751 . . . . 6.09 113.028 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 12' ' ' PRO . 23.5 m -116.39 -18.75 10.37 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.468 -0.893 . . . . 2.06 109.544 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -47.03 -33.94 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.266 -0.573 . . . . 1.36 110.479 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.526 HH21 ' CB ' ' A' ' 19' ' ' ASP . 1.2 mmp_? -78.64 -38.15 40.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.853 -1.139 . . . . 3.74 110.408 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.9 -49.24 73.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.954 -1.869 . . . . 0.65 105.954 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.439 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 3.7 tmtm? -57.44 -51.58 68.85 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.641 -1.163 . . . . 1.53 110.047 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.526 ' CB ' HH21 ' A' ' 16' ' ' ARG . 9.7 t70 -57.66 -59.12 5.69 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.394 -0.922 . . . . 2.73 109.401 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 tp -49.07 -60.08 3.08 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.883 0.849 . . . . 0.95 109.599 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 33' ' ' TYR . . . -48.66 -53.13 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.668 -1.151 . . . . 0.7 109.362 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.439 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 tt0 -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.212 1.006 . . . . 2.07 108.615 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -49.11 -49.99 39.27 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.11 -1.405 . . . . 4.76 107.984 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.1 mt -63.89 -31.54 72.76 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.848 -0.797 . . . . 1.28 108.848 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 t -64.06 -29.52 70.65 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.173 -1.788 . . . . 1.14 106.173 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 7.0 t30 -95.73 32.38 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.014 -1.106 . . . . 1.82 108.014 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.467 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 40.5 mt-10 -130.09 -66.06 0.8 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.681 -1.145 . . . . 2.79 108.791 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.3 mpt_? -116.17 132.72 56.58 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 108.258 -1.016 . . . . 4.63 108.258 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.5 30.06 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.775 -0.77 . . . . 4.25 111.732 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -112.78 -25.82 8.88 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.141 -1.429 . . . . 2.84 107.141 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -98.02 117.64 32.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.574 -1.194 . . . . 1.16 112.999 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -124.27 136.59 54.25 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.136 -1.847 . . . . 3.28 106.551 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.444 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 7.9 p90 -117.66 158.73 24.14 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 118.622 -1.231 . . . . 1.16 109.176 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -144.7 119.82 10.1 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.206 -0.906 . . . . 4.27 110.227 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -98.33 119.06 36.35 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.064 -1.828 . . . . 1.36 106.064 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.4 154.2 21.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.608 -1.627 . . . . 1.38 106.608 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -117.95 131.54 56.49 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.184 -1.406 . . . . 2.83 108.565 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.0 pt -46.73 -37.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.08 -1.418 . . . . 1.22 113.912 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -95.26 18.44 12.38 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.76 -1.176 . . . . 5.69 112.651 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.86 -47.54 3.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.722 -0.844 . . . . 1.54 108.722 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -88.99 -22.72 22.87 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.798 -1.092 . . . . 4.82 110.635 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.49 52.85 1.39 Allowed Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.589 -1.291 . . . . 1.94 110.615 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.8 mt -106.71 134.78 47.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 106.287 -1.746 . . . . 1.6 106.287 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -91.96 -144.16 0.2 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.817 -1.153 . . . . 2.51 109.173 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 57' ' ' GLU . 26.5 mmmt -116.74 -33.52 4.79 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.577 -1.638 . . . . 6.64 106.577 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.17 -46.58 80.24 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.362 -1.718 . . . . 3.96 106.362 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' CG ' ' NZ ' ' A' ' 51' ' ' LYS . 26.9 t70 -63.88 -16.85 62.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.914 -1.039 . . . . 2.2 111.343 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.64 -48.14 5.63 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 108.468 -0.938 . . . . 1.36 108.468 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.35 -47.03 62.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 3.48 107.271 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -67.87 -18.73 64.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.702 -1.135 . . . . 3.8 111.451 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' NZ ' ' CG ' ' A' ' 47' ' ' ASP . 36.5 mttp -86.65 -41.58 14.12 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.827 -0.749 . . . . 2.26 111.218 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . . . -92.23 -36.17 13.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.144 -0.622 . . . . 1.25 110.676 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.95 -66.91 0.38 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 105.501 -3.039 . . . . 3.41 105.501 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 33.2 mttm 31.44 -162.61 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 CA-C-N 112.533 -1.834 . . . . 7.04 113.178 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -103.75 -157.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.202 1.935 . . . . 4.29 109.915 131.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.04 113.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.946 -1.501 . . . . 7.06 106.946 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 24.9 mt-10 -119.31 -175.6 2.97 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.503 -0.771 . . . . 5.96 112.692 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 59' ' ' VAL . 4.9 t -92.07 -136.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.42 -1.326 . . . . 4.63 107.42 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.413 ' N ' HG23 ' A' ' 58' ' ' THR . 7.0 m -127.26 162.66 46.96 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.627 -0.879 . . . . 1.81 108.627 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 83.7 Cg_endo -100.34 163.51 8.2 Favored 'Cis proline' 0 N--CA 1.486 1.085 0 O-C-N 122.507 0.741 . . . . 1.9 111.888 2.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -119.7 112.1 18.85 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.644 -1.243 . . . . 3.56 107.644 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -101.48 143.62 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.761 -0.776 . . . . 1.08 111.011 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.422 ' HB2' ' CG1' ' A' ' 4' ' ' VAL . 24.7 m-85 -134.31 156.48 48.37 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 113.245 -1.798 . . . . 1.38 109.964 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 66' ' ' GLN . 54.5 t -131.56 122.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.869 -1.53 . . . . 0.9 106.869 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 66' ' ' GLN . 12.3 m-20 55.02 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.059 -0.657 . . . . 3.26 109.29 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.4 tt0 -133.18 -16.93 2.41 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.604 -1.18 . . . . 5.15 110.692 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' VAL . 19.1 pt20 -81.59 161.54 23.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.921 -0.711 . . . . 4.4 110.503 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -108.34 147.56 31.33 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.184 -0.917 . . . . 1.41 108.611 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 78' ' ' TRP . 5.2 mm -116.21 -49.66 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.12 -1.032 . . . . 0.79 109.483 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.27 -121.07 3.05 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.954 -1.258 . . . . 1.16 109.954 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.97 -164.47 18.53 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.623 -0.991 . . . . 1.11 110.623 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -53.52 -56.51 16.41 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 120.903 0.382 . . . . 2.13 111.203 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -45.39 -53.18 9.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.035 0.921 . . . . 1.61 110.779 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.39 65.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.158 -1.837 . . . . 2.79 109.295 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -48.24 -52.91 19.02 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.133 -1.027 . . . . 0.85 110.08 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.11 -56.7 14.24 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.097 -1.041 . . . . 0.79 110.122 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -55.66 28.49 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.54 -0.864 . . . . 0.87 109.922 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.422 ' CD1' HD12 ' A' ' 69' ' ' ILE . 89.7 t90 -48.89 -53.31 20.04 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.22 -0.592 . . . . 0.67 110.077 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.2 t -46.69 -58.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 CA-C-N 115.05 -0.977 . . . . 0.77 110.614 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -43.07 -43.09 4.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.816 1.413 . . . . 2.2 114.816 -177.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -97.79 3.56 49.97 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 118.15 -1.42 . . . . 3.87 113.536 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -117.09 -39.89 3.17 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.793 -0.763 . . . . 1.34 111.306 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.2 mt -113.56 37.83 3.11 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.619 -0.719 . . . . 2.4 112.051 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -101.0 37.99 1.64 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.057 -1.057 . . . . 4.21 109.322 178.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 116.689 -1.624 . . . . 5.78 108.148 179.333 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 tpp . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 109.005 -0.739 . . . . 3.08 109.005 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.446 ' NE2' ' HB3' ' A' ' 32' ' ' GLN . 33.4 mm-40 -119.6 118.7 31.69 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.569 -1.271 . . . . 4.32 107.569 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 11.1 m -114.27 131.58 56.45 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.341 -0.543 . . . . 0.91 110.996 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.99 146.72 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.822 -1.151 . . . . 1.69 112.57 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.4 mp -111.34 129.58 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.458 -1.682 . . . . 1.81 106.458 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 81.0 m-85 -118.63 119.92 35.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.15 -0.62 . . . . 1.7 110.492 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.27 -158.72 26.96 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 124.637 1.211 . . . . 1.86 112.037 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -106.26 107.43 18.43 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.44 0.638 . . . . 5.74 110.097 -179.1 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t -78.11 -155.05 0.07 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.897 -0.592 . . . . 7.27 111.113 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 25.02 21.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.22 -1.552 . . . . 4.12 109.22 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' ' 15' ' ' VAL . 59.2 m -142.38 150.92 56.57 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 120.46 -0.496 . . . . 3.95 110.587 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.87 31.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.629 2.219 . . . . 4.93 112.479 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 83.6 t80 -125.13 -63.78 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.626 -1.249 . . . . 7.9 107.626 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 60' ' ' PRO . 89.5 m -78.68 -29.16 45.42 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 118.554 -1.258 . . . . 3.66 109.4 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 11' ' ' CYS . 67.4 t -62.19 -48.14 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.376 -1.342 . . . . 1.68 107.376 178.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -57.71 -28.5 63.9 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.155 -1.018 . . . . 3.85 109.853 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 62' ' ' ILE . . . -69.86 -48.44 58.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.749 -1.945 . . . . 1.18 105.749 177.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HE2' ' N ' ' A' ' 19' ' ' ASP . 3.5 tmpt? -50.21 -45.61 53.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.399 -1.704 . . . . 2.04 106.399 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 72.8 m-20 -58.44 -62.77 1.6 Allowed 'General case' 0 C--O 1.19 -2.029 0 C-N-CA 119.277 -0.969 . . . . 2.93 109.949 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 62.0 tp -46.5 -48.63 19.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.765 -0.774 . . . . 0.91 110.287 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.69 85.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.112 -0.699 . . . . 0.68 109.112 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.63 -38.68 82.01 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.734 -0.839 . . . . 1.79 108.734 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 23.6 tttm -58.77 -65.17 0.7 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.608 -1.627 . . . . 5.31 106.608 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.419 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 37.0 mt -45.6 -44.69 13.22 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.935 -1.135 . . . . 0.97 107.935 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.0 t -54.44 -43.42 71.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.419 -1.264 . . . . 0.99 109.809 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 18.3 t30 -78.39 -2.09 36.57 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.999 -0.68 . . . . 2.12 110.241 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' CD ' ' HZ3' ' A' ' 23' ' ' LYS . 77.2 mm-40 -89.7 -50.35 6.12 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.197 -0.601 . . . . 3.14 112.411 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.478 HH21 ' CB ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -137.81 155.91 48.51 Favored 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 118.679 -1.208 . . . . 4.1 113.986 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.05 31.03 0.08 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.029 -0.987 . . . . 4.23 111.825 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -125.52 -24.95 3.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.595 -0.73 . . . . 3.26 109.261 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 25' ' ' SER . 15.5 t80 -101.58 122.48 43.93 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 114.468 1.285 . . . . 1.13 114.468 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.446 ' HB3' ' NE2' ' A' ' 2' ' ' GLN . 11.0 tp-100 -133.64 159.51 40.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.646 -1.983 . . . . 6.03 105.646 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 3' ' ' THR . 15.6 p90 -141.8 167.37 22.31 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.266 -0.974 . . . . 1.02 108.851 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.3 152.24 31.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 124.023 0.827 . . . . 4.45 109.511 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.62 124.49 49.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.914 -1.143 . . . . 1.63 107.914 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.87 152.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.249 -0.98 . . . . 1.55 110.435 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -102.82 142.08 34.56 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.664 1.221 . . . . 3.48 111.133 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 38' ' ' ILE . 15.4 pt -66.45 -32.96 60.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 113.084 -1.871 . . . . 1.18 111.665 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -10.72 44.17 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.403 -0.919 . . . . 6.07 111.29 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.29 14.99 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.468 -0.938 . . . . 2.23 108.468 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.33 -43.53 13.62 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.61 -0.836 . . . . 3.78 110.651 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.47 49.0 0.57 Allowed Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.318 -1.113 . . . . 2.18 110.318 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.2 mt -106.48 135.14 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.052 -1.462 . . . . 1.65 107.052 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.504 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 4.9 p -108.09 171.53 7.35 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.59 -1.244 . . . . 2.23 113.111 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -17.24 62.74 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.194 -0.912 . . . . 3.78 109.586 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 16.2 mp0 -94.57 -50.02 5.38 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.487 -1.301 . . . . 3.7 107.487 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.504 ' HB3' ' H ' ' A' ' 44' ' ' THR . 53.8 t0 -55.75 -50.9 69.14 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 108.3 -1.0 . . . . 2.89 108.3 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.06 -49.5 68.86 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.345 -0.983 . . . . 1.56 108.345 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.4 tt0 -47.07 -52.04 16.12 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.51 -0.876 . . . . 3.59 108.969 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -62.31 -48.61 79.1 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.99 -1.004 . . . . 6.64 112.008 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -52.15 -44.25 64.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.642 0.589 . . . . 2.5 110.54 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.468 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -88.84 -57.25 2.97 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.963 -1.095 . . . . 1.17 109.339 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.1 -67.38 0.47 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.466 -1.854 . . . . 3.2 108.466 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 22.8 mmtm -143.84 55.64 3.73 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.336 0.865 . . . . 8.95 113.336 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.468 ' CD ' ' HB3' ' A' ' 52' ' ' ALA . 10.2 Cg_endo -91.26 159.06 3.77 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.703 1.602 . . . . 6.87 109.087 137.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.18 -61.46 2.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.056 -0.658 . . . . 5.36 109.724 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -128.67 33.05 4.71 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.335 -0.987 . . . . 6.7 108.335 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.9 p -89.67 69.63 7.75 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.954 -0.698 . . . . 4.9 110.139 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -114.37 140.43 25.11 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.26 -0.882 . . . . 2.99 110.28 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 5.3 Cg_exo -72.5 155.09 99.03 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.615 -1.411 . . . . 3.62 112.598 -0.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.592 ' CG ' ' NE2' ' A' ' 68' ' ' HIS . 1.7 tp-100 -121.45 165.84 15.01 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.426 -1.324 . . . . 4.47 107.426 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.47 HD11 ' HB1' ' A' ' 17' ' ' ALA . 34.4 mt -121.38 145.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.296 -0.962 . . . . 1.54 112.977 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 68' ' ' HIS . 40.5 m-85 -127.21 152.63 47.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.589 -2.096 . . . . 1.05 106.823 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 66' ' ' GLN . 55.9 t -125.38 126.17 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.95 -1.5 . . . . 1.12 106.95 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 53.55 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.076 0.86 . . . . 2.51 109.304 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 64' ' ' VAL . 6.3 mm-40 -139.55 10.53 2.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.866 0.691 . . . . 5.79 112.866 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' A' ' 67' ' ' GLN . 22.1 mm-40 -118.17 179.91 3.96 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.439 -0.504 . . . . 6.71 111.086 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 61' ' ' GLN . 29.5 t-80 -117.48 143.67 45.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.961 0.788 . . . . 1.57 109.467 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -115.63 -39.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.793 -1.163 . . . . 0.95 111.141 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.67 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.852 -2.099 . . . . 1.36 107.852 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.28 -72.76 0.81 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.427 -1.368 . . . . 2.89 110.646 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 10.5 t80 -136.03 -50.61 0.7 Allowed 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 119.964 -0.694 . . . . 1.54 109.77 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.01 61.69 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.678 1.228 . . . . 1.58 108.823 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -57.26 12.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 111.929 -2.396 . . . . 2.58 109.012 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -47.04 -52.33 15.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.643 -0.823 . . . . 0.92 109.997 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.13 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.816 -1.154 . . . . 0.84 109.099 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.69 -53.52 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.975 -1.09 . . . . 0.9 109.797 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -53.92 -51.34 64.06 Favored 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.285 0.564 . . . . 0.68 110.355 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.5 t -48.38 -49.44 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.987 -1.006 . . . . 0.75 111.473 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -44.13 -30.18 0.73 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.891 1.441 . . . . 2.01 114.891 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 82' ' ' ASN . 13.9 pt-20 -112.48 -35.23 5.62 Favored 'General case' 0 N--CA 1.506 2.363 0 C-N-CA 119.537 -0.865 . . . . 4.95 113.219 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.48 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 16.1 m120 -82.01 -23.84 35.75 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.037 -1.065 . . . . 1.34 109.579 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.471 HD22 ' C ' ' A' ' 82' ' ' ASN . 2.2 mm? -113.09 -41.19 3.77 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.631 -0.713 . . . . 1.75 109.67 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 1.3 t0 33.75 48.18 0.2 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 125.5 1.75 . . . . 3.92 111.713 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.423 ' C ' HH22 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 116.823 -1.56 . . . . 6.91 107.734 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 32.0 tpp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.805 . . . . 2.95 108.825 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.68 110.65 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.731 0.777 . . . . 5.12 109.45 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.0 m -92.81 105.96 18.01 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.378 -1.712 . . . . 1.21 106.378 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 19.9 t -105.29 138.72 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.438 -0.905 . . . . 1.1 110.811 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.95 103.67 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.779 1.299 . . . . 1.18 108.337 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -85.65 90.14 7.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.509 -1.293 . . . . 1.55 107.509 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.459 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -124.48 145.06 15.67 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.254 -1.938 . . . . 1.66 108.254 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 139.82 49.41 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.644 -1.222 . . . . 5.06 110.205 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 10' ' ' GLY . 3.4 m 61.34 55.48 2.89 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.946 -1.024 . . . . 5.8 108.902 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' SER . . . -3.15 83.83 0.0 OUTLIER Glycine 0 N--CA 1.511 3.635 0 O-C-N 124.782 1.301 . . . . 3.77 114.872 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.4 m -112.74 157.13 41.32 Favored Pre-proline 0 N--CA 1.498 1.948 0 C-N-CA 119.577 -0.849 . . . . 4.2 109.79 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.0 -13.82 0.24 Allowed 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.922 2.414 . . . . 2.74 114.056 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -73.11 -14.1 61.32 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.688 -0.805 . . . . 4.89 111.889 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.555 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.4 m -107.13 -29.23 9.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.24 -1.022 . . . . 1.97 108.24 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.1 t -44.24 -63.65 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 114.506 1.299 . . . . 2.11 114.506 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -52.04 -44.39 64.21 Favored 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 118.044 -1.462 . . . . 3.84 111.808 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.9 63.39 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.742 -1.207 . . . . 1.04 107.742 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 5.1 ttpp -47.09 -55.89 7.54 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.327 -0.851 . . . . 1.48 109.256 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.439 ' CG ' ' NH2' ' A' ' 16' ' ' ARG . 5.8 t70 -52.8 -58.35 7.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 123.683 0.614 . . . . 3.21 110.013 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -50.92 -55.41 17.28 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.545 -0.862 . . . . 0.91 111.126 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.15 83.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.411 -0.915 . . . . 0.71 108.68 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.3 tt0 -59.52 -46.37 89.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.252 -0.885 . . . . 1.97 110.086 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.585 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -52.54 -57.16 10.82 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.979 -1.089 . . . . 4.28 108.117 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 42.6 mt -48.49 -43.66 35.18 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 1.17 107.601 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.9 t -58.53 -46.25 87.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.192 -1.367 . . . . 1.06 110.58 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -91.96 41.51 1.07 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.807 -1.553 . . . . 2.07 106.807 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.585 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.9 tp10 -128.29 -66.06 0.87 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.709 -2.042 . . . . 3.39 106.483 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.47 ' NH2' ' HB2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -122.45 153.46 39.08 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 106.341 -1.725 . . . . 4.35 106.341 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.07 32.3 1.52 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 118.367 -1.333 . . . . 5.51 111.933 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -113.64 -23.23 9.85 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.959 -1.497 . . . . 3.21 106.959 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 25' ' ' SER . 28.6 t80 -103.04 118.23 36.36 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.584 -1.189 . . . . 1.0 109.342 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -130.28 142.26 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.381 -1.34 . . . . 4.13 107.381 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -117.67 159.86 22.25 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 118.479 -1.288 . . . . 1.32 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.61 142.6 37.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.275 0.985 . . . . 4.58 109.255 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 35' ' ' TYR . 10.0 t80 -106.34 135.4 47.9 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.542 -2.021 . . . . 1.44 105.542 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.97 156.91 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.296 -0.961 . . . . 2.62 109.215 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.97 160.1 24.23 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.153 0.501 . . . . 2.8 109.796 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 pt -75.79 -32.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.998 -1.081 . . . . 1.82 111.439 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -35.87 55.16 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.356 -1.338 . . . . 5.64 108.494 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.56 -53.26 18.97 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.307 -0.86 . . . . 1.92 109.196 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.35 -46.38 10.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.042 0.839 . . . . 3.74 109.942 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.08 52.01 0.58 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 108.948 -1.661 . . . . 1.5 108.948 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.82 160.76 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 115.047 -0.577 . . . . 1.56 110.885 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -119.68 -170.82 2.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.787 -1.19 . . . . 2.08 107.787 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -90.86 -24.17 20.33 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 118.0 -1.48 . . . . 6.45 109.339 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.662 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 3.0 mp0 -72.87 -47.56 44.97 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.126 -1.435 . . . . 3.22 107.126 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.58 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 30.3 t70 -57.38 -39.2 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.071 0.939 . . . . 2.8 108.619 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.32 -46.03 78.3 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.49 -1.232 . . . . 1.39 107.714 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -46.21 -48.98 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.281 -1.377 . . . . 3.77 107.281 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.97 -59.13 5.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.152 -0.931 . . . . 4.41 110.62 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.58 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 17.3 mtmm -66.83 -5.41 12.21 Favored 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 120.338 -0.545 . . . . 2.75 112.457 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' CB ' HE22 ' A' ' 61' ' ' GLN . . . -105.3 -33.51 8.18 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.727 -0.67 . . . . 1.03 111.769 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.96 31.63 2.88 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.712 -1.755 . . . . 3.39 108.712 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.533 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 50.7 tttm -144.62 121.28 6.28 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.91 -1.144 . . . . 6.98 107.91 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -19.8 -131.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 124.472 3.448 . . . . 4.32 114.641 -143.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.79 -54.18 7.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 113.862 -1.517 . . . . 5.25 107.719 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 50.23 -160.36 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.772 -0.649 . . . . 8.22 112.099 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -139.59 -151.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.494 -0.882 . . . . 3.99 109.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.08 151.72 42.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.001 -0.74 . . . . 1.76 109.001 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -93.22 167.25 22.24 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 O-C-N 123.236 1.124 . . . . 1.92 111.135 2.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.542 HE22 ' CB ' ' A' ' 52' ' ' ALA . 25.8 mt-30 -116.84 131.12 57.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.181 -1.415 . . . . 2.58 107.181 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 75' ' ' PHE . 94.9 mt -104.73 144.96 13.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 118.989 -1.084 . . . . 1.27 109.943 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -135.69 148.57 48.96 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 113.373 -1.74 . . . . 0.99 108.816 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 66' ' ' GLN . 68.6 t -115.1 92.99 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 104.651 -2.352 . . . . 0.93 104.651 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 1' ' ' MET . 5.3 m-20 66.82 -74.5 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.32 1.013 . . . . 2.58 109.656 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 64' ' ' VAL . 63.4 mt-30 -133.8 -15.59 2.35 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.808 -1.087 . . . . 3.43 110.999 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.408 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 71.6 mt-30 -75.34 128.19 34.83 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.425 -0.954 . . . . 4.17 108.425 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.533 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 10.9 t-160 -90.36 136.56 32.98 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.081 -1.822 . . . . 1.03 106.081 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 75' ' ' PHE . 16.8 mm -108.5 -50.27 7.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.665 -0.814 . . . . 1.02 109.413 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.55 -122.76 5.26 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 118.94 -1.6 . . . . 1.53 111.85 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.97 -173.66 39.27 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.085 -1.055 . . . . 1.16 111.67 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 29.6 t80 -60.07 -51.19 70.71 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.758 -0.777 . . . . 1.66 111.354 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -43.98 -48.53 8.68 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.736 1.255 . . . . 1.57 108.91 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -58.69 -57.49 12.77 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.051 -2.34 . . . . 2.78 108.616 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HA ' HG21 ' A' ' 69' ' ' ILE . 7.6 t80 -48.7 -54.19 15.84 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.009 -0.996 . . . . 1.08 110.864 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.02 -53.01 56.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.69 -1.226 . . . . 0.84 107.69 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.07 -59.21 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.283 -0.967 . . . . 1.16 109.835 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.487 ' CD1' HD12 ' A' ' 69' ' ' ILE . 62.9 t90 -48.65 -52.87 21.0 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 119.852 -0.739 . . . . 1.44 110.964 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.423 ' CG2' ' CE1' ' A' ' 75' ' ' PHE . 43.0 t -54.49 -43.81 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.779 -1.168 . . . . 1.04 109.031 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -78.39 11.1 2.59 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.733 -0.667 . . . . 3.0 112.793 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.88 -36.28 2.4 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 120.505 -0.478 . . . . 4.68 110.819 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -96.93 -29.52 13.64 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.366 -0.834 . . . . 1.85 112.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.1 mt -119.58 26.13 9.58 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.071 -1.052 . . . . 2.15 111.586 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.12 41.56 1.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.056 -1.057 . . . . 4.42 110.252 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 116.04 -1.933 . . . . 5.68 109.172 -179.91 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 122.503 1.144 . . . . 3.03 108.356 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -114.6 158.83 21.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.455 -1.313 . . . . 5.28 107.455 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.622 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 5.5 m -107.15 142.14 37.31 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.296 -1.001 . . . . 1.68 108.296 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.441 ' C ' HD12 ' A' ' 5' ' ' ILE . 3.2 t -129.04 117.57 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.881 -1.526 . . . . 1.11 106.881 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.4 mp -107.35 131.72 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.913 -1.143 . . . . 1.08 107.913 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.72 108.42 17.86 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 106.506 -1.664 . . . . 2.18 106.506 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.8 -171.11 12.75 Favored Glycine 0 N--CA 1.503 3.128 0 C-N-CA 118.832 -1.652 . . . . 1.77 112.514 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.87 147.25 37.39 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 114.611 -0.795 . . . . 5.23 108.875 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -53.04 130.54 34.24 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 120.067 -0.653 . . . . 5.77 112.389 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 155.26 25.32 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.618 -0.801 . . . . 3.18 111.394 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.5 m 74.56 108.51 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.951 1.03 . . . . 3.64 111.767 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.61 59.43 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.799 1.666 . . . . 4.78 111.255 162.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -115.18 -69.84 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.254 -0.885 . . . . 4.76 108.767 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -52.4 -41.69 63.4 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.04 -1.467 . . . . 2.61 107.04 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -43.3 -42.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.833 -1.531 . . . . 2.93 110.113 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.22 -33.74 1.65 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 123.508 0.505 . . . . 4.77 112.225 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.476 ' HB3' HG12 ' A' ' 5' ' ' ILE . . . -67.5 -44.35 78.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.446 -0.946 . . . . 1.09 108.446 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HG3' ' CD1' ' A' ' 33' ' ' TYR . 9.4 ttpp -52.99 -49.58 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.457 -1.683 . . . . 2.27 106.457 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' LEU . 65.7 m-20 -55.85 -60.1 3.93 Favored 'General case' 0 C--O 1.183 -2.414 0 CA-C-N 113.317 -1.765 . . . . 3.95 110.305 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' ASP . 31.5 tp -43.8 -61.25 1.49 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.485 -1.286 . . . . 0.96 109.323 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.47 67.27 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.352 -0.84 . . . . 1.19 111.277 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 40.1 tt0 -65.17 -56.07 14.99 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.955 0.883 . . . . 2.02 111.083 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.557 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -50.8 -43.38 58.73 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.448 -1.315 . . . . 3.9 107.448 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -66.73 -44.17 82.26 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.289 -1.004 . . . . 1.72 108.289 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 27' ' ' GLU . 28.9 t -50.07 -48.75 52.89 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.906 -1.043 . . . . 2.09 108.699 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -83.72 38.64 0.64 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.878 1.323 . . . . 2.01 108.782 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 tt0 -137.61 -50.3 0.61 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 113.164 -1.835 . . . . 3.16 109.117 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -104.03 -32.71 9.08 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.05 -0.977 . . . . 3.67 111.371 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 78.49 8.62 2.15 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.193 0.933 . . . . 4.76 111.026 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.51 7.58 17.51 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.496 -0.882 . . . . 3.93 112.443 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -124.54 142.37 51.39 Favored 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 119.717 -0.793 . . . . 1.99 110.798 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -126.49 170.98 11.45 Favored 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 120.428 -0.509 . . . . 4.39 111.109 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.622 ' HA ' ' H ' ' A' ' 3' ' ' THR . 18.7 p90 -142.84 169.33 17.77 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.726 0.774 . . . . 2.18 112.694 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 3' ' ' THR . 43.7 mm-40 -148.31 128.31 13.59 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 113.829 -1.532 . . . . 4.03 108.085 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -113.63 111.2 21.46 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.083 -1.451 . . . . 1.3 107.083 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.8 157.77 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.935 -0.706 . . . . 1.65 110.167 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.28 139.08 43.5 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 105.049 -2.204 . . . . 2.96 105.049 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.4 pt -50.19 -33.47 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.935 -1.106 . . . . 1.22 113.666 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -50.08 25.89 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 117.67 -1.612 . . . . 6.71 110.379 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -31.08 -52.67 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.256 0.973 . . . . 1.95 111.672 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.23 -43.13 18.01 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.62 1.2 . . . . 4.35 111.069 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.72 51.56 0.45 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.432 -2.267 . . . . 1.58 107.432 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 75.6 mt -108.16 141.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.562 -0.819 . . . . 1.91 110.626 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.3 p -117.08 -89.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.855 -1.165 . . . . 3.31 107.855 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.569 ' HZ3' ' CD ' ' A' ' 57' ' ' GLU . 33.5 tttp -140.87 -48.07 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.37 -0.974 . . . . 4.25 108.37 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 10.3 mp0 -47.9 -55.64 9.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.02 0.825 . . . . 2.86 109.711 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -53.08 -60.86 2.76 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.559 -0.746 . . . . 2.71 109.533 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.58 -38.44 59.98 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.348 -0.941 . . . . 1.44 110.045 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.96 -53.33 58.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.209 -1.404 . . . . 4.36 107.209 178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.07 -47.98 79.68 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.25 -1.795 . . . . 4.09 110.476 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -56.66 -50.5 71.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.377 -0.829 . . . . 2.74 110.182 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -53.74 46.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.152 -0.931 . . . . 1.37 111.676 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.19 -15.59 43.08 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.519 -1.432 . . . . 2.56 109.519 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.8 pttp -123.96 -178.91 0.72 Allowed Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.955 -0.698 . . . . 6.07 110.133 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 49.2 Cg_exo -56.6 142.56 90.49 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.235 1.29 . . . . 4.36 112.077 165.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -153.84 102.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 4.95 107.025 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.569 ' CD ' ' HZ3' ' A' ' 45' ' ' LYS . 15.6 mm-40 -111.77 -15.78 13.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.703 -0.799 . . . . 7.12 110.705 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 59' ' ' VAL . 24.0 m -121.69 172.29 8.24 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.979 -0.688 . . . . 4.65 110.265 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 58' ' ' THR . 27.3 m -105.22 169.38 7.14 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 109.278 -0.638 . . . . 2.6 109.278 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -99.97 176.6 6.73 Favored 'Cis proline' 0 N--CA 1.488 1.192 0 O-C-N 122.815 0.903 . . . . 1.99 110.544 -8.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 99.5 mm-40 -125.35 140.78 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.075 -1.05 . . . . 3.42 108.693 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -126.7 145.17 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.874 -0.73 . . . . 1.12 110.444 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.08 162.51 31.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.538 -1.21 . . . . 1.37 109.461 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.533 HG11 ' CH2' ' A' ' 78' ' ' TRP . 49.6 t -141.45 119.19 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 124.526 1.141 . . . . 1.17 108.979 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 50.81 -102.73 0.12 Allowed 'General case' 0 N--CA 1.514 2.742 0 CA-C-N 119.774 1.17 . . . . 2.35 111.008 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -123.82 31.88 5.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.618 -1.174 . . . . 4.48 109.43 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -122.59 164.49 18.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.568 -0.742 . . . . 4.09 110.361 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -122.54 125.6 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.155 -1.054 . . . . 1.25 108.155 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.65 -54.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.951 -1.5 . . . . 1.57 106.951 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 112.23 -99.23 1.04 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.471 -1.347 . . . . 1.52 110.572 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.56 163.63 13.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.414 -1.374 . . . . 1.24 110.707 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.41 -54.29 33.99 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.074 -0.65 . . . . 1.75 111.759 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -34.58 -64.69 0.24 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.663 0.986 . . . . 1.69 113.663 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.94 -38.0 75.15 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.925 -0.71 . . . . 4.54 111.649 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -43.49 -41.54 4.44 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.794 -0.817 . . . . 1.18 108.794 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.96 -52.03 64.3 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.497 -0.774 . . . . 1.3 110.773 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' LYS . . . -67.22 -53.8 26.83 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.342 -0.844 . . . . 1.36 109.172 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.533 ' CH2' HG11 ' A' ' 64' ' ' VAL . 84.3 t90 -42.23 -55.54 3.26 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.16 -1.052 . . . . 1.03 108.16 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -46.04 -50.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 114.984 -1.007 . . . . 1.4 109.94 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' NZ ' ' C ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -42.56 -57.45 2.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 124.568 1.168 . . . . 3.63 113.295 -178.184 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -106.01 25.43 10.95 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.351 -1.34 . . . . 3.51 112.365 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 78' ' ' TRP . 12.3 m-80 -119.33 -36.43 3.37 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.947 -1.131 . . . . 2.27 107.947 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.44 11.45 17.2 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.238 -1.764 . . . . 2.32 106.238 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 p30 31.58 70.22 0.09 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 125.338 1.649 . . . . 7.99 112.484 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.484 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-N 113.675 -1.602 . . . . 6.28 110.138 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.5 mpp? . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.19 -1.041 . . . . 2.6 108.19 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 65' ' ' ASP . 38.8 mt-30 -100.24 102.72 14.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.516 -0.92 . . . . 4.32 108.516 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.4 m -84.32 100.27 11.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.264 -1.754 . . . . 1.13 106.264 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.32 127.44 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.313 -1.312 . . . . 1.08 110.206 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mm -96.38 119.16 44.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 104.568 -2.382 . . . . 1.29 104.568 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.523 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.4 m-85 -104.71 109.29 21.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.318 -1.364 . . . . 1.43 107.318 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.61 118.9 0.46 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 116.208 -2.901 . . . . 2.28 112.708 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.455 ' HB3' ' OD1' ' A' ' 37' ' ' ASP . 4.8 ptm180 -86.11 55.74 3.67 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.413 -1.393 . . . . 5.05 111.902 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.0 p -90.47 -54.05 4.17 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 117.434 -1.706 . . . . 6.3 109.144 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.68 -52.73 4.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 106.4 -2.68 . . . . 4.06 106.4 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' TYR . 8.3 m -78.05 156.78 79.31 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.758 -1.571 . . . . 4.87 106.758 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.85 64.26 0.15 Allowed 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 123.55 2.834 . . . . 2.95 115.135 -147.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' CYS . 21.2 m-30 -121.69 -70.24 0.79 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.029 -1.841 . . . . 5.8 106.029 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.3 m -65.06 -32.46 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.337 -1.745 . . . . 1.99 106.613 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.4 t -44.13 -45.08 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 114.895 -1.048 . . . . 1.34 109.907 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.478 HH12 ' CG ' ' A' ' 19' ' ' ASP . 2.5 tpt180 -68.91 -47.09 66.65 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.852 -0.739 . . . . 4.13 110.239 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.67 -46.31 70.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.121 -1.437 . . . . 0.73 107.121 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.1 tmtt? -54.14 -60.53 3.21 Favored 'General case' 0 C--O 1.203 -1.37 0 CA-C-N 114.824 -1.08 . . . . 2.03 108.402 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.5 t70 -48.53 -54.64 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.817 -0.753 . . . . 2.77 110.442 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.9 tp -54.85 -57.18 12.61 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.308 -0.957 . . . . 1.48 109.954 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.24 -42.95 52.75 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.949 -1.023 . . . . 0.74 109.906 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 36.6 tt0 -65.62 -51.74 57.33 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.544 -0.753 . . . . 2.16 109.07 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 23.6 ttpp -44.55 -54.21 6.28 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.457 -1.312 . . . . 5.7 107.457 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 50.9 mt -60.67 -36.38 78.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.58 1.175 . . . . 1.18 109.707 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -59.32 -28.46 66.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.057 -0.974 . . . . 1.09 109.532 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -89.19 29.37 1.08 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.548 0.689 . . . . 2.72 109.149 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.426 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 73.3 mt-10 -135.07 -65.96 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.184 -1.006 . . . . 3.29 112.621 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -104.42 149.38 25.46 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.976 -1.09 . . . . 4.65 108.585 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -53.26 57.44 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.852 1.797 . . . . 4.1 115.852 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 1' ' ' MET . 50.6 t0 -84.45 44.82 1.07 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.657 -1.617 . . . . 5.84 111.683 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 83' ' ' LEU . 16.2 t80 -126.04 84.63 2.29 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 105.997 -1.853 . . . . 1.07 105.997 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -109.51 143.75 38.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.866 -1.531 . . . . 3.65 106.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -123.56 157.49 33.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.143 -1.423 . . . . 1.18 110.371 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -145.33 150.12 36.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.788 -1.097 . . . . 4.13 108.62 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -110.77 127.15 55.25 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.198 -1.038 . . . . 2.16 108.198 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.523 HG11 ' CE1' ' A' ' 6' ' ' PHE . 2.3 p -131.02 151.33 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 118.819 -1.153 . . . . 2.31 109.826 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -113.66 135.4 53.97 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.345 -1.354 . . . . 3.0 107.345 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 37.7 pt -61.29 -27.18 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.631 -1.228 . . . . 1.9 110.586 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -74.38 -24.87 59.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.894 -1.122 . . . . 5.76 110.996 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.1 -40.4 15.74 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 1.99 110.124 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -77.36 -40.6 43.37 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.403 -1.272 . . . . 4.25 111.362 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.63 51.02 0.72 Allowed Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.188 -1.482 . . . . 2.13 110.038 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 8.2 mt -112.32 135.2 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.456 -0.898 . . . . 2.32 109.304 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 47.1 p -106.8 173.76 6.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.242 -0.583 . . . . 1.88 110.014 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -52.52 -51.58 58.86 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.219 -1.4 . . . . 4.92 107.219 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.6 -60.66 3.12 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.77 -1.559 . . . . 3.77 110.45 178.015 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 44' ' ' THR . 33.3 t70 -51.92 -41.86 62.33 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.392 -0.923 . . . . 2.08 111.305 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.464 ' HG ' HG21 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -59.63 -57.91 10.9 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.577 -0.849 . . . . 1.91 109.356 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 33.8 tt0 -44.36 -52.3 7.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.962 -1.125 . . . . 3.28 107.962 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.58 -45.26 85.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.796 -1.093 . . . . 4.23 111.404 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -40.24 50.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.703 1.252 . . . . 2.73 110.924 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -90.65 -48.71 6.9 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.732 -1.122 . . . . 1.33 109.946 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.411 ' C ' ' HG3' ' A' ' 54' ' ' LYS . . . 135.23 -68.6 0.53 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 107.373 -2.291 . . . . 3.14 107.373 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 53' ' ' GLY . 51.9 mttp -155.22 56.24 1.35 Allowed Pre-proline 0 N--CA 1.51 2.544 0 N-CA-C 113.252 0.834 . . . . 10.25 113.252 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.458 ' CD ' ' HB3' ' A' ' 52' ' ' ALA . 91.3 Cg_endo -98.66 42.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 121.758 1.639 . . . . 6.08 110.129 152.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t 36.48 -118.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.255 -1.338 . . . . 5.95 110.707 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -120.03 39.41 3.69 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.742 -0.383 . . . . 8.08 110.83 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.7 p -88.12 149.84 23.69 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.326 -1.349 . . . . 5.12 111.417 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.08 165.57 17.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 CA-C-N 115.075 -0.966 . . . . 2.74 108.757 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -78.81 171.96 63.17 Favored 'Cis proline' 0 N--CA 1.485 0.978 0 C-N-CA 123.636 -1.402 . . . . 2.09 110.354 -5.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.456 HE22 ' HG2' ' A' ' 55' ' ' PRO . 42.6 mt-30 -136.63 157.75 46.05 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.941 -1.103 . . . . 2.91 109.944 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.4 mm -114.09 139.76 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 120.303 -0.559 . . . . 1.5 110.527 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.6 145.71 48.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.726 0.641 . . . . 1.1 109.781 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 72.2 t -124.57 95.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.761 -0.776 . . . . 0.9 109.951 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.435 ' HA ' ' HB2' ' A' ' 2' ' ' GLN . 0.6 OUTLIER 65.21 -74.41 0.05 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.639 -1.619 . . . . 3.27 110.942 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -133.84 -7.34 2.77 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.232 -0.895 . . . . 4.22 112.294 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.409 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 6.7 pt20 -104.82 165.09 11.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.955 -0.698 . . . . 4.17 110.556 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -105.96 143.79 33.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.191 -1.781 . . . . 1.04 106.191 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.522 HD12 ' CD1' ' A' ' 78' ' ' TRP . 23.4 mm -106.0 -37.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.621 -1.231 . . . . 1.09 109.65 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -132.86 7.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.09 -2.004 . . . . 1.2 108.09 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.66 -164.25 24.3 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.527 -1.429 . . . . 1.34 109.527 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 16' ' ' ARG . 44.0 t80 -61.34 -49.17 78.05 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.027 -1.069 . . . . 1.62 111.408 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.39 -52.38 13.07 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 1.73 109.991 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.23 -53.64 54.28 Favored 'General case' 0 C--O 1.197 -1.695 0 CA-C-N 113.461 -1.7 . . . . 2.12 109.045 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -48.45 -48.45 37.57 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.821 -0.627 . . . . 0.98 110.74 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.36 69.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.18 -1.008 . . . . 0.88 108.485 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.4 -62.67 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.919 -1.112 . . . . 0.94 110.126 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.522 ' CD1' HD12 ' A' ' 69' ' ' ILE . 67.2 t90 -42.69 -51.42 5.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.698 -0.853 . . . . 0.87 108.698 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.433 ' CG1' HD11 ' A' ' 24' ' ' LEU . 6.6 t -53.65 -59.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.906 -1.043 . . . . 0.81 109.482 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 18.4 tptt -54.35 -16.73 2.38 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.252 -0.886 . . . . 3.36 113.226 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -107.54 -44.61 4.24 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.29 -0.964 . . . . 3.67 113.384 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' C ' HD22 ' A' ' 83' ' ' LEU . 14.1 m-80 -82.7 -25.16 33.22 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.846 -0.741 . . . . 1.5 110.104 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.551 HD11 ' CD1' ' A' ' 31' ' ' PHE . 2.6 mm? -109.08 -41.36 4.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.255 -0.646 . . . . 2.18 109.255 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.78 80.7 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.862 -1.517 . . . . 4.02 108.652 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-N 112.118 -2.31 . . . . 7.96 110.367 -179.456 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 107.851 -1.166 . . . . 3.04 107.851 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -115.81 110.27 18.82 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.32 -0.552 . . . . 4.53 110.567 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.5 m -96.5 150.0 21.11 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.861 -0.736 . . . . 1.0 110.611 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.509 ' C ' HD12 ' A' ' 5' ' ' ILE . 17.2 t -133.77 139.44 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 115.791 -0.641 . . . . 0.92 110.788 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 4' ' ' VAL . 1.2 mp -113.73 126.48 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.127 -1.805 . . . . 1.06 106.127 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 63' ' ' PHE . 22.7 m-85 -108.83 109.3 20.38 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.698 -1.223 . . . . 1.69 107.698 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.574 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -134.02 -169.31 12.02 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.788 -1.672 . . . . 1.33 112.134 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.0 tmm_? -102.03 64.24 0.94 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.891 -1.522 . . . . 5.83 106.891 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.455 ' OG ' ' NH2' ' A' ' 39' ' ' ARG . 4.5 m 58.31 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.495 -1.229 . . . . 5.38 111.152 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -123.1 84.27 0.37 Allowed Glycine 0 N--CA 1.499 2.88 0 N-CA-C 110.53 -1.028 . . . . 2.98 110.53 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' TYR . 41.3 t -128.93 109.98 18.44 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.455 -0.572 . . . . 4.92 109.455 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -40.55 -27.57 0.28 Allowed 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 124.534 3.489 . . . . 3.93 115.817 -153.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' CYS . 98.9 m-85 -72.5 -37.4 68.4 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.241 -0.984 . . . . 4.4 110.701 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.574 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.2 m -61.01 -39.91 91.53 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.401 -1.703 . . . . 2.0 106.401 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.69 -38.46 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.287 -0.965 . . . . 1.29 109.078 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.536 HH12 ' CG ' ' A' ' 19' ' ' ASP . 9.6 mmm180 -76.81 -51.01 12.13 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.683 -0.689 . . . . 4.07 110.978 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.419 ' HB1' HG13 ' A' ' 5' ' ' ILE . . . -52.32 -42.78 64.11 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.738 -1.579 . . . . 0.83 106.738 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -58.32 -57.87 11.01 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 113.66 -1.609 . . . . 1.75 107.731 178.153 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.536 ' CG ' HH12 ' A' ' 16' ' ' ARG . 2.2 t70 -51.56 -57.27 9.58 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.428 -1.309 . . . . 3.13 109.986 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 79' ' ' VAL . 37.1 tp -47.16 -50.71 19.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.131 -0.692 . . . . 1.11 109.131 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 33' ' ' TYR . . . -60.1 -45.43 92.99 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.612 -0.835 . . . . 1.06 110.496 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 25' ' ' SER . 18.0 tt0 -65.04 -49.8 68.72 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.464 0.65 . . . . 2.31 110.767 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -56.95 -51.85 67.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.063 -1.458 . . . . 4.19 107.063 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.4 mt -52.02 -51.35 57.97 Favored 'General case' 0 C--O 1.199 -1.566 0 N-CA-C 106.441 -1.689 . . . . 1.18 106.441 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 4.6 t -43.32 -24.53 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.57 -0.741 . . . . 1.18 112.037 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -100.07 -39.5 8.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.214 0.321 . . . . 2.16 111.005 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.54 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 28.2 mt-10 -72.96 -26.74 61.47 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.327 0.584 . . . . 3.31 110.657 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HE ' ' C ' ' A' ' 85' ' ' ALA . 2.1 mmp_? -101.44 175.05 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.352 -0.84 . . . . 4.06 110.888 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -107.74 -41.09 5.1 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 115.225 -0.898 . . . . 5.56 110.511 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 30' ' ' ASP . 8.3 t70 -109.63 53.46 0.69 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 122.438 1.113 . . . . 4.99 109.283 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 25' ' ' SER . 8.1 t80 -131.71 110.42 10.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.256 -0.978 . . . . 1.08 110.055 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -124.27 152.37 43.1 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.988 -1.856 . . . . 3.37 105.988 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.53 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 7.1 p90 -140.46 154.57 46.68 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 117.884 -1.527 . . . . 1.16 111.153 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.51 154.72 47.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.692 -1.225 . . . . 4.04 107.692 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.61 139.73 49.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.926 -1.509 . . . . 1.34 106.926 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.32 139.03 51.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 124.24 0.963 . . . . 2.12 109.955 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -105.95 116.68 32.35 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.694 -1.595 . . . . 2.53 106.694 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.8 pt -54.88 -20.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 118.788 -1.165 . . . . 1.17 111.299 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.455 ' NH2' ' OG ' ' A' ' 9' ' ' SER . 40.6 ttp-105 -86.13 -61.44 1.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.561 -0.855 . . . . 6.86 109.285 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.18 -43.48 0.22 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.093 0.871 . . . . 1.45 111.514 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -94.0 -44.75 7.9 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.582 -0.847 . . . . 3.11 112.04 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.51 54.31 0.65 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.212 -1.555 . . . . 1.98 109.212 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.91 127.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 107.497 -1.297 . . . . 2.24 107.497 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 p -119.85 166.22 13.57 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.197 -1.001 . . . . 3.17 110.697 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.617 ' CD ' ' H ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -41.69 -45.9 3.59 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.379 -0.828 . . . . 5.29 110.885 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 19.9 mp0 -60.51 -55.24 35.76 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.071 -0.651 . . . . 4.19 110.239 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 25.0 t70 -60.32 -39.86 88.53 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.598 -0.841 . . . . 2.92 110.689 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB3' HE22 ' A' ' 61' ' ' GLN . 59.0 mt -62.08 -48.73 78.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.124 -0.944 . . . . 1.61 109.128 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.76 -59.96 2.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.205 -0.907 . . . . 4.67 108.709 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -46.64 -40.84 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 125.029 1.456 . . . . 4.17 112.341 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 25.1 mtmm -94.46 -4.24 48.57 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.578 -1.192 . . . . 2.91 114.101 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -113.49 -38.37 4.37 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.799 -0.76 . . . . 1.1 112.724 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.46 43.98 66.69 Favored Glycine 0 N--CA 1.491 2.365 0 O-C-N 124.395 1.059 . . . . 3.36 113.151 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HD2' ' CE1' ' A' ' 68' ' ' HIS . 59.5 mttm -138.53 180.0 1.18 Allowed Pre-proline 0 N--CA 1.504 2.256 0 C-N-CA 119.296 -0.962 . . . . 7.55 110.345 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -33.46 82.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.111 2.54 . . . . 5.74 112.37 127.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 57' ' ' GLU . 27.6 m -101.66 -42.99 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 115.791 -0.64 . . . . 5.41 112.34 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.462 ' N ' HG23 ' A' ' 56' ' ' VAL . 2.4 tt0 61.37 -108.39 0.32 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.651 -0.87 . . . . 7.05 108.651 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 59' ' ' VAL . 53.5 p -129.92 -86.51 0.53 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.623 -1.231 . . . . 4.3 111.143 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.41 ' N ' ' OG1' ' A' ' 58' ' ' THR . 14.2 m -137.98 164.66 39.23 Favored Pre-proline 0 C--N 1.291 -1.966 0 N-CA-C 109.771 -0.455 . . . . 1.77 109.771 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -94.36 148.08 10.18 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 124.594 -1.002 . . . . 1.62 110.314 -9.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.422 HE22 ' HB3' ' A' ' 48' ' ' LEU . 67.6 mt-30 -111.23 142.78 42.98 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.984 -1.086 . . . . 2.55 108.282 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.1 mp -113.44 142.31 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.987 0.898 . . . . 1.64 110.02 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 6' ' ' PHE . 20.0 m-85 -121.21 136.3 55.0 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.354 -2.091 . . . . 1.36 105.354 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.618 HG11 ' CH2' ' A' ' 78' ' ' TRP . 5.8 t -115.05 106.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.817 -0.753 . . . . 1.33 109.114 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 66.91 -72.6 0.08 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.581 -0.736 . . . . 2.49 111.982 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 64' ' ' VAL . 8.7 mm-40 -136.74 -11.02 1.81 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 113.704 1.002 . . . . 3.88 113.704 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -117.01 161.6 19.13 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.749 -1.18 . . . . 5.96 114.003 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.542 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.0 t-160 -90.06 133.67 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.725 -1.213 . . . . 1.01 107.725 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.53 -39.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.541 -0.863 . . . . 0.87 110.235 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.82 -142.27 13.69 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.177 -1.569 . . . . 1.17 109.177 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.85 173.65 41.8 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.389 -1.484 . . . . 1.22 109.389 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 23.7 t80 -42.87 -45.99 5.13 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.301 -0.96 . . . . 1.8 111.209 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.4 -58.12 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.797 0.808 . . . . 1.8 110.054 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.2 -39.84 80.01 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.148 -1.387 . . . . 2.07 109.581 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.66 -56.83 17.16 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.897 -1.121 . . . . 1.28 109.384 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.26 -56.01 19.99 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.83 -0.748 . . . . 0.92 110.284 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.59 -54.5 43.34 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.432 -0.907 . . . . 1.04 109.43 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.618 ' CH2' HG11 ' A' ' 64' ' ' VAL . 89.3 t90 -46.74 -55.5 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.836 -0.746 . . . . 1.17 110.457 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.429 HG21 HD21 ' A' ' 20' ' ' LEU . 53.5 t -47.94 -55.5 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.847 -1.07 . . . . 0.8 111.218 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.72 -46.86 7.73 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.615 0.968 . . . . 2.03 113.615 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -103.96 34.42 3.03 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 118.956 -1.097 . . . . 4.4 112.512 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -141.05 -49.03 0.42 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.929 -0.767 . . . . 1.51 108.929 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 85' ' ' ALA . 29.8 mt -112.71 46.15 1.24 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.964 -1.017 . . . . 2.07 109.434 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -83.4 50.06 1.69 Allowed 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.092 -1.448 . . . . 3.7 107.092 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.468 ' C ' ' HE ' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 115.996 -1.954 . . . . 5.15 107.34 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 108.285 -1.006 . . . . 2.99 108.285 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -106.76 102.78 12.13 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.744 0.783 . . . . 4.59 111.761 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.3 m -94.22 129.77 40.71 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.348 -1.353 . . . . 0.92 107.348 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 43.3 t -119.67 134.71 62.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.034 -1.066 . . . . 1.05 110.318 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -107.55 121.51 60.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.789 -2.3 . . . . 1.23 104.789 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -114.99 91.13 3.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 102.977 -2.972 . . . . 1.84 102.977 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -128.05 -167.34 12.23 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 118.535 -1.793 . . . . 1.29 114.375 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.96 95.2 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.838 -1.181 . . . . 5.01 110.717 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.409 ' OG ' ' NH1' ' A' ' 8' ' ' ARG . 2.9 p -53.36 144.27 16.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.94 -1.133 . . . . 4.93 107.94 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.9 -36.0 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.082 -2.407 . . . . 2.74 107.082 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -97.78 133.71 23.13 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.205 -1.035 . . . . 4.31 108.205 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.77 51.27 0.89 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.455 2.103 . . . . 2.96 111.488 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.89 -64.33 1.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.048 -1.093 . . . . 4.33 108.048 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -54.98 -29.91 58.04 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 115.149 -0.932 . . . . 2.1 108.902 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.1 t -42.79 -44.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.367 -1.288 . . . . 1.38 109.914 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 4.4 mmp_? -63.44 -52.03 63.21 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.087 -1.045 . . . . 2.89 111.008 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' CB ' HD11 ' A' ' 62' ' ' ILE . . . -59.62 -45.06 93.05 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.468 -0.893 . . . . 0.99 110.572 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 7.3 ttpp -61.25 -52.12 66.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.172 -1.011 . . . . 2.05 108.851 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -53.65 -53.66 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.252 -0.579 . . . . 2.36 109.848 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 79' ' ' VAL . 14.8 tp -55.52 -65.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.344 -0.942 . . . . 1.21 109.038 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.55 -46.47 19.38 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.987 -0.685 . . . . 1.03 110.411 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.482 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 43.8 tt0 -58.77 -54.17 50.08 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.251 1.024 . . . . 2.14 111.38 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -54.49 -50.36 67.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 113.694 -1.594 . . . . 6.82 106.822 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -53.38 -50.81 64.33 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.261 -1.385 . . . . 1.11 107.261 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.501 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 7.6 t -43.78 -24.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.433 -0.803 . . . . 1.33 112.507 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.09 -31.29 8.34 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.439 -0.801 . . . . 2.22 110.864 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.52 -36.47 73.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.088 . . . . 3.85 108.061 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -119.03 117.31 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.477 0.656 . . . . 3.67 109.597 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -63.88 3.68 0.36 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.956 1.095 . . . . 3.8 113.956 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 1' ' ' MET . 11.4 p-10 -114.67 7.61 16.02 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.058 -0.719 . . . . 3.09 109.058 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 12.6 t80 -109.35 129.65 55.52 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.866 -0.734 . . . . 1.14 112.855 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -129.56 150.85 50.71 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.627 -1.62 . . . . 3.58 106.627 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 8.4 p90 -133.89 160.06 38.8 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.316 -1.354 . . . . 1.17 110.821 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -134.07 135.38 43.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.73 0.644 . . . . 4.39 110.342 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -108.08 109.84 21.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.003 -1.851 . . . . 1.75 106.003 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.24 141.4 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.379 -1.711 . . . . 1.55 106.379 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 9.0 t70 -110.17 155.05 22.47 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.074 -1.05 . . . . 2.78 110.844 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 pt -84.16 -34.87 10.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 117.993 -1.483 . . . . 1.46 112.435 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.508 ' HE ' ' N ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -98.24 -58.01 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.321 -1.752 . . . . 5.14 108.845 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -39.09 -39.91 0.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 124.198 0.936 . . . . 3.18 111.255 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.48 -36.38 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.071 -1.451 . . . . 4.64 110.862 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.23 69.77 0.61 Allowed Glycine 0 N--CA 1.5 2.948 0 C-N-CA 118.448 -1.834 . . . . 2.55 113.128 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 mm -115.04 157.18 15.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.148 -1.797 . . . . 2.43 106.148 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.7 p -107.39 137.14 45.98 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.69 -1.204 . . . . 3.0 110.454 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -55.04 -31.39 61.06 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.716 -1.216 . . . . 3.79 107.716 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 7.1 mp0 -59.42 -64.94 0.76 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.209 -0.663 . . . . 3.46 109.209 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 4.6 t70 -48.1 -49.45 31.82 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.069 0.938 . . . . 2.97 111.185 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.2 mt -61.8 -54.46 42.03 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.606 -1.179 . . . . 2.37 109.295 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -44.44 -46.12 9.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.837 -1.171 . . . . 3.61 107.837 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 8.5 tm0? -60.13 -58.89 6.58 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.781 -1.554 . . . . 4.31 110.974 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -17.89 63.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.141 1.534 . . . . 2.93 115.141 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.68 -38.28 13.19 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.736 -0.786 . . . . 1.36 111.143 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.481 ' C ' ' HG3' ' A' ' 54' ' ' LYS . . . 112.94 57.82 0.42 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.274 -1.93 . . . . 2.81 108.274 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HG3' ' C ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 37.2 76.03 0.49 Allowed Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 124.954 1.032 . . . . 6.94 111.651 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 1.8 Cg_endo -90.35 33.79 0.33 Allowed 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 122.821 2.348 . . . . 6.61 111.103 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.421 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.4 t 32.06 -102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 113.685 -1.598 . . . . 6.47 113.826 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 7.6 tp10 -125.04 46.11 2.41 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.579 -0.448 . . . . 8.01 110.216 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.0 p -119.44 124.36 46.32 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.285 1.217 . . . . 5.11 114.285 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 33.1 m -132.93 166.11 31.69 Favored Pre-proline 0 N--CA 1.504 2.238 0 N-CA-C 107.27 -1.381 . . . . 2.34 107.27 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 50.9 Cg_endo -79.61 170.72 66.53 Favored 'Cis proline' 0 N--CA 1.491 1.35 0 O-C-N 122.19 0.574 . . . . 1.65 110.886 -7.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.54 150.57 50.13 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.786 -0.766 . . . . 2.38 111.109 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.427 HD11 ' CB ' ' A' ' 17' ' ' ALA . 36.9 mm -119.69 141.45 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.039 -0.982 . . . . 1.88 110.295 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.406 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 23.7 m-85 -120.69 153.85 36.36 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.69 -1.141 . . . . 1.38 109.162 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 66' ' ' GLN . 85.9 t -129.83 100.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.06 -1.459 . . . . 1.0 107.06 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 1' ' ' MET . 23.8 m-20 54.93 -79.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 124.409 1.068 . . . . 2.58 112.721 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 64' ' ' VAL . 1.4 tm0? -120.53 -24.78 5.72 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.518 -1.219 . . . . 6.16 112.666 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -95.18 155.18 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.355 -0.938 . . . . 4.3 111.705 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -102.36 140.03 37.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 105.341 -2.096 . . . . 0.93 105.341 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.52 -42.3 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 118.11 -1.436 . . . . 0.92 110.793 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.0 -129.51 5.14 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.463 -1.455 . . . . 1.12 109.463 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.4 178.65 25.43 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.679 -1.248 . . . . 1.29 110.424 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 45.7 t80 -45.45 -36.03 4.15 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.311 -0.956 . . . . 1.63 111.422 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -58.94 -62.06 2.17 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.602 -0.839 . . . . 1.7 109.426 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.26 -39.99 64.3 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.895 -1.048 . . . . 2.21 109.109 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.82 -56.37 22.02 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.199 -1.0 . . . . 1.2 109.683 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.0 -51.12 64.95 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.86 -0.736 . . . . 0.84 110.054 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -53.81 54.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.833 -0.747 . . . . 0.8 109.465 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -48.05 -53.29 16.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.44 -0.948 . . . . 0.88 108.44 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 20' ' ' LEU . 25.2 t -50.9 -61.18 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 114.648 -1.16 . . . . 0.84 109.185 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.48 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.14 -51.94 7.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.739 0.649 . . . . 2.04 112.581 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.85 16.28 7.12 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.664 -1.214 . . . . 4.73 113.845 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -128.28 -43.98 1.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.61 -0.836 . . . . 2.15 110.393 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.07 36.51 2.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.867 -0.733 . . . . 2.41 110.722 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.48 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 2.3 t70 . . . . . 0 C--N 1.292 -1.922 0 N-CA-C 106.181 -1.785 . . . . 4.17 106.181 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.66 -0.867 . . . . 2.36 108.66 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -84.89 111.57 19.78 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.262 0.977 . . . . 4.74 109.583 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.9 m -104.12 123.39 47.18 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 0.88 109.208 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.406 ' C ' HD12 ' A' ' 5' ' ' ILE . 40.2 t -116.13 130.89 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.347 -0.941 . . . . 1.02 109.928 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -106.12 131.9 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.974 -1.862 . . . . 1.16 105.974 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -117.42 108.57 15.72 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 105.563 -2.014 . . . . 1.46 105.563 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.64 -160.07 8.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.505 -1.331 . . . . 1.47 110.381 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -113.62 -162.04 0.79 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.222 -0.991 . . . . 4.66 108.732 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -128.89 154.54 46.4 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.49 -1.232 . . . . 5.11 109.452 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 -44.83 1.37 Allowed Glycine 0 N--CA 1.5 2.908 0 C-N-CA 119.386 -1.388 . . . . 3.1 114.229 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.5 m -106.33 146.89 33.89 Favored Pre-proline 0 N--CA 1.498 1.936 0 C-N-CA 118.694 -1.202 . . . . 3.78 111.944 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.49 65.61 8.2 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.41 2.073 . . . . 3.0 111.276 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -112.92 -73.54 0.66 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.655 -1.239 . . . . 4.97 107.655 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.0 m -53.53 -25.15 15.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.356 -0.979 . . . . 2.09 108.356 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -41.65 -39.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 114.624 -1.171 . . . . 1.39 109.779 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.613 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 1.1 tpm_? -75.83 -50.24 15.71 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.15 -1.02 . . . . 3.5 110.255 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.69 54.17 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.758 -1.177 . . . . 1.03 108.321 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 14.6 ttpp -67.59 -58.38 4.8 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 107.448 -1.315 . . . . 2.11 107.448 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -45.04 -42.93 8.95 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.539 -0.864 . . . . 2.39 109.696 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.9 tp -62.62 -63.73 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.668 -1.151 . . . . 0.95 108.275 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.84 -45.9 15.29 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.444 0.64 . . . . 0.86 109.833 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 26.7 tt0 -64.57 -44.28 91.2 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.6 -1.182 . . . . 2.83 109.583 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -54.7 43.79 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.872 -1.529 . . . . 6.1 106.872 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.27 -45.53 68.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.761 -1.563 . . . . 1.11 107.691 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 32' ' ' GLN . 8.3 t -54.9 -25.82 31.62 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.979 -1.009 . . . . 1.15 111.447 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 1.1 t30 -105.63 9.83 33.13 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.888 -0.782 . . . . 2.08 108.888 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -117.65 -32.73 4.77 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 115.985 -0.552 . . . . 3.26 110.53 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.44 153.59 24.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.819 -0.808 . . . . 4.37 108.819 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.71 -26.59 25.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.865 -0.607 . . . . 4.28 110.565 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.51 13.67 29.14 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.694 -0.802 . . . . 2.74 110.471 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -112.47 124.79 53.29 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.297 1.591 . . . . 1.23 115.297 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.404 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 63.4 mt-30 -143.02 156.54 44.86 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.397 -2.075 . . . . 3.64 105.397 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -142.3 170.9 14.83 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 117.71 -1.596 . . . . 1.39 111.77 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -138.17 145.21 41.24 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.654 -1.612 . . . . 4.14 109.112 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -122.5 122.76 39.7 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.944 -1.873 . . . . 2.05 105.944 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.71 137.41 54.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.651 -1.241 . . . . 1.29 107.651 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.69 129.83 47.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.034 -1.099 . . . . 2.31 108.034 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.51 -28.9 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 119.935 -0.706 . . . . 1.81 111.005 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.606 ' NH1' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -79.79 -40.52 28.49 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.588 -1.264 . . . . 6.78 107.588 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.606 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -39.17 -54.18 1.8 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 120.962 -0.295 . . . . 1.51 110.727 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' GLY . 48.9 mt-10 -110.79 41.42 1.8 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 124.502 1.126 . . . . 4.2 109.95 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 20.1 66.17 0.01 OUTLIER Glycine 0 N--CA 1.508 3.48 0 O-C-N 124.205 0.94 . . . . 2.39 113.31 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 44' ' ' THR . 48.4 mt -93.4 162.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.863 -0.735 . . . . 1.75 109.807 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 43' ' ' ILE . 45.9 p -113.12 178.38 4.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.798 -0.637 . . . . 2.08 109.925 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -73.55 -52.86 12.07 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.607 -1.237 . . . . 6.27 109.864 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.4 mp0 -43.3 -52.67 5.65 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.339 -0.544 . . . . 3.88 110.162 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.583 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 4.1 t70 -51.57 -57.36 9.32 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.06 -0.656 . . . . 2.47 110.3 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mt -53.51 -46.05 69.93 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 115.02 -0.991 . . . . 1.31 110.245 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -47.07 -54.78 9.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.47 -0.937 . . . . 3.64 108.47 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -49.23 -29.85 6.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.215 1.572 . . . . 3.77 111.285 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.583 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 10.8 mptt -82.54 -47.36 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.127 -0.942 . . . . 2.53 112.311 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HB2' ' NE2' ' A' ' 61' ' ' GLN . . . -75.27 -45.96 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.628 1.344 . . . . 1.0 114.628 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.63 -42.65 1.91 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 107.295 -2.322 . . . . 2.4 107.295 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -84.18 169.53 16.64 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 106.696 -1.594 . . . . 7.22 106.696 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.04 163.53 5.9 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.942 -1.215 . . . . 4.16 108.942 161.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -124.0 38.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.93 -1.108 . . . . 5.41 109.762 179.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -26.14 -64.06 0.07 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.257 -1.338 . . . . 5.16 111.163 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -116.79 -154.5 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.122 -0.944 . . . . 4.12 109.763 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.44 175.76 3.25 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.068 -1.086 . . . . 1.81 108.068 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.459 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 71.6 Cg_endo -103.6 -170.71 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.112 0 O-C-N 122.406 0.687 . . . . 1.71 111.672 -18.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.548 ' NE2' ' HB2' ' A' ' 52' ' ' ALA . 13.6 mt-30 -141.94 151.79 42.91 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 115.686 -0.688 . . . . 2.63 110.716 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.9 mp -124.79 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 115.527 -0.76 . . . . 1.55 109.286 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 16.8 m-85 -127.27 150.74 49.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.19 -1.368 . . . . 1.01 109.894 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.449 HG23 ' CG1' ' A' ' 69' ' ' ILE . 55.5 t -120.5 125.32 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.055 -1.461 . . . . 0.91 107.055 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.458 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 11.1 t70 57.41 -94.76 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.775 -1.194 . . . . 4.47 107.775 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -131.99 2.47 3.99 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.389 -0.823 . . . . 3.89 110.938 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.458 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 1.4 mt-30 -97.09 167.31 11.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 110.018 -0.364 . . . . 4.27 110.018 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 15.0 t-160 -108.28 139.53 42.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.587 -1.264 . . . . 0.83 107.587 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.449 ' CG1' HG23 ' A' ' 64' ' ' VAL . 26.7 mm -101.73 -42.89 9.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.075 -1.05 . . . . 1.08 108.55 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.52 -132.43 5.45 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.07 -2.012 . . . . 1.34 108.07 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 72' ' ' TYR . . . -114.74 -175.22 18.59 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.054 -1.218 . . . . 1.31 110.054 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.508 ' OH ' ' HG2' ' A' ' 16' ' ' ARG . 1.8 t80 -33.03 -54.42 0.38 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.405 0.622 . . . . 2.19 111.194 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.98 -68.77 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.562 -1.199 . . . . 1.91 110.939 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -51.1 -38.94 54.79 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.696 -1.593 . . . . 2.41 110.846 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 62' ' ' ILE . 37.9 t80 -64.99 -51.71 60.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.833 -1.147 . . . . 0.83 109.903 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.12 76.18 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.185 -1.006 . . . . 0.95 109.6 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.02 -58.99 5.45 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.102 -1.039 . . . . 0.82 109.109 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.418 ' CH2' HG21 ' A' ' 64' ' ' VAL . 90.7 t90 -42.58 -51.01 5.3 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.196 -1.039 . . . . 0.73 108.196 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -52.66 -65.58 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.296 0 N-CA-C 107.857 -1.164 . . . . 0.82 107.857 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -49.25 -29.48 5.84 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.507 1.299 . . . . 2.3 114.507 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -105.82 7.64 32.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.231 0.826 . . . . 4.06 113.231 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -129.05 -35.54 1.83 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.01 -0.676 . . . . 1.56 110.378 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -106.35 26.02 10.37 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.131 -0.628 . . . . 2.02 109.872 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 C--N 1.299 -1.603 0 N-CA-C 108.548 -0.908 . . . . 3.87 108.548 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 30' ' ' ASP . 47.5 mtm . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.531 -0.914 . . . . 2.98 108.531 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.07 155.13 20.72 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 123.833 0.708 . . . . 4.06 109.107 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 2.8 m -143.74 143.7 31.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.021 -1.103 . . . . 1.51 108.021 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.0 t -127.84 126.61 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 119.033 -1.067 . . . . 1.22 112.526 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.8 mp -109.34 130.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.787 -1.19 . . . . 1.27 107.787 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -111.02 111.67 22.94 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 105.006 -2.22 . . . . 1.66 105.006 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.676 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -129.09 -143.82 5.6 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.536 -1.316 . . . . 1.58 112.8 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.32 -167.27 1.83 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 114.404 -0.898 . . . . 5.73 109.969 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m -86.53 64.25 8.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.096 -0.642 . . . . 5.65 111.428 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.63 53.83 1.1 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.504 -1.332 . . . . 3.28 109.78 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' TYR . 49.4 t -107.31 98.03 21.33 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.568 -1.271 . . . . 4.63 107.568 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.43 -20.76 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.264 2.642 . . . . 3.15 113.699 -159.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' CYS . 30.1 m-85 -71.62 -30.92 66.32 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.325 -0.55 . . . . 5.19 112.099 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -83.8 -30.41 26.59 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.7 -1.6 . . . . 1.94 106.811 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -50.05 -49.85 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 115.483 -0.78 . . . . 1.24 109.344 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.604 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 3.9 mmp_? -58.59 -52.47 65.54 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.38 -0.928 . . . . 2.86 111.047 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.92 63.44 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.261 -1.375 . . . . 0.63 107.729 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -49.19 -58.8 4.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 124.42 1.075 . . . . 2.21 109.265 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.74 -52.19 50.45 Favored 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 120.025 -0.67 . . . . 2.63 110.952 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 tp -52.5 -63.86 1.0 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.078 -0.712 . . . . 0.86 109.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.76 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.059 -0.719 . . . . 0.66 109.059 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.2 tt0 -55.36 -42.01 73.34 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.129 -0.941 . . . . 2.63 110.273 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -64.13 -54.63 30.87 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.036 -1.066 . . . . 5.94 108.339 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.524 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 43.1 mt -49.1 -47.55 45.13 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.124 -2.176 . . . . 1.04 105.124 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.19 -47.77 24.03 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.943 -1.026 . . . . 1.1 110.831 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.22 -35.24 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.656 -0.818 . . . . 2.13 112.154 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -72.3 -36.55 68.97 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.084 -0.646 . . . . 4.24 111.323 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.529 HH21 ' CG ' ' A' ' 30' ' ' ASP . 10.9 ptm85 -136.49 113.59 10.56 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.683 -0.807 . . . . 3.65 111.559 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -62.17 12.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 114.572 1.323 . . . . 4.7 114.572 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.529 ' CG ' HH21 ' A' ' 28' ' ' ARG . 10.1 p-10 -111.65 -1.88 15.57 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.066 -0.716 . . . . 3.64 109.066 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 91.4 t80 -109.65 116.81 32.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.637 -0.825 . . . . 1.15 110.352 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -121.73 167.81 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.148 -0.686 . . . . 3.13 109.148 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 30.1 p90 -161.55 168.78 22.96 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.091 -0.644 . . . . 1.7 110.21 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 152.09 41.11 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 109.599 -0.519 . . . . 4.93 109.599 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -118.44 135.7 54.21 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.306 -0.958 . . . . 1.39 109.284 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -127.8 159.33 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.401 -0.963 . . . . 1.36 108.401 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -113.71 129.11 56.62 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.698 -1.964 . . . . 2.53 105.698 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -43.67 -26.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.393 -0.523 . . . . 2.14 111.585 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -73.0 -59.44 2.7 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 120.469 -0.492 . . . . 6.78 109.993 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.32 -47.15 0.4 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.467 1.105 . . . . 1.95 111.202 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.82 -45.68 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.511 -1.222 . . . . 4.27 110.813 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.49 49.45 0.8 Allowed Glycine 0 N--CA 1.505 3.268 0 N-CA-C 109.417 -1.473 . . . . 2.79 109.417 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.472 HG21 ' HG ' ' A' ' 48' ' ' LEU . 15.9 mt -113.19 148.51 16.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.064 -0.568 . . . . 2.84 111.015 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.6 p -118.7 -92.77 0.53 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.01 -1.076 . . . . 5.13 110.113 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.428 ' NZ ' ' OE1' ' A' ' 46' ' ' GLU . 11.4 tttm -138.45 -55.16 0.63 Allowed 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.652 -1.24 . . . . 4.48 107.652 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.8 mm-40 -43.24 -50.43 6.48 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.367 -0.933 . . . . 5.52 110.92 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 51' ' ' LYS . 33.3 t70 -63.31 -54.74 32.34 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.35 -0.94 . . . . 3.24 111.195 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HG ' HG21 ' A' ' 43' ' ' ILE . 6.1 mt -53.52 -43.86 68.69 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.698 -0.801 . . . . 2.56 110.025 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.83 -53.76 54.57 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.495 -1.298 . . . . 4.52 107.495 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -53.11 -58.11 8.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 124.188 0.93 . . . . 4.58 110.367 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 47' ' ' ASP . 48.0 mttp -54.0 -50.23 67.09 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.166 -0.925 . . . . 2.81 111.367 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' CG ' ' A' ' 68' ' ' HIS . . . -54.45 -55.94 23.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.723 -1.581 . . . . 1.57 111.418 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.04 36.44 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.271 -1.532 . . . . 3.12 109.271 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -102.79 161.35 23.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.164 -0.68 . . . . 7.67 109.164 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.32 111.21 3.23 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.784 1.656 . . . . 4.69 111.451 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.402 HG11 ' NE2' ' A' ' 61' ' ' GLN . 15.4 m -131.02 159.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 123.335 0.397 . . . . 6.01 110.082 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -133.65 -43.08 0.83 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 123.511 0.507 . . . . 6.57 111.957 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -114.54 -148.31 0.43 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.651 -0.82 . . . . 4.96 109.696 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.81 173.6 2.9 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 109.576 -0.527 . . . . 2.45 109.576 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.557 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 73.9 Cg_endo -100.03 -177.68 4.0 Favored 'Cis proline' 0 N--CA 1.483 0.874 0 O-C-N 122.348 0.657 . . . . 1.67 111.319 -11.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.402 ' NE2' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -134.46 145.01 48.44 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.445 -0.798 . . . . 2.48 111.025 -179.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.566 HG21 ' CD1' ' A' ' 75' ' ' PHE . 4.3 mp -124.77 145.78 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 115.171 -0.922 . . . . 1.65 110.863 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.72 160.99 33.88 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.084 -1.871 . . . . 1.1 108.539 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.478 HG23 ' CG1' ' A' ' 69' ' ' ILE . 60.6 t -112.4 175.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.827 -1.916 . . . . 2.15 105.827 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 64' ' ' VAL . 38.8 t70 -61.35 -8.84 4.31 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.991 -1.084 . . . . 3.71 111.014 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -122.95 -56.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.459 1.281 . . . . 7.51 114.459 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.56 176.02 5.91 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.816 -0.753 . . . . 6.78 112.641 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.526 ' CG ' ' HA ' ' A' ' 52' ' ' ALA . 13.2 t-80 -93.05 154.56 18.04 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.483 -2.043 . . . . 0.94 105.483 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.478 ' CG1' HG23 ' A' ' 64' ' ' VAL . 37.0 mm -115.07 -49.13 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.379 -1.328 . . . . 1.08 111.291 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 145.49 -130.99 4.0 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 1.18 109.708 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.84 -173.39 20.63 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.248 -1.141 . . . . 1.2 110.248 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.91 -52.34 1.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 120.163 -0.615 . . . . 1.97 110.746 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -50.47 -58.76 5.0 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.843 0.83 . . . . 1.85 110.106 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.468 ' HB3' HG22 ' A' ' 69' ' ' ILE . 1.7 m-20 -54.33 -54.31 42.1 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.792 -1.095 . . . . 2.71 110.126 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD1' HG21 ' A' ' 62' ' ' ILE . 25.7 t80 -54.2 -52.34 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.778 -0.769 . . . . 1.09 110.997 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.61 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.625 -0.83 . . . . 1.19 109.014 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.07 -55.85 28.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.376 -0.929 . . . . 1.25 110.021 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -49.71 -51.84 35.7 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.705 -0.798 . . . . 1.15 109.346 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.429 ' CG1' HD11 ' A' ' 24' ' ' LEU . 29.0 t -49.73 -63.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 124.131 0.894 . . . . 1.06 108.706 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -44.63 -48.48 10.47 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.03 -0.986 . . . . 2.15 111.154 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.57 27.55 2.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 117.567 -1.653 . . . . 3.8 113.987 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.68 -41.79 0.28 Allowed 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 119.437 -0.905 . . . . 1.24 112.108 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.413 ' CD1' HD13 ' A' ' 24' ' ' LEU . 18.7 mt -109.98 2.96 20.01 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 120.012 -0.675 . . . . 1.98 111.845 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 . . . . . 0 C--N 1.308 -1.2 0 CA-C-O 121.569 0.7 . . . . 4.98 109.577 -178.357 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mmm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.208 -0.664 . . . . 3.22 109.208 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -88.96 97.75 11.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.879 -0.601 . . . . 3.86 110.172 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.9 m -84.4 123.38 30.16 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.828 -1.149 . . . . 0.99 109.207 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.67 131.41 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.828 -0.749 . . . . 1.1 112.277 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.45 116.89 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.703 -1.962 . . . . 1.15 105.703 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -99.43 103.89 15.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.661 -1.607 . . . . 1.58 106.661 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -122.78 -123.33 2.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.523 -1.431 . . . . 1.45 109.523 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' N ' ' OH ' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -135.88 -114.37 0.19 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.879 -1.128 . . . . 5.89 109.403 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 p -113.58 -74.81 0.61 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.808 -1.182 . . . . 4.86 107.808 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.92 63.36 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.534 -2.227 . . . . 2.9 107.534 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.6 t -100.19 97.47 6.28 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.935 -0.706 . . . . 4.98 109.524 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.56 -25.57 41.6 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.062 1.841 . . . . 3.27 111.847 -170.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.91 -9.74 58.95 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.332 -0.947 . . . . 6.19 111.576 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 3.5 m -101.07 -37.3 8.66 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.784 -1.561 . . . . 2.25 106.784 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -42.71 -35.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 114.721 -1.127 . . . . 1.27 110.128 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 7.3 mmm180 -71.51 -55.17 8.38 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.049 -1.46 . . . . 4.05 110.525 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.7 43.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.622 -1.251 . . . . 0.86 107.622 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -58.79 -49.88 76.01 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.539 -1.664 . . . . 1.94 109.035 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.6 t70 -60.44 -49.33 78.02 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.735 -1.186 . . . . 2.89 111.075 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 42.1 tp -60.51 -55.32 34.91 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.979 -1.088 . . . . 0.88 110.0 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.85 64.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.335 -1.357 . . . . 0.96 107.335 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.628 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 31.8 tt0 -48.61 -49.43 36.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.388 1.055 . . . . 2.14 109.359 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HE3' ' CA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -50.74 -63.52 1.1 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.344 -1.354 . . . . 6.66 107.344 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 83' ' ' LEU . 54.3 mt -45.53 -53.54 8.83 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.872 -1.158 . . . . 1.33 107.872 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 15.1 t -52.02 -33.25 37.67 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.21 -1.359 . . . . 1.73 112.939 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -112.32 25.33 11.63 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.161 -0.927 . . . . 3.13 109.197 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -133.62 -48.47 0.82 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.161 -0.927 . . . . 3.24 111.568 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 30' ' ' ASP . 21.9 mtp85 -113.38 133.08 55.35 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.194 -0.912 . . . . 3.12 110.508 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -80.9 35.04 0.36 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.395 -1.322 . . . . 3.7 111.372 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.4 p30 -130.2 -4.58 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.843 -1.526 . . . . 3.9 108.132 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' A' ' 25' ' ' SER . 23.7 t80 -127.86 141.45 51.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.599 -0.84 . . . . 1.15 112.608 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.427 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 35.4 mm-40 -140.75 141.04 34.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.218 -1.401 . . . . 3.99 107.218 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.628 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -127.21 162.34 26.39 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 118.62 -1.232 . . . . 1.28 113.721 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 147.45 27.99 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.611 -1.632 . . . . 4.65 109.333 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.538 ' OH ' ' N ' ' A' ' 8' ' ' ARG . 57.6 t80 -113.41 146.34 39.67 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.765 -1.198 . . . . 1.19 107.765 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.21 163.96 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.616 -0.834 . . . . 1.65 110.25 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -121.13 121.24 37.43 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.24 -2.133 . . . . 2.23 105.24 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -51.29 -17.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 118.825 -1.15 . . . . 1.88 110.806 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 4.2 ttp-105 -95.05 23.97 5.23 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.72 -0.792 . . . . 6.25 109.666 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.84 -43.69 3.97 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.102 -1.444 . . . . 1.55 107.102 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -93.48 -42.37 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.541 -2.022 . . . . 4.65 105.541 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.21 56.71 0.58 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.222 -1.951 . . . . 1.35 108.222 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.7 149.84 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.501 . . . . 1.37 111.067 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 -170.87 1.92 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.607 -0.724 . . . . 1.94 109.431 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 13.3 ttpp -77.06 -28.29 54.67 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.491 -0.884 . . . . 5.33 110.668 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 16.7 mp0 -70.71 -57.13 5.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 3.32 108.149 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -48.52 -42.66 33.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.104 -0.953 . . . . 2.4 110.422 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.76 -38.77 53.55 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.954 -1.021 . . . . 1.74 110.895 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.483 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 5.2 tt0 -55.74 -47.71 76.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.306 -1.368 . . . . 3.43 107.306 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.0 -30.83 26.83 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.322 -1.308 . . . . 5.1 110.811 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -88.97 -57.6 2.84 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.536 -1.211 . . . . 2.34 112.244 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -50.5 -33.35 21.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.783 -1.099 . . . . 1.45 112.029 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.79 73.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 106.521 -2.632 . . . . 3.67 106.521 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -133.26 -169.9 0.22 Allowed Pre-proline 0 C--N 1.296 -1.737 0 CA-C-N 113.089 -1.555 . . . . 6.32 107.834 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -86.6 143.5 7.34 Favored 'Trans proline' 0 C--N 1.299 -2.026 0 C-N-CA 120.893 1.062 . . . . 3.5 110.989 138.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -118.29 160.46 17.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.731 -1.211 . . . . 5.75 107.731 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -101.65 -109.69 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.084 -1.046 . . . . 6.73 108.693 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.9 p -120.26 -73.48 0.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.266 -1.013 . . . . 4.88 108.266 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -147.8 149.76 34.26 Favored Pre-proline 0 C--N 1.289 -2.048 0 CA-C-N 114.149 -1.387 . . . . 2.47 107.966 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.636 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 26.0 Cg_endo -103.66 155.8 3.01 Favored 'Cis proline' 0 C--N 1.32 -0.966 0 CA-C-N 118.671 0.561 . . . . 1.69 112.241 -6.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.46 149.43 41.28 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 107.085 -1.45 . . . . 2.74 107.085 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 58.0 mt -127.48 141.33 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.651 -0.82 . . . . 1.27 113.136 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -124.54 145.15 49.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.306 -1.77 . . . . 1.5 110.283 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 71.1 t -117.75 90.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.412 -0.959 . . . . 1.2 108.412 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 t70 70.9 -75.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.263 -0.88 . . . . 2.57 109.05 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -134.18 -20.87 1.88 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.786 -1.097 . . . . 3.55 111.381 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -89.51 158.1 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.759 -1.176 . . . . 4.9 110.8 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.576 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 11.8 t-160 -103.71 142.32 34.54 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.473 -0.936 . . . . 0.92 108.473 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 mm -111.55 -46.14 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.041 -1.063 . . . . 0.93 108.959 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.15 -113.82 1.01 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.504 -1.439 . . . . 1.17 109.504 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.429 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -119.25 -173.81 15.61 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.372 -1.091 . . . . 1.22 110.372 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 18.5 t80 -47.1 -49.2 22.36 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.354 -0.939 . . . . 1.39 111.516 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -54.67 17.17 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.687 0.756 . . . . 1.65 110.123 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -58.38 -52.64 64.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.666 -1.606 . . . . 2.44 110.481 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.97 -44.68 96.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.508 -0.769 . . . . 1.19 111.834 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.91 -58.18 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.728 -0.789 . . . . 1.03 109.226 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.76 -55.43 35.21 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.569 -1.253 . . . . 1.14 108.893 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.43 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 63.6 t90 -44.75 -54.18 6.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 123.549 0.531 . . . . 0.95 111.485 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -43.54 -59.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.962 -0.563 . . . . 0.82 110.265 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HG3' ' OE2' ' A' ' 81' ' ' GLU . 18.2 tptp -43.8 -30.19 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.394 1.628 . . . . 2.11 115.394 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.422 ' OE2' ' HG3' ' A' ' 80' ' ' LYS . 2.9 mp0 -107.82 4.5 25.57 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 119.579 1.082 . . . . 4.74 112.62 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -120.56 -31.57 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.721 -0.791 . . . . 1.38 111.045 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 24' ' ' LEU . 55.0 mt -116.94 26.84 9.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.792 -0.763 . . . . 1.7 111.954 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 C-N-CA 119.698 -0.801 . . . . 3.6 110.647 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.446 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 3.9 ptm . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 107.728 -1.212 . . . . 3.83 107.728 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.48 HE22 ' C ' ' A' ' 33' ' ' TYR . 60.5 tp60 -111.57 142.0 44.42 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 123.478 0.487 . . . . 4.73 109.839 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 m -120.4 148.72 43.41 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.771 -0.771 . . . . 1.39 109.025 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.49 139.19 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 118.868 -1.133 . . . . 1.05 112.595 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.463 HD12 ' HB1' ' A' ' 17' ' ' ALA . 17.2 mm -111.1 136.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.55 -1.278 . . . . 1.54 107.55 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.15 84.98 2.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.585 -1.635 . . . . 2.2 106.585 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -135.1 -163.28 10.05 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.496 -2.241 . . . . 1.27 107.496 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 9' ' ' SER . 4.2 tpt180 -141.35 167.68 21.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.256 -0.977 . . . . 6.19 108.581 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 8' ' ' ARG . 78.9 p -85.76 64.83 8.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.307 -0.627 . . . . 4.68 109.307 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 11' ' ' CYS . . . -120.75 61.13 0.52 Allowed Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.505 -1.438 . . . . 4.68 109.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.755 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 30.7 t 108.82 165.44 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.685 0 N-CA-C 105.605 -1.998 . . . . 4.71 105.605 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 50.5 Cg_exo -54.76 75.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.023 1.149 . . . . 3.11 113.023 165.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.403 ' CD2' ' HB3' ' A' ' 11' ' ' CYS . 6.5 m-85 -113.82 -77.89 0.58 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.573 -0.451 . . . . 4.85 109.915 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.45 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.7 m -55.02 -29.12 56.7 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 118.041 -1.464 . . . . 2.44 108.022 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -42.54 -38.59 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.164 -1.38 . . . . 1.51 110.205 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.495 ' NH2' ' HB3' ' A' ' 19' ' ' ASP . 6.6 mmm180 -77.11 -53.63 7.54 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.957 -1.497 . . . . 3.61 110.093 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.463 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -49.16 -42.59 40.25 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.208 -0.997 . . . . 1.07 109.185 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HE3' ' CZ ' ' A' ' 33' ' ' TYR . 2.3 tptm -60.19 -60.0 4.51 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.898 -1.501 . . . . 2.74 108.687 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.495 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 3.4 t70 -50.51 -42.65 55.15 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.984 -1.086 . . . . 2.6 110.029 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 79' ' ' VAL . 8.6 tp -63.22 -66.93 0.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.686 -1.205 . . . . 1.11 109.185 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.97 -39.82 9.48 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 120.312 -0.555 . . . . 1.04 110.524 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 26.6 tt0 -65.55 -53.04 47.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.151 -0.932 . . . . 2.31 110.389 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -53.54 39.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.566 -1.642 . . . . 6.81 106.566 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.4 mt -53.51 -40.62 65.55 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.544 -1.207 . . . . 1.39 108.216 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -59.7 -35.62 74.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.874 -1.057 . . . . 1.03 110.594 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -83.98 -28.08 27.99 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.042 -0.663 . . . . 1.77 110.891 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.3 -47.22 44.5 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.208 -0.597 . . . . 3.42 111.35 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -109.18 164.97 11.96 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.143 -1.023 . . . . 4.44 110.907 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.632 -1.618 . . . . 4.0 106.632 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 1' ' ' MET . 3.5 t70 -82.86 41.19 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.924 -1.489 . . . . 3.58 108.686 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -145.46 93.23 2.34 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.546 -1.262 . . . . 1.07 112.651 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -99.55 155.06 17.78 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 104.526 -2.398 . . . . 3.35 104.526 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.548 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 7.3 p90 -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.059 -1.056 . . . . 1.73 108.784 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -149.02 152.44 36.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.701 -0.852 . . . . 4.77 108.701 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -121.46 123.15 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.841 -1.17 . . . . 2.11 107.841 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.28 145.39 20.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.97 -2.233 . . . . 1.92 104.97 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 11.1 t70 -111.18 160.1 17.25 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.544 -1.263 . . . . 2.55 108.512 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.26 -30.24 5.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 117.778 -1.569 . . . . 1.25 108.87 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 3.1 tpm_? -93.18 -59.31 2.06 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.74 -0.664 . . . . 5.31 110.339 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -47.19 -33.29 5.15 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.655 -0.818 . . . . 1.66 110.972 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.22 -46.31 8.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.954 0.784 . . . . 3.97 109.334 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 54.23 1.05 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.722 -1.751 . . . . 1.49 108.722 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 mt -99.74 162.7 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.544 -0.91 . . . . 1.53 108.544 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 p -113.36 148.78 35.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.942 0.776 . . . . 2.43 112.184 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.606 ' HG3' ' CG1' ' A' ' 56' ' ' VAL . 35.0 tttm -49.3 -54.26 17.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.588 -0.893 . . . . 4.26 108.588 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 3.6 mp0 -46.62 -62.91 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.725 -1.125 . . . . 3.25 111.006 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.15 -56.71 8.33 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 120.401 -0.519 . . . . 2.16 110.895 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.8 -50.17 69.2 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.7 -0.682 . . . . 1.25 110.229 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.97 -56.14 16.06 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 3.04 107.535 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -49.77 -43.92 48.48 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.107 -1.406 . . . . 3.96 109.071 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HD2' ' CE2' ' A' ' 63' ' ' PHE . 6.2 tmtt? -63.85 -46.39 85.23 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.133 -1.394 . . . . 7.24 112.231 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -71.19 -48.51 51.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 113.068 0.766 . . . . 1.06 113.068 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.94 -33.85 6.18 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.065 -2.414 . . . . 2.54 107.065 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -83.83 141.53 41.25 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 114.447 -0.876 . . . . 7.78 108.649 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -41.92 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 122.358 2.039 . . . . 3.87 110.712 161.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.606 ' CG1' ' HG3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER 33.32 -95.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 115.637 1.717 . . . . 5.22 115.637 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 5.3 tp10 109.14 -170.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 102.475 -3.158 . . . . 7.18 102.475 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.498 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 14.9 p -104.03 -152.49 0.46 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.181 -1.414 . . . . 4.33 107.181 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.07 146.64 51.88 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 107.881 -1.155 . . . . 2.8 107.881 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 96.6 Cg_endo -98.46 162.46 10.42 Favored 'Cis proline' 0 N--CA 1.489 1.223 0 O-C-N 122.858 0.925 . . . . 2.43 111.637 10.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -114.06 151.34 32.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.578 -1.267 . . . . 2.85 107.578 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.423 HD12 ' CB ' ' A' ' 75' ' ' PHE . 6.2 mt -123.2 143.24 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.066 -1.054 . . . . 1.8 111.798 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.422 ' CE2' ' HD2' ' A' ' 51' ' ' LYS . 31.7 m-85 -136.36 159.06 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.751 -1.568 . . . . 1.09 107.874 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 66' ' ' GLN . 74.6 t -127.6 130.44 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.531 -0.914 . . . . 0.87 108.531 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.08 -81.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 124.398 1.061 . . . . 2.77 110.603 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.3 pt20 -138.33 -14.2 1.32 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.229 -0.896 . . . . 3.87 110.976 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -85.46 168.96 14.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.696 0.623 . . . . 4.88 111.209 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.53 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.3 t-160 -113.01 139.66 48.47 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.617 -0.72 . . . . 0.87 109.267 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mm -109.69 -34.37 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.304 -1.358 . . . . 1.15 109.215 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.96 -136.17 8.77 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.169 -1.491 . . . . 1.2 109.539 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.39 169.2 17.1 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.749 -1.215 . . . . 1.49 110.656 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.6 t80 -40.53 -57.27 1.87 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 112.608 0.596 . . . . 1.52 112.608 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 p -43.25 -69.31 0.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.026 0.917 . . . . 1.6 111.213 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -52.1 30.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.174 -1.83 . . . . 2.83 110.316 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' CE1' ' CE3' ' A' ' 78' ' ' TRP . 58.3 t80 -44.61 -46.54 10.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.345 -0.843 . . . . 1.74 111.03 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -40.83 -48.17 3.03 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 119.62 -0.832 . . . . 1.1 111.006 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.99 77.93 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.839 -1.144 . . . . 1.17 109.713 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.464 ' CZ2' HG21 ' A' ' 64' ' ' VAL . 90.5 t90 -50.94 -44.99 60.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.724 -0.843 . . . . 0.7 108.724 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG21 HD21 ' A' ' 20' ' ' LEU . 79.7 t -57.23 -33.99 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.662 -1.154 . . . . 1.08 110.23 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 13.7 tptp -87.57 18.52 3.88 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.265 -0.974 . . . . 2.26 111.726 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.21 -45.47 0.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.271 -0.972 . . . . 3.85 111.826 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -84.86 -2.16 57.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.992 -1.083 . . . . 1.76 111.745 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.416 HD12 HG13 ' A' ' 79' ' ' VAL . 86.0 mt -123.25 21.32 9.63 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.209 -0.996 . . . . 1.8 110.742 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.297 -1.686 0 N-CA-C 108.075 -1.084 . . . . 4.09 108.075 179.48 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.387 -0.598 . . . . 3.46 109.387 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 18.6 mt-30 -112.01 164.51 13.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.118 0.485 . . . . 3.85 111.82 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.1 m -152.35 121.48 6.67 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 116.434 -0.348 . . . . 1.14 110.159 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.491 ' C ' HD12 ' A' ' 5' ' ' ILE . 6.6 t -109.19 137.91 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.103 -1.039 . . . . 1.02 110.09 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp -109.32 98.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 124.768 1.293 . . . . 1.05 108.077 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CE1' HG11 ' A' ' 4' ' ' VAL . 76.4 m-85 -93.76 92.75 7.61 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 105.774 -1.936 . . . . 1.41 105.774 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -125.07 -150.69 7.85 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.825 -1.178 . . . . 1.27 111.766 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.459 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.3 tpt180 -124.26 123.53 40.45 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.812 -0.81 . . . . 5.27 108.812 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -78.45 53.78 1.34 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.662 0.744 . . . . 5.39 109.397 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.34 -46.37 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.733 -1.347 . . . . 3.16 109.733 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.575 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 32.1 t -111.78 156.1 42.12 Favored Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.779 -0.822 . . . . 3.76 108.779 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 6.1 Cg_endo -72.55 48.53 1.31 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.491 1.461 . . . . 3.23 111.446 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -99.99 -58.62 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.361 -0.978 . . . . 4.36 108.361 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.3 m -53.26 -36.19 60.84 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.423 -1.325 . . . . 2.46 107.423 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.41 -30.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.079 -1.873 . . . . 1.34 111.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' ARG . 39.4 mmt180 -72.28 -39.85 68.02 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.983 -1.087 . . . . 5.82 110.302 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 62' ' ' ILE . . . -65.22 -46.7 79.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.217 -1.771 . . . . 0.84 106.217 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 2.1 ttpp -51.99 -48.91 64.2 Favored 'General case' 0 C--O 1.2 -1.532 0 CA-C-N 114.099 -1.409 . . . . 1.59 108.97 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -57.42 -65.68 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.646 -0.706 . . . . 2.94 111.251 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.4 tp -51.31 -51.85 50.57 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.083 -1.047 . . . . 1.05 110.073 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.13 -51.52 63.98 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.618 -1.173 . . . . 0.79 109.747 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 19.6 tt0 -55.93 -49.0 74.69 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.047 -0.978 . . . . 1.88 109.35 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HD2' ' C ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -52.23 -55.1 23.36 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.034 -1.466 . . . . 4.35 107.657 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.82 -37.17 63.3 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.756 -0.831 . . . . 1.01 108.756 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 5.7 t -55.71 -40.74 72.84 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.815 -1.18 . . . . 1.04 107.815 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -98.3 40.36 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.961 -1.496 . . . . 2.05 106.961 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.53 -52.3 0.39 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.242 -1.344 . . . . 2.8 111.663 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -106.23 -11.45 16.04 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.973 -1.091 . . . . 4.61 111.177 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 71.51 -40.55 0.48 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 124.15 0.906 . . . . 4.72 112.59 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 1' ' ' MET . 5.3 p-10 -80.96 4.23 20.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.705 -1.198 . . . . 2.71 107.863 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.502 ' CD2' ' HE3' ' A' ' 1' ' ' MET . 6.0 t80 -95.23 102.35 14.15 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.554 1.159 . . . . 1.48 108.011 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 37.7 mt-30 -119.29 118.62 31.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.201 -1.037 . . . . 3.12 108.201 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.41 160.04 15.94 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.731 -1.188 . . . . 1.38 110.574 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.429 ' CG ' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -142.26 148.84 38.76 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.076 -1.42 . . . . 4.71 108.9 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -112.21 136.19 51.93 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.042 -1.096 . . . . 1.45 108.042 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.42 152.04 27.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.213 -1.773 . . . . 1.3 106.213 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.68 142.2 47.52 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.409 -0.916 . . . . 2.19 109.008 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.9 pt -48.3 -36.95 6.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.927 -0.709 . . . . 1.27 111.188 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -76.74 -44.88 31.38 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.002 -1.079 . . . . 6.42 111.473 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.76 -54.36 2.65 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 119.529 -0.868 . . . . 1.75 110.422 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 42' ' ' GLY . 64.9 mt-10 -93.47 25.18 3.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 114.3 -1.318 . . . . 4.27 111.255 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 30.51 57.0 0.24 Allowed Glycine 0 N--CA 1.508 3.455 0 N-CA-C 112.074 -0.41 . . . . 1.63 112.074 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.6 161.52 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.933 -0.766 . . . . 1.88 108.933 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -119.93 154.62 34.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.706 0.765 . . . . 1.98 109.513 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -45.13 -42.12 8.63 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.071 1.137 . . . . 4.13 114.071 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.702 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 14.2 mp0 -65.02 -56.5 12.73 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.818 -0.753 . . . . 3.07 110.608 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.56 -50.21 24.49 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.19 -1.041 . . . . 2.44 108.19 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.94 -48.94 74.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.159 -1.382 . . . . 1.29 108.551 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.511 HE21 ' H ' ' A' ' 56' ' ' VAL . 5.4 tp60 -44.78 -45.02 9.77 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.936 -1.135 . . . . 4.88 107.936 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.15 -49.54 69.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.898 1.374 . . . . 3.45 109.587 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.58 -48.95 62.98 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.155 -0.683 . . . . 2.42 109.155 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -19.69 56.98 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.429 -0.952 . . . . 1.04 108.429 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.67 32.57 17.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.375 -1.89 . . . . 2.73 108.375 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -143.66 158.21 57.19 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-N 114.096 -1.052 . . . . 7.45 108.707 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.86 68.87 4.67 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.675 1.584 . . . . 3.68 111.25 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.511 ' H ' HE21 ' A' ' 49' ' ' GLN . 4.8 p -101.71 125.1 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.982 -0.687 . . . . 6.39 110.804 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.71 -2.82 10.36 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 112.918 0.711 . . . . 6.2 112.918 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 p -116.08 -169.27 1.57 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.637 -0.825 . . . . 4.25 111.579 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.8 164.59 33.93 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.415 -0.811 . . . . 2.89 108.992 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.69 157.44 71.82 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 124.236 -1.152 . . . . 2.88 109.747 -7.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -98.25 101.42 12.88 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 103.916 -2.624 . . . . 3.37 103.916 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 17' ' ' ALA . 8.2 mt -91.59 133.12 34.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 113.167 -1.833 . . . . 1.34 111.266 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -125.64 153.57 43.6 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 112.979 -1.919 . . . . 1.09 109.798 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 66' ' ' GLN . 80.0 t -122.2 95.91 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.882 -1.155 . . . . 0.84 107.882 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.5 -72.72 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 125.189 1.556 . . . . 2.63 110.557 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 64' ' ' VAL . 41.7 tp60 -129.78 -18.06 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.475 -1.239 . . . . 6.0 111.363 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -91.61 172.95 8.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.276 -0.97 . . . . 3.52 111.18 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -119.92 149.72 41.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 106.797 -1.557 . . . . 1.74 106.797 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 78' ' ' TRP . 21.3 mm -116.25 -55.95 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.687 -0.805 . . . . 0.89 111.069 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.58 -135.05 4.76 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.667 -1.254 . . . . 1.53 110.26 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.37 -74.31 0.94 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 111.141 -0.783 . . . . 2.47 111.141 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -137.97 -55.85 0.66 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 118.724 -1.19 . . . . 2.73 109.343 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 p -41.95 -52.4 4.14 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 123.118 1.437 . . . . 2.05 109.658 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -36.46 84.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.005 -2.362 . . . . 2.08 109.964 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.19 -51.01 61.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.496 -0.882 . . . . 1.21 109.108 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.5 64.81 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.276 -0.969 . . . . 1.34 109.28 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.88 -58.9 6.14 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.788 -1.165 . . . . 1.03 108.998 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.481 ' CD1' HD12 ' A' ' 69' ' ' ILE . 87.6 t90 -44.5 -55.54 5.02 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.519 -0.764 . . . . 0.76 109.301 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.466 HG13 HD12 ' A' ' 83' ' ' LEU . 2.7 t -44.79 -60.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 114.231 -1.35 . . . . 1.04 108.853 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -50.21 -39.88 45.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.21 -0.905 . . . . 2.52 112.937 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 11.7 pt-20 -104.52 36.09 2.52 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.592 -0.843 . . . . 4.33 113.067 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -147.5 -36.11 0.22 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.216 1.007 . . . . 1.56 110.038 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 79' ' ' VAL . 22.3 mt -99.44 -24.03 14.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.523 -1.217 . . . . 2.65 110.794 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t0 . . . . . 0 N--CA 1.499 2.008 0 O-C-N 125.105 1.503 . . . . 4.1 108.082 179.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.487 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.4 mpp? . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 108.004 -1.11 . . . . 2.38 108.004 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.42 ' C ' HE21 ' A' ' 2' ' ' GLN . 0.0 OUTLIER -83.16 102.61 11.98 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 124.023 0.827 . . . . 4.04 109.459 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 5.7 m -96.69 116.38 29.03 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.963 -1.095 . . . . 1.48 109.925 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 t -123.7 136.95 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.397 -0.819 . . . . 1.01 112.448 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.41 HG21 ' SG ' ' A' ' 14' ' ' CYS . 5.4 mm -110.39 125.03 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.747 -1.205 . . . . 1.27 107.747 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 82.1 m-85 -102.47 114.99 29.67 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.21 -1.774 . . . . 1.73 106.21 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.29 -148.78 7.99 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.409 -1.077 . . . . 1.69 110.409 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.5 ttm180 -138.8 141.74 38.74 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.846 -0.742 . . . . 6.24 110.613 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 t -54.98 73.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.983 -1.462 . . . . 6.59 112.761 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 118.5 26.62 2.58 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 120.45 -0.881 . . . . 4.03 113.096 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 13' ' ' TYR . 9.7 t -122.31 138.0 28.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 C-N-CA 118.728 -1.189 . . . . 4.8 110.048 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.02 53.08 4.42 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.884 1.723 . . . . 4.44 111.2 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.545 ' CE2' ' SG ' ' A' ' 11' ' ' CYS . 20.3 m-30 -111.73 -68.21 0.95 Allowed 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.302 -0.559 . . . . 5.67 112.147 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 16' ' ' ARG . 3.5 t -54.49 -29.34 49.89 Favored 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 118.014 -1.474 . . . . 4.4 108.912 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 15' ' ' VAL . 7.2 t -44.75 -12.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 114.027 -1.442 . . . . 2.3 112.072 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.599 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -108.87 -42.37 4.49 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.534 -0.867 . . . . 3.54 109.607 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.17 75.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.345 -1.724 . . . . 0.75 106.345 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -54.97 -39.82 69.36 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 114.588 -1.187 . . . . 2.11 108.686 179.14 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.457 ' CG ' HH12 ' A' ' 16' ' ' ARG . 0.2 OUTLIER -66.32 -62.42 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.212 0.529 . . . . 2.76 111.488 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' CD2' ' A' ' 75' ' ' PHE . 15.3 tp -56.36 -43.27 78.98 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.408 -0.917 . . . . 1.09 110.045 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.08 72.69 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.725 -1.19 . . . . 1.08 108.296 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 11.3 tt0 -48.14 -47.33 34.83 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.44 -0.948 . . . . 2.42 108.44 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -48.57 -52.9 20.49 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 118.756 -1.178 . . . . 4.15 110.62 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.5 mt -65.52 -46.24 80.4 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 123.721 0.638 . . . . 1.18 111.78 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 22' ' ' GLU . 1.5 p -57.9 -25.37 60.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 118.922 -1.111 . . . . 2.81 111.15 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 8.8 t30 -91.75 27.98 1.91 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.028 -1.069 . . . . 1.78 108.647 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 72.5 mt-10 -121.17 -65.7 1.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.951 -0.7 . . . . 3.4 110.252 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -122.26 -166.77 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.811 -1.086 . . . . 3.83 111.746 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -107.45 -4.65 18.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.912 -1.04 . . . . 5.79 111.027 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.9 p-10 -84.29 -9.59 58.35 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.919 -1.141 . . . . 3.26 107.919 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CZ ' HG21 ' A' ' 3' ' ' THR . 29.8 t80 -116.02 96.9 5.79 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.492 -0.883 . . . . 1.56 110.817 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -112.11 128.07 56.1 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.255 -2.128 . . . . 4.23 105.255 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.1 OUTLIER -123.28 143.25 50.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.118 -1.433 . . . . 1.58 113.74 -177.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -139.1 161.67 36.81 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 113.822 -1.536 . . . . 4.39 109.409 178.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.451 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 30.6 t80 -118.98 142.62 47.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 1.37 109.115 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -132.19 147.02 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.348 -0.982 . . . . 1.39 108.348 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 3.3 t70 -122.48 114.74 21.11 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 119.038 -1.065 . . . . 2.58 112.434 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -49.3 -31.46 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.477 -0.783 . . . . 1.51 111.522 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.506 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.03 -63.44 1.31 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.284 -1.766 . . . . 5.41 108.723 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -30.49 -45.51 0.06 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.667 1.23 . . . . 2.62 111.671 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -94.22 -53.37 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.905 -1.118 . . . . 3.64 111.465 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.58 51.87 0.2 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 118.989 -1.576 . . . . 1.75 111.47 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.7 mt -103.87 157.73 5.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.775 -1.565 . . . . 1.87 106.775 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.0 p -115.88 158.35 23.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.653 -0.819 . . . . 2.34 109.084 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -52.18 -40.29 61.27 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.961 -1.096 . . . . 4.75 111.833 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 23.3 mp0 -47.73 -63.76 0.97 Allowed 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 121.663 0.744 . . . . 3.4 110.261 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -44.31 -44.62 8.25 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 114.354 -1.294 . . . . 2.82 111.978 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.77 -41.7 64.76 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.336 -1.302 . . . . 2.07 110.5 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 55' ' ' PRO . 14.0 tt0 -57.28 -40.12 77.1 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.301 -1.741 . . . . 3.17 106.301 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -15.54 11.84 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.355 -1.293 . . . . 3.59 110.692 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -104.11 -37.73 7.21 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.671 -0.695 . . . . 2.5 110.51 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.497 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -72.0 -37.79 69.75 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.725 -1.125 . . . . 1.51 112.65 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -45.62 1.87 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 107.957 -2.057 . . . . 2.84 107.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 17.8 pttp -101.35 176.31 1.94 Allowed Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.556 -1.646 . . . . 5.93 106.556 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 64.9 Cg_exo -48.67 155.15 2.53 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 120.67 0.913 . . . . 3.79 110.93 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 56' ' ' VAL . 3.9 m -72.43 -30.99 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.447 -0.901 . . . . 5.99 111.312 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.58 -145.92 0.32 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.047 -0.661 . . . . 7.4 109.383 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -95.38 168.04 10.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.604 -0.838 . . . . 4.27 110.003 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.01 152.26 39.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.634 -1.247 . . . . 2.4 107.634 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 13' ' ' TYR . 73.7 Cg_endo -97.03 160.2 12.07 Favored 'Cis proline' 0 C--N 1.304 -1.78 0 C-N-CA 123.828 -1.322 . . . . 2.43 109.664 17.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 1.4 tp-100 -110.16 132.45 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.069 -2.197 . . . . 3.4 105.069 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' A' ' 75' ' ' PHE . 5.3 mt -112.71 137.53 45.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.037 -1.065 . . . . 1.79 111.013 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -127.5 138.78 53.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.407 -1.724 . . . . 1.27 107.807 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 66' ' ' GLN . 40.6 t -121.73 108.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 124.462 1.101 . . . . 1.26 109.183 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.01 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.141 -0.689 . . . . 2.94 109.141 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -138.05 -9.82 1.53 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.484 -1.234 . . . . 3.87 110.034 179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.82 146.62 26.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.678 -0.49 . . . . 4.57 109.678 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.497 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 14.6 t-160 -105.85 135.55 47.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.159 -1.423 . . . . 1.19 107.159 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 78' ' ' TRP . 9.9 mm -103.7 -41.06 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 118.588 -1.245 . . . . 0.89 109.775 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 128.39 -114.74 1.88 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.324 -2.31 . . . . 1.36 107.324 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 60' ' ' PRO . . . -129.87 -169.13 12.46 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 118.558 -1.782 . . . . 1.15 111.23 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.7 t80 -61.96 176.28 0.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 105.738 -1.949 . . . . 3.07 105.738 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.471 ' CB ' ' O ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 78.23 -64.69 0.27 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.413 -1.328 . . . . 3.06 107.413 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -41.62 83.05 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.398 -1.334 . . . . 2.62 107.398 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.56 ' HB2' HD12 ' A' ' 62' ' ' ILE . 15.8 t80 -41.84 -49.88 4.43 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 113.915 -1.493 . . . . 1.15 110.041 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.66 71.28 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.412 -0.915 . . . . 1.06 109.061 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.14 -53.99 51.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.887 -1.125 . . . . 0.94 109.435 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.43 ' CD1' HD12 ' A' ' 69' ' ' ILE . 70.2 t90 -50.3 -53.45 28.58 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.746 -0.782 . . . . 1.11 110.065 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.0 t -43.98 -56.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.312 -0.858 . . . . 0.94 109.336 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 80' ' ' LYS . 6.2 tmtm? -44.83 -23.86 0.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 116.953 -1.499 . . . . 2.86 115.044 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.18 6.2 10.26 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 120.94 1.7 . . . . 4.79 112.971 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.23 -25.74 5.63 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.846 -0.742 . . . . 1.31 109.725 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.89 28.03 4.22 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.16 -0.927 . . . . 2.02 111.096 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 18.6 p-10 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 122.229 1.014 . . . . 4.4 109.099 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.838 -0.801 . . . . 2.9 108.838 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.458 ' OE1' ' HB2' ' A' ' 34' ' ' GLN . 6.2 tt0 -84.17 144.52 28.93 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 119.104 -1.039 . . . . 4.85 109.447 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.7 m -96.39 134.73 39.18 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.169 -1.419 . . . . 1.81 107.169 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.487 ' C ' HD12 ' A' ' 5' ' ' ILE . 6.7 t -125.42 122.22 62.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.593 -1.262 . . . . 1.14 107.593 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -107.17 123.65 62.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 105.419 -2.067 . . . . 1.01 105.419 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -117.78 117.07 28.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 2.72 108.587 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.46 159.43 8.39 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.875 -1.155 . . . . 1.98 111.247 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -112.89 139.09 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.194 -1.039 . . . . 5.13 108.194 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.538 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 10.9 p -102.89 -65.15 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.124 -1.03 . . . . 6.46 109.709 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.27 -47.88 0.99 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 105.967 -2.853 . . . . 3.43 105.967 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.5 m -94.7 165.2 17.73 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 106.354 -1.721 . . . . 4.53 106.354 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.04 67.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.844 2.363 . . . . 3.38 112.528 165.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -115.0 -65.34 1.2 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.628 -0.878 . . . . 6.11 108.628 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 18.1 m -53.46 -33.82 55.59 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.404 1.097 . . . . 2.22 108.388 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 15' ' ' VAL . 22.3 t -44.46 -47.12 2.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 113.002 -1.908 . . . . 1.43 111.259 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -50.01 -48.8 52.34 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.71 -0.796 . . . . 3.21 110.534 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.27 -52.69 25.81 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.552 -1.277 . . . . 0.87 107.552 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -53.76 -45.21 70.54 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 114.759 -1.11 . . . . 1.95 110.53 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.525 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 43.7 m-20 -62.21 -56.72 15.85 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.336 -0.546 . . . . 3.19 111.663 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.407 HD23 ' CD2' ' A' ' 75' ' ' PHE . 18.7 tp -57.79 -52.02 67.2 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.029 -0.73 . . . . 0.79 109.029 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.73 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.74 -0.837 . . . . 0.65 108.74 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.442 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 42.3 tt0 -58.38 -47.76 82.8 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.7 -0.8 . . . . 2.35 110.428 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' NZ ' ' OE1' ' A' ' 27' ' ' GLU . 17.6 tptp -57.45 -54.96 40.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 116.563 -2.055 . . . . 4.63 107.879 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' LYS . 47.7 mt -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.533 -1.667 . . . . 1.4 107.63 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 6.5 t -49.84 -42.44 47.34 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.785 -0.643 . . . . 1.04 109.494 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.433 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 t-20 -72.89 -29.49 63.2 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.742 -0.663 . . . . 2.77 111.13 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 1.6 mm-40 -86.33 -40.14 15.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.292 1.219 . . . . 3.84 114.292 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -114.25 139.36 49.46 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.923 -0.711 . . . . 4.32 112.216 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.35 -40.88 98.48 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.225 -0.898 . . . . 4.08 113.273 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.75 20.28 1.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.405 -0.918 . . . . 3.44 111.36 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 4.4 t80 -115.28 123.02 47.72 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.544 -1.262 . . . . 1.13 111.63 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -136.04 172.39 13.08 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.824 -1.547 . . . . 3.45 106.824 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -145.35 149.45 34.81 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.501 -1.28 . . . . 1.36 110.919 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.458 ' HB2' ' OE1' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -136.87 139.78 41.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.113 0.883 . . . . 5.02 109.252 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.67 121.2 34.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.178 -1.009 . . . . 1.71 108.83 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.99 153.59 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.866 -0.734 . . . . 1.64 109.708 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -108.69 124.3 50.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.092 -1.447 . . . . 2.51 107.092 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.7 pt -40.02 -41.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.709 -0.796 . . . . 1.29 111.816 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -31.47 61.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 118.998 -1.081 . . . . 5.37 111.778 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.1 -53.59 32.76 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.416 -0.914 . . . . 1.4 111.593 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -94.63 -34.49 12.59 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.477 -0.889 . . . . 3.65 111.872 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.48 50.43 0.66 Allowed Glycine 0 N--CA 1.503 3.12 0 N-CA-C 109.332 -1.507 . . . . 1.51 109.332 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.8 mt -96.55 137.15 25.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.312 -0.995 . . . . 1.61 108.312 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.4 p -107.35 166.34 10.72 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.929 -1.108 . . . . 2.37 112.067 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 57' ' ' GLU . 8.8 ttpt -56.86 -35.25 68.66 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.573 -1.194 . . . . 4.78 109.967 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 24.0 mp0 -68.93 -47.72 65.02 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.052 -1.092 . . . . 3.54 108.052 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.66 -49.96 74.74 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 117.793 -1.563 . . . . 2.53 108.332 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -53.66 -54.46 37.42 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.017 -1.073 . . . . 1.63 108.367 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.46 -51.79 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.544 0.527 . . . . 5.32 109.95 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -53.09 -54.32 37.32 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.38 -0.971 . . . . 4.67 108.38 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -55.72 -38.25 69.49 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.724 -1.126 . . . . 2.78 110.523 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -59.54 -48.0 83.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 123.68 0.612 . . . . 1.99 110.4 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.42 -40.47 2.72 Favored Glycine 0 N--CA 1.499 2.833 0 C-N-CA 120.152 -1.023 . . . . 4.3 112.102 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.427 ' O ' HG12 ' A' ' 56' ' ' VAL . 64.4 mttp -124.23 154.53 68.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 C-N-CA 120.066 -0.654 . . . . 10.46 109.316 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.11 70.05 6.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.91 2.407 . . . . 5.73 113.563 -138.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 54' ' ' LYS . 2.7 p -136.99 128.58 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.983 -0.687 . . . . 6.75 109.97 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 2.3 mt-10 -122.15 67.23 0.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.75 -0.833 . . . . 8.85 108.75 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 p -113.8 149.15 35.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.137 0.791 . . . . 5.4 113.137 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -117.92 144.13 34.0 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.086 -1.079 . . . . 3.11 108.086 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HG2' ' SG ' ' A' ' 14' ' ' CYS . 22.7 Cg_exo -66.31 171.05 39.35 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 123.933 -1.278 . . . . 3.02 110.871 -18.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -130.55 152.65 49.7 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.845 -1.539 . . . . 2.96 106.845 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 mt -121.55 143.66 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 119.586 -0.845 . . . . 1.16 111.402 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -131.07 165.82 22.41 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.873 -1.512 . . . . 1.05 108.161 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.537 HG11 ' CH2' ' A' ' 78' ' ' TRP . 32.0 t -138.61 105.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 124.174 0.921 . . . . 1.3 110.921 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' GLN . 3.6 t70 54.5 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.996 0.81 . . . . 2.81 113.019 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . 66.4 mt-30 -137.85 23.83 2.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 123.476 0.485 . . . . 5.48 111.295 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 68' ' ' HIS . 31.6 tt0 -131.03 159.45 37.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.222 -1.029 . . . . 4.45 108.222 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.504 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.6 t-160 -112.0 137.11 50.46 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 107.871 -1.159 . . . . 1.24 107.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.443 HD12 ' C ' ' A' ' 68' ' ' HIS . 1.7 mp -106.3 -46.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 119.682 -0.807 . . . . 1.59 112.131 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.26 -98.94 0.56 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.856 -1.298 . . . . 1.33 109.856 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.87 177.92 17.32 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 120.234 -0.984 . . . . 1.21 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -50.41 -47.43 56.51 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.787 -0.765 . . . . 1.45 111.048 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -43.96 -57.26 3.42 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.609 0.718 . . . . 1.66 111.11 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.71 -49.01 79.23 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.658 -1.155 . . . . 2.05 109.069 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CD2' HD23 ' A' ' 20' ' ' LEU . 15.3 t80 -44.82 -52.07 8.88 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.277 -0.969 . . . . 0.95 110.145 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 -57.96 9.48 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 120.007 -0.677 . . . . 0.83 111.562 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.34 42.35 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 118.372 -1.331 . . . . 1.08 109.303 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.61 ' CH2' HD21 ' A' ' 83' ' ' LEU . 75.8 t90 -41.61 -52.4 3.79 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.323 -0.853 . . . . 0.98 110.631 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -44.59 -46.2 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 115.551 -0.749 . . . . 0.91 110.721 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.535 ' C ' ' HD3' ' A' ' 80' ' ' LYS . 5.8 tmtm? -48.92 -38.77 23.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.981 1.104 . . . . 3.26 113.981 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -108.19 -31.72 7.79 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 114.716 1.376 . . . . 4.84 114.716 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.445 ' C ' HD22 ' A' ' 83' ' ' LEU . 1.7 m-80 -83.5 -22.95 32.34 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.976 -1.49 . . . . 1.89 110.574 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.61 HD21 ' CH2' ' A' ' 78' ' ' TRP . 3.3 mm? -108.6 -55.65 2.36 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.619 -0.832 . . . . 2.62 108.949 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 O-C-N 126.852 2.595 . . . . 4.32 112.728 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.8 mtm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.975 -1.12 . . . . 2.29 107.975 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -113.73 116.45 29.43 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.489 0.493 . . . . 4.18 110.743 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 24.1 m -110.81 119.04 37.8 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.013 -1.106 . . . . 0.92 108.013 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.489 ' C ' HD12 ' A' ' 5' ' ' ILE . 43.3 t -114.57 135.54 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 119.687 -0.805 . . . . 0.96 111.248 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -113.43 123.31 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 124.52 1.138 . . . . 1.12 108.016 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -108.92 92.58 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.322 -2.103 . . . . 2.14 105.322 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.05 -171.81 15.9 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.04 -2.424 . . . . 1.41 107.04 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -95.44 174.53 6.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 116.726 -1.99 . . . . 4.67 110.365 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -55.76 76.65 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.906 -1.952 . . . . 5.97 109.323 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 97.07 74.04 1.17 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 106.885 -2.486 . . . . 3.67 106.885 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.465 ' HB2' ' H ' ' A' ' 8' ' ' ARG . 42.1 t -111.95 94.9 26.8 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 119.749 -0.78 . . . . 6.41 109.213 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 1.3 Cg_endo -41.11 -21.77 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.368 2.045 . . . . 3.95 113.026 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -72.85 -45.03 60.55 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.464 -1.294 . . . . 4.09 109.339 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.481 ' SG ' HG21 ' A' ' 5' ' ' ILE . 5.2 t -54.83 -39.8 68.94 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.283 -0.967 . . . . 4.34 108.79 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.8 t -43.75 -36.56 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 115.387 -0.824 . . . . 1.31 111.7 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.621 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 2.9 mmp_? -82.41 -45.63 14.57 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 119.106 -1.038 . . . . 3.33 109.708 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.03 60.76 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.683 -1.599 . . . . 0.81 106.683 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.615 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.8 tmtt? -56.73 -59.62 4.76 Favored 'General case' 0 C--O 1.187 -2.187 0 CA-C-N 113.342 -1.754 . . . . 2.21 108.657 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.615 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -48.58 -54.04 16.06 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 118.909 -1.116 . . . . 2.51 111.141 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.51 -60.89 2.74 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.494 -0.775 . . . . 0.9 110.574 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.82 77.73 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.278 -0.569 . . . . 0.99 110.564 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' SER . 31.4 tt0 -56.24 -49.52 73.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 124.445 1.091 . . . . 1.95 109.528 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -49.95 -61.56 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.125 -1.03 . . . . 4.5 108.259 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.451 HD11 HG13 ' A' ' 79' ' ' VAL . 47.1 mt -50.6 -57.63 7.74 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.108 -1.071 . . . . 1.28 108.108 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 8.3 t -34.59 -47.79 0.34 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.191 -1.368 . . . . 1.01 110.885 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -85.52 -30.72 23.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.628 1.205 . . . . 2.36 112.654 -179.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.548 ' HB2' ' HD2' ' A' ' 28' ' ' ARG . 80.8 mt-10 -70.0 -32.45 70.63 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.071 -1.052 . . . . 3.22 110.629 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.548 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.54 37.52 2.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.203 -1.399 . . . . 4.9 113.831 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' ARG . 48.0 m-20 28.81 52.76 0.07 Allowed 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 114.611 1.337 . . . . 4.9 114.611 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -155.18 -45.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 117.983 -1.487 . . . . 3.7 113.679 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -81.38 69.04 7.93 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.553 -0.859 . . . . 2.56 110.306 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.41 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 1.1 mp0 -83.48 147.03 28.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.701 -1.222 . . . . 4.71 107.701 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 3' ' ' THR . 46.5 p90 -119.46 161.75 20.01 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.561 -1.255 . . . . 1.1 112.196 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -129.78 136.04 49.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.305 -1.316 . . . . 3.93 107.91 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 3.6 t80 -113.7 117.94 32.95 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.615 -1.254 . . . . 1.56 107.615 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.13 146.9 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.833 -1.173 . . . . 1.4 107.833 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.1 143.42 45.51 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.629 1.204 . . . . 2.32 111.749 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 8' ' ' ARG . 18.8 pt -56.93 -40.75 74.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 112.262 -2.245 . . . . 1.23 112.257 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.402 ' NH2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -86.41 -10.07 55.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.216 -0.994 . . . . 5.32 111.656 -178.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.51 -49.02 6.92 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.699 -0.852 . . . . 1.41 108.699 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.37 -37.66 43.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.669 -1.605 . . . . 3.6 111.191 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 46.42 1.86 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.634 -1.786 . . . . 1.36 108.634 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.495 HG21 ' HG ' ' A' ' 48' ' ' LEU . 22.2 mt -87.25 146.94 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.847 -1.168 . . . . 1.57 107.847 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -110.64 176.4 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.919 -0.712 . . . . 2.47 111.124 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -67.31 -57.77 6.04 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.188 -1.412 . . . . 5.32 107.188 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 1.7 mp0 -47.86 -48.51 31.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.753 -1.112 . . . . 4.58 110.023 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 26.6 t70 -64.64 -56.59 12.87 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.353 -0.939 . . . . 2.02 110.48 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.495 ' HG ' HG21 ' A' ' 43' ' ' ILE . 1.3 mt -56.69 -40.23 75.23 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.459 -0.896 . . . . 1.55 111.131 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -62.0 -43.83 98.0 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.722 -1.585 . . . . 3.64 106.722 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -56.78 -40.05 75.17 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.276 -0.875 . . . . 3.74 108.762 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 48.2 mmtm -64.12 -51.95 61.45 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.261 -0.882 . . . . 2.27 111.459 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.62 70.06 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 112.877 0.695 . . . . 1.63 112.877 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.36 -47.53 1.01 Allowed Glycine 0 N--CA 1.503 3.152 0 C-N-CA 119.44 -1.362 . . . . 2.72 112.205 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -110.45 174.36 2.41 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.732 . . . . 7.59 109.022 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.36 68.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.98 1.787 . . . . 5.6 110.903 143.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.4 47.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.18 -1.045 . . . . 6.29 108.18 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -82.66 72.47 9.73 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.908 -1.042 . . . . 8.17 108.671 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 p -103.57 100.62 10.46 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.753 -1.112 . . . . 5.09 108.798 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 m -74.56 138.36 74.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 C-N-CA 117.759 -1.576 . . . . 1.68 109.598 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -93.91 137.56 6.87 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 O-C-N 122.932 0.964 . . . . 1.79 111.623 7.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.42 ' NE2' HD22 ' A' ' 48' ' ' LEU . 7.2 mp0 -97.65 142.87 28.92 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.287 -1.746 . . . . 3.73 106.287 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.8 mp -115.29 143.77 24.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.416 -0.913 . . . . 1.57 109.474 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.286 -1.779 . . . . 1.17 108.785 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.67 118.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 105.466 -2.05 . . . . 0.93 105.466 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 64.67 -86.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.621 -1.251 . . . . 3.27 107.621 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.62 5.3 1.04 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.084 -0.962 . . . . 3.58 109.204 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -91.2 162.16 14.76 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.359 -0.978 . . . . 3.71 108.359 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -108.67 138.15 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.633 -0.877 . . . . 0.91 108.633 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -106.87 -43.85 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.383 -0.927 . . . . 0.83 109.151 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.7 -134.9 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.015 -1.634 . . . . 1.15 109.015 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.44 179.27 25.62 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 108.969 -1.652 . . . . 1.19 108.969 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -45.62 -38.52 6.71 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 118.953 -1.099 . . . . 1.53 110.789 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -54.15 -63.29 1.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.372 0.606 . . . . 1.77 109.72 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.79 -47.28 80.54 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.115 -0.948 . . . . 2.36 108.538 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.45 ' CD1' HG21 ' A' ' 62' ' ' ILE . 42.4 t80 -47.16 -51.63 17.75 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.339 -0.846 . . . . 0.87 110.536 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.11 -53.08 62.12 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.02 -1.072 . . . . 0.81 109.687 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.34 -56.43 16.72 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.139 -1.024 . . . . 0.82 109.967 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -48.94 -57.62 6.19 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.038 -0.983 . . . . 0.7 108.605 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.451 HG13 HD11 ' A' ' 24' ' ' LEU . 26.9 t -46.08 -52.84 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 124.255 0.972 . . . . 0.8 108.725 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -57.73 -54.92 41.47 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.81 1.041 . . . . 3.19 113.81 -178.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.405 ' N ' ' HE3' ' A' ' 80' ' ' LYS . 1.5 pt-20 -73.11 -29.16 62.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.432 1.271 . . . . 4.42 114.432 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -90.57 -31.94 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.803 -1.159 . . . . 1.8 109.919 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.16 53.07 0.93 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.749 -1.204 . . . . 2.82 107.749 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.521 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 4.8 t0 . . . . . 0 C--N 1.289 -2.033 0 CA-C-N 114.345 -1.298 . . . . 4.77 109.361 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 107.062 -1.458 . . . . 3.0 107.062 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -106.44 107.04 17.85 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.529 -0.915 . . . . 4.03 108.529 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.436 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 25.0 m -93.13 136.14 33.66 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.685 -0.806 . . . . 0.97 109.403 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.524 ' C ' HD12 ' A' ' 5' ' ' ILE . 5.3 t -122.62 128.57 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 119.397 -0.921 . . . . 0.97 108.709 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -111.27 136.98 45.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 124.29 0.994 . . . . 1.13 108.898 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -108.16 112.34 24.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 102.456 -3.164 . . . . 2.45 102.456 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.531 ' HA2' ' SG ' ' A' ' 14' ' ' CYS . . . -109.32 -166.15 20.31 Favored Glycine 0 N--CA 1.501 2.975 0 C-N-CA 118.552 -1.785 . . . . 1.83 114.195 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.479 HH12 ' CB ' ' A' ' 58' ' ' THR . 7.8 ttt85 -108.76 -141.6 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.892 -1.154 . . . . 7.96 109.348 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.51 176.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.572 0.701 . . . . 5.71 112.073 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.05 67.23 2.75 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.837 -0.905 . . . . 5.16 110.837 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 50.5 t -128.37 152.75 78.63 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.247 -1.39 . . . . 5.67 107.247 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.515 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 32.0 Cg_endo -70.21 67.16 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.42 1.414 . . . . 5.15 111.334 172.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -109.4 -94.6 0.41 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.92 -1.141 . . . . 4.22 107.92 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' HA2' ' A' ' 7' ' ' GLY . 46.5 m -52.46 -20.47 2.9 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.618 -0.833 . . . . 2.5 109.132 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 18' ' ' LYS . 91.6 t -45.89 -33.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.923 -1.035 . . . . 2.79 110.301 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -44.87 -35.84 3.0 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.461 -0.896 . . . . 2.99 110.379 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 5' ' ' ILE . . . -66.37 -43.37 86.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.097 -1.446 . . . . 1.09 107.097 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HE2' ' N ' ' A' ' 19' ' ' ASP . 3.3 tmpt? -57.7 -45.28 85.89 Favored 'General case' 0 C--O 1.196 -1.724 0 N-CA-C 107.855 -1.165 . . . . 1.74 107.855 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 68.9 m-20 -63.09 -60.76 3.0 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.835 -0.62 . . . . 3.31 109.788 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 tp -48.41 -55.21 11.45 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.951 -0.7 . . . . 0.92 109.815 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.33 82.21 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.872 -0.731 . . . . 1.16 109.919 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 27.5 tt0 -45.43 -49.77 13.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 123.593 0.558 . . . . 1.96 110.789 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 23.0 tptp -52.07 -56.22 15.77 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 118.316 -1.353 . . . . 4.71 110.972 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.448 HD11 ' CG1' ' A' ' 79' ' ' VAL . 33.7 mt -52.7 -48.85 66.31 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.326 -1.731 . . . . 1.31 106.326 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -47.19 -38.69 12.42 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.543 -2.117 . . . . 1.06 108.731 178.369 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -117.75 42.25 2.67 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.136 -0.938 . . . . 2.38 110.201 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.527 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 30.8 tt0 -117.29 -59.63 1.92 Allowed 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.152 -1.425 . . . . 3.31 107.152 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.527 ' HD3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -117.97 16.36 14.23 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.698 -2.334 . . . . 3.71 104.698 177.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.0 OUTLIER 34.46 47.2 0.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 123.221 1.486 . . . . 6.0 109.156 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.02 9.52 8.73 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 111.694 -2.503 . . . . 4.82 111.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.436 ' CZ ' ' OG1' ' A' ' 3' ' ' THR . 21.0 t80 -134.85 147.73 49.96 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.963 -0.695 . . . . 1.67 110.012 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -135.25 151.53 50.68 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.07 -0.715 . . . . 3.17 109.07 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 42.6 p90 -139.29 155.94 47.38 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.2 -1.0 . . . . 1.67 111.367 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -135.97 138.56 42.41 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.839 -1.171 . . . . 4.47 107.839 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -114.05 133.27 55.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.749 -1.18 . . . . 1.26 109.091 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 37' ' ' ASP . 92.4 t -129.7 167.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.889 0.852 . . . . 1.37 110.857 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 36' ' ' VAL . 29.6 t0 -118.48 128.12 54.29 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.296 -1.002 . . . . 2.14 108.296 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.3 pt -43.81 -34.53 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.49 0.662 . . . . 1.59 111.235 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 2.3 ttm105 -74.6 -54.97 6.44 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.222 -0.899 . . . . 5.98 110.007 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -36.54 -55.13 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.168 0.918 . . . . 2.1 112.237 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -74.6 -41.47 60.38 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 124.147 0.904 . . . . 4.52 109.748 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.45 46.4 1.14 Allowed Glycine 0 N--CA 1.502 3.082 0 N-CA-C 108.317 -1.913 . . . . 2.06 108.317 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mt -98.93 152.97 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.128 -1.036 . . . . 2.08 110.474 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.1 p -116.69 141.3 48.38 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.768 -1.106 . . . . 2.53 108.852 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -45.04 -51.05 10.45 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.258 -0.977 . . . . 5.04 110.807 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 2.7 mp0 -50.94 -47.25 61.12 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.875 -0.73 . . . . 5.82 110.358 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' OD1' ' NZ ' ' A' ' 51' ' ' LYS . 4.5 t0 -53.94 -55.5 26.48 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.401 -0.92 . . . . 3.67 108.55 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.21 -50.94 63.68 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 114.962 -1.017 . . . . 2.6 109.198 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 20.3 mt-30 -49.19 -49.24 43.61 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.293 -1.321 . . . . 6.58 108.283 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.64 -55.94 19.65 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.79 -1.095 . . . . 5.33 110.527 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' NZ ' ' OD1' ' A' ' 47' ' ' ASP . 41.3 mttp -53.88 -47.68 70.84 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 115.633 -0.712 . . . . 3.34 111.843 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.31 -55.96 26.93 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.481 -1.236 . . . . 2.26 112.601 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.29 -34.49 5.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.001 -1.64 . . . . 3.95 109.001 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -106.21 146.37 32.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 120.09 -0.644 . . . . 6.61 109.645 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.23 89.79 0.32 Allowed 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.825 2.35 . . . . 4.89 111.635 -171.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.423 HG11 HE22 ' A' ' 61' ' ' GLN . 5.1 m -98.46 -177.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 C-N-CA 119.828 -0.749 . . . . 6.18 109.102 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 11.1 tp10 -110.15 -68.7 0.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.966 0.791 . . . . 7.53 110.679 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.479 ' CB ' HH12 ' A' ' 8' ' ' ARG . 2.0 p -144.39 -61.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.645 1.212 . . . . 5.91 109.746 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 8' ' ' ARG . 27.4 m -132.11 178.76 1.6 Allowed Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 112.749 -2.023 . . . . 2.59 107.863 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 28.7 Cg_endo -70.01 138.36 49.32 Favored 'Cis proline' 0 N--CA 1.491 1.335 0 O-C-N 122.994 0.997 . . . . 3.13 111.369 -25.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.423 HE22 HG11 ' A' ' 56' ' ' VAL . 6.6 mm-40 -125.49 125.39 43.22 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.461 -0.94 . . . . 2.46 108.461 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.5 mp -122.54 141.37 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.042 0.925 . . . . 1.93 110.92 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -128.04 163.0 25.52 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 113.13 -1.85 . . . . 1.2 108.783 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.01 124.26 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 118.587 -0.72 . . . . 1.48 109.252 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 50.95 -97.38 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.773 -0.771 . . . . 2.21 111.778 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -129.63 27.52 5.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.447 -1.252 . . . . 3.87 111.02 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -130.66 168.61 16.86 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 116.293 -0.412 . . . . 3.75 111.019 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.526 ' ND1' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t-80 -116.72 144.34 44.56 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.964 -0.754 . . . . 1.06 108.964 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.35 -54.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 118.612 -1.235 . . . . 1.1 109.602 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 144.47 -128.41 3.24 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.617 -1.277 . . . . 1.17 110.626 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -111.96 -171.81 18.91 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.261 -1.447 . . . . 1.18 110.284 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -44.99 -40.61 6.61 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.671 -1.211 . . . . 1.5 109.694 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -55.21 -63.98 0.99 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.417 0.627 . . . . 2.05 110.062 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -46.48 71.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.769 -1.105 . . . . 2.88 110.002 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.401 ' CD1' HG21 ' A' ' 62' ' ' ILE . 41.5 t80 -61.23 -50.5 72.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.748 -0.781 . . . . 1.09 111.312 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.93 -57.07 10.51 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.569 -0.852 . . . . 1.08 109.441 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.16 24.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.688 -0.805 . . . . 0.9 110.112 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -43.42 -46.9 6.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 124.118 0.886 . . . . 1.25 109.395 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.448 ' CG1' HD11 ' A' ' 24' ' ' LEU . 19.1 t -62.75 -67.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.923 -1.035 . . . . 0.99 108.896 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -45.35 -34.99 3.29 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 115.845 1.794 . . . . 2.24 115.845 -176.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' OE2' ' NZ ' ' A' ' 80' ' ' LYS . 1.3 mp0 -101.63 9.41 41.13 Favored 'General case' 0 N--CA 1.512 2.652 0 C-N-CA 118.376 -1.33 . . . . 4.71 113.841 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -128.07 -35.83 2.01 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.951 -0.7 . . . . 1.81 109.325 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.92 23.13 14.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.546 -0.862 . . . . 1.99 109.643 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 8.7 t70 . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 107.382 -1.34 . . . . 3.94 107.382 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpp? . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.226 1.013 . . . . 2.74 109.291 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.444 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 2.0 mp0 -104.0 105.19 15.29 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.312 -1.313 . . . . 5.71 108.173 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.4 m -97.26 117.99 32.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.338 -0.945 . . . . 1.11 110.392 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.9 t -113.9 142.31 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 115.532 -0.758 . . . . 1.09 109.79 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.7 mm -114.25 133.77 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.585 -2.006 . . . . 2.0 105.585 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -121.65 80.09 1.64 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.629 -1.619 . . . . 1.9 106.629 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.28 -177.35 24.17 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.727 -1.225 . . . . 1.35 111.823 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -122.54 94.15 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.362 -1.347 . . . . 6.56 107.362 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.439 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 4.6 t -74.31 73.6 1.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.008 -1.077 . . . . 6.95 111.097 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -41.02 -50.88 4.25 Favored Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.096 -0.802 . . . . 3.12 111.096 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.452 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 17.3 m -111.87 -170.1 0.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 106.691 -1.596 . . . . 4.67 106.691 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 52.8 Cg_exo -53.0 73.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 120.856 1.038 . . . . 4.32 111.409 153.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -119.54 -85.09 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.042 -0.725 . . . . 4.76 109.042 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -60.19 -24.73 65.02 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 106.993 -1.484 . . . . 2.06 106.993 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' OG ' ' A' ' 9' ' ' SER . 57.3 t -43.81 -32.65 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 CA-C-N 114.278 -1.328 . . . . 1.63 109.634 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -71.56 -50.12 34.13 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.55 -1.26 . . . . 3.53 109.666 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.93 -44.46 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.018 -1.845 . . . . 0.78 106.018 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.464 ' C ' ' HD2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -56.09 -58.91 5.93 Favored 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 113.712 -1.586 . . . . 1.67 107.034 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -43.04 -57.96 2.65 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 120.11 -0.636 . . . . 3.52 110.798 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.98 -62.92 1.29 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.874 -1.057 . . . . 0.78 110.086 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB1' ' CB ' ' A' ' 33' ' ' TYR . . . -53.1 -54.57 33.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.15 -1.02 . . . . 0.69 109.28 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 41.5 tt0 -45.33 -52.63 9.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.088 0.867 . . . . 2.11 110.778 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -58.85 -53.0 63.32 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.881 -1.128 . . . . 4.81 108.457 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -51.93 -41.29 61.91 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.625 -0.83 . . . . 1.12 110.233 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.1 p -73.9 -6.58 48.08 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.272 -0.971 . . . . 1.97 112.047 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -115.72 31.53 6.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.076 -1.453 . . . . 2.5 107.076 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 23' ' ' LYS . 5.8 mm-40 -140.73 -51.65 0.47 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.009 -1.45 . . . . 4.6 107.884 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.587 HH12 ' CG ' ' A' ' 30' ' ' ASP . 13.5 mtp-105 -93.63 -170.42 2.35 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.519 -1.218 . . . . 4.05 111.119 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -111.09 -48.77 3.08 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.453 -0.794 . . . . 5.26 111.24 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.587 ' CG ' HH12 ' A' ' 28' ' ' ARG . 2.8 p30 -83.33 8.1 14.57 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.533 -0.867 . . . . 2.76 111.16 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 25' ' ' SER . 3.3 t80 -104.34 114.44 28.67 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.567 -0.853 . . . . 1.32 111.602 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -130.14 157.5 42.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.048 -1.834 . . . . 3.7 106.048 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 21.2 p90 -129.47 160.89 31.74 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.411 -1.315 . . . . 1.4 110.881 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -141.62 149.22 40.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.019 0.824 . . . . 4.52 110.193 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -126.29 113.39 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.687 -1.597 . . . . 1.54 106.687 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.04 157.82 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.073 -1.825 . . . . 1.39 106.073 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -124.74 140.46 52.91 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.28 -1.368 . . . . 2.58 111.239 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.442 ' C ' HH11 ' A' ' 39' ' ' ARG . 16.7 pt -61.78 -21.94 27.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.066 -0.97 . . . . 1.29 111.517 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.506 ' HA ' HH11 ' A' ' 39' ' ' ARG . 3.3 tpp180 -95.43 -51.48 4.55 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.789 -0.819 . . . . 7.39 108.789 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.75 -49.3 5.69 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.538 1.149 . . . . 1.4 110.148 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -99.55 36.82 1.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.576 -0.85 . . . . 4.64 112.553 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 34.27 65.16 0.36 Allowed Glycine 0 N--CA 1.512 3.715 0 CA-C-O 121.792 0.662 . . . . 1.59 114.168 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.469 HG23 ' HB3' ' A' ' 47' ' ' ASP . 58.1 mt -109.96 148.08 13.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.004 -0.598 . . . . 1.61 109.607 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -126.18 177.86 6.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.965 -1.494 . . . . 2.22 106.965 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -51.68 -47.92 63.68 Favored 'General case' 0 C--O 1.191 -1.984 0 C-N-CA 119.798 -0.761 . . . . 5.36 110.427 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 6.3 mp0 -44.18 -52.59 7.24 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 113.862 1.06 . . . . 3.31 113.862 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 43' ' ' ILE . 50.2 t0 -65.97 -55.86 14.64 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.052 -1.059 . . . . 3.03 109.564 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.489 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.2 mt -53.66 -42.33 67.75 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.548 -0.861 . . . . 1.52 110.201 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -59.21 -42.26 90.53 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.174 -1.417 . . . . 3.99 107.174 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.75 -20.92 60.36 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.851 -1.068 . . . . 3.45 110.589 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -79.96 -46.48 16.61 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.959 -0.696 . . . . 3.28 111.386 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.09 -28.3 11.1 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.73 -0.788 . . . . 1.45 113.009 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.92 -56.76 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 105.767 -2.933 . . . . 4.06 105.767 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.5 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 57.3 mttp 60.1 126.85 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.997 0 CA-C-O 123.266 1.508 . . . . 9.06 114.935 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' C ' ' HB3' ' A' ' 54' ' ' LYS . 12.0 Cg_endo -52.53 139.3 56.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.69 2.26 . . . . 3.65 109.391 96.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 58' ' ' THR . 7.9 p -74.35 72.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 118.952 -1.099 . . . . 5.98 110.768 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.08 33.0 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 119.743 -0.783 . . . . 7.73 112.169 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 56' ' ' VAL . 80.5 p 39.27 -109.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 115.035 1.494 . . . . 3.98 115.035 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.87 149.33 72.77 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 114.219 -1.355 . . . . 1.69 109.724 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.452 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 98.7 Cg_endo -96.37 -175.4 4.63 Favored 'Cis proline' 0 C--N 1.32 -0.925 0 O-C-N 123.15 1.079 . . . . 2.04 110.049 0.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 1.9 mt-30 -138.89 133.78 32.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 124.489 1.118 . . . . 3.01 109.788 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.8 mt -118.07 140.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 120.107 -0.637 . . . . 1.35 110.926 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.85 148.82 52.66 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.73 -1.577 . . . . 0.96 110.658 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.599 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 38.2 t -123.17 111.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.14 -1.059 . . . . 0.87 108.14 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.98 -76.07 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.103 0.954 . . . . 3.21 109.403 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 64' ' ' VAL . 45.0 tt0 -142.94 -9.11 0.8 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.058 -1.428 . . . . 4.38 110.663 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -92.12 168.79 11.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.746 -0.382 . . . . 5.37 110.677 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.413 ' CE1' ' NE2' ' A' ' 61' ' ' GLN . 44.1 t-80 -119.19 153.17 35.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.708 -1.219 . . . . 1.27 107.708 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.0 -50.75 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 119.007 -1.077 . . . . 1.1 109.698 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 164.98 -158.25 31.01 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.959 -1.656 . . . . 1.19 108.959 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 60' ' ' PRO . . . -87.59 -67.6 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.88 -1.629 . . . . 2.85 110.159 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 73' ' ' THR . 61.7 t80 -152.03 179.92 8.05 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.547 -0.861 . . . . 3.75 108.788 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 72' ' ' TYR . 85.0 m 67.73 -68.14 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.629 0.581 . . . . 2.99 110.212 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.53 -51.1 5.21 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.105 0.955 . . . . 3.71 110.155 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.44 -36.96 2.16 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.615 -1.63 . . . . 1.3 112.696 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.59 -49.19 57.09 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.325 -0.95 . . . . 1.37 109.848 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.06 62.51 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.463 -0.94 . . . . 1.46 108.463 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.599 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 78.3 t90 -46.61 -53.81 10.77 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.775 -1.102 . . . . 0.92 109.038 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.555 HG13 HD12 ' A' ' 83' ' ' LEU . 80.4 t -55.42 -41.61 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.904 -1.119 . . . . 1.08 109.534 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.501 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -65.01 -38.89 92.43 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.88 -1.054 . . . . 2.21 113.437 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.37 -12.53 12.99 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 115.815 1.783 . . . . 4.71 115.815 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.436 ' CG ' ' NE1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -92.22 -16.33 26.34 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.544 -0.862 . . . . 1.72 109.996 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.555 HD12 HG13 ' A' ' 79' ' ' VAL . 59.6 mt -102.31 -73.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.454 -0.898 . . . . 3.44 109.16 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.25 0 O-C-N 124.287 0.992 . . . . 4.14 112.003 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.658 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.498 -0.556 . . . . 2.83 109.498 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -94.1 96.97 9.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 123.703 0.627 . . . . 3.97 110.809 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.6 m -91.62 126.04 36.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.043 -0.725 . . . . 1.06 109.043 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.527 ' C ' HD12 ' A' ' 5' ' ' ILE . 16.6 t -129.02 141.76 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.708 -1.197 . . . . 1.18 109.664 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -111.28 132.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.117 -2.179 . . . . 1.26 105.117 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 50.0 m-85 -124.2 116.31 22.49 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.262 -0.644 . . . . 1.89 109.262 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.11 -179.35 20.47 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.251 -1.452 . . . . 2.24 112.353 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -127.23 163.61 23.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.76 -0.72 . . . . 5.52 109.623 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -106.11 -53.12 2.68 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.113 0.959 . . . . 7.76 109.363 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.79 -61.51 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 105.814 -2.914 . . . . 4.92 105.814 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 13' ' ' TYR . 9.6 m -96.24 170.39 7.61 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 106.388 -1.708 . . . . 5.25 106.388 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.93 73.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.365 2.043 . . . . 3.06 111.605 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' CYS . 6.3 t80 -119.63 -60.93 1.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.768 . . . . 5.54 108.925 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 29.8 m -54.64 -39.53 68.06 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 122.615 1.198 . . . . 2.27 108.193 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.0 t -44.41 -50.29 2.01 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 CA-C-N 113.396 -1.729 . . . . 1.28 111.278 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 8.5 mmm180 -56.92 -41.17 77.68 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.105 -1.038 . . . . 3.78 110.243 -178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.12 80.05 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.218 -1.401 . . . . 0.77 107.218 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -52.5 65.06 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.76 -1.176 . . . . 1.79 107.855 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.05 -52.17 9.26 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.458 -0.897 . . . . 3.13 110.628 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' A' ' 75' ' ' PHE . 40.9 tp -58.49 -60.38 3.89 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 120.41 -0.516 . . . . 0.81 110.656 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.31 -44.22 44.13 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.969 -1.014 . . . . 0.64 109.45 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.91 -51.46 66.84 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 124.709 1.256 . . . . 1.74 109.358 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -50.21 -56.16 12.25 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.394 -0.922 . . . . 4.33 108.674 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.497 HD11 HG21 ' A' ' 79' ' ' VAL . 44.6 mt -57.3 -44.36 84.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.341 1.026 . . . . 1.14 109.179 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 t -51.89 -29.9 21.78 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.979 -1.464 . . . . 0.99 109.61 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.474 ' CG ' ' O ' ' A' ' 26' ' ' ASN . 5.9 t-20 -96.38 25.77 4.79 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.152 -0.931 . . . . 2.71 110.935 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.7 mt-10 -138.74 -35.44 0.58 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.504 -0.771 . . . . 2.52 110.537 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 30' ' ' ASP . 43.3 mtp85 -114.71 129.86 56.74 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.759 -0.776 . . . . 3.75 112.017 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.16 32.56 0.28 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.242 1.02 . . . . 3.62 109.742 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.3 p30 -136.49 -1.7 2.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.708 -1.587 . . . . 3.16 109.243 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -120.64 124.53 45.47 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.653 0.739 . . . . 0.92 112.635 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -142.76 155.13 44.8 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.131 -1.433 . . . . 4.85 107.131 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -134.76 163.88 28.81 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.105 -1.438 . . . . 1.27 112.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.65 154.52 44.43 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 124.604 1.19 . . . . 5.21 109.389 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.42 ' HD1' ' N ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -127.88 124.63 37.94 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.9 -0.72 . . . . 2.7 110.162 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' N ' ' HD1' ' A' ' 35' ' ' TYR . 2.4 t -123.41 149.88 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.379 -1.341 . . . . 1.87 107.379 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -123.55 124.91 43.89 Favored 'General case' 0 N--CA 1.51 2.57 0 C-N-CA 117.816 -1.554 . . . . 2.37 110.412 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 pt -43.5 -38.76 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 113.435 -1.711 . . . . 1.52 114.017 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 24.35 6.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.237 -0.985 . . . . 8.48 112.905 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.95 -43.96 2.74 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.012 -1.107 . . . . 2.02 108.012 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -92.45 -28.68 16.69 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.686 -1.597 . . . . 5.96 111.288 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.4 0.66 Allowed Glycine 0 N--CA 1.503 3.103 0 C-N-CA 119.364 -1.398 . . . . 1.95 111.132 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.9 mt -112.46 156.84 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.665 -0.814 . . . . 2.11 108.984 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -101.24 -170.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.428 -0.953 . . . . 2.54 108.428 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -49.98 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.722 -1.584 . . . . 4.65 106.722 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.69 -52.25 24.38 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.372 -0.931 . . . . 3.87 110.118 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.85 -44.93 40.11 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 120.064 -0.654 . . . . 2.65 111.49 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 1.8 mt -70.14 -42.83 72.06 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.886 0.85 . . . . 1.63 109.011 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 49' ' ' GLN . 3.4 tp-100 -58.27 -32.48 68.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.625 -1.25 . . . . 5.06 107.625 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 0.96 7.74 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.048 -1.433 . . . . 4.15 110.263 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 57.3 mttp -115.85 -42.72 3.06 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.57 -1.195 . . . . 2.3 109.824 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -81.02 -50.89 9.12 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.358 -0.837 . . . . 1.05 111.476 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.74 -55.54 2.28 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.65 -2.18 . . . . 2.77 107.65 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HD3' HE22 ' A' ' 61' ' ' GLN . 44.4 mtmt 31.14 -147.39 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 CA-C-N 112.526 -1.837 . . . . 7.92 113.566 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 57.2 Cg_endo -92.37 -166.95 0.17 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.962 1.775 . . . . 4.08 112.416 128.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -98.52 81.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.369 -0.832 . . . . 6.85 109.543 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -115.4 -94.25 0.48 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.948 1.092 . . . . 5.41 113.948 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 59' ' ' VAL . 1.3 m -142.86 -156.05 0.65 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 118.972 -1.091 . . . . 4.55 113.738 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.572 ' H ' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -114.78 -169.05 0.14 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 114.389 -1.278 . . . . 3.35 108.966 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.651 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 31.7 Cg_endo -68.57 -175.42 9.49 Favored 'Cis proline' 0 N--CA 1.499 1.815 0 O-C-N 122.182 0.57 . . . . 2.75 111.553 -28.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.462 HE22 ' HD3' ' A' ' 54' ' ' LYS . 19.3 tp60 -134.74 150.95 50.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 123.976 0.798 . . . . 2.83 111.864 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mt -123.67 142.51 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.711 -1.218 . . . . 1.07 107.711 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.21 156.56 48.5 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.844 -1.071 . . . . 1.01 110.004 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.6 t -138.12 115.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.017 -0.673 . . . . 1.33 109.653 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 1' ' ' MET . 1.2 m-20 54.44 -101.94 0.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.253 -1.017 . . . . 3.28 108.253 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -125.75 39.55 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.857 -0.794 . . . . 3.98 108.857 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -127.51 161.78 27.97 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.416 -0.811 . . . . 3.49 109.984 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.509 ' CD2' ' N ' ' A' ' 69' ' ' ILE . 5.5 t-160 -122.54 142.42 50.62 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.753 -1.203 . . . . 1.15 107.753 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.509 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 28.1 mm -101.33 -99.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 118.704 -1.198 . . . . 1.83 107.877 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.42 65.29 0.21 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.401 -1.38 . . . . 4.23 110.611 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.66 -175.33 17.52 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.995 -1.642 . . . . 1.52 108.995 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' PHE . 13.6 t80 -110.08 -60.75 1.75 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.356 -0.938 . . . . 1.51 109.947 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -46.09 -34.11 3.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.578 -1.638 . . . . 4.91 106.578 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.6 -44.11 97.61 Favored 'General case' 0 C--O 1.2 -1.537 0 CA-C-N 113.077 -1.874 . . . . 3.41 108.87 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CD2' HD23 ' A' ' 20' ' ' LEU . 11.9 t80 -63.45 -41.52 98.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.476 -0.935 . . . . 1.11 108.476 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -62.48 -56.15 20.86 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.365 -0.934 . . . . 1.3 108.966 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.15 43.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.325 -1.361 . . . . 1.28 107.325 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.438 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 80.1 t90 -36.47 -54.73 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.981 0.801 . . . . 1.1 110.413 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.497 HG21 HD11 ' A' ' 24' ' ' LEU . 41.4 t -43.92 -60.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 115.199 -0.91 . . . . 1.48 111.92 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -44.33 -29.61 0.7 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.614 0.968 . . . . 3.16 113.614 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -109.06 -27.02 9.86 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.628 -0.829 . . . . 4.13 113.044 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -83.98 -34.13 24.43 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.042 -1.063 . . . . 1.84 111.017 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.44 HD12 HG13 ' A' ' 79' ' ' VAL . 68.0 mt -102.47 -44.79 5.26 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.042 -1.836 . . . . 3.45 106.042 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 126.497 2.373 . . . . 5.19 111.501 179.551 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.579 ' H2 ' ' CG ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.344 0.592 . . . . 2.69 110.04 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -109.65 99.44 8.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.579 -2.378 . . . . 4.43 104.579 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.461 HG21 ' CE1' ' A' ' 75' ' ' PHE . 27.1 m -88.4 103.42 15.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.906 -1.497 . . . . 1.37 109.868 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 63.3 t -94.47 130.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.751 -0.659 . . . . 1.28 110.292 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.494 HG21 ' SG ' ' A' ' 14' ' ' CYS . 1.6 mp -113.74 116.86 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.411 -1.7 . . . . 1.08 106.411 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.627 ' CE2' HD13 ' A' ' 43' ' ' ILE . 2.8 m-30 -106.33 98.38 8.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.826 -1.916 . . . . 2.65 105.826 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 60' ' ' PRO . . . -130.59 -159.99 9.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.42 -1.371 . . . . 1.62 112.481 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' CZ ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -124.4 130.1 51.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.02 -1.474 . . . . 5.0 107.02 179.016 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.474 ' OG ' ' CZ ' ' A' ' 8' ' ' ARG . 1.6 p -51.77 106.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.632 -0.827 . . . . 4.9 108.95 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . 134.08 -12.42 4.73 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.699 -1.238 . . . . 3.61 111.16 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 97.1 m -95.3 90.94 0.66 Allowed Pre-proline 0 N--CA 1.501 2.122 0 C-N-CA 119.493 -0.883 . . . . 5.57 110.682 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 10' ' ' GLY . 28.3 Cg_endo -58.78 -3.57 1.55 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.741 2.961 . . . . 3.69 112.719 -162.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 11' ' ' CYS . 9.5 m-30 -71.44 -37.27 71.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.62 -1.252 . . . . 4.92 107.62 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 3.6 t -58.56 -43.19 89.29 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.143 -1.423 . . . . 3.62 108.21 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.42 -57.74 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.428 -0.952 . . . . 1.34 108.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 6.5 mmp_? -49.93 -48.45 51.81 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.649 -1.22 . . . . 3.73 109.649 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.0 -54.77 40.86 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.887 -1.525 . . . . 0.83 108.266 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -46.22 -49.08 17.58 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.177 -0.609 . . . . 1.71 109.879 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.479 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 35.1 m-20 -63.28 -55.68 22.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.887 -0.597 . . . . 3.29 110.188 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.5 tp -48.53 -55.73 10.27 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.987 -1.085 . . . . 0.91 109.239 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -58.69 -36.22 73.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.656 -0.818 . . . . 1.07 109.668 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.6 tt0 -51.31 -47.55 62.58 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.051 -1.059 . . . . 1.9 109.819 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -44.73 -60.15 2.16 Favored 'General case' 0 N--CA 1.514 2.751 0 C-N-CA 119.419 -0.912 . . . . 6.99 109.657 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 47.6 mt -45.53 -52.39 10.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.224 -1.353 . . . . 2.03 107.916 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -53.48 -37.34 62.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.662 -1.608 . . . . 1.36 111.415 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -104.22 37.1 2.17 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.048 0.928 . . . . 2.02 108.549 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 28' ' ' ARG . 58.9 tt0 -130.11 -51.39 1.11 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.177 -1.374 . . . . 4.76 107.517 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 27' ' ' GLU . 9.7 ptp180 -124.79 -178.39 4.14 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 112.368 -2.196 . . . . 3.11 108.619 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -116.29 27.95 8.9 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.486 0.66 . . . . 4.62 110.685 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.421 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 3.0 p30 -120.26 -8.41 9.68 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.453 -0.794 . . . . 3.06 112.701 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -108.68 130.15 55.34 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.109 1.522 . . . . 1.34 115.109 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' N ' ' NE2' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -138.31 153.14 49.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.891 -1.152 . . . . 3.58 107.891 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.91 156.25 35.04 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.528 -0.869 . . . . 1.16 109.978 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -130.12 118.22 21.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.62 0.575 . . . . 4.7 109.914 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.496 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -107.47 112.62 25.49 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.721 -0.792 . . . . 2.23 109.287 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 156.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 123.89 0.744 . . . . 1.6 109.642 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.3 t70 -114.06 131.47 56.37 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 106.869 -1.53 . . . . 2.36 106.869 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 pt -47.78 -39.96 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 114.348 1.24 . . . . 1.18 114.348 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.506 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -85.98 -45.14 11.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.607 -1.637 . . . . 5.04 108.422 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 39' ' ' ARG . . . -35.38 -56.86 0.62 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 124.068 0.855 . . . . 1.73 110.918 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -105.5 44.53 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 124.083 0.864 . . . . 5.74 110.97 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 23.53 68.15 0.03 OUTLIER Glycine 0 N--CA 1.504 3.215 0 CA-C-N 114.773 -1.103 . . . . 2.0 114.597 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.627 HD13 ' CE2' ' A' ' 6' ' ' PHE . 34.3 mt -101.08 140.26 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.432 -1.692 . . . . 1.91 106.432 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.9 p -104.41 169.98 8.16 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.442 -0.903 . . . . 3.27 111.195 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.458 ' CA ' ' HZ2' ' A' ' 45' ' ' LYS . 5.0 mmmp? -70.83 -35.33 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 117.806 -1.558 . . . . 5.01 111.963 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.72 -55.18 38.26 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.924 -1.51 . . . . 6.55 106.924 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.476 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 25.0 t70 -48.68 -48.1 40.27 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 115.094 -0.957 . . . . 2.85 111.657 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.84 -50.22 67.5 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.836 -1.074 . . . . 2.01 110.743 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.45 -45.44 66.04 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.418 -1.327 . . . . 4.66 107.418 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -23.33 40.13 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.613 -1.63 . . . . 4.01 111.211 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 7.9 mtmm -96.8 -32.74 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.308 -0.557 . . . . 2.35 110.849 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.531 ' HB2' HE22 ' A' ' 61' ' ' GLN . . . -75.41 -44.26 45.6 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.093 -0.643 . . . . 1.38 112.021 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.0 -48.75 0.91 Allowed Glycine 0 N--CA 1.501 3.031 0 N-CA-C 108.232 -1.947 . . . . 3.32 108.232 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.565 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 3.8 ttpm? -91.4 166.58 17.88 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.245 -2.131 . . . . 6.29 105.245 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.565 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.5 Cg_endo -48.22 155.61 1.92 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.685 -1.313 . . . . 5.29 108.685 146.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 m -118.79 149.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.897 -1.121 . . . . 5.11 110.562 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 15.6 mp0 -87.19 -69.47 0.68 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.073 0.858 . . . . 6.3 111.17 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 59' ' ' VAL . 26.7 m -143.8 173.64 11.5 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.731 -0.788 . . . . 3.64 110.871 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 58' ' ' THR . 15.7 m -101.92 159.17 30.18 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.818 -1.179 . . . . 1.94 107.818 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 10.0 Cg_endo -92.01 147.26 14.33 Favored 'Cis proline' 0 C--N 1.318 -1.057 0 CA-C-N 118.554 0.519 . . . . 1.67 111.454 9.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.531 HE22 ' HB2' ' A' ' 52' ' ' ALA . 18.6 mt-30 -107.78 147.47 30.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.922 -0.711 . . . . 2.85 109.47 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.459 HD12 ' CB ' ' A' ' 75' ' ' PHE . 4.4 mt -121.18 141.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.268 -0.973 . . . . 1.37 112.489 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 19.7 m-85 -128.62 153.28 47.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 114.608 -1.178 . . . . 0.97 108.998 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.6 t -122.33 102.05 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.487 -1.301 . . . . 0.98 107.487 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.579 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 37.2 m-20 65.49 -83.58 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.772 0.796 . . . . 2.38 110.25 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -126.3 -15.43 5.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.398 -1.274 . . . . 4.23 109.717 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -81.37 167.86 19.0 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.421 -0.512 . . . . 3.69 111.27 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -123.43 136.26 54.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.439 -1.689 . . . . 1.22 106.439 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' A' ' 75' ' ' PHE . 26.0 mm -107.07 -31.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.33 -0.948 . . . . 0.79 110.204 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.4 -117.98 3.8 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.48 -1.448 . . . . 1.33 109.48 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.36 -172.77 18.96 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.285 -1.126 . . . . 1.32 110.285 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -56.01 -53.21 59.67 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.095 -1.042 . . . . 1.54 113.253 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 p -40.92 -58.63 1.65 Allowed 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.726 -0.79 . . . . 1.74 110.833 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.56 -57.74 10.68 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 113.677 -1.601 . . . . 2.05 108.964 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HA ' HG21 ' A' ' 69' ' ' ILE . 70.1 t80 -45.82 -52.91 10.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.747 -0.781 . . . . 0.88 111.497 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -55.99 18.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.469 -0.892 . . . . 1.05 109.145 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.62 -58.98 5.36 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.623 -0.831 . . . . 0.9 109.518 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.406 ' O ' ' HB2' ' A' ' 82' ' ' ASN . 74.3 t90 -41.99 -53.61 3.8 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.738 -0.664 . . . . 0.89 109.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.18 -60.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 124.094 0.871 . . . . 0.98 109.796 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.78 -55.79 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.127 1.158 . . . . 2.68 114.127 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -93.42 28.6 2.2 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 117.184 -1.807 . . . . 5.49 114.305 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 78' ' ' TRP . 40.9 m-80 -140.2 -36.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 119.124 -1.03 . . . . 2.86 110.195 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.0 -26.25 9.36 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.518 -0.765 . . . . 1.99 111.161 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 124.002 0.814 . . . . 6.57 110.365 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.47 0.652 . . . . 3.28 110.013 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.74 160.77 14.05 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.15 -0.932 . . . . 5.85 111.602 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.3 m -124.68 146.61 49.03 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 109.843 -0.429 . . . . 1.4 109.843 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.77 132.95 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.415 -0.957 . . . . 1.7 108.415 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.3 mp -118.29 121.99 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.48 -0.933 . . . . 1.31 108.48 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -115.04 113.57 24.24 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 106.745 -1.576 . . . . 1.65 106.745 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . 160.94 -169.3 36.54 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.279 -1.915 . . . . 1.77 108.443 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -126.51 173.66 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 116.854 -1.938 . . . . 4.78 112.3 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.12 -179.96 4.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.008 -1.451 . . . . 5.73 109.778 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.48 -49.22 0.91 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.116 -1.993 . . . . 3.97 108.116 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.8 t -128.24 101.04 22.44 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 107.391 -1.337 . . . . 4.81 107.391 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 14' ' ' CYS . 2.3 Cg_endo -31.05 -56.14 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.634 2.223 . . . . 4.32 113.06 -122.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 53.15 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.874 1.065 . . . . 6.52 113.874 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' PRO . 18.2 m -115.85 -6.22 12.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.348 -0.541 . . . . 2.29 110.797 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -43.03 -57.54 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 119.743 -0.783 . . . . 2.42 111.78 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.576 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -60.09 -35.47 75.27 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 117.481 -1.688 . . . . 4.27 109.891 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.27 -51.64 68.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.177 -1.409 . . . . 0.82 107.667 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 18.0 tptp -53.14 -50.52 64.38 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 120.26 -0.576 . . . . 2.45 111.724 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.576 ' CG ' HH22 ' A' ' 16' ' ' ARG . 6.9 t0 -66.36 -53.91 30.71 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.784 0.802 . . . . 2.66 110.165 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 tp -49.93 -53.44 26.13 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.199 -1.037 . . . . 1.47 108.199 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.95 76.18 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.427 -0.953 . . . . 1.06 108.427 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 4.8 tp10 -46.68 -62.98 1.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.465 1.126 . . . . 2.91 110.677 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.42 -50.1 17.18 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 113.585 -1.643 . . . . 4.28 110.921 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 mt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.169 -0.923 . . . . 1.53 110.321 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -58.52 -40.89 84.14 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.024 -0.732 . . . . 1.27 109.024 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -89.05 29.84 1.01 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.947 -1.131 . . . . 2.74 107.947 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -120.82 -59.19 1.77 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.257 -1.016 . . . . 3.47 108.257 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' A' ' 84' ' ' ASP . 3.4 mtt180 -116.5 152.28 34.39 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.352 -0.981 . . . . 4.08 108.352 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -74.98 -36.05 62.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.644 -0.822 . . . . 4.91 110.176 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 30' ' ' ASP . 5.5 t70 -83.51 41.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.666 -0.813 . . . . 4.31 109.998 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 25' ' ' SER . 50.9 t80 -142.65 72.43 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.322 -0.951 . . . . 1.21 108.622 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -100.2 138.13 37.69 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.272 -1.01 . . . . 3.69 108.272 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -118.36 155.77 30.11 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.15 -1.02 . . . . 1.42 112.84 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -121.69 130.21 53.3 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 3.76 107.92 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -119.49 114.6 22.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.65 -1.241 . . . . 1.7 107.65 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.84 145.93 32.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.483 -0.781 . . . . 2.88 109.653 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 11.3 t70 -97.62 140.19 32.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.126 -1.435 . . . . 3.21 107.126 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.426 ' C ' HH11 ' A' ' 39' ' ' ARG . 9.5 pt -48.31 -29.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 112.895 0.702 . . . . 2.07 112.895 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.463 ' HA ' HH11 ' A' ' 39' ' ' ARG . 0.7 OUTLIER -94.75 22.65 6.14 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.276 -0.97 . . . . 6.91 111.749 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.2 -50.68 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.246 -0.581 . . . . 1.52 109.662 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -95.58 -13.81 24.1 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.5 -0.88 . . . . 3.37 109.755 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.59 58.76 1.17 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.137 -1.985 . . . . 1.56 108.137 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -101.1 141.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 120.117 -0.633 . . . . 2.22 111.582 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 p -123.14 161.54 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 124.538 1.149 . . . . 2.59 109.437 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -43.91 -57.34 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.705 -0.68 . . . . 4.29 109.493 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -44.49 -49.28 9.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 123.826 0.704 . . . . 3.85 111.128 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.78 -50.66 72.58 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.976 -1.49 . . . . 3.08 109.221 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -42.82 64.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.152 -0.931 . . . . 1.83 108.92 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.0 -47.87 79.8 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.6 -1.259 . . . . 4.18 107.6 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -60.19 -50.29 74.25 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.984 0.803 . . . . 4.83 110.562 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 51' ' ' LYS . 2.8 tppt? -55.62 -50.23 70.71 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.428 -1.26 . . . . 3.16 111.508 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.596 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -74.24 -47.49 34.92 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.315 -1.311 . . . . 1.18 113.077 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.86 42.71 5.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.048 -1.621 . . . . 2.48 109.048 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 54' ' ' LYS . 75.5 mmtt -128.41 -176.29 0.51 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.521 -0.918 . . . . 6.36 108.521 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 50.9 Cg_exo -50.82 -157.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.46 1.44 . . . . 4.04 111.235 147.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 m -114.16 70.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.784 -0.643 . . . . 5.81 112.273 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 3.1 mp0 -75.03 54.51 0.67 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.14 -0.936 . . . . 6.17 112.217 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p 41.26 -112.53 0.16 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 115.666 1.728 . . . . 3.98 115.666 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.12 171.55 6.43 Favored Pre-proline 0 N--CA 1.498 1.955 0 CA-C-N 115.569 -0.741 . . . . 1.98 109.402 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.51 173.35 11.98 Favored 'Cis proline' 0 N--CA 1.487 1.109 0 O-C-N 122.616 0.798 . . . . 1.9 110.351 -20.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.75 150.49 49.78 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.905 . . . . 2.74 110.521 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.418 ' C ' ' CD1' ' A' ' 63' ' ' PHE . 48.2 mt -123.16 148.03 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.747 -0.66 . . . . 1.17 109.267 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 9.4 m-85 -131.06 165.39 23.34 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.767 -1.106 . . . . 1.13 109.494 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.428 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 55.7 t -134.8 112.31 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.481 -1.236 . . . . 0.89 110.148 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 66' ' ' GLN . 0.6 OUTLIER 53.94 -85.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.464 0.542 . . . . 2.64 112.464 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.438 ' H ' ' HB3' ' A' ' 65' ' ' ASP . 54.0 mt-30 -139.13 23.18 2.58 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.82 -0.627 . . . . 4.55 110.334 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -123.99 153.96 40.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.398 -0.964 . . . . 3.86 108.398 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.596 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.0 t-160 -108.6 139.77 42.91 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.829 -1.174 . . . . 1.08 107.829 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.75 -45.94 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 118.744 -1.183 . . . . 0.92 110.032 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 138.21 -123.83 2.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.391 -1.484 . . . . 1.37 109.391 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.11 -174.72 19.64 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.147 -1.181 . . . . 1.44 110.147 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -47.4 -60.33 2.59 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.817 1.043 . . . . 2.21 113.817 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -36.31 -59.82 0.61 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.685 1.231 . . . . 2.08 111.369 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -51.78 68.32 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.374 -2.193 . . . . 2.08 109.584 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -47.15 -50.54 20.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.516 -1.274 . . . . 0.94 109.632 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.09 13.14 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.51 -1.276 . . . . 1.14 109.253 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.25 -54.12 35.23 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.484 -0.886 . . . . 0.93 110.861 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.428 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 89.7 t90 -51.17 -50.58 58.7 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.146 -0.479 . . . . 0.74 110.441 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -49.41 -50.62 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.213 -0.903 . . . . 1.17 111.681 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -40.42 -38.5 0.83 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.703 1.372 . . . . 2.24 114.703 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.88 -25.8 6.67 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.973 1.101 . . . . 5.64 113.973 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -79.47 -14.36 58.95 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 117.491 -1.683 . . . . 1.92 108.101 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -121.8 13.34 10.7 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.905 -1.146 . . . . 2.17 107.905 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 28' ' ' ARG . 3.7 p30 . . . . . 0 N--CA 1.488 1.472 0 CA-C-N 113.469 -1.696 . . . . 6.23 114.661 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 107.996 -1.113 . . . . 2.45 107.996 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -109.67 128.77 55.48 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.194 -0.669 . . . . 4.97 109.194 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -112.71 125.07 53.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.731 -0.788 . . . . 0.91 109.476 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 63' ' ' PHE . 14.5 p -121.35 144.46 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.405 -0.918 . . . . 2.72 109.362 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -118.35 118.77 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 125.173 1.545 . . . . 2.17 108.98 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -107.81 73.41 0.9 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.446 -1.687 . . . . 1.98 106.446 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.4 -179.66 21.84 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.786 -1.673 . . . . 1.45 111.431 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 126.47 52.68 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.076 -1.824 . . . . 6.1 106.076 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -117.29 -168.19 1.44 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.139 0.971 . . . . 6.91 112.768 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.56 -47.32 1.02 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.253 -1.939 . . . . 4.22 108.253 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.91 116.25 31.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.476 -1.305 . . . . 5.48 107.476 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 14' ' ' CYS . 50.1 Cg_exo -17.74 -68.49 0.02 OUTLIER 'Trans proline' 0 C--O 1.197 -1.533 0 C-N-CA 122.598 2.199 . . . . 4.03 112.924 -127.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 47.36 -66.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 113.028 0.751 . . . . 6.09 113.028 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 12' ' ' PRO . 23.5 m -116.39 -18.75 10.37 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.468 -0.893 . . . . 2.06 109.544 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -47.03 -33.94 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.266 -0.573 . . . . 1.36 110.479 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.526 HH21 ' CB ' ' A' ' 19' ' ' ASP . 1.2 mmp_? -78.64 -38.15 40.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.853 -1.139 . . . . 3.74 110.408 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.9 -49.24 73.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.954 -1.869 . . . . 0.65 105.954 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.439 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 3.7 tmtm? -57.44 -51.58 68.85 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.641 -1.163 . . . . 1.53 110.047 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.526 ' CB ' HH21 ' A' ' 16' ' ' ARG . 9.7 t70 -57.66 -59.12 5.69 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.394 -0.922 . . . . 2.73 109.401 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 tp -49.07 -60.08 3.08 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.883 0.849 . . . . 0.95 109.599 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 33' ' ' TYR . . . -48.66 -53.13 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.668 -1.151 . . . . 0.7 109.362 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.439 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 tt0 -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.212 1.006 . . . . 2.07 108.615 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -49.11 -49.99 39.27 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.11 -1.405 . . . . 4.76 107.984 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.1 mt -63.89 -31.54 72.76 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.848 -0.797 . . . . 1.28 108.848 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 t -64.06 -29.52 70.65 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.173 -1.788 . . . . 1.14 106.173 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 7.0 t30 -95.73 32.38 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.014 -1.106 . . . . 1.82 108.014 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.467 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 40.5 mt-10 -130.09 -66.06 0.8 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.681 -1.145 . . . . 2.79 108.791 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.3 mpt_? -116.17 132.72 56.58 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 108.258 -1.016 . . . . 4.63 108.258 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.5 30.06 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.775 -0.77 . . . . 4.25 111.732 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -112.78 -25.82 8.88 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.141 -1.429 . . . . 2.84 107.141 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -98.02 117.64 32.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.574 -1.194 . . . . 1.16 112.999 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -124.27 136.59 54.25 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.136 -1.847 . . . . 3.28 106.551 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.444 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 7.9 p90 -117.66 158.73 24.14 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 118.622 -1.231 . . . . 1.16 109.176 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.432 ' N ' ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -144.7 119.82 10.1 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.206 -0.906 . . . . 4.27 110.227 -178.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -98.33 119.06 36.35 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.064 -1.828 . . . . 1.36 106.064 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.4 154.2 21.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.608 -1.627 . . . . 1.38 106.608 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -117.95 131.54 56.49 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.184 -1.406 . . . . 2.83 108.565 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.0 pt -46.73 -37.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.08 -1.418 . . . . 1.22 113.912 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -95.26 18.44 12.38 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.76 -1.176 . . . . 5.69 112.651 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.86 -47.54 3.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.722 -0.844 . . . . 1.54 108.722 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -88.99 -22.72 22.87 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.798 -1.092 . . . . 4.82 110.635 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.49 52.85 1.39 Allowed Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.589 -1.291 . . . . 1.94 110.615 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.8 mt -106.71 134.78 47.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 106.287 -1.746 . . . . 1.6 106.287 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -91.96 -144.16 0.2 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.817 -1.153 . . . . 2.51 109.173 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 57' ' ' GLU . 26.5 mmmt -116.74 -33.52 4.79 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.577 -1.638 . . . . 6.64 106.577 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.17 -46.58 80.24 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.362 -1.718 . . . . 3.96 106.362 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' CG ' ' NZ ' ' A' ' 51' ' ' LYS . 26.9 t70 -63.88 -16.85 62.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.914 -1.039 . . . . 2.2 111.343 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.64 -48.14 5.63 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 108.468 -0.938 . . . . 1.36 108.468 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.35 -47.03 62.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 3.48 107.271 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -18.73 64.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.702 -1.135 . . . . 3.8 111.451 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' NZ ' ' CG ' ' A' ' 47' ' ' ASP . 36.5 mttp -86.65 -41.58 14.12 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.827 -0.749 . . . . 2.26 111.218 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . . . -92.23 -36.17 13.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.144 -0.622 . . . . 1.25 110.676 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.95 -66.91 0.38 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 105.501 -3.039 . . . . 3.41 105.501 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 33.2 mttm 31.44 -162.61 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 CA-C-N 112.533 -1.834 . . . . 7.04 113.178 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -103.75 -157.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.202 1.935 . . . . 4.29 109.915 131.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.04 113.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.946 -1.501 . . . . 7.06 106.946 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 24.9 mt-10 -119.31 -175.6 2.97 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.503 -0.771 . . . . 5.96 112.692 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 59' ' ' VAL . 4.9 t -92.07 -136.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.42 -1.326 . . . . 4.63 107.42 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.413 ' N ' HG23 ' A' ' 58' ' ' THR . 7.0 m -127.26 162.66 46.96 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.627 -0.879 . . . . 1.81 108.627 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 83.7 Cg_endo -100.34 163.51 8.2 Favored 'Cis proline' 0 N--CA 1.486 1.085 0 O-C-N 122.507 0.741 . . . . 1.9 111.888 2.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -119.7 112.1 18.85 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.644 -1.243 . . . . 3.56 107.644 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -101.48 143.62 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.761 -0.776 . . . . 1.08 111.011 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.422 ' HB2' ' CG1' ' A' ' 4' ' ' VAL . 24.7 m-85 -134.31 156.48 48.37 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 113.245 -1.798 . . . . 1.38 109.964 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 66' ' ' GLN . 54.5 t -131.56 122.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.869 -1.53 . . . . 0.9 106.869 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 66' ' ' GLN . 12.3 m-20 55.02 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.059 -0.657 . . . . 3.26 109.29 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.4 tt0 -133.18 -16.93 2.41 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.604 -1.18 . . . . 5.15 110.692 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' VAL . 19.1 pt20 -81.59 161.54 23.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.921 -0.711 . . . . 4.4 110.503 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -108.34 147.56 31.33 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.184 -0.917 . . . . 1.41 108.611 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 78' ' ' TRP . 5.2 mm -116.21 -49.66 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.12 -1.032 . . . . 0.79 109.483 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.27 -121.07 3.05 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.954 -1.258 . . . . 1.16 109.954 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.97 -164.47 18.53 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.623 -0.991 . . . . 1.11 110.623 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -53.52 -56.51 16.41 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 120.903 0.382 . . . . 2.13 111.203 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -45.39 -53.18 9.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.035 0.921 . . . . 1.61 110.779 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.39 65.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.158 -1.837 . . . . 2.79 109.295 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -48.24 -52.91 19.02 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.133 -1.027 . . . . 0.85 110.08 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.11 -56.7 14.24 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.097 -1.041 . . . . 0.79 110.122 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -55.66 28.49 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.54 -0.864 . . . . 0.87 109.922 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.422 ' CD1' HD12 ' A' ' 69' ' ' ILE . 89.7 t90 -48.89 -53.31 20.04 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.22 -0.592 . . . . 0.67 110.077 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.2 t -46.69 -58.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 CA-C-N 115.05 -0.977 . . . . 0.77 110.614 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -43.07 -43.09 4.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.816 1.413 . . . . 2.2 114.816 -177.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -97.79 3.56 49.97 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 118.15 -1.42 . . . . 3.87 113.536 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -117.09 -39.89 3.17 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.793 -0.763 . . . . 1.34 111.306 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.2 mt -113.56 37.83 3.11 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.619 -0.719 . . . . 2.4 112.051 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 C-N-CA 119.057 -1.057 . . . . 4.21 109.322 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 tpp . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 109.005 -0.739 . . . . 3.08 109.005 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -119.6 118.7 31.69 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.569 -1.271 . . . . 4.32 107.569 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 11.1 m -114.27 131.58 56.45 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.341 -0.543 . . . . 0.91 110.996 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.99 146.72 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.822 -1.151 . . . . 1.69 112.57 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.4 mp -111.34 129.58 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.458 -1.682 . . . . 1.81 106.458 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 81.0 m-85 -118.63 119.92 35.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.15 -0.62 . . . . 1.7 110.492 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.27 -158.72 26.96 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 124.637 1.211 . . . . 1.86 112.037 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -106.26 107.43 18.43 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.44 0.638 . . . . 5.74 110.097 -179.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t -78.11 -155.05 0.07 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.897 -0.592 . . . . 7.27 111.113 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 25.02 21.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.22 -1.552 . . . . 4.12 109.22 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' ' 15' ' ' VAL . 59.2 m -142.38 150.92 56.57 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 120.46 -0.496 . . . . 3.95 110.587 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.87 31.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.629 2.219 . . . . 4.93 112.479 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 83.6 t80 -125.13 -63.78 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.626 -1.249 . . . . 7.9 107.626 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 60' ' ' PRO . 89.5 m -78.68 -29.16 45.42 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 118.554 -1.258 . . . . 3.66 109.4 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 11' ' ' CYS . 67.4 t -62.19 -48.14 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.376 -1.342 . . . . 1.68 107.376 178.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -57.71 -28.5 63.9 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.155 -1.018 . . . . 3.85 109.853 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 62' ' ' ILE . . . -69.86 -48.44 58.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.749 -1.945 . . . . 1.18 105.749 177.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HE2' ' N ' ' A' ' 19' ' ' ASP . 3.5 tmpt? -50.21 -45.61 53.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.399 -1.704 . . . . 2.04 106.399 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.523 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 72.8 m-20 -58.44 -62.77 1.6 Allowed 'General case' 0 C--O 1.19 -2.029 0 C-N-CA 119.277 -0.969 . . . . 2.93 109.949 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 62.0 tp -46.5 -48.63 19.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.765 -0.774 . . . . 0.91 110.287 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.69 85.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.112 -0.699 . . . . 0.68 109.112 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.63 -38.68 82.01 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.734 -0.839 . . . . 1.79 108.734 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.5 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 23.6 tttm -58.77 -65.17 0.7 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.608 -1.627 . . . . 5.31 106.608 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.419 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 37.0 mt -45.6 -44.69 13.22 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.935 -1.135 . . . . 0.97 107.935 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.0 t -54.44 -43.42 71.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.419 -1.264 . . . . 0.99 109.809 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 18.3 t30 -78.39 -2.09 36.57 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.999 -0.68 . . . . 2.12 110.241 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.5 ' CD ' ' HZ3' ' A' ' 23' ' ' LYS . 77.2 mm-40 -89.7 -50.35 6.12 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.197 -0.601 . . . . 3.14 112.411 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.478 HH21 ' CB ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -137.81 155.91 48.51 Favored 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 118.679 -1.208 . . . . 4.1 113.986 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.05 31.03 0.08 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.029 -0.987 . . . . 4.23 111.825 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -125.52 -24.95 3.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.595 -0.73 . . . . 3.26 109.261 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 25' ' ' SER . 15.5 t80 -101.58 122.48 43.93 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 114.468 1.285 . . . . 1.13 114.468 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' NE2' ' H ' ' A' ' 33' ' ' TYR . 61.2 tp60 -133.64 159.51 40.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.646 -1.983 . . . . 6.03 105.646 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 3' ' ' THR . 15.6 p90 -141.8 167.37 22.31 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.266 -0.974 . . . . 1.02 108.851 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.3 152.24 31.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 124.023 0.827 . . . . 4.45 109.511 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.62 124.49 49.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.914 -1.143 . . . . 1.63 107.914 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.87 152.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.249 -0.98 . . . . 1.55 110.435 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -102.82 142.08 34.56 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.664 1.221 . . . . 3.48 111.133 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 38' ' ' ILE . 15.4 pt -66.45 -32.96 60.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 113.084 -1.871 . . . . 1.18 111.665 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -10.72 44.17 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.403 -0.919 . . . . 6.07 111.29 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.29 14.99 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.468 -0.938 . . . . 2.23 108.468 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.33 -43.53 13.62 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.61 -0.836 . . . . 3.78 110.651 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.47 49.0 0.57 Allowed Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.318 -1.113 . . . . 2.18 110.318 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.2 mt -106.48 135.14 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.052 -1.462 . . . . 1.65 107.052 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.504 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 4.9 p -108.09 171.53 7.35 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.59 -1.244 . . . . 2.23 113.111 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -17.24 62.74 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.194 -0.912 . . . . 3.78 109.586 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 16.2 mp0 -94.57 -50.02 5.38 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.487 -1.301 . . . . 3.7 107.487 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.504 ' HB3' ' H ' ' A' ' 44' ' ' THR . 53.8 t0 -55.75 -50.9 69.14 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 108.3 -1.0 . . . . 2.89 108.3 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.06 -49.5 68.86 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.345 -0.983 . . . . 1.56 108.345 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.4 tt0 -47.07 -52.04 16.12 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.51 -0.876 . . . . 3.59 108.969 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -62.31 -48.61 79.1 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.99 -1.004 . . . . 6.64 112.008 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -52.15 -44.25 64.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.642 0.589 . . . . 2.5 110.54 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.468 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -88.84 -57.25 2.97 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.963 -1.095 . . . . 1.17 109.339 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.1 -67.38 0.47 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.466 -1.854 . . . . 3.2 108.466 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 22.8 mmtm -143.84 55.64 3.73 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.336 0.865 . . . . 8.95 113.336 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.468 ' CD ' ' HB3' ' A' ' 52' ' ' ALA . 10.2 Cg_endo -91.26 159.06 3.77 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.703 1.602 . . . . 6.87 109.087 137.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.18 -61.46 2.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.056 -0.658 . . . . 5.36 109.724 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -128.67 33.05 4.71 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.335 -0.987 . . . . 6.7 108.335 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.9 p -89.67 69.63 7.75 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.954 -0.698 . . . . 4.9 110.139 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -114.37 140.43 25.11 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.26 -0.882 . . . . 2.99 110.28 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 5.3 Cg_exo -72.5 155.09 99.03 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.615 -1.411 . . . . 3.62 112.598 -0.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.592 ' CG ' ' NE2' ' A' ' 68' ' ' HIS . 1.7 tp-100 -121.45 165.84 15.01 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.426 -1.324 . . . . 4.47 107.426 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.47 HD11 ' HB1' ' A' ' 17' ' ' ALA . 34.4 mt -121.38 145.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.296 -0.962 . . . . 1.54 112.977 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 68' ' ' HIS . 40.5 m-85 -127.21 152.63 47.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.589 -2.096 . . . . 1.05 106.823 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 66' ' ' GLN . 55.9 t -125.38 126.17 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.95 -1.5 . . . . 1.12 106.95 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 53.55 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.076 0.86 . . . . 2.51 109.304 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -139.55 10.53 2.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.866 0.691 . . . . 5.79 112.866 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' A' ' 67' ' ' GLN . 22.1 mm-40 -118.17 179.91 3.96 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.439 -0.504 . . . . 6.71 111.086 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 61' ' ' GLN . 29.5 t-80 -117.48 143.67 45.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.961 0.788 . . . . 1.57 109.467 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -115.63 -39.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.793 -1.163 . . . . 0.95 111.141 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.67 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.852 -2.099 . . . . 1.36 107.852 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.28 -72.76 0.81 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.427 -1.368 . . . . 2.89 110.646 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 10.5 t80 -136.03 -50.61 0.7 Allowed 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 119.964 -0.694 . . . . 1.54 109.77 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.01 61.69 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.678 1.228 . . . . 1.58 108.823 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -57.26 12.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 111.929 -2.396 . . . . 2.58 109.012 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -47.04 -52.33 15.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.643 -0.823 . . . . 0.92 109.997 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.13 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.816 -1.154 . . . . 0.84 109.099 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.69 -53.52 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.975 -1.09 . . . . 0.9 109.797 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -53.92 -51.34 64.06 Favored 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.285 0.564 . . . . 0.68 110.355 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.5 t -48.38 -49.44 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.987 -1.006 . . . . 0.75 111.473 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -44.13 -30.18 0.73 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.891 1.441 . . . . 2.01 114.891 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 82' ' ' ASN . 13.9 pt-20 -112.48 -35.23 5.62 Favored 'General case' 0 N--CA 1.506 2.363 0 C-N-CA 119.537 -0.865 . . . . 4.95 113.219 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.48 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 39.5 m-80 -82.01 -23.84 35.75 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.037 -1.065 . . . . 1.34 109.579 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.471 HD22 ' C ' ' A' ' 82' ' ' ASN . 2.2 mm? -113.09 -41.19 3.77 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.631 -0.713 . . . . 1.75 109.67 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 N--CA 1.502 2.132 0 O-C-N 125.5 1.75 . . . . 3.92 111.713 179.609 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.46 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 32.0 tpp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.805 . . . . 2.95 108.825 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.68 110.65 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.731 0.777 . . . . 5.12 109.45 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.0 m -92.81 105.96 18.01 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.378 -1.712 . . . . 1.21 106.378 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 19.9 t -105.29 138.72 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.438 -0.905 . . . . 1.1 110.811 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.95 103.67 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.779 1.299 . . . . 1.18 108.337 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -85.65 90.14 7.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.509 -1.293 . . . . 1.55 107.509 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.459 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -124.48 145.06 15.67 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.254 -1.938 . . . . 1.66 108.254 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 139.82 49.41 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.644 -1.222 . . . . 5.06 110.205 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 10' ' ' GLY . 3.4 m 61.34 55.48 2.89 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.946 -1.024 . . . . 5.8 108.902 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' SER . . . -3.15 83.83 0.0 OUTLIER Glycine 0 N--CA 1.511 3.635 0 O-C-N 124.782 1.301 . . . . 3.77 114.872 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.4 m -112.74 157.13 41.32 Favored Pre-proline 0 N--CA 1.498 1.948 0 C-N-CA 119.577 -0.849 . . . . 4.2 109.79 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.0 -13.82 0.24 Allowed 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.922 2.414 . . . . 2.74 114.056 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -73.11 -14.1 61.32 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.688 -0.805 . . . . 4.89 111.889 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.555 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.4 m -107.13 -29.23 9.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.24 -1.022 . . . . 1.97 108.24 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.1 t -44.24 -63.65 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 114.506 1.299 . . . . 2.11 114.506 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -52.04 -44.39 64.21 Favored 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 118.044 -1.462 . . . . 3.84 111.808 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.9 63.39 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.742 -1.207 . . . . 1.04 107.742 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 5.1 ttpp -47.09 -55.89 7.54 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.327 -0.851 . . . . 1.48 109.256 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.439 ' CG ' ' NH2' ' A' ' 16' ' ' ARG . 5.8 t70 -52.8 -58.35 7.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 123.683 0.614 . . . . 3.21 110.013 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -50.92 -55.41 17.28 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.545 -0.862 . . . . 0.91 111.126 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.15 83.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.411 -0.915 . . . . 0.71 108.68 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.3 tt0 -59.52 -46.37 89.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.252 -0.885 . . . . 1.97 110.086 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.585 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -52.54 -57.16 10.82 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.979 -1.089 . . . . 4.28 108.117 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 42.6 mt -48.49 -43.66 35.18 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 1.17 107.601 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.9 t -58.53 -46.25 87.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.192 -1.367 . . . . 1.06 110.58 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.96 41.51 1.07 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.807 -1.553 . . . . 2.07 106.807 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.585 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.9 tp10 -128.29 -66.06 0.87 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.709 -2.042 . . . . 3.39 106.483 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.47 ' NH2' ' HB2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -122.45 153.46 39.08 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 106.341 -1.725 . . . . 4.35 106.341 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.07 32.3 1.52 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 118.367 -1.333 . . . . 5.51 111.933 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -113.64 -23.23 9.85 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.959 -1.497 . . . . 3.21 106.959 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 25' ' ' SER . 28.6 t80 -103.04 118.23 36.36 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.584 -1.189 . . . . 1.0 109.342 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -130.28 142.26 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.381 -1.34 . . . . 4.13 107.381 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -117.67 159.86 22.25 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 118.479 -1.288 . . . . 1.32 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.61 142.6 37.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.275 0.985 . . . . 4.58 109.255 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 35' ' ' TYR . 10.0 t80 -106.34 135.4 47.9 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.542 -2.021 . . . . 1.44 105.542 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.97 156.91 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.296 -0.961 . . . . 2.62 109.215 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.97 160.1 24.23 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.153 0.501 . . . . 2.8 109.796 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 pt -75.79 -32.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.998 -1.081 . . . . 1.82 111.439 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -35.87 55.16 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.356 -1.338 . . . . 5.64 108.494 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.56 -53.26 18.97 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.307 -0.86 . . . . 1.92 109.196 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.35 -46.38 10.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.042 0.839 . . . . 3.74 109.942 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.08 52.01 0.58 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 108.948 -1.661 . . . . 1.5 108.948 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.82 160.76 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 115.047 -0.577 . . . . 1.56 110.885 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -119.68 -170.82 2.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.787 -1.19 . . . . 2.08 107.787 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -90.86 -24.17 20.33 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 118.0 -1.48 . . . . 6.45 109.339 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.662 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 3.0 mp0 -72.87 -47.56 44.97 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.126 -1.435 . . . . 3.22 107.126 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.58 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 30.3 t70 -57.38 -39.2 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.071 0.939 . . . . 2.8 108.619 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.32 -46.03 78.3 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.49 -1.232 . . . . 1.39 107.714 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -46.21 -48.98 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.281 -1.377 . . . . 3.77 107.281 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.97 -59.13 5.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.152 -0.931 . . . . 4.41 110.62 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.58 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 17.3 mtmm -66.83 -5.41 12.21 Favored 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 120.338 -0.545 . . . . 2.75 112.457 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' CB ' HE22 ' A' ' 61' ' ' GLN . . . -105.3 -33.51 8.18 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.727 -0.67 . . . . 1.03 111.769 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.96 31.63 2.88 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.712 -1.755 . . . . 3.39 108.712 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.533 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 50.7 tttm -144.62 121.28 6.28 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.91 -1.144 . . . . 6.98 107.91 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -19.8 -131.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 124.472 3.448 . . . . 4.32 114.641 -143.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.79 -54.18 7.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 113.862 -1.517 . . . . 5.25 107.719 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 50.23 -160.36 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.772 -0.649 . . . . 8.22 112.099 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -139.59 -151.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.494 -0.882 . . . . 3.99 109.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.08 151.72 42.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.001 -0.74 . . . . 1.76 109.001 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -93.22 167.25 22.24 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 O-C-N 123.236 1.124 . . . . 1.92 111.135 2.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.542 HE22 ' CB ' ' A' ' 52' ' ' ALA . 25.8 mt-30 -116.84 131.12 57.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.181 -1.415 . . . . 2.58 107.181 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 75' ' ' PHE . 94.9 mt -104.73 144.96 13.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 118.989 -1.084 . . . . 1.27 109.943 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -135.69 148.57 48.96 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 113.373 -1.74 . . . . 0.99 108.816 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 66' ' ' GLN . 68.6 t -115.1 92.99 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 104.651 -2.352 . . . . 0.93 104.651 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 1' ' ' MET . 5.3 m-20 66.82 -74.5 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.32 1.013 . . . . 2.58 109.656 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 64' ' ' VAL . 63.4 mt-30 -133.8 -15.59 2.35 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.808 -1.087 . . . . 3.43 110.999 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.408 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 71.6 mt-30 -75.34 128.19 34.83 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.425 -0.954 . . . . 4.17 108.425 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.533 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 10.9 t-160 -90.36 136.56 32.98 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.081 -1.822 . . . . 1.03 106.081 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 75' ' ' PHE . 16.8 mm -108.5 -50.27 7.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.665 -0.814 . . . . 1.02 109.413 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.55 -122.76 5.26 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 118.94 -1.6 . . . . 1.53 111.85 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.97 -173.66 39.27 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.085 -1.055 . . . . 1.16 111.67 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 29.6 t80 -60.07 -51.19 70.71 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.758 -0.777 . . . . 1.66 111.354 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -43.98 -48.53 8.68 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.736 1.255 . . . . 1.57 108.91 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -58.69 -57.49 12.77 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.051 -2.34 . . . . 2.78 108.616 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HA ' HG21 ' A' ' 69' ' ' ILE . 7.6 t80 -48.7 -54.19 15.84 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.009 -0.996 . . . . 1.08 110.864 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.02 -53.01 56.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.69 -1.226 . . . . 0.84 107.69 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.07 -59.21 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.283 -0.967 . . . . 1.16 109.835 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.487 ' CD1' HD12 ' A' ' 69' ' ' ILE . 62.9 t90 -48.65 -52.87 21.0 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 119.852 -0.739 . . . . 1.44 110.964 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.423 ' CG2' ' CE1' ' A' ' 75' ' ' PHE . 43.0 t -54.49 -43.81 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.779 -1.168 . . . . 1.04 109.031 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -78.39 11.1 2.59 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.733 -0.667 . . . . 3.0 112.793 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.88 -36.28 2.4 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 120.505 -0.478 . . . . 4.68 110.819 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -96.93 -29.52 13.64 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.366 -0.834 . . . . 1.85 112.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.1 mt -119.58 26.13 9.58 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.071 -1.052 . . . . 2.15 111.586 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 C-N-CA 119.056 -1.057 . . . . 4.42 110.252 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 122.503 1.144 . . . . 3.03 108.356 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -114.6 158.83 21.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.455 -1.313 . . . . 5.28 107.455 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.622 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 5.5 m -107.15 142.14 37.31 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.296 -1.001 . . . . 1.68 108.296 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.441 ' C ' HD12 ' A' ' 5' ' ' ILE . 3.2 t -129.04 117.57 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.881 -1.526 . . . . 1.11 106.881 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.4 mp -107.35 131.72 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.913 -1.143 . . . . 1.08 107.913 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.72 108.42 17.86 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 106.506 -1.664 . . . . 2.18 106.506 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.8 -171.11 12.75 Favored Glycine 0 N--CA 1.503 3.128 0 C-N-CA 118.832 -1.652 . . . . 1.77 112.514 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.87 147.25 37.39 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 114.611 -0.795 . . . . 5.23 108.875 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -53.04 130.54 34.24 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 120.067 -0.653 . . . . 5.77 112.389 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 155.26 25.32 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.618 -0.801 . . . . 3.18 111.394 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.5 m 74.56 108.51 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.951 1.03 . . . . 3.64 111.767 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.61 59.43 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.799 1.666 . . . . 4.78 111.255 162.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -115.18 -69.84 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.254 -0.885 . . . . 4.76 108.767 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -52.4 -41.69 63.4 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.04 -1.467 . . . . 2.61 107.04 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -43.3 -42.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.833 -1.531 . . . . 2.93 110.113 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.22 -33.74 1.65 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 123.508 0.505 . . . . 4.77 112.225 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.476 ' HB3' HG12 ' A' ' 5' ' ' ILE . . . -67.5 -44.35 78.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.446 -0.946 . . . . 1.09 108.446 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HG3' ' CD1' ' A' ' 33' ' ' TYR . 9.4 ttpp -52.99 -49.58 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.457 -1.683 . . . . 2.27 106.457 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' LEU . 65.7 m-20 -55.85 -60.1 3.93 Favored 'General case' 0 C--O 1.183 -2.414 0 CA-C-N 113.317 -1.765 . . . . 3.95 110.305 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' ASP . 31.5 tp -43.8 -61.25 1.49 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.485 -1.286 . . . . 0.96 109.323 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.47 67.27 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.352 -0.84 . . . . 1.19 111.277 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 40.1 tt0 -65.17 -56.07 14.99 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.955 0.883 . . . . 2.02 111.083 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.557 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -50.8 -43.38 58.73 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.448 -1.315 . . . . 3.9 107.448 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -66.73 -44.17 82.26 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.289 -1.004 . . . . 1.72 108.289 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 27' ' ' GLU . 28.9 t -50.07 -48.75 52.89 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.906 -1.043 . . . . 2.09 108.699 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 11.6 t30 -83.72 38.64 0.64 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.878 1.323 . . . . 2.01 108.782 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 tt0 -137.61 -50.3 0.61 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 113.164 -1.835 . . . . 3.16 109.117 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -104.03 -32.71 9.08 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.05 -0.977 . . . . 3.67 111.371 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 78.49 8.62 2.15 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.193 0.933 . . . . 4.76 111.026 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.51 7.58 17.51 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.496 -0.882 . . . . 3.93 112.443 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -124.54 142.37 51.39 Favored 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 119.717 -0.793 . . . . 1.99 110.798 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -126.49 170.98 11.45 Favored 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 120.428 -0.509 . . . . 4.39 111.109 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.622 ' HA ' ' H ' ' A' ' 3' ' ' THR . 18.7 p90 -142.84 169.33 17.77 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.726 0.774 . . . . 2.18 112.694 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 3' ' ' THR . 43.7 mm-40 -148.31 128.31 13.59 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 113.829 -1.532 . . . . 4.03 108.085 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -113.63 111.2 21.46 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.083 -1.451 . . . . 1.3 107.083 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.8 157.77 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.935 -0.706 . . . . 1.65 110.167 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.28 139.08 43.5 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 105.049 -2.204 . . . . 2.96 105.049 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.4 pt -50.19 -33.47 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.935 -1.106 . . . . 1.22 113.666 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -50.08 25.89 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 117.67 -1.612 . . . . 6.71 110.379 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -31.08 -52.67 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.256 0.973 . . . . 1.95 111.672 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.23 -43.13 18.01 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.62 1.2 . . . . 4.35 111.069 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.72 51.56 0.45 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.432 -2.267 . . . . 1.58 107.432 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 75.6 mt -108.16 141.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.562 -0.819 . . . . 1.91 110.626 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.3 p -117.08 -89.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.855 -1.165 . . . . 3.31 107.855 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.569 ' HZ3' ' CD ' ' A' ' 57' ' ' GLU . 33.5 tttp -140.87 -48.07 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.37 -0.974 . . . . 4.25 108.37 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 10.3 mp0 -47.9 -55.64 9.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.02 0.825 . . . . 2.86 109.711 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -53.08 -60.86 2.76 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.559 -0.746 . . . . 2.71 109.533 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.58 -38.44 59.98 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.348 -0.941 . . . . 1.44 110.045 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.96 -53.33 58.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.209 -1.404 . . . . 4.36 107.209 178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.07 -47.98 79.68 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.25 -1.795 . . . . 4.09 110.476 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -56.66 -50.5 71.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.377 -0.829 . . . . 2.74 110.182 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -53.74 46.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.152 -0.931 . . . . 1.37 111.676 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.19 -15.59 43.08 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.519 -1.432 . . . . 2.56 109.519 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.8 pttp -123.96 -178.91 0.72 Allowed Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.955 -0.698 . . . . 6.07 110.133 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 49.2 Cg_exo -56.6 142.56 90.49 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.235 1.29 . . . . 4.36 112.077 165.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -153.84 102.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 4.95 107.025 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.569 ' CD ' ' HZ3' ' A' ' 45' ' ' LYS . 15.6 mm-40 -111.77 -15.78 13.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.703 -0.799 . . . . 7.12 110.705 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 59' ' ' VAL . 24.0 m -121.69 172.29 8.24 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.979 -0.688 . . . . 4.65 110.265 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 58' ' ' THR . 27.3 m -105.22 169.38 7.14 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 109.278 -0.638 . . . . 2.6 109.278 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -99.97 176.6 6.73 Favored 'Cis proline' 0 N--CA 1.488 1.192 0 O-C-N 122.815 0.903 . . . . 1.99 110.544 -8.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 99.5 mm-40 -125.35 140.78 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.075 -1.05 . . . . 3.42 108.693 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -126.7 145.17 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.874 -0.73 . . . . 1.12 110.444 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.08 162.51 31.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.538 -1.21 . . . . 1.37 109.461 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.533 HG11 ' CH2' ' A' ' 78' ' ' TRP . 49.6 t -141.45 119.19 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 124.526 1.141 . . . . 1.17 108.979 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 50.81 -102.73 0.12 Allowed 'General case' 0 N--CA 1.514 2.742 0 CA-C-N 119.774 1.17 . . . . 2.35 111.008 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -123.82 31.88 5.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.618 -1.174 . . . . 4.48 109.43 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -122.59 164.49 18.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.568 -0.742 . . . . 4.09 110.361 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -122.54 125.6 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.155 -1.054 . . . . 1.25 108.155 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.65 -54.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.951 -1.5 . . . . 1.57 106.951 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 112.23 -99.23 1.04 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.471 -1.347 . . . . 1.52 110.572 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.56 163.63 13.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.414 -1.374 . . . . 1.24 110.707 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.41 -54.29 33.99 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.074 -0.65 . . . . 1.75 111.759 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -34.58 -64.69 0.24 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.663 0.986 . . . . 1.69 113.663 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.94 -38.0 75.15 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.925 -0.71 . . . . 4.54 111.649 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -43.49 -41.54 4.44 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.794 -0.817 . . . . 1.18 108.794 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.96 -52.03 64.3 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.497 -0.774 . . . . 1.3 110.773 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' LYS . . . -67.22 -53.8 26.83 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.342 -0.844 . . . . 1.36 109.172 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.533 ' CH2' HG11 ' A' ' 64' ' ' VAL . 84.3 t90 -42.23 -55.54 3.26 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.16 -1.052 . . . . 1.03 108.16 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -46.04 -50.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 114.984 -1.007 . . . . 1.4 109.94 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -42.56 -57.45 2.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 124.568 1.168 . . . . 3.63 113.295 -178.184 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -106.01 25.43 10.95 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.351 -1.34 . . . . 3.51 112.365 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 78' ' ' TRP . 12.3 m-80 -119.33 -36.43 3.37 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.947 -1.131 . . . . 2.27 107.947 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.44 11.45 17.2 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.238 -1.764 . . . . 2.32 106.238 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.487 1.377 0 O-C-N 125.338 1.649 . . . . 7.99 112.484 179.636 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.5 mpp? . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.19 -1.041 . . . . 2.6 108.19 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 65' ' ' ASP . 49.7 mt-30 -100.24 102.72 14.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.516 -0.92 . . . . 4.32 108.516 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.4 m -84.32 100.27 11.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.264 -1.754 . . . . 1.13 106.264 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.32 127.44 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.313 -1.312 . . . . 1.08 110.206 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mm -96.38 119.16 44.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 104.568 -2.382 . . . . 1.29 104.568 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.523 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.4 m-85 -104.71 109.29 21.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.318 -1.364 . . . . 1.43 107.318 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.61 118.9 0.46 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 116.208 -2.901 . . . . 2.28 112.708 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.455 ' HB3' ' OD1' ' A' ' 37' ' ' ASP . 4.8 ptm180 -86.11 55.74 3.67 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.413 -1.393 . . . . 5.05 111.902 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.0 p -90.47 -54.05 4.17 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 117.434 -1.706 . . . . 6.3 109.144 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.68 -52.73 4.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 106.4 -2.68 . . . . 4.06 106.4 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' TYR . 8.3 m -78.05 156.78 79.31 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.758 -1.571 . . . . 4.87 106.758 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.85 64.26 0.15 Allowed 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 123.55 2.834 . . . . 2.95 115.135 -147.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' CYS . 21.2 m-30 -121.69 -70.24 0.79 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.029 -1.841 . . . . 5.8 106.029 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.3 m -65.06 -32.46 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.337 -1.745 . . . . 1.99 106.613 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.4 t -44.13 -45.08 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 114.895 -1.048 . . . . 1.34 109.907 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.478 HH12 ' CG ' ' A' ' 19' ' ' ASP . 2.5 tpt180 -68.91 -47.09 66.65 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.852 -0.739 . . . . 4.13 110.239 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.67 -46.31 70.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.121 -1.437 . . . . 0.73 107.121 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.1 tmtt? -54.14 -60.53 3.21 Favored 'General case' 0 C--O 1.203 -1.37 0 CA-C-N 114.824 -1.08 . . . . 2.03 108.402 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.5 t70 -48.53 -54.64 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.817 -0.753 . . . . 2.77 110.442 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.9 tp -54.85 -57.18 12.61 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.308 -0.957 . . . . 1.48 109.954 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.24 -42.95 52.75 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.949 -1.023 . . . . 0.74 109.906 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 36.6 tt0 -65.62 -51.74 57.33 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.544 -0.753 . . . . 2.16 109.07 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 23.6 ttpp -44.55 -54.21 6.28 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.457 -1.312 . . . . 5.7 107.457 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 50.9 mt -60.67 -36.38 78.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.58 1.175 . . . . 1.18 109.707 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -59.32 -28.46 66.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.057 -0.974 . . . . 1.09 109.532 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -89.19 29.37 1.08 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.548 0.689 . . . . 2.72 109.149 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 73.3 mt-10 -135.07 -65.96 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.184 -1.006 . . . . 3.29 112.621 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -104.42 149.38 25.46 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.976 -1.09 . . . . 4.65 108.585 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -53.26 57.44 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.852 1.797 . . . . 4.1 115.852 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 1' ' ' MET . 50.6 t0 -84.45 44.82 1.07 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.657 -1.617 . . . . 5.84 111.683 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 83' ' ' LEU . 16.2 t80 -126.04 84.63 2.29 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 105.997 -1.853 . . . . 1.07 105.997 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -109.51 143.75 38.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.866 -1.531 . . . . 3.65 106.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -123.56 157.49 33.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.143 -1.423 . . . . 1.18 110.371 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -145.33 150.12 36.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.788 -1.097 . . . . 4.13 108.62 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -110.77 127.15 55.25 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.198 -1.038 . . . . 2.16 108.198 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.523 HG11 ' CE1' ' A' ' 6' ' ' PHE . 2.3 p -131.02 151.33 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 118.819 -1.153 . . . . 2.31 109.826 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -113.66 135.4 53.97 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.345 -1.354 . . . . 3.0 107.345 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 37.7 pt -61.29 -27.18 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.631 -1.228 . . . . 1.9 110.586 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -74.38 -24.87 59.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.894 -1.122 . . . . 5.76 110.996 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.1 -40.4 15.74 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 1.99 110.124 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -77.36 -40.6 43.37 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.403 -1.272 . . . . 4.25 111.362 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.63 51.02 0.72 Allowed Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.188 -1.482 . . . . 2.13 110.038 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 8.2 mt -112.32 135.2 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.456 -0.898 . . . . 2.32 109.304 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 47.1 p -106.8 173.76 6.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.242 -0.583 . . . . 1.88 110.014 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -52.52 -51.58 58.86 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.219 -1.4 . . . . 4.92 107.219 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.6 -60.66 3.12 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.77 -1.559 . . . . 3.77 110.45 178.015 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 44' ' ' THR . 33.3 t70 -51.92 -41.86 62.33 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.392 -0.923 . . . . 2.08 111.305 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.464 ' HG ' HG21 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -59.63 -57.91 10.9 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.577 -0.849 . . . . 1.91 109.356 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 33.8 tt0 -44.36 -52.3 7.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.962 -1.125 . . . . 3.28 107.962 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.58 -45.26 85.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.796 -1.093 . . . . 4.23 111.404 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -40.24 50.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.703 1.252 . . . . 2.73 110.924 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -90.65 -48.71 6.9 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.732 -1.122 . . . . 1.33 109.946 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.411 ' C ' ' HG3' ' A' ' 54' ' ' LYS . . . 135.23 -68.6 0.53 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 107.373 -2.291 . . . . 3.14 107.373 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 53' ' ' GLY . 51.9 mttp -155.22 56.24 1.35 Allowed Pre-proline 0 N--CA 1.51 2.544 0 N-CA-C 113.252 0.834 . . . . 10.25 113.252 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.458 ' CD ' ' HB3' ' A' ' 52' ' ' ALA . 91.3 Cg_endo -98.66 42.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 121.758 1.639 . . . . 6.08 110.129 152.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t 36.48 -118.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.255 -1.338 . . . . 5.95 110.707 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -120.03 39.41 3.69 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.742 -0.383 . . . . 8.08 110.83 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.7 p -88.12 149.84 23.69 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.326 -1.349 . . . . 5.12 111.417 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.08 165.57 17.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 CA-C-N 115.075 -0.966 . . . . 2.74 108.757 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -78.81 171.96 63.17 Favored 'Cis proline' 0 N--CA 1.485 0.978 0 C-N-CA 123.636 -1.402 . . . . 2.09 110.354 -5.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.456 HE22 ' HG2' ' A' ' 55' ' ' PRO . 42.6 mt-30 -136.63 157.75 46.05 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.941 -1.103 . . . . 2.91 109.944 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.4 mm -114.09 139.76 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 120.303 -0.559 . . . . 1.5 110.527 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.6 145.71 48.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.726 0.641 . . . . 1.1 109.781 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 72.2 t -124.57 95.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.761 -0.776 . . . . 0.9 109.951 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.435 ' HA ' ' HB2' ' A' ' 2' ' ' GLN . 0.6 OUTLIER 65.21 -74.41 0.05 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.639 -1.619 . . . . 3.27 110.942 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -133.84 -7.34 2.77 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.232 -0.895 . . . . 4.22 112.294 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.409 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 6.7 pt20 -104.82 165.09 11.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.955 -0.698 . . . . 4.17 110.556 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -105.96 143.79 33.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.191 -1.781 . . . . 1.04 106.191 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.522 HD12 ' CD1' ' A' ' 78' ' ' TRP . 23.4 mm -106.0 -37.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.621 -1.231 . . . . 1.09 109.65 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -132.86 7.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.09 -2.004 . . . . 1.2 108.09 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.66 -164.25 24.3 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.527 -1.429 . . . . 1.34 109.527 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 16' ' ' ARG . 44.0 t80 -61.34 -49.17 78.05 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.027 -1.069 . . . . 1.62 111.408 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.39 -52.38 13.07 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 1.73 109.991 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.23 -53.64 54.28 Favored 'General case' 0 C--O 1.197 -1.695 0 CA-C-N 113.461 -1.7 . . . . 2.12 109.045 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -48.45 -48.45 37.57 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.821 -0.627 . . . . 0.98 110.74 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.36 69.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.18 -1.008 . . . . 0.88 108.485 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.4 -62.67 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.919 -1.112 . . . . 0.94 110.126 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.522 ' CD1' HD12 ' A' ' 69' ' ' ILE . 67.2 t90 -42.69 -51.42 5.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.698 -0.853 . . . . 0.87 108.698 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.433 ' CG1' HD11 ' A' ' 24' ' ' LEU . 6.6 t -53.65 -59.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.906 -1.043 . . . . 0.81 109.482 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 18.4 tptt -54.35 -16.73 2.38 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.252 -0.886 . . . . 3.36 113.226 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -107.54 -44.61 4.24 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.29 -0.964 . . . . 3.67 113.384 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' C ' HD22 ' A' ' 83' ' ' LEU . 14.1 m-80 -82.7 -25.16 33.22 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.846 -0.741 . . . . 1.5 110.104 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.551 HD11 ' CD1' ' A' ' 31' ' ' PHE . 2.6 mm? -109.08 -41.36 4.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.255 -0.646 . . . . 2.18 109.255 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-N 113.862 -1.517 . . . . 4.02 108.652 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 107.851 -1.166 . . . . 3.04 107.851 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -115.81 110.27 18.82 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.32 -0.552 . . . . 4.53 110.567 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.5 m -96.5 150.0 21.11 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.861 -0.736 . . . . 1.0 110.611 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.509 ' C ' HD12 ' A' ' 5' ' ' ILE . 17.2 t -133.77 139.44 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 115.791 -0.641 . . . . 0.92 110.788 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 4' ' ' VAL . 1.2 mp -113.73 126.48 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.127 -1.805 . . . . 1.06 106.127 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 63' ' ' PHE . 22.7 m-85 -108.83 109.3 20.38 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.698 -1.223 . . . . 1.69 107.698 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.574 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -134.02 -169.31 12.02 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.788 -1.672 . . . . 1.33 112.134 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.0 tmm_? -102.03 64.24 0.94 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.891 -1.522 . . . . 5.83 106.891 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.455 ' OG ' ' NH2' ' A' ' 39' ' ' ARG . 4.5 m 58.31 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.495 -1.229 . . . . 5.38 111.152 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -123.1 84.27 0.37 Allowed Glycine 0 N--CA 1.499 2.88 0 N-CA-C 110.53 -1.028 . . . . 2.98 110.53 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' TYR . 41.3 t -128.93 109.98 18.44 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.455 -0.572 . . . . 4.92 109.455 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -40.55 -27.57 0.28 Allowed 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 124.534 3.489 . . . . 3.93 115.817 -153.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' CYS . 98.9 m-85 -72.5 -37.4 68.4 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.241 -0.984 . . . . 4.4 110.701 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.574 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.2 m -61.01 -39.91 91.53 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.401 -1.703 . . . . 2.0 106.401 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.69 -38.46 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.287 -0.965 . . . . 1.29 109.078 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.536 HH12 ' CG ' ' A' ' 19' ' ' ASP . 9.6 mmm180 -76.81 -51.01 12.13 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.683 -0.689 . . . . 4.07 110.978 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.419 ' HB1' HG13 ' A' ' 5' ' ' ILE . . . -52.32 -42.78 64.11 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.738 -1.579 . . . . 0.83 106.738 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -58.32 -57.87 11.01 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 113.66 -1.609 . . . . 1.75 107.731 178.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.536 ' CG ' HH12 ' A' ' 16' ' ' ARG . 2.2 t70 -51.56 -57.27 9.58 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.428 -1.309 . . . . 3.13 109.986 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 79' ' ' VAL . 37.1 tp -47.16 -50.71 19.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.131 -0.692 . . . . 1.11 109.131 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 33' ' ' TYR . . . -60.1 -45.43 92.99 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.612 -0.835 . . . . 1.06 110.496 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 25' ' ' SER . 18.0 tt0 -65.04 -49.8 68.72 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.464 0.65 . . . . 2.31 110.767 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.54 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -56.95 -51.85 67.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.063 -1.458 . . . . 4.19 107.063 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.4 mt -52.02 -51.35 57.97 Favored 'General case' 0 C--O 1.199 -1.566 0 N-CA-C 106.441 -1.689 . . . . 1.18 106.441 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 4.6 t -43.32 -24.53 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.57 -0.741 . . . . 1.18 112.037 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.07 -39.5 8.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.214 0.321 . . . . 2.16 111.005 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.54 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 28.2 mt-10 -72.96 -26.74 61.47 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.327 0.584 . . . . 3.31 110.657 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -101.44 175.05 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.352 -0.84 . . . . 4.06 110.888 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -107.74 -41.09 5.1 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 115.225 -0.898 . . . . 5.56 110.511 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 30' ' ' ASP . 8.3 t70 -109.63 53.46 0.69 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 122.438 1.113 . . . . 4.99 109.283 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 25' ' ' SER . 8.1 t80 -131.71 110.42 10.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.256 -0.978 . . . . 1.08 110.055 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -124.27 152.37 43.1 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.988 -1.856 . . . . 3.37 105.988 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.53 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 7.1 p90 -140.46 154.57 46.68 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 117.884 -1.527 . . . . 1.16 111.153 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.51 154.72 47.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.692 -1.225 . . . . 4.04 107.692 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.61 139.73 49.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.926 -1.509 . . . . 1.34 106.926 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.32 139.03 51.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 124.24 0.963 . . . . 2.12 109.955 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -105.95 116.68 32.35 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.694 -1.595 . . . . 2.53 106.694 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.8 pt -54.88 -20.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 118.788 -1.165 . . . . 1.17 111.299 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.455 ' NH2' ' OG ' ' A' ' 9' ' ' SER . 40.6 ttp-105 -86.13 -61.44 1.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.561 -0.855 . . . . 6.86 109.285 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.18 -43.48 0.22 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.093 0.871 . . . . 1.45 111.514 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -94.0 -44.75 7.9 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.582 -0.847 . . . . 3.11 112.04 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.51 54.31 0.65 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.212 -1.555 . . . . 1.98 109.212 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.91 127.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 107.497 -1.297 . . . . 2.24 107.497 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 p -119.85 166.22 13.57 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.197 -1.001 . . . . 3.17 110.697 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.617 ' CD ' ' H ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -41.69 -45.9 3.59 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.379 -0.828 . . . . 5.29 110.885 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 19.9 mp0 -60.51 -55.24 35.76 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.071 -0.651 . . . . 4.19 110.239 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 25.0 t70 -60.32 -39.86 88.53 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.598 -0.841 . . . . 2.92 110.689 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.08 -48.73 78.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.124 -0.944 . . . . 1.61 109.128 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.76 -59.96 2.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.205 -0.907 . . . . 4.67 108.709 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -46.64 -40.84 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 125.029 1.456 . . . . 4.17 112.341 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 25.1 mtmm -94.46 -4.24 48.57 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.578 -1.192 . . . . 2.91 114.101 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.635 ' CB ' HE22 ' A' ' 61' ' ' GLN . . . -113.49 -38.37 4.37 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.799 -0.76 . . . . 1.1 112.724 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.46 43.98 66.69 Favored Glycine 0 N--CA 1.491 2.365 0 O-C-N 124.395 1.059 . . . . 3.36 113.151 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HD2' ' CE1' ' A' ' 68' ' ' HIS . 59.5 mttm -138.53 180.0 1.18 Allowed Pre-proline 0 N--CA 1.504 2.256 0 C-N-CA 119.296 -0.962 . . . . 7.55 110.345 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -33.46 82.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.111 2.54 . . . . 5.74 112.37 127.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 57' ' ' GLU . 27.6 m -101.66 -42.99 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 115.791 -0.64 . . . . 5.41 112.34 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.462 ' N ' HG23 ' A' ' 56' ' ' VAL . 2.4 tt0 61.37 -108.39 0.32 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.651 -0.87 . . . . 7.05 108.651 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 59' ' ' VAL . 53.5 p -129.92 -86.51 0.53 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.623 -1.231 . . . . 4.3 111.143 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.41 ' N ' ' OG1' ' A' ' 58' ' ' THR . 14.2 m -137.98 164.66 39.23 Favored Pre-proline 0 C--N 1.291 -1.966 0 N-CA-C 109.771 -0.455 . . . . 1.77 109.771 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -94.36 148.08 10.18 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 124.594 -1.002 . . . . 1.62 110.314 -9.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.635 HE22 ' CB ' ' A' ' 52' ' ' ALA . 33.4 mt-30 -111.23 142.78 42.98 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.984 -1.086 . . . . 2.55 108.282 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.1 mp -113.44 142.31 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.987 0.898 . . . . 1.64 110.02 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 6' ' ' PHE . 20.0 m-85 -121.21 136.3 55.0 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.354 -2.091 . . . . 1.36 105.354 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.618 HG11 ' CH2' ' A' ' 78' ' ' TRP . 5.8 t -115.05 106.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.817 -0.753 . . . . 1.33 109.114 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 66.91 -72.6 0.08 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.581 -0.736 . . . . 2.49 111.982 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -136.74 -11.02 1.81 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 113.704 1.002 . . . . 3.88 113.704 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -117.01 161.6 19.13 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.749 -1.18 . . . . 5.96 114.003 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.542 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.0 t-160 -90.06 133.67 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.725 -1.213 . . . . 1.01 107.725 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.53 -39.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.541 -0.863 . . . . 0.87 110.235 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.82 -142.27 13.69 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.177 -1.569 . . . . 1.17 109.177 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.85 173.65 41.8 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.389 -1.484 . . . . 1.22 109.389 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 23.7 t80 -42.87 -45.99 5.13 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.301 -0.96 . . . . 1.8 111.209 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.4 -58.12 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.797 0.808 . . . . 1.8 110.054 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.2 -39.84 80.01 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.148 -1.387 . . . . 2.07 109.581 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.66 -56.83 17.16 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.897 -1.121 . . . . 1.28 109.384 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.26 -56.01 19.99 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.83 -0.748 . . . . 0.92 110.284 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.59 -54.5 43.34 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.432 -0.907 . . . . 1.04 109.43 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.618 ' CH2' HG11 ' A' ' 64' ' ' VAL . 89.3 t90 -46.74 -55.5 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.836 -0.746 . . . . 1.17 110.457 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.429 HG21 HD21 ' A' ' 20' ' ' LEU . 53.5 t -47.94 -55.5 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.847 -1.07 . . . . 0.8 111.218 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.72 -46.86 7.73 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.615 0.968 . . . . 2.03 113.615 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -103.96 34.42 3.03 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 118.956 -1.097 . . . . 4.4 112.512 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -141.05 -49.03 0.42 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.929 -0.767 . . . . 1.51 108.929 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.8 mt -112.71 46.15 1.24 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.964 -1.017 . . . . 2.07 109.434 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t0 . . . . . 0 C--N 1.291 -1.969 0 N-CA-C 107.092 -1.448 . . . . 3.7 107.092 179.091 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 108.285 -1.006 . . . . 2.99 108.285 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -106.76 102.78 12.13 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.744 0.783 . . . . 4.59 111.761 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.3 m -94.22 129.77 40.71 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.348 -1.353 . . . . 0.92 107.348 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 43.3 t -119.67 134.71 62.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.034 -1.066 . . . . 1.05 110.318 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -107.55 121.51 60.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.789 -2.3 . . . . 1.23 104.789 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -114.99 91.13 3.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 102.977 -2.972 . . . . 1.84 102.977 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -128.05 -167.34 12.23 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 118.535 -1.793 . . . . 1.29 114.375 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.96 95.2 5.34 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.838 -1.181 . . . . 5.01 110.717 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.409 ' OG ' ' NH1' ' A' ' 8' ' ' ARG . 2.9 p -53.36 144.27 16.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.94 -1.133 . . . . 4.93 107.94 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.9 -36.0 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.082 -2.407 . . . . 2.74 107.082 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -97.78 133.71 23.13 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.205 -1.035 . . . . 4.31 108.205 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.77 51.27 0.89 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.455 2.103 . . . . 2.96 111.488 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.89 -64.33 1.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.048 -1.093 . . . . 4.33 108.048 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -54.98 -29.91 58.04 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 115.149 -0.932 . . . . 2.1 108.902 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.1 t -42.79 -44.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.367 -1.288 . . . . 1.38 109.914 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 4.4 mmp_? -63.44 -52.03 63.21 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.087 -1.045 . . . . 2.89 111.008 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' CB ' HD11 ' A' ' 62' ' ' ILE . . . -59.62 -45.06 93.05 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.468 -0.893 . . . . 0.99 110.572 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 7.3 ttpp -61.25 -52.12 66.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.172 -1.011 . . . . 2.05 108.851 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -53.65 -53.66 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.252 -0.579 . . . . 2.36 109.848 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 79' ' ' VAL . 14.8 tp -55.52 -65.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.344 -0.942 . . . . 1.21 109.038 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.55 -46.47 19.38 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.987 -0.685 . . . . 1.03 110.411 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 43.8 tt0 -58.77 -54.17 50.08 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.251 1.024 . . . . 2.14 111.38 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -54.49 -50.36 67.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 113.694 -1.594 . . . . 6.82 106.822 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.8 mt -53.38 -50.81 64.33 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.261 -1.385 . . . . 1.11 107.261 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.501 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 7.6 t -43.78 -24.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.433 -0.803 . . . . 1.33 112.507 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.09 -31.29 8.34 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.439 -0.801 . . . . 2.22 110.864 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.52 -36.47 73.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.088 . . . . 3.85 108.061 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.455 HH11 ' C ' ' A' ' 85' ' ' ALA . 19.4 mtp180 -119.03 117.31 28.44 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.477 0.656 . . . . 3.67 109.597 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -63.88 3.68 0.36 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.956 1.095 . . . . 3.8 113.956 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 1' ' ' MET . 11.4 p-10 -114.67 7.61 16.02 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.058 -0.719 . . . . 3.09 109.058 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 12.6 t80 -109.35 129.65 55.52 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.866 -0.734 . . . . 1.14 112.855 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -129.56 150.85 50.71 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.627 -1.62 . . . . 3.58 106.627 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 8.4 p90 -133.89 160.06 38.8 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.316 -1.354 . . . . 1.17 110.821 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -134.07 135.38 43.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.73 0.644 . . . . 4.39 110.342 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -108.08 109.84 21.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.003 -1.851 . . . . 1.75 106.003 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.24 141.4 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.379 -1.711 . . . . 1.55 106.379 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 9.0 t70 -110.17 155.05 22.47 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.074 -1.05 . . . . 2.78 110.844 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 pt -84.16 -34.87 10.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 117.993 -1.483 . . . . 1.46 112.435 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.508 ' HE ' ' N ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -98.24 -58.01 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.321 -1.752 . . . . 5.14 108.845 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -39.09 -39.91 0.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 124.198 0.936 . . . . 3.18 111.255 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.48 -36.38 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.071 -1.451 . . . . 4.64 110.862 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.23 69.77 0.61 Allowed Glycine 0 N--CA 1.5 2.948 0 C-N-CA 118.448 -1.834 . . . . 2.55 113.128 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 mm -115.04 157.18 15.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.148 -1.797 . . . . 2.43 106.148 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.7 p -107.39 137.14 45.98 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.69 -1.204 . . . . 3.0 110.454 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -55.04 -31.39 61.06 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.716 -1.216 . . . . 3.79 107.716 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 7.1 mp0 -59.42 -64.94 0.76 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.209 -0.663 . . . . 3.46 109.209 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 4.6 t70 -48.1 -49.45 31.82 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.069 0.938 . . . . 2.97 111.185 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.2 mt -61.8 -54.46 42.03 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.606 -1.179 . . . . 2.37 109.295 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -44.44 -46.12 9.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.837 -1.171 . . . . 3.61 107.837 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 8.5 tm0? -60.13 -58.89 6.58 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.781 -1.554 . . . . 4.31 110.974 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -17.89 63.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.141 1.534 . . . . 2.93 115.141 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.68 -38.28 13.19 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.736 -0.786 . . . . 1.36 111.143 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.481 ' C ' ' HG3' ' A' ' 54' ' ' LYS . . . 112.94 57.82 0.42 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.274 -1.93 . . . . 2.81 108.274 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HG3' ' C ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 37.2 76.03 0.49 Allowed Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 124.954 1.032 . . . . 6.94 111.651 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 1.8 Cg_endo -90.35 33.79 0.33 Allowed 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 122.821 2.348 . . . . 6.61 111.103 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.421 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.4 t 32.06 -102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 113.685 -1.598 . . . . 6.47 113.826 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 7.6 tp10 -125.04 46.11 2.41 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.579 -0.448 . . . . 8.01 110.216 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.0 p -119.44 124.36 46.32 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.285 1.217 . . . . 5.11 114.285 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 60' ' ' PRO . 33.1 m -132.93 166.11 31.69 Favored Pre-proline 0 N--CA 1.504 2.238 0 N-CA-C 107.27 -1.381 . . . . 2.34 107.27 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 50.9 Cg_endo -79.61 170.72 66.53 Favored 'Cis proline' 0 N--CA 1.491 1.35 0 O-C-N 122.19 0.574 . . . . 1.65 110.886 -7.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.54 150.57 50.13 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.786 -0.766 . . . . 2.38 111.109 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.427 HD11 ' CB ' ' A' ' 17' ' ' ALA . 36.9 mm -119.69 141.45 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.039 -0.982 . . . . 1.88 110.295 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.406 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 23.7 m-85 -120.69 153.85 36.36 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.69 -1.141 . . . . 1.38 109.162 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 66' ' ' GLN . 85.9 t -129.83 100.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.06 -1.459 . . . . 1.0 107.06 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 1' ' ' MET . 23.8 m-20 54.93 -79.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 124.409 1.068 . . . . 2.58 112.721 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 64' ' ' VAL . 1.4 tm0? -120.53 -24.78 5.72 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.518 -1.219 . . . . 6.16 112.666 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -95.18 155.18 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.355 -0.938 . . . . 4.3 111.705 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -102.36 140.03 37.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 105.341 -2.096 . . . . 0.93 105.341 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.52 -42.3 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 118.11 -1.436 . . . . 0.92 110.793 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.0 -129.51 5.14 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.463 -1.455 . . . . 1.12 109.463 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.4 178.65 25.43 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.679 -1.248 . . . . 1.29 110.424 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 45.7 t80 -45.45 -36.03 4.15 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.311 -0.956 . . . . 1.63 111.422 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -58.94 -62.06 2.17 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.602 -0.839 . . . . 1.7 109.426 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.26 -39.99 64.3 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.895 -1.048 . . . . 2.21 109.109 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.82 -56.37 22.02 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.199 -1.0 . . . . 1.2 109.683 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.0 -51.12 64.95 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.86 -0.736 . . . . 0.84 110.054 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -53.81 54.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.833 -0.747 . . . . 0.8 109.465 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -48.05 -53.29 16.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.44 -0.948 . . . . 0.88 108.44 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 20' ' ' LEU . 25.2 t -50.9 -61.18 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 114.648 -1.16 . . . . 0.84 109.185 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.14 -51.94 7.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.739 0.649 . . . . 2.04 112.581 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.85 16.28 7.12 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.664 -1.214 . . . . 4.73 113.845 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -128.28 -43.98 1.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.61 -0.836 . . . . 2.15 110.393 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.07 36.51 2.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.867 -0.733 . . . . 2.41 110.722 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.48 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 2.3 t70 -89.25 54.05 2.84 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.181 -1.785 . . . . 4.17 106.181 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.455 ' C ' HH11 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.501 2.115 0 CA-C-N 112.645 -2.07 . . . . 4.79 107.196 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.66 -0.867 . . . . 2.36 108.66 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -84.89 111.57 19.78 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 124.262 0.977 . . . . 4.74 109.583 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.9 m -104.12 123.39 47.18 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 0.88 109.208 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.406 ' C ' HD12 ' A' ' 5' ' ' ILE . 40.2 t -116.13 130.89 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.347 -0.941 . . . . 1.02 109.928 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -106.12 131.9 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 105.974 -1.862 . . . . 1.16 105.974 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -117.42 108.57 15.72 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 105.563 -2.014 . . . . 1.46 105.563 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.64 -160.07 8.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.505 -1.331 . . . . 1.47 110.381 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -113.62 -162.04 0.79 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.222 -0.991 . . . . 4.66 108.732 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -128.89 154.54 46.4 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.49 -1.232 . . . . 5.11 109.452 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 -44.83 1.37 Allowed Glycine 0 N--CA 1.5 2.908 0 C-N-CA 119.386 -1.388 . . . . 3.1 114.229 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.5 m -106.33 146.89 33.89 Favored Pre-proline 0 N--CA 1.498 1.936 0 C-N-CA 118.694 -1.202 . . . . 3.78 111.944 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.49 65.61 8.2 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.41 2.073 . . . . 3.0 111.276 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -112.92 -73.54 0.66 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.655 -1.239 . . . . 4.97 107.655 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.0 m -53.53 -25.15 15.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.356 -0.979 . . . . 2.09 108.356 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -41.65 -39.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 114.624 -1.171 . . . . 1.39 109.779 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.613 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 1.1 tpm_? -75.83 -50.24 15.71 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.15 -1.02 . . . . 3.5 110.255 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.69 54.17 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.758 -1.177 . . . . 1.03 108.321 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 14.6 ttpp -67.59 -58.38 4.8 Favored 'General case' 0 C--O 1.195 -1.77 0 N-CA-C 107.448 -1.315 . . . . 2.11 107.448 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -45.04 -42.93 8.95 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.539 -0.864 . . . . 2.39 109.696 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.9 tp -62.62 -63.73 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.668 -1.151 . . . . 0.95 108.275 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.84 -45.9 15.29 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.444 0.64 . . . . 0.86 109.833 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 26.7 tt0 -64.57 -44.28 91.2 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.6 -1.182 . . . . 2.83 109.583 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -54.7 43.79 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.872 -1.529 . . . . 6.1 106.872 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.27 -45.53 68.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.761 -1.563 . . . . 1.11 107.691 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 32' ' ' GLN . 8.3 t -54.9 -25.82 31.62 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.979 -1.009 . . . . 1.15 111.447 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 1.1 t30 -105.63 9.83 33.13 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.888 -0.782 . . . . 2.08 108.888 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -117.65 -32.73 4.77 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 115.985 -0.552 . . . . 3.26 110.53 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.571 HH12 ' C ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -110.44 153.59 24.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.819 -0.808 . . . . 4.37 108.819 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.71 -26.59 25.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.865 -0.607 . . . . 4.28 110.565 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.51 13.67 29.14 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.694 -0.802 . . . . 2.74 110.471 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -112.47 124.79 53.29 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.297 1.591 . . . . 1.23 115.297 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 63.4 mt-30 -143.02 156.54 44.86 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.397 -2.075 . . . . 3.64 105.397 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -142.3 170.9 14.83 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 117.71 -1.596 . . . . 1.39 111.77 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -138.17 145.21 41.24 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.654 -1.612 . . . . 4.14 109.112 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -122.5 122.76 39.7 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.944 -1.873 . . . . 2.05 105.944 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -120.71 137.41 54.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.651 -1.241 . . . . 1.29 107.651 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.69 129.83 47.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.034 -1.099 . . . . 2.31 108.034 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.51 -28.9 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 119.935 -0.706 . . . . 1.81 111.005 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.606 ' NH1' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -79.79 -40.52 28.49 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.588 -1.264 . . . . 6.78 107.588 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.606 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -39.17 -54.18 1.8 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 120.962 -0.295 . . . . 1.51 110.727 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' GLY . 48.9 mt-10 -110.79 41.42 1.8 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 124.502 1.126 . . . . 4.2 109.95 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 20.1 66.17 0.01 OUTLIER Glycine 0 N--CA 1.508 3.48 0 O-C-N 124.205 0.94 . . . . 2.39 113.31 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 44' ' ' THR . 48.4 mt -93.4 162.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.863 -0.735 . . . . 1.75 109.807 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 43' ' ' ILE . 45.9 p -113.12 178.38 4.3 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.798 -0.637 . . . . 2.08 109.925 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -73.55 -52.86 12.07 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.607 -1.237 . . . . 6.27 109.864 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.4 mp0 -43.3 -52.67 5.65 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.339 -0.544 . . . . 3.88 110.162 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.583 ' CG ' ' HZ3' ' A' ' 51' ' ' LYS . 4.1 t70 -51.57 -57.36 9.32 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.06 -0.656 . . . . 2.47 110.3 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 mt -53.51 -46.05 69.93 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 115.02 -0.991 . . . . 1.31 110.245 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -47.07 -54.78 9.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.47 -0.937 . . . . 3.64 108.47 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -49.23 -29.85 6.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.215 1.572 . . . . 3.77 111.285 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.583 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 10.8 mptt -82.54 -47.36 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.127 -0.942 . . . . 2.53 112.311 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HB2' ' NE2' ' A' ' 61' ' ' GLN . . . -75.27 -45.96 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.628 1.344 . . . . 1.0 114.628 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.63 -42.65 1.91 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 107.295 -2.322 . . . . 2.4 107.295 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -84.18 169.53 16.64 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 106.696 -1.594 . . . . 7.22 106.696 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.04 163.53 5.9 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.942 -1.215 . . . . 4.16 108.942 161.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -124.0 38.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.93 -1.108 . . . . 5.41 109.762 179.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -26.14 -64.06 0.07 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.257 -1.338 . . . . 5.16 111.163 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -116.79 -154.5 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.122 -0.944 . . . . 4.12 109.763 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.44 175.76 3.25 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.068 -1.086 . . . . 1.81 108.068 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.459 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 71.6 Cg_endo -103.6 -170.71 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.112 0 O-C-N 122.406 0.687 . . . . 1.71 111.672 -18.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.548 ' NE2' ' HB2' ' A' ' 52' ' ' ALA . 13.6 mt-30 -141.94 151.79 42.91 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 115.686 -0.688 . . . . 2.63 110.716 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.9 mp -124.79 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 115.527 -0.76 . . . . 1.55 109.286 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 16.8 m-85 -127.27 150.74 49.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.19 -1.368 . . . . 1.01 109.894 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.449 HG23 ' CG1' ' A' ' 69' ' ' ILE . 55.5 t -120.5 125.32 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.055 -1.461 . . . . 0.91 107.055 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.458 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 11.1 t70 57.41 -94.76 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.775 -1.194 . . . . 4.47 107.775 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -131.99 2.47 3.99 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.389 -0.823 . . . . 3.89 110.938 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 1.4 mt-30 -97.09 167.31 11.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 110.018 -0.364 . . . . 4.27 110.018 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 15.0 t-160 -108.28 139.53 42.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.587 -1.264 . . . . 0.83 107.587 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.449 ' CG1' HG23 ' A' ' 64' ' ' VAL . 26.7 mm -101.73 -42.89 9.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.075 -1.05 . . . . 1.08 108.55 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.52 -132.43 5.45 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.07 -2.012 . . . . 1.34 108.07 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 72' ' ' TYR . . . -114.74 -175.22 18.59 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.054 -1.218 . . . . 1.31 110.054 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.508 ' OH ' ' HG2' ' A' ' 16' ' ' ARG . 1.8 t80 -33.03 -54.42 0.38 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.405 0.622 . . . . 2.19 111.194 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.98 -68.77 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.562 -1.199 . . . . 1.91 110.939 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -51.1 -38.94 54.79 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.696 -1.593 . . . . 2.41 110.846 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 62' ' ' ILE . 37.9 t80 -64.99 -51.71 60.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.833 -1.147 . . . . 0.83 109.903 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.12 76.18 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.185 -1.006 . . . . 0.95 109.6 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.02 -58.99 5.45 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.102 -1.039 . . . . 0.82 109.109 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.418 ' CH2' HG21 ' A' ' 64' ' ' VAL . 90.7 t90 -42.58 -51.01 5.3 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.196 -1.039 . . . . 0.73 108.196 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -52.66 -65.58 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.296 0 N-CA-C 107.857 -1.164 . . . . 0.82 107.857 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -49.25 -29.48 5.84 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.507 1.299 . . . . 2.3 114.507 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -105.82 7.64 32.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.231 0.826 . . . . 4.06 113.231 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -129.05 -35.54 1.83 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.01 -0.676 . . . . 1.56 110.378 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -106.35 26.02 10.37 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.131 -0.628 . . . . 2.02 109.872 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -82.36 53.6 2.34 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.548 -0.908 . . . . 3.87 108.548 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.571 ' C ' HH12 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.878 -1.058 . . . . 5.48 109.3 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 30' ' ' ASP . 47.5 mtm . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.531 -0.914 . . . . 2.98 108.531 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.07 155.13 20.72 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 123.833 0.708 . . . . 4.06 109.107 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 2.8 m -143.74 143.7 31.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.021 -1.103 . . . . 1.51 108.021 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.0 t -127.84 126.61 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 C-N-CA 119.033 -1.067 . . . . 1.22 112.526 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.8 mp -109.34 130.06 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.787 -1.19 . . . . 1.27 107.787 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -111.02 111.67 22.94 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 105.006 -2.22 . . . . 1.66 105.006 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.676 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -129.09 -143.82 5.6 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.536 -1.316 . . . . 1.58 112.8 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.32 -167.27 1.83 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 114.404 -0.898 . . . . 5.73 109.969 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m -86.53 64.25 8.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.096 -0.642 . . . . 5.65 111.428 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.63 53.83 1.1 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.504 -1.332 . . . . 3.28 109.78 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' TYR . 49.4 t -107.31 98.03 21.33 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.568 -1.271 . . . . 4.63 107.568 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.43 -20.76 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.264 2.642 . . . . 3.15 113.699 -159.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' CYS . 30.1 m-85 -71.62 -30.92 66.32 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.325 -0.55 . . . . 5.19 112.099 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.1 m -83.8 -30.41 26.59 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.7 -1.6 . . . . 1.94 106.811 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -50.05 -49.85 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 115.483 -0.78 . . . . 1.24 109.344 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.604 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 3.9 mmp_? -58.59 -52.47 65.54 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.38 -0.928 . . . . 2.86 111.047 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.92 63.44 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.261 -1.375 . . . . 0.63 107.729 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -49.19 -58.8 4.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 124.42 1.075 . . . . 2.21 109.265 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.74 -52.19 50.45 Favored 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 120.025 -0.67 . . . . 2.63 110.952 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 tp -52.5 -63.86 1.0 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.078 -0.712 . . . . 0.86 109.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.76 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.059 -0.719 . . . . 0.66 109.059 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.2 tt0 -55.36 -42.01 73.34 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.129 -0.941 . . . . 2.63 110.273 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -64.13 -54.63 30.87 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 119.036 -1.066 . . . . 5.94 108.339 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.524 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 43.1 mt -49.1 -47.55 45.13 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.124 -2.176 . . . . 1.04 105.124 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.19 -47.77 24.03 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.943 -1.026 . . . . 1.1 110.831 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.22 -35.24 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.656 -0.818 . . . . 2.13 112.154 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -72.3 -36.55 68.97 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.084 -0.646 . . . . 4.24 111.323 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.529 HH21 ' CG ' ' A' ' 30' ' ' ASP . 10.9 ptm85 -136.49 113.59 10.56 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.683 -0.807 . . . . 3.65 111.559 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -62.17 12.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 114.572 1.323 . . . . 4.7 114.572 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.529 ' CG ' HH21 ' A' ' 28' ' ' ARG . 10.1 p-10 -111.65 -1.88 15.57 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.066 -0.716 . . . . 3.64 109.066 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 91.4 t80 -109.65 116.81 32.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.637 -0.825 . . . . 1.15 110.352 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -121.73 167.81 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.148 -0.686 . . . . 3.13 109.148 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 30.1 p90 -161.55 168.78 22.96 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.091 -0.644 . . . . 1.7 110.21 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 152.09 41.11 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 109.599 -0.519 . . . . 4.93 109.599 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -118.44 135.7 54.21 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.306 -0.958 . . . . 1.39 109.284 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -127.8 159.33 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.401 -0.963 . . . . 1.36 108.401 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -113.71 129.11 56.62 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.698 -1.964 . . . . 2.53 105.698 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pp -43.67 -26.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.393 -0.523 . . . . 2.14 111.585 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -73.0 -59.44 2.7 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 120.469 -0.492 . . . . 6.78 109.993 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.32 -47.15 0.4 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.467 1.105 . . . . 1.95 111.202 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.82 -45.68 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.511 -1.222 . . . . 4.27 110.813 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.49 49.45 0.8 Allowed Glycine 0 N--CA 1.505 3.268 0 N-CA-C 109.417 -1.473 . . . . 2.79 109.417 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.472 HG21 ' HG ' ' A' ' 48' ' ' LEU . 15.9 mt -113.19 148.51 16.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.064 -0.568 . . . . 2.84 111.015 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.6 p -118.7 -92.77 0.53 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.01 -1.076 . . . . 5.13 110.113 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' NZ ' ' OE1' ' A' ' 46' ' ' GLU . 11.4 tttm -138.45 -55.16 0.63 Allowed 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.652 -1.24 . . . . 4.48 107.652 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.8 mm-40 -43.24 -50.43 6.48 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.367 -0.933 . . . . 5.52 110.92 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 51' ' ' LYS . 33.3 t70 -63.31 -54.74 32.34 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.35 -0.94 . . . . 3.24 111.195 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HG ' HG21 ' A' ' 43' ' ' ILE . 6.1 mt -53.52 -43.86 68.69 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.698 -0.801 . . . . 2.56 110.025 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.83 -53.76 54.57 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.495 -1.298 . . . . 4.52 107.495 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -53.11 -58.11 8.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 124.188 0.93 . . . . 4.58 110.367 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 47' ' ' ASP . 48.0 mttp -54.0 -50.23 67.09 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.166 -0.925 . . . . 2.81 111.367 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' CG ' ' A' ' 68' ' ' HIS . . . -54.45 -55.94 23.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.723 -1.581 . . . . 1.57 111.418 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.04 36.44 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.271 -1.532 . . . . 3.12 109.271 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -102.79 161.35 23.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.164 -0.68 . . . . 7.67 109.164 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.32 111.21 3.23 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.784 1.656 . . . . 4.69 111.451 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.402 HG11 ' NE2' ' A' ' 61' ' ' GLN . 15.4 m -131.02 159.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 123.335 0.397 . . . . 6.01 110.082 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -133.65 -43.08 0.83 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 123.511 0.507 . . . . 6.57 111.957 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -114.54 -148.31 0.43 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.651 -0.82 . . . . 4.96 109.696 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.81 173.6 2.9 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 109.576 -0.527 . . . . 2.45 109.576 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.557 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 73.9 Cg_endo -100.03 -177.68 4.0 Favored 'Cis proline' 0 N--CA 1.483 0.874 0 O-C-N 122.348 0.657 . . . . 1.67 111.319 -11.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.402 ' NE2' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -134.46 145.01 48.44 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.445 -0.798 . . . . 2.48 111.025 -179.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.566 HG21 ' CD1' ' A' ' 75' ' ' PHE . 4.3 mp -124.77 145.78 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 115.171 -0.922 . . . . 1.65 110.863 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.72 160.99 33.88 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.084 -1.871 . . . . 1.1 108.539 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.478 HG23 ' CG1' ' A' ' 69' ' ' ILE . 60.6 t -112.4 175.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.827 -1.916 . . . . 2.15 105.827 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 64' ' ' VAL . 38.8 t70 -61.35 -8.84 4.31 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.991 -1.084 . . . . 3.71 111.014 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -122.95 -56.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.459 1.281 . . . . 7.51 114.459 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.56 176.02 5.91 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 119.816 -0.753 . . . . 6.78 112.641 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' CG ' ' HA ' ' A' ' 52' ' ' ALA . 13.2 t-80 -93.05 154.56 18.04 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.483 -2.043 . . . . 0.94 105.483 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.478 ' CG1' HG23 ' A' ' 64' ' ' VAL . 37.0 mm -115.07 -49.13 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.379 -1.328 . . . . 1.08 111.291 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 145.49 -130.99 4.0 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 1.18 109.708 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.84 -173.39 20.63 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.248 -1.141 . . . . 1.2 110.248 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.91 -52.34 1.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 120.163 -0.615 . . . . 1.97 110.746 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -50.47 -58.76 5.0 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.843 0.83 . . . . 1.85 110.106 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.468 ' HB3' HG22 ' A' ' 69' ' ' ILE . 1.7 m-20 -54.33 -54.31 42.1 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.792 -1.095 . . . . 2.71 110.126 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD1' HG21 ' A' ' 62' ' ' ILE . 25.7 t80 -54.2 -52.34 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.778 -0.769 . . . . 1.09 110.997 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.61 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.625 -0.83 . . . . 1.19 109.014 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.07 -55.85 28.9 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.376 -0.929 . . . . 1.25 110.021 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -49.71 -51.84 35.7 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.705 -0.798 . . . . 1.15 109.346 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.429 ' CG1' HD11 ' A' ' 24' ' ' LEU . 29.0 t -49.73 -63.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 124.131 0.894 . . . . 1.06 108.706 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -44.63 -48.48 10.47 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.03 -0.986 . . . . 2.15 111.154 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.57 27.55 2.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 117.567 -1.653 . . . . 3.8 113.987 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.68 -41.79 0.28 Allowed 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 119.437 -0.905 . . . . 1.24 112.108 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.413 ' CD1' HD13 ' A' ' 24' ' ' LEU . 18.7 mt -109.98 2.96 20.01 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 120.012 -0.675 . . . . 1.98 111.845 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -103.26 -134.7 0.32 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.569 0.7 . . . . 4.98 109.577 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.964 0 CA-C-N 113.895 -1.502 . . . . 7.82 107.591 179.384 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mmm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.208 -0.664 . . . . 3.22 109.208 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -88.96 97.75 11.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.879 -0.601 . . . . 3.86 110.172 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.9 m -84.4 123.38 30.16 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.828 -1.149 . . . . 0.99 109.207 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.67 131.41 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.828 -0.749 . . . . 1.1 112.277 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.45 116.89 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.703 -1.962 . . . . 1.15 105.703 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -99.43 103.89 15.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.661 -1.607 . . . . 1.58 106.661 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -122.78 -123.33 2.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.523 -1.431 . . . . 1.45 109.523 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' N ' ' OH ' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -135.88 -114.37 0.19 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.879 -1.128 . . . . 5.89 109.403 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 p -113.58 -74.81 0.61 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.808 -1.182 . . . . 4.86 107.808 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.92 63.36 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.534 -2.227 . . . . 2.9 107.534 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.6 t -100.19 97.47 6.28 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.935 -0.706 . . . . 4.98 109.524 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.56 -25.57 41.6 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.062 1.841 . . . . 3.27 111.847 -170.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.91 -9.74 58.95 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.332 -0.947 . . . . 6.19 111.576 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 3.5 m -101.07 -37.3 8.66 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.784 -1.561 . . . . 2.25 106.784 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -42.71 -35.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 114.721 -1.127 . . . . 1.27 110.128 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 7.3 mmm180 -71.51 -55.17 8.38 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.049 -1.46 . . . . 4.05 110.525 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.7 43.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.622 -1.251 . . . . 0.86 107.622 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -58.79 -49.88 76.01 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.539 -1.664 . . . . 1.94 109.035 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.6 t70 -60.44 -49.33 78.02 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.735 -1.186 . . . . 2.89 111.075 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 42.1 tp -60.51 -55.32 34.91 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.979 -1.088 . . . . 0.88 110.0 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.85 64.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.335 -1.357 . . . . 0.96 107.335 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.628 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 31.8 tt0 -48.61 -49.43 36.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.388 1.055 . . . . 2.14 109.359 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HE3' ' CA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -50.74 -63.52 1.1 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.344 -1.354 . . . . 6.66 107.344 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 83' ' ' LEU . 54.3 mt -45.53 -53.54 8.83 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.872 -1.158 . . . . 1.33 107.872 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 15.1 t -52.02 -33.25 37.67 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.21 -1.359 . . . . 1.73 112.939 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -112.32 25.33 11.63 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.161 -0.927 . . . . 3.13 109.197 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -133.62 -48.47 0.82 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.161 -0.927 . . . . 3.24 111.568 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 30' ' ' ASP . 21.9 mtp85 -113.38 133.08 55.35 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.194 -0.912 . . . . 3.12 110.508 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -80.9 35.04 0.36 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.395 -1.322 . . . . 3.7 111.372 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.4 p30 -130.2 -4.58 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.843 -1.526 . . . . 3.9 108.132 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' A' ' 25' ' ' SER . 23.7 t80 -127.86 141.45 51.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.599 -0.84 . . . . 1.15 112.608 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.427 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 35.4 mm-40 -140.75 141.04 34.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.218 -1.401 . . . . 3.99 107.218 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.628 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -127.21 162.34 26.39 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 118.62 -1.232 . . . . 1.28 113.721 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 147.45 27.99 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.611 -1.632 . . . . 4.65 109.333 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.538 ' OH ' ' N ' ' A' ' 8' ' ' ARG . 57.6 t80 -113.41 146.34 39.67 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.765 -1.198 . . . . 1.19 107.765 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.21 163.96 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.616 -0.834 . . . . 1.65 110.25 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -121.13 121.24 37.43 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 105.24 -2.133 . . . . 2.23 105.24 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -51.29 -17.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 118.825 -1.15 . . . . 1.88 110.806 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 4.2 ttp-105 -95.05 23.97 5.23 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.72 -0.792 . . . . 6.25 109.666 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.84 -43.69 3.97 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.102 -1.444 . . . . 1.55 107.102 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -93.48 -42.37 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.541 -2.022 . . . . 4.65 105.541 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.21 56.71 0.58 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.222 -1.951 . . . . 1.35 108.222 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.7 149.84 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.501 . . . . 1.37 111.067 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 -170.87 1.92 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.607 -0.724 . . . . 1.94 109.431 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 13.3 ttpp -77.06 -28.29 54.67 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.491 -0.884 . . . . 5.33 110.668 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 16.7 mp0 -70.71 -57.13 5.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 3.32 108.149 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -48.52 -42.66 33.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.104 -0.953 . . . . 2.4 110.422 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.76 -38.77 53.55 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.954 -1.021 . . . . 1.74 110.895 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.483 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 5.2 tt0 -55.74 -47.71 76.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.306 -1.368 . . . . 3.43 107.306 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.0 -30.83 26.83 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.322 -1.308 . . . . 5.1 110.811 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -88.97 -57.6 2.84 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.536 -1.211 . . . . 2.34 112.244 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -50.5 -33.35 21.12 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.783 -1.099 . . . . 1.45 112.029 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.79 73.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 106.521 -2.632 . . . . 3.67 106.521 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -133.26 -169.9 0.22 Allowed Pre-proline 0 C--N 1.296 -1.737 0 CA-C-N 113.089 -1.555 . . . . 6.32 107.834 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -86.6 143.5 7.34 Favored 'Trans proline' 0 C--N 1.299 -2.026 0 C-N-CA 120.893 1.062 . . . . 3.5 110.989 138.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -118.29 160.46 17.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.731 -1.211 . . . . 5.75 107.731 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -101.65 -109.69 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.084 -1.046 . . . . 6.73 108.693 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.9 p -120.26 -73.48 0.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.266 -1.013 . . . . 4.88 108.266 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -147.8 149.76 34.26 Favored Pre-proline 0 C--N 1.289 -2.048 0 CA-C-N 114.149 -1.387 . . . . 2.47 107.966 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.636 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 26.0 Cg_endo -103.66 155.8 3.01 Favored 'Cis proline' 0 C--N 1.32 -0.966 0 CA-C-N 118.671 0.561 . . . . 1.69 112.241 -6.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.46 149.43 41.28 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 107.085 -1.45 . . . . 2.74 107.085 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 58.0 mt -127.48 141.33 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.651 -0.82 . . . . 1.27 113.136 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -124.54 145.15 49.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.306 -1.77 . . . . 1.5 110.283 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 71.1 t -117.75 90.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.412 -0.959 . . . . 1.2 108.412 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 t70 70.9 -75.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.263 -0.88 . . . . 2.57 109.05 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -134.18 -20.87 1.88 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.786 -1.097 . . . . 3.55 111.381 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -89.51 158.1 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.759 -1.176 . . . . 4.9 110.8 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.576 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 11.8 t-160 -103.71 142.32 34.54 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.473 -0.936 . . . . 0.92 108.473 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 mm -111.55 -46.14 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.041 -1.063 . . . . 0.93 108.959 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.15 -113.82 1.01 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.504 -1.439 . . . . 1.17 109.504 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -119.25 -173.81 15.61 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 110.372 -1.091 . . . . 1.22 110.372 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 18.5 t80 -47.1 -49.2 22.36 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.354 -0.939 . . . . 1.39 111.516 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -54.67 17.17 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.687 0.756 . . . . 1.65 110.123 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -58.38 -52.64 64.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.666 -1.606 . . . . 2.44 110.481 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.97 -44.68 96.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.508 -0.769 . . . . 1.19 111.834 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.91 -58.18 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.728 -0.789 . . . . 1.03 109.226 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.76 -55.43 35.21 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.569 -1.253 . . . . 1.14 108.893 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.43 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 63.6 t90 -44.75 -54.18 6.57 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 123.549 0.531 . . . . 0.95 111.485 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -43.54 -59.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.962 -0.563 . . . . 0.82 110.265 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HG3' ' OE2' ' A' ' 81' ' ' GLU . 18.2 tptp -43.8 -30.19 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.394 1.628 . . . . 2.11 115.394 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.422 ' OE2' ' HG3' ' A' ' 80' ' ' LYS . 2.9 mp0 -107.82 4.5 25.57 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 119.579 1.082 . . . . 4.74 112.62 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -120.56 -31.57 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.721 -0.791 . . . . 1.38 111.045 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 24' ' ' LEU . 55.0 mt -116.94 26.84 9.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.792 -0.763 . . . . 1.7 111.954 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.42 50.15 1.95 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.698 -0.801 . . . . 3.6 110.647 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.425 ' C ' HH12 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.499 2.02 0 CA-C-O 116.035 -1.936 . . . . 5.55 111.57 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 3.9 ptm . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 107.728 -1.212 . . . . 3.83 107.728 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.48 HE22 ' C ' ' A' ' 33' ' ' TYR . 60.5 tp60 -111.57 142.0 44.42 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 123.478 0.487 . . . . 4.73 109.839 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 m -120.4 148.72 43.41 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.771 -0.771 . . . . 1.39 109.025 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.49 139.19 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 118.868 -1.133 . . . . 1.05 112.595 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.463 HD12 ' HB1' ' A' ' 17' ' ' ALA . 17.2 mm -111.1 136.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.55 -1.278 . . . . 1.54 107.55 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.15 84.98 2.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.585 -1.635 . . . . 2.2 106.585 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -135.1 -163.28 10.05 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.496 -2.241 . . . . 1.27 107.496 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 9' ' ' SER . 4.2 tpt180 -141.35 167.68 21.58 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.256 -0.977 . . . . 6.19 108.581 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 8' ' ' ARG . 78.9 p -85.76 64.83 8.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.307 -0.627 . . . . 4.68 109.307 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 11' ' ' CYS . . . -120.75 61.13 0.52 Allowed Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.505 -1.438 . . . . 4.68 109.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.755 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 30.7 t 108.82 165.44 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.685 0 N-CA-C 105.605 -1.998 . . . . 4.71 105.605 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 50.5 Cg_exo -54.76 75.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.023 1.149 . . . . 3.11 113.023 165.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.403 ' CD2' ' HB3' ' A' ' 11' ' ' CYS . 6.5 m-85 -113.82 -77.89 0.58 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.573 -0.451 . . . . 4.85 109.915 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.45 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.7 m -55.02 -29.12 56.7 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 118.041 -1.464 . . . . 2.44 108.022 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -42.54 -38.59 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 114.164 -1.38 . . . . 1.51 110.205 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.495 ' NH2' ' HB3' ' A' ' 19' ' ' ASP . 6.6 mmm180 -77.11 -53.63 7.54 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 117.957 -1.497 . . . . 3.61 110.093 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.463 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -49.16 -42.59 40.25 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.208 -0.997 . . . . 1.07 109.185 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HE3' ' CZ ' ' A' ' 33' ' ' TYR . 2.3 tptm -60.19 -60.0 4.51 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.898 -1.501 . . . . 2.74 108.687 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.495 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 3.4 t70 -50.51 -42.65 55.15 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.984 -1.086 . . . . 2.6 110.029 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 79' ' ' VAL . 8.6 tp -63.22 -66.93 0.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.686 -1.205 . . . . 1.11 109.185 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.97 -39.82 9.48 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 120.312 -0.555 . . . . 1.04 110.524 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 26.6 tt0 -65.55 -53.04 47.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.151 -0.932 . . . . 2.31 110.389 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -53.54 39.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.566 -1.642 . . . . 6.81 106.566 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.4 mt -53.51 -40.62 65.55 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.544 -1.207 . . . . 1.39 108.216 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -59.7 -35.62 74.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.874 -1.057 . . . . 1.03 110.594 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -83.98 -28.08 27.99 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.042 -0.663 . . . . 1.77 110.891 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.3 -47.22 44.5 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.208 -0.597 . . . . 3.42 111.35 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -109.18 164.97 11.96 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.143 -1.023 . . . . 4.44 110.907 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.632 -1.618 . . . . 4.0 106.632 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 1' ' ' MET . 3.5 t70 -82.86 41.19 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.924 -1.489 . . . . 3.58 108.686 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -145.46 93.23 2.34 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.546 -1.262 . . . . 1.07 112.651 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -99.55 155.06 17.78 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 104.526 -2.398 . . . . 3.35 104.526 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.548 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 7.3 p90 -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.059 -1.056 . . . . 1.73 108.784 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -149.02 152.44 36.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.701 -0.852 . . . . 4.77 108.701 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -121.46 123.15 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.841 -1.17 . . . . 2.11 107.841 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.28 145.39 20.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.97 -2.233 . . . . 1.92 104.97 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 11.1 t70 -111.18 160.1 17.25 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.544 -1.263 . . . . 2.55 108.512 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.26 -30.24 5.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 117.778 -1.569 . . . . 1.25 108.87 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 3.1 tpm_? -93.18 -59.31 2.06 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.74 -0.664 . . . . 5.31 110.339 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -47.19 -33.29 5.15 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.655 -0.818 . . . . 1.66 110.972 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.22 -46.31 8.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.954 0.784 . . . . 3.97 109.334 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 54.23 1.05 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.722 -1.751 . . . . 1.49 108.722 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 mt -99.74 162.7 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.544 -0.91 . . . . 1.53 108.544 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 p -113.36 148.78 35.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.942 0.776 . . . . 2.43 112.184 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.606 ' HG3' ' CG1' ' A' ' 56' ' ' VAL . 35.0 tttm -49.3 -54.26 17.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.588 -0.893 . . . . 4.26 108.588 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 3.6 mp0 -46.62 -62.91 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.725 -1.125 . . . . 3.25 111.006 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.15 -56.71 8.33 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 120.401 -0.519 . . . . 2.16 110.895 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.8 -50.17 69.2 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 115.7 -0.682 . . . . 1.25 110.229 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.97 -56.14 16.06 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 3.04 107.535 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -49.77 -43.92 48.48 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.107 -1.406 . . . . 3.96 109.071 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HD2' ' CE2' ' A' ' 63' ' ' PHE . 6.2 tmtt? -63.85 -46.39 85.23 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.133 -1.394 . . . . 7.24 112.231 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -71.19 -48.51 51.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 113.068 0.766 . . . . 1.06 113.068 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.94 -33.85 6.18 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.065 -2.414 . . . . 2.54 107.065 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -83.83 141.53 41.25 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 114.447 -0.876 . . . . 7.78 108.649 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -41.92 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 122.358 2.039 . . . . 3.87 110.712 161.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.606 ' CG1' ' HG3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER 33.32 -95.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 115.637 1.717 . . . . 5.22 115.637 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 5.3 tp10 109.14 -170.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 102.475 -3.158 . . . . 7.18 102.475 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.498 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 14.9 p -104.03 -152.49 0.46 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.181 -1.414 . . . . 4.33 107.181 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.07 146.64 51.88 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 107.881 -1.155 . . . . 2.8 107.881 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 96.6 Cg_endo -98.46 162.46 10.42 Favored 'Cis proline' 0 N--CA 1.489 1.223 0 O-C-N 122.858 0.925 . . . . 2.43 111.637 10.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -114.06 151.34 32.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.578 -1.267 . . . . 2.85 107.578 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.423 HD12 ' CB ' ' A' ' 75' ' ' PHE . 6.2 mt -123.2 143.24 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.066 -1.054 . . . . 1.8 111.798 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.422 ' CE2' ' HD2' ' A' ' 51' ' ' LYS . 31.7 m-85 -136.36 159.06 42.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.751 -1.568 . . . . 1.09 107.874 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 66' ' ' GLN . 74.6 t -127.6 130.44 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.531 -0.914 . . . . 0.87 108.531 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.08 -81.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 124.398 1.061 . . . . 2.77 110.603 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.3 pt20 -138.33 -14.2 1.32 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.229 -0.896 . . . . 3.87 110.976 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -85.46 168.96 14.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.696 0.623 . . . . 4.88 111.209 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.53 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.3 t-160 -113.01 139.66 48.47 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.617 -0.72 . . . . 0.87 109.267 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mm -109.69 -34.37 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.304 -1.358 . . . . 1.15 109.215 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.96 -136.17 8.77 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.169 -1.491 . . . . 1.2 109.539 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.39 169.2 17.1 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.749 -1.215 . . . . 1.49 110.656 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.6 t80 -40.53 -57.27 1.87 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 112.608 0.596 . . . . 1.52 112.608 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 p -43.25 -69.31 0.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.026 0.917 . . . . 1.6 111.213 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -52.1 30.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.174 -1.83 . . . . 2.83 110.316 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' CE1' ' CE3' ' A' ' 78' ' ' TRP . 58.3 t80 -44.61 -46.54 10.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.345 -0.843 . . . . 1.74 111.03 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -40.83 -48.17 3.03 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 119.62 -0.832 . . . . 1.1 111.006 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.99 77.93 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.839 -1.144 . . . . 1.17 109.713 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.464 ' CZ2' HG21 ' A' ' 64' ' ' VAL . 90.5 t90 -50.94 -44.99 60.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.724 -0.843 . . . . 0.7 108.724 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG21 HD21 ' A' ' 20' ' ' LEU . 79.7 t -57.23 -33.99 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.662 -1.154 . . . . 1.08 110.23 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 13.7 tptp -87.57 18.52 3.88 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.265 -0.974 . . . . 2.26 111.726 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.21 -45.47 0.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.271 -0.972 . . . . 3.85 111.826 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -84.86 -2.16 57.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.992 -1.083 . . . . 1.76 111.745 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.416 HD12 HG13 ' A' ' 79' ' ' VAL . 86.0 mt -123.25 21.32 9.63 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.209 -0.996 . . . . 1.8 110.742 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.08 46.62 1.4 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.075 -1.084 . . . . 4.09 108.075 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.957 0 CA-C-N 113.078 -1.874 . . . . 6.25 109.506 -179.374 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.387 -0.598 . . . . 3.46 109.387 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 18.6 mt-30 -112.01 164.51 13.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.118 0.485 . . . . 3.85 111.82 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.1 m -152.35 121.48 6.67 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 116.434 -0.348 . . . . 1.14 110.159 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.491 ' C ' HD12 ' A' ' 5' ' ' ILE . 6.6 t -109.19 137.91 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.103 -1.039 . . . . 1.02 110.09 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp -109.32 98.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 124.768 1.293 . . . . 1.05 108.077 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CE1' HG11 ' A' ' 4' ' ' VAL . 76.4 m-85 -93.76 92.75 7.61 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 105.774 -1.936 . . . . 1.41 105.774 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -125.07 -150.69 7.85 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.825 -1.178 . . . . 1.27 111.766 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.3 tpt180 -124.26 123.53 40.45 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.812 -0.81 . . . . 5.27 108.812 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -78.45 53.78 1.34 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.662 0.744 . . . . 5.39 109.397 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.34 -46.37 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.733 -1.347 . . . . 3.16 109.733 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.575 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 32.1 t -111.78 156.1 42.12 Favored Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.779 -0.822 . . . . 3.76 108.779 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 6.1 Cg_endo -72.55 48.53 1.31 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.491 1.461 . . . . 3.23 111.446 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -99.99 -58.62 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.361 -0.978 . . . . 4.36 108.361 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.3 m -53.26 -36.19 60.84 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.423 -1.325 . . . . 2.46 107.423 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.41 -30.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.079 -1.873 . . . . 1.34 111.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' ARG . 39.4 mmt180 -72.28 -39.85 68.02 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.983 -1.087 . . . . 5.82 110.302 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 62' ' ' ILE . . . -65.22 -46.7 79.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.217 -1.771 . . . . 0.84 106.217 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 2.1 ttpp -51.99 -48.91 64.2 Favored 'General case' 0 C--O 1.2 -1.532 0 CA-C-N 114.099 -1.409 . . . . 1.59 108.97 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -57.42 -65.68 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.646 -0.706 . . . . 2.94 111.251 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.4 tp -51.31 -51.85 50.57 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.083 -1.047 . . . . 1.05 110.073 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.13 -51.52 63.98 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.618 -1.173 . . . . 0.79 109.747 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 19.6 tt0 -55.93 -49.0 74.69 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.047 -0.978 . . . . 1.88 109.35 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HD2' ' C ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -52.23 -55.1 23.36 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.034 -1.466 . . . . 4.35 107.657 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.82 -37.17 63.3 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.756 -0.831 . . . . 1.01 108.756 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 5.7 t -55.71 -40.74 72.84 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.815 -1.18 . . . . 1.04 107.815 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -98.3 40.36 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.961 -1.496 . . . . 2.05 106.961 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.53 -52.3 0.39 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.242 -1.344 . . . . 2.8 111.663 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -106.23 -11.45 16.04 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.973 -1.091 . . . . 4.61 111.177 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 71.51 -40.55 0.48 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 124.15 0.906 . . . . 4.72 112.59 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 1' ' ' MET . 5.3 p-10 -80.96 4.23 20.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.705 -1.198 . . . . 2.71 107.863 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.502 ' CD2' ' HE3' ' A' ' 1' ' ' MET . 6.0 t80 -95.23 102.35 14.15 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.554 1.159 . . . . 1.48 108.011 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 37.7 mt-30 -119.29 118.62 31.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.201 -1.037 . . . . 3.12 108.201 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.41 160.04 15.94 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.731 -1.188 . . . . 1.38 110.574 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.429 ' CG ' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -142.26 148.84 38.76 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.076 -1.42 . . . . 4.71 108.9 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -112.21 136.19 51.93 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.042 -1.096 . . . . 1.45 108.042 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.42 152.04 27.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.213 -1.773 . . . . 1.3 106.213 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.68 142.2 47.52 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.409 -0.916 . . . . 2.19 109.008 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.9 pt -48.3 -36.95 6.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.927 -0.709 . . . . 1.27 111.188 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -76.74 -44.88 31.38 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.002 -1.079 . . . . 6.42 111.473 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.76 -54.36 2.65 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 119.529 -0.868 . . . . 1.75 110.422 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 42' ' ' GLY . 64.9 mt-10 -93.47 25.18 3.56 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 114.3 -1.318 . . . . 4.27 111.255 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 30.51 57.0 0.24 Allowed Glycine 0 N--CA 1.508 3.455 0 N-CA-C 112.074 -0.41 . . . . 1.63 112.074 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.6 161.52 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.933 -0.766 . . . . 1.88 108.933 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -119.93 154.62 34.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.706 0.765 . . . . 1.98 109.513 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -45.13 -42.12 8.63 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.071 1.137 . . . . 4.13 114.071 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.702 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 14.2 mp0 -65.02 -56.5 12.73 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.818 -0.753 . . . . 3.07 110.608 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.56 -50.21 24.49 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.19 -1.041 . . . . 2.44 108.19 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.94 -48.94 74.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.159 -1.382 . . . . 1.29 108.551 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.511 HE21 ' H ' ' A' ' 56' ' ' VAL . 5.4 tp60 -44.78 -45.02 9.77 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.936 -1.135 . . . . 4.88 107.936 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.15 -49.54 69.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.898 1.374 . . . . 3.45 109.587 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.58 -48.95 62.98 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.155 -0.683 . . . . 2.42 109.155 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -19.69 56.98 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.429 -0.952 . . . . 1.04 108.429 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.67 32.57 17.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.375 -1.89 . . . . 2.73 108.375 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -143.66 158.21 57.19 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-N 114.096 -1.052 . . . . 7.45 108.707 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.86 68.87 4.67 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.675 1.584 . . . . 3.68 111.25 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.511 ' H ' HE21 ' A' ' 49' ' ' GLN . 4.8 p -101.71 125.1 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.982 -0.687 . . . . 6.39 110.804 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.71 -2.82 10.36 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 112.918 0.711 . . . . 6.2 112.918 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 p -116.08 -169.27 1.57 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.637 -0.825 . . . . 4.25 111.579 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.8 164.59 33.93 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.415 -0.811 . . . . 2.89 108.992 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.69 157.44 71.82 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 124.236 -1.152 . . . . 2.88 109.747 -7.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -98.25 101.42 12.88 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 103.916 -2.624 . . . . 3.37 103.916 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 17' ' ' ALA . 8.2 mt -91.59 133.12 34.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 113.167 -1.833 . . . . 1.34 111.266 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -125.64 153.57 43.6 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 112.979 -1.919 . . . . 1.09 109.798 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 66' ' ' GLN . 80.0 t -122.2 95.91 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.882 -1.155 . . . . 0.84 107.882 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.5 -72.72 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 125.189 1.556 . . . . 2.63 110.557 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 64' ' ' VAL . 41.7 tp60 -129.78 -18.06 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.475 -1.239 . . . . 6.0 111.363 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -91.61 172.95 8.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.276 -0.97 . . . . 3.52 111.18 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -119.92 149.72 41.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 106.797 -1.557 . . . . 1.74 106.797 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 78' ' ' TRP . 21.3 mm -116.25 -55.95 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.687 -0.805 . . . . 0.89 111.069 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.58 -135.05 4.76 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.667 -1.254 . . . . 1.53 110.26 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.37 -74.31 0.94 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 111.141 -0.783 . . . . 2.47 111.141 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -137.97 -55.85 0.66 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 118.724 -1.19 . . . . 2.73 109.343 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 p -41.95 -52.4 4.14 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 123.118 1.437 . . . . 2.05 109.658 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -36.46 84.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.005 -2.362 . . . . 2.08 109.964 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.19 -51.01 61.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.496 -0.882 . . . . 1.21 109.108 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.5 64.81 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.276 -0.969 . . . . 1.34 109.28 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.88 -58.9 6.14 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.788 -1.165 . . . . 1.03 108.998 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.481 ' CD1' HD12 ' A' ' 69' ' ' ILE . 87.6 t90 -44.5 -55.54 5.02 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.519 -0.764 . . . . 0.76 109.301 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.466 HG13 HD12 ' A' ' 83' ' ' LEU . 2.7 t -44.79 -60.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 114.231 -1.35 . . . . 1.04 108.853 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -50.21 -39.88 45.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.21 -0.905 . . . . 2.52 112.937 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 11.7 pt-20 -104.52 36.09 2.52 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.592 -0.843 . . . . 4.33 113.067 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -147.5 -36.11 0.22 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.216 1.007 . . . . 1.56 110.038 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 79' ' ' VAL . 22.3 mt -99.44 -24.03 14.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.523 -1.217 . . . . 2.65 110.794 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -93.29 -64.82 1.05 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 125.105 1.503 . . . . 4.1 108.082 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.803 0 CA-C-N 112.708 -2.042 . . . . 8.72 109.261 179.878 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.487 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.4 mpp? . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 108.004 -1.11 . . . . 2.38 108.004 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.42 ' C ' HE21 ' A' ' 2' ' ' GLN . 0.0 OUTLIER -83.16 102.61 11.98 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 124.023 0.827 . . . . 4.04 109.459 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 5.7 m -96.69 116.38 29.03 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.963 -1.095 . . . . 1.48 109.925 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 t -123.7 136.95 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.397 -0.819 . . . . 1.01 112.448 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.41 HG21 ' SG ' ' A' ' 14' ' ' CYS . 5.4 mm -110.39 125.03 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.747 -1.205 . . . . 1.27 107.747 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 82.1 m-85 -102.47 114.99 29.67 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.21 -1.774 . . . . 1.73 106.21 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.29 -148.78 7.99 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.409 -1.077 . . . . 1.69 110.409 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.5 ttm180 -138.8 141.74 38.74 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 119.846 -0.742 . . . . 6.24 110.613 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 t -54.98 73.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.983 -1.462 . . . . 6.59 112.761 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 118.5 26.62 2.58 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 120.45 -0.881 . . . . 4.03 113.096 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 13' ' ' TYR . 9.7 t -122.31 138.0 28.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 C-N-CA 118.728 -1.189 . . . . 4.8 110.048 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.02 53.08 4.42 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.884 1.723 . . . . 4.44 111.2 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.545 ' CE2' ' SG ' ' A' ' 11' ' ' CYS . 20.3 m-30 -111.73 -68.21 0.95 Allowed 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.302 -0.559 . . . . 5.67 112.147 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 16' ' ' ARG . 3.5 t -54.49 -29.34 49.89 Favored 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 118.014 -1.474 . . . . 4.4 108.912 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 15' ' ' VAL . 7.2 t -44.75 -12.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 114.027 -1.442 . . . . 2.3 112.072 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.599 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -108.87 -42.37 4.49 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.534 -0.867 . . . . 3.54 109.607 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.17 75.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.345 -1.724 . . . . 0.75 106.345 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -54.97 -39.82 69.36 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 114.588 -1.187 . . . . 2.11 108.686 179.14 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.457 ' CG ' HH12 ' A' ' 16' ' ' ARG . 0.2 OUTLIER -66.32 -62.42 1.48 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.212 0.529 . . . . 2.76 111.488 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' CD2' ' A' ' 75' ' ' PHE . 15.3 tp -56.36 -43.27 78.98 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.408 -0.917 . . . . 1.09 110.045 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.08 72.69 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.725 -1.19 . . . . 1.08 108.296 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 11.3 tt0 -48.14 -47.33 34.83 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.44 -0.948 . . . . 2.42 108.44 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -48.57 -52.9 20.49 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 118.756 -1.178 . . . . 4.15 110.62 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.5 mt -65.52 -46.24 80.4 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 123.721 0.638 . . . . 1.18 111.78 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 22' ' ' GLU . 1.5 p -57.9 -25.37 60.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 118.922 -1.111 . . . . 2.81 111.15 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 8.8 t30 -91.75 27.98 1.91 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.028 -1.069 . . . . 1.78 108.647 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 72.5 mt-10 -121.17 -65.7 1.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.951 -0.7 . . . . 3.4 110.252 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.501 HH22 ' C ' ' A' ' 85' ' ' ALA . 2.9 mpt_? -122.26 -166.77 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.811 -1.086 . . . . 3.83 111.746 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -107.45 -4.65 18.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.912 -1.04 . . . . 5.79 111.027 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.9 p-10 -84.29 -9.59 58.35 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.919 -1.141 . . . . 3.26 107.919 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CZ ' HG21 ' A' ' 3' ' ' THR . 29.8 t80 -116.02 96.9 5.79 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.492 -0.883 . . . . 1.56 110.817 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -112.11 128.07 56.1 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.255 -2.128 . . . . 4.23 105.255 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.1 OUTLIER -123.28 143.25 50.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.118 -1.433 . . . . 1.58 113.74 -177.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -139.1 161.67 36.81 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 113.822 -1.536 . . . . 4.39 109.409 178.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.451 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 30.6 t80 -118.98 142.62 47.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.115 -0.698 . . . . 1.37 109.115 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -132.19 147.02 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.348 -0.982 . . . . 1.39 108.348 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 3.3 t70 -122.48 114.74 21.11 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 119.038 -1.065 . . . . 2.58 112.434 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -49.3 -31.46 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.477 -0.783 . . . . 1.51 111.522 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.506 ' O ' ' NE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.03 -63.44 1.31 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.284 -1.766 . . . . 5.41 108.723 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -30.49 -45.51 0.06 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.667 1.23 . . . . 2.62 111.671 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -94.22 -53.37 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.905 -1.118 . . . . 3.64 111.465 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.58 51.87 0.2 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 118.989 -1.576 . . . . 1.75 111.47 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.7 mt -103.87 157.73 5.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.775 -1.565 . . . . 1.87 106.775 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.0 p -115.88 158.35 23.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.653 -0.819 . . . . 2.34 109.084 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -52.18 -40.29 61.27 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 118.961 -1.096 . . . . 4.75 111.833 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 23.3 mp0 -47.73 -63.76 0.97 Allowed 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 121.663 0.744 . . . . 3.4 110.261 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -44.31 -44.62 8.25 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 114.354 -1.294 . . . . 2.82 111.978 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.77 -41.7 64.76 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.336 -1.302 . . . . 2.07 110.5 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 55' ' ' PRO . 14.0 tt0 -57.28 -40.12 77.1 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.301 -1.741 . . . . 3.17 106.301 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -15.54 11.84 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.355 -1.293 . . . . 3.59 110.692 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -104.11 -37.73 7.21 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.671 -0.695 . . . . 2.5 110.51 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.497 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -72.0 -37.79 69.75 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.725 -1.125 . . . . 1.51 112.65 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -45.62 1.87 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 107.957 -2.057 . . . . 2.84 107.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 17.8 pttp -101.35 176.31 1.94 Allowed Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.556 -1.646 . . . . 5.93 106.556 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 64.9 Cg_exo -48.67 155.15 2.53 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 120.67 0.913 . . . . 3.79 110.93 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 56' ' ' VAL . 3.9 m -72.43 -30.99 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.447 -0.901 . . . . 5.99 111.312 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.58 -145.92 0.32 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.047 -0.661 . . . . 7.4 109.383 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -95.38 168.04 10.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.604 -0.838 . . . . 4.27 110.003 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.01 152.26 39.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.634 -1.247 . . . . 2.4 107.634 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 13' ' ' TYR . 73.7 Cg_endo -97.03 160.2 12.07 Favored 'Cis proline' 0 C--N 1.304 -1.78 0 C-N-CA 123.828 -1.322 . . . . 2.43 109.664 17.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 1.4 tp-100 -110.16 132.45 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 105.069 -2.197 . . . . 3.4 105.069 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' A' ' 75' ' ' PHE . 5.3 mt -112.71 137.53 45.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.037 -1.065 . . . . 1.79 111.013 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -127.5 138.78 53.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.407 -1.724 . . . . 1.27 107.807 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 66' ' ' GLN . 40.6 t -121.73 108.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 124.462 1.101 . . . . 1.26 109.183 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.01 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.141 -0.689 . . . . 2.94 109.141 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -138.05 -9.82 1.53 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.484 -1.234 . . . . 3.87 110.034 179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.82 146.62 26.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.678 -0.49 . . . . 4.57 109.678 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.497 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 14.6 t-160 -105.85 135.55 47.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.159 -1.423 . . . . 1.19 107.159 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 78' ' ' TRP . 9.9 mm -103.7 -41.06 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 118.588 -1.245 . . . . 0.89 109.775 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 128.39 -114.74 1.88 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 107.324 -2.31 . . . . 1.36 107.324 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 60' ' ' PRO . . . -129.87 -169.13 12.46 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 118.558 -1.782 . . . . 1.15 111.23 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 35.7 t80 -61.96 176.28 0.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 105.738 -1.949 . . . . 3.07 105.738 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.471 ' CB ' ' O ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 78.23 -64.69 0.27 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.413 -1.328 . . . . 3.06 107.413 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -41.62 83.05 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.398 -1.334 . . . . 2.62 107.398 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.56 ' HB2' HD12 ' A' ' 62' ' ' ILE . 15.8 t80 -41.84 -49.88 4.43 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 113.915 -1.493 . . . . 1.15 110.041 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.66 71.28 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.412 -0.915 . . . . 1.06 109.061 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.14 -53.99 51.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.887 -1.125 . . . . 0.94 109.435 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.43 ' CD1' HD12 ' A' ' 69' ' ' ILE . 70.2 t90 -50.3 -53.45 28.58 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.746 -0.782 . . . . 1.11 110.065 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.0 t -43.98 -56.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.312 -0.858 . . . . 0.94 109.336 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 80' ' ' LYS . 6.2 tmtm? -44.83 -23.86 0.17 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 116.953 -1.499 . . . . 2.86 115.044 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.18 6.2 10.26 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-N 120.94 1.7 . . . . 4.79 112.971 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.23 -25.74 5.63 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.846 -0.742 . . . . 1.31 109.725 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.89 28.03 4.22 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.16 -0.927 . . . . 2.02 111.096 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 80' ' ' LYS . 18.6 p-10 -93.89 30.08 1.93 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.229 1.014 . . . . 4.4 109.099 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.501 ' C ' HH22 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.544 0 CA-C-N 113.227 -1.806 . . . . 5.53 108.042 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.838 -0.801 . . . . 2.9 108.838 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.458 ' OE1' ' HB2' ' A' ' 34' ' ' GLN . 6.2 tt0 -84.17 144.52 28.93 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 119.104 -1.039 . . . . 4.85 109.447 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.7 m -96.39 134.73 39.18 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.169 -1.419 . . . . 1.81 107.169 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.487 ' C ' HD12 ' A' ' 5' ' ' ILE . 6.7 t -125.42 122.22 62.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.593 -1.262 . . . . 1.14 107.593 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -107.17 123.65 62.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 105.419 -2.067 . . . . 1.01 105.419 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -117.78 117.07 28.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 2.72 108.587 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.46 159.43 8.39 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.875 -1.155 . . . . 1.98 111.247 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -112.89 139.09 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.194 -1.039 . . . . 5.13 108.194 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.538 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 10.9 p -102.89 -65.15 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.124 -1.03 . . . . 6.46 109.709 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.27 -47.88 0.99 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 105.967 -2.853 . . . . 3.43 105.967 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.5 m -94.7 165.2 17.73 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 106.354 -1.721 . . . . 4.53 106.354 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.04 67.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.844 2.363 . . . . 3.38 112.528 165.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -115.0 -65.34 1.2 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.628 -0.878 . . . . 6.11 108.628 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 18.1 m -53.46 -33.82 55.59 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.404 1.097 . . . . 2.22 108.388 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 15' ' ' VAL . 22.3 t -44.46 -47.12 2.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 113.002 -1.908 . . . . 1.43 111.259 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -50.01 -48.8 52.34 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.71 -0.796 . . . . 3.21 110.534 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.27 -52.69 25.81 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.552 -1.277 . . . . 0.87 107.552 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -53.76 -45.21 70.54 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 114.759 -1.11 . . . . 1.95 110.53 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.525 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 43.7 m-20 -62.21 -56.72 15.85 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.336 -0.546 . . . . 3.19 111.663 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.407 HD23 ' CD2' ' A' ' 75' ' ' PHE . 18.7 tp -57.79 -52.02 67.2 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.029 -0.73 . . . . 0.79 109.029 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.73 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.74 -0.837 . . . . 0.65 108.74 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 42.3 tt0 -58.38 -47.76 82.8 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.7 -0.8 . . . . 2.35 110.428 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' NZ ' ' OE1' ' A' ' 27' ' ' GLU . 17.6 tptp -57.45 -54.96 40.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 116.563 -2.055 . . . . 4.63 107.879 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' LYS . 47.7 mt -48.6 -46.11 38.98 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.533 -1.667 . . . . 1.4 107.63 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 31' ' ' PHE . 6.5 t -49.84 -42.44 47.34 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.785 -0.643 . . . . 1.04 109.494 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.433 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 t-20 -72.89 -29.49 63.2 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.742 -0.663 . . . . 2.77 111.13 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 1.6 mm-40 -86.33 -40.14 15.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.292 1.219 . . . . 3.84 114.292 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HE ' ' C ' ' A' ' 85' ' ' ALA . 28.4 mtp180 -114.25 139.36 49.46 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.923 -0.711 . . . . 4.32 112.216 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.35 -40.88 98.48 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.225 -0.898 . . . . 4.08 113.273 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.75 20.28 1.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.405 -0.918 . . . . 3.44 111.36 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 4.4 t80 -115.28 123.02 47.72 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.544 -1.262 . . . . 1.13 111.63 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -136.04 172.39 13.08 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 106.824 -1.547 . . . . 3.45 106.824 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -145.35 149.45 34.81 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.501 -1.28 . . . . 1.36 110.919 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.458 ' HB2' ' OE1' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -136.87 139.78 41.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.113 0.883 . . . . 5.02 109.252 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.67 121.2 34.92 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.178 -1.009 . . . . 1.71 108.83 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.99 153.59 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.866 -0.734 . . . . 1.64 109.708 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -108.69 124.3 50.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.092 -1.447 . . . . 2.51 107.092 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.7 pt -40.02 -41.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.709 -0.796 . . . . 1.29 111.816 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -31.47 61.87 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 118.998 -1.081 . . . . 5.37 111.778 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.1 -53.59 32.76 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.416 -0.914 . . . . 1.4 111.593 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -94.63 -34.49 12.59 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.477 -0.889 . . . . 3.65 111.872 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.48 50.43 0.66 Allowed Glycine 0 N--CA 1.503 3.12 0 N-CA-C 109.332 -1.507 . . . . 1.51 109.332 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.8 mt -96.55 137.15 25.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.312 -0.995 . . . . 1.61 108.312 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.4 p -107.35 166.34 10.72 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.929 -1.108 . . . . 2.37 112.067 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 57' ' ' GLU . 8.8 ttpt -56.86 -35.25 68.66 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.573 -1.194 . . . . 4.78 109.967 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 24.0 mp0 -68.93 -47.72 65.02 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.052 -1.092 . . . . 3.54 108.052 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.66 -49.96 74.74 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 117.793 -1.563 . . . . 2.53 108.332 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -53.66 -54.46 37.42 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.017 -1.073 . . . . 1.63 108.367 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -51.46 -51.79 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.544 0.527 . . . . 5.32 109.95 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -53.09 -54.32 37.32 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.38 -0.971 . . . . 4.67 108.38 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -55.72 -38.25 69.49 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.724 -1.126 . . . . 2.78 110.523 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -59.54 -48.0 83.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 123.68 0.612 . . . . 1.99 110.4 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.42 -40.47 2.72 Favored Glycine 0 N--CA 1.499 2.833 0 C-N-CA 120.152 -1.023 . . . . 4.3 112.102 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.427 ' O ' HG12 ' A' ' 56' ' ' VAL . 64.4 mttp -124.23 154.53 68.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 C-N-CA 120.066 -0.654 . . . . 10.46 109.316 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.11 70.05 6.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.91 2.407 . . . . 5.73 113.563 -138.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 54' ' ' LYS . 2.7 p -136.99 128.58 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.983 -0.687 . . . . 6.75 109.97 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 2.3 mt-10 -122.15 67.23 0.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.75 -0.833 . . . . 8.85 108.75 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 p -113.8 149.15 35.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.137 0.791 . . . . 5.4 113.137 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -117.92 144.13 34.0 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.086 -1.079 . . . . 3.11 108.086 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HG2' ' SG ' ' A' ' 14' ' ' CYS . 22.7 Cg_exo -66.31 171.05 39.35 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 123.933 -1.278 . . . . 3.02 110.871 -18.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -130.55 152.65 49.7 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.845 -1.539 . . . . 2.96 106.845 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 mt -121.55 143.66 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 119.586 -0.845 . . . . 1.16 111.402 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -131.07 165.82 22.41 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.873 -1.512 . . . . 1.05 108.161 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.537 HG11 ' CH2' ' A' ' 78' ' ' TRP . 32.0 t -138.61 105.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 124.174 0.921 . . . . 1.3 110.921 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' GLN . 3.6 t70 54.5 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.996 0.81 . . . . 2.81 113.019 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . 66.4 mt-30 -137.85 23.83 2.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 123.476 0.485 . . . . 5.48 111.295 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 68' ' ' HIS . 31.6 tt0 -131.03 159.45 37.48 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.222 -1.029 . . . . 4.45 108.222 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.504 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.6 t-160 -112.0 137.11 50.46 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 107.871 -1.159 . . . . 1.24 107.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.443 HD12 ' C ' ' A' ' 68' ' ' HIS . 1.7 mp -106.3 -46.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 119.682 -0.807 . . . . 1.59 112.131 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.26 -98.94 0.56 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.856 -1.298 . . . . 1.33 109.856 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.87 177.92 17.32 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 120.234 -0.984 . . . . 1.21 111.098 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -50.41 -47.43 56.51 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 119.787 -0.765 . . . . 1.45 111.048 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -43.96 -57.26 3.42 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.609 0.718 . . . . 1.66 111.11 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.71 -49.01 79.23 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.658 -1.155 . . . . 2.05 109.069 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CD2' HD23 ' A' ' 20' ' ' LEU . 15.3 t80 -44.82 -52.07 8.88 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.277 -0.969 . . . . 0.95 110.145 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 -57.96 9.48 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 120.007 -0.677 . . . . 0.83 111.562 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.34 42.35 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 118.372 -1.331 . . . . 1.08 109.303 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.61 ' CH2' HD21 ' A' ' 83' ' ' LEU . 75.8 t90 -41.61 -52.4 3.79 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.323 -0.853 . . . . 0.98 110.631 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -44.59 -46.2 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 115.551 -0.749 . . . . 0.91 110.721 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.535 ' C ' ' HD3' ' A' ' 80' ' ' LYS . 5.8 tmtm? -48.92 -38.77 23.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.981 1.104 . . . . 3.26 113.981 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -108.19 -31.72 7.79 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 114.716 1.376 . . . . 4.84 114.716 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.445 ' C ' HD22 ' A' ' 83' ' ' LEU . 1.7 m-80 -83.5 -22.95 32.34 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.976 -1.49 . . . . 1.89 110.574 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.61 HD21 ' CH2' ' A' ' 78' ' ' TRP . 3.3 mm? -108.6 -55.65 2.36 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.619 -0.832 . . . . 2.62 108.949 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.11 -69.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 126.852 2.595 . . . . 4.32 112.728 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . . . . . . 0 C--N 1.28 -2.438 0 CA-C-O 116.349 -1.786 . . . . 5.58 109.995 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.8 mtm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.975 -1.12 . . . . 2.29 107.975 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -113.73 116.45 29.43 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.489 0.493 . . . . 4.18 110.743 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 24.1 m -110.81 119.04 37.8 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.013 -1.106 . . . . 0.92 108.013 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.489 ' C ' HD12 ' A' ' 5' ' ' ILE . 43.3 t -114.57 135.54 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 119.687 -0.805 . . . . 0.96 111.248 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -113.43 123.31 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 124.52 1.138 . . . . 1.12 108.016 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -108.92 92.58 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.322 -2.103 . . . . 2.14 105.322 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.05 -171.81 15.9 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.04 -2.424 . . . . 1.41 107.04 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -95.44 174.53 6.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 116.726 -1.99 . . . . 4.67 110.365 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -55.76 76.65 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.906 -1.952 . . . . 5.97 109.323 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 97.07 74.04 1.17 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 106.885 -2.486 . . . . 3.67 106.885 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.465 ' HB2' ' H ' ' A' ' 8' ' ' ARG . 42.1 t -111.95 94.9 26.8 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 119.749 -0.78 . . . . 6.41 109.213 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 1.3 Cg_endo -41.11 -21.77 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.368 2.045 . . . . 3.95 113.026 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -72.85 -45.03 60.55 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.464 -1.294 . . . . 4.09 109.339 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.481 ' SG ' HG21 ' A' ' 5' ' ' ILE . 5.2 t -54.83 -39.8 68.94 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.283 -0.967 . . . . 4.34 108.79 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.8 t -43.75 -36.56 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 115.387 -0.824 . . . . 1.31 111.7 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.621 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 2.9 mmp_? -82.41 -45.63 14.57 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 119.106 -1.038 . . . . 3.33 109.708 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.03 60.76 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 106.683 -1.599 . . . . 0.81 106.683 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.615 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.8 tmtt? -56.73 -59.62 4.76 Favored 'General case' 0 C--O 1.187 -2.187 0 CA-C-N 113.342 -1.754 . . . . 2.21 108.657 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.615 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -48.58 -54.04 16.06 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 118.909 -1.116 . . . . 2.51 111.141 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.51 -60.89 2.74 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.494 -0.775 . . . . 0.9 110.574 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.82 77.73 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.278 -0.569 . . . . 0.99 110.564 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' SER . 31.4 tt0 -56.24 -49.52 73.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 124.445 1.091 . . . . 1.95 109.528 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -49.95 -61.56 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.125 -1.03 . . . . 4.5 108.259 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.451 HD11 HG13 ' A' ' 79' ' ' VAL . 47.1 mt -50.6 -57.63 7.74 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.108 -1.071 . . . . 1.28 108.108 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 8.3 t -34.59 -47.79 0.34 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.191 -1.368 . . . . 1.01 110.885 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -85.52 -30.72 23.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.628 1.205 . . . . 2.36 112.654 -179.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.548 ' HB2' ' HD2' ' A' ' 28' ' ' ARG . 80.8 mt-10 -70.0 -32.45 70.63 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.071 -1.052 . . . . 3.22 110.629 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.548 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -135.54 37.52 2.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.203 -1.399 . . . . 4.9 113.831 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' ARG . 48.0 m-20 28.81 52.76 0.07 Allowed 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 114.611 1.337 . . . . 4.9 114.611 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -155.18 -45.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 117.983 -1.487 . . . . 3.7 113.679 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -81.38 69.04 7.93 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 119.553 -0.859 . . . . 2.56 110.306 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.41 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 1.1 mp0 -83.48 147.03 28.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.701 -1.222 . . . . 4.71 107.701 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 3' ' ' THR . 46.5 p90 -119.46 161.75 20.01 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.561 -1.255 . . . . 1.1 112.196 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -129.78 136.04 49.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.305 -1.316 . . . . 3.93 107.91 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 3.6 t80 -113.7 117.94 32.95 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.615 -1.254 . . . . 1.56 107.615 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.13 146.9 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.833 -1.173 . . . . 1.4 107.833 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.1 143.42 45.51 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.629 1.204 . . . . 2.32 111.749 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 8' ' ' ARG . 18.8 pt -56.93 -40.75 74.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 112.262 -2.245 . . . . 1.23 112.257 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.402 ' NH2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -86.41 -10.07 55.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.216 -0.994 . . . . 5.32 111.656 -178.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.51 -49.02 6.92 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.699 -0.852 . . . . 1.41 108.699 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.37 -37.66 43.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.669 -1.605 . . . . 3.6 111.191 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 46.42 1.86 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.634 -1.786 . . . . 1.36 108.634 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.495 HG21 ' HG ' ' A' ' 48' ' ' LEU . 22.2 mt -87.25 146.94 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.847 -1.168 . . . . 1.57 107.847 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -110.64 176.4 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.919 -0.712 . . . . 2.47 111.124 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -67.31 -57.77 6.04 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.188 -1.412 . . . . 5.32 107.188 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 1.7 mp0 -47.86 -48.51 31.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.753 -1.112 . . . . 4.58 110.023 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 26.6 t70 -64.64 -56.59 12.87 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.353 -0.939 . . . . 2.02 110.48 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.495 ' HG ' HG21 ' A' ' 43' ' ' ILE . 1.3 mt -56.69 -40.23 75.23 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.459 -0.896 . . . . 1.55 111.131 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -62.0 -43.83 98.0 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.722 -1.585 . . . . 3.64 106.722 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -56.78 -40.05 75.17 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.276 -0.875 . . . . 3.74 108.762 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 48.2 mmtm -64.12 -51.95 61.45 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.261 -0.882 . . . . 2.27 111.459 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.62 70.06 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 112.877 0.695 . . . . 1.63 112.877 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.36 -47.53 1.01 Allowed Glycine 0 N--CA 1.503 3.152 0 C-N-CA 119.44 -1.362 . . . . 2.72 112.205 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -110.45 174.36 2.41 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.732 . . . . 7.59 109.022 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.36 68.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.98 1.787 . . . . 5.6 110.903 143.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.4 47.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.18 -1.045 . . . . 6.29 108.18 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -82.66 72.47 9.73 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.908 -1.042 . . . . 8.17 108.671 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 p -103.57 100.62 10.46 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.753 -1.112 . . . . 5.09 108.798 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 m -74.56 138.36 74.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 C-N-CA 117.759 -1.576 . . . . 1.68 109.598 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -93.91 137.56 6.87 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 O-C-N 122.932 0.964 . . . . 1.79 111.623 7.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.42 ' NE2' HD22 ' A' ' 48' ' ' LEU . 7.2 mp0 -97.65 142.87 28.92 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.287 -1.746 . . . . 3.73 106.287 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.8 mp -115.29 143.77 24.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.416 -0.913 . . . . 1.57 109.474 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.286 -1.779 . . . . 1.17 108.785 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.67 118.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 105.466 -2.05 . . . . 0.93 105.466 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 64.67 -86.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.621 -1.251 . . . . 3.27 107.621 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.62 5.3 1.04 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.084 -0.962 . . . . 3.58 109.204 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -91.2 162.16 14.76 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.359 -0.978 . . . . 3.71 108.359 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -108.67 138.15 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.633 -0.877 . . . . 0.91 108.633 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -106.87 -43.85 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.383 -0.927 . . . . 0.83 109.151 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.7 -134.9 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.015 -1.634 . . . . 1.15 109.015 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -103.44 179.27 25.62 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 108.969 -1.652 . . . . 1.19 108.969 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -45.62 -38.52 6.71 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 118.953 -1.099 . . . . 1.53 110.789 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -54.15 -63.29 1.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.372 0.606 . . . . 1.77 109.72 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.79 -47.28 80.54 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.115 -0.948 . . . . 2.36 108.538 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.45 ' CD1' HG21 ' A' ' 62' ' ' ILE . 42.4 t80 -47.16 -51.63 17.75 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.339 -0.846 . . . . 0.87 110.536 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.11 -53.08 62.12 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.02 -1.072 . . . . 0.81 109.687 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.34 -56.43 16.72 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.139 -1.024 . . . . 0.82 109.967 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -48.94 -57.62 6.19 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.038 -0.983 . . . . 0.7 108.605 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.451 HG13 HD11 ' A' ' 24' ' ' LEU . 26.9 t -46.08 -52.84 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 124.255 0.972 . . . . 0.8 108.725 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' NZ ' ' CG ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -57.73 -54.92 41.47 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.81 1.041 . . . . 3.19 113.81 -178.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' N ' ' HE3' ' A' ' 80' ' ' LYS . 1.5 pt-20 -73.11 -29.16 62.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.432 1.271 . . . . 4.42 114.432 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -90.57 -31.94 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.803 -1.159 . . . . 1.8 109.919 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.16 53.07 0.93 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.749 -1.204 . . . . 2.82 107.749 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.521 ' CG ' ' NZ ' ' A' ' 80' ' ' LYS . 4.8 t0 -78.95 49.83 0.96 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.345 -1.298 . . . . 4.77 109.361 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.451 ' C ' HH12 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.503 2.225 0 CA-C-O 116.481 -1.723 . . . . 5.1 109.162 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 107.062 -1.458 . . . . 3.0 107.062 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -106.44 107.04 17.85 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.529 -0.915 . . . . 4.03 108.529 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.436 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 25.0 m -93.13 136.14 33.66 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.685 -0.806 . . . . 0.97 109.403 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.524 ' C ' HD12 ' A' ' 5' ' ' ILE . 5.3 t -122.62 128.57 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 119.397 -0.921 . . . . 0.97 108.709 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -111.27 136.98 45.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 124.29 0.994 . . . . 1.13 108.898 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -108.16 112.34 24.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 102.456 -3.164 . . . . 2.45 102.456 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.531 ' HA2' ' SG ' ' A' ' 14' ' ' CYS . . . -109.32 -166.15 20.31 Favored Glycine 0 N--CA 1.501 2.975 0 C-N-CA 118.552 -1.785 . . . . 1.83 114.195 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.479 HH12 ' CB ' ' A' ' 58' ' ' THR . 7.8 ttt85 -108.76 -141.6 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.892 -1.154 . . . . 7.96 109.348 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.51 176.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.572 0.701 . . . . 5.71 112.073 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.05 67.23 2.75 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.837 -0.905 . . . . 5.16 110.837 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 12' ' ' PRO . 50.5 t -128.37 152.75 78.63 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.247 -1.39 . . . . 5.67 107.247 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.515 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 32.0 Cg_endo -70.21 67.16 2.02 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.42 1.414 . . . . 5.15 111.334 172.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -109.4 -94.6 0.41 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.92 -1.141 . . . . 4.22 107.92 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' HA2' ' A' ' 7' ' ' GLY . 46.5 m -52.46 -20.47 2.9 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.618 -0.833 . . . . 2.5 109.132 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 18' ' ' LYS . 91.6 t -45.89 -33.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.923 -1.035 . . . . 2.79 110.301 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -44.87 -35.84 3.0 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.461 -0.896 . . . . 2.99 110.379 179.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 5' ' ' ILE . . . -66.37 -43.37 86.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.097 -1.446 . . . . 1.09 107.097 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HE2' ' N ' ' A' ' 19' ' ' ASP . 3.3 tmpt? -57.7 -45.28 85.89 Favored 'General case' 0 C--O 1.196 -1.724 0 N-CA-C 107.855 -1.165 . . . . 1.74 107.855 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 68.9 m-20 -63.09 -60.76 3.0 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.835 -0.62 . . . . 3.31 109.788 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 tp -48.41 -55.21 11.45 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.951 -0.7 . . . . 0.92 109.815 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.33 82.21 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.872 -0.731 . . . . 1.16 109.919 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 27.5 tt0 -45.43 -49.77 13.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 123.593 0.558 . . . . 1.96 110.789 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 23.0 tptp -52.07 -56.22 15.77 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 118.316 -1.353 . . . . 4.71 110.972 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.448 HD11 ' CG1' ' A' ' 79' ' ' VAL . 33.7 mt -52.7 -48.85 66.31 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.326 -1.731 . . . . 1.31 106.326 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -47.19 -38.69 12.42 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.543 -2.117 . . . . 1.06 108.731 178.369 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -117.75 42.25 2.67 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.136 -0.938 . . . . 2.38 110.201 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.527 ' HB3' ' HD3' ' A' ' 28' ' ' ARG . 30.8 tt0 -117.29 -59.63 1.92 Allowed 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.152 -1.425 . . . . 3.31 107.152 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.527 ' HD3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -117.97 16.36 14.23 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.698 -2.334 . . . . 3.71 104.698 177.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.0 OUTLIER 34.46 47.2 0.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 123.221 1.486 . . . . 6.0 109.156 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.02 9.52 8.73 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 111.694 -2.503 . . . . 4.82 111.076 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.436 ' CZ ' ' OG1' ' A' ' 3' ' ' THR . 21.0 t80 -134.85 147.73 49.96 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.963 -0.695 . . . . 1.67 110.012 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -135.25 151.53 50.68 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.07 -0.715 . . . . 3.17 109.07 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 42.6 p90 -139.29 155.94 47.38 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.2 -1.0 . . . . 1.67 111.367 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -135.97 138.56 42.41 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.839 -1.171 . . . . 4.47 107.839 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -114.05 133.27 55.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.749 -1.18 . . . . 1.26 109.091 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 37' ' ' ASP . 92.4 t -129.7 167.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.889 0.852 . . . . 1.37 110.857 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 36' ' ' VAL . 29.6 t0 -118.48 128.12 54.29 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.296 -1.002 . . . . 2.14 108.296 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.3 pt -43.81 -34.53 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.49 0.662 . . . . 1.59 111.235 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 2.3 ttm105 -74.6 -54.97 6.44 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.222 -0.899 . . . . 5.98 110.007 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -36.54 -55.13 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.168 0.918 . . . . 2.1 112.237 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -74.6 -41.47 60.38 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 124.147 0.904 . . . . 4.52 109.748 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.45 46.4 1.14 Allowed Glycine 0 N--CA 1.502 3.082 0 N-CA-C 108.317 -1.913 . . . . 2.06 108.317 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mt -98.93 152.97 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.128 -1.036 . . . . 2.08 110.474 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.1 p -116.69 141.3 48.38 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.768 -1.106 . . . . 2.53 108.852 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -45.04 -51.05 10.45 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.258 -0.977 . . . . 5.04 110.807 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 2.7 mp0 -50.94 -47.25 61.12 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.875 -0.73 . . . . 5.82 110.358 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' OD1' ' NZ ' ' A' ' 51' ' ' LYS . 4.5 t0 -53.94 -55.5 26.48 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.401 -0.92 . . . . 3.67 108.55 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.21 -50.94 63.68 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 114.962 -1.017 . . . . 2.6 109.198 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 20.3 mt-30 -49.19 -49.24 43.61 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.293 -1.321 . . . . 6.58 108.283 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.64 -55.94 19.65 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.79 -1.095 . . . . 5.33 110.527 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' NZ ' ' OD1' ' A' ' 47' ' ' ASP . 41.3 mttp -53.88 -47.68 70.84 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 115.633 -0.712 . . . . 3.34 111.843 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.31 -55.96 26.93 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.481 -1.236 . . . . 2.26 112.601 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.29 -34.49 5.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.001 -1.64 . . . . 3.95 109.001 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -106.21 146.37 32.81 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 120.09 -0.644 . . . . 6.61 109.645 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.23 89.79 0.32 Allowed 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.825 2.35 . . . . 4.89 111.635 -171.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.423 HG11 HE22 ' A' ' 61' ' ' GLN . 5.1 m -98.46 -177.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 C-N-CA 119.828 -0.749 . . . . 6.18 109.102 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 11.1 tp10 -110.15 -68.7 0.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.966 0.791 . . . . 7.53 110.679 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.479 ' CB ' HH12 ' A' ' 8' ' ' ARG . 2.0 p -144.39 -61.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.645 1.212 . . . . 5.91 109.746 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 8' ' ' ARG . 27.4 m -132.11 178.76 1.6 Allowed Pre-proline 0 C--N 1.289 -2.064 0 CA-C-N 112.749 -2.023 . . . . 2.59 107.863 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 28.7 Cg_endo -70.01 138.36 49.32 Favored 'Cis proline' 0 N--CA 1.491 1.335 0 O-C-N 122.994 0.997 . . . . 3.13 111.369 -25.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.423 HE22 HG11 ' A' ' 56' ' ' VAL . 6.6 mm-40 -125.49 125.39 43.22 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.461 -0.94 . . . . 2.46 108.461 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.5 mp -122.54 141.37 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.042 0.925 . . . . 1.93 110.92 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -128.04 163.0 25.52 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 113.13 -1.85 . . . . 1.2 108.783 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.0 t -138.01 124.26 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 118.587 -0.72 . . . . 1.48 109.252 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 50.95 -97.38 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.773 -0.771 . . . . 2.21 111.778 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -129.63 27.52 5.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.447 -1.252 . . . . 3.87 111.02 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -130.66 168.61 16.86 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 116.293 -0.412 . . . . 3.75 111.019 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' ND1' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t-80 -116.72 144.34 44.56 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.964 -0.754 . . . . 1.06 108.964 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.35 -54.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 118.612 -1.235 . . . . 1.1 109.602 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 144.47 -128.41 3.24 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.617 -1.277 . . . . 1.17 110.626 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -111.96 -171.81 18.91 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.261 -1.447 . . . . 1.18 110.284 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -44.99 -40.61 6.61 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.671 -1.211 . . . . 1.5 109.694 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -55.21 -63.98 0.99 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.417 0.627 . . . . 2.05 110.062 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -46.48 71.64 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.769 -1.105 . . . . 2.88 110.002 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.401 ' CD1' HG21 ' A' ' 62' ' ' ILE . 41.5 t80 -61.23 -50.5 72.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.748 -0.781 . . . . 1.09 111.312 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.93 -57.07 10.51 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.569 -0.852 . . . . 1.08 109.441 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.16 24.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.688 -0.805 . . . . 0.9 110.112 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -43.42 -46.9 6.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 124.118 0.886 . . . . 1.25 109.395 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.448 ' CG1' HD11 ' A' ' 24' ' ' LEU . 19.1 t -62.75 -67.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.923 -1.035 . . . . 0.99 108.896 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -45.35 -34.99 3.29 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 115.845 1.794 . . . . 2.24 115.845 -176.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' OE2' ' NZ ' ' A' ' 80' ' ' LYS . 1.3 mp0 -101.63 9.41 41.13 Favored 'General case' 0 N--CA 1.512 2.652 0 C-N-CA 118.376 -1.33 . . . . 4.71 113.841 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -128.07 -35.83 2.01 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.951 -0.7 . . . . 1.81 109.325 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.92 23.13 14.94 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.546 -0.862 . . . . 1.99 109.643 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 8.7 t70 -70.63 -20.82 62.69 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.382 -1.34 . . . . 3.94 107.382 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.651 0 N-CA-C 105.857 -1.905 . . . . 5.19 105.857 178.134 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpp? . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.226 1.013 . . . . 2.74 109.291 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.444 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 2.0 mp0 -104.0 105.19 15.29 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.312 -1.313 . . . . 5.71 108.173 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.4 m -97.26 117.99 32.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.338 -0.945 . . . . 1.11 110.392 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.9 t -113.9 142.31 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 115.532 -0.758 . . . . 1.09 109.79 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.7 mm -114.25 133.77 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.585 -2.006 . . . . 2.0 105.585 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -121.65 80.09 1.64 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.629 -1.619 . . . . 1.9 106.629 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.28 -177.35 24.17 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.727 -1.225 . . . . 1.35 111.823 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -122.54 94.15 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.362 -1.347 . . . . 6.56 107.362 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.439 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 4.6 t -74.31 73.6 1.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.008 -1.077 . . . . 6.95 111.097 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -41.02 -50.88 4.25 Favored Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.096 -0.802 . . . . 3.12 111.096 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.452 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 17.3 m -111.87 -170.1 0.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 106.691 -1.596 . . . . 4.67 106.691 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 11' ' ' CYS . 52.8 Cg_exo -53.0 73.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 120.856 1.038 . . . . 4.32 111.409 153.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -119.54 -85.09 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.042 -0.725 . . . . 4.76 109.042 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -60.19 -24.73 65.02 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 106.993 -1.484 . . . . 2.06 106.993 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' OG ' ' A' ' 9' ' ' SER . 57.3 t -43.81 -32.65 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 CA-C-N 114.278 -1.328 . . . . 1.63 109.634 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -71.56 -50.12 34.13 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.55 -1.26 . . . . 3.53 109.666 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.93 -44.46 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.018 -1.845 . . . . 0.78 106.018 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.464 ' C ' ' HD2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -56.09 -58.91 5.93 Favored 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 113.712 -1.586 . . . . 1.67 107.034 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -43.04 -57.96 2.65 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 120.11 -0.636 . . . . 3.52 110.798 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.98 -62.92 1.29 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.874 -1.057 . . . . 0.78 110.086 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB1' ' CB ' ' A' ' 33' ' ' TYR . . . -53.1 -54.57 33.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.15 -1.02 . . . . 0.69 109.28 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 41.5 tt0 -45.33 -52.63 9.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.088 0.867 . . . . 2.11 110.778 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -58.85 -53.0 63.32 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.881 -1.128 . . . . 4.81 108.457 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -51.93 -41.29 61.91 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.625 -0.83 . . . . 1.12 110.233 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.1 p -73.9 -6.58 48.08 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.272 -0.971 . . . . 1.97 112.047 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -115.72 31.53 6.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.076 -1.453 . . . . 2.5 107.076 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 23' ' ' LYS . 5.8 mm-40 -140.73 -51.65 0.47 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.009 -1.45 . . . . 4.6 107.884 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HE ' ' C ' ' A' ' 85' ' ' ALA . 13.5 mtp-105 -93.63 -170.42 2.35 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.519 -1.218 . . . . 4.05 111.119 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -111.09 -48.77 3.08 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.453 -0.794 . . . . 5.26 111.24 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.587 ' CG ' HH12 ' A' ' 28' ' ' ARG . 2.8 p30 -83.33 8.1 14.57 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.533 -0.867 . . . . 2.76 111.16 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 25' ' ' SER . 3.3 t80 -104.34 114.44 28.67 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.567 -0.853 . . . . 1.32 111.602 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -130.14 157.5 42.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.048 -1.834 . . . . 3.7 106.048 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 21.2 p90 -129.47 160.89 31.74 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.411 -1.315 . . . . 1.4 110.881 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -141.62 149.22 40.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.019 0.824 . . . . 4.52 110.193 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -126.29 113.39 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.687 -1.597 . . . . 1.54 106.687 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.04 157.82 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.073 -1.825 . . . . 1.39 106.073 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -124.74 140.46 52.91 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.28 -1.368 . . . . 2.58 111.239 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.442 ' C ' HH11 ' A' ' 39' ' ' ARG . 16.7 pt -61.78 -21.94 27.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.066 -0.97 . . . . 1.29 111.517 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.506 ' HA ' HH11 ' A' ' 39' ' ' ARG . 3.3 tpp180 -95.43 -51.48 4.55 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.789 -0.819 . . . . 7.39 108.789 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.75 -49.3 5.69 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.538 1.149 . . . . 1.4 110.148 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -99.55 36.82 1.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.576 -0.85 . . . . 4.64 112.553 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 34.27 65.16 0.36 Allowed Glycine 0 N--CA 1.512 3.715 0 CA-C-O 121.792 0.662 . . . . 1.59 114.168 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.469 HG23 ' HB3' ' A' ' 47' ' ' ASP . 58.1 mt -109.96 148.08 13.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.004 -0.598 . . . . 1.61 109.607 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -126.18 177.86 6.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.965 -1.494 . . . . 2.22 106.965 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -51.68 -47.92 63.68 Favored 'General case' 0 C--O 1.191 -1.984 0 C-N-CA 119.798 -0.761 . . . . 5.36 110.427 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 6.3 mp0 -44.18 -52.59 7.24 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 113.862 1.06 . . . . 3.31 113.862 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 43' ' ' ILE . 50.2 t0 -65.97 -55.86 14.64 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.052 -1.059 . . . . 3.03 109.564 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.489 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.2 mt -53.66 -42.33 67.75 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.548 -0.861 . . . . 1.52 110.201 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -59.21 -42.26 90.53 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.174 -1.417 . . . . 3.99 107.174 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.75 -20.92 60.36 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.851 -1.068 . . . . 3.45 110.589 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -79.96 -46.48 16.61 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.959 -0.696 . . . . 3.28 111.386 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.09 -28.3 11.1 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.73 -0.788 . . . . 1.45 113.009 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.92 -56.76 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 105.767 -2.933 . . . . 4.06 105.767 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.5 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 57.3 mttp 60.1 126.85 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.997 0 CA-C-O 123.266 1.508 . . . . 9.06 114.935 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' C ' ' HB3' ' A' ' 54' ' ' LYS . 12.0 Cg_endo -52.53 139.3 56.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.69 2.26 . . . . 3.65 109.391 96.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 58' ' ' THR . 7.9 p -74.35 72.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 118.952 -1.099 . . . . 5.98 110.768 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.08 33.0 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 119.743 -0.783 . . . . 7.73 112.169 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 56' ' ' VAL . 80.5 p 39.27 -109.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 115.035 1.494 . . . . 3.98 115.035 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.87 149.33 72.77 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 114.219 -1.355 . . . . 1.69 109.724 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.452 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 98.7 Cg_endo -96.37 -175.4 4.63 Favored 'Cis proline' 0 C--N 1.32 -0.925 0 O-C-N 123.15 1.079 . . . . 2.04 110.049 0.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 1.9 mt-30 -138.89 133.78 32.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 124.489 1.118 . . . . 3.01 109.788 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.8 mt -118.07 140.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 120.107 -0.637 . . . . 1.35 110.926 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.85 148.82 52.66 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.73 -1.577 . . . . 0.96 110.658 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.599 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 38.2 t -123.17 111.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.14 -1.059 . . . . 0.87 108.14 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.98 -76.07 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.103 0.954 . . . . 3.21 109.403 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 64' ' ' VAL . 45.0 tt0 -142.94 -9.11 0.8 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.058 -1.428 . . . . 4.38 110.663 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -92.12 168.79 11.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.746 -0.382 . . . . 5.37 110.677 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.413 ' CE1' ' NE2' ' A' ' 61' ' ' GLN . 44.1 t-80 -119.19 153.17 35.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.708 -1.219 . . . . 1.27 107.708 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.0 -50.75 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 119.007 -1.077 . . . . 1.1 109.698 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 164.98 -158.25 31.01 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.959 -1.656 . . . . 1.19 108.959 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 60' ' ' PRO . . . -87.59 -67.6 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.88 -1.629 . . . . 2.85 110.159 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 73' ' ' THR . 61.7 t80 -152.03 179.92 8.05 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 119.547 -0.861 . . . . 3.75 108.788 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 72' ' ' TYR . 85.0 m 67.73 -68.14 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.629 0.581 . . . . 2.99 110.212 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.53 -51.1 5.21 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.105 0.955 . . . . 3.71 110.155 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.44 -36.96 2.16 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.615 -1.63 . . . . 1.3 112.696 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.59 -49.19 57.09 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.325 -0.95 . . . . 1.37 109.848 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.06 62.51 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.463 -0.94 . . . . 1.46 108.463 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.599 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 78.3 t90 -46.61 -53.81 10.77 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.775 -1.102 . . . . 0.92 109.038 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.555 HG13 HD12 ' A' ' 83' ' ' LEU . 80.4 t -55.42 -41.61 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.904 -1.119 . . . . 1.08 109.534 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.501 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -65.01 -38.89 92.43 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.88 -1.054 . . . . 2.21 113.437 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.37 -12.53 12.99 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 115.815 1.783 . . . . 4.71 115.815 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.436 ' CG ' ' NE1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -92.22 -16.33 26.34 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.544 -0.862 . . . . 1.72 109.996 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.555 HD12 HG13 ' A' ' 79' ' ' VAL . 59.6 mt -102.31 -73.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.454 -0.898 . . . . 3.44 109.16 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 31.65 42.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 124.287 0.992 . . . . 4.14 112.003 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.603 ' C ' ' HE ' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 115.984 -1.96 . . . . 5.4 107.455 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.658 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.498 -0.556 . . . . 2.83 109.498 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -94.1 96.97 9.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 123.703 0.627 . . . . 3.97 110.809 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.6 m -91.62 126.04 36.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.043 -0.725 . . . . 1.06 109.043 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.527 ' C ' HD12 ' A' ' 5' ' ' ILE . 16.6 t -129.02 141.76 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.708 -1.197 . . . . 1.18 109.664 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -111.28 132.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.117 -2.179 . . . . 1.26 105.117 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 50.0 m-85 -124.2 116.31 22.49 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.262 -0.644 . . . . 1.89 109.262 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.11 -179.35 20.47 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.251 -1.452 . . . . 2.24 112.353 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -127.23 163.61 23.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.76 -0.72 . . . . 5.52 109.623 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -106.11 -53.12 2.68 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.113 0.959 . . . . 7.76 109.363 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.79 -61.51 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 105.814 -2.914 . . . . 4.92 105.814 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 13' ' ' TYR . 9.6 m -96.24 170.39 7.61 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 106.388 -1.708 . . . . 5.25 106.388 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.93 73.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.365 2.043 . . . . 3.06 111.605 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' CYS . 6.3 t80 -119.63 -60.93 1.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.768 . . . . 5.54 108.925 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 29.8 m -54.64 -39.53 68.06 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 122.615 1.198 . . . . 2.27 108.193 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.0 t -44.41 -50.29 2.01 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.437 0 CA-C-N 113.396 -1.729 . . . . 1.28 111.278 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 8.5 mmm180 -56.92 -41.17 77.68 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.105 -1.038 . . . . 3.78 110.243 -178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.12 80.05 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.218 -1.401 . . . . 0.77 107.218 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -52.5 65.06 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.76 -1.176 . . . . 1.79 107.855 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.05 -52.17 9.26 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.458 -0.897 . . . . 3.13 110.628 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' A' ' 75' ' ' PHE . 40.9 tp -58.49 -60.38 3.89 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 120.41 -0.516 . . . . 0.81 110.656 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.31 -44.22 44.13 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.969 -1.014 . . . . 0.64 109.45 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.91 -51.46 66.84 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 124.709 1.256 . . . . 1.74 109.358 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -50.21 -56.16 12.25 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.394 -0.922 . . . . 4.33 108.674 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.497 HD11 HG21 ' A' ' 79' ' ' VAL . 44.6 mt -57.3 -44.36 84.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.341 1.026 . . . . 1.14 109.179 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 t -51.89 -29.9 21.78 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.979 -1.464 . . . . 0.99 109.61 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.474 ' CG ' ' O ' ' A' ' 26' ' ' ASN . 5.9 t-20 -96.38 25.77 4.79 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.152 -0.931 . . . . 2.71 110.935 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.7 mt-10 -138.74 -35.44 0.58 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.504 -0.771 . . . . 2.52 110.537 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 30' ' ' ASP . 43.3 mtp85 -114.71 129.86 56.74 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.759 -0.776 . . . . 3.75 112.017 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.16 32.56 0.28 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.242 1.02 . . . . 3.62 109.742 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.3 p30 -136.49 -1.7 2.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.708 -1.587 . . . . 3.16 109.243 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -120.64 124.53 45.47 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.653 0.739 . . . . 0.92 112.635 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -142.76 155.13 44.8 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.131 -1.433 . . . . 4.85 107.131 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -134.76 163.88 28.81 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.105 -1.438 . . . . 1.27 112.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.65 154.52 44.43 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 124.604 1.19 . . . . 5.21 109.389 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.42 ' HD1' ' N ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -127.88 124.63 37.94 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.9 -0.72 . . . . 2.7 110.162 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' N ' ' HD1' ' A' ' 35' ' ' TYR . 2.4 t -123.41 149.88 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.379 -1.341 . . . . 1.87 107.379 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -123.55 124.91 43.89 Favored 'General case' 0 N--CA 1.51 2.57 0 C-N-CA 117.816 -1.554 . . . . 2.37 110.412 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 pt -43.5 -38.76 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 113.435 -1.711 . . . . 1.52 114.017 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 24.35 6.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.237 -0.985 . . . . 8.48 112.905 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.95 -43.96 2.74 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.012 -1.107 . . . . 2.02 108.012 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -92.45 -28.68 16.69 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.686 -1.597 . . . . 5.96 111.288 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.4 0.66 Allowed Glycine 0 N--CA 1.503 3.103 0 C-N-CA 119.364 -1.398 . . . . 1.95 111.132 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.9 mt -112.46 156.84 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.665 -0.814 . . . . 2.11 108.984 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -101.24 -170.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.428 -0.953 . . . . 2.54 108.428 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -49.98 5.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.722 -1.584 . . . . 4.65 106.722 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.69 -52.25 24.38 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.372 -0.931 . . . . 3.87 110.118 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.85 -44.93 40.11 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 120.064 -0.654 . . . . 2.65 111.49 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 1.8 mt -70.14 -42.83 72.06 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.886 0.85 . . . . 1.63 109.011 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 49' ' ' GLN . 3.4 tp-100 -58.27 -32.48 68.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.625 -1.25 . . . . 5.06 107.625 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 0.96 7.74 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.048 -1.433 . . . . 4.15 110.263 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 57.3 mttp -115.85 -42.72 3.06 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.57 -1.195 . . . . 2.3 109.824 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -81.02 -50.89 9.12 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.358 -0.837 . . . . 1.05 111.476 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.74 -55.54 2.28 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.65 -2.18 . . . . 2.77 107.65 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HD3' HE22 ' A' ' 61' ' ' GLN . 44.4 mtmt 31.14 -147.39 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 CA-C-N 112.526 -1.837 . . . . 7.92 113.566 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 57.2 Cg_endo -92.37 -166.95 0.17 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.962 1.775 . . . . 4.08 112.416 128.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -98.52 81.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.369 -0.832 . . . . 6.85 109.543 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -115.4 -94.25 0.48 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.948 1.092 . . . . 5.41 113.948 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 59' ' ' VAL . 1.3 m -142.86 -156.05 0.65 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 118.972 -1.091 . . . . 4.55 113.738 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.572 ' H ' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -114.78 -169.05 0.14 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 114.389 -1.278 . . . . 3.35 108.966 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.651 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 31.7 Cg_endo -68.57 -175.42 9.49 Favored 'Cis proline' 0 N--CA 1.499 1.815 0 O-C-N 122.182 0.57 . . . . 2.75 111.553 -28.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.462 HE22 ' HD3' ' A' ' 54' ' ' LYS . 19.3 tp60 -134.74 150.95 50.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 123.976 0.798 . . . . 2.83 111.864 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mt -123.67 142.51 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.711 -1.218 . . . . 1.07 107.711 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.21 156.56 48.5 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.844 -1.071 . . . . 1.01 110.004 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.6 t -138.12 115.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.017 -0.673 . . . . 1.33 109.653 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 1' ' ' MET . 1.2 m-20 54.44 -101.94 0.13 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.253 -1.017 . . . . 3.28 108.253 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -125.75 39.55 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.857 -0.794 . . . . 3.98 108.857 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -127.51 161.78 27.97 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.416 -0.811 . . . . 3.49 109.984 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.509 ' CD2' ' N ' ' A' ' 69' ' ' ILE . 5.5 t-160 -122.54 142.42 50.62 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.753 -1.203 . . . . 1.15 107.753 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.509 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 28.1 mm -101.33 -99.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 118.704 -1.198 . . . . 1.83 107.877 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.42 65.29 0.21 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.401 -1.38 . . . . 4.23 110.611 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.66 -175.33 17.52 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.995 -1.642 . . . . 1.52 108.995 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' PHE . 13.6 t80 -110.08 -60.75 1.75 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.356 -0.938 . . . . 1.51 109.947 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -46.09 -34.11 3.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.578 -1.638 . . . . 4.91 106.578 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.6 -44.11 97.61 Favored 'General case' 0 C--O 1.2 -1.537 0 CA-C-N 113.077 -1.874 . . . . 3.41 108.87 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CD2' HD23 ' A' ' 20' ' ' LEU . 11.9 t80 -63.45 -41.52 98.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.476 -0.935 . . . . 1.11 108.476 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -62.48 -56.15 20.86 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.365 -0.934 . . . . 1.3 108.966 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.15 43.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.325 -1.361 . . . . 1.28 107.325 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.438 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 80.1 t90 -36.47 -54.73 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.981 0.801 . . . . 1.1 110.413 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.497 HG21 HD11 ' A' ' 24' ' ' LEU . 41.4 t -43.92 -60.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 115.199 -0.91 . . . . 1.48 111.92 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -44.33 -29.61 0.7 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.614 0.968 . . . . 3.16 113.614 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -109.06 -27.02 9.86 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.628 -0.829 . . . . 4.13 113.044 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -83.98 -34.13 24.43 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.042 -1.063 . . . . 1.84 111.017 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.44 HD12 HG13 ' A' ' 79' ' ' VAL . 68.0 mt -102.47 -44.79 5.26 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.042 -1.836 . . . . 3.45 106.042 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 60.67 -65.92 0.05 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 126.497 2.373 . . . . 5.19 111.501 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.234 0 O-C-N 125.197 1.561 . . . . 5.33 109.45 179.481 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.579 ' H2 ' ' CG ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.344 0.592 . . . . 2.69 110.04 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -109.65 99.44 8.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.579 -2.378 . . . . 4.43 104.579 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.461 HG21 ' CE1' ' A' ' 75' ' ' PHE . 27.1 m -88.4 103.42 15.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.906 -1.497 . . . . 1.37 109.868 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 63.3 t -94.47 130.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.751 -0.659 . . . . 1.28 110.292 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.494 HG21 ' SG ' ' A' ' 14' ' ' CYS . 1.6 mp -113.74 116.86 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 106.411 -1.7 . . . . 1.08 106.411 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.627 ' CE2' HD13 ' A' ' 43' ' ' ILE . 2.8 m-30 -106.33 98.38 8.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.826 -1.916 . . . . 2.65 105.826 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 60' ' ' PRO . . . -130.59 -159.99 9.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.42 -1.371 . . . . 1.62 112.481 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' CZ ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -124.4 130.1 51.88 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.02 -1.474 . . . . 5.0 107.02 179.016 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.474 ' OG ' ' CZ ' ' A' ' 8' ' ' ARG . 1.6 p -51.77 106.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.632 -0.827 . . . . 4.9 108.95 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . 134.08 -12.42 4.73 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.699 -1.238 . . . . 3.61 111.16 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 97.1 m -95.3 90.94 0.66 Allowed Pre-proline 0 N--CA 1.501 2.122 0 C-N-CA 119.493 -0.883 . . . . 5.57 110.682 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 10' ' ' GLY . 28.3 Cg_endo -58.78 -3.57 1.55 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.741 2.961 . . . . 3.69 112.719 -162.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 11' ' ' CYS . 9.5 m-30 -71.44 -37.27 71.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.62 -1.252 . . . . 4.92 107.62 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 35' ' ' TYR . 3.6 t -58.56 -43.19 89.29 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.143 -1.423 . . . . 3.62 108.21 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.42 -57.74 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.428 -0.952 . . . . 1.34 108.428 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 6.5 mmp_? -49.93 -48.45 51.81 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.649 -1.22 . . . . 3.73 109.649 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.0 -54.77 40.86 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.887 -1.525 . . . . 0.83 108.266 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.5 tmtm? -46.22 -49.08 17.58 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.177 -0.609 . . . . 1.71 109.879 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.479 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 35.1 m-20 -63.28 -55.68 22.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.887 -0.597 . . . . 3.29 110.188 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.5 tp -48.53 -55.73 10.27 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.987 -1.085 . . . . 0.91 109.239 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -58.69 -36.22 73.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.656 -0.818 . . . . 1.07 109.668 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.6 tt0 -51.31 -47.55 62.58 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.051 -1.059 . . . . 1.9 109.819 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -44.73 -60.15 2.16 Favored 'General case' 0 N--CA 1.514 2.751 0 C-N-CA 119.419 -0.912 . . . . 6.99 109.657 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 47.6 mt -45.53 -52.39 10.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.224 -1.353 . . . . 2.03 107.916 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -53.48 -37.34 62.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.662 -1.608 . . . . 1.36 111.415 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -104.22 37.1 2.17 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.048 0.928 . . . . 2.02 108.549 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 28' ' ' ARG . 58.9 tt0 -130.11 -51.39 1.11 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.177 -1.374 . . . . 4.76 107.517 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 27' ' ' GLU . 9.7 ptp180 -124.79 -178.39 4.14 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 112.368 -2.196 . . . . 3.11 108.619 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -116.29 27.95 8.9 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.486 0.66 . . . . 4.62 110.685 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.421 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 3.0 p30 -120.26 -8.41 9.68 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.453 -0.794 . . . . 3.06 112.701 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -108.68 130.15 55.34 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.109 1.522 . . . . 1.34 115.109 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' N ' ' NE2' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -138.31 153.14 49.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.891 -1.152 . . . . 3.58 107.891 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.91 156.25 35.04 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.528 -0.869 . . . . 1.16 109.978 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -130.12 118.22 21.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 123.62 0.575 . . . . 4.7 109.914 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.496 ' CD1' ' SG ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -107.47 112.62 25.49 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.721 -0.792 . . . . 2.23 109.287 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 156.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 123.89 0.744 . . . . 1.6 109.642 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.3 t70 -114.06 131.47 56.37 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 106.869 -1.53 . . . . 2.36 106.869 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 pt -47.78 -39.96 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 114.348 1.24 . . . . 1.18 114.348 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.506 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -85.98 -45.14 11.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.607 -1.637 . . . . 5.04 108.422 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 39' ' ' ARG . . . -35.38 -56.86 0.62 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 124.068 0.855 . . . . 1.73 110.918 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -105.5 44.53 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 124.083 0.864 . . . . 5.74 110.97 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 23.53 68.15 0.03 OUTLIER Glycine 0 N--CA 1.504 3.215 0 CA-C-N 114.773 -1.103 . . . . 2.0 114.597 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.627 HD13 ' CE2' ' A' ' 6' ' ' PHE . 34.3 mt -101.08 140.26 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.432 -1.692 . . . . 1.91 106.432 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.9 p -104.41 169.98 8.16 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.442 -0.903 . . . . 3.27 111.195 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.458 ' CA ' ' HZ2' ' A' ' 45' ' ' LYS . 5.0 mmmp? -70.83 -35.33 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 117.806 -1.558 . . . . 5.01 111.963 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.72 -55.18 38.26 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.924 -1.51 . . . . 6.55 106.924 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.476 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 25.0 t70 -48.68 -48.1 40.27 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 115.094 -0.957 . . . . 2.85 111.657 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.84 -50.22 67.5 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.836 -1.074 . . . . 2.01 110.743 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.45 -45.44 66.04 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.418 -1.327 . . . . 4.66 107.418 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -23.33 40.13 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.613 -1.63 . . . . 4.01 111.211 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 7.9 mtmm -96.8 -32.74 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.308 -0.557 . . . . 2.35 110.849 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.531 ' HB2' HE22 ' A' ' 61' ' ' GLN . . . -75.41 -44.26 45.6 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.093 -0.643 . . . . 1.38 112.021 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.0 -48.75 0.91 Allowed Glycine 0 N--CA 1.501 3.031 0 N-CA-C 108.232 -1.947 . . . . 3.32 108.232 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.565 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 3.8 ttpm? -91.4 166.58 17.88 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.245 -2.131 . . . . 6.29 105.245 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.565 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 2.5 Cg_endo -48.22 155.61 1.92 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 N-CA-C 108.685 -1.313 . . . . 5.29 108.685 146.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 m -118.79 149.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.897 -1.121 . . . . 5.11 110.562 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 15.6 mp0 -87.19 -69.47 0.68 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.073 0.858 . . . . 6.3 111.17 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 59' ' ' VAL . 26.7 m -143.8 173.64 11.5 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.731 -0.788 . . . . 3.64 110.871 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 58' ' ' THR . 15.7 m -101.92 159.17 30.18 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.818 -1.179 . . . . 1.94 107.818 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 10.0 Cg_endo -92.01 147.26 14.33 Favored 'Cis proline' 0 C--N 1.318 -1.057 0 CA-C-N 118.554 0.519 . . . . 1.67 111.454 9.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.531 HE22 ' HB2' ' A' ' 52' ' ' ALA . 18.6 mt-30 -107.78 147.47 30.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.922 -0.711 . . . . 2.85 109.47 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.459 HD12 ' CB ' ' A' ' 75' ' ' PHE . 4.4 mt -121.18 141.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.268 -0.973 . . . . 1.37 112.489 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 19.7 m-85 -128.62 153.28 47.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 114.608 -1.178 . . . . 0.97 108.998 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.6 t -122.33 102.05 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.487 -1.301 . . . . 0.98 107.487 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.579 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 37.2 m-20 65.49 -83.58 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.772 0.796 . . . . 2.38 110.25 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -126.3 -15.43 5.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.398 -1.274 . . . . 4.23 109.717 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -81.37 167.86 19.0 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.421 -0.512 . . . . 3.69 111.27 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -123.43 136.26 54.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.439 -1.689 . . . . 1.22 106.439 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' A' ' 75' ' ' PHE . 26.0 mm -107.07 -31.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.33 -0.948 . . . . 0.79 110.204 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.4 -117.98 3.8 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.48 -1.448 . . . . 1.33 109.48 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.36 -172.77 18.96 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.285 -1.126 . . . . 1.32 110.285 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -56.01 -53.21 59.67 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.095 -1.042 . . . . 1.54 113.253 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 p -40.92 -58.63 1.65 Allowed 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.726 -0.79 . . . . 1.74 110.833 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.56 -57.74 10.68 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 113.677 -1.601 . . . . 2.05 108.964 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HA ' HG21 ' A' ' 69' ' ' ILE . 70.1 t80 -45.82 -52.91 10.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.747 -0.781 . . . . 0.88 111.497 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -55.99 18.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.469 -0.892 . . . . 1.05 109.145 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.62 -58.98 5.36 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.623 -0.831 . . . . 0.9 109.518 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.406 ' O ' ' HB2' ' A' ' 82' ' ' ASN . 74.3 t90 -41.99 -53.61 3.8 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.738 -0.664 . . . . 0.89 109.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.18 -60.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 124.094 0.871 . . . . 0.98 109.796 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.445 ' NZ ' ' C ' ' A' ' 85' ' ' ALA . 0.1 OUTLIER -44.78 -55.79 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.127 1.158 . . . . 2.68 114.127 -177.048 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -93.42 28.6 2.2 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 117.184 -1.807 . . . . 5.49 114.305 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 78' ' ' TRP . 40.9 m-80 -140.2 -36.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 119.124 -1.03 . . . . 2.86 110.195 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.0 -26.25 9.36 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.518 -0.765 . . . . 1.99 111.161 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 0.2 OUTLIER -89.52 -69.9 0.69 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.002 0.814 . . . . 6.57 110.365 -179.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.445 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.5 2.058 0 O-C-N 126.519 2.387 . . . . 8.72 106.211 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.47 0.652 . . . . 3.28 110.013 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.74 160.77 14.05 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.15 -0.932 . . . . 5.85 111.602 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.3 m -124.68 146.61 49.03 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 109.843 -0.429 . . . . 1.4 109.843 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.77 132.95 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.415 -0.957 . . . . 1.7 108.415 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.3 mp -118.29 121.99 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.48 -0.933 . . . . 1.31 108.48 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -115.04 113.57 24.24 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 106.745 -1.576 . . . . 1.65 106.745 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . 160.94 -169.3 36.54 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 118.279 -1.915 . . . . 1.77 108.443 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -126.51 173.66 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 116.854 -1.938 . . . . 4.78 112.3 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.12 -179.96 4.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.008 -1.451 . . . . 5.73 109.778 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.48 -49.22 0.91 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.116 -1.993 . . . . 3.97 108.116 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.8 t -128.24 101.04 22.44 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 107.391 -1.337 . . . . 4.81 107.391 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 14' ' ' CYS . 2.3 Cg_endo -31.05 -56.14 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.634 2.223 . . . . 4.32 113.06 -122.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 53.15 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.874 1.065 . . . . 6.52 113.874 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' PRO . 18.2 m -115.85 -6.22 12.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.348 -0.541 . . . . 2.29 110.797 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -43.03 -57.54 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 119.743 -0.783 . . . . 2.42 111.78 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.576 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -60.09 -35.47 75.27 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 117.481 -1.688 . . . . 4.27 109.891 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.27 -51.64 68.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.177 -1.409 . . . . 0.82 107.667 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 18.0 tptp -53.14 -50.52 64.38 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 120.26 -0.576 . . . . 2.45 111.724 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.576 ' CG ' HH22 ' A' ' 16' ' ' ARG . 6.9 t0 -66.36 -53.91 30.71 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.784 0.802 . . . . 2.66 110.165 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 tp -49.93 -53.44 26.13 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.199 -1.037 . . . . 1.47 108.199 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.54 -48.95 76.18 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.427 -0.953 . . . . 1.06 108.427 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 4.8 tp10 -46.68 -62.98 1.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.465 1.126 . . . . 2.91 110.677 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.42 -50.1 17.18 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 113.585 -1.643 . . . . 4.28 110.921 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 mt -66.15 -40.09 90.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.169 -0.923 . . . . 1.53 110.321 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -58.52 -40.89 84.14 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.024 -0.732 . . . . 1.27 109.024 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -89.05 29.84 1.01 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.947 -1.131 . . . . 2.74 107.947 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -120.82 -59.19 1.77 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.257 -1.016 . . . . 3.47 108.257 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' A' ' 84' ' ' ASP . 3.4 mtt180 -116.5 152.28 34.39 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.352 -0.981 . . . . 4.08 108.352 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -74.98 -36.05 62.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.644 -0.822 . . . . 4.91 110.176 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 30' ' ' ASP . 5.5 t70 -83.51 41.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.666 -0.813 . . . . 4.31 109.998 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 25' ' ' SER . 50.9 t80 -142.65 72.43 1.37 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.322 -0.951 . . . . 1.21 108.622 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -100.2 138.13 37.69 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.272 -1.01 . . . . 3.69 108.272 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -118.36 155.77 30.11 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.15 -1.02 . . . . 1.42 112.84 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -121.69 130.21 53.3 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 3.76 107.92 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -119.49 114.6 22.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.65 -1.241 . . . . 1.7 107.65 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.84 145.93 32.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.483 -0.781 . . . . 2.88 109.653 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 11.3 t70 -97.62 140.19 32.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.126 -1.435 . . . . 3.21 107.126 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.426 ' C ' HH11 ' A' ' 39' ' ' ARG . 9.5 pt -48.31 -29.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 112.895 0.702 . . . . 2.07 112.895 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.463 ' HA ' HH11 ' A' ' 39' ' ' ARG . 0.7 OUTLIER -94.75 22.65 6.14 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.276 -0.97 . . . . 6.91 111.749 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.2 -50.68 3.71 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.246 -0.581 . . . . 1.52 109.662 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -95.58 -13.81 24.1 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.5 -0.88 . . . . 3.37 109.755 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.59 58.76 1.17 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.137 -1.985 . . . . 1.56 108.137 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -101.1 141.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 120.117 -0.633 . . . . 2.22 111.582 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 p -123.14 161.54 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 124.538 1.149 . . . . 2.59 109.437 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -43.91 -57.34 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.705 -0.68 . . . . 4.29 109.493 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -44.49 -49.28 9.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 123.826 0.704 . . . . 3.85 111.128 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.78 -50.66 72.58 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.976 -1.49 . . . . 3.08 109.221 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -42.82 64.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.152 -0.931 . . . . 1.83 108.92 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.0 -47.87 79.8 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.6 -1.259 . . . . 4.18 107.6 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -60.19 -50.29 74.25 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.984 0.803 . . . . 4.83 110.562 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 51' ' ' LYS . 2.8 tppt? -55.62 -50.23 70.71 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.428 -1.26 . . . . 3.16 111.508 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.596 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -74.24 -47.49 34.92 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.315 -1.311 . . . . 1.18 113.077 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.86 42.71 5.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.048 -1.621 . . . . 2.48 109.048 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 54' ' ' LYS . 75.5 mmtt -128.41 -176.29 0.51 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.521 -0.918 . . . . 6.36 108.521 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 54' ' ' LYS . 50.9 Cg_exo -50.82 -157.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.46 1.44 . . . . 4.04 111.235 147.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 m -114.16 70.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.784 -0.643 . . . . 5.81 112.273 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 3.1 mp0 -75.03 54.51 0.67 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.14 -0.936 . . . . 6.17 112.217 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p 41.26 -112.53 0.16 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 115.666 1.728 . . . . 3.98 115.666 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.12 171.55 6.43 Favored Pre-proline 0 N--CA 1.498 1.955 0 CA-C-N 115.569 -0.741 . . . . 1.98 109.402 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.51 173.35 11.98 Favored 'Cis proline' 0 N--CA 1.487 1.109 0 O-C-N 122.616 0.798 . . . . 1.9 110.351 -20.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.75 150.49 49.78 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.439 -0.905 . . . . 2.74 110.521 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.418 ' C ' ' CD1' ' A' ' 63' ' ' PHE . 48.2 mt -123.16 148.03 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.747 -0.66 . . . . 1.17 109.267 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 9.4 m-85 -131.06 165.39 23.34 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.767 -1.106 . . . . 1.13 109.494 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.428 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 55.7 t -134.8 112.31 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.481 -1.236 . . . . 0.89 110.148 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 66' ' ' GLN . 0.6 OUTLIER 53.94 -85.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.464 0.542 . . . . 2.64 112.464 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' H ' ' HB3' ' A' ' 65' ' ' ASP . 54.0 mt-30 -139.13 23.18 2.58 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.82 -0.627 . . . . 4.55 110.334 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -123.99 153.96 40.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.398 -0.964 . . . . 3.86 108.398 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.596 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.0 t-160 -108.6 139.77 42.91 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.829 -1.174 . . . . 1.08 107.829 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.75 -45.94 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 118.744 -1.183 . . . . 0.92 110.032 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 138.21 -123.83 2.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.391 -1.484 . . . . 1.37 109.391 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.11 -174.72 19.64 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.147 -1.181 . . . . 1.44 110.147 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -47.4 -60.33 2.59 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.817 1.043 . . . . 2.21 113.817 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -36.31 -59.82 0.61 Allowed 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.685 1.231 . . . . 2.08 111.369 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -51.78 68.32 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.374 -2.193 . . . . 2.08 109.584 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -47.15 -50.54 20.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.516 -1.274 . . . . 0.94 109.632 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.09 13.14 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.51 -1.276 . . . . 1.14 109.253 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.25 -54.12 35.23 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.484 -0.886 . . . . 0.93 110.861 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.428 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 89.7 t90 -51.17 -50.58 58.7 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.146 -0.479 . . . . 0.74 110.441 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -49.41 -50.62 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.213 -0.903 . . . . 1.17 111.681 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -40.42 -38.5 0.83 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.703 1.372 . . . . 2.24 114.703 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.88 -25.8 6.67 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.973 1.101 . . . . 5.64 113.973 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -79.47 -14.36 58.95 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 117.491 -1.683 . . . . 1.92 108.101 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -121.8 13.34 10.7 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.905 -1.146 . . . . 2.17 107.905 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 28' ' ' ARG . 3.7 p30 32.27 80.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.469 -1.696 . . . . 6.23 114.661 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 116.546 -1.692 . . . . 7.94 108.948 178.357 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 107.996 -1.113 . . . . 2.45 107.996 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -109.67 128.77 55.48 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.194 -0.669 . . . . 4.97 109.194 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -112.71 125.07 53.91 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.731 -0.788 . . . . 0.91 109.476 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 63' ' ' PHE . 14.5 p -121.35 144.46 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.405 -0.918 . . . . 2.72 109.362 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -118.35 118.77 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 125.173 1.545 . . . . 2.17 108.98 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -107.81 73.41 0.9 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.446 -1.687 . . . . 1.98 106.446 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.4 -179.66 21.84 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.786 -1.673 . . . . 1.45 111.431 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 126.47 52.68 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.076 -1.824 . . . . 6.1 106.076 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -117.29 -168.19 1.44 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.139 0.971 . . . . 6.91 112.768 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.56 -47.32 1.02 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.253 -1.939 . . . . 4.22 108.253 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -120.91 116.25 31.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.476 -1.305 . . . . 5.48 107.476 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 14' ' ' CYS . 50.1 Cg_exo -17.74 -68.49 0.02 OUTLIER 'Trans proline' 0 C--O 1.197 -1.533 0 C-N-CA 122.598 2.199 . . . . 4.03 112.924 -127.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 47.36 -66.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 113.028 0.751 . . . . 6.09 113.028 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 12' ' ' PRO . 23.5 m -116.39 -18.75 10.37 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.468 -0.893 . . . . 2.06 109.544 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -47.03 -33.94 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.266 -0.573 . . . . 1.36 110.479 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.526 HH21 ' CB ' ' A' ' 19' ' ' ASP . 1.2 mmp_? -78.64 -38.15 40.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.853 -1.139 . . . . 3.74 110.408 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.9 -49.24 73.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.954 -1.869 . . . . 0.65 105.954 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.439 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 3.7 tmtm? -57.44 -51.58 68.85 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.641 -1.163 . . . . 1.53 110.047 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.526 ' CB ' HH21 ' A' ' 16' ' ' ARG . 9.7 t70 -57.66 -59.12 5.69 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.394 -0.922 . . . . 2.73 109.401 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 tp -49.07 -60.08 3.08 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.883 0.849 . . . . 0.95 109.599 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 33' ' ' TYR . . . -48.66 -53.13 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.668 -1.151 . . . . 0.7 109.362 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.439 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 tt0 -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.212 1.006 . . . . 2.07 108.615 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -49.11 -49.99 39.27 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.11 -1.405 . . . . 4.76 107.984 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.1 mt -63.89 -31.54 72.76 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.848 -0.797 . . . . 1.28 108.848 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 t -64.06 -29.52 70.65 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.173 -1.788 . . . . 1.14 106.173 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 7.0 t30 -95.73 32.38 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.014 -1.106 . . . . 1.82 108.014 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.467 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 40.5 mt-10 -130.09 -66.06 0.8 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.681 -1.145 . . . . 2.79 108.791 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.3 mpt_? -116.17 132.72 56.58 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 108.258 -1.016 . . . . 4.63 108.258 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.5 30.06 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.775 -0.77 . . . . 4.25 111.732 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -112.78 -25.82 8.88 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.141 -1.429 . . . . 2.84 107.141 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -98.02 117.64 32.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.574 -1.194 . . . . 1.16 112.999 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -124.27 136.59 54.25 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.136 -1.847 . . . . 3.28 106.551 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.444 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 7.9 p90 -117.66 158.73 24.14 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 118.622 -1.231 . . . . 1.16 109.176 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.432 ' N ' ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -144.7 119.82 10.1 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.206 -0.906 . . . . 4.27 110.227 -178.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -98.33 119.06 36.35 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.064 -1.828 . . . . 1.36 106.064 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.4 154.2 21.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.608 -1.627 . . . . 1.38 106.608 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -117.95 131.54 56.49 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.184 -1.406 . . . . 2.83 108.565 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.0 pt -46.73 -37.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.08 -1.418 . . . . 1.22 113.912 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -95.26 18.44 12.38 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.76 -1.176 . . . . 5.69 112.651 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.86 -47.54 3.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.722 -0.844 . . . . 1.54 108.722 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -88.99 -22.72 22.87 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.798 -1.092 . . . . 4.82 110.635 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.49 52.85 1.39 Allowed Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.589 -1.291 . . . . 1.94 110.615 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.8 mt -106.71 134.78 47.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 106.287 -1.746 . . . . 1.6 106.287 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -91.96 -144.16 0.2 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.817 -1.153 . . . . 2.51 109.173 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 57' ' ' GLU . 26.5 mmmt -116.74 -33.52 4.79 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.577 -1.638 . . . . 6.64 106.577 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.17 -46.58 80.24 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.362 -1.718 . . . . 3.96 106.362 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' CG ' ' NZ ' ' A' ' 51' ' ' LYS . 26.9 t70 -63.88 -16.85 62.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.914 -1.039 . . . . 2.2 111.343 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.64 -48.14 5.63 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 108.468 -0.938 . . . . 1.36 108.468 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.35 -47.03 62.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 3.48 107.271 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -18.73 64.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.702 -1.135 . . . . 3.8 111.451 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' NZ ' ' CG ' ' A' ' 47' ' ' ASP . 36.5 mttp -86.65 -41.58 14.12 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.827 -0.749 . . . . 2.26 111.218 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . . . -92.23 -36.17 13.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.144 -0.622 . . . . 1.25 110.676 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.95 -66.91 0.38 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 105.501 -3.039 . . . . 3.41 105.501 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 33.2 mttm 31.44 -162.61 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 CA-C-N 112.533 -1.834 . . . . 7.04 113.178 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -103.75 -157.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.202 1.935 . . . . 4.29 109.915 131.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.04 113.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.946 -1.501 . . . . 7.06 106.946 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 24.9 mt-10 -119.31 -175.6 2.97 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.503 -0.771 . . . . 5.96 112.692 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 59' ' ' VAL . 4.9 t -92.07 -136.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.42 -1.326 . . . . 4.63 107.42 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.413 ' N ' HG23 ' A' ' 58' ' ' THR . 7.0 m -127.26 162.66 46.96 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.627 -0.879 . . . . 1.81 108.627 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 83.7 Cg_endo -100.34 163.51 8.2 Favored 'Cis proline' 0 N--CA 1.486 1.085 0 O-C-N 122.507 0.741 . . . . 1.9 111.888 2.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -119.7 112.1 18.85 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.644 -1.243 . . . . 3.56 107.644 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -101.48 143.62 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.761 -0.776 . . . . 1.08 111.011 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.422 ' HB2' ' CG1' ' A' ' 4' ' ' VAL . 24.7 m-85 -134.31 156.48 48.37 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 113.245 -1.798 . . . . 1.38 109.964 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 66' ' ' GLN . 54.5 t -131.56 122.23 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.869 -1.53 . . . . 0.9 106.869 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 66' ' ' GLN . 12.3 m-20 55.02 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.059 -0.657 . . . . 3.26 109.29 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.4 tt0 -133.18 -16.93 2.41 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.604 -1.18 . . . . 5.15 110.692 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' VAL . 19.1 pt20 -81.59 161.54 23.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.921 -0.711 . . . . 4.4 110.503 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -108.34 147.56 31.33 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.184 -0.917 . . . . 1.41 108.611 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 78' ' ' TRP . 5.2 mm -116.21 -49.66 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.12 -1.032 . . . . 0.79 109.483 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.27 -121.07 3.05 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.954 -1.258 . . . . 1.16 109.954 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.97 -164.47 18.53 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.623 -0.991 . . . . 1.11 110.623 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -53.52 -56.51 16.41 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 120.903 0.382 . . . . 2.13 111.203 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -45.39 -53.18 9.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.035 0.921 . . . . 1.61 110.779 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.39 65.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.158 -1.837 . . . . 2.79 109.295 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -48.24 -52.91 19.02 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.133 -1.027 . . . . 0.85 110.08 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.11 -56.7 14.24 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.097 -1.041 . . . . 0.79 110.122 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -55.66 28.49 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.54 -0.864 . . . . 0.87 109.922 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.422 ' CD1' HD12 ' A' ' 69' ' ' ILE . 89.7 t90 -48.89 -53.31 20.04 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.22 -0.592 . . . . 0.67 110.077 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.2 t -46.69 -58.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 CA-C-N 115.05 -0.977 . . . . 0.77 110.614 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -43.07 -43.09 4.21 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.816 1.413 . . . . 2.2 114.816 -177.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -97.79 3.56 49.97 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 118.15 -1.42 . . . . 3.87 113.536 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -117.09 -39.89 3.17 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.793 -0.763 . . . . 1.34 111.306 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.2 mt -113.56 37.83 3.11 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.619 -0.719 . . . . 2.4 112.051 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -101.0 37.99 1.64 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.057 -1.057 . . . . 4.21 109.322 178.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 116.689 -1.624 . . . . 5.78 108.148 179.333 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 tpp . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 109.005 -0.739 . . . . 3.08 109.005 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -119.6 118.7 31.69 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.569 -1.271 . . . . 4.32 107.569 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 11.1 m -114.27 131.58 56.45 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.341 -0.543 . . . . 0.91 110.996 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.99 146.72 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.822 -1.151 . . . . 1.69 112.57 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.4 mp -111.34 129.58 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.458 -1.682 . . . . 1.81 106.458 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 81.0 m-85 -118.63 119.92 35.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.15 -0.62 . . . . 1.7 110.492 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.27 -158.72 26.96 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 124.637 1.211 . . . . 1.86 112.037 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -106.26 107.43 18.43 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.44 0.638 . . . . 5.74 110.097 -179.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t -78.11 -155.05 0.07 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.897 -0.592 . . . . 7.27 111.113 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 25.02 21.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.22 -1.552 . . . . 4.12 109.22 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' ' 15' ' ' VAL . 59.2 m -142.38 150.92 56.57 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 120.46 -0.496 . . . . 3.95 110.587 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.87 31.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.629 2.219 . . . . 4.93 112.479 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 83.6 t80 -125.13 -63.78 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.626 -1.249 . . . . 7.9 107.626 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 60' ' ' PRO . 89.5 m -78.68 -29.16 45.42 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 118.554 -1.258 . . . . 3.66 109.4 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 11' ' ' CYS . 67.4 t -62.19 -48.14 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.376 -1.342 . . . . 1.68 107.376 178.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -57.71 -28.5 63.9 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.155 -1.018 . . . . 3.85 109.853 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 62' ' ' ILE . . . -69.86 -48.44 58.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.749 -1.945 . . . . 1.18 105.749 177.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HE2' ' N ' ' A' ' 19' ' ' ASP . 3.5 tmpt? -50.21 -45.61 53.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.399 -1.704 . . . . 2.04 106.399 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 72.8 m-20 -58.44 -62.77 1.6 Allowed 'General case' 0 C--O 1.19 -2.029 0 C-N-CA 119.277 -0.969 . . . . 2.93 109.949 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 62.0 tp -46.5 -48.63 19.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.765 -0.774 . . . . 0.91 110.287 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.69 85.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.112 -0.699 . . . . 0.68 109.112 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.63 -38.68 82.01 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.734 -0.839 . . . . 1.79 108.734 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 23.6 tttm -58.77 -65.17 0.7 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.608 -1.627 . . . . 5.31 106.608 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.419 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 37.0 mt -45.6 -44.69 13.22 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.935 -1.135 . . . . 0.97 107.935 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 3.0 t -54.44 -43.42 71.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.419 -1.264 . . . . 0.99 109.809 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 18.3 t30 -78.39 -2.09 36.57 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.999 -0.68 . . . . 2.12 110.241 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' CD ' ' HZ3' ' A' ' 23' ' ' LYS . 77.2 mm-40 -89.7 -50.35 6.12 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.197 -0.601 . . . . 3.14 112.411 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.478 HH21 ' CB ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -137.81 155.91 48.51 Favored 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 118.679 -1.208 . . . . 4.1 113.986 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.05 31.03 0.08 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.029 -0.987 . . . . 4.23 111.825 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -125.52 -24.95 3.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.595 -0.73 . . . . 3.26 109.261 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 25' ' ' SER . 15.5 t80 -101.58 122.48 43.93 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 114.468 1.285 . . . . 1.13 114.468 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' NE2' ' H ' ' A' ' 33' ' ' TYR . 61.2 tp60 -133.64 159.51 40.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.646 -1.983 . . . . 6.03 105.646 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 3' ' ' THR . 15.6 p90 -141.8 167.37 22.31 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.266 -0.974 . . . . 1.02 108.851 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.3 152.24 31.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 124.023 0.827 . . . . 4.45 109.511 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.62 124.49 49.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.914 -1.143 . . . . 1.63 107.914 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.87 152.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.249 -0.98 . . . . 1.55 110.435 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -102.82 142.08 34.56 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.664 1.221 . . . . 3.48 111.133 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 38' ' ' ILE . 15.4 pt -66.45 -32.96 60.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 113.084 -1.871 . . . . 1.18 111.665 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -10.72 44.17 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.403 -0.919 . . . . 6.07 111.29 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.29 14.99 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.468 -0.938 . . . . 2.23 108.468 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -85.33 -43.53 13.62 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.61 -0.836 . . . . 3.78 110.651 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.47 49.0 0.57 Allowed Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.318 -1.113 . . . . 2.18 110.318 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.2 mt -106.48 135.14 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.052 -1.462 . . . . 1.65 107.052 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.504 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 4.9 p -108.09 171.53 7.35 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.59 -1.244 . . . . 2.23 113.111 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -17.24 62.74 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.194 -0.912 . . . . 3.78 109.586 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 16.2 mp0 -94.57 -50.02 5.38 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.487 -1.301 . . . . 3.7 107.487 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.504 ' HB3' ' H ' ' A' ' 44' ' ' THR . 53.8 t0 -55.75 -50.9 69.14 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 108.3 -1.0 . . . . 2.89 108.3 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.06 -49.5 68.86 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.345 -0.983 . . . . 1.56 108.345 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.4 tt0 -47.07 -52.04 16.12 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.51 -0.876 . . . . 3.59 108.969 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -62.31 -48.61 79.1 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.99 -1.004 . . . . 6.64 112.008 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -52.15 -44.25 64.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.642 0.589 . . . . 2.5 110.54 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.468 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -88.84 -57.25 2.97 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.963 -1.095 . . . . 1.17 109.339 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.1 -67.38 0.47 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.466 -1.854 . . . . 3.2 108.466 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 22.8 mmtm -143.84 55.64 3.73 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.336 0.865 . . . . 8.95 113.336 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.468 ' CD ' ' HB3' ' A' ' 52' ' ' ALA . 10.2 Cg_endo -91.26 159.06 3.77 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.703 1.602 . . . . 6.87 109.087 137.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.18 -61.46 2.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.056 -0.658 . . . . 5.36 109.724 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -128.67 33.05 4.71 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.335 -0.987 . . . . 6.7 108.335 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.9 p -89.67 69.63 7.75 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.954 -0.698 . . . . 4.9 110.139 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -114.37 140.43 25.11 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.26 -0.882 . . . . 2.99 110.28 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 5.3 Cg_exo -72.5 155.09 99.03 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.615 -1.411 . . . . 3.62 112.598 -0.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.592 ' CG ' ' NE2' ' A' ' 68' ' ' HIS . 1.7 tp-100 -121.45 165.84 15.01 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.426 -1.324 . . . . 4.47 107.426 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.47 HD11 ' HB1' ' A' ' 17' ' ' ALA . 34.4 mt -121.38 145.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.296 -0.962 . . . . 1.54 112.977 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 68' ' ' HIS . 40.5 m-85 -127.21 152.63 47.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.589 -2.096 . . . . 1.05 106.823 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 66' ' ' GLN . 55.9 t -125.38 126.17 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.95 -1.5 . . . . 1.12 106.95 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 53.55 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.076 0.86 . . . . 2.51 109.304 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -139.55 10.53 2.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.866 0.691 . . . . 5.79 112.866 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' A' ' 67' ' ' GLN . 22.1 mm-40 -118.17 179.91 3.96 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.439 -0.504 . . . . 6.71 111.086 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 61' ' ' GLN . 29.5 t-80 -117.48 143.67 45.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 123.961 0.788 . . . . 1.57 109.467 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.4 mm -115.63 -39.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.793 -1.163 . . . . 0.95 111.141 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.67 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.852 -2.099 . . . . 1.36 107.852 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.28 -72.76 0.81 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.427 -1.368 . . . . 2.89 110.646 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 10.5 t80 -136.03 -50.61 0.7 Allowed 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 119.964 -0.694 . . . . 1.54 109.77 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.01 61.69 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.678 1.228 . . . . 1.58 108.823 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.24 -57.26 12.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 111.929 -2.396 . . . . 2.58 109.012 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -47.04 -52.33 15.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.643 -0.823 . . . . 0.92 109.997 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.13 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.816 -1.154 . . . . 0.84 109.099 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.69 -53.52 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.975 -1.09 . . . . 0.9 109.797 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -53.92 -51.34 64.06 Favored 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.285 0.564 . . . . 0.68 110.355 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.5 t -48.38 -49.44 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.987 -1.006 . . . . 0.75 111.473 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -44.13 -30.18 0.73 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.891 1.441 . . . . 2.01 114.891 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 82' ' ' ASN . 13.9 pt-20 -112.48 -35.23 5.62 Favored 'General case' 0 N--CA 1.506 2.363 0 C-N-CA 119.537 -0.865 . . . . 4.95 113.219 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.48 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 39.5 m-80 -82.01 -23.84 35.75 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.037 -1.065 . . . . 1.34 109.579 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.471 HD22 ' C ' ' A' ' 82' ' ' ASN . 2.2 mm? -113.09 -41.19 3.77 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.631 -0.713 . . . . 1.75 109.67 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 1.3 t0 33.75 48.18 0.2 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 125.5 1.75 . . . . 3.92 111.713 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.423 ' C ' HH22 ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 116.823 -1.56 . . . . 6.91 107.734 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 32.0 tpp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.805 . . . . 2.95 108.825 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.68 110.65 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.731 0.777 . . . . 5.12 109.45 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.0 m -92.81 105.96 18.01 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.378 -1.712 . . . . 1.21 106.378 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 19.9 t -105.29 138.72 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.438 -0.905 . . . . 1.1 110.811 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.95 103.67 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.779 1.299 . . . . 1.18 108.337 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -85.65 90.14 7.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.509 -1.293 . . . . 1.55 107.509 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.459 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -124.48 145.06 15.67 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.254 -1.938 . . . . 1.66 108.254 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 139.82 49.41 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.644 -1.222 . . . . 5.06 110.205 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 10' ' ' GLY . 3.4 m 61.34 55.48 2.89 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.946 -1.024 . . . . 5.8 108.902 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' SER . . . -3.15 83.83 0.0 OUTLIER Glycine 0 N--CA 1.511 3.635 0 O-C-N 124.782 1.301 . . . . 3.77 114.872 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.4 m -112.74 157.13 41.32 Favored Pre-proline 0 N--CA 1.498 1.948 0 C-N-CA 119.577 -0.849 . . . . 4.2 109.79 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.0 -13.82 0.24 Allowed 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.922 2.414 . . . . 2.74 114.056 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -73.11 -14.1 61.32 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.688 -0.805 . . . . 4.89 111.889 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.555 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 3.4 m -107.13 -29.23 9.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.24 -1.022 . . . . 1.97 108.24 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.1 t -44.24 -63.65 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 114.506 1.299 . . . . 2.11 114.506 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -52.04 -44.39 64.21 Favored 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 118.044 -1.462 . . . . 3.84 111.808 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.9 63.39 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.742 -1.207 . . . . 1.04 107.742 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 5.1 ttpp -47.09 -55.89 7.54 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.327 -0.851 . . . . 1.48 109.256 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.439 ' CG ' ' NH2' ' A' ' 16' ' ' ARG . 5.8 t70 -52.8 -58.35 7.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 123.683 0.614 . . . . 3.21 110.013 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -50.92 -55.41 17.28 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.545 -0.862 . . . . 0.91 111.126 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.15 83.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.411 -0.915 . . . . 0.71 108.68 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.3 tt0 -59.52 -46.37 89.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.252 -0.885 . . . . 1.97 110.086 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.585 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -52.54 -57.16 10.82 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.979 -1.089 . . . . 4.28 108.117 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 42.6 mt -48.49 -43.66 35.18 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 1.17 107.601 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.9 t -58.53 -46.25 87.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.192 -1.367 . . . . 1.06 110.58 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.96 41.51 1.07 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.807 -1.553 . . . . 2.07 106.807 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.585 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.9 tp10 -128.29 -66.06 0.87 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.709 -2.042 . . . . 3.39 106.483 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.47 ' NH2' ' HB2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -122.45 153.46 39.08 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 106.341 -1.725 . . . . 4.35 106.341 179.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.07 32.3 1.52 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 118.367 -1.333 . . . . 5.51 111.933 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -113.64 -23.23 9.85 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.959 -1.497 . . . . 3.21 106.959 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 25' ' ' SER . 28.6 t80 -103.04 118.23 36.36 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.584 -1.189 . . . . 1.0 109.342 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -130.28 142.26 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.381 -1.34 . . . . 4.13 107.381 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -117.67 159.86 22.25 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 118.479 -1.288 . . . . 1.32 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.61 142.6 37.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.275 0.985 . . . . 4.58 109.255 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 35' ' ' TYR . 10.0 t80 -106.34 135.4 47.9 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.542 -2.021 . . . . 1.44 105.542 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.97 156.91 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.296 -0.961 . . . . 2.62 109.215 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.97 160.1 24.23 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.153 0.501 . . . . 2.8 109.796 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 pt -75.79 -32.45 24.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.998 -1.081 . . . . 1.82 111.439 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -35.87 55.16 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.356 -1.338 . . . . 5.64 108.494 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.56 -53.26 18.97 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.307 -0.86 . . . . 1.92 109.196 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.35 -46.38 10.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.042 0.839 . . . . 3.74 109.942 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.08 52.01 0.58 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 108.948 -1.661 . . . . 1.5 108.948 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.82 160.76 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 115.047 -0.577 . . . . 1.56 110.885 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -119.68 -170.82 2.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.787 -1.19 . . . . 2.08 107.787 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -90.86 -24.17 20.33 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 118.0 -1.48 . . . . 6.45 109.339 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.662 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 3.0 mp0 -72.87 -47.56 44.97 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.126 -1.435 . . . . 3.22 107.126 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.58 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 30.3 t70 -57.38 -39.2 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.071 0.939 . . . . 2.8 108.619 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.32 -46.03 78.3 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.49 -1.232 . . . . 1.39 107.714 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -46.21 -48.98 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.281 -1.377 . . . . 3.77 107.281 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.97 -59.13 5.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.152 -0.931 . . . . 4.41 110.62 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.58 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 17.3 mtmm -66.83 -5.41 12.21 Favored 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 120.338 -0.545 . . . . 2.75 112.457 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' CB ' HE22 ' A' ' 61' ' ' GLN . . . -105.3 -33.51 8.18 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.727 -0.67 . . . . 1.03 111.769 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.96 31.63 2.88 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.712 -1.755 . . . . 3.39 108.712 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.533 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 50.7 tttm -144.62 121.28 6.28 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.91 -1.144 . . . . 6.98 107.91 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -19.8 -131.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 124.472 3.448 . . . . 4.32 114.641 -143.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.79 -54.18 7.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 113.862 -1.517 . . . . 5.25 107.719 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 50.23 -160.36 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.772 -0.649 . . . . 8.22 112.099 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -139.59 -151.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.494 -0.882 . . . . 3.99 109.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.08 151.72 42.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.001 -0.74 . . . . 1.76 109.001 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -93.22 167.25 22.24 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 O-C-N 123.236 1.124 . . . . 1.92 111.135 2.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.542 HE22 ' CB ' ' A' ' 52' ' ' ALA . 25.8 mt-30 -116.84 131.12 57.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.181 -1.415 . . . . 2.58 107.181 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 75' ' ' PHE . 94.9 mt -104.73 144.96 13.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 118.989 -1.084 . . . . 1.27 109.943 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -135.69 148.57 48.96 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 113.373 -1.74 . . . . 0.99 108.816 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 66' ' ' GLN . 68.6 t -115.1 92.99 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 104.651 -2.352 . . . . 0.93 104.651 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 1' ' ' MET . 5.3 m-20 66.82 -74.5 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.32 1.013 . . . . 2.58 109.656 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 64' ' ' VAL . 63.4 mt-30 -133.8 -15.59 2.35 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.808 -1.087 . . . . 3.43 110.999 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.408 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 71.6 mt-30 -75.34 128.19 34.83 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.425 -0.954 . . . . 4.17 108.425 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.533 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 10.9 t-160 -90.36 136.56 32.98 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.081 -1.822 . . . . 1.03 106.081 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 75' ' ' PHE . 16.8 mm -108.5 -50.27 7.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.665 -0.814 . . . . 1.02 109.413 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.55 -122.76 5.26 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 118.94 -1.6 . . . . 1.53 111.85 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.97 -173.66 39.27 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.085 -1.055 . . . . 1.16 111.67 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 29.6 t80 -60.07 -51.19 70.71 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.758 -0.777 . . . . 1.66 111.354 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -43.98 -48.53 8.68 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.736 1.255 . . . . 1.57 108.91 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -58.69 -57.49 12.77 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.051 -2.34 . . . . 2.78 108.616 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HA ' HG21 ' A' ' 69' ' ' ILE . 7.6 t80 -48.7 -54.19 15.84 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.009 -0.996 . . . . 1.08 110.864 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.02 -53.01 56.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.69 -1.226 . . . . 0.84 107.69 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.07 -59.21 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.283 -0.967 . . . . 1.16 109.835 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.487 ' CD1' HD12 ' A' ' 69' ' ' ILE . 62.9 t90 -48.65 -52.87 21.0 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 119.852 -0.739 . . . . 1.44 110.964 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.423 ' CG2' ' CE1' ' A' ' 75' ' ' PHE . 43.0 t -54.49 -43.81 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 118.779 -1.168 . . . . 1.04 109.031 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -78.39 11.1 2.59 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.733 -0.667 . . . . 3.0 112.793 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.88 -36.28 2.4 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 120.505 -0.478 . . . . 4.68 110.819 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -96.93 -29.52 13.64 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.366 -0.834 . . . . 1.85 112.164 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.1 mt -119.58 26.13 9.58 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.071 -1.052 . . . . 2.15 111.586 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.12 41.56 1.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.056 -1.057 . . . . 4.42 110.252 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 116.04 -1.933 . . . . 5.68 109.172 -179.91 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 122.503 1.144 . . . . 3.03 108.356 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -114.6 158.83 21.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.455 -1.313 . . . . 5.28 107.455 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.622 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 5.5 m -107.15 142.14 37.31 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.296 -1.001 . . . . 1.68 108.296 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.441 ' C ' HD12 ' A' ' 5' ' ' ILE . 3.2 t -129.04 117.57 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.881 -1.526 . . . . 1.11 106.881 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.4 mp -107.35 131.72 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.913 -1.143 . . . . 1.08 107.913 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.72 108.42 17.86 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 106.506 -1.664 . . . . 2.18 106.506 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.8 -171.11 12.75 Favored Glycine 0 N--CA 1.503 3.128 0 C-N-CA 118.832 -1.652 . . . . 1.77 112.514 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.87 147.25 37.39 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 114.611 -0.795 . . . . 5.23 108.875 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -53.04 130.54 34.24 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 120.067 -0.653 . . . . 5.77 112.389 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 155.26 25.32 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.618 -0.801 . . . . 3.18 111.394 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.5 m 74.56 108.51 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.951 1.03 . . . . 3.64 111.767 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.61 59.43 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.799 1.666 . . . . 4.78 111.255 162.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -115.18 -69.84 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.254 -0.885 . . . . 4.76 108.767 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -52.4 -41.69 63.4 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.04 -1.467 . . . . 2.61 107.04 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -43.3 -42.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.833 -1.531 . . . . 2.93 110.113 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.22 -33.74 1.65 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 123.508 0.505 . . . . 4.77 112.225 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.476 ' HB3' HG12 ' A' ' 5' ' ' ILE . . . -67.5 -44.35 78.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.446 -0.946 . . . . 1.09 108.446 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HG3' ' CD1' ' A' ' 33' ' ' TYR . 9.4 ttpp -52.99 -49.58 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.457 -1.683 . . . . 2.27 106.457 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' LEU . 65.7 m-20 -55.85 -60.1 3.93 Favored 'General case' 0 C--O 1.183 -2.414 0 CA-C-N 113.317 -1.765 . . . . 3.95 110.305 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' ASP . 31.5 tp -43.8 -61.25 1.49 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.485 -1.286 . . . . 0.96 109.323 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.47 67.27 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.352 -0.84 . . . . 1.19 111.277 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 40.1 tt0 -65.17 -56.07 14.99 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.955 0.883 . . . . 2.02 111.083 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.557 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -50.8 -43.38 58.73 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.448 -1.315 . . . . 3.9 107.448 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -66.73 -44.17 82.26 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.289 -1.004 . . . . 1.72 108.289 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 27' ' ' GLU . 28.9 t -50.07 -48.75 52.89 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.906 -1.043 . . . . 2.09 108.699 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 11.6 t30 -83.72 38.64 0.64 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.878 1.323 . . . . 2.01 108.782 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 1.5 tt0 -137.61 -50.3 0.61 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 113.164 -1.835 . . . . 3.16 109.117 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -104.03 -32.71 9.08 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 115.05 -0.977 . . . . 3.67 111.371 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 78.49 8.62 2.15 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.193 0.933 . . . . 4.76 111.026 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -113.51 7.58 17.51 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.496 -0.882 . . . . 3.93 112.443 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -124.54 142.37 51.39 Favored 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 119.717 -0.793 . . . . 1.99 110.798 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -126.49 170.98 11.45 Favored 'General case' 0 N--CA 1.512 2.672 0 C-N-CA 120.428 -0.509 . . . . 4.39 111.109 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.622 ' HA ' ' H ' ' A' ' 3' ' ' THR . 18.7 p90 -142.84 169.33 17.77 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.726 0.774 . . . . 2.18 112.694 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 3' ' ' THR . 43.7 mm-40 -148.31 128.31 13.59 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 113.829 -1.532 . . . . 4.03 108.085 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -113.63 111.2 21.46 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.083 -1.451 . . . . 1.3 107.083 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.8 157.77 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.935 -0.706 . . . . 1.65 110.167 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.28 139.08 43.5 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 105.049 -2.204 . . . . 2.96 105.049 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.4 pt -50.19 -33.47 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 118.935 -1.106 . . . . 1.22 113.666 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -50.08 25.89 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 117.67 -1.612 . . . . 6.71 110.379 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -31.08 -52.67 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.256 0.973 . . . . 1.95 111.672 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.23 -43.13 18.01 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.62 1.2 . . . . 4.35 111.069 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.72 51.56 0.45 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.432 -2.267 . . . . 1.58 107.432 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 75.6 mt -108.16 141.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.562 -0.819 . . . . 1.91 110.626 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.3 p -117.08 -89.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.855 -1.165 . . . . 3.31 107.855 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.569 ' HZ3' ' CD ' ' A' ' 57' ' ' GLU . 33.5 tttp -140.87 -48.07 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.37 -0.974 . . . . 4.25 108.37 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 10.3 mp0 -47.9 -55.64 9.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.02 0.825 . . . . 2.86 109.711 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -53.08 -60.86 2.76 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.559 -0.746 . . . . 2.71 109.533 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -52.58 -38.44 59.98 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.348 -0.941 . . . . 1.44 110.045 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.96 -53.33 58.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.209 -1.404 . . . . 4.36 107.209 178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.07 -47.98 79.68 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.25 -1.795 . . . . 4.09 110.476 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -56.66 -50.5 71.91 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.377 -0.829 . . . . 2.74 110.182 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.71 -53.74 46.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.152 -0.931 . . . . 1.37 111.676 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.19 -15.59 43.08 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.519 -1.432 . . . . 2.56 109.519 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.8 pttp -123.96 -178.91 0.72 Allowed Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.955 -0.698 . . . . 6.07 110.133 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 54' ' ' LYS . 49.2 Cg_exo -56.6 142.56 90.49 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.235 1.29 . . . . 4.36 112.077 165.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -153.84 102.59 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 4.95 107.025 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.569 ' CD ' ' HZ3' ' A' ' 45' ' ' LYS . 15.6 mm-40 -111.77 -15.78 13.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.703 -0.799 . . . . 7.12 110.705 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 59' ' ' VAL . 24.0 m -121.69 172.29 8.24 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.979 -0.688 . . . . 4.65 110.265 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 58' ' ' THR . 27.3 m -105.22 169.38 7.14 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 109.278 -0.638 . . . . 2.6 109.278 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -99.97 176.6 6.73 Favored 'Cis proline' 0 N--CA 1.488 1.192 0 O-C-N 122.815 0.903 . . . . 1.99 110.544 -8.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 99.5 mm-40 -125.35 140.78 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.075 -1.05 . . . . 3.42 108.693 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -126.7 145.17 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.874 -0.73 . . . . 1.12 110.444 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.08 162.51 31.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.538 -1.21 . . . . 1.37 109.461 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.533 HG11 ' CH2' ' A' ' 78' ' ' TRP . 49.6 t -141.45 119.19 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 124.526 1.141 . . . . 1.17 108.979 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 50.81 -102.73 0.12 Allowed 'General case' 0 N--CA 1.514 2.742 0 CA-C-N 119.774 1.17 . . . . 2.35 111.008 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -123.82 31.88 5.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.618 -1.174 . . . . 4.48 109.43 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -122.59 164.49 18.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.568 -0.742 . . . . 4.09 110.361 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -122.54 125.6 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.155 -1.054 . . . . 1.25 108.155 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.65 -54.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.951 -1.5 . . . . 1.57 106.951 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 61' ' ' GLN . . . 112.23 -99.23 1.04 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.471 -1.347 . . . . 1.52 110.572 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.56 163.63 13.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.414 -1.374 . . . . 1.24 110.707 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.41 -54.29 33.99 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.074 -0.65 . . . . 1.75 111.759 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -34.58 -64.69 0.24 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.663 0.986 . . . . 1.69 113.663 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.94 -38.0 75.15 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.925 -0.71 . . . . 4.54 111.649 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -43.49 -41.54 4.44 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.794 -0.817 . . . . 1.18 108.794 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.96 -52.03 64.3 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.497 -0.774 . . . . 1.3 110.773 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' LYS . . . -67.22 -53.8 26.83 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.342 -0.844 . . . . 1.36 109.172 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.533 ' CH2' HG11 ' A' ' 64' ' ' VAL . 84.3 t90 -42.23 -55.54 3.26 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.16 -1.052 . . . . 1.03 108.16 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -46.04 -50.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 114.984 -1.007 . . . . 1.4 109.94 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' NZ ' ' C ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -42.56 -57.45 2.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 124.568 1.168 . . . . 3.63 113.295 -178.184 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -106.01 25.43 10.95 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.351 -1.34 . . . . 3.51 112.365 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 78' ' ' TRP . 12.3 m-80 -119.33 -36.43 3.37 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.947 -1.131 . . . . 2.27 107.947 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.6 mt -114.44 11.45 17.2 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.238 -1.764 . . . . 2.32 106.238 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 p30 31.58 70.22 0.09 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 125.338 1.649 . . . . 7.99 112.484 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.484 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-N 113.675 -1.602 . . . . 6.28 110.138 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.5 mpp? . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.19 -1.041 . . . . 2.6 108.19 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 65' ' ' ASP . 49.7 mt-30 -100.24 102.72 14.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.516 -0.92 . . . . 4.32 108.516 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.4 m -84.32 100.27 11.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.264 -1.754 . . . . 1.13 106.264 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.32 127.44 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.313 -1.312 . . . . 1.08 110.206 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mm -96.38 119.16 44.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 104.568 -2.382 . . . . 1.29 104.568 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.523 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.4 m-85 -104.71 109.29 21.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.318 -1.364 . . . . 1.43 107.318 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.61 118.9 0.46 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 116.208 -2.901 . . . . 2.28 112.708 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.455 ' HB3' ' OD1' ' A' ' 37' ' ' ASP . 4.8 ptm180 -86.11 55.74 3.67 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.413 -1.393 . . . . 5.05 111.902 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.0 p -90.47 -54.05 4.17 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 117.434 -1.706 . . . . 6.3 109.144 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.68 -52.73 4.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 106.4 -2.68 . . . . 4.06 106.4 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' TYR . 8.3 m -78.05 156.78 79.31 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 106.758 -1.571 . . . . 4.87 106.758 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.85 64.26 0.15 Allowed 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 123.55 2.834 . . . . 2.95 115.135 -147.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' CYS . 21.2 m-30 -121.69 -70.24 0.79 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.029 -1.841 . . . . 5.8 106.029 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.3 m -65.06 -32.46 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.337 -1.745 . . . . 1.99 106.613 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.4 t -44.13 -45.08 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 114.895 -1.048 . . . . 1.34 109.907 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.478 HH12 ' CG ' ' A' ' 19' ' ' ASP . 2.5 tpt180 -68.91 -47.09 66.65 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.852 -0.739 . . . . 4.13 110.239 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.67 -46.31 70.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.121 -1.437 . . . . 0.73 107.121 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 1.1 tmtt? -54.14 -60.53 3.21 Favored 'General case' 0 C--O 1.203 -1.37 0 CA-C-N 114.824 -1.08 . . . . 2.03 108.402 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 16' ' ' ARG . 5.5 t70 -48.53 -54.64 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.817 -0.753 . . . . 2.77 110.442 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.9 tp -54.85 -57.18 12.61 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.308 -0.957 . . . . 1.48 109.954 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.24 -42.95 52.75 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.949 -1.023 . . . . 0.74 109.906 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 36.6 tt0 -65.62 -51.74 57.33 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.544 -0.753 . . . . 2.16 109.07 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 23.6 ttpp -44.55 -54.21 6.28 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.457 -1.312 . . . . 5.7 107.457 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 50.9 mt -60.67 -36.38 78.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.58 1.175 . . . . 1.18 109.707 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -59.32 -28.46 66.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.057 -0.974 . . . . 1.09 109.532 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -89.19 29.37 1.08 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.548 0.689 . . . . 2.72 109.149 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.426 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 73.3 mt-10 -135.07 -65.96 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.184 -1.006 . . . . 3.29 112.621 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -104.42 149.38 25.46 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.976 -1.09 . . . . 4.65 108.585 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -53.26 57.44 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.852 1.797 . . . . 4.1 115.852 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 1' ' ' MET . 50.6 t0 -84.45 44.82 1.07 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.657 -1.617 . . . . 5.84 111.683 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 83' ' ' LEU . 16.2 t80 -126.04 84.63 2.29 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 105.997 -1.853 . . . . 1.07 105.997 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -109.51 143.75 38.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.866 -1.531 . . . . 3.65 106.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -123.56 157.49 33.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.143 -1.423 . . . . 1.18 110.371 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -145.33 150.12 36.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.788 -1.097 . . . . 4.13 108.62 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -110.77 127.15 55.25 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.198 -1.038 . . . . 2.16 108.198 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.523 HG11 ' CE1' ' A' ' 6' ' ' PHE . 2.3 p -131.02 151.33 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 118.819 -1.153 . . . . 2.31 109.826 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -113.66 135.4 53.97 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.345 -1.354 . . . . 3.0 107.345 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 37.7 pt -61.29 -27.18 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.631 -1.228 . . . . 1.9 110.586 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -74.38 -24.87 59.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.894 -1.122 . . . . 5.76 110.996 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.1 -40.4 15.74 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 1.99 110.124 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -77.36 -40.6 43.37 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.403 -1.272 . . . . 4.25 111.362 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.63 51.02 0.72 Allowed Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.188 -1.482 . . . . 2.13 110.038 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 8.2 mt -112.32 135.2 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.456 -0.898 . . . . 2.32 109.304 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' A' ' 47' ' ' ASP . 47.1 p -106.8 173.76 6.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.242 -0.583 . . . . 1.88 110.014 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -52.52 -51.58 58.86 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.219 -1.4 . . . . 4.92 107.219 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -55.6 -60.66 3.12 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.77 -1.559 . . . . 3.77 110.45 178.015 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 44' ' ' THR . 33.3 t70 -51.92 -41.86 62.33 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.392 -0.923 . . . . 2.08 111.305 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.464 ' HG ' HG21 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -59.63 -57.91 10.9 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.577 -0.849 . . . . 1.91 109.356 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 33.8 tt0 -44.36 -52.3 7.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.962 -1.125 . . . . 3.28 107.962 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.58 -45.26 85.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.796 -1.093 . . . . 4.23 111.404 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -40.24 50.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.703 1.252 . . . . 2.73 110.924 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -90.65 -48.71 6.9 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.732 -1.122 . . . . 1.33 109.946 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.411 ' C ' ' HG3' ' A' ' 54' ' ' LYS . . . 135.23 -68.6 0.53 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 107.373 -2.291 . . . . 3.14 107.373 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 53' ' ' GLY . 51.9 mttp -155.22 56.24 1.35 Allowed Pre-proline 0 N--CA 1.51 2.544 0 N-CA-C 113.252 0.834 . . . . 10.25 113.252 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.458 ' CD ' ' HB3' ' A' ' 52' ' ' ALA . 91.3 Cg_endo -98.66 42.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 121.758 1.639 . . . . 6.08 110.129 152.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t 36.48 -118.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.255 -1.338 . . . . 5.95 110.707 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -120.03 39.41 3.69 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.742 -0.383 . . . . 8.08 110.83 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.7 p -88.12 149.84 23.69 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.326 -1.349 . . . . 5.12 111.417 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.08 165.57 17.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 CA-C-N 115.075 -0.966 . . . . 2.74 108.757 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -78.81 171.96 63.17 Favored 'Cis proline' 0 N--CA 1.485 0.978 0 C-N-CA 123.636 -1.402 . . . . 2.09 110.354 -5.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.456 HE22 ' HG2' ' A' ' 55' ' ' PRO . 42.6 mt-30 -136.63 157.75 46.05 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.941 -1.103 . . . . 2.91 109.944 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.4 mm -114.09 139.76 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 C-N-CA 120.303 -0.559 . . . . 1.5 110.527 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.6 145.71 48.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.726 0.641 . . . . 1.1 109.781 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG11 ' CZ2' ' A' ' 78' ' ' TRP . 72.2 t -124.57 95.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.761 -0.776 . . . . 0.9 109.951 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.435 ' HA ' ' HB2' ' A' ' 2' ' ' GLN . 0.6 OUTLIER 65.21 -74.41 0.05 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.639 -1.619 . . . . 3.27 110.942 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -133.84 -7.34 2.77 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.232 -0.895 . . . . 4.22 112.294 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.409 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 6.7 pt20 -104.82 165.09 11.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.955 -0.698 . . . . 4.17 110.556 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -105.96 143.79 33.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.191 -1.781 . . . . 1.04 106.191 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.522 HD12 ' CD1' ' A' ' 78' ' ' TRP . 23.4 mm -106.0 -37.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.621 -1.231 . . . . 1.09 109.65 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -132.86 7.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.09 -2.004 . . . . 1.2 108.09 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.66 -164.25 24.3 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.527 -1.429 . . . . 1.34 109.527 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 16' ' ' ARG . 44.0 t80 -61.34 -49.17 78.05 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.027 -1.069 . . . . 1.62 111.408 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.39 -52.38 13.07 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 1.73 109.991 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.23 -53.64 54.28 Favored 'General case' 0 C--O 1.197 -1.695 0 CA-C-N 113.461 -1.7 . . . . 2.12 109.045 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -48.45 -48.45 37.57 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.821 -0.627 . . . . 0.98 110.74 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.36 69.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.18 -1.008 . . . . 0.88 108.485 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.4 -62.67 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.919 -1.112 . . . . 0.94 110.126 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.522 ' CD1' HD12 ' A' ' 69' ' ' ILE . 67.2 t90 -42.69 -51.42 5.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.698 -0.853 . . . . 0.87 108.698 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.433 ' CG1' HD11 ' A' ' 24' ' ' LEU . 6.6 t -53.65 -59.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.906 -1.043 . . . . 0.81 109.482 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 18.4 tptt -54.35 -16.73 2.38 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.252 -0.886 . . . . 3.36 113.226 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -107.54 -44.61 4.24 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.29 -0.964 . . . . 3.67 113.384 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' C ' HD22 ' A' ' 83' ' ' LEU . 14.1 m-80 -82.7 -25.16 33.22 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.846 -0.741 . . . . 1.5 110.104 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.551 HD11 ' CD1' ' A' ' 31' ' ' PHE . 2.6 mm? -109.08 -41.36 4.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.255 -0.646 . . . . 2.18 109.255 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.78 80.7 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.862 -1.517 . . . . 4.02 108.652 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-N 112.118 -2.31 . . . . 7.96 110.367 -179.456 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 107.851 -1.166 . . . . 3.04 107.851 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -115.81 110.27 18.82 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.32 -0.552 . . . . 4.53 110.567 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.5 m -96.5 150.0 21.11 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.861 -0.736 . . . . 1.0 110.611 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.509 ' C ' HD12 ' A' ' 5' ' ' ILE . 17.2 t -133.77 139.44 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 115.791 -0.641 . . . . 0.92 110.788 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 4' ' ' VAL . 1.2 mp -113.73 126.48 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.127 -1.805 . . . . 1.06 106.127 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 63' ' ' PHE . 22.7 m-85 -108.83 109.3 20.38 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.698 -1.223 . . . . 1.69 107.698 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.574 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . -134.02 -169.31 12.02 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.788 -1.672 . . . . 1.33 112.134 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.0 tmm_? -102.03 64.24 0.94 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.891 -1.522 . . . . 5.83 106.891 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.455 ' OG ' ' NH2' ' A' ' 39' ' ' ARG . 4.5 m 58.31 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.495 -1.229 . . . . 5.38 111.152 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -123.1 84.27 0.37 Allowed Glycine 0 N--CA 1.499 2.88 0 N-CA-C 110.53 -1.028 . . . . 2.98 110.53 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' TYR . 41.3 t -128.93 109.98 18.44 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.455 -0.572 . . . . 4.92 109.455 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -40.55 -27.57 0.28 Allowed 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 124.534 3.489 . . . . 3.93 115.817 -153.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' CYS . 98.9 m-85 -72.5 -37.4 68.4 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.241 -0.984 . . . . 4.4 110.701 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.574 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 2.2 m -61.01 -39.91 91.53 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 106.401 -1.703 . . . . 2.0 106.401 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.69 -38.46 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.287 -0.965 . . . . 1.29 109.078 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.536 HH12 ' CG ' ' A' ' 19' ' ' ASP . 9.6 mmm180 -76.81 -51.01 12.13 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.683 -0.689 . . . . 4.07 110.978 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.419 ' HB1' HG13 ' A' ' 5' ' ' ILE . . . -52.32 -42.78 64.11 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.738 -1.579 . . . . 0.83 106.738 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -58.32 -57.87 11.01 Favored 'General case' 0 C--O 1.203 -1.384 0 CA-C-N 113.66 -1.609 . . . . 1.75 107.731 178.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.536 ' CG ' HH12 ' A' ' 16' ' ' ARG . 2.2 t70 -51.56 -57.27 9.58 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.428 -1.309 . . . . 3.13 109.986 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 79' ' ' VAL . 37.1 tp -47.16 -50.71 19.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.131 -0.692 . . . . 1.11 109.131 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 33' ' ' TYR . . . -60.1 -45.43 92.99 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.612 -0.835 . . . . 1.06 110.496 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 25' ' ' SER . 18.0 tt0 -65.04 -49.8 68.72 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.464 0.65 . . . . 2.31 110.767 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -56.95 -51.85 67.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.063 -1.458 . . . . 4.19 107.063 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.4 mt -52.02 -51.35 57.97 Favored 'General case' 0 C--O 1.199 -1.566 0 N-CA-C 106.441 -1.689 . . . . 1.18 106.441 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 4.6 t -43.32 -24.53 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 115.57 -0.741 . . . . 1.18 112.037 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.07 -39.5 8.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.214 0.321 . . . . 2.16 111.005 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.54 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 28.2 mt-10 -72.96 -26.74 61.47 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.327 0.584 . . . . 3.31 110.657 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HE ' ' C ' ' A' ' 85' ' ' ALA . 2.1 mmp_? -101.44 175.05 5.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.352 -0.84 . . . . 4.06 110.888 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -107.74 -41.09 5.1 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 115.225 -0.898 . . . . 5.56 110.511 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 30' ' ' ASP . 8.3 t70 -109.63 53.46 0.69 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 122.438 1.113 . . . . 4.99 109.283 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 25' ' ' SER . 8.1 t80 -131.71 110.42 10.87 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.256 -0.978 . . . . 1.08 110.055 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -124.27 152.37 43.1 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.988 -1.856 . . . . 3.37 105.988 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.53 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 7.1 p90 -140.46 154.57 46.68 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 117.884 -1.527 . . . . 1.16 111.153 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.51 154.72 47.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.692 -1.225 . . . . 4.04 107.692 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.61 139.73 49.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.926 -1.509 . . . . 1.34 106.926 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.32 139.03 51.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 124.24 0.963 . . . . 2.12 109.955 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -105.95 116.68 32.35 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.694 -1.595 . . . . 2.53 106.694 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.8 pt -54.88 -20.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 118.788 -1.165 . . . . 1.17 111.299 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.455 ' NH2' ' OG ' ' A' ' 9' ' ' SER . 40.6 ttp-105 -86.13 -61.44 1.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.561 -0.855 . . . . 6.86 109.285 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -35.18 -43.48 0.22 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.093 0.871 . . . . 1.45 111.514 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -94.0 -44.75 7.9 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.582 -0.847 . . . . 3.11 112.04 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.51 54.31 0.65 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.212 -1.555 . . . . 1.98 109.212 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.91 127.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 107.497 -1.297 . . . . 2.24 107.497 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 p -119.85 166.22 13.57 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.197 -1.001 . . . . 3.17 110.697 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.617 ' CD ' ' H ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -41.69 -45.9 3.59 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.379 -0.828 . . . . 5.29 110.885 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 19.9 mp0 -60.51 -55.24 35.76 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.071 -0.651 . . . . 4.19 110.239 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' CG ' ' HZ1' ' A' ' 51' ' ' LYS . 25.0 t70 -60.32 -39.86 88.53 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.598 -0.841 . . . . 2.92 110.689 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.08 -48.73 78.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.124 -0.944 . . . . 1.61 109.128 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.76 -59.96 2.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.205 -0.907 . . . . 4.67 108.709 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -46.64 -40.84 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 125.029 1.456 . . . . 4.17 112.341 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 25.1 mtmm -94.46 -4.24 48.57 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.578 -1.192 . . . . 2.91 114.101 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.635 ' CB ' HE22 ' A' ' 61' ' ' GLN . . . -113.49 -38.37 4.37 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.799 -0.76 . . . . 1.1 112.724 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.46 43.98 66.69 Favored Glycine 0 N--CA 1.491 2.365 0 O-C-N 124.395 1.059 . . . . 3.36 113.151 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HD2' ' CE1' ' A' ' 68' ' ' HIS . 59.5 mttm -138.53 180.0 1.18 Allowed Pre-proline 0 N--CA 1.504 2.256 0 C-N-CA 119.296 -0.962 . . . . 7.55 110.345 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -33.46 82.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.111 2.54 . . . . 5.74 112.37 127.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 57' ' ' GLU . 27.6 m -101.66 -42.99 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 115.791 -0.64 . . . . 5.41 112.34 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.462 ' N ' HG23 ' A' ' 56' ' ' VAL . 2.4 tt0 61.37 -108.39 0.32 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.651 -0.87 . . . . 7.05 108.651 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 59' ' ' VAL . 53.5 p -129.92 -86.51 0.53 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.623 -1.231 . . . . 4.3 111.143 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.41 ' N ' ' OG1' ' A' ' 58' ' ' THR . 14.2 m -137.98 164.66 39.23 Favored Pre-proline 0 C--N 1.291 -1.966 0 N-CA-C 109.771 -0.455 . . . . 1.77 109.771 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -94.36 148.08 10.18 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 124.594 -1.002 . . . . 1.62 110.314 -9.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.635 HE22 ' CB ' ' A' ' 52' ' ' ALA . 33.4 mt-30 -111.23 142.78 42.98 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.984 -1.086 . . . . 2.55 108.282 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.1 mp -113.44 142.31 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.987 0.898 . . . . 1.64 110.02 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 6' ' ' PHE . 20.0 m-85 -121.21 136.3 55.0 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.354 -2.091 . . . . 1.36 105.354 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.618 HG11 ' CH2' ' A' ' 78' ' ' TRP . 5.8 t -115.05 106.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.817 -0.753 . . . . 1.33 109.114 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 66.91 -72.6 0.08 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.581 -0.736 . . . . 2.49 111.982 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -136.74 -11.02 1.81 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 113.704 1.002 . . . . 3.88 113.704 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -117.01 161.6 19.13 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.749 -1.18 . . . . 5.96 114.003 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.542 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.0 t-160 -90.06 133.67 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.725 -1.213 . . . . 1.01 107.725 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.53 -39.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.541 -0.863 . . . . 0.87 110.235 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.82 -142.27 13.69 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.177 -1.569 . . . . 1.17 109.177 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.85 173.65 41.8 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.389 -1.484 . . . . 1.22 109.389 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 23.7 t80 -42.87 -45.99 5.13 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.301 -0.96 . . . . 1.8 111.209 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.4 -58.12 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.797 0.808 . . . . 1.8 110.054 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.2 -39.84 80.01 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.148 -1.387 . . . . 2.07 109.581 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.66 -56.83 17.16 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.897 -1.121 . . . . 1.28 109.384 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.26 -56.01 19.99 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.83 -0.748 . . . . 0.92 110.284 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.59 -54.5 43.34 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.432 -0.907 . . . . 1.04 109.43 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.618 ' CH2' HG11 ' A' ' 64' ' ' VAL . 89.3 t90 -46.74 -55.5 7.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.836 -0.746 . . . . 1.17 110.457 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.429 HG21 HD21 ' A' ' 20' ' ' LEU . 53.5 t -47.94 -55.5 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.847 -1.07 . . . . 0.8 111.218 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.72 -46.86 7.73 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.615 0.968 . . . . 2.03 113.615 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -103.96 34.42 3.03 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 118.956 -1.097 . . . . 4.4 112.512 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -141.05 -49.03 0.42 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.929 -0.767 . . . . 1.51 108.929 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 85' ' ' ALA . 29.8 mt -112.71 46.15 1.24 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.964 -1.017 . . . . 2.07 109.434 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -83.4 50.06 1.69 Allowed 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.092 -1.448 . . . . 3.7 107.092 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.468 ' C ' ' HE ' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 115.996 -1.954 . . . . 5.15 107.34 -179.154 . . . . . . . . 1 1 . 1 stop_ save_